<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>japan</title>
		<link>https://biospectrumasia.com/rssfeed/country/japan</link>
		<atom:link href="https://biospectrumasia.com/rssfeed/country/japan" rel="self" type="application/rss+xml" />
		<description>japan</description>
					<item>
			<title>Takeda and Zuellig Pharma partner to expand medicine access across Southeast Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/28706/takeda-and-zuellig-pharma-partner-to-expand-medicine-access-across-southeast-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28706/takeda-and-zuellig-pharma-partner-to-expand-medicine-access-across-southeast-asia.html</link>
			<pubDate>Thu, 19 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-28706.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28706/takeda-and-zuellig-pharma-partner-to-expand-medicine-access-across-southeast-asia.html</guid>
		</item>	
				<item>
			<title>Myriad Genetics expands SRL partnership in Japan to support future growth</title>
			<atom:link href="https://biospectrumasia.com/news/50/28695/myriad-genetics-expands-srl-partnership-in-japan-to-support-future-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28695/myriad-genetics-expands-srl-partnership-in-japan-to-support-future-growth.html</link>
			<pubDate>Wed, 18 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-28695.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28695/myriad-genetics-expands-srl-partnership-in-japan-to-support-future-growth.html</guid>
		</item>	
				<item>
			<title>Kyorin inks $140 Million deal for Japan rights to Edesa’s respiratory drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/28696/kyorin-inks-140-million-deal-for-japan-rights-to-edesas-respiratory-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28696/kyorin-inks-140-million-deal-for-japan-rights-to-edesas-respiratory-drug.html</link>
			<pubDate>Tue, 17 Nov 2026 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28696/kyorin-inks-140-million-deal-for-japan-rights-to-edesas-respiratory-drug.html</guid>
		</item>	
				<item>
			<title>Acadia Pharma to commercialise DAYBUE® STIX (trofinetide) in Japan for treatment of Rett syndrome</title>
			<atom:link href="https://biospectrumasia.com/news/50/28692/acadia-pharma-to-commercialise-daybue-stix-trofinetide-in-japan-for-treatment-of-rett-syndrome.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28692/acadia-pharma-to-commercialise-daybue-stix-trofinetide-in-japan-for-treatment-of-rett-syndrome.html</link>
			<pubDate>Tue, 17 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_17_11_2026_121837_mms_businesswire_com-28692.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28692/acadia-pharma-to-commercialise-daybue-stix-trofinetide-in-japan-for-treatment-of-rett-syndrome.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi brings treatment for Gram-Negative Bacterial Infections in Singapore and Malaysia</title>
			<atom:link href="https://biospectrumasia.com/news/50/28682/japans-shionogi-brings-treatment-for-gram-negative-bacterial-infections-in-singapore-and-malaysia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28682/japans-shionogi-brings-treatment-for-gram-negative-bacterial-infections-in-singapore-and-malaysia.html</link>
			<pubDate>Mon, 16 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_11_2026_132923_d1q8ayifrecoel_cloudfront_net-28682.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28682/japans-shionogi-brings-treatment-for-gram-negative-bacterial-infections-in-singapore-and-malaysia.html</guid>
		</item>	
				<item>
			<title>Leqembi® Pen subcutaneous treatment for early Alzheimer&#039;s disease launches in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/28673/leqembi-pen-subcutaneous-treatment-for-early-alzheimers-disease-launches-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28673/leqembi-pen-subcutaneous-treatment-for-early-alzheimers-disease-launches-in-japan.html</link>
			<pubDate>Fri, 13 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_13_11_2026_161722_www_drugs_com-28673.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28673/leqembi-pen-subcutaneous-treatment-for-early-alzheimers-disease-launches-in-japan.html</guid>
		</item>	
				<item>
			<title>C2N Diagnostics and LSI Medience bring PrecivityAD2® Alzheimer’s Disease blood test to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/28664/c2n-diagnostics-and-lsi-medience-bring-precivityad2-alzheimers-disease-blood-test-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28664/c2n-diagnostics-and-lsi-medience-bring-precivityad2-alzheimers-disease-blood-test-to-japan.html</link>
			<pubDate>Thu, 12 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_12_11_2026_164039_img_magnific_com-28664.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28664/c2n-diagnostics-and-lsi-medience-bring-precivityad2-alzheimers-disease-blood-test-to-japan.html</guid>
		</item>	
				<item>
			<title>Edesa Biotech partners with Kyorin Pharma to develop and commercialise Paridiprubart in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/28659/edesa-biotech-partners-with-kyorin-pharma-to-develop-and-commercialise-paridiprubart-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28659/edesa-biotech-partners-with-kyorin-pharma-to-develop-and-commercialise-paridiprubart-in-japan.html</link>
			<pubDate>Tue, 10 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-28659.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28659/edesa-biotech-partners-with-kyorin-pharma-to-develop-and-commercialise-paridiprubart-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nxera Pharma inks agreement worth $1.47 B with AbbVie for IBD drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/28648/japans-nxera-pharma-inks-agreement-worth-1-47-b-with-abbvie-for-ibd-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28648/japans-nxera-pharma-inks-agreement-worth-1-47-b-with-abbvie-for-ibd-drug.html</link>
			<pubDate>Fri, 06 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_6_11_2026_21431_www_nxera_life-28648.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28648/japans-nxera-pharma-inks-agreement-worth-1-47-b-with-abbvie-for-ibd-drug.html</guid>
		</item>	
				<item>
			<title>Minghui Pharma and ASKA Pharma enter into license agreement worth $330 M for IGF-1R Antibody in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/28643/minghui-pharma-and-aska-pharma-enter-into-license-agreement-worth-330-m-for-igf-1r-antibody-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28643/minghui-pharma-and-aska-pharma-enter-into-license-agreement-worth-330-m-for-igf-1r-antibody-in-japan.html</link>
			<pubDate>Thu, 05 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_5_11_2026_83821_s3_eu_north_1_amazonaws_com-28643.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28643/minghui-pharma-and-aska-pharma-enter-into-license-agreement-worth-330-m-for-igf-1r-antibody-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi transfers generic drug business to Zhejiang Gaozhi Pharma in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/28625/japans-shionogi-transfers-generic-drug-business-to-zhejiang-gaozhi-pharma-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28625/japans-shionogi-transfers-generic-drug-business-to-zhejiang-gaozhi-pharma-in-china.html</link>
			<pubDate>Tue, 03 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_3_11_2026_1332_vativorx_com-28625.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28625/japans-shionogi-transfers-generic-drug-business-to-zhejiang-gaozhi-pharma-in-china.html</guid>
		</item>	
				<item>
			<title>CellProthera selected for JETRO’s Japan Entry Acceleration Program</title>
			<atom:link href="https://biospectrumasia.com/news/50/28631/cellprothera-selected-for-jetros-japan-entry-acceleration-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28631/cellprothera-selected-for-jetros-japan-entry-acceleration-program.html</link>
			<pubDate>Tue, 03 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1200x680-28631.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28631/cellprothera-selected-for-jetros-japan-entry-acceleration-program.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT invests $6.8 M in product development for Malaria, NTDs and Ebola</title>
			<atom:link href="https://biospectrumasia.com/news/50/28618/japans-ghit-invests-6-8-m-in-product-development-for-malaria-ntds-and-ebola.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28618/japans-ghit-invests-6-8-m-in-product-development-for-malaria-ntds-and-ebola.html</link>
			<pubDate>Fri, 30 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-28618.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28618/japans-ghit-invests-6-8-m-in-product-development-for-malaria-ntds-and-ebola.html</guid>
		</item>	
				<item>
			<title>PDRadiopharma injects JPY 16.5 B into new manufacturing facility in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/28597/pdradiopharma-injects-jpy-16-5-b-into-new-manufacturing-facility-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28597/pdradiopharma-injects-jpy-16-5-b-into-new-manufacturing-facility-in-japan.html</link>
			<pubDate>Thu, 29 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_29_10_2026_125042_adragos_pharma_com-28597.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28597/pdradiopharma-injects-jpy-16-5-b-into-new-manufacturing-facility-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka BioVentures begins strategic equity investments</title>
			<atom:link href="https://biospectrumasia.com/news/50/28592/japans-otsuka-bioventures-begins-strategic-equity-investments.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28592/japans-otsuka-bioventures-begins-strategic-equity-investments.html</link>
			<pubDate>Wed, 28 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_10_2026_16324_www_otsuka_co_jp-28592.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28592/japans-otsuka-bioventures-begins-strategic-equity-investments.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma inks $400 M deal with AI Proteins to develop novel miniprotein-based therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/28576/japans-astellas-pharma-inks-400-m-deal-with-ai-proteins-to-develop-novel-miniprotein-based-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28576/japans-astellas-pharma-inks-400-m-deal-with-ai-proteins-to-develop-novel-miniprotein-based-therapeutics.html</link>
			<pubDate>Mon, 26 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-28576.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28576/japans-astellas-pharma-inks-400-m-deal-with-ai-proteins-to-develop-novel-miniprotein-based-therapeutics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Govt selects NovAccel&#039;s project to establish Global Actinium-225 Manufacturing Hub</title>
			<atom:link href="https://biospectrumasia.com/news/50/28560/japans-govt-selects-novaccels-project-to-establish-global-actinium-225-manufacturing-hub.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28560/japans-govt-selects-novaccels-project-to-establish-global-actinium-225-manufacturing-hub.html</link>
			<pubDate>Thu, 22 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_22_10_2026_13021_www_bing_com-28560.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28560/japans-govt-selects-novaccels-project-to-establish-global-actinium-225-manufacturing-hub.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Toho Holdings invests in biotech startup AdipoSeeds</title>
			<atom:link href="https://biospectrumasia.com/news/50/28549/japans-toho-holdings-invests-in-biotech-startup-adiposeeds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28549/japans-toho-holdings-invests-in-biotech-startup-adiposeeds.html</link>
			<pubDate>Wed, 21 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_20_10_2026_2231_www_bing_com-28549.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28549/japans-toho-holdings-invests-in-biotech-startup-adiposeeds.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s JCR Pharma receives marketing authorisation in Kuwait for Enzyme Replacement Therapy to treat Hunter Syndrome</title>
			<atom:link href="https://biospectrumasia.com/news/50/28532/japans-jcr-pharma-receives-marketing-authorisation-in-kuwait-for-enzyme-replacement-therapy-to-treat-hunter-syndrome.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28532/japans-jcr-pharma-receives-marketing-authorisation-in-kuwait-for-enzyme-replacement-therapy-to-treat-hunter-syndrome.html</link>
			<pubDate>Thu, 15 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_10_2026_114746_www_jcrpharm_co_jp-28532.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28532/japans-jcr-pharma-receives-marketing-authorisation-in-kuwait-for-enzyme-replacement-therapy-to-treat-hunter-syndrome.html</guid>
		</item>	
				<item>
			<title>ITOCHU Corp signs capital alliance agreement with MOLCURE Inc. for AI-based drug discovery in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/28514/itochu-corp-signs-capital-alliance-agreement-with-molcure-inc-for-ai-based-drug-discovery-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28514/itochu-corp-signs-capital-alliance-agreement-with-molcure-inc-for-ai-based-drug-discovery-in-japan.html</link>
			<pubDate>Wed, 14 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-28514.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28514/itochu-corp-signs-capital-alliance-agreement-with-molcure-inc-for-ai-based-drug-discovery-in-japan.html</guid>
		</item>	
				<item>
			<title>Open for Trials, Open for Deals: Japan Rewrites Its Biotech Playbook</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/28530/open-for-trials-open-for-deals-japan-rewrites-its-biotech-playbook.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/28530/open-for-trials-open-for-deals-japan-rewrites-its-biotech-playbook.html</link>
			<pubDate>Wed, 14 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cb670735_302d_408c_82e4_41f6af342377-28530.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/28530/open-for-trials-open-for-deals-japan-rewrites-its-biotech-playbook.html</guid>
		</item>	
				<item>
			<title>Ono Pharma inks $100 M agreement with Biohaven to develop and commercialise IgG degraders in Japan, South Korea, Taiwan, and ASEAN countries</title>
			<atom:link href="https://biospectrumasia.com/news/50/28510/ono-pharma-inks-100-m-agreement-with-biohaven-to-develop-and-commercialise-igg-degraders-in-japan-south-korea-taiwan-and-asean-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28510/ono-pharma-inks-100-m-agreement-with-biohaven-to-develop-and-commercialise-igg-degraders-in-japan-south-korea-taiwan-and-asean-countries.html</link>
			<pubDate>Mon, 12 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-28510.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28510/ono-pharma-inks-100-m-agreement-with-biohaven-to-develop-and-commercialise-igg-degraders-in-japan-south-korea-taiwan-and-asean-countries.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu initiates validation of mass spec solution for core labs in Australia</title>
			<atom:link href="https://biospectrumasia.com/news/50/28503/japans-shimadzu-initiates-validation-of-mass-spec-solution-for-core-labs-in-australia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28503/japans-shimadzu-initiates-validation-of-mass-spec-solution-for-core-labs-in-australia.html</link>
			<pubDate>Fri, 09 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_10_2026_234136_www_shimadzu_com-28503.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28503/japans-shimadzu-initiates-validation-of-mass-spec-solution-for-core-labs-in-australia.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi continues rare disease expansion with acquisition of IntraBio for $2 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/28492/japans-shionogi-continues-rare-disease-expansion-with-acquisition-of-intrabio-for-2-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28492/japans-shionogi-continues-rare-disease-expansion-with-acquisition-of-intrabio-for-2-b.html</link>
			<pubDate>Thu, 08 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_8_10_2026_12752_intrabio_com-28492.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28492/japans-shionogi-continues-rare-disease-expansion-with-acquisition-of-intrabio-for-2-b.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Third Way: BioJapan Day 2 Maps the Routes Out and the Reasons to Come In</title>
			<atom:link href="https://biospectrumasia.com/news/50/28497/japans-third-way-biojapan-day-2-maps-the-routes-out-and-the-reasons-to-come-in.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28497/japans-third-way-biojapan-day-2-maps-the-routes-out-and-the-reasons-to-come-in.html</link>
			<pubDate>Thu, 08 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/52e9fb6f_c666_4431_9114_4f8ca54d2d97-28497.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28497/japans-third-way-biojapan-day-2-maps-the-routes-out-and-the-reasons-to-come-in.html</guid>
		</item>	
				<item>
			<title>Docquity extends Asian healthcare intelligence to Japan through deepened strategic partnership with exMedio </title>
			<atom:link href="https://biospectrumasia.com/news/50/28479/docquity-extends-asian-healthcare-intelligence-to-japan-through-deepened-strategic-partnership-with-exmedio-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28479/docquity-extends-asian-healthcare-intelligence-to-japan-through-deepened-strategic-partnership-with-exmedio-.html</link>
			<pubDate>Wed, 07 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_7_10_2026_115937_www_bing_com-28479.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28479/docquity-extends-asian-healthcare-intelligence-to-japan-through-deepened-strategic-partnership-with-exmedio-.html</guid>
		</item>	
				<item>
			<title>Beyond Self-Reliance: BioJapan Turns 40 by Asking Japan to Orchestrate</title>
			<atom:link href="https://biospectrumasia.com/news/50/28490/beyond-self-reliance-biojapan-turns-40-by-asking-japan-to-orchestrate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28490/beyond-self-reliance-biojapan-turns-40-by-asking-japan-to-orchestrate.html</link>
			<pubDate>Wed, 07 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-28490.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28490/beyond-self-reliance-biojapan-turns-40-by-asking-japan-to-orchestrate.html</guid>
		</item>	
				<item>
			<title>Japan-Ghana partnership to advance next-generation vaccine R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/50/28480/japan-ghana-partnership-to-advance-next-generation-vaccine-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28480/japan-ghana-partnership-to-advance-next-generation-vaccine-rd.html</link>
			<pubDate>Tue, 06 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_6_10_2026_123936_www_cn_chiba_u_jp-28480.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28480/japan-ghana-partnership-to-advance-next-generation-vaccine-rd.html</guid>
		</item>	
				<item>
			<title>Japanese startup Celaid Therapeutics completes second close of Series B financing round with $2.6 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/28474/japanese-startup-celaid-therapeutics-completes-second-close-of-series-b-financing-round-with-2-6-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28474/japanese-startup-celaid-therapeutics-completes-second-close-of-series-b-financing-round-with-2-6-m.html</link>
			<pubDate>Mon, 05 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_5_10_2026_15260_celaidtx_com-28474.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28474/japanese-startup-celaid-therapeutics-completes-second-close-of-series-b-financing-round-with-2-6-m.html</guid>
		</item>	
				<item>
			<title>Toho, Reprocell partner for domestic distribution of regenerative medical product Stemchymal® in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/28462/toho-reprocell-partner-for-domestic-distribution-of-regenerative-medical-product-stemchymal-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28462/toho-reprocell-partner-for-domestic-distribution-of-regenerative-medical-product-stemchymal-in-japan.html</link>
			<pubDate>Sat, 03 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_3_10_2026_13754_www_bing_com-28462.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28462/toho-reprocell-partner-for-domestic-distribution-of-regenerative-medical-product-stemchymal-in-japan.html</guid>
		</item>	
				<item>
			<title>Chugai and InxMed enter into worldwide license agreement for RAF-MEK Molecular Glue</title>
			<atom:link href="https://biospectrumasia.com/news/50/28460/chugai-and-inxmed-enter-into-worldwide-license-agreement-for-raf-mek-molecular-glue.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28460/chugai-and-inxmed-enter-into-worldwide-license-agreement-for-raf-mek-molecular-glue.html</link>
			<pubDate>Wed, 30 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_9_2026_132326_www_bing_com-28460.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28460/chugai-and-inxmed-enter-into-worldwide-license-agreement-for-raf-mek-molecular-glue.html</guid>
		</item>	
				<item>
			<title>Japan Agency for Medical Research and Development provides ¥2.8 B grant to United Immunity</title>
			<atom:link href="https://biospectrumasia.com/news/50/28442/japan-agency-for-medical-research-and-development-provides-2-8-b-grant-to-united-immunity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28442/japan-agency-for-medical-research-and-development-provides-2-8-b-grant-to-united-immunity.html</link>
			<pubDate>Mon, 28 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_9_2026_113146_unitedimmunity_co_jp-28442.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28442/japan-agency-for-medical-research-and-development-provides-2-8-b-grant-to-united-immunity.html</guid>
		</item>	
				<item>
			<title>Lundbeck wins Japan approval for Vyepti in migraine prevention</title>
			<atom:link href="https://biospectrumasia.com/news/50/28398/lundbeck-wins-japan-approval-for-vyepti-in-migraine-prevention.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28398/lundbeck-wins-japan-approval-for-vyepti-in-migraine-prevention.html</link>
			<pubDate>Mon, 21 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_21_9_2026_124344_www_bing_com-28398.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28398/lundbeck-wins-japan-approval-for-vyepti-in-migraine-prevention.html</guid>
		</item>	
				<item>
			<title>Gujarat Themis Biosyn completes acquisition of Japan-based MicroBiopharm to boost fermentation capabilities</title>
			<atom:link href="https://biospectrumasia.com/news/50/28394/gujarat-themis-biosyn-completes-acquisition-of-japan-based-microbiopharm-to-boost-fermentation-capabilities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28394/gujarat-themis-biosyn-completes-acquisition-of-japan-based-microbiopharm-to-boost-fermentation-capabilities.html</link>
			<pubDate>Fri, 18 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_9_2026_1704_www_microbiopharm_com-28394.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28394/gujarat-themis-biosyn-completes-acquisition-of-japan-based-microbiopharm-to-boost-fermentation-capabilities.html</guid>
		</item>	
				<item>
			<title>Japan approves subcutaneous formulation of LEQEMBI® for treatment of early Alzheimer’s Disease </title>
			<atom:link href="https://biospectrumasia.com/news/50/28386/japan-approves-subcutaneous-formulation-of-leqembi-for-treatment-of-early-alzheimers-disease-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28386/japan-approves-subcutaneous-formulation-of-leqembi-for-treatment-of-early-alzheimers-disease-.html</link>
			<pubDate>Thu, 17 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_17_9_2026_12517_www_bing_com-28386.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28386/japan-approves-subcutaneous-formulation-of-leqembi-for-treatment-of-early-alzheimers-disease-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu merges UK business to strengthen capabilities for MS and XPS instruments</title>
			<atom:link href="https://biospectrumasia.com/news/50/28378/japans-shimadzu-merges-uk-business-to-strengthen-capabilities-for-ms-and-xps-instruments.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28378/japans-shimadzu-merges-uk-business-to-strengthen-capabilities-for-ms-and-xps-instruments.html</link>
			<pubDate>Wed, 16 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_9_2026_135659_www_shimadzu_com-28378.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28378/japans-shimadzu-merges-uk-business-to-strengthen-capabilities-for-ms-and-xps-instruments.html</guid>
		</item>	
				<item>
			<title>Viome partners with Ezaki Glico to bring precision health intelligence to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/28370/viome-partners-with-ezaki-glico-to-bring-precision-health-intelligence-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28370/viome-partners-with-ezaki-glico-to-bring-precision-health-intelligence-to-japan.html</link>
			<pubDate>Tue, 15 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_9_2026_125631_www_viome_com-28370.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28370/viome-partners-with-ezaki-glico-to-bring-precision-health-intelligence-to-japan.html</guid>
		</item>	
				<item>
			<title>New partnership to strengthen CAR-T cell therapy manufacturing capabilities in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/28362/new-partnership-to-strengthen-car-t-cell-therapy-manufacturing-capabilities-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28362/new-partnership-to-strengthen-car-t-cell-therapy-manufacturing-capabilities-in-japan-.html</link>
			<pubDate>Sun, 13 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-28362.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28362/new-partnership-to-strengthen-car-t-cell-therapy-manufacturing-capabilities-in-japan-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nipro Corp establishes Asia Pacific regional headquarters in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/50/28364/japans-nipro-corp-establishes-asia-pacific-regional-headquarters-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28364/japans-nipro-corp-establishes-asia-pacific-regional-headquarters-in-singapore.html</link>
			<pubDate>Fri, 11 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/edb-28364.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28364/japans-nipro-corp-establishes-asia-pacific-regional-headquarters-in-singapore.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Hodogaya Chemical sets up Nucleic Acid CDMO subsidiary</title>
			<atom:link href="https://biospectrumasia.com/news/50/28350/japans-hodogaya-chemical-sets-up-nucleic-acid-cdmo-subsidiary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28350/japans-hodogaya-chemical-sets-up-nucleic-acid-cdmo-subsidiary.html</link>
			<pubDate>Wed, 09 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_9_2026_231330_www_hodogaya_co_jp-28350.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28350/japans-hodogaya-chemical-sets-up-nucleic-acid-cdmo-subsidiary.html</guid>
		</item>	
				<item>
			<title>Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities</title>
			<atom:link href="https://biospectrumasia.com/news/50/28314/weave-bio-announces-collaboration-with-takeda-to-deploy-ai-native-regulatory-automation-across-key-drug-development-activities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28314/weave-bio-announces-collaboration-with-takeda-to-deploy-ai-native-regulatory-automation-across-key-drug-development-activities.html</link>
			<pubDate>Wed, 09 Sep 2026 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28314/weave-bio-announces-collaboration-with-takeda-to-deploy-ai-native-regulatory-automation-across-key-drug-development-activities.html</guid>
		</item>	
				<item>
			<title>Japanese pharma firm Shionogi receives marketing approval in Australia for antibiotic Cefiderocol</title>
			<atom:link href="https://biospectrumasia.com/news/50/28340/japanese-pharma-firm-shionogi-receives-marketing-approval-in-australia-for-antibiotic-cefiderocol.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28340/japanese-pharma-firm-shionogi-receives-marketing-approval-in-australia-for-antibiotic-cefiderocol.html</link>
			<pubDate>Tue, 08 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_8_9_2026_163240_www_bing_com-28340.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28340/japanese-pharma-firm-shionogi-receives-marketing-approval-in-australia-for-antibiotic-cefiderocol.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono Pharma enters into drug discovery partnership with Aitia for neurological diseases treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/28319/japans-ono-pharma-enters-into-drug-discovery-partnership-with-aitia-for-neurological-diseases-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28319/japans-ono-pharma-enters-into-drug-discovery-partnership-with-aitia-for-neurological-diseases-treatment.html</link>
			<pubDate>Fri, 04 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_9_2026_164442_www_bing_com-28319.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28319/japans-ono-pharma-enters-into-drug-discovery-partnership-with-aitia-for-neurological-diseases-treatment.html</guid>
		</item>	
				<item>
			<title>Samsung Bioepis gains marketing approval in Japan for 130mg intravenous infusion of Ustekinumab Biosimilar</title>
			<atom:link href="https://biospectrumasia.com/news/50/28315/samsung-bioepis-gains-marketing-approval-in-japan-for-130mg-intravenous-infusion-of-ustekinumab-biosimilar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28315/samsung-bioepis-gains-marketing-approval-in-japan-for-130mg-intravenous-infusion-of-ustekinumab-biosimilar.html</link>
			<pubDate>Thu, 03 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_3_9_2026_143135_www_bing_com-28315.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28315/samsung-bioepis-gains-marketing-approval-in-japan-for-130mg-intravenous-infusion-of-ustekinumab-biosimilar.html</guid>
		</item>	
				<item>
			<title>Astellas enters voluntary agreement with U.S. government supporting affordable access to medicines</title>
			<atom:link href="https://biospectrumasia.com/news/50/28300/astellas-enters-voluntary-agreement-with-u-s-government-supporting-affordable-access-to-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28300/astellas-enters-voluntary-agreement-with-u-s-government-supporting-affordable-access-to-medicines.html</link>
			<pubDate>Tue, 01 Sep 2026 05:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28300/astellas-enters-voluntary-agreement-with-u-s-government-supporting-affordable-access-to-medicines.html</guid>
		</item>	
				<item>
			<title>Longevity Life Sciences partners Mitsubishi Gas Chemical to expand cellular health platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/28279/longevity-life-sciences-partners-mitsubishi-gas-chemical-to-expand-cellular-health-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28279/longevity-life-sciences-partners-mitsubishi-gas-chemical-to-expand-cellular-health-platform.html</link>
			<pubDate>Fri, 28 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lls_mgc_partnership-28279.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28279/longevity-life-sciences-partners-mitsubishi-gas-chemical-to-expand-cellular-health-platform.html</guid>
		</item>	
				<item>
			<title>PENTAX Medical and MAGENTIQ EYE expand global partnership to advance AI-assisted colonoscopy</title>
			<atom:link href="https://biospectrumasia.com/news/50/28265/pentax-medical-and-magentiq-eye-expand-global-partnership-to-advance-ai-assisted-colonoscopy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28265/pentax-medical-and-magentiq-eye-expand-global-partnership-to-advance-ai-assisted-colonoscopy.html</link>
			<pubDate>Thu, 27 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_27_8_2026_113712_magentiq_com-28265.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28265/pentax-medical-and-magentiq-eye-expand-global-partnership-to-advance-ai-assisted-colonoscopy.html</guid>
		</item>	
				<item>
			<title>Shimadzu invests in OptQC to advance next-generation R&amp;D infrastructure for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/28263/shimadzu-invests-in-optqc-to-advance-next-generation-rd-infrastructure-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28263/shimadzu-invests-in-optqc-to-advance-next-generation-rd-infrastructure-for-drug-discovery.html</link>
			<pubDate>Wed, 26 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_26_8_2026_13322_www_optqc_com-28263.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28263/shimadzu-invests-in-optqc-to-advance-next-generation-rd-infrastructure-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s SkyDrive inks medical logistics partnership with Air India and Suzuki</title>
			<atom:link href="https://biospectrumasia.com/news/50/28252/japans-skydrive-inks-medical-logistics-partnership-with-air-india-and-suzuki.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28252/japans-skydrive-inks-medical-logistics-partnership-with-air-india-and-suzuki.html</link>
			<pubDate>Tue, 25 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_25_8_2026_1363_www_businesswire_com-28252.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28252/japans-skydrive-inks-medical-logistics-partnership-with-air-india-and-suzuki.html</guid>
		</item>	
				<item>
			<title>ABio on developing LANFA as a next-generation alternative to PEG in drug delivery</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/28255/abio-on-developing-lanfa-as-a-next-generation-alternative-to-peg-in-drug-delivery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/28255/abio-on-developing-lanfa-as-a-next-generation-alternative-to-peg-in-drug-delivery.html</link>
			<pubDate>Tue, 25 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/koichi_yoshimi_abio_interview-28255.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/28255/abio-on-developing-lanfa-as-a-next-generation-alternative-to-peg-in-drug-delivery.html</guid>
		</item>	
				<item>
			<title>Global CRO Novotech strengthens presence in Japan with new Tokyo office</title>
			<atom:link href="https://biospectrumasia.com/news/50/28245/global-cro-novotech-strengthens-presence-in-japan-with-new-tokyo-office.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28245/global-cro-novotech-strengthens-presence-in-japan-with-new-tokyo-office.html</link>
			<pubDate>Mon, 24 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_24_8_2026_164851_www_bing_com-28245.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28245/global-cro-novotech-strengthens-presence-in-japan-with-new-tokyo-office.html</guid>
		</item>	
				<item>
			<title>US-Japan collaboration for liquid biopsy screening in lung cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/28233/us-japan-collaboration-for-liquid-biopsy-screening-in-lung-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28233/us-japan-collaboration-for-liquid-biopsy-screening-in-lung-cancer.html</link>
			<pubDate>Fri, 21 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_21_8_2026_165318_www_pillarbiosci_com-28233.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28233/us-japan-collaboration-for-liquid-biopsy-screening-in-lung-cancer.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Chugai Pharma signs exclusive license agreement with GSK for anti-dengue virus antibody AID351</title>
			<atom:link href="https://biospectrumasia.com/news/50/28226/japans-chugai-pharma-signs-exclusive-license-agreement-with-gsk-for-anti-dengue-virus-antibody-aid351.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28226/japans-chugai-pharma-signs-exclusive-license-agreement-with-gsk-for-anti-dengue-virus-antibody-aid351.html</link>
			<pubDate>Thu, 20 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_20_8_2026_95932_www_bing_com-28226.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28226/japans-chugai-pharma-signs-exclusive-license-agreement-with-gsk-for-anti-dengue-virus-antibody-aid351.html</guid>
		</item>	
				<item>
			<title>LEO Pharma buys Tanabe’s rare disease drug dersimelagon for $435 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/28218/leo-pharma-buys-tanabes-rare-disease-drug-dersimelagon-for-435-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28218/leo-pharma-buys-tanabes-rare-disease-drug-dersimelagon-for-435-m.html</link>
			<pubDate>Tue, 18 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_8_2026_194435_www_bing_com-28218.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28218/leo-pharma-buys-tanabes-rare-disease-drug-dersimelagon-for-435-m.html</guid>
		</item>	
				<item>
			<title>Adneuris Therapeutics inks $35 M deal with Maruishi Pharma to advance Cebranopadol in Japan and South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/28197/adneuris-therapeutics-inks-35-m-deal-with-maruishi-pharma-to-advance-cebranopadol-in-japan-and-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28197/adneuris-therapeutics-inks-35-m-deal-with-maruishi-pharma-to-advance-cebranopadol-in-japan-and-south-korea.html</link>
			<pubDate>Mon, 17 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-28197.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28197/adneuris-therapeutics-inks-35-m-deal-with-maruishi-pharma-to-advance-cebranopadol-in-japan-and-south-korea.html</guid>
		</item>	
				<item>
			<title>German tech firm adesso and Hitachi Digital Services announce global partnership</title>
			<atom:link href="https://biospectrumasia.com/news/50/28189/german-tech-firm-adesso-and-hitachi-digital-services-announce-global-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28189/german-tech-firm-adesso-and-hitachi-digital-services-announce-global-partnership.html</link>
			<pubDate>Fri, 14 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/group_picture-28189.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28189/german-tech-firm-adesso-and-hitachi-digital-services-announce-global-partnership.html</guid>
		</item>	
				<item>
			<title>Chugai and UCSF establish master collaboration agreement for drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/50/28178/chugai-and-ucsf-establish-master-collaboration-agreement-for-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28178/chugai-and-ucsf-establish-master-collaboration-agreement-for-drug-discovery-research.html</link>
			<pubDate>Tue, 11 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-28178.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28178/chugai-and-ucsf-establish-master-collaboration-agreement-for-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujifilm and Taiho Pharma join hands to develop next-generation ADC manufacturing technologies</title>
			<atom:link href="https://biospectrumasia.com/news/50/28149/japans-fujifilm-and-taiho-pharma-join-hands-to-develop-next-generation-adc-manufacturing-technologies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28149/japans-fujifilm-and-taiho-pharma-join-hands-to-develop-next-generation-adc-manufacturing-technologies.html</link>
			<pubDate>Wed, 05 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_5_8_2026_121020_www_bing_com-28149.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28149/japans-fujifilm-and-taiho-pharma-join-hands-to-develop-next-generation-adc-manufacturing-technologies.html</guid>
		</item>	
				<item>
			<title>Zuellig Pharma’s John Graham on strengthening medicine authenticity across Asia</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/28153/zuellig-pharmas-john-graham-on-strengthening-medicine-authenticity-across-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/28153/zuellig-pharmas-john-graham-on-strengthening-medicine-authenticity-across-asia.html</link>
			<pubDate>Wed, 05 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/john_graham_biospectrum_asia_interview-28153.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/28153/zuellig-pharmas-john-graham-on-strengthening-medicine-authenticity-across-asia.html</guid>
		</item>	
				<item>
			<title>Monash University, Fujitsu and CSIRO unite to advance Australia&#039;s quantum research capability</title>
			<atom:link href="https://biospectrumasia.com/news/50/28143/monash-university-fujitsu-and-csiro-unite-to-advance-australias-quantum-research-capability.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28143/monash-university-fujitsu-and-csiro-unite-to-advance-australias-quantum-research-capability.html</link>
			<pubDate>Tue, 04 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_8_2026_121722_www_monash_edu-28143.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28143/monash-university-fujitsu-and-csiro-unite-to-advance-australias-quantum-research-capability.html</guid>
		</item>	
				<item>
			<title>Otsuka’s SIMTRIYO Wins World-First FDA Approval for ADHD</title>
			<atom:link href="https://biospectrumasia.com/news/50/28142/otsukas-simtriyo-wins-world-first-fda-approval-for-adhd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28142/otsukas-simtriyo-wins-world-first-fda-approval-for-adhd.html</link>
			<pubDate>Mon, 03 Aug 2026 08:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28142/otsukas-simtriyo-wins-world-first-fda-approval-for-adhd.html</guid>
		</item>	
				<item>
			<title>Ember LifeSciences and Alfresa Corp to improve quality of pharmaceutical cold chain in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/28126/ember-lifesciences-and-alfresa-corp-to-improve-quality-of-pharmaceutical-cold-chain-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28126/ember-lifesciences-and-alfresa-corp-to-improve-quality-of-pharmaceutical-cold-chain-in-japan.html</link>
			<pubDate>Sat, 01 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_1_8_2026_2146_www_emberlifesciences_com-28126.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28126/ember-lifesciences-and-alfresa-corp-to-improve-quality-of-pharmaceutical-cold-chain-in-japan.html</guid>
		</item>	
				<item>
			<title>“Japan needs a deeper base of specialist healthcare investors”</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/28134/japan-needs-a-deeper-base-of-specialist-healthcare-investors.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/28134/japan-needs-a-deeper-base-of-specialist-healthcare-investors.html</link>
			<pubDate>Sat, 01 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_1_8_2026_15221_www_jetro_go_jp-28134.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/28134/japan-needs-a-deeper-base-of-specialist-healthcare-investors.html</guid>
		</item>	
				<item>
			<title>Ono Pharmaceutical partners with Phylo to embed agentic AI with every discovery scientist</title>
			<atom:link href="https://biospectrumasia.com/news/50/28123/ono-pharmaceutical-partners-with-phylo-to-embed-agentic-ai-with-every-discovery-scientist.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28123/ono-pharmaceutical-partners-with-phylo-to-embed-agentic-ai-with-every-discovery-scientist.html</link>
			<pubDate>Thu, 30 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_7_2026_1509_www_bing_com-28123.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28123/ono-pharmaceutical-partners-with-phylo-to-embed-agentic-ai-with-every-discovery-scientist.html</guid>
		</item>	
				<item>
			<title>Nippon Kayaku and Celltrion Healthcare Japan join hands for stable supply of biopharmaceuticals</title>
			<atom:link href="https://biospectrumasia.com/news/50/28115/nippon-kayaku-and-celltrion-healthcare-japan-join-hands-for-stable-supply-of-biopharmaceuticals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28115/nippon-kayaku-and-celltrion-healthcare-japan-join-hands-for-stable-supply-of-biopharmaceuticals.html</link>
			<pubDate>Wed, 29 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-28115.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28115/nippon-kayaku-and-celltrion-healthcare-japan-join-hands-for-stable-supply-of-biopharmaceuticals.html</guid>
		</item>	
				<item>
			<title>Boston Scientific highlights pulsed field ablation’s growing role in APAC atrial fibrillation care</title>
			<atom:link href="https://biospectrumasia.com/news/50/28114/boston-scientific-highlights-pulsed-field-ablations-growing-role-in-apac-atrial-fibrillation-care.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28114/boston-scientific-highlights-pulsed-field-ablations-growing-role-in-apac-atrial-fibrillation-care.html</link>
			<pubDate>Tue, 28 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot2026_07_28at1_21_29a-28114.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28114/boston-scientific-highlights-pulsed-field-ablations-growing-role-in-apac-atrial-fibrillation-care.html</guid>
		</item>	
				<item>
			<title>Shimadzu releases GCMS-TQ RX Series Gas Chromatograph-Mass Spectrometer</title>
			<atom:link href="https://biospectrumasia.com/news/50/28105/shimadzu-releases-gcms-tq-rx-series-gas-chromatograph-mass-spectrometer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28105/shimadzu-releases-gcms-tq-rx-series-gas-chromatograph-mass-spectrometer.html</link>
			<pubDate>Mon, 27 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_27_7_2026_131442_www_shimadzu_com-28105.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28105/shimadzu-releases-gcms-tq-rx-series-gas-chromatograph-mass-spectrometer.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT Fund injects approx. JPY 140 M in portable rapid diagnostic system for Ebola Disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/28098/japans-ghit-fund-injects-approx-jpy-140-m-in-portable-rapid-diagnostic-system-for-ebola-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28098/japans-ghit-fund-injects-approx-jpy-140-m-in-portable-rapid-diagnostic-system-for-ebola-disease.html</link>
			<pubDate>Fri, 24 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-28098.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28098/japans-ghit-fund-injects-approx-jpy-140-m-in-portable-rapid-diagnostic-system-for-ebola-disease.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kyoto University partners with BostonGene to advance biomarker discovery for combination immunotherapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/28085/japans-kyoto-university-partners-with-bostongene-to-advance-biomarker-discovery-for-combination-immunotherapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28085/japans-kyoto-university-partners-with-bostongene-to-advance-biomarker-discovery-for-combination-immunotherapy.html</link>
			<pubDate>Thu, 23 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_23_7_2026_12342_www_bing_com-28085.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28085/japans-kyoto-university-partners-with-bostongene-to-advance-biomarker-discovery-for-combination-immunotherapy.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s JCR Pharma receives marketing authorisation in UAE for IZCARGO to treat Hunter Syndrome</title>
			<atom:link href="https://biospectrumasia.com/news/50/28073/japans-jcr-pharma-receives-marketing-authorisation-in-uae-for-izcargo-to-treat-hunter-syndrome.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28073/japans-jcr-pharma-receives-marketing-authorisation-in-uae-for-izcargo-to-treat-hunter-syndrome.html</link>
			<pubDate>Wed, 22 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_22_7_2026_125017_www_bing_com-28073.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28073/japans-jcr-pharma-receives-marketing-authorisation-in-uae-for-izcargo-to-treat-hunter-syndrome.html</guid>
		</item>	
				<item>
			<title>Japanese startup Rege Nephro secures $10.6 M to expand kidney disease pipeline</title>
			<atom:link href="https://biospectrumasia.com/news/50/28068/japanese-startup-rege-nephro-secures-10-6-m-to-expand-kidney-disease-pipeline.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28068/japanese-startup-rege-nephro-secures-10-6-m-to-expand-kidney-disease-pipeline.html</link>
			<pubDate>Tue, 21 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-28068.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28068/japanese-startup-rege-nephro-secures-10-6-m-to-expand-kidney-disease-pipeline.html</guid>
		</item>	
				<item>
			<title>Galderma launches Alastin® in Japan and key markets across Asia Pacific</title>
			<atom:link href="https://biospectrumasia.com/news/50/28059/galderma-launches-alastin-in-japan-and-key-markets-across-asia-pacific.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28059/galderma-launches-alastin-in-japan-and-key-markets-across-asia-pacific.html</link>
			<pubDate>Mon, 20 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_20_7_2026_122833_www_galderma_com-28059.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28059/galderma-launches-alastin-in-japan-and-key-markets-across-asia-pacific.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s DNP to acquire Kyowa Pharma Chemical in CDMO expansion</title>
			<atom:link href="https://biospectrumasia.com/company-results/50/28043/japans-dnp-to-acquire-kyowa-pharma-chemical-in-cdmo-expansion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/50/28043/japans-dnp-to-acquire-kyowa-pharma-chemical-in-cdmo-expansion.html</link>
			<pubDate>Fri, 17 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_17_7_2026_132934_www_kyowa_pharma_co_jp-28043.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/50/28043/japans-dnp-to-acquire-kyowa-pharma-chemical-in-cdmo-expansion.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT injects $18 M in Malaria, Tuberculosis and NTD R&amp;D projects</title>
			<atom:link href="https://biospectrumasia.com/news/50/28023/japans-ghit-injects-18-m-in-malaria-tuberculosis-and-ntd-rd-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28023/japans-ghit-injects-18-m-in-malaria-tuberculosis-and-ntd-rd-projects.html</link>
			<pubDate>Thu, 16 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_7_2026_123324_-28023.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28023/japans-ghit-injects-18-m-in-malaria-tuberculosis-and-ntd-rd-projects.html</guid>
		</item>	
				<item>
			<title>Boostimmune secures Japanese patent for sequence-independent TCTP antibody technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/28012/boostimmune-secures-japanese-patent-for-sequence-independent-tctp-antibody-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28012/boostimmune-secures-japanese-patent-for-sequence-independent-tctp-antibody-technology.html</link>
			<pubDate>Tue, 14 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_14_7_2026_103636_www_boostimmune_com-28012.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28012/boostimmune-secures-japanese-patent-for-sequence-independent-tctp-antibody-technology.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu buys Tescan as wholly owned subsidiary for $711 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/28011/japans-shimadzu-buys-tescan-as-wholly-owned-subsidiary-for-711-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/28011/japans-shimadzu-buys-tescan-as-wholly-owned-subsidiary-for-711-m.html</link>
			<pubDate>Mon, 13 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_13_7_2026_151727_tescan_com-28011.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/28011/japans-shimadzu-buys-tescan-as-wholly-owned-subsidiary-for-711-m.html</guid>
		</item>	
				<item>
			<title>Godavari Biorefineries secures Japanese patent for advanced stem-cell targeted anti-cancer molecule</title>
			<atom:link href="https://biospectrumasia.com/news/50/27995/godavari-biorefineries-secures-japanese-patent-for-advanced-stem-cell-targeted-anti-cancer-molecule.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27995/godavari-biorefineries-secures-japanese-patent-for-advanced-stem-cell-targeted-anti-cancer-molecule.html</link>
			<pubDate>Thu, 09 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_7_2026_163256_-27995.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27995/godavari-biorefineries-secures-japanese-patent-for-advanced-stem-cell-targeted-anti-cancer-molecule.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Tanabe sells Pharma Factory to Towa Pharmaceutical</title>
			<atom:link href="https://biospectrumasia.com/news/50/27976/japans-tanabe-sells-pharma-factory-to-towa-pharmaceutical.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27976/japans-tanabe-sells-pharma-factory-to-towa-pharmaceutical.html</link>
			<pubDate>Wed, 08 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_8_7_2026_172433_www_tanabe_pharma_com-27976.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27976/japans-tanabe-sells-pharma-factory-to-towa-pharmaceutical.html</guid>
		</item>	
				<item>
			<title>UCL and Eisai renew partnership to accelerate treatments for neurodegenerative diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/27964/ucl-and-eisai-renew-partnership-to-accelerate-treatments-for-neurodegenerative-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27964/ucl-and-eisai-renew-partnership-to-accelerate-treatments-for-neurodegenerative-diseases.html</link>
			<pubDate>Mon, 06 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_6_7_2026_124156_-27964.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27964/ucl-and-eisai-renew-partnership-to-accelerate-treatments-for-neurodegenerative-diseases.html</guid>
		</item>	
				<item>
			<title>REPROCELL seeks Japan approval for stem cell therapy in spinocerebellar ataxia</title>
			<atom:link href="https://biospectrumasia.com/news/50/27972/reprocell-seeks-japan-approval-for-stem-cell-therapy-in-spinocerebellar-ataxia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27972/reprocell-seeks-japan-approval-for-stem-cell-therapy-in-spinocerebellar-ataxia.html</link>
			<pubDate>Mon, 06 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/reprocell_logo_800_640_tile-27972.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27972/reprocell-seeks-japan-approval-for-stem-cell-therapy-in-spinocerebellar-ataxia.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine inks deal worth $600 M with Takeda to advance strategic AI drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/27957/insilico-medicine-inks-deal-worth-600-m-with-takeda-to-advance-strategic-ai-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27957/insilico-medicine-inks-deal-worth-600-m-with-takeda-to-advance-strategic-ai-drug-discovery.html</link>
			<pubDate>Fri, 03 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/32-27957.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27957/insilico-medicine-inks-deal-worth-600-m-with-takeda-to-advance-strategic-ai-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nippon Shinyaku partners with Elixirgen to develop drug for Duchenne Muscular Dystrophy treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/27926/japans-nippon-shinyaku-partners-with-elixirgen-to-develop-drug-for-duchenne-muscular-dystrophy-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27926/japans-nippon-shinyaku-partners-with-elixirgen-to-develop-drug-for-duchenne-muscular-dystrophy-treatment.html</link>
			<pubDate>Mon, 29 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_29_6_2026_13313_-27926.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27926/japans-nippon-shinyaku-partners-with-elixirgen-to-develop-drug-for-duchenne-muscular-dystrophy-treatment.html</guid>
		</item>	
				<item>
			<title>First PMDA-approved molecular residual disease (MRD) test enters Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27898/first-pmda-approved-molecular-residual-disease-mrd-test-enters-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27898/first-pmda-approved-molecular-residual-disease-mrd-test-enters-japan.html</link>
			<pubDate>Wed, 24 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_24_6_2026_192717_www_natera_com-27898.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27898/first-pmda-approved-molecular-residual-disease-mrd-test-enters-japan.html</guid>
		</item>	
				<item>
			<title>Shimadzu Corporation releases PPSQ-51A/53A SPD-40 model protein sequencers</title>
			<atom:link href="https://biospectrumasia.com/news/50/27847/shimadzu-corporation-releases-ppsq-51a-53a-spd-40-model-protein-sequencers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27847/shimadzu-corporation-releases-ppsq-51a-53a-spd-40-model-protein-sequencers.html</link>
			<pubDate>Mon, 22 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_22_6_2026_131039_www_shimadzu_com-27847.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27847/shimadzu-corporation-releases-ppsq-51a-53a-spd-40-model-protein-sequencers.html</guid>
		</item>	
				<item>
			<title>AITRICS signs MoU with Yokohama City University for joint research on Medical AI</title>
			<atom:link href="https://biospectrumasia.com/news/50/27841/aitrics-signs-mou-with-yokohama-city-university-for-joint-research-on-medical-ai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27841/aitrics-signs-mou-with-yokohama-city-university-for-joint-research-on-medical-ai.html</link>
			<pubDate>Fri, 19 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-27841.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27841/aitrics-signs-mou-with-yokohama-city-university-for-joint-research-on-medical-ai.html</guid>
		</item>	
				<item>
			<title>Sonire Secures $13M NEDO Funding for HIFU Pancreatic Cancer Platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/27836/sonire-secures-13m-nedo-funding-for-hifu-pancreatic-cancer-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27836/sonire-secures-13m-nedo-funding-for-hifu-pancreatic-cancer-platform.html</link>
			<pubDate>Thu, 18 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sonire_therapeutics_logo_770x500_1-27836.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27836/sonire-secures-13m-nedo-funding-for-hifu-pancreatic-cancer-platform.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Axcelead DDP joins Eli Lilly TuneLab to advance AI drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/27837/japans-axcelead-ddp-joins-eli-lilly-tunelab-to-advance-ai-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27837/japans-axcelead-ddp-joins-eli-lilly-tunelab-to-advance-ai-drug-discovery.html</link>
			<pubDate>Thu, 18 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_6_2026_115740_axcelead_us_com-27837.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27837/japans-axcelead-ddp-joins-eli-lilly-tunelab-to-advance-ai-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Eisai invests £48 M to build cold-chain capability in UK</title>
			<atom:link href="https://biospectrumasia.com/news/50/27822/japans-eisai-invests-48-m-to-build-cold-chain-capability-in-uk.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27822/japans-eisai-invests-48-m-to-build-cold-chain-capability-in-uk.html</link>
			<pubDate>Wed, 17 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_17_6_2026_113751_www_eisai_eu-27822.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27822/japans-eisai-invests-48-m-to-build-cold-chain-capability-in-uk.html</guid>
		</item>	
				<item>
			<title>Fujifilm and Horiba co-develop high-sensitivity inline Raman measurement system</title>
			<atom:link href="https://biospectrumasia.com/news/50/27831/fujifilm-and-horiba-co-develop-high-sensitivity-inline-raman-measurement-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27831/fujifilm-and-horiba-co-develop-high-sensitivity-inline-raman-measurement-system.html</link>
			<pubDate>Wed, 17 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_17_6_2026_133012_www_horiba_com-27831.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27831/fujifilm-and-horiba-co-develop-high-sensitivity-inline-raman-measurement-system.html</guid>
		</item>	
				<item>
			<title>J&amp;J highlights endoscopic remission as key goal in APAC IBD care</title>
			<atom:link href="https://biospectrumasia.com/news/50/27808/jj-highlights-endoscopic-remission-as-key-goal-in-apac-ibd-care.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27808/jj-highlights-endoscopic-remission-as-key-goal-in-apac-ibd-care.html</link>
			<pubDate>Mon, 15 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/earl_dancel-27808.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27808/jj-highlights-endoscopic-remission-as-key-goal-in-apac-ibd-care.html</guid>
		</item>	
				<item>
			<title>Rznomics Reports Interim Data for RNA Gene Therapy in Recurrent Glioblastoma</title>
			<atom:link href="https://biospectrumasia.com/news/50/27809/rznomics-reports-interim-data-for-rna-gene-therapy-in-recurrent-glioblastoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27809/rznomics-reports-interim-data-for-rna-gene-therapy-in-recurrent-glioblastoma.html</link>
			<pubDate>Mon, 15 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_3_-27809.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27809/rznomics-reports-interim-data-for-rna-gene-therapy-in-recurrent-glioblastoma.html</guid>
		</item>	
				<item>
			<title>Nirrin Technologies and S.T. Japan announce exclusive distribution partnership for TALOS™</title>
			<atom:link href="https://biospectrumasia.com/news/50/27812/nirrin-technologies-and-s-t-japan-announce-exclusive-distribution-partnership-for-talos.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27812/nirrin-technologies-and-s-t-japan-announce-exclusive-distribution-partnership-for-talos.html</link>
			<pubDate>Mon, 15 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_6_2026_193243_www_nirrin_tech-27812.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27812/nirrin-technologies-and-s-t-japan-announce-exclusive-distribution-partnership-for-talos.html</guid>
		</item>	
				<item>
			<title>Japan-based Lotte Holdings announces investment in ClearideBio Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/27796/japan-based-lotte-holdings-announces-investment-in-clearidebio-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27796/japan-based-lotte-holdings-announces-investment-in-clearidebio-therapeutics.html</link>
			<pubDate>Fri, 12 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-27796.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27796/japan-based-lotte-holdings-announces-investment-in-clearidebio-therapeutics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GNI Group buys Ayumi Pharmaceutical for ¥44.8 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/27773/japans-gni-group-buys-ayumi-pharmaceutical-for-44-8-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27773/japans-gni-group-buys-ayumi-pharmaceutical-for-44-8-b.html</link>
			<pubDate>Tue, 09 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_6_2026_122142_www_gnipharma_com-27773.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27773/japans-gni-group-buys-ayumi-pharmaceutical-for-44-8-b.html</guid>
		</item>	
				<item>
			<title>DHL Supply Chain and Toho Holdings sign MoU to strengthen healthcare logistics in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27760/dhl-supply-chain-and-toho-holdings-sign-mou-to-strengthen-healthcare-logistics-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27760/dhl-supply-chain-and-toho-holdings-sign-mou-to-strengthen-healthcare-logistics-in-japan.html</link>
			<pubDate>Mon, 08 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-27760.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27760/dhl-supply-chain-and-toho-holdings-sign-mou-to-strengthen-healthcare-logistics-in-japan.html</guid>
		</item>	
				<item>
			<title>FunPep and Crafton Biotech enter into joint research agreement for therapeutic mRNA vaccines in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27740/funpep-and-crafton-biotech-enter-into-joint-research-agreement-for-therapeutic-mrna-vaccines-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27740/funpep-and-crafton-biotech-enter-into-joint-research-agreement-for-therapeutic-mrna-vaccines-in-japan.html</link>
			<pubDate>Fri, 05 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-27740.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27740/funpep-and-crafton-biotech-enter-into-joint-research-agreement-for-therapeutic-mrna-vaccines-in-japan.html</guid>
		</item>	
				<item>
			<title>Global biopharma leaders meet Japanese PM to reinforce action for retaining Japan’s leadership in life sciences</title>
			<atom:link href="https://biospectrumasia.com/news/50/27733/global-biopharma-leaders-meet-japanese-pm-to-reinforce-action-for-retaining-japans-leadership-in-life-sciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27733/global-biopharma-leaders-meet-japanese-pm-to-reinforce-action-for-retaining-japans-leadership-in-life-sciences.html</link>
			<pubDate>Wed, 03 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_3_6_2026_121211_www_bing_com-27733.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27733/global-biopharma-leaders-meet-japanese-pm-to-reinforce-action-for-retaining-japans-leadership-in-life-sciences.html</guid>
		</item>	
				<item>
			<title>Japanese dental startup Toregem raises $5.3 M to treat congenital tooth agenesis</title>
			<atom:link href="https://biospectrumasia.com/news/50/27721/japanese-dental-startup-toregem-raises-5-3-m-to-treat-congenital-tooth-agenesis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27721/japanese-dental-startup-toregem-raises-5-3-m-to-treat-congenital-tooth-agenesis.html</link>
			<pubDate>Tue, 02 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2_6_2026_114827_-27721.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27721/japanese-dental-startup-toregem-raises-5-3-m-to-treat-congenital-tooth-agenesis.html</guid>
		</item>	
				<item>
			<title>Meiji Seika Pharma invests in GHIC’s global health security fund</title>
			<atom:link href="https://biospectrumasia.com/news/50/27714/meiji-seika-pharma-invests-in-ghics-global-health-security-fund.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27714/meiji-seika-pharma-invests-in-ghics-global-health-security-fund.html</link>
			<pubDate>Mon, 01 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_1_6_2026_13291_ghicfunds_org-27714.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27714/meiji-seika-pharma-invests-in-ghics-global-health-security-fund.html</guid>
		</item>	
				<item>
			<title>PREMIA and Lind expand AI-powered clinical trial screening across Asia-Pacific</title>
			<atom:link href="https://biospectrumasia.com/news/50/27694/premia-and-lind-expand-ai-powered-clinical-trial-screening-across-asia-pacific.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27694/premia-and-lind-expand-ai-powered-clinical-trial-screening-across-asia-pacific.html</link>
			<pubDate>Fri, 29 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_29_5_2026_124426_www_premia_inc_com-27694.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27694/premia-and-lind-expand-ai-powered-clinical-trial-screening-across-asia-pacific.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Asahi Kasei acquires license for novel ADC technology from Noguchi Institute </title>
			<atom:link href="https://biospectrumasia.com/news/50/27695/japans-asahi-kasei-acquires-license-for-novel-adc-technology-from-noguchi-institute-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27695/japans-asahi-kasei-acquires-license-for-novel-adc-technology-from-noguchi-institute-.html</link>
			<pubDate>Thu, 28 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_5_2026_125542_finance_yahoo_com-27695.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27695/japans-asahi-kasei-acquires-license-for-novel-adc-technology-from-noguchi-institute-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus buys BioProtect for $270 M to expand portfolio of urological technologies </title>
			<atom:link href="https://biospectrumasia.com/news/50/27692/japans-olympus-buys-bioprotect-for-270-m-to-expand-portfolio-of-urological-technologies-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27692/japans-olympus-buys-bioprotect-for-270-m-to-expand-portfolio-of-urological-technologies-.html</link>
			<pubDate>Wed, 27 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_27_5_2026_13544_www_prnewswire_com-27692.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27692/japans-olympus-buys-bioprotect-for-270-m-to-expand-portfolio-of-urological-technologies-.html</guid>
		</item>	
				<item>
			<title>Japan’s Nissha acquires Vietnam&#039;s medical devices manufacturer USM Healthcare</title>
			<atom:link href="https://biospectrumasia.com/news/50/27683/japans-nissha-acquires-vietnams-medical-devices-manufacturer-usm-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27683/japans-nissha-acquires-vietnams-medical-devices-manufacturer-usm-healthcare.html</link>
			<pubDate>Tue, 26 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_26_5_2026_12355_usm_com_vn-27683.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27683/japans-nissha-acquires-vietnams-medical-devices-manufacturer-usm-healthcare.html</guid>
		</item>	
				<item>
			<title>FUJIFILM Cellular Dynamics Launches New iPSC Manufacturing Facility in Madison</title>
			<atom:link href="https://biospectrumasia.com/news/50/27671/fujifilm-cellular-dynamics-launches-new-ipsc-manufacturing-facility-in-madison.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27671/fujifilm-cellular-dynamics-launches-new-ipsc-manufacturing-facility-in-madison.html</link>
			<pubDate>Wed, 20 May 2026 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27671/fujifilm-cellular-dynamics-launches-new-ipsc-manufacturing-facility-in-madison.html</guid>
		</item>	
				<item>
			<title>Samsung Bioepis launches Ustekinumab biosimilar in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27665/samsung-bioepis-launches-ustekinumab-biosimilar-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27665/samsung-bioepis-launches-ustekinumab-biosimilar-in-japan.html</link>
			<pubDate>Wed, 20 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_20_5_2026_22456_www_bing_com-27665.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27665/samsung-bioepis-launches-ustekinumab-biosimilar-in-japan.html</guid>
		</item>	
				<item>
			<title>Fujifilm launches balloon-less endobronchial ultrasound bronchoscope for pulmonary care</title>
			<atom:link href="https://biospectrumasia.com/news/50/27659/fujifilm-launches-balloon-less-endobronchial-ultrasound-bronchoscope-for-pulmonary-care.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27659/fujifilm-launches-balloon-less-endobronchial-ultrasound-bronchoscope-for-pulmonary-care.html</link>
			<pubDate>Tue, 19 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pul-27659.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27659/fujifilm-launches-balloon-less-endobronchial-ultrasound-bronchoscope-for-pulmonary-care.html</guid>
		</item>	
				<item>
			<title>ImmunityBio signs exclusive US agreement with Japan BCG Laboratory</title>
			<atom:link href="https://biospectrumasia.com/news/50/27651/immunitybio-signs-exclusive-us-agreement-with-japan-bcg-laboratory.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27651/immunitybio-signs-exclusive-us-agreement-with-japan-bcg-laboratory.html</link>
			<pubDate>Mon, 18 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-27651.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27651/immunitybio-signs-exclusive-us-agreement-with-japan-bcg-laboratory.html</guid>
		</item>	
				<item>
			<title>Fujitsu and IBM Japan formalise collaboration in healthcare sector</title>
			<atom:link href="https://biospectrumasia.com/news/50/27642/fujitsu-and-ibm-japan-formalise-collaboration-in-healthcare-sector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27642/fujitsu-and-ibm-japan-formalise-collaboration-in-healthcare-sector.html</link>
			<pubDate>Fri, 15 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_5_2026_184649_www_bing_com-27642.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27642/fujitsu-and-ibm-japan-formalise-collaboration-in-healthcare-sector.html</guid>
		</item>	
				<item>
			<title>Hokkaido University leverages BostonGene’s AI-powered platform to advance precision oncology</title>
			<atom:link href="https://biospectrumasia.com/news/50/27627/hokkaido-university-leverages-bostongenes-ai-powered-platform-to-advance-precision-oncology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27627/hokkaido-university-leverages-bostongenes-ai-powered-platform-to-advance-precision-oncology.html</link>
			<pubDate>Wed, 13 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-27627.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27627/hokkaido-university-leverages-bostongenes-ai-powered-platform-to-advance-precision-oncology.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kyowa Kirin to build research hub for strengthening drug discovery capabilities </title>
			<atom:link href="https://biospectrumasia.com/news/50/27618/japans-kyowa-kirin-to-build-research-hub-for-strengthening-drug-discovery-capabilities-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27618/japans-kyowa-kirin-to-build-research-hub-for-strengthening-drug-discovery-capabilities-.html</link>
			<pubDate>Tue, 12 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_12_5_2026_114511_-27618.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27618/japans-kyowa-kirin-to-build-research-hub-for-strengthening-drug-discovery-capabilities-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo unveils five-year business plan focused on oncology innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/27612/japans-daiichi-sankyo-unveils-five-year-business-plan-focused-on-oncology-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27612/japans-daiichi-sankyo-unveils-five-year-business-plan-focused-on-oncology-innovation.html</link>
			<pubDate>Mon, 11 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_11_5_2026_124959_www_daiichisankyo_com-27612.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27612/japans-daiichi-sankyo-unveils-five-year-business-plan-focused-on-oncology-innovation.html</guid>
		</item>	
				<item>
			<title>Waiv enters collaboration with Daiichi Sankyo to deliver AI-derived biomarkers for ADC programme</title>
			<atom:link href="https://biospectrumasia.com/news/50/27602/waiv-enters-collaboration-with-daiichi-sankyo-to-deliver-ai-derived-biomarkers-for-adc-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27602/waiv-enters-collaboration-with-daiichi-sankyo-to-deliver-ai-derived-biomarkers-for-adc-programme.html</link>
			<pubDate>Thu, 07 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_7_5_2026_111658_wearewaiv_com-27602.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27602/waiv-enters-collaboration-with-daiichi-sankyo-to-deliver-ai-derived-biomarkers-for-adc-programme.html</guid>
		</item>	
				<item>
			<title>Medical Excellence Japan signs MoUs with NATHEALTH and YEIDA in India</title>
			<atom:link href="https://biospectrumasia.com/news/50/27605/medical-excellence-japan-signs-mous-with-nathealth-and-yeida-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27605/medical-excellence-japan-signs-mous-with-nathealth-and-yeida-in-india.html</link>
			<pubDate>Thu, 07 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_7_5_2026_23118_www_linkedin_com-27605.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27605/medical-excellence-japan-signs-mous-with-nathealth-and-yeida-in-india.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus inks global distribution agreement with Korean startup EndoRobotics</title>
			<atom:link href="https://biospectrumasia.com/news/50/27591/japans-olympus-inks-global-distribution-agreement-with-korean-startup-endorobotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27591/japans-olympus-inks-global-distribution-agreement-with-korean-startup-endorobotics.html</link>
			<pubDate>Tue, 05 May 2026 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_5_5_2026_111931_www_olympus_global_com-27591.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27591/japans-olympus-inks-global-distribution-agreement-with-korean-startup-endorobotics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s KM Biologics enters into technology collaboration with Serum Institute of India</title>
			<atom:link href="https://biospectrumasia.com/news/50/27586/japans-km-biologics-enters-into-technology-collaboration-with-serum-institute-of-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27586/japans-km-biologics-enters-into-technology-collaboration-with-serum-institute-of-india.html</link>
			<pubDate>Sun, 03 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-27586.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27586/japans-km-biologics-enters-into-technology-collaboration-with-serum-institute-of-india.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi joins World Economic Forum and signs Davos Compact on Antimicrobial Resistance</title>
			<atom:link href="https://biospectrumasia.com/news/50/27584/japans-shionogi-joins-world-economic-forum-and-signs-davos-compact-on-antimicrobial-resistance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27584/japans-shionogi-joins-world-economic-forum-and-signs-davos-compact-on-antimicrobial-resistance.html</link>
			<pubDate>Fri, 01 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/22-27584.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27584/japans-shionogi-joins-world-economic-forum-and-signs-davos-compact-on-antimicrobial-resistance.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu acquires majority stake in German startup Plasmion</title>
			<atom:link href="https://biospectrumasia.com/news/50/27575/japans-shimadzu-acquires-majority-stake-in-german-startup-plasmion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27575/japans-shimadzu-acquires-majority-stake-in-german-startup-plasmion.html</link>
			<pubDate>Thu, 30 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_4_2026_115614_www_shimadzu_com-27575.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27575/japans-shimadzu-acquires-majority-stake-in-german-startup-plasmion.html</guid>
		</item>	
				<item>
			<title>Japan, Taiwan strengthen collaboration in healthcare and drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/27558/japan-taiwan-strengthen-collaboration-in-healthcare-and-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27558/japan-taiwan-strengthen-collaboration-in-healthcare-and-drug-discovery.html</link>
			<pubDate>Tue, 28 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_4_2026_111333_www_shonan_ipark_com-27558.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27558/japan-taiwan-strengthen-collaboration-in-healthcare-and-drug-discovery.html</guid>
		</item>	
				<item>
			<title>IMG Pharma enters into definitive agreement to acquire Matsumoto Pharmaceutical in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27556/img-pharma-enters-into-definitive-agreement-to-acquire-matsumoto-pharmaceutical-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27556/img-pharma-enters-into-definitive-agreement-to-acquire-matsumoto-pharmaceutical-in-japan.html</link>
			<pubDate>Mon, 27 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/22-27556.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27556/img-pharma-enters-into-definitive-agreement-to-acquire-matsumoto-pharmaceutical-in-japan.html</guid>
		</item>	
				<item>
			<title>Singapore and Japan deepen collaboration to enhance access to health products</title>
			<atom:link href="https://biospectrumasia.com/news/50/27538/singapore-and-japan-deepen-collaboration-to-enhance-access-to-health-products.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27538/singapore-and-japan-deepen-collaboration-to-enhance-access-to-health-products.html</link>
			<pubDate>Thu, 23 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_23_4_2026_124519_www_hsa_gov_sg-27538.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27538/singapore-and-japan-deepen-collaboration-to-enhance-access-to-health-products.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT Fund announces investment of $8.5 M in five R&amp;D projects</title>
			<atom:link href="https://biospectrumasia.com/news/50/27535/japans-ghit-fund-announces-investment-of-8-5-m-in-five-rd-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27535/japans-ghit-fund-announces-investment-of-8-5-m-in-five-rd-projects.html</link>
			<pubDate>Wed, 22 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_22_4_2026_15650_-27535.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27535/japans-ghit-fund-announces-investment-of-8-5-m-in-five-rd-projects.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda terminates mRNA-targeted small-molecule drugs research pact with Veritas</title>
			<atom:link href="https://biospectrumasia.com/news/50/27521/japans-takeda-terminates-mrna-targeted-small-molecule-drugs-research-pact-with-veritas.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27521/japans-takeda-terminates-mrna-targeted-small-molecule-drugs-research-pact-with-veritas.html</link>
			<pubDate>Sat, 18 Apr 2026 00:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_4_2026_122450_www_veritasinsilico_com-27521.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27521/japans-takeda-terminates-mrna-targeted-small-molecule-drugs-research-pact-with-veritas.html</guid>
		</item>	
				<item>
			<title>Shionogi makes investment in Japanese startup Restore Vision to develop visual restoration gene therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/27510/shionogi-makes-investment-in-japanese-startup-restore-vision-to-develop-visual-restoration-gene-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27510/shionogi-makes-investment-in-japanese-startup-restore-vision-to-develop-visual-restoration-gene-therapy.html</link>
			<pubDate>Thu, 16 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_4_2026_102241_restore_vis_com-27510.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27510/shionogi-makes-investment-in-japanese-startup-restore-vision-to-develop-visual-restoration-gene-therapy.html</guid>
		</item>	
				<item>
			<title>4D Path partners with Daiichi Sankyo to advance AI-driven ADC programme</title>
			<atom:link href="https://biospectrumasia.com/news/50/27499/4d-path-partners-with-daiichi-sankyo-to-advance-ai-driven-adc-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27499/4d-path-partners-with-daiichi-sankyo-to-advance-ai-driven-adc-programme.html</link>
			<pubDate>Wed, 15 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_4_2026_121016_-27499.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27499/4d-path-partners-with-daiichi-sankyo-to-advance-ai-driven-adc-programme.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nippon Shinyaku partners with xFOREST Therapeutics on drug discovery research targeting RNA structures</title>
			<atom:link href="https://biospectrumasia.com/news/50/27495/japans-nippon-shinyaku-partners-with-xforest-therapeutics-on-drug-discovery-research-targeting-rna-structures.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27495/japans-nippon-shinyaku-partners-with-xforest-therapeutics-on-drug-discovery-research-targeting-rna-structures.html</link>
			<pubDate>Tue, 14 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_14_4_2026_61159_-27495.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27495/japans-nippon-shinyaku-partners-with-xforest-therapeutics-on-drug-discovery-research-targeting-rna-structures.html</guid>
		</item>	
				<item>
			<title>NEXTBIOMEDICAL secures exclusive distribution agreement for Nexsphere-F™ in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27484/nextbiomedical-secures-exclusive-distribution-agreement-for-nexsphere-f-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27484/nextbiomedical-secures-exclusive-distribution-agreement-for-nexsphere-f-in-japan.html</link>
			<pubDate>Fri, 10 Apr 2026 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_11_4_2026_92410_www_bvmmedical_com-27484.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27484/nextbiomedical-secures-exclusive-distribution-agreement-for-nexsphere-f-in-japan.html</guid>
		</item>	
				<item>
			<title>ATLATL announces agreement with Daiichi Sankyo to deepen APAC biotech innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/27471/atlatl-announces-agreement-with-daiichi-sankyo-to-deepen-apac-biotech-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27471/atlatl-announces-agreement-with-daiichi-sankyo-to-deepen-apac-biotech-innovation.html</link>
			<pubDate>Thu, 09 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_8_4_2026_222445_www_atlatl_center-27471.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27471/atlatl-announces-agreement-with-daiichi-sankyo-to-deepen-apac-biotech-innovation.html</guid>
		</item>	
				<item>
			<title>Shionogi Receives Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats</title>
			<atom:link href="https://biospectrumasia.com/news/50/27475/shionogi-receives-contract-with-u-s-government-to-enhance-national-preparedness-for-drug-resistant-bacterial-threats.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27475/shionogi-receives-contract-with-u-s-government-to-enhance-national-preparedness-for-drug-resistant-bacterial-threats.html</link>
			<pubDate>Wed, 08 Apr 2026 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27475/shionogi-receives-contract-with-u-s-government-to-enhance-national-preparedness-for-drug-resistant-bacterial-threats.html</guid>
		</item>	
				<item>
			<title>ATLATL Announces Agreement with Daiichi Sankyo to Deepen APAC Biotech Innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/27476/atlatl-announces-agreement-with-daiichi-sankyo-to-deepen-apac-biotech-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27476/atlatl-announces-agreement-with-daiichi-sankyo-to-deepen-apac-biotech-innovation.html</link>
			<pubDate>Wed, 08 Apr 2026 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27476/atlatl-announces-agreement-with-daiichi-sankyo-to-deepen-apac-biotech-innovation.html</guid>
		</item>	
				<item>
			<title>Japan-based Toho’s VC Arm makes investment in American startup Metaphore Biotech</title>
			<atom:link href="https://biospectrumasia.com/news/50/27468/japan-based-tohos-vc-arm-makes-investment-in-american-startup-metaphore-biotech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27468/japan-based-tohos-vc-arm-makes-investment-in-american-startup-metaphore-biotech.html</link>
			<pubDate>Wed, 08 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-27468.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27468/japan-based-tohos-vc-arm-makes-investment-in-american-startup-metaphore-biotech.html</guid>
		</item>	
				<item>
			<title>Mochida grants LG Chem rights to develop &amp; market Dinagest in South Korea and Thailand</title>
			<atom:link href="https://biospectrumasia.com/news/50/27463/mochida-grants-lg-chem-rights-to-develop-market-dinagest-in-south-korea-and-thailand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27463/mochida-grants-lg-chem-rights-to-develop-market-dinagest-in-south-korea-and-thailand.html</link>
			<pubDate>Tue, 07 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_7_4_2026_171218_www_bing_com-27463.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27463/mochida-grants-lg-chem-rights-to-develop-market-dinagest-in-south-korea-and-thailand.html</guid>
		</item>	
				<item>
			<title>Transgene and NEC Bio to advance vaccine development for head and neck cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/27451/transgene-and-nec-bio-to-advance-vaccine-development-for-head-and-neck-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27451/transgene-and-nec-bio-to-advance-vaccine-development-for-head-and-neck-cancer.html</link>
			<pubDate>Fri, 03 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/123_20-27451.php" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27451/transgene-and-nec-bio-to-advance-vaccine-development-for-head-and-neck-cancer.html</guid>
		</item>	
				<item>
			<title>NJ Bio collaborates with Ajinomoto Bio‑Pharma to strengthen support for ADC development</title>
			<atom:link href="https://biospectrumasia.com/news/50/27448/nj-bio-collaborates-with-ajinomoto-biopharma-to-strengthen-support-for-adc-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27448/nj-bio-collaborates-with-ajinomoto-biopharma-to-strengthen-support-for-adc-development.html</link>
			<pubDate>Thu, 02 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-27448.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27448/nj-bio-collaborates-with-ajinomoto-biopharma-to-strengthen-support-for-adc-development.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka Pharma buys Transcend Therapeutics for $1.2 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/27430/japans-otsuka-pharma-buys-transcend-therapeutics-for-1-2-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27430/japans-otsuka-pharma-buys-transcend-therapeutics-for-1-2-b.html</link>
			<pubDate>Tue, 31 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_3_2026_122033_www_bing_com-27430.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27430/japans-otsuka-pharma-buys-transcend-therapeutics-for-1-2-b.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Meiji Seika Pharma invests in Centivax to develop next-gen universal vaccine platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/27427/japans-meiji-seika-pharma-invests-in-centivax-to-develop-next-gen-universal-vaccine-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27427/japans-meiji-seika-pharma-invests-in-centivax-to-develop-next-gen-universal-vaccine-platform.html</link>
			<pubDate>Mon, 30 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_3_2026_19932_www_centivax_com-27427.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27427/japans-meiji-seika-pharma-invests-in-centivax-to-develop-next-gen-universal-vaccine-platform.html</guid>
		</item>	
				<item>
			<title>Cytiva and Yoshindo advance domestic biosimilar manufacturing in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27400/cytiva-and-yoshindo-advance-domestic-biosimilar-manufacturing-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27400/cytiva-and-yoshindo-advance-domestic-biosimilar-manufacturing-in-japan.html</link>
			<pubDate>Tue, 24 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-27400.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27400/cytiva-and-yoshindo-advance-domestic-biosimilar-manufacturing-in-japan.html</guid>
		</item>	
				<item>
			<title>Oxford Nanopore and A.D.A.M. Innovations to accelerate advanced genomic medicine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27378/oxford-nanopore-and-a-d-a-m-innovations-to-accelerate-advanced-genomic-medicine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27378/oxford-nanopore-and-a-d-a-m-innovations-to-accelerate-advanced-genomic-medicine-in-japan.html</link>
			<pubDate>Wed, 18 Mar 2026 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27378/oxford-nanopore-and-a-d-a-m-innovations-to-accelerate-advanced-genomic-medicine-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujifilm invests in Valanx Biotech to strengthen ADC CDMO capabilities</title>
			<atom:link href="https://biospectrumasia.com/news/50/27368/japans-fujifilm-invests-in-valanx-biotech-to-strengthen-adc-cdmo-capabilities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27368/japans-fujifilm-invests-in-valanx-biotech-to-strengthen-adc-cdmo-capabilities.html</link>
			<pubDate>Wed, 18 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-27368.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27368/japans-fujifilm-invests-in-valanx-biotech-to-strengthen-adc-cdmo-capabilities.html</guid>
		</item>	
				<item>
			<title>Eli Lilly invests additional 20 B yen in Japan to enhance pharma supply capacity</title>
			<atom:link href="https://biospectrumasia.com/news/50/27360/eli-lilly-invests-additional-20-b-yen-in-japan-to-enhance-pharma-supply-capacity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27360/eli-lilly-invests-additional-20-b-yen-in-japan-to-enhance-pharma-supply-capacity.html</link>
			<pubDate>Tue, 17 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_17_3_2026_162140_-27360.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27360/eli-lilly-invests-additional-20-b-yen-in-japan-to-enhance-pharma-supply-capacity.html</guid>
		</item>	
				<item>
			<title>Fujitsu Japan to build mechanism for data analysis and referred-patient management</title>
			<atom:link href="https://biospectrumasia.com/news/50/27361/fujitsu-japan-to-build-mechanism-for-data-analysis-and-referred-patient-management.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27361/fujitsu-japan-to-build-mechanism-for-data-analysis-and-referred-patient-management.html</link>
			<pubDate>Mon, 16 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_banner_with_doctor_working_laptop-27361.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27361/fujitsu-japan-to-build-mechanism-for-data-analysis-and-referred-patient-management.html</guid>
		</item>	
				<item>
			<title>PsiQuantum partners with National Cancer Center Japan to accelerate drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/27345/psiquantum-partners-with-national-cancer-center-japan-to-accelerate-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27345/psiquantum-partners-with-national-cancer-center-japan-to-accelerate-drug-discovery.html</link>
			<pubDate>Sun, 15 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_3_2026_103754_-27345.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27345/psiquantum-partners-with-national-cancer-center-japan-to-accelerate-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Precision for Medicine continues Asia Pacific expansion with new office in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27325/precision-for-medicine-continues-asia-pacific-expansion-with-new-office-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27325/precision-for-medicine-continues-asia-pacific-expansion-with-new-office-in-japan.html</link>
			<pubDate>Thu, 12 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_12_3_2026_12117_www_precisionformedicine_com-27325.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27325/precision-for-medicine-continues-asia-pacific-expansion-with-new-office-in-japan.html</guid>
		</item>	
				<item>
			<title>Curatis and Neupharma ink deal worth CHF 83.5 M for peritumoral brain edema treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27329/curatis-and-neupharma-ink-deal-worth-chf-83-5-m-for-peritumoral-brain-edema-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27329/curatis-and-neupharma-ink-deal-worth-chf-83-5-m-for-peritumoral-brain-edema-treatment-in-japan.html</link>
			<pubDate>Wed, 11 Mar 2026 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-27329.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27329/curatis-and-neupharma-ink-deal-worth-chf-83-5-m-for-peritumoral-brain-edema-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Merck signs MoU with Cyto-Facto to advance Cell &amp; Gene Therapy manufacturing in APAC region</title>
			<atom:link href="https://biospectrumasia.com/news/50/27332/merck-signs-mou-with-cyto-facto-to-advance-cell-gene-therapy-manufacturing-in-apac-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27332/merck-signs-mou-with-cyto-facto-to-advance-cell-gene-therapy-manufacturing-in-apac-region.html</link>
			<pubDate>Wed, 11 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-27332.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27332/merck-signs-mou-with-cyto-facto-to-advance-cell-gene-therapy-manufacturing-in-apac-region.html</guid>
		</item>	
				<item>
			<title>Pfizer, ASKA Pharma to co-promote RSV vaccine Abrysvo in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27312/pfizer-aska-pharma-to-co-promote-rsv-vaccine-abrysvo-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27312/pfizer-aska-pharma-to-co-promote-rsv-vaccine-abrysvo-in-japan.html</link>
			<pubDate>Tue, 10 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/abrysvo_packshot_880x450-27312.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27312/pfizer-aska-pharma-to-co-promote-rsv-vaccine-abrysvo-in-japan.html</guid>
		</item>	
				<item>
			<title>Fujitsu and DT-Axis collaborate to advance digital health in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27305/fujitsu-and-dt-axis-collaborate-to-advance-digital-health-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27305/fujitsu-and-dt-axis-collaborate-to-advance-digital-health-in-japan.html</link>
			<pubDate>Mon, 09 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_3_2026_132120_-27305.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27305/fujitsu-and-dt-axis-collaborate-to-advance-digital-health-in-japan.html</guid>
		</item>	
				<item>
			<title>Kyowa Kirin Announces Discontinuation of Rocatinlimab clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/27306/kyowa-kirin-announces-discontinuation-of-rocatinlimab-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27306/kyowa-kirin-announces-discontinuation-of-rocatinlimab-clinical-trials.html</link>
			<pubDate>Sun, 08 Mar 2026 12:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27306/kyowa-kirin-announces-discontinuation-of-rocatinlimab-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Reprocell launches GMP master cell bank manufacturing for clinical iPSCs </title>
			<atom:link href="https://biospectrumasia.com/news/50/27282/japans-reprocell-launches-gmp-master-cell-bank-manufacturing-for-clinical-ipscs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27282/japans-reprocell-launches-gmp-master-cell-bank-manufacturing-for-clinical-ipscs-.html</link>
			<pubDate>Wed, 04 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_3_2026_123323_www_reprocell_com-27282.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27282/japans-reprocell-launches-gmp-master-cell-bank-manufacturing-for-clinical-ipscs-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PHCbi introduces LiCellGrowâ„¢ Cell Expansion System</title>
			<atom:link href="https://biospectrumasia.com/news/50/27273/japans-phcbi-introduces-licellgrow-cell-expansion-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27273/japans-phcbi-introduces-licellgrow-cell-expansion-system.html</link>
			<pubDate>Mon, 02 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/phc-27273.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27273/japans-phcbi-introduces-licellgrow-cell-expansion-system.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Asahi Kasei acquires Germany&#039;s Aicuris for €780 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/27253/japans-asahi-kasei-acquires-germanys-aicuris-for-780-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27253/japans-asahi-kasei-acquires-germanys-aicuris-for-780-m.html</link>
			<pubDate>Fri, 27 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_27_2_2026_215456_-27253.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27253/japans-asahi-kasei-acquires-germanys-aicuris-for-780-m.html</guid>
		</item>	
				<item>
			<title>Sumitomo partners Launch Malaria Vaccine Project</title>
			<atom:link href="https://biospectrumasia.com/news/50/27247/sumitomo-partners-launch-malaria-vaccine-project.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27247/sumitomo-partners-launch-malaria-vaccine-project.html</link>
			<pubDate>Wed, 25 Feb 2026 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27247/sumitomo-partners-launch-malaria-vaccine-project.html</guid>
		</item>	
				<item>
			<title>Sarepta Therapeutics announces commercial launch of ELEVIDYS in Japan for DMD treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/27244/sarepta-therapeutics-announces-commercial-launch-of-elevidys-in-japan-for-dmd-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27244/sarepta-therapeutics-announces-commercial-launch-of-elevidys-in-japan-for-dmd-treatment.html</link>
			<pubDate>Wed, 25 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-27244.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27244/sarepta-therapeutics-announces-commercial-launch-of-elevidys-in-japan-for-dmd-treatment.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas announces $1.37 B deal with Vir Biotechnology to develop T-Cell therapies for prostate cancer </title>
			<atom:link href="https://biospectrumasia.com/news/50/27232/japans-astellas-announces-1-37-b-deal-with-vir-biotechnology-to-develop-t-cell-therapies-for-prostate-cancer-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27232/japans-astellas-announces-1-37-b-deal-with-vir-biotechnology-to-develop-t-cell-therapies-for-prostate-cancer-.html</link>
			<pubDate>Tue, 24 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_24_2_2026_12514_-27232.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27232/japans-astellas-announces-1-37-b-deal-with-vir-biotechnology-to-develop-t-cell-therapies-for-prostate-cancer-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu Future Innovation Fund invests in cardiac healthcare startup A-wave</title>
			<atom:link href="https://biospectrumasia.com/news/50/27227/japans-shimadzu-future-innovation-fund-invests-in-cardiac-healthcare-startup-a-wave.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27227/japans-shimadzu-future-innovation-fund-invests-in-cardiac-healthcare-startup-a-wave.html</link>
			<pubDate>Fri, 20 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_20_2_2026_191833_-27227.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27227/japans-shimadzu-future-innovation-fund-invests-in-cardiac-healthcare-startup-a-wave.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo collaborates with BostonGene to accelerate AI-based drug development</title>
			<atom:link href="https://biospectrumasia.com/news/50/27210/japans-daiichi-sankyo-collaborates-with-bostongene-to-accelerate-ai-based-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27210/japans-daiichi-sankyo-collaborates-with-bostongene-to-accelerate-ai-based-drug-development.html</link>
			<pubDate>Wed, 18 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_2_2026_165439_www_bing_com-27210.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27210/japans-daiichi-sankyo-collaborates-with-bostongene-to-accelerate-ai-based-drug-development.html</guid>
		</item>	
				<item>
			<title>Japan approves Clinigen&#039;s world-first therapeutic human breast milk fortifier to manage VLBW infants</title>
			<atom:link href="https://biospectrumasia.com/news/50/27207/japan-approves-clinigens-world-first-therapeutic-human-breast-milk-fortifier-to-manage-vlbw-infants.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27207/japan-approves-clinigens-world-first-therapeutic-human-breast-milk-fortifier-to-manage-vlbw-infants.html</link>
			<pubDate>Mon, 16 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wmremove_transformed_32_-27207.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27207/japan-approves-clinigens-world-first-therapeutic-human-breast-milk-fortifier-to-manage-vlbw-infants.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nxera Pharma licenses GPCR-targeted programme to NewCo</title>
			<atom:link href="https://biospectrumasia.com/news/50/27201/japans-nxera-pharma-licenses-gpcr-targeted-programme-to-newco.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27201/japans-nxera-pharma-licenses-gpcr-targeted-programme-to-newco.html</link>
			<pubDate>Fri, 13 Feb 2026 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_14_2_2026_122143_-27201.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27201/japans-nxera-pharma-licenses-gpcr-targeted-programme-to-newco.html</guid>
		</item>	
				<item>
			<title>Galderma accelerates growth with two new launches in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27195/galderma-accelerates-growth-with-two-new-launches-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27195/galderma-accelerates-growth-with-two-new-launches-in-japan.html</link>
			<pubDate>Thu, 12 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_12_2_2026_91221_www_galderma_com-27195.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27195/galderma-accelerates-growth-with-two-new-launches-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda and Iambic ink $1.7 B deal to advance AI driven design of small molecules</title>
			<atom:link href="https://biospectrumasia.com/news/50/27186/takeda-and-iambic-ink-1-7-b-deal-to-advance-ai-driven-design-of-small-molecules.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27186/takeda-and-iambic-ink-1-7-b-deal-to-advance-ai-driven-design-of-small-molecules.html</link>
			<pubDate>Wed, 11 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_11_2_2026_181818_www_iambic_ai-27186.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27186/takeda-and-iambic-ink-1-7-b-deal-to-advance-ai-driven-design-of-small-molecules.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Saisei Ventures launches bridge-to-biotech venture creation initiative</title>
			<atom:link href="https://biospectrumasia.com/news/50/27183/japans-saisei-ventures-launches-bridge-to-biotech-venture-creation-initiative.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27183/japans-saisei-ventures-launches-bridge-to-biotech-venture-creation-initiative.html</link>
			<pubDate>Tue, 10 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_10_2_2026_93057_www_bing_com-27183.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27183/japans-saisei-ventures-launches-bridge-to-biotech-venture-creation-initiative.html</guid>
		</item>	
				<item>
			<title>TANAKA PRECIOUS METAL TECHNOLOGIES establishes total solutions system for contract manufacturing of various test kits including in vitro diagnostics</title>
			<atom:link href="https://biospectrumasia.com/news/50/27176/tanaka-precious-metal-technologies-establishes-total-solutions-system-for-contract-manufacturing-of-various-test-kits-including-in-vitro-diagnostics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27176/tanaka-precious-metal-technologies-establishes-total-solutions-system-for-contract-manufacturing-of-various-test-kits-including-in-vitro-diagnostics.html</link>
			<pubDate>Fri, 06 Feb 2026 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27176/tanaka-precious-metal-technologies-establishes-total-solutions-system-for-contract-manufacturing-of-various-test-kits-including-in-vitro-diagnostics.html</guid>
		</item>	
				<item>
			<title>Fujitsu Japan and JMDC announce collaboration to build sustainable healthcare system in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/27177/fujitsu-japan-and-jmdc-announce-collaboration-to-build-sustainable-healthcare-system-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27177/fujitsu-japan-and-jmdc-announce-collaboration-to-build-sustainable-healthcare-system-in-japan-.html</link>
			<pubDate>Fri, 06 Feb 2026 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27177/fujitsu-japan-and-jmdc-announce-collaboration-to-build-sustainable-healthcare-system-in-japan-.html</guid>
		</item>	
				<item>
			<title>Sky Labs inks distribution agreement with Otsuka Pharma for &#039;CART BP pro&#039; in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27170/sky-labs-inks-distribution-agreement-with-otsuka-pharma-for-cart-bp-pro-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27170/sky-labs-inks-distribution-agreement-with-otsuka-pharma-for-cart-bp-pro-in-japan.html</link>
			<pubDate>Fri, 06 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_6_2_2026_9437_www_skylabs_io-27170.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27170/sky-labs-inks-distribution-agreement-with-otsuka-pharma-for-cart-bp-pro-in-japan.html</guid>
		</item>	
				<item>
			<title>Richter and Fuji strengthen strategic collaboration in women healthcare segment</title>
			<atom:link href="https://biospectrumasia.com/news/50/27169/richter-and-fuji-strengthen-strategic-collaboration-in-women-healthcare-segment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27169/richter-and-fuji-strengthen-strategic-collaboration-in-women-healthcare-segment.html</link>
			<pubDate>Thu, 05 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_5_2_2026_124728_-27169.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27169/richter-and-fuji-strengthen-strategic-collaboration-in-women-healthcare-segment.html</guid>
		</item>	
				<item>
			<title>Amgen ends Rocatinlimab collaboration with Japan&#039;s Kyowa Kirin</title>
			<atom:link href="https://biospectrumasia.com/news/50/27164/amgen-ends-rocatinlimab-collaboration-with-japans-kyowa-kirin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27164/amgen-ends-rocatinlimab-collaboration-with-japans-kyowa-kirin.html</link>
			<pubDate>Wed, 04 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_2_2026_122350_-27164.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27164/amgen-ends-rocatinlimab-collaboration-with-japans-kyowa-kirin.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT invests $8.8 M in malaria, tuberculosis, and NTD R&amp;D projects</title>
			<atom:link href="https://biospectrumasia.com/news/50/27165/japans-ghit-invests-8-8-m-in-malaria-tuberculosis-and-ntd-rd-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27165/japans-ghit-invests-8-8-m-in-malaria-tuberculosis-and-ntd-rd-projects.html</link>
			<pubDate>Tue, 03 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_3_2_2026_142328_-27165.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27165/japans-ghit-invests-8-8-m-in-malaria-tuberculosis-and-ntd-rd-projects.html</guid>
		</item>	
				<item>
			<title>Alfresa Launches End-to-End Platform to Support Biotech Entry into Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27156/alfresa-launches-end-to-end-platform-to-support-biotech-entry-into-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27156/alfresa-launches-end-to-end-platform-to-support-biotech-entry-into-japan.html</link>
			<pubDate>Mon, 02 Feb 2026 08:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27156/alfresa-launches-end-to-end-platform-to-support-biotech-entry-into-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Medical Corporation Nasukai forms strategic alliance with Daibi Medical Aesthetics</title>
			<atom:link href="https://biospectrumasia.com/news/50/27151/japans-medical-corporation-nasukai-forms-strategic-alliance-with-daibi-medical-aesthetics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27151/japans-medical-corporation-nasukai-forms-strategic-alliance-with-daibi-medical-aesthetics.html</link>
			<pubDate>Mon, 02 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2_2_2026_122323_en_prnasia_com-27151.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27151/japans-medical-corporation-nasukai-forms-strategic-alliance-with-daibi-medical-aesthetics.html</guid>
		</item>	
				<item>
			<title>Takeda Unveils Leadership and Organizational Changes to Accelerate Growth</title>
			<atom:link href="https://biospectrumasia.com/news/50/27149/takeda-unveils-leadership-and-organizational-changes-to-accelerate-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27149/takeda-unveils-leadership-and-organizational-changes-to-accelerate-growth.html</link>
			<pubDate>Sun, 01 Feb 2026 22:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27149/takeda-unveils-leadership-and-organizational-changes-to-accelerate-growth.html</guid>
		</item>	
				<item>
			<title>Japan strengthening biopharma capabilities</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/27144/japan-strengthening-biopharma-capabilities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/27144/japan-strengthening-biopharma-capabilities.html</link>
			<pubDate>Sat, 31 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_1_2026_175653_-27144.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/27144/japan-strengthening-biopharma-capabilities.html</guid>
		</item>	
				<item>
			<title>Japan develops monitoring technique for early diagnosis and treatment of glaucoma</title>
			<atom:link href="https://biospectrumasia.com/news/50/27147/japan-develops-monitoring-technique-for-early-diagnosis-and-treatment-of-glaucoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27147/japan-develops-monitoring-technique-for-early-diagnosis-and-treatment-of-glaucoma.html</link>
			<pubDate>Sat, 31 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_1_2026_225548_-27147.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27147/japan-develops-monitoring-technique-for-early-diagnosis-and-treatment-of-glaucoma.html</guid>
		</item>	
				<item>
			<title>Fujirebio expands neuro testing portfolio with fully automated LumipulseÂ® G pTau 217 CSF assay</title>
			<atom:link href="https://biospectrumasia.com/news/50/27133/fujirebio-expands-neuro-testing-portfolio-with-fully-automated-lumipulse-g-ptau-217-csf-assay.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27133/fujirebio-expands-neuro-testing-portfolio-with-fully-automated-lumipulse-g-ptau-217-csf-assay.html</link>
			<pubDate>Thu, 29 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_29_1_2026_202628_www_fujirebio_com-27133.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27133/fujirebio-expands-neuro-testing-portfolio-with-fully-automated-lumipulse-g-ptau-217-csf-assay.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Veritas In Silico partners with SpiroChem for discovery of next generation RNA drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/27126/japans-veritas-in-silico-partners-with-spirochem-for-discovery-of-next-generation-rna-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27126/japans-veritas-in-silico-partners-with-spirochem-for-discovery-of-next-generation-rna-drugs.html</link>
			<pubDate>Wed, 28 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_1_2026_151330_spirochem_com-27126.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27126/japans-veritas-in-silico-partners-with-spirochem-for-discovery-of-next-generation-rna-drugs.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka and Towa form strategic partnership in pharmaceutical manufacturing</title>
			<atom:link href="https://biospectrumasia.com/news/50/27121/japans-otsuka-and-towa-form-strategic-partnership-in-pharmaceutical-manufacturing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27121/japans-otsuka-and-towa-form-strategic-partnership-in-pharmaceutical-manufacturing.html</link>
			<pubDate>Tue, 27 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-27121.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27121/japans-otsuka-and-towa-form-strategic-partnership-in-pharmaceutical-manufacturing.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo unveils new Toronto headquarters to accelerate investment and innovation in oncology</title>
			<atom:link href="https://biospectrumasia.com/news/50/27115/japans-daiichi-sankyo-unveils-new-toronto-headquarters-to-accelerate-investment-and-innovation-in-oncology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27115/japans-daiichi-sankyo-unveils-new-toronto-headquarters-to-accelerate-investment-and-innovation-in-oncology.html</link>
			<pubDate>Fri, 23 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_23_1_2026_115615_en_prnasia_com-27115.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27115/japans-daiichi-sankyo-unveils-new-toronto-headquarters-to-accelerate-investment-and-innovation-in-oncology.html</guid>
		</item>	
				<item>
			<title>GSK and Shionogi agree to replace Pfizer&#039;s stake in ViiV Healthcare</title>
			<atom:link href="https://biospectrumasia.com/news/50/27113/gsk-and-shionogi-agree-to-replace-pfizers-stake-in-viiv-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27113/gsk-and-shionogi-agree-to-replace-pfizers-stake-in-viiv-healthcare.html</link>
			<pubDate>Wed, 21 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ps-27113.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27113/gsk-and-shionogi-agree-to-replace-pfizers-stake-in-viiv-healthcare.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda partners with Halozyme to continue advancing Vedolizumab with ENHANZEÂ® drug-delivery technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/27082/japans-takeda-partners-with-halozyme-to-continue-advancing-vedolizumab-with-enhanze-drug-delivery-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27082/japans-takeda-partners-with-halozyme-to-continue-advancing-vedolizumab-with-enhanze-drug-delivery-technology.html</link>
			<pubDate>Mon, 12 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_12_1_2026_131851_halozyme_com-27082.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27082/japans-takeda-partners-with-halozyme-to-continue-advancing-vedolizumab-with-enhanze-drug-delivery-technology.html</guid>
		</item>	
				<item>
			<title>Santhera licenses AGAMREE to Japan&#039;s Nxera Pharma in $205 M Asia-Pacific deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/27074/santhera-licenses-agamree-to-japans-nxera-pharma-in-205-m-asia-pacific-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27074/santhera-licenses-agamree-to-japans-nxera-pharma-in-205-m-asia-pacific-deal.html</link>
			<pubDate>Fri, 09 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_1_2026_122050_-27074.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27074/santhera-licenses-agamree-to-japans-nxera-pharma-in-205-m-asia-pacific-deal.html</guid>
		</item>	
				<item>
			<title>Sectra begins implementation of first digital pathology project in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27070/sectra-begins-implementation-of-first-digital-pathology-project-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27070/sectra-begins-implementation-of-first-digital-pathology-project-in-japan.html</link>
			<pubDate>Thu, 08 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_8_1_2026_94529_medical_sectra_com-27070.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27070/sectra-begins-implementation-of-first-digital-pathology-project-in-japan.html</guid>
		</item>	
				<item>
			<title>Sanofi announces sales transfer of anticancer agent JEVTANA to Taiho in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27058/sanofi-announces-sales-transfer-of-anticancer-agent-jevtana-to-taiho-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27058/sanofi-announces-sales-transfer-of-anticancer-agent-jevtana-to-taiho-in-japan.html</link>
			<pubDate>Tue, 06 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jev-27058.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27058/sanofi-announces-sales-transfer-of-anticancer-agent-jevtana-to-taiho-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan Pushes Startups to Power the Next Biotech Cycle</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/27045/japan-pushes-startups-to-power-the-next-biotech-cycle.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/27045/japan-pushes-startups-to-power-the-next-biotech-cycle.html</link>
			<pubDate>Sat, 03 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bio-27045.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/27045/japan-pushes-startups-to-power-the-next-biotech-cycle.html</guid>
		</item>	
				<item>
			<title>Shionogi expands rare disease presence with acquisition of global rights to Tanabe&#039;s RADICAVA for $2.5 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/27053/shionogi-expands-rare-disease-presence-with-acquisition-of-global-rights-to-tanabes-radicava-for-2-5-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27053/shionogi-expands-rare-disease-presence-with-acquisition-of-global-rights-to-tanabes-radicava-for-2-5-b.html</link>
			<pubDate>Fri, 02 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/img_product_shot-27053.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27053/shionogi-expands-rare-disease-presence-with-acquisition-of-global-rights-to-tanabes-radicava-for-2-5-b.html</guid>
		</item>	
				<item>
			<title>Fujifilm announces opening of one of Japan&#039;s largest Bio CDMO facilities</title>
			<atom:link href="https://biospectrumasia.com/news/50/27038/fujifilm-announces-opening-of-one-of-japans-largest-bio-cdmo-facilities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27038/fujifilm-announces-opening-of-one-of-japans-largest-bio-cdmo-facilities.html</link>
			<pubDate>Fri, 26 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fuji-27038.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27038/fujifilm-announces-opening-of-one-of-japans-largest-bio-cdmo-facilities.html</guid>
		</item>	
				<item>
			<title>Soothe Healthcare partners with Japan&#039;s Osaki Medical to bring maternal care products to India</title>
			<atom:link href="https://biospectrumasia.com/news/50/27035/soothe-healthcare-partners-with-japans-osaki-medical-to-bring-maternal-care-products-to-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27035/soothe-healthcare-partners-with-japans-osaki-medical-to-bring-maternal-care-products-to-india.html</link>
			<pubDate>Wed, 24 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_24_12_2025_114625_-27035.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27035/soothe-healthcare-partners-with-japans-osaki-medical-to-bring-maternal-care-products-to-india.html</guid>
		</item>	
				<item>
			<title>Asahi Kasei Pharma to relocate global R&amp;D hub to Shonan iPark in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/27031/asahi-kasei-pharma-to-relocate-global-rd-hub-to-shonan-ipark-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27031/asahi-kasei-pharma-to-relocate-global-rd-hub-to-shonan-ipark-in-japan.html</link>
			<pubDate>Tue, 23 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_23_12_2025_19240_www_businesswire_com-27031.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27031/asahi-kasei-pharma-to-relocate-global-rd-hub-to-shonan-ipark-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Chitose and Fujifilm Biosciences partner to drive global innovation and biopharma manufacturing</title>
			<atom:link href="https://biospectrumasia.com/news/50/27023/japans-chitose-and-fujifilm-biosciences-partner-to-drive-global-innovation-and-biopharma-manufacturing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27023/japans-chitose-and-fujifilm-biosciences-partner-to-drive-global-innovation-and-biopharma-manufacturing.html</link>
			<pubDate>Mon, 22 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fuji-27023.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27023/japans-chitose-and-fujifilm-biosciences-partner-to-drive-global-innovation-and-biopharma-manufacturing.html</guid>
		</item>	
				<item>
			<title>MEDIPOST Grants Teikoku Seiyaku Exclusive Japan Rights to CARTISTEM Knee OA Therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/27026/medipost-grants-teikoku-seiyaku-exclusive-japan-rights-to-cartistem-knee-oa-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27026/medipost-grants-teikoku-seiyaku-exclusive-japan-rights-to-cartistem-knee-oa-therapy.html</link>
			<pubDate>Sun, 21 Dec 2025 16:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27026/medipost-grants-teikoku-seiyaku-exclusive-japan-rights-to-cartistem-knee-oa-therapy.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Meiji Seika Pharma collaborates with MBC BioLabs for global innovation in drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/27024/japans-meiji-seika-pharma-collaborates-with-mbc-biolabs-for-global-innovation-in-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27024/japans-meiji-seika-pharma-collaborates-with-mbc-biolabs-for-global-innovation-in-drug-discovery.html</link>
			<pubDate>Fri, 19 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dd-27024.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27024/japans-meiji-seika-pharma-collaborates-with-mbc-biolabs-for-global-innovation-in-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PRISM BioLab partners with US-based startup Talus Bioscience for AI-based drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/27021/japans-prism-biolab-partners-with-us-based-startup-talus-bioscience-for-ai-based-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27021/japans-prism-biolab-partners-with-us-based-startup-talus-bioscience-for-ai-based-drug-discovery.html</link>
			<pubDate>Thu, 18 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ss-27021.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27021/japans-prism-biolab-partners-with-us-based-startup-talus-bioscience-for-ai-based-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus triples Venture Capital Fund investment to strengthen MedTech leadership</title>
			<atom:link href="https://biospectrumasia.com/news/50/27010/japans-olympus-triples-venture-capital-fund-investment-to-strengthen-medtech-leadership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27010/japans-olympus-triples-venture-capital-fund-investment-to-strengthen-medtech-leadership.html</link>
			<pubDate>Mon, 15 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_12_2025_122523_-27010.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27010/japans-olympus-triples-venture-capital-fund-investment-to-strengthen-medtech-leadership.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kyowa Kirin names Dr Abdul Mullick as President and Chief Executive Officer</title>
			<atom:link href="https://biospectrumasia.com/news/50/27006/japans-kyowa-kirin-names-dr-abdul-mullick-as-president-and-chief-executive-officer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27006/japans-kyowa-kirin-names-dr-abdul-mullick-as-president-and-chief-executive-officer.html</link>
			<pubDate>Fri, 12 Dec 2025 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kk-27006.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27006/japans-kyowa-kirin-names-dr-abdul-mullick-as-president-and-chief-executive-officer.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Chugai establishes partnering office in US to accelerate global open innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/27001/japans-chugai-establishes-partnering-office-in-us-to-accelerate-global-open-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/27001/japans-chugai-establishes-partnering-office-in-us-to-accelerate-global-open-innovation.html</link>
			<pubDate>Fri, 12 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_13_12_2025_10208_-27001.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/27001/japans-chugai-establishes-partnering-office-in-us-to-accelerate-global-open-innovation.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT invests $460,000 for development of Mpox detection test prototype</title>
			<atom:link href="https://biospectrumasia.com/news/50/26984/japans-ghit-invests-460000-for-development-of-mpox-detection-test-prototype.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26984/japans-ghit-invests-460000-for-development-of-mpox-detection-test-prototype.html</link>
			<pubDate>Tue, 09 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mpoxx-26984.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26984/japans-ghit-invests-460000-for-development-of-mpox-detection-test-prototype.html</guid>
		</item>	
				<item>
			<title>Johnson &amp; Johnson announces breakthrough in Lung Cancer treatment with combination therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/26973/johnson-johnson-announces-breakthrough-in-lung-cancer-treatment-with-combination-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26973/johnson-johnson-announces-breakthrough-in-lung-cancer-treatment-with-combination-therapy.html</link>
			<pubDate>Sat, 06 Dec 2025 09:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2025_12_05_192055-26973.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26973/johnson-johnson-announces-breakthrough-in-lung-cancer-treatment-with-combination-therapy.html</guid>
		</item>	
				<item>
			<title>Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing</title>
			<atom:link href="https://biospectrumasia.com/news/50/26963/meiji-seika-pharma-invests-in-lyric-bio-for-next-generation-human-immunoglobulin-manufacturing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26963/meiji-seika-pharma-invests-in-lyric-bio-for-next-generation-human-immunoglobulin-manufacturing.html</link>
			<pubDate>Wed, 03 Dec 2025 05:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26963/meiji-seika-pharma-invests-in-lyric-bio-for-next-generation-human-immunoglobulin-manufacturing.html</guid>
		</item>	
				<item>
			<title>Japanese firms focus on developing cancer vaccines utilising whole-genome information</title>
			<atom:link href="https://biospectrumasia.com/news/50/26952/japanese-firms-focus-on-developing-cancer-vaccines-utilising-whole-genome-information.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26952/japanese-firms-focus-on-developing-cancer-vaccines-utilising-whole-genome-information.html</link>
			<pubDate>Tue, 02 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2_12_2025_135134_-26952.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26952/japanese-firms-focus-on-developing-cancer-vaccines-utilising-whole-genome-information.html</guid>
		</item>	
				<item>
			<title>Fujitsu develops multi-AI agent collaboration technology to optimise pharma supply chains</title>
			<atom:link href="https://biospectrumasia.com/news/50/26947/fujitsu-develops-multi-ai-agent-collaboration-technology-to-optimise-pharma-supply-chains.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26947/fujitsu-develops-multi-ai-agent-collaboration-technology-to-optimise-pharma-supply-chains.html</link>
			<pubDate>Mon, 01 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma_ai-26947.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26947/fujitsu-develops-multi-ai-agent-collaboration-technology-to-optimise-pharma-supply-chains.html</guid>
		</item>	
				<item>
			<title>South Korean medical AI startup AITRICS has established an office in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26912/south-korean-medical-ai-startup-aitrics-has-established-an-office-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26912/south-korean-medical-ai-startup-aitrics-has-established-an-office-in-japan.html</link>
			<pubDate>Fri, 21 Nov 2025 19:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26912/south-korean-medical-ai-startup-aitrics-has-established-an-office-in-japan.html</guid>
		</item>	
				<item>
			<title>Telix Pharma opens first cyclotron facility in Asia Pacific region</title>
			<atom:link href="https://biospectrumasia.com/news/50/26909/telix-pharma-opens-first-cyclotron-facility-in-asia-pacific-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26909/telix-pharma-opens-first-cyclotron-facility-in-asia-pacific-region.html</link>
			<pubDate>Fri, 21 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_21_11_2025_16739_jp_telixpharma_com-26909.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26909/telix-pharma-opens-first-cyclotron-facility-in-asia-pacific-region.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nxera announces restructuring to focus pipeline on obesity and metabolic diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/26904/japans-nxera-announces-restructuring-to-focus-pipeline-on-obesity-and-metabolic-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26904/japans-nxera-announces-restructuring-to-focus-pipeline-on-obesity-and-metabolic-diseases.html</link>
			<pubDate>Thu, 20 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_20_11_2025_141242_-26904.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26904/japans-nxera-announces-restructuring-to-focus-pipeline-on-obesity-and-metabolic-diseases.html</guid>
		</item>	
				<item>
			<title>Teijin and BioVaramÂ partnersÂ to expand Regenerative Medicine and Implantable Medical devices access in Japan and India</title>
			<atom:link href="https://biospectrumasia.com/news/50/26908/teijin-and-biovarampartnersto-expand-regenerative-medicine-and-implantable-medical-devices-access-in-japan-and-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26908/teijin-and-biovarampartnersto-expand-regenerative-medicine-and-implantable-medical-devices-access-in-japan-and-india.html</link>
			<pubDate>Thu, 20 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/synfolium-26908.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26908/teijin-and-biovarampartnersto-expand-regenerative-medicine-and-implantable-medical-devices-access-in-japan-and-india.html</guid>
		</item>	
				<item>
			<title>Taiwan CareTech Alliance enters Japan&#039;s ageing market with smart elderly care products</title>
			<atom:link href="https://biospectrumasia.com/news/50/26894/taiwan-caretech-alliance-enters-japans-ageing-market-with-smart-elderly-care-products.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26894/taiwan-caretech-alliance-enters-japans-ageing-market-with-smart-elderly-care-products.html</link>
			<pubDate>Wed, 19 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/taiwan-26894.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26894/taiwan-caretech-alliance-enters-japans-ageing-market-with-smart-elderly-care-products.html</guid>
		</item>	
				<item>
			<title>Swiss based Debiopharm Launches â€œIDEAL Japanâ€ to Spur Cancer Research Innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/26897/swiss-based-debiopharm-launches-ideal-japan-to-spur-cancer-research-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26897/swiss-based-debiopharm-launches-ideal-japan-to-spur-cancer-research-innovation.html</link>
			<pubDate>Tue, 18 Nov 2025 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26897/swiss-based-debiopharm-launches-ideal-japan-to-spur-cancer-research-innovation.html</guid>
		</item>	
				<item>
			<title>BostonGene and Kyoto University accelerate precision drug development</title>
			<atom:link href="https://biospectrumasia.com/news/50/26875/bostongene-and-kyoto-university-accelerate-precision-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26875/bostongene-and-kyoto-university-accelerate-precision-drug-development.html</link>
			<pubDate>Thu, 13 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_13_11_2025_133627_-26875.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26875/bostongene-and-kyoto-university-accelerate-precision-drug-development.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kaneka expands global reach with launch of brain aneurysm embolisation coil in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/50/26846/japans-kaneka-expands-global-reach-with-launch-of-brain-aneurysm-embolisation-coil-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26846/japans-kaneka-expands-global-reach-with-launch-of-brain-aneurysm-embolisation-coil-in-europe.html</link>
			<pubDate>Mon, 10 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_10_11_2025_132538_www_businesswire_com-26846.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26846/japans-kaneka-expands-global-reach-with-launch-of-brain-aneurysm-embolisation-coil-in-europe.html</guid>
		</item>	
				<item>
			<title>Fujifilm launches Joint Research with National Cancer Center in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26840/fujifilm-launches-joint-research-with-national-cancer-center-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26840/fujifilm-launches-joint-research-with-national-cancer-center-in-japan.html</link>
			<pubDate>Fri, 07 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-26840.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26840/fujifilm-launches-joint-research-with-national-cancer-center-in-japan.html</guid>
		</item>	
				<item>
			<title>NEXT Oncology expands to Japan in partnership with Kansai Medical University</title>
			<atom:link href="https://biospectrumasia.com/news/50/26845/next-oncology-expands-to-japan-in-partnership-with-kansai-medical-university.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26845/next-oncology-expands-to-japan-in-partnership-with-kansai-medical-university.html</link>
			<pubDate>Thu, 06 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/next_onco-26845.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26845/next-oncology-expands-to-japan-in-partnership-with-kansai-medical-university.html</guid>
		</item>	
				<item>
			<title>4DMT and Otsuka ink deal worth $336 M to advance eye disease treatment in APAC</title>
			<atom:link href="https://biospectrumasia.com/news/50/26832/4dmt-and-otsuka-ink-deal-worth-336-m-to-advance-eye-disease-treatment-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26832/4dmt-and-otsuka-ink-deal-worth-336-m-to-advance-eye-disease-treatment-in-apac.html</link>
			<pubDate>Tue, 04 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_11_2025_135258_-26832.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26832/4dmt-and-otsuka-ink-deal-worth-336-m-to-advance-eye-disease-treatment-in-apac.html</guid>
		</item>	
				<item>
			<title>Boehringer Ingelheim acquires license of autoimmune drug from Japan&#039;s Kyowa Kirin for â‚¬ 640 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/26815/boehringer-ingelheim-acquires-license-of-autoimmune-drug-from-japans-kyowa-kirin-for-640-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26815/boehringer-ingelheim-acquires-license-of-autoimmune-drug-from-japans-kyowa-kirin-for-640-m.html</link>
			<pubDate>Mon, 03 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-26815.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26815/boehringer-ingelheim-acquires-license-of-autoimmune-drug-from-japans-kyowa-kirin-for-640-m.html</guid>
		</item>	
				<item>
			<title>â€œPoint of care will change the CDMO business structure from Centralise to De-Centralise cell manufacturingâ€ </title>
			<atom:link href="https://biospectrumasia.com/opinion/50/26825/point-of-care-will-change-the-cdmo-business-structure-from-centralise-to-de-centralise-cell-manufacturing-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/26825/point-of-care-will-change-the-cdmo-business-structure-from-centralise-to-de-centralise-cell-manufacturing-.html</link>
			<pubDate>Sat, 01 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeshi_hosoyama-26825.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/26825/point-of-care-will-change-the-cdmo-business-structure-from-centralise-to-de-centralise-cell-manufacturing-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT Fund invests Â¥1.73 B in new TB, NTD, and malaria Projects</title>
			<atom:link href="https://biospectrumasia.com/news/50/26806/japans-ghit-fund-invests-1-73-b-in-new-tb-ntd-and-malaria-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26806/japans-ghit-fund-invests-1-73-b-in-new-tb-ntd-and-malaria-projects.html</link>
			<pubDate>Thu, 30 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lab-26806.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26806/japans-ghit-fund-invests-1-73-b-in-new-tb-ntd-and-malaria-projects.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Chugai to acquire Renalys Pharma for JPY 16 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/26792/japans-chugai-to-acquire-renalys-pharma-for-jpy-16-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26792/japans-chugai-to-acquire-renalys-pharma-for-jpy-16-b.html</link>
			<pubDate>Wed, 29 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26792/japans-chugai-to-acquire-renalys-pharma-for-jpy-16-b.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus launches new surgical energy device for hemostatic cutting and Vessel Sealing</title>
			<atom:link href="https://biospectrumasia.com/news/50/26786/japans-olympus-launches-new-surgical-energy-device-for-hemostatic-cutting-and-vessel-sealing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26786/japans-olympus-launches-new-surgical-energy-device-for-hemostatic-cutting-and-vessel-sealing.html</link>
			<pubDate>Tue, 28 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_10_2025_93118_www_olympus_global_com-26786.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26786/japans-olympus-launches-new-surgical-energy-device-for-hemostatic-cutting-and-vessel-sealing.html</guid>
		</item>	
				<item>
			<title>MEDINET to develop and commercialise first Made-in-India cell therapy product in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26797/medinet-to-develop-and-commercialise-first-made-in-india-cell-therapy-product-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26797/medinet-to-develop-and-commercialise-first-made-in-india-cell-therapy-product-in-japan.html</link>
			<pubDate>Tue, 28 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_10_2025_193142_www_stempeutics_com-26797.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26797/medinet-to-develop-and-commercialise-first-made-in-india-cell-therapy-product-in-japan.html</guid>
		</item>	
				<item>
			<title>Naobios and Tokyo Metropolitan Institute of Medical Science to develop new vaccine against mpox</title>
			<atom:link href="https://biospectrumasia.com/news/50/26782/naobios-and-tokyo-metropolitan-institute-of-medical-science-to-develop-new-vaccine-against-mpox.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26782/naobios-and-tokyo-metropolitan-institute-of-medical-science-to-develop-new-vaccine-against-mpox.html</link>
			<pubDate>Mon, 27 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vax-26782.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26782/naobios-and-tokyo-metropolitan-institute-of-medical-science-to-develop-new-vaccine-against-mpox.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda forms $11.4 B global oncology partnership with Innovent Biologics</title>
			<atom:link href="https://biospectrumasia.com/news/50/26780/japans-takeda-forms-11-4-b-global-oncology-partnership-with-innovent-biologics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26780/japans-takeda-forms-11-4-b-global-oncology-partnership-with-innovent-biologics.html</link>
			<pubDate>Thu, 23 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_23_10_2025_103058_-26780.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26780/japans-takeda-forms-11-4-b-global-oncology-partnership-with-innovent-biologics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Chugai inks $1.08 B deal with Rani Therapeutics for multiple high-value therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/26770/japans-chugai-inks-1-08-b-deal-with-rani-therapeutics-for-multiple-high-value-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26770/japans-chugai-inks-1-08-b-deal-with-rani-therapeutics-for-multiple-high-value-therapeutics.html</link>
			<pubDate>Tue, 21 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_21_10_2025_124044_ir_ranitherapeutics_com-26770.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26770/japans-chugai-inks-1-08-b-deal-with-rani-therapeutics-for-multiple-high-value-therapeutics.html</guid>
		</item>	
				<item>
			<title>A.D.A.M. Innovations, SOPHiA GENETICS to advance liquid biopsy testing in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26764/a-d-a-m-innovations-sophia-genetics-to-advance-liquid-biopsy-testing-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26764/a-d-a-m-innovations-sophia-genetics-to-advance-liquid-biopsy-testing-in-japan.html</link>
			<pubDate>Fri, 17 Oct 2025 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_10_2025_224426_-26764.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26764/a-d-a-m-innovations-sophia-genetics-to-advance-liquid-biopsy-testing-in-japan.html</guid>
		</item>	
				<item>
			<title>Sumitomo, Novo Nordisk to co-promote obesity drug Wegovy in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26761/sumitomo-novo-nordisk-to-co-promote-obesity-drug-wegovy-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26761/sumitomo-novo-nordisk-to-co-promote-obesity-drug-wegovy-in-japan.html</link>
			<pubDate>Thu, 16 Oct 2025 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_10_2025_221348_-26761.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26761/sumitomo-novo-nordisk-to-co-promote-obesity-drug-wegovy-in-japan.html</guid>
		</item>	
				<item>
			<title>Chugai Secures Japan Rights to Roche&#039;s GLP-1/GIP Drug CT-388 for Obesity and Diabetes</title>
			<atom:link href="https://biospectrumasia.com/news/50/26750/chugai-secures-japan-rights-to-roches-glp-1-gip-drug-ct-388-for-obesity-and-diabetes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26750/chugai-secures-japan-rights-to-roches-glp-1-gip-drug-ct-388-for-obesity-and-diabetes.html</link>
			<pubDate>Tue, 14 Oct 2025 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26750/chugai-secures-japan-rights-to-roches-glp-1-gip-drug-ct-388-for-obesity-and-diabetes.html</guid>
		</item>	
				<item>
			<title>UK and Japan biotech associations sign landmark deal to accelerate innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/26745/uk-and-japan-biotech-associations-sign-landmark-deal-to-accelerate-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26745/uk-and-japan-biotech-associations-sign-landmark-deal-to-accelerate-innovation.html</link>
			<pubDate>Mon, 13 Oct 2025 12:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_13_10_2025_223428_www_bioindustry_org-26745.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26745/uk-and-japan-biotech-associations-sign-landmark-deal-to-accelerate-innovation.html</guid>
		</item>	
				<item>
			<title>Gunze Medical and HistoSonics enter into distribution agreement in Japan for non-invasive ultrasound therapy devices</title>
			<atom:link href="https://biospectrumasia.com/news/50/26729/gunze-medical-and-histosonics-enter-into-distribution-agreement-in-japan-for-non-invasive-ultrasound-therapy-devices.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26729/gunze-medical-and-histosonics-enter-into-distribution-agreement-in-japan-for-non-invasive-ultrasound-therapy-devices.html</link>
			<pubDate>Fri, 10 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_10_10_2025_173453_mms_businesswire_com-26729.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26729/gunze-medical-and-histosonics-enter-into-distribution-agreement-in-japan-for-non-invasive-ultrasound-therapy-devices.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Alpha Fusion and Kobe City Medical Center General Hospital establish At-211 investigational drug supply system</title>
			<atom:link href="https://biospectrumasia.com/news/50/26728/japans-alpha-fusion-and-kobe-city-medical-center-general-hospital-establish-at-211-investigational-drug-supply-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26728/japans-alpha-fusion-and-kobe-city-medical-center-general-hospital-establish-at-211-investigational-drug-supply-system.html</link>
			<pubDate>Thu, 09 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_10_2025_111733_-26728.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26728/japans-alpha-fusion-and-kobe-city-medical-center-general-hospital-establish-at-211-investigational-drug-supply-system.html</guid>
		</item>	
				<item>
			<title>Rentschler Biopharma further expands services in Japan and South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/26721/rentschler-biopharma-further-expands-services-in-japan-and-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26721/rentschler-biopharma-further-expands-services-in-japan-and-south-korea.html</link>
			<pubDate>Wed, 08 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/12-26721.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26721/rentschler-biopharma-further-expands-services-in-japan-and-south-korea.html</guid>
		</item>	
				<item>
			<title>New initiative to connect Japanese medtech startups with Singapore-based venture capital firms</title>
			<atom:link href="https://biospectrumasia.com/news/50/26724/new-initiative-to-connect-japanese-medtech-startups-with-singapore-based-venture-capital-firms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26724/new-initiative-to-connect-japanese-medtech-startups-with-singapore-based-venture-capital-firms.html</link>
			<pubDate>Wed, 08 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/_pic1-26724.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26724/new-initiative-to-connect-japanese-medtech-startups-with-singapore-based-venture-capital-firms.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kubota to introduce myopia management device in Thailand</title>
			<atom:link href="https://biospectrumasia.com/news/50/26718/japans-kubota-to-introduce-myopia-management-device-in-thailand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26718/japans-kubota-to-introduce-myopia-management-device-in-thailand.html</link>
			<pubDate>Tue, 07 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_7_10_2025_112129_kubotaglass_com-26718.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26718/japans-kubota-to-introduce-myopia-management-device-in-thailand.html</guid>
		</item>	
				<item>
			<title>Japan approves world&#039;s first iodine-treated total hip replacement system</title>
			<atom:link href="https://biospectrumasia.com/news/50/26697/japan-approves-worlds-first-iodine-treated-total-hip-replacement-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26697/japan-approves-worlds-first-iodine-treated-total-hip-replacement-system.html</link>
			<pubDate>Mon, 06 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_6_10_2025_93638_www_zimmerbiomet_in-26697.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26697/japan-approves-worlds-first-iodine-treated-total-hip-replacement-system.html</guid>
		</item>	
				<item>
			<title>Olympus launches SecureFlex, a Single-use fine needle biopsy device</title>
			<atom:link href="https://biospectrumasia.com/news/50/26716/olympus-launches-secureflex-a-single-use-fine-needle-biopsy-device.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26716/olympus-launches-secureflex-a-single-use-fine-needle-biopsy-device.html</link>
			<pubDate>Mon, 06 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed_9_-26716.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26716/olympus-launches-secureflex-a-single-use-fine-needle-biopsy-device.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo establishes third research institute in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/26711/japans-daiichi-sankyo-establishes-third-research-institute-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26711/japans-daiichi-sankyo-establishes-third-research-institute-in-us.html</link>
			<pubDate>Fri, 03 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lab-26711.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26711/japans-daiichi-sankyo-establishes-third-research-institute-in-us.html</guid>
		</item>	
				<item>
			<title>Australia&#039;s Cell Therapies partners with Teijin to expand access to advanced cell and gene therapies in Japan and APAC region</title>
			<atom:link href="https://biospectrumasia.com/news/50/26690/australias-cell-therapies-partners-with-teijin-to-expand-access-to-advanced-cell-and-gene-therapies-in-japan-and-apac-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26690/australias-cell-therapies-partners-with-teijin-to-expand-access-to-advanced-cell-and-gene-therapies-in-japan-and-apac-region.html</link>
			<pubDate>Wed, 01 Oct 2025 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_1_10_2025_125052_www_teijin_com-26690.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26690/australias-cell-therapies-partners-with-teijin-to-expand-access-to-advanced-cell-and-gene-therapies-in-japan-and-apac-region.html</guid>
		</item>	
				<item>
			<title>Takeda to discontinue cell therapy research</title>
			<atom:link href="https://biospectrumasia.com/news/50/26696/takeda-to-discontinue-cell-therapy-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26696/takeda-to-discontinue-cell-therapy-research.html</link>
			<pubDate>Wed, 01 Oct 2025 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26696/takeda-to-discontinue-cell-therapy-research.html</guid>
		</item>	
				<item>
			<title>Lantheus divests rights of prostate cancer PET tracer in Japan to GE HealthCare</title>
			<atom:link href="https://biospectrumasia.com/news/50/26683/lantheus-divests-rights-of-prostate-cancer-pet-tracer-in-japan-to-ge-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26683/lantheus-divests-rights-of-prostate-cancer-pet-tracer-in-japan-to-ge-healthcare.html</link>
			<pubDate>Tue, 30 Sep 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_9_2025_11041_-26683.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26683/lantheus-divests-rights-of-prostate-cancer-pet-tracer-in-japan-to-ge-healthcare.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus launches AI-powered endoscopy in US &amp; Europe markets</title>
			<atom:link href="https://biospectrumasia.com/news/50/26687/japans-olympus-launches-ai-powered-endoscopy-in-us-europe-markets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26687/japans-olympus-launches-ai-powered-endoscopy-in-us-europe-markets.html</link>
			<pubDate>Tue, 30 Sep 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-26687.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26687/japans-olympus-launches-ai-powered-endoscopy-in-us-europe-markets.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Hitachi partners with ELITech for molecular testing for infectious disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/26673/japans-hitachi-partners-with-elitech-for-molecular-testing-for-infectious-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26673/japans-hitachi-partners-with-elitech-for-molecular-testing-for-infectious-disease.html</link>
			<pubDate>Fri, 26 Sep 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_26_9_2025_121449_-26673.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26673/japans-hitachi-partners-with-elitech-for-molecular-testing-for-infectious-disease.html</guid>
		</item>	
				<item>
			<title>Genomenon and Compass Bioinformatics to transform genomic diagnostics in US and Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26670/genomenon-and-compass-bioinformatics-to-transform-genomic-diagnostics-in-us-and-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26670/genomenon-and-compass-bioinformatics-to-transform-genomic-diagnostics-in-us-and-japan.html</link>
			<pubDate>Wed, 24 Sep 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene-26670.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26670/genomenon-and-compass-bioinformatics-to-transform-genomic-diagnostics-in-us-and-japan.html</guid>
		</item>	
				<item>
			<title>xFOREST Therapeutics, Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/26654/xforest-therapeutics-axcelead-ddp-launch-joint-research-initiative-on-rna-structure-targeted-small-molecule-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26654/xforest-therapeutics-axcelead-ddp-launch-joint-research-initiative-on-rna-structure-targeted-small-molecule-drug-discovery.html</link>
			<pubDate>Fri, 19 Sep 2025 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26654/xforest-therapeutics-axcelead-ddp-launch-joint-research-initiative-on-rna-structure-targeted-small-molecule-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu announces launch of Gas Chromatograph FluxEdge GC System</title>
			<atom:link href="https://biospectrumasia.com/news/50/26607/japans-shimadzu-announces-launch-of-gas-chromatograph-fluxedge-gc-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26607/japans-shimadzu-announces-launch-of-gas-chromatograph-fluxedge-gc-system.html</link>
			<pubDate>Mon, 15 Sep 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_9_2025_162356_www_shimadzu_com-26607.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26607/japans-shimadzu-announces-launch-of-gas-chromatograph-fluxedge-gc-system.html</guid>
		</item>	
				<item>
			<title>Japan to revolutionise Alzheimer&#039;s Disease treatment with LIPUS-Brain Device</title>
			<atom:link href="https://biospectrumasia.com/news/50/26601/japan-to-revolutionise-alzheimers-disease-treatment-with-lipus-brain-device.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26601/japan-to-revolutionise-alzheimers-disease-treatment-with-lipus-brain-device.html</link>
			<pubDate>Tue, 09 Sep 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_9_2025_13727_sw_innovation_com-26601.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26601/japan-to-revolutionise-alzheimers-disease-treatment-with-lipus-brain-device.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PHC Holdings inks MoU to transfer EversenseÂ® CGM distribution to strategic partner Senseonics</title>
			<atom:link href="https://biospectrumasia.com/news/50/26590/japans-phc-holdings-inks-mou-to-transfer-eversense-cgm-distribution-to-strategic-partner-senseonics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26590/japans-phc-holdings-inks-mou-to-transfer-eversense-cgm-distribution-to-strategic-partner-senseonics.html</link>
			<pubDate>Thu, 04 Sep 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_9_2025_114243_www_eversensecgm_com-26590.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26590/japans-phc-holdings-inks-mou-to-transfer-eversense-cgm-distribution-to-strategic-partner-senseonics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Medipal and JCR Pharma to co-develop novel therapy for rare lysosomal storage disorder</title>
			<atom:link href="https://biospectrumasia.com/news/50/26585/japans-medipal-and-jcr-pharma-to-co-develop-novel-therapy-for-rare-lysosomal-storage-disorder.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26585/japans-medipal-and-jcr-pharma-to-co-develop-novel-therapy-for-rare-lysosomal-storage-disorder.html</link>
			<pubDate>Tue, 02 Sep 2025 05:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan_block_003-26585.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26585/japans-medipal-and-jcr-pharma-to-co-develop-novel-therapy-for-rare-lysosomal-storage-disorder.html</guid>
		</item>	
				<item>
			<title>ColartixÂ® hydrolyzed cartilage matrix is patented by Rousselot in Europe, Japan, and China</title>
			<atom:link href="https://biospectrumasia.com/news/50/26579/colartix-hydrolyzed-cartilage-matrix-is-patented-by-rousselot-in-europe-japan-and-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26579/colartix-hydrolyzed-cartilage-matrix-is-patented-by-rousselot-in-europe-japan-and-china.html</link>
			<pubDate>Tue, 02 Sep 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/white_pills_plastic_bottle-26579.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26579/colartix-hydrolyzed-cartilage-matrix-is-patented-by-rousselot-in-europe-japan-and-china.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Celaid, AGC partner on stem cell technology expansion and evaluation research</title>
			<atom:link href="https://biospectrumasia.com/news/50/26563/japans-celaid-agc-partner-on-stem-cell-technology-expansion-and-evaluation-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26563/japans-celaid-agc-partner-on-stem-cell-technology-expansion-and-evaluation-research.html</link>
			<pubDate>Fri, 29 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sc-26563.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26563/japans-celaid-agc-partner-on-stem-cell-technology-expansion-and-evaluation-research.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nippon to establish Singapore-based JV to license drugs in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/26546/japans-nippon-to-establish-singapore-based-jv-to-license-drugs-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26546/japans-nippon-to-establish-singapore-based-jv-to-license-drugs-in-asia.html</link>
			<pubDate>Wed, 27 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_27_8_2025_12324_-26546.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26546/japans-nippon-to-establish-singapore-based-jv-to-license-drugs-in-asia.html</guid>
		</item>	
				<item>
			<title>Thailand approves Meiji&#039;s REZUROCKÂ® for treatment of chronic graft-versus-host disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/26538/thailand-approves-meijis-rezurock-for-treatment-of-chronic-graft-versus-host-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26538/thailand-approves-meijis-rezurock-for-treatment-of-chronic-graft-versus-host-disease.html</link>
			<pubDate>Tue, 26 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_26_8_2025_12039_-26538.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26538/thailand-approves-meijis-rezurock-for-treatment-of-chronic-graft-versus-host-disease.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Terumo to acquire OrganOx for $1.5 B marking strategic entry into organ transplantation-related sector</title>
			<atom:link href="https://biospectrumasia.com/news/50/26536/japans-terumo-to-acquire-organox-for-1-5-b-marking-strategic-entry-into-organ-transplantation-related-sector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26536/japans-terumo-to-acquire-organox-for-1-5-b-marking-strategic-entry-into-organ-transplantation-related-sector.html</link>
			<pubDate>Mon, 25 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2025_08_25_155712-26536.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26536/japans-terumo-to-acquire-organox-for-1-5-b-marking-strategic-entry-into-organ-transplantation-related-sector.html</guid>
		</item>	
				<item>
			<title>First-of-its-kind tool for screening autism becomes available in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26518/first-of-its-kind-tool-for-screening-autism-becomes-available-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26518/first-of-its-kind-tool-for-screening-autism-becomes-available-in-japan.html</link>
			<pubDate>Thu, 21 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_21_8_2025_16236_www_clearstrandasd_com-26518.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26518/first-of-its-kind-tool-for-screening-autism-becomes-available-in-japan.html</guid>
		</item>	
				<item>
			<title>Teleflex introduces Barrigel Rectal Spacer in Japan for prostate cancer radiotherapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/26516/teleflex-introduces-barrigel-rectal-spacer-in-japan-for-prostate-cancer-radiotherapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26516/teleflex-introduces-barrigel-rectal-spacer-in-japan-for-prostate-cancer-radiotherapy.html</link>
			<pubDate>Wed, 20 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pc-26516.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26516/teleflex-introduces-barrigel-rectal-spacer-in-japan-for-prostate-cancer-radiotherapy.html</guid>
		</item>	
				<item>
			<title>Nicox and Kowa sign â‚¬191.5 M deal for glaucoma treatment </title>
			<atom:link href="https://biospectrumasia.com/news/50/26508/nicox-and-kowa-sign-191-5-m-deal-for-glaucoma-treatment-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26508/nicox-and-kowa-sign-191-5-m-deal-for-glaucoma-treatment-.html</link>
			<pubDate>Tue, 19 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gla-26508.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26508/nicox-and-kowa-sign-191-5-m-deal-for-glaucoma-treatment-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Solasia Pharma licenses DARVIAS and Episil to Firebird for 19 countries</title>
			<atom:link href="https://biospectrumasia.com/news/50/26488/japans-solasia-pharma-licenses-darvias-and-episil-to-firebird-for-19-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26488/japans-solasia-pharma-licenses-darvias-and-episil-to-firebird-for-19-countries.html</link>
			<pubDate>Tue, 12 Aug 2025 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicine_9164-26488.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26488/japans-solasia-pharma-licenses-darvias-and-episil-to-firebird-for-19-countries.html</guid>
		</item>	
				<item>
			<title>Japan approves Biostar&#039;s Angel Stem Cell Therapy for clinical use</title>
			<atom:link href="https://biospectrumasia.com/news/50/26483/japan-approves-biostars-angel-stem-cell-therapy-for-clinical-use.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26483/japan-approves-biostars-angel-stem-cell-therapy-for-clinical-use.html</link>
			<pubDate>Tue, 12 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-26483.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26483/japan-approves-biostars-angel-stem-cell-therapy-for-clinical-use.html</guid>
		</item>	
				<item>
			<title>Shimadzu to launch particle analysis system in Japan and overseas for analysis of microplastics</title>
			<atom:link href="https://biospectrumasia.com/news/50/26476/shimadzu-to-launch-particle-analysis-system-in-japan-and-overseas-for-analysis-of-microplastics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26476/shimadzu-to-launch-particle-analysis-system-in-japan-and-overseas-for-analysis-of-microplastics.html</link>
			<pubDate>Mon, 11 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_11_8_2025_133930_www_shimadzu_com-26476.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26476/shimadzu-to-launch-particle-analysis-system-in-japan-and-overseas-for-analysis-of-microplastics.html</guid>
		</item>	
				<item>
			<title>Astria licenses rare disease drug Navenibart to Japan&#039;s Kaken Pharma in $32 M deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/26473/astria-licenses-rare-disease-drug-navenibart-to-japans-kaken-pharma-in-32-m-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26473/astria-licenses-rare-disease-drug-navenibart-to-japans-kaken-pharma-in-32-m-deal.html</link>
			<pubDate>Fri, 08 Aug 2025 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_8_2025_232531_-26473.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26473/astria-licenses-rare-disease-drug-navenibart-to-japans-kaken-pharma-in-32-m-deal.html</guid>
		</item>	
				<item>
			<title>Shimadzu inks new collaborative agreement with Kyoto University in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26443/shimadzu-inks-new-collaborative-agreement-with-kyoto-university-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26443/shimadzu-inks-new-collaborative-agreement-with-kyoto-university-in-japan.html</link>
			<pubDate>Thu, 31 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_7_2025_9315_www_shimadzu_com-26443.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26443/shimadzu-inks-new-collaborative-agreement-with-kyoto-university-in-japan.html</guid>
		</item>	
				<item>
			<title>Viridian Therapeutics and Kissei Pharma ink deal worth $315 M focusing on thyroid eye disease in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26440/viridian-therapeutics-and-kissei-pharma-ink-deal-worth-315-m-focusing-on-thyroid-eye-disease-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26440/viridian-therapeutics-and-kissei-pharma-ink-deal-worth-315-m-focusing-on-thyroid-eye-disease-in-japan.html</link>
			<pubDate>Wed, 30 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_7_2025_175011_-26440.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26440/viridian-therapeutics-and-kissei-pharma-ink-deal-worth-315-m-focusing-on-thyroid-eye-disease-in-japan.html</guid>
		</item>	
				<item>
			<title>China&#039;s Tigermed acquires Japanese CRO Micron to expand medical imaging capabilities in APAC</title>
			<atom:link href="https://biospectrumasia.com/news/50/26423/chinas-tigermed-acquires-japanese-cro-micron-to-expand-medical-imaging-capabilities-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26423/chinas-tigermed-acquires-japanese-cro-micron-to-expand-medical-imaging-capabilities-in-apac.html</link>
			<pubDate>Tue, 29 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1748922401726-26423.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26423/chinas-tigermed-acquires-japanese-cro-micron-to-expand-medical-imaging-capabilities-in-apac.html</guid>
		</item>	
				<item>
			<title>Asahi Kasei expands Planova production with new spinning plant in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26437/asahi-kasei-expands-planova-production-with-new-spinning-plant-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26437/asahi-kasei-expands-planova-production-with-new-spinning-plant-in-japan.html</link>
			<pubDate>Tue, 29 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/planova_s20n_virus_removal_filters-26437.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26437/asahi-kasei-expands-planova-production-with-new-spinning-plant-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus enters strategic partnership to develop endoluminal gastrointestinal robotics</title>
			<atom:link href="https://biospectrumasia.com/news/50/26408/japans-olympus-enters-strategic-partnership-to-develop-endoluminal-gastrointestinal-robotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26408/japans-olympus-enters-strategic-partnership-to-develop-endoluminal-gastrointestinal-robotics.html</link>
			<pubDate>Fri, 25 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_25_7_2025_131738_www_olympus_global_com-26408.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26408/japans-olympus-enters-strategic-partnership-to-develop-endoluminal-gastrointestinal-robotics.html</guid>
		</item>	
				<item>
			<title>Japan launches nationwide initiative to promote gastric health and early detection of gastric cancer, Co-initiated by Mirxes Japan &amp; Nagawa</title>
			<atom:link href="https://biospectrumasia.com/news/50/26394/japan-launches-nationwide-initiative-to-promote-gastric-health-and-early-detection-of-gastric-cancer-co-initiated-by-mirxes-japan-nagawa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26394/japan-launches-nationwide-initiative-to-promote-gastric-health-and-early-detection-of-gastric-cancer-co-initiated-by-mirxes-japan-nagawa.html</link>
			<pubDate>Thu, 24 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan_2-26394.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26394/japan-launches-nationwide-initiative-to-promote-gastric-health-and-early-detection-of-gastric-cancer-co-initiated-by-mirxes-japan-nagawa.html</guid>
		</item>	
				<item>
			<title>Alloy Therapeutics and Kansai Startup Academia Coalition accelerate global growth of Japanese life science startups</title>
			<atom:link href="https://biospectrumasia.com/news/50/26387/alloy-therapeutics-and-kansai-startup-academia-coalition-accelerate-global-growth-of-japanese-life-science-startups.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26387/alloy-therapeutics-and-kansai-startup-academia-coalition-accelerate-global-growth-of-japanese-life-science-startups.html</link>
			<pubDate>Wed, 23 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-26387.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26387/alloy-therapeutics-and-kansai-startup-academia-coalition-accelerate-global-growth-of-japanese-life-science-startups.html</guid>
		</item>	
				<item>
			<title>GARDP partners with Institute of Science Tokyo to focus on drug resistant infections</title>
			<atom:link href="https://biospectrumasia.com/news/50/26382/gardp-partners-with-institute-of-science-tokyo-to-focus-on-drug-resistant-infections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26382/gardp-partners-with-institute-of-science-tokyo-to-focus-on-drug-resistant-infections.html</link>
			<pubDate>Tue, 22 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-26382.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26382/gardp-partners-with-institute-of-science-tokyo-to-focus-on-drug-resistant-infections.html</guid>
		</item>	
				<item>
			<title>NKGen Biotech and HekaBio enter strategic partnership to bring novel NK cell therapy to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26370/nkgen-biotech-and-hekabio-enter-strategic-partnership-to-bring-novel-nk-cell-therapy-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26370/nkgen-biotech-and-hekabio-enter-strategic-partnership-to-bring-novel-nk-cell-therapy-to-japan.html</link>
			<pubDate>Mon, 21 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nk-26370.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26370/nkgen-biotech-and-hekabio-enter-strategic-partnership-to-bring-novel-nk-cell-therapy-to-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT announces investment of $7.3 M in Malaria and TB R&amp;D projects</title>
			<atom:link href="https://biospectrumasia.com/news/50/26360/japans-ghit-announces-investment-of-7-3-m-in-malaria-and-tb-rd-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26360/japans-ghit-announces-investment-of-7-3-m-in-malaria-and-tb-rd-projects.html</link>
			<pubDate>Fri, 18 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_17_7_2025_16254_-26360.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26360/japans-ghit-announces-investment-of-7-3-m-in-malaria-and-tb-rd-projects.html</guid>
		</item>	
				<item>
			<title>Fujitsu and Acer Medical deploy AI tool to assess disease risk in elderly patients through gait abnormality</title>
			<atom:link href="https://biospectrumasia.com/news/50/26348/fujitsu-and-acer-medical-deploy-ai-tool-to-assess-disease-risk-in-elderly-patients-through-gait-abnormality.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26348/fujitsu-and-acer-medical-deploy-ai-tool-to-assess-disease-risk-in-elderly-patients-through-gait-abnormality.html</link>
			<pubDate>Wed, 16 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_7_2025_111427_-26348.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26348/fujitsu-and-acer-medical-deploy-ai-tool-to-assess-disease-risk-in-elderly-patients-through-gait-abnormality.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Next-generation &#039;nanoball&#039; approach strives for a paradigm shift in vaccine technology</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/26354/japans-next-generation-nanoball-approach-strives-for-a-paradigm-shift-in-vaccine-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/26354/japans-next-generation-nanoball-approach-strives-for-a-paradigm-shift-in-vaccine-technology.html</link>
			<pubDate>Wed, 16 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image_9_edited-26354.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/26354/japans-next-generation-nanoball-approach-strives-for-a-paradigm-shift-in-vaccine-technology.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s JCR Pharma and Acumen announce collaboration to develop therapy for Alzheimer&#039;s Disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/26346/japans-jcr-pharma-and-acumen-announce-collaboration-to-develop-therapy-for-alzheimers-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26346/japans-jcr-pharma-and-acumen-announce-collaboration-to-develop-therapy-for-alzheimers-disease.html</link>
			<pubDate>Tue, 15 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alz-26346.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26346/japans-jcr-pharma-and-acumen-announce-collaboration-to-develop-therapy-for-alzheimers-disease.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Omron Healthcare to soon roll out Made-in-India blood pressure monitors</title>
			<atom:link href="https://biospectrumasia.com/news/50/26334/japans-omron-healthcare-to-soon-roll-out-made-in-india-blood-pressure-monitors.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26334/japans-omron-healthcare-to-soon-roll-out-made-in-india-blood-pressure-monitors.html</link>
			<pubDate>Fri, 11 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_11_7_2025_163517_-26334.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26334/japans-omron-healthcare-to-soon-roll-out-made-in-india-blood-pressure-monitors.html</guid>
		</item>	
				<item>
			<title>I Peace and Vita Therapeutics to develop iPS cells for transplantation therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/26331/i-peace-and-vita-therapeutics-to-develop-ips-cells-for-transplantation-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26331/i-peace-and-vita-therapeutics-to-develop-ips-cells-for-transplantation-therapy.html</link>
			<pubDate>Thu, 10 Jul 2025 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_10_7_2025_22278_-26331.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26331/i-peace-and-vita-therapeutics-to-develop-ips-cells-for-transplantation-therapy.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s JCR Pharma licenses gene therapy platform to AstraZeneca Rare Disease unit for $825 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/26324/japans-jcr-pharma-licenses-gene-therapy-platform-to-astrazeneca-rare-disease-unit-for-825-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26324/japans-jcr-pharma-licenses-gene-therapy-platform-to-astrazeneca-rare-disease-unit-for-825-m.html</link>
			<pubDate>Thu, 10 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_10_7_2025_1940_www_jcrpharm_co_jp-26324.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26324/japans-jcr-pharma-licenses-gene-therapy-platform-to-astrazeneca-rare-disease-unit-for-825-m.html</guid>
		</item>	
				<item>
			<title>Chugai and Gero ink $250 M deal to develop new therapies for age-related diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/26315/chugai-and-gero-ink-250-m-deal-to-develop-new-therapies-for-age-related-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26315/chugai-and-gero-ink-250-m-deal-to-develop-new-therapies-for-age-related-diseases.html</link>
			<pubDate>Wed, 09 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ab-26315.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26315/chugai-and-gero-ink-250-m-deal-to-develop-new-therapies-for-age-related-diseases.html</guid>
		</item>	
				<item>
			<title>Verified Clinical Trials launches operations in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26314/verified-clinical-trials-launches-operations-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26314/verified-clinical-trials-launches-operations-in-japan.html</link>
			<pubDate>Tue, 08 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ct-26314.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26314/verified-clinical-trials-launches-operations-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu receives US FDA&#039;s premarketing notification for Positive PET system</title>
			<atom:link href="https://biospectrumasia.com/news/50/26309/japans-shimadzu-receives-us-fdas-premarketing-notification-for-positive-pet-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26309/japans-shimadzu-receives-us-fdas-premarketing-notification-for-positive-pet-system.html</link>
			<pubDate>Mon, 07 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_7_7_2025_131247_www_shimadzu_com-26309.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26309/japans-shimadzu-receives-us-fdas-premarketing-notification-for-positive-pet-system.html</guid>
		</item>	
				<item>
			<title>BioVersys inks deal worth CHF 479 M with Japan&#039;s Shionogi to treat infectious diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/26301/bioversys-inks-deal-worth-chf-479-m-with-japans-shionogi-to-treat-infectious-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26301/bioversys-inks-deal-worth-chf-479-m-with-japans-shionogi-to-treat-infectious-diseases.html</link>
			<pubDate>Fri, 04 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_7_2025_105342_www_bioversys_com-26301.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26301/bioversys-inks-deal-worth-chf-479-m-with-japans-shionogi-to-treat-infectious-diseases.html</guid>
		</item>	
				<item>
			<title>AN Venture Partners announces one of the largest Japan focused biotech funds to date</title>
			<atom:link href="https://biospectrumasia.com/news/50/26296/an-venture-partners-announces-one-of-the-largest-japan-focused-biotech-funds-to-date.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26296/an-venture-partners-announces-one-of-the-largest-japan-focused-biotech-funds-to-date.html</link>
			<pubDate>Thu, 03 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_3_7_2025_11856_-26296.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26296/an-venture-partners-announces-one-of-the-largest-japan-focused-biotech-funds-to-date.html</guid>
		</item>	
				<item>
			<title>PHC announces exclusive distribution of MaxCyte ExPERT platform in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26289/phc-announces-exclusive-distribution-of-maxcyte-expert-platform-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26289/phc-announces-exclusive-distribution-of-maxcyte-expert-platform-in-japan.html</link>
			<pubDate>Wed, 02 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2_7_2025_124826_mms_businesswire_com-26289.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26289/phc-announces-exclusive-distribution-of-maxcyte-expert-platform-in-japan.html</guid>
		</item>	
				<item>
			<title>AvenCell Japan wins $40 M AMED grant to advance allogeneic CAR-T programme</title>
			<atom:link href="https://biospectrumasia.com/news/50/26276/avencell-japan-wins-40-m-amed-grant-to-advance-allogeneic-car-t-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26276/avencell-japan-wins-40-m-amed-grant-to-advance-allogeneic-car-t-programme.html</link>
			<pubDate>Tue, 01 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/grant-26276.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26276/avencell-japan-wins-40-m-amed-grant-to-advance-allogeneic-car-t-programme.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s strategic medtech alignment with India</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/26283/japans-strategic-medtech-alignment-with-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/26283/japans-strategic-medtech-alignment-with-india.html</link>
			<pubDate>Tue, 01 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_1_7_2025_185312_-26283.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/26283/japans-strategic-medtech-alignment-with-india.html</guid>
		</item>	
				<item>
			<title>â€œThe burden on medical and long-term care systems due to ageing is expected to intensify in Japanâ€  </title>
			<atom:link href="https://biospectrumasia.com/opinion/50/26285/the-burden-on-medical-and-long-term-care-systems-due-to-ageing-is-expected-to-intensify-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/26285/the-burden-on-medical-and-long-term-care-systems-due-to-ageing-is-expected-to-intensify-in-japan-.html</link>
			<pubDate>Tue, 01 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shinomiyaken_akhealthcare-26285.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/26285/the-burden-on-medical-and-long-term-care-systems-due-to-ageing-is-expected-to-intensify-in-japan-.html</guid>
		</item>	
				<item>
			<title>AGC Biologics expands cell therapy development operations to Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/26263/agc-biologics-expands-cell-therapy-development-operations-to-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26263/agc-biologics-expands-cell-therapy-development-operations-to-asia.html</link>
			<pubDate>Thu, 26 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agc-26263.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26263/agc-biologics-expands-cell-therapy-development-operations-to-asia.html</guid>
		</item>	
				<item>
			<title>Ono Pharma and Vertex to commercialise Povetacicept in Japan and South Korea for nephropathy treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/26246/ono-pharma-and-vertex-to-commercialise-povetacicept-in-japan-and-south-korea-for-nephropathy-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26246/ono-pharma-and-vertex-to-commercialise-povetacicept-in-japan-and-south-korea-for-nephropathy-treatment.html</link>
			<pubDate>Tue, 24 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-26246.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26246/ono-pharma-and-vertex-to-commercialise-povetacicept-in-japan-and-south-korea-for-nephropathy-treatment.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujirebio acquires Plasma Services Group to provide biological raw materials to IVD industries</title>
			<atom:link href="https://biospectrumasia.com/news/50/26250/japans-fujirebio-acquires-plasma-services-group-to-provide-biological-raw-materials-to-ivd-industries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26250/japans-fujirebio-acquires-plasma-services-group-to-provide-biological-raw-materials-to-ivd-industries.html</link>
			<pubDate>Tue, 24 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drop-26250.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26250/japans-fujirebio-acquires-plasma-services-group-to-provide-biological-raw-materials-to-ivd-industries.html</guid>
		</item>	
				<item>
			<title>Harbour BioMed &amp; Otsuka Pharma ink $670 M agreement for treatment of autoimmune diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/26240/harbour-biomed-otsuka-pharma-ink-670-m-agreement-for-treatment-of-autoimmune-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26240/harbour-biomed-otsuka-pharma-ink-670-m-agreement-for-treatment-of-autoimmune-diseases.html</link>
			<pubDate>Mon, 23 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cell-26240.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26240/harbour-biomed-otsuka-pharma-ink-670-m-agreement-for-treatment-of-autoimmune-diseases.html</guid>
		</item>	
				<item>
			<title>Japan gives nod to Israeli startup MedHub-AI&#039;s coronary physiology diagnostic software</title>
			<atom:link href="https://biospectrumasia.com/news/50/26231/japan-gives-nod-to-israeli-startup-medhub-ais-coronary-physiology-diagnostic-software.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26231/japan-gives-nod-to-israeli-startup-medhub-ais-coronary-physiology-diagnostic-software.html</link>
			<pubDate>Fri, 20 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_20_6_2025_121447_www_medhub_ai_com-26231.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26231/japan-gives-nod-to-israeli-startup-medhub-ais-coronary-physiology-diagnostic-software.html</guid>
		</item>	
				<item>
			<title>NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26225/nec-and-chugai-pharmaceutical-use-ai-to-potentially-enhance-cancer-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26225/nec-and-chugai-pharmaceutical-use-ai-to-potentially-enhance-cancer-treatment-in-japan.html</link>
			<pubDate>Thu, 19 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jap-26225.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26225/nec-and-chugai-pharmaceutical-use-ai-to-potentially-enhance-cancer-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Avata Biosciences partners with Oceanus Bio for developing oral cannabidiol therapies to address Epilepsy and Schizophrenia</title>
			<atom:link href="https://biospectrumasia.com/news/50/26217/avata-biosciences-partners-with-oceanus-bio-for-developing-oral-cannabidiol-therapies-to-address-epilepsy-and-schizophrenia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26217/avata-biosciences-partners-with-oceanus-bio-for-developing-oral-cannabidiol-therapies-to-address-epilepsy-and-schizophrenia.html</link>
			<pubDate>Wed, 18 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/brain-26217.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26217/avata-biosciences-partners-with-oceanus-bio-for-developing-oral-cannabidiol-therapies-to-address-epilepsy-and-schizophrenia.html</guid>
		</item>	
				<item>
			<title>HekaBio teams up with Alfresa Holdings Corp accelerating access to innovative therapies in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26209/hekabio-teams-up-with-alfresa-holdings-corp-accelerating-access-to-innovative-therapies-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26209/hekabio-teams-up-with-alfresa-holdings-corp-accelerating-access-to-innovative-therapies-in-japan.html</link>
			<pubDate>Tue, 17 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jap-26209.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26209/hekabio-teams-up-with-alfresa-holdings-corp-accelerating-access-to-innovative-therapies-in-japan.html</guid>
		</item>	
				<item>
			<title>SDP Japan raises $31 M to rollout advanced surgical care models </title>
			<atom:link href="https://biospectrumasia.com/news/50/26196/sdp-japan-raises-31-m-to-rollout-advanced-surgical-care-models-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26196/sdp-japan-raises-31-m-to-rollout-advanced-surgical-care-models-.html</link>
			<pubDate>Mon, 16 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sure-26196.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26196/sdp-japan-raises-31-m-to-rollout-advanced-surgical-care-models-.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Research Institute and Astellas collaborate to support pharma startups in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26192/mitsubishi-research-institute-and-astellas-collaborate-to-support-pharma-startups-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26192/mitsubishi-research-institute-and-astellas-collaborate-to-support-pharma-startups-in-japan.html</link>
			<pubDate>Fri, 13 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-26192.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26192/mitsubishi-research-institute-and-astellas-collaborate-to-support-pharma-startups-in-japan.html</guid>
		</item>	
				<item>
			<title>Olympus announces full market release of AI-powered emphysema screening programme</title>
			<atom:link href="https://biospectrumasia.com/news/50/26181/olympus-announces-full-market-release-of-ai-powered-emphysema-screening-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26181/olympus-announces-full-market-release-of-ai-powered-emphysema-screening-programme.html</link>
			<pubDate>Thu, 12 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oly-26181.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26181/olympus-announces-full-market-release-of-ai-powered-emphysema-screening-programme.html</guid>
		</item>	
				<item>
			<title>Cardio Diagnostics secures Japanese patent for AI-driven cardiovascular disease detection technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/26177/cardio-diagnostics-secures-japanese-patent-for-ai-driven-cardiovascular-disease-detection-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26177/cardio-diagnostics-secures-japanese-patent-for-ai-driven-cardiovascular-disease-detection-technology.html</link>
			<pubDate>Tue, 10 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/card-26177.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26177/cardio-diagnostics-secures-japanese-patent-for-ai-driven-cardiovascular-disease-detection-technology.html</guid>
		</item>	
				<item>
			<title>Samsung Bioepis enters into strategic partnership with Nipro for commercialisation of multiple biosimilars in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26168/samsung-bioepis-enters-into-strategic-partnership-with-nipro-for-commercialisation-of-multiple-biosimilars-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26168/samsung-bioepis-enters-into-strategic-partnership-with-nipro-for-commercialisation-of-multiple-biosimilars-in-japan.html</link>
			<pubDate>Mon, 09 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sam-26168.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26168/samsung-bioepis-enters-into-strategic-partnership-with-nipro-for-commercialisation-of-multiple-biosimilars-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan transforms engineered heart tissues for precise drug testing</title>
			<atom:link href="https://biospectrumasia.com/news/50/26166/japan-transforms-engineered-heart-tissues-for-precise-drug-testing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26166/japan-transforms-engineered-heart-tissues-for-precise-drug-testing.html</link>
			<pubDate>Sat, 07 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_7_6_2025_171648_www_cira_kyoto_u_ac_jp-26166.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26166/japan-transforms-engineered-heart-tissues-for-precise-drug-testing.html</guid>
		</item>	
				<item>
			<title>Telix Pharma establishes new operations in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26155/telix-pharma-establishes-new-operations-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26155/telix-pharma-establishes-new-operations-in-japan.html</link>
			<pubDate>Thu, 05 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/telix-26155.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26155/telix-pharma-establishes-new-operations-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese startup ThinkCyte unveils cloud-based platform for AI-driven cell morphology data analysis</title>
			<atom:link href="https://biospectrumasia.com/news/50/26149/japanese-startup-thinkcyte-unveils-cloud-based-platform-for-ai-driven-cell-morphology-data-analysis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26149/japanese-startup-thinkcyte-unveils-cloud-based-platform-for-ai-driven-cell-morphology-data-analysis.html</link>
			<pubDate>Wed, 04 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_6_2025_105711_thinkcyte_com-26149.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26149/japanese-startup-thinkcyte-unveils-cloud-based-platform-for-ai-driven-cell-morphology-data-analysis.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujifilm rebrands Life Sciences companies to represent board spectrum portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/50/26142/japans-fujifilm-rebrands-life-sciences-companies-to-represent-board-spectrum-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26142/japans-fujifilm-rebrands-life-sciences-companies-to-represent-board-spectrum-portfolio.html</link>
			<pubDate>Tue, 03 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_3_6_2025_112536_www_fujifilm_com-26142.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26142/japans-fujifilm-rebrands-life-sciences-companies-to-represent-board-spectrum-portfolio.html</guid>
		</item>	
				<item>
			<title>Sumitomo and Novo Nordisk to co-promote Ozempic in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26139/sumitomo-and-novo-nordisk-to-co-promote-ozempic-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26139/sumitomo-and-novo-nordisk-to-co-promote-ozempic-in-japan.html</link>
			<pubDate>Mon, 02 Jun 2025 08:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26139/sumitomo-and-novo-nordisk-to-co-promote-ozempic-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai launches ParietÂ® S, first proton pump inhibitor RX-to-OTC in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/26138/eisai-launches-pariet-s-first-proton-pump-inhibitor-rx-to-otc-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26138/eisai-launches-pariet-s-first-proton-pump-inhibitor-rx-to-otc-in-japan-.html</link>
			<pubDate>Mon, 02 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2_6_2025_112413_www_eisai_com-26138.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26138/eisai-launches-pariet-s-first-proton-pump-inhibitor-rx-to-otc-in-japan-.html</guid>
		</item>	
				<item>
			<title> Japan establishes first next-gen commercial production site for CAR-T cell therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/26118/-japan-establishes-first-next-gen-commercial-production-site-for-car-t-cell-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26118/-japan-establishes-first-next-gen-commercial-production-site-for-car-t-cell-therapies.html</link>
			<pubDate>Fri, 30 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-26118.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26118/-japan-establishes-first-next-gen-commercial-production-site-for-car-t-cell-therapies.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus announces US FDA clearance of its most advanced imaging endoscopes</title>
			<atom:link href="https://biospectrumasia.com/news/50/26105/japans-olympus-announces-us-fda-clearance-of-its-most-advanced-imaging-endoscopes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26105/japans-olympus-announces-us-fda-clearance-of-its-most-advanced-imaging-endoscopes.html</link>
			<pubDate>Wed, 28 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/edof_scope-26105.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26105/japans-olympus-announces-us-fda-clearance-of-its-most-advanced-imaging-endoscopes.html</guid>
		</item>	
				<item>
			<title>Fujitsu, THERS utilise AI to accelerate clinical research and tackle &#039;drug loss&#039; in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26081/fujitsu-thers-utilise-ai-to-accelerate-clinical-research-and-tackle-drug-loss-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26081/fujitsu-thers-utilise-ai-to-accelerate-clinical-research-and-tackle-drug-loss-in-japan.html</link>
			<pubDate>Mon, 26 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ai-26081.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26081/fujitsu-thers-utilise-ai-to-accelerate-clinical-research-and-tackle-drug-loss-in-japan.html</guid>
		</item>	
				<item>
			<title>Alloy Therapeutics enters Japanese market by establishing operations at Shonan Health Innovation Park</title>
			<atom:link href="https://biospectrumasia.com/news/50/26076/alloy-therapeutics-enters-japanese-market-by-establishing-operations-at-shonan-health-innovation-park.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26076/alloy-therapeutics-enters-japanese-market-by-establishing-operations-at-shonan-health-innovation-park.html</link>
			<pubDate>Fri, 23 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cell-26076.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26076/alloy-therapeutics-enters-japanese-market-by-establishing-operations-at-shonan-health-innovation-park.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ubitus collaborates with MacKay Memorial Hospital in Taiwan for AI-powered multi-modal medical robots</title>
			<atom:link href="https://biospectrumasia.com/news/50/26074/japans-ubitus-collaborates-with-mackay-memorial-hospital-in-taiwan-for-ai-powered-multi-modal-medical-robots.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26074/japans-ubitus-collaborates-with-mackay-memorial-hospital-in-taiwan-for-ai-powered-multi-modal-medical-robots.html</link>
			<pubDate>Thu, 22 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ubitus_image-26074.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26074/japans-ubitus-collaborates-with-mackay-memorial-hospital-in-taiwan-for-ai-powered-multi-modal-medical-robots.html</guid>
		</item>	
				<item>
			<title>Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26068/biocon-biologics-and-yoshindo-expand-access-to-ustekinumab-biosimilar-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26068/biocon-biologics-and-yoshindo-expand-access-to-ustekinumab-biosimilar-in-japan.html</link>
			<pubDate>Wed, 21 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/injection-26068.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26068/biocon-biologics-and-yoshindo-expand-access-to-ustekinumab-biosimilar-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese startup RevolKa secures $1.4 M funding to advance therapeutic programmes</title>
			<atom:link href="https://biospectrumasia.com/news/50/26057/japanese-startup-revolka-secures-1-4-m-funding-to-advance-therapeutic-programmes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26057/japanese-startup-revolka-secures-1-4-m-funding-to-advance-therapeutic-programmes.html</link>
			<pubDate>Tue, 20 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_20_5_2025_94545_www_revolka_com-26057.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26057/japanese-startup-revolka-secures-1-4-m-funding-to-advance-therapeutic-programmes.html</guid>
		</item>	
				<item>
			<title>Collaboration to accelerate genomics innovation in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/26045/collaboration-to-accelerate-genomics-innovation-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26045/collaboration-to-accelerate-genomics-innovation-in-japan.html</link>
			<pubDate>Fri, 16 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/geno-26045.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26045/collaboration-to-accelerate-genomics-innovation-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan approves Sarepta&#039;s gene therapy to treat Duchenne Muscular Dystrophy</title>
			<atom:link href="https://biospectrumasia.com/news/50/26031/japan-approves-sareptas-gene-therapy-to-treat-duchenne-muscular-dystrophy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26031/japan-approves-sareptas-gene-therapy-to-treat-duchenne-muscular-dystrophy.html</link>
			<pubDate>Wed, 14 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene-26031.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26031/japan-approves-sareptas-gene-therapy-to-treat-duchenne-muscular-dystrophy.html</guid>
		</item>	
				<item>
			<title>Shionogi, Cilcare Ink Research Collab on Novel Hearing Loss Drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/26021/shionogi-cilcare-ink-research-collab-on-novel-hearing-loss-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26021/shionogi-cilcare-ink-research-collab-on-novel-hearing-loss-drugs.html</link>
			<pubDate>Mon, 12 May 2025 12:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26021/shionogi-cilcare-ink-research-collab-on-novel-hearing-loss-drugs.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi inks new partnership agreement to support antimicrobial stewardship in Kenya</title>
			<atom:link href="https://biospectrumasia.com/news/50/26011/japans-shionogi-inks-new-partnership-agreement-to-support-antimicrobial-stewardship-in-kenya.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/26011/japans-shionogi-inks-new-partnership-agreement-to-support-antimicrobial-stewardship-in-kenya.html</link>
			<pubDate>Fri, 09 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amr-26011.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/26011/japans-shionogi-inks-new-partnership-agreement-to-support-antimicrobial-stewardship-in-kenya.html</guid>
		</item>	
				<item>
			<title>Genezen and Optieum Biotechnologies partner to manufacture CAR-T Therapy for Glioblastoma</title>
			<atom:link href="https://biospectrumasia.com/news/50/25988/genezen-and-optieum-biotechnologies-partner-to-manufacture-car-t-therapy-for-glioblastoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25988/genezen-and-optieum-biotechnologies-partner-to-manufacture-car-t-therapy-for-glioblastoma.html</link>
			<pubDate>Tue, 06 May 2025 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25988/genezen-and-optieum-biotechnologies-partner-to-manufacture-car-t-therapy-for-glioblastoma.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi announces further agreement with Apnimed for sleep disorder treatments</title>
			<atom:link href="https://biospectrumasia.com/news/50/25983/japans-shionogi-announces-further-agreement-with-apnimed-for-sleep-disorder-treatments.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25983/japans-shionogi-announces-further-agreement-with-apnimed-for-sleep-disorder-treatments.html</link>
			<pubDate>Mon, 05 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sleep-25983.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25983/japans-shionogi-announces-further-agreement-with-apnimed-for-sleep-disorder-treatments.html</guid>
		</item>	
				<item>
			<title>Ken Shinomiya becomes leader of Japan-based Asahi Kasei&#039;s healthcare sector</title>
			<atom:link href="https://biospectrumasia.com/news/50/25977/ken-shinomiya-becomes-leader-of-japan-based-asahi-kaseis-healthcare-sector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25977/ken-shinomiya-becomes-leader-of-japan-based-asahi-kaseis-healthcare-sector.html</link>
			<pubDate>Fri, 02 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-25977.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25977/ken-shinomiya-becomes-leader-of-japan-based-asahi-kaseis-healthcare-sector.html</guid>
		</item>	
				<item>
			<title>Olympus appoints Bob White as new CEO</title>
			<atom:link href="https://biospectrumasia.com/news/50/25953/olympus-appoints-bob-white-as-new-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25953/olympus-appoints-bob-white-as-new-ceo.html</link>
			<pubDate>Mon, 28 Apr 2025 20:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2_5_2025_22812_photos_acnnewswire_com-25953.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25953/olympus-appoints-bob-white-as-new-ceo.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT announces investment of $4.5 M to develop diagnostics for TB</title>
			<atom:link href="https://biospectrumasia.com/news/50/25931/japans-ghit-announces-investment-of-4-5-m-to-develop-diagnostics-for-tb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25931/japans-ghit-announces-investment-of-4-5-m-to-develop-diagnostics-for-tb.html</link>
			<pubDate>Wed, 23 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/inv-25931.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25931/japans-ghit-announces-investment-of-4-5-m-to-develop-diagnostics-for-tb.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono collaborates with Jorna Therapeutics to generate novel RNA editing therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/25918/japans-ono-collaborates-with-jorna-therapeutics-to-generate-novel-rna-editing-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25918/japans-ono-collaborates-with-jorna-therapeutics-to-generate-novel-rna-editing-therapeutics.html</link>
			<pubDate>Tue, 22 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_banner_with_doctor_holding_tablet_23_2149611236-25918.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25918/japans-ono-collaborates-with-jorna-therapeutics-to-generate-novel-rna-editing-therapeutics.html</guid>
		</item>	
				<item>
			<title>Wayfinder Biosciences and Daiichi Sankyo to develop novel RNA-targeting therapies for neurodegenerative diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/25904/wayfinder-biosciences-and-daiichi-sankyo-to-develop-novel-rna-targeting-therapies-for-neurodegenerative-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25904/wayfinder-biosciences-and-daiichi-sankyo-to-develop-novel-rna-targeting-therapies-for-neurodegenerative-diseases.html</link>
			<pubDate>Fri, 18 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-25904.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25904/wayfinder-biosciences-and-daiichi-sankyo-to-develop-novel-rna-targeting-therapies-for-neurodegenerative-diseases.html</guid>
		</item>	
				<item>
			<title>Hapatune expands global presence with new life science marketing subsidiary in Tokyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/25901/hapatune-expands-global-presence-with-new-life-science-marketing-subsidiary-in-tokyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25901/hapatune-expands-global-presence-with-new-life-science-marketing-subsidiary-in-tokyo.html</link>
			<pubDate>Thu, 17 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tool-25901.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25901/hapatune-expands-global-presence-with-new-life-science-marketing-subsidiary-in-tokyo.html</guid>
		</item>	
				<item>
			<title>Nikon CeLL Innovation partners with RoosterBio for manufacturing human stem cells and extracellular vesicle in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25894/nikon-cell-innovation-partners-with-roosterbio-for-manufacturing-human-stem-cells-and-extracellular-vesicle-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25894/nikon-cell-innovation-partners-with-roosterbio-for-manufacturing-human-stem-cells-and-extracellular-vesicle-in-japan.html</link>
			<pubDate>Wed, 16 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_4_2025_192555_-25894.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25894/nikon-cell-innovation-partners-with-roosterbio-for-manufacturing-human-stem-cells-and-extracellular-vesicle-in-japan.html</guid>
		</item>	
				<item>
			<title>Saisei Ventures launches executive fellows programme for Japan&#039;s biotech leadership pipeline</title>
			<atom:link href="https://biospectrumasia.com/news/50/25884/saisei-ventures-launches-executive-fellows-programme-for-japans-biotech-leadership-pipeline.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25884/saisei-ventures-launches-executive-fellows-programme-for-japans-biotech-leadership-pipeline.html</link>
			<pubDate>Tue, 15 Apr 2025 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bio-25884.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25884/saisei-ventures-launches-executive-fellows-programme-for-japans-biotech-leadership-pipeline.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PRISM BioLab and Elix join forces to accelerate AI-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/25879/japans-prism-biolab-and-elix-join-forces-to-accelerate-ai-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25879/japans-prism-biolab-and-elix-join-forces-to-accelerate-ai-driven-drug-discovery.html</link>
			<pubDate>Mon, 14 Apr 2025 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ppi-25879.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25879/japans-prism-biolab-and-elix-join-forces-to-accelerate-ai-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Asahi Kasei establishes life science unit to drive bioprocess businesses forward</title>
			<atom:link href="https://biospectrumasia.com/news/50/25853/japans-asahi-kasei-establishes-life-science-unit-to-drive-bioprocess-businesses-forward.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25853/japans-asahi-kasei-establishes-life-science-unit-to-drive-bioprocess-businesses-forward.html</link>
			<pubDate>Wed, 09 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_4_2025_154344_bionovascientific_com-25853.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25853/japans-asahi-kasei-establishes-life-science-unit-to-drive-bioprocess-businesses-forward.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Asahi Kasei establishes &quot;Asahi Kasei Life Science&quot; to drive its bioprocess businesses forward</title>
			<atom:link href="https://biospectrumasia.com/news/50/25854/japans-asahi-kasei-establishes-asahi-kasei-life-science-to-drive-its-bioprocess-businesses-forward.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25854/japans-asahi-kasei-establishes-asahi-kasei-life-science-to-drive-its-bioprocess-businesses-forward.html</link>
			<pubDate>Wed, 09 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25854/japans-asahi-kasei-establishes-asahi-kasei-life-science-to-drive-its-bioprocess-businesses-forward.html</guid>
		</item>	
				<item>
			<title>AGC Biologics taps Thermo Scientific for 5,000 L DynaDrive SUBs at Yokohama site in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25841/agc-biologics-taps-thermo-scientific-for-5000-l-dynadrive-subs-at-yokohama-site-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25841/agc-biologics-taps-thermo-scientific-for-5000-l-dynadrive-subs-at-yokohama-site-in-japan.html</link>
			<pubDate>Tue, 08 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_8_4_2025_104914_-25841.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25841/agc-biologics-taps-thermo-scientific-for-5000-l-dynadrive-subs-at-yokohama-site-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Marubeni buys Sumitomo&#039;s Asia pharma biz for Â¥45 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/25832/japans-marubeni-buys-sumitomos-asia-pharma-biz-for-45-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25832/japans-marubeni-buys-sumitomos-asia-pharma-biz-for-45-b.html</link>
			<pubDate>Mon, 07 Apr 2025 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-25832.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25832/japans-marubeni-buys-sumitomos-asia-pharma-biz-for-45-b.html</guid>
		</item>	
				<item>
			<title>Astellas pushes translational and clinical oncology research in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25825/astellas-pushes-translational-and-clinical-oncology-research-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25825/astellas-pushes-translational-and-clinical-oncology-research-in-japan.html</link>
			<pubDate>Fri, 04 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_4_2025_183530_-25825.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25825/astellas-pushes-translational-and-clinical-oncology-research-in-japan.html</guid>
		</item>	
				<item>
			<title>Shionogi inks commercial deal for Cefiderocol in Australia and New Zealand</title>
			<atom:link href="https://biospectrumasia.com/news/50/25819/shionogi-inks-commercial-deal-for-cefiderocol-in-australia-and-new-zealand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25819/shionogi-inks-commercial-deal-for-cefiderocol-in-australia-and-new-zealand.html</link>
			<pubDate>Thu, 03 Apr 2025 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2_4_2025_213053_-25819.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25819/shionogi-inks-commercial-deal-for-cefiderocol-in-australia-and-new-zealand.html</guid>
		</item>	
				<item>
			<title>Shin-Etsu Chemical to invest Â¥10 B in pharma cellulose biz in Japan and Europe</title>
			<atom:link href="https://biospectrumasia.com/news/50/25820/shin-etsu-chemical-to-invest-10-b-in-pharma-cellulose-biz-in-japan-and-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25820/shin-etsu-chemical-to-invest-10-b-in-pharma-cellulose-biz-in-japan-and-europe.html</link>
			<pubDate>Thu, 03 Apr 2025 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-25820.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25820/shin-etsu-chemical-to-invest-10-b-in-pharma-cellulose-biz-in-japan-and-europe.html</guid>
		</item>	
				<item>
			<title>Mitsubishi builds new, rental-lab-type R&amp;D facility in Kobe Biomedical Innovation Cluster in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25821/mitsubishi-builds-new-rental-lab-type-rd-facility-in-kobe-biomedical-innovation-cluster-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25821/mitsubishi-builds-new-rental-lab-type-rd-facility-in-kobe-biomedical-innovation-cluster-in-japan.html</link>
			<pubDate>Wed, 02 Apr 2025 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medtech-25821.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25821/mitsubishi-builds-new-rental-lab-type-rd-facility-in-kobe-biomedical-innovation-cluster-in-japan.html</guid>
		</item>	
				<item>
			<title>NUS expands startup hub in Tokyo to propel deep tech innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/25809/nus-expands-startup-hub-in-tokyo-to-propel-deep-tech-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25809/nus-expands-startup-hub-in-tokyo-to-propel-deep-tech-innovation.html</link>
			<pubDate>Tue, 01 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sh-25809.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25809/nus-expands-startup-hub-in-tokyo-to-propel-deep-tech-innovation.html</guid>
		</item>	
				<item>
			<title>SNBL and Tasso establish Joint Venture in Japan to distribute on-demand blood collection device</title>
			<atom:link href="https://biospectrumasia.com/news/50/25799/snbl-and-tasso-establish-joint-venture-in-japan-to-distribute-on-demand-blood-collection-device.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25799/snbl-and-tasso-establish-joint-venture-in-japan-to-distribute-on-demand-blood-collection-device.html</link>
			<pubDate>Fri, 28 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_3_2025_125312_www_tassoinc_com-25799.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25799/snbl-and-tasso-establish-joint-venture-in-japan-to-distribute-on-demand-blood-collection-device.html</guid>
		</item>	
				<item>
			<title>Alumis and Kaken Pharma announce collaboration worth $140 M for dermatology treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25783/alumis-and-kaken-pharma-announce-collaboration-worth-140-m-for-dermatology-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25783/alumis-and-kaken-pharma-announce-collaboration-worth-140-m-for-dermatology-treatment-in-japan.html</link>
			<pubDate>Thu, 27 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/derma-25783.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25783/alumis-and-kaken-pharma-announce-collaboration-worth-140-m-for-dermatology-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Taiho Pharma buys ADC firm Araris Biotech for $740 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/25748/japans-taiho-pharma-buys-adc-firm-araris-biotech-for-740-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25748/japans-taiho-pharma-buys-adc-firm-araris-biotech-for-740-m.html</link>
			<pubDate>Thu, 20 Mar 2025 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/adc-25748.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25748/japans-taiho-pharma-buys-adc-firm-araris-biotech-for-740-m.html</guid>
		</item>	
				<item>
			<title>US-based Alamar Biosciences expands commercial support in Asia Pacific region</title>
			<atom:link href="https://biospectrumasia.com/news/50/25758/us-based-alamar-biosciences-expands-commercial-support-in-asia-pacific-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25758/us-based-alamar-biosciences-expands-commercial-support-in-asia-pacific-region.html</link>
			<pubDate>Thu, 20 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lab-25758.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25758/us-based-alamar-biosciences-expands-commercial-support-in-asia-pacific-region.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s RegCell secures $45.8M in funding and completes U.S. headquarters transition </title>
			<atom:link href="https://biospectrumasia.com/news/50/25753/japans-regcell-secures-45-8m-in-funding-and-completes-u-s-headquarters-transition-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25753/japans-regcell-secures-45-8m-in-funding-and-completes-u-s-headquarters-transition-.html</link>
			<pubDate>Wed, 19 Mar 2025 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25753/japans-regcell-secures-45-8m-in-funding-and-completes-u-s-headquarters-transition-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT invests $11.4 M for treatment of neglected tropical diseases </title>
			<atom:link href="https://biospectrumasia.com/news/50/25744/japans-ghit-invests-11-4-m-for-treatment-of-neglected-tropical-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25744/japans-ghit-invests-11-4-m-for-treatment-of-neglected-tropical-diseases-.html</link>
			<pubDate>Wed, 19 Mar 2025 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rd-25744.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25744/japans-ghit-invests-11-4-m-for-treatment-of-neglected-tropical-diseases-.html</guid>
		</item>	
				<item>
			<title>ABL Diagnostics partners with Riken Genesis to expand microbiology genotyping in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25739/abl-diagnostics-partners-with-riken-genesis-to-expand-microbiology-genotyping-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25739/abl-diagnostics-partners-with-riken-genesis-to-expand-microbiology-genotyping-in-japan.html</link>
			<pubDate>Tue, 18 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_3_2025_112736_www_abldiagnostics_com-25739.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25739/abl-diagnostics-partners-with-riken-genesis-to-expand-microbiology-genotyping-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Murata announces production of world&#039;s first metal cell fractionation filter</title>
			<atom:link href="https://biospectrumasia.com/news/50/25733/japans-murata-announces-production-of-worlds-first-metal-cell-fractionation-filter.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25733/japans-murata-announces-production-of-worlds-first-metal-cell-fractionation-filter.html</link>
			<pubDate>Mon, 17 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cellnetta_02-25733.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25733/japans-murata-announces-production-of-worlds-first-metal-cell-fractionation-filter.html</guid>
		</item>	
				<item>
			<title>ENCell signs MoU with Cell Resources Corp to pave way for market entry in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25720/encell-signs-mou-with-cell-resources-corp-to-pave-way-for-market-entry-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25720/encell-signs-mou-with-cell-resources-corp-to-pave-way-for-market-entry-in-japan.html</link>
			<pubDate>Fri, 14 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/encell_image-25720.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25720/encell-signs-mou-with-cell-resources-corp-to-pave-way-for-market-entry-in-japan.html</guid>
		</item>	
				<item>
			<title>CII partners with SMRJ to host business meetings for medtech companies in India and Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25723/cii-partners-with-smrj-to-host-business-meetings-for-medtech-companies-in-india-and-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25723/cii-partners-with-smrj-to-host-business-meetings-for-medtech-companies-in-india-and-japan.html</link>
			<pubDate>Fri, 14 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_imaging-25723.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25723/cii-partners-with-smrj-to-host-business-meetings-for-medtech-companies-in-india-and-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo and Nosis Biosciences partner to advance RNA medicines</title>
			<atom:link href="https://biospectrumasia.com/news/50/25714/daiichi-sankyo-and-nosis-biosciences-partner-to-advance-rna-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25714/daiichi-sankyo-and-nosis-biosciences-partner-to-advance-rna-medicines.html</link>
			<pubDate>Thu, 13 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rna_1269045566-25714.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25714/daiichi-sankyo-and-nosis-biosciences-partner-to-advance-rna-medicines.html</guid>
		</item>	
				<item>
			<title>Ono buys rare blood cancer therapy from Ionis for $280 million</title>
			<atom:link href="https://biospectrumasia.com/news/50/25715/ono-buys-rare-blood-cancer-therapy-from-ionis-for-280-million.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25715/ono-buys-rare-blood-cancer-therapy-from-ionis-for-280-million.html</link>
			<pubDate>Wed, 12 Mar 2025 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25715/ono-buys-rare-blood-cancer-therapy-from-ionis-for-280-million.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s Amaran Biotech signs MoU with Nippon to expand CDMO business</title>
			<atom:link href="https://biospectrumasia.com/news/50/25708/taiwans-amaran-biotech-signs-mou-with-nippon-to-expand-cdmo-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25708/taiwans-amaran-biotech-signs-mou-with-nippon-to-expand-cdmo-business.html</link>
			<pubDate>Wed, 12 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/manu-25708.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25708/taiwans-amaran-biotech-signs-mou-with-nippon-to-expand-cdmo-business.html</guid>
		</item>	
				<item>
			<title>Japan grants Orphan Drug Designation to Lundbeck&#039;s potential treatment for Multiple System Atrophy</title>
			<atom:link href="https://biospectrumasia.com/news/50/25704/japan-grants-orphan-drug-designation-to-lundbecks-potential-treatment-for-multiple-system-atrophy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25704/japan-grants-orphan-drug-designation-to-lundbecks-potential-treatment-for-multiple-system-atrophy.html</link>
			<pubDate>Tue, 11 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oddd-25704.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25704/japan-grants-orphan-drug-designation-to-lundbecks-potential-treatment-for-multiple-system-atrophy.html</guid>
		</item>	
				<item>
			<title>Shimadzu announces launch of two models of Scanning Electron Microscope SUPERSCAN SS-4000</title>
			<atom:link href="https://biospectrumasia.com/news/50/25697/shimadzu-announces-launch-of-two-models-of-scanning-electron-microscope-superscan-ss-4000.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25697/shimadzu-announces-launch-of-two-models-of-scanning-electron-microscope-superscan-ss-4000.html</link>
			<pubDate>Mon, 10 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_10_3_2025_991_www_shimadzu_com-25697.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25697/shimadzu-announces-launch-of-two-models-of-scanning-electron-microscope-superscan-ss-4000.html</guid>
		</item>	
				<item>
			<title>CEPI funds Nagasaki University&#039;s â€˜Nanoball&#039; technology to help defeat Disease X</title>
			<atom:link href="https://biospectrumasia.com/news/50/25700/cepi-funds-nagasaki-universitys-nanoball-technology-to-help-defeat-disease-x.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25700/cepi-funds-nagasaki-universitys-nanoball-technology-to-help-defeat-disease-x.html</link>
			<pubDate>Mon, 10 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image002_1_-25700.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25700/cepi-funds-nagasaki-universitys-nanoball-technology-to-help-defeat-disease-x.html</guid>
		</item>	
				<item>
			<title>Indaptus Therapeutics extends patent portfolio in China, Japan, and Israel</title>
			<atom:link href="https://biospectrumasia.com/news/50/25693/indaptus-therapeutics-extends-patent-portfolio-in-china-japan-and-israel.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25693/indaptus-therapeutics-extends-patent-portfolio-in-china-japan-and-israel.html</link>
			<pubDate>Fri, 07 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_7_3_2025_113832_-25693.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25693/indaptus-therapeutics-extends-patent-portfolio-in-china-japan-and-israel.html</guid>
		</item>	
				<item>
			<title>Astellas and Yaskawa to establish joint venture in Japan focused on cell therapy manufacturing</title>
			<atom:link href="https://biospectrumasia.com/news/50/25687/astellas-and-yaskawa-to-establish-joint-venture-in-japan-focused-on-cell-therapy-manufacturing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25687/astellas-and-yaskawa-to-establish-joint-venture-in-japan-focused-on-cell-therapy-manufacturing.html</link>
			<pubDate>Thu, 06 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rob-25687.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25687/astellas-and-yaskawa-to-establish-joint-venture-in-japan-focused-on-cell-therapy-manufacturing.html</guid>
		</item>	
				<item>
			<title>Olympus to launch single-use hemostasis clip in US, with plans for global expansion</title>
			<atom:link href="https://biospectrumasia.com/news/50/25677/olympus-to-launch-single-use-hemostasis-clip-in-us-with-plans-for-global-expansion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25677/olympus-to-launch-single-use-hemostasis-clip-in-us-with-plans-for-global-expansion.html</link>
			<pubDate>Wed, 05 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clip-25677.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25677/olympus-to-launch-single-use-hemostasis-clip-in-us-with-plans-for-global-expansion.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi inks agreement with Osaka Metropolitan University to establish model for city resilient to infectious diseases </title>
			<atom:link href="https://biospectrumasia.com/news/50/25674/japans-shionogi-inks-agreement-with-osaka-metropolitan-university-to-establish-model-for-city-resilient-to-infectious-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25674/japans-shionogi-inks-agreement-with-osaka-metropolitan-university-to-establish-model-for-city-resilient-to-infectious-diseases-.html</link>
			<pubDate>Tue, 04 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/city-25674.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25674/japans-shionogi-inks-agreement-with-osaka-metropolitan-university-to-establish-model-for-city-resilient-to-infectious-diseases-.html</guid>
		</item>	
				<item>
			<title>â€œPersonalised medicine is now a reality, not just an aspirationâ€</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/25662/personalised-medicine-is-now-a-reality-not-just-an-aspiration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/25662/personalised-medicine-is-now-a-reality-not-just-an-aspiration.html</link>
			<pubDate>Sat, 01 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antoinette_terumo-25662.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/25662/personalised-medicine-is-now-a-reality-not-just-an-aspiration.html</guid>
		</item>	
				<item>
			<title>Eisai grants exclusive development and distribution rights for Tasurgratinib in Greater China to SciClone Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/25654/eisai-grants-exclusive-development-and-distribution-rights-for-tasurgratinib-in-greater-china-to-sciclone-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25654/eisai-grants-exclusive-development-and-distribution-rights-for-tasurgratinib-in-greater-china-to-sciclone-pharma.html</link>
			<pubDate>Fri, 28 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cv-25654.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25654/eisai-grants-exclusive-development-and-distribution-rights-for-tasurgratinib-in-greater-china-to-sciclone-pharma.html</guid>
		</item>	
				<item>
			<title>WuXi Biologics Successfully Passes Japan PMDA GMP Inspection Again</title>
			<atom:link href="https://biospectrumasia.com/news/50/25655/wuxi-biologics-successfully-passes-japan-pmda-gmp-inspection-again.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25655/wuxi-biologics-successfully-passes-japan-pmda-gmp-inspection-again.html</link>
			<pubDate>Fri, 28 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-25655.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25655/wuxi-biologics-successfully-passes-japan-pmda-gmp-inspection-again.html</guid>
		</item>	
				<item>
			<title>CSL receives approval for ANDEMBRY in Japan to prevent hereditary angioedema</title>
			<atom:link href="https://biospectrumasia.com/news/50/25612/csl-receives-approval-for-andembry-in-japan-to-prevent-hereditary-angioedema.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25612/csl-receives-approval-for-andembry-in-japan-to-prevent-hereditary-angioedema.html</link>
			<pubDate>Fri, 21 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oip-25612.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25612/csl-receives-approval-for-andembry-in-japan-to-prevent-hereditary-angioedema.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s NEC invests in Aetion, US-based provider of healthcare analytics platforms</title>
			<atom:link href="https://biospectrumasia.com/news/50/25607/japans-nec-invests-in-aetion-us-based-provider-of-healthcare-analytics-platforms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25607/japans-nec-invests-in-aetion-us-based-provider-of-healthcare-analytics-platforms.html</link>
			<pubDate>Wed, 19 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/data-25607.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25607/japans-nec-invests-in-aetion-us-based-provider-of-healthcare-analytics-platforms.html</guid>
		</item>	
				<item>
			<title>Takeda Reports Strong Q4 2024 Performance with 9.8% Revenue Growth, Driven by Oncology and Plasma-Derived Therapies</title>
			<atom:link href="https://biospectrumasia.com/company-results/50/25594/takeda-reports-strong-q4-2024-performance-with-9-8-revenue-growth-driven-by-oncology-and-plasma-derived-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/50/25594/takeda-reports-strong-q4-2024-performance-with-9-8-revenue-growth-driven-by-oncology-and-plasma-derived-therapies.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_finanacilla_review-25594.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/50/25594/takeda-reports-strong-q4-2024-performance-with-9-8-revenue-growth-driven-by-oncology-and-plasma-derived-therapies.html</guid>
		</item>	
				<item>
			<title>Japan builds machine learning model to predict amyloid beta accumulation in brain</title>
			<atom:link href="https://biospectrumasia.com/news/50/25598/japan-builds-machine-learning-model-to-predict-amyloid-beta-accumulation-in-brain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25598/japan-builds-machine-learning-model-to-predict-amyloid-beta-accumulation-in-brain.html</link>
			<pubDate>Mon, 17 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ad-25598.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25598/japan-builds-machine-learning-model-to-predict-amyloid-beta-accumulation-in-brain.html</guid>
		</item>	
				<item>
			<title>TriNetX and Fujitsu launch JV to increase Japanese patients&#039; access to life-changing medicines </title>
			<atom:link href="https://biospectrumasia.com/news/50/25572/trinetx-and-fujitsu-launch-jv-to-increase-japanese-patients-access-to-life-changing-medicines-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25572/trinetx-and-fujitsu-launch-jv-to-increase-japanese-patients-access-to-life-changing-medicines-.html</link>
			<pubDate>Thu, 13 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jap-25572.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25572/trinetx-and-fujitsu-launch-jv-to-increase-japanese-patients-access-to-life-changing-medicines-.html</guid>
		</item>	
				<item>
			<title>Yokogawa Launches OpreXâ„¢ Quality Management System to Enhance Quality Assurance</title>
			<atom:link href="https://biospectrumasia.com/news/50/25562/yokogawa-launches-oprex-quality-management-system-to-enhance-quality-assurance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25562/yokogawa-launches-oprex-quality-management-system-to-enhance-quality-assurance.html</link>
			<pubDate>Tue, 11 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oprex_quality_management_system_e-25562.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25562/yokogawa-launches-oprex-quality-management-system-to-enhance-quality-assurance.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PHC partners with CCRM in Canada to develop primary T-cell expansion culture processes</title>
			<atom:link href="https://biospectrumasia.com/news/50/25552/japans-phc-partners-with-ccrm-in-canada-to-develop-primary-t-cell-expansion-culture-processes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25552/japans-phc-partners-with-ccrm-in-canada-to-develop-primary-t-cell-expansion-culture-processes.html</link>
			<pubDate>Mon, 10 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_10_2_2025_123510_mms_businesswire_com-25552.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25552/japans-phc-partners-with-ccrm-in-canada-to-develop-primary-t-cell-expansion-culture-processes.html</guid>
		</item>	
				<item>
			<title>Bain Capital to acquire Mitsubishi Tanabe Pharma Corporation for $3.3 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/25545/bain-capital-to-acquire-mitsubishi-tanabe-pharma-corporation-for-3-3-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25545/bain-capital-to-acquire-mitsubishi-tanabe-pharma-corporation-for-3-3-b.html</link>
			<pubDate>Thu, 06 Feb 2025 10:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acq-25545.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25545/bain-capital-to-acquire-mitsubishi-tanabe-pharma-corporation-for-3-3-b.html</guid>
		</item>	
				<item>
			<title>ValGenesis and Hitachi join forces to digitally transform Japan&#039;s life sciences sector</title>
			<atom:link href="https://biospectrumasia.com/news/50/25540/valgenesis-and-hitachi-join-forces-to-digitally-transform-japans-life-sciences-sector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25540/valgenesis-and-hitachi-join-forces-to-digitally-transform-japans-life-sciences-sector.html</link>
			<pubDate>Wed, 05 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_5_2_2025_215634_www_valgenesis_com-25540.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25540/valgenesis-and-hitachi-join-forces-to-digitally-transform-japans-life-sciences-sector.html</guid>
		</item>	
				<item>
			<title>MediBuddy partners with Japan&#039;s Elecom to launch smart health devices in India</title>
			<atom:link href="https://biospectrumasia.com/news/50/25533/medibuddy-partners-with-japans-elecom-to-launch-smart-health-devices-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25533/medibuddy-partners-with-japans-elecom-to-launch-smart-health-devices-in-india.html</link>
			<pubDate>Tue, 04 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medibuddy_elecom_partnership-25533.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25533/medibuddy-partners-with-japans-elecom-to-launch-smart-health-devices-in-india.html</guid>
		</item>	
				<item>
			<title>JETRO collaborates with Mayo Clinic to support Japanese digital health startups</title>
			<atom:link href="https://biospectrumasia.com/news/50/25509/jetro-collaborates-with-mayo-clinic-to-support-japanese-digital-health-startups.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25509/jetro-collaborates-with-mayo-clinic-to-support-japanese-digital-health-startups.html</link>
			<pubDate>Fri, 31 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ju-25509.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25509/jetro-collaborates-with-mayo-clinic-to-support-japanese-digital-health-startups.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo appoints Hiroyuki Okuzawa as Chief Executive Officer</title>
			<atom:link href="https://biospectrumasia.com/news/50/25510/daiichi-sankyo-appoints-hiroyuki-okuzawa-as-chief-executive-officer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25510/daiichi-sankyo-appoints-hiroyuki-okuzawa-as-chief-executive-officer.html</link>
			<pubDate>Fri, 31 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_1_2025_10328_www_daiichisankyo_com-25510.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25510/daiichi-sankyo-appoints-hiroyuki-okuzawa-as-chief-executive-officer.html</guid>
		</item>	
				<item>
			<title>GHIT announces $12.7 M worth investment for developing diagnostics and drugs for malaria, NTDs</title>
			<atom:link href="https://biospectrumasia.com/news/50/25514/ghit-announces-12-7-m-worth-investment-for-developing-diagnostics-and-drugs-for-malaria-ntds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25514/ghit-announces-12-7-m-worth-investment-for-developing-diagnostics-and-drugs-for-malaria-ntds.html</link>
			<pubDate>Fri, 31 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_1_2025_103927_-25514.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25514/ghit-announces-12-7-m-worth-investment-for-developing-diagnostics-and-drugs-for-malaria-ntds.html</guid>
		</item>	
				<item>
			<title>â€œDemand for skilled medtech professionals in the Asia Pacific region is growing rapidlyâ€</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/25522/demand-for-skilled-medtech-professionals-in-the-asia-pacific-region-is-growing-rapidly.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/25522/demand-for-skilled-medtech-professionals-in-the-asia-pacific-region-is-growing-rapidly.html</link>
			<pubDate>Sat, 01 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/marc_radatt-25522.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/25522/demand-for-skilled-medtech-professionals-in-the-asia-pacific-region-is-growing-rapidly.html</guid>
		</item>	
				<item>
			<title>Chugai and GSK sign collaboration agreement for anti-dengue virus antibody AID351</title>
			<atom:link href="https://biospectrumasia.com/news/50/25525/chugai-and-gsk-sign-collaboration-agreement-for-anti-dengue-virus-antibody-aid351.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25525/chugai-and-gsk-sign-collaboration-agreement-for-anti-dengue-virus-antibody-aid351.html</link>
			<pubDate>Fri, 31 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_1_2025_232244_chugai_pharmabody_com-25525.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25525/chugai-and-gsk-sign-collaboration-agreement-for-anti-dengue-virus-antibody-aid351.html</guid>
		</item>	
				<item>
			<title>Julie Kim to succeed Christophe Weber as CEO of Takeda in June 2026</title>
			<atom:link href="https://biospectrumasia.com/news/50/25511/julie-kim-to-succeed-christophe-weber-as-ceo-of-takeda-in-june-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25511/julie-kim-to-succeed-christophe-weber-as-ceo-of-takeda-in-june-2026.html</link>
			<pubDate>Thu, 30 Jan 2025 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_1_2025_102158_www_takeda_com-25511.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25511/julie-kim-to-succeed-christophe-weber-as-ceo-of-takeda-in-june-2026.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research</title>
			<atom:link href="https://biospectrumasia.com/news/50/25507/japans-thinkcyte-expands-product-portfolio-to-drive-innovation-in-drug-discovery-and-disease-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25507/japans-thinkcyte-expands-product-portfolio-to-drive-innovation-in-drug-discovery-and-disease-research.html</link>
			<pubDate>Wed, 29 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_29_1_2025_121956_en_prnasia_com-25507.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25507/japans-thinkcyte-expands-product-portfolio-to-drive-innovation-in-drug-discovery-and-disease-research.html</guid>
		</item>	
				<item>
			<title>AB2 Bio signs licensing agreement worth $500 M with Nippon Shinyaku for ultra-rare autoimmune disease treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/25500/ab2-bio-signs-licensing-agreement-worth-500-m-with-nippon-shinyaku-for-ultra-rare-autoimmune-disease-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25500/ab2-bio-signs-licensing-agreement-worth-500-m-with-nippon-shinyaku-for-ultra-rare-autoimmune-disease-treatment.html</link>
			<pubDate>Tue, 28 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lab-25500.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25500/ab2-bio-signs-licensing-agreement-worth-500-m-with-nippon-shinyaku-for-ultra-rare-autoimmune-disease-treatment.html</guid>
		</item>	
				<item>
			<title>AstraZeneca and Daiichi Sankyo&#039;s Datroway Approved in US, Cuts Cancer Progression Risk by 37%</title>
			<atom:link href="https://biospectrumasia.com/news/50/25499/astrazeneca-and-daiichi-sankyos-datroway-approved-in-us-cuts-cancer-progression-risk-by-37.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25499/astrazeneca-and-daiichi-sankyos-datroway-approved-in-us-cuts-cancer-progression-risk-by-37.html</link>
			<pubDate>Mon, 27 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_1-25499.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25499/astrazeneca-and-daiichi-sankyos-datroway-approved-in-us-cuts-cancer-progression-risk-by-37.html</guid>
		</item>	
				<item>
			<title>Renascience to open branch lab of Northwestern University Longevity Institute in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/25486/renascience-to-open-branch-lab-of-northwestern-university-longevity-institute-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25486/renascience-to-open-branch-lab-of-northwestern-university-longevity-institute-in-japan-.html</link>
			<pubDate>Fri, 24 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jap-25486.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25486/renascience-to-open-branch-lab-of-northwestern-university-longevity-institute-in-japan-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo establishes Smart research lab in US to expedite drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/25476/japans-daiichi-sankyo-establishes-smart-research-lab-in-us-to-expedite-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25476/japans-daiichi-sankyo-establishes-smart-research-lab-in-us-to-expedite-drug-discovery.html</link>
			<pubDate>Thu, 23 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jap-25476.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25476/japans-daiichi-sankyo-establishes-smart-research-lab-in-us-to-expedite-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Sumitomo to market Johnson &amp; Johnson&#039;s schizophrenia drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25470/sumitomo-to-market-johnson-johnsons-schizophrenia-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25470/sumitomo-to-market-johnson-johnsons-schizophrenia-drug-in-japan.html</link>
			<pubDate>Tue, 21 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_21_1_2025_193643_-25470.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25470/sumitomo-to-market-johnson-johnsons-schizophrenia-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Shimadzu releases world&#039;s first gas chromatograph systems with CO2 reduction visualisation function</title>
			<atom:link href="https://biospectrumasia.com/news/50/25465/shimadzu-releases-worlds-first-gas-chromatograph-systems-with-co2-reduction-visualisation-function.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25465/shimadzu-releases-worlds-first-gas-chromatograph-systems-with-co2-reduction-visualisation-function.html</link>
			<pubDate>Mon, 20 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_20_1_2025_22626_www_shimadzu_com-25465.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25465/shimadzu-releases-worlds-first-gas-chromatograph-systems-with-co2-reduction-visualisation-function.html</guid>
		</item>	
				<item>
			<title>Germany&#039;s BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/25446/germanys-biomed-x-institute-launches-new-collaboration-with-japanese-firm-daiichi-sankyo-in-cancer-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25446/germanys-biomed-x-institute-launches-new-collaboration-with-japanese-firm-daiichi-sankyo-in-cancer-therapy.html</link>
			<pubDate>Thu, 16 Jan 2025 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bio-25446.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25446/germanys-biomed-x-institute-launches-new-collaboration-with-japanese-firm-daiichi-sankyo-in-cancer-therapy.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo buys cancer ADC from Glycotope for $132.5 million </title>
			<atom:link href="https://biospectrumasia.com/news/50/25440/daiichi-sankyo-buys-cancer-adc-from-glycotope-for-132-5-million-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25440/daiichi-sankyo-buys-cancer-adc-from-glycotope-for-132-5-million-.html</link>
			<pubDate>Wed, 15 Jan 2025 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25440/daiichi-sankyo-buys-cancer-adc-from-glycotope-for-132-5-million-.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s Advanced Genomics and Cancer Precision Medicine partner to launch bladder cancer screening test in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25438/taiwans-advanced-genomics-and-cancer-precision-medicine-partner-to-launch-bladder-cancer-screening-test-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25438/taiwans-advanced-genomics-and-cancer-precision-medicine-partner-to-launch-bladder-cancer-screening-test-in-japan.html</link>
			<pubDate>Wed, 15 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_1_2025_85851_-25438.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25438/taiwans-advanced-genomics-and-cancer-precision-medicine-partner-to-launch-bladder-cancer-screening-test-in-japan.html</guid>
		</item>	
				<item>
			<title>Terumo, FUJIFILM partner to accelerate T Cell expansion for cell therapy developers  </title>
			<atom:link href="https://biospectrumasia.com/news/50/25435/terumo-fujifilm-partner-to-accelerate-t-cell-expansion-for-cell-therapy-developers-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25435/terumo-fujifilm-partner-to-accelerate-t-cell-expansion-for-cell-therapy-developers-.html</link>
			<pubDate>Tue, 14 Jan 2025 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25435/terumo-fujifilm-partner-to-accelerate-t-cell-expansion-for-cell-therapy-developers-.html</guid>
		</item>	
				<item>
			<title>CN Bio signs strategic partnership with Primetech Corporation to establish distribution channel for OOC solutions in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25439/cn-bio-signs-strategic-partnership-with-primetech-corporation-to-establish-distribution-channel-for-ooc-solutions-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25439/cn-bio-signs-strategic-partnership-with-primetech-corporation-to-establish-distribution-channel-for-ooc-solutions-in-japan.html</link>
			<pubDate>Tue, 14 Jan 2025 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25439/cn-bio-signs-strategic-partnership-with-primetech-corporation-to-establish-distribution-channel-for-ooc-solutions-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s NEC and Biomy to expand AI-based analytical platforms in digital pathology</title>
			<atom:link href="https://biospectrumasia.com/news/50/25423/japans-nec-and-biomy-to-expand-ai-based-analytical-platforms-in-digital-pathology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25423/japans-nec-and-biomy-to-expand-ai-based-analytical-platforms-in-digital-pathology.html</link>
			<pubDate>Fri, 10 Jan 2025 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/path-25423.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25423/japans-nec-and-biomy-to-expand-ai-based-analytical-platforms-in-digital-pathology.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kaneka Corporation acquires 96.8% of shares of Israeli medical equipment company EndoStream</title>
			<atom:link href="https://biospectrumasia.com/news/50/25408/japans-kaneka-corporation-acquires-96-8-of-shares-of-israeli-medical-equipment-company-endostream.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25408/japans-kaneka-corporation-acquires-96-8-of-shares-of-israeli-medical-equipment-company-endostream.html</link>
			<pubDate>Thu, 09 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_1_2025_12727_www_businesswire_com-25408.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25408/japans-kaneka-corporation-acquires-96-8-of-shares-of-israeli-medical-equipment-company-endostream.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe gets Taiwan rights for Rigel/Kissei&#039;s oral spleen tyrosine inhibitor Fostamatinib </title>
			<atom:link href="https://biospectrumasia.com/news/50/25405/mitsubishi-tanabe-gets-taiwan-rights-for-rigel-kisseis-oral-spleen-tyrosine-inhibitor-fostamatinib-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25405/mitsubishi-tanabe-gets-taiwan-rights-for-rigel-kisseis-oral-spleen-tyrosine-inhibitor-fostamatinib-.html</link>
			<pubDate>Wed, 08 Jan 2025 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25405/mitsubishi-tanabe-gets-taiwan-rights-for-rigel-kisseis-oral-spleen-tyrosine-inhibitor-fostamatinib-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kaken Pharma enters into license agreement for STAT6 inhibitor with Johnson &amp; Johnson for $1.2 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/25393/japans-kaken-pharma-enters-into-license-agreement-for-stat6-inhibitor-with-johnson-johnson-for-1-2-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25393/japans-kaken-pharma-enters-into-license-agreement-for-stat6-inhibitor-with-johnson-johnson-for-1-2-b.html</link>
			<pubDate>Tue, 07 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agmt-25393.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25393/japans-kaken-pharma-enters-into-license-agreement-for-stat6-inhibitor-with-johnson-johnson-for-1-2-b.html</guid>
		</item>	
				<item>
			<title>Japanese firms JCR Pharmaceuticals and Modalis Therapeutics move forward with development of novel gene therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/25391/japanese-firms-jcr-pharmaceuticals-and-modalis-therapeutics-move-forward-with-development-of-novel-gene-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25391/japanese-firms-jcr-pharmaceuticals-and-modalis-therapeutics-move-forward-with-development-of-novel-gene-therapy.html</link>
			<pubDate>Mon, 06 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene_therapy-25391.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25391/japanese-firms-jcr-pharmaceuticals-and-modalis-therapeutics-move-forward-with-development-of-novel-gene-therapy.html</guid>
		</item>	
				<item>
			<title>Japan approves first and only facilitated subcutaneous immunoglobulin for Agammaglobulinemia and Hypogammaglobulinemia</title>
			<atom:link href="https://biospectrumasia.com/news/50/25386/japan-approves-first-and-only-facilitated-subcutaneous-immunoglobulin-for-agammaglobulinemia-and-hypogammaglobulinemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25386/japan-approves-first-and-only-facilitated-subcutaneous-immunoglobulin-for-agammaglobulinemia-and-hypogammaglobulinemia.html</link>
			<pubDate>Sun, 05 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-25386.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25386/japan-approves-first-and-only-facilitated-subcutaneous-immunoglobulin-for-agammaglobulinemia-and-hypogammaglobulinemia.html</guid>
		</item>	
				<item>
			<title>Axcelead DDP enters into drug discovery service agreement with Astellas for targeted protein degraders</title>
			<atom:link href="https://biospectrumasia.com/news/50/25370/axcelead-ddp-enters-into-drug-discovery-service-agreement-with-astellas-for-targeted-protein-degraders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25370/axcelead-ddp-enters-into-drug-discovery-service-agreement-with-astellas-for-targeted-protein-degraders.html</link>
			<pubDate>Wed, 01 Jan 2025 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25370/axcelead-ddp-enters-into-drug-discovery-service-agreement-with-astellas-for-targeted-protein-degraders.html</guid>
		</item>	
				<item>
			<title>Kaken to acquire US based Aadi Bioscience for $100 Million to establish global footprint</title>
			<atom:link href="https://biospectrumasia.com/news/50/25364/kaken-to-acquire-us-based-aadi-bioscience-for-100-million-to-establish-global-footprint.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25364/kaken-to-acquire-us-based-aadi-bioscience-for-100-million-to-establish-global-footprint.html</link>
			<pubDate>Tue, 24 Dec 2024 21:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25364/kaken-to-acquire-us-based-aadi-bioscience-for-100-million-to-establish-global-footprint.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujirebio and Eisai to establish diagnostic technologies for various neurodegenerative diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/25365/japans-fujirebio-and-eisai-to-establish-diagnostic-technologies-for-various-neurodegenerative-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25365/japans-fujirebio-and-eisai-to-establish-diagnostic-technologies-for-various-neurodegenerative-diseases.html</link>
			<pubDate>Tue, 24 Dec 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neuro-25365.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25365/japans-fujirebio-and-eisai-to-establish-diagnostic-technologies-for-various-neurodegenerative-diseases.html</guid>
		</item>	
				<item>
			<title>Astellas inks a $20 million deal with Sangamo to improve neurological gene therapy capabilities</title>
			<atom:link href="https://biospectrumasia.com/news/50/25357/astellas-inks-a-20-million-deal-with-sangamo-to-improve-neurological-gene-therapy-capabilities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25357/astellas-inks-a-20-million-deal-with-sangamo-to-improve-neurological-gene-therapy-capabilities.html</link>
			<pubDate>Mon, 23 Dec 2024 11:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25357/astellas-inks-a-20-million-deal-with-sangamo-to-improve-neurological-gene-therapy-capabilities.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sumitomo to establish regenerative medicine and cell therapy joint venture</title>
			<atom:link href="https://biospectrumasia.com/news/50/25350/japans-sumitomo-to-establish-regenerative-medicine-and-cell-therapy-joint-venture.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25350/japans-sumitomo-to-establish-regenerative-medicine-and-cell-therapy-joint-venture.html</link>
			<pubDate>Fri, 20 Dec 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/regenerative_cell_therapy-25350.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25350/japans-sumitomo-to-establish-regenerative-medicine-and-cell-therapy-joint-venture.html</guid>
		</item>	
				<item>
			<title>Takeda, Tohoku University form alliance to strengthen drug discovery capabilities in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25340/takeda-tohoku-university-form-alliance-to-strengthen-drug-discovery-capabilities-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25340/takeda-tohoku-university-form-alliance-to-strengthen-drug-discovery-capabilities-in-japan.html</link>
			<pubDate>Wed, 18 Dec 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-25340.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25340/takeda-tohoku-university-form-alliance-to-strengthen-drug-discovery-capabilities-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu develops platform to support gene therapy manufacturing</title>
			<atom:link href="https://biospectrumasia.com/news/50/25336/japans-shimadzu-develops-platform-to-support-gene-therapy-manufacturing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25336/japans-shimadzu-develops-platform-to-support-gene-therapy-manufacturing.html</link>
			<pubDate>Tue, 17 Dec 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-25336.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25336/japans-shimadzu-develops-platform-to-support-gene-therapy-manufacturing.html</guid>
		</item>	
				<item>
			<title>Eisai Subsidiary inks â‚¬117 M deal for schizophrenia treatment in Japan and other Asian territories</title>
			<atom:link href="https://biospectrumasia.com/news/50/25329/eisai-subsidiary-inks-117-m-deal-for-schizophrenia-treatment-in-japan-and-other-asian-territories.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25329/eisai-subsidiary-inks-117-m-deal-for-schizophrenia-treatment-in-japan-and-other-asian-territories.html</link>
			<pubDate>Mon, 16 Dec 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/schizophrenia_1-25329.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25329/eisai-subsidiary-inks-117-m-deal-for-schizophrenia-treatment-in-japan-and-other-asian-territories.html</guid>
		</item>	
				<item>
			<title>CellProthera and SKGH partner to advance stem cell Therapy in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25324/cellprothera-and-skgh-partner-to-advance-stem-cell-therapy-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25324/cellprothera-and-skgh-partner-to-advance-stem-cell-therapy-in-japan.html</link>
			<pubDate>Thu, 12 Dec 2024 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25324/cellprothera-and-skgh-partner-to-advance-stem-cell-therapy-in-japan.html</guid>
		</item>	
				<item>
			<title>TMC Japan BioBridge to provide Japanese healthcare innovators path to enter US market</title>
			<atom:link href="https://biospectrumasia.com/news/50/25312/tmc-japan-biobridge-to-provide-japanese-healthcare-innovators-path-to-enter-us-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25312/tmc-japan-biobridge-to-provide-japanese-healthcare-innovators-path-to-enter-us-market.html</link>
			<pubDate>Tue, 10 Dec 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jap-25312.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25312/tmc-japan-biobridge-to-provide-japanese-healthcare-innovators-path-to-enter-us-market.html</guid>
		</item>	
				<item>
			<title>Israel&#039;s Teva Pharma to divest business venture in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25303/israels-teva-pharma-to-divest-business-venture-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25303/israels-teva-pharma-to-divest-business-venture-in-japan.html</link>
			<pubDate>Fri, 06 Dec 2024 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_8_12_2024_192334_-25303.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25303/israels-teva-pharma-to-divest-business-venture-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai and Biogen launch Alzheimer&#039;s drug in South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/25299/eisai-and-biogen-launch-alzheimers-drug-in-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25299/eisai-and-biogen-launch-alzheimers-drug-in-south-korea.html</link>
			<pubDate>Wed, 04 Dec 2024 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25299/eisai-and-biogen-launch-alzheimers-drug-in-south-korea.html</guid>
		</item>	
				<item>
			<title>Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/25293/takeda-strengthens-oncology-pipeline-with-elritercept-through-licensing-agreement-with-keros-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25293/takeda-strengthens-oncology-pipeline-with-elritercept-through-licensing-agreement-with-keros-therapeutics.html</link>
			<pubDate>Tue, 03 Dec 2024 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25293/takeda-strengthens-oncology-pipeline-with-elritercept-through-licensing-agreement-with-keros-therapeutics.html</guid>
		</item>	
				<item>
			<title>GE to acquire Japanese radiopharma company Nihon Medi-Physics (NMP)</title>
			<atom:link href="https://biospectrumasia.com/news/50/25287/ge-to-acquire-japanese-radiopharma-company-nihon-medi-physics-nmp.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25287/ge-to-acquire-japanese-radiopharma-company-nihon-medi-physics-nmp.html</link>
			<pubDate>Mon, 02 Dec 2024 08:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25287/ge-to-acquire-japanese-radiopharma-company-nihon-medi-physics-nmp.html</guid>
		</item>	
				<item>
			<title>Japanese AI startup Recursive signs MoU with King Abdullah International Medical Research Center </title>
			<atom:link href="https://biospectrumasia.com/news/50/25280/japanese-ai-startup-recursive-signs-mou-with-king-abdullah-international-medical-research-center-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25280/japanese-ai-startup-recursive-signs-mou-with-king-abdullah-international-medical-research-center-.html</link>
			<pubDate>Thu, 28 Nov 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25280/japanese-ai-startup-recursive-signs-mou-with-king-abdullah-international-medical-research-center-.html</guid>
		</item>	
				<item>
			<title>SOHM, Inc. secures key patent in Japan for revolutionary gene editing technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/25263/sohm-inc-secures-key-patent-in-japan-for-revolutionary-gene-editing-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25263/sohm-inc-secures-key-patent-in-japan-for-revolutionary-gene-editing-technology.html</link>
			<pubDate>Wed, 27 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene-25263.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25263/sohm-inc-secures-key-patent-in-japan-for-revolutionary-gene-editing-technology.html</guid>
		</item>	
				<item>
			<title>Eisai and Biogen Japan collaborate to lead dementia genomics R&amp;D with NCNP in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25258/eisai-and-biogen-japan-collaborate-to-lead-dementia-genomics-rd-with-ncnp-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25258/eisai-and-biogen-japan-collaborate-to-lead-dementia-genomics-rd-with-ncnp-in-japan.html</link>
			<pubDate>Tue, 26 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dementia_detected_through_brain_imaging_872147_67724-25258.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25258/eisai-and-biogen-japan-collaborate-to-lead-dementia-genomics-rd-with-ncnp-in-japan.html</guid>
		</item>	
				<item>
			<title>IIT Roorkee and Kyoto University open joint-research lab in Japan with focus on healthy ageing</title>
			<atom:link href="https://biospectrumasia.com/news/50/25254/iit-roorkee-and-kyoto-university-open-joint-research-lab-in-japan-with-focus-on-healthy-ageing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25254/iit-roorkee-and-kyoto-university-open-joint-research-lab-in-japan-with-focus-on-healthy-ageing.html</link>
			<pubDate>Mon, 25 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/l1_1fjo2-25254.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25254/iit-roorkee-and-kyoto-university-open-joint-research-lab-in-japan-with-focus-on-healthy-ageing.html</guid>
		</item>	
				<item>
			<title>Kura Oncology &amp; Kyowa Kirin ink billion dollar deal to develop and commercialise  Ziftomenib for acute leukemia treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/25243/kura-oncology-kyowa-kirin-ink-billion-dollar-deal-to-develop-and-commercialise-ziftomenib-for-acute-leukemia-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25243/kura-oncology-kyowa-kirin-ink-billion-dollar-deal-to-develop-and-commercialise-ziftomenib-for-acute-leukemia-treatment.html</link>
			<pubDate>Sat, 23 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-25243.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25243/kura-oncology-kyowa-kirin-ink-billion-dollar-deal-to-develop-and-commercialise-ziftomenib-for-acute-leukemia-treatment.html</guid>
		</item>	
				<item>
			<title>MedTech Actuator establishes first Japanese office in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25238/medtech-actuator-establishes-first-japanese-office-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25238/medtech-actuator-establishes-first-japanese-office-in-japan.html</link>
			<pubDate>Wed, 20 Nov 2024 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25238/medtech-actuator-establishes-first-japanese-office-in-japan.html</guid>
		</item>	
				<item>
			<title>Singleron Joins Forces with TOMY Digital Biology to Transform Single Cell Analysis in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25235/singleron-joins-forces-with-tomy-digital-biology-to-transform-single-cell-analysis-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25235/singleron-joins-forces-with-tomy-digital-biology-to-transform-single-cell-analysis-in-japan.html</link>
			<pubDate>Wed, 20 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20241120_tomy_singleron_1_-25235.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25235/singleron-joins-forces-with-tomy-digital-biology-to-transform-single-cell-analysis-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s SBI to launch first Saudi Arabia biotech fund</title>
			<atom:link href="https://biospectrumasia.com/news/50/25233/japans-sbi-to-launch-first-saudi-arabia-biotech-fund.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25233/japans-sbi-to-launch-first-saudi-arabia-biotech-fund.html</link>
			<pubDate>Tue, 19 Nov 2024 17:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25233/japans-sbi-to-launch-first-saudi-arabia-biotech-fund.html</guid>
		</item>	
				<item>
			<title>Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25209/meiji-seika-pharma-invests-in-arcalis-to-boost-production-of-mrna-vaccines-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25209/meiji-seika-pharma-invests-in-arcalis-to-boost-production-of-mrna-vaccines-in-japan.html</link>
			<pubDate>Mon, 18 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_11_2024_93234_-25209.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25209/meiji-seika-pharma-invests-in-arcalis-to-boost-production-of-mrna-vaccines-in-japan.html</guid>
		</item>	
				<item>
			<title>Kaken Pharmaceutical and Numab Therapeutics collaborate on inflammatory bowel disease treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/25221/kaken-pharmaceutical-and-numab-therapeutics-collaborate-on-inflammatory-bowel-disease-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25221/kaken-pharmaceutical-and-numab-therapeutics-collaborate-on-inflammatory-bowel-disease-treatment.html</link>
			<pubDate>Fri, 15 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hfthfjtg-25221.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25221/kaken-pharmaceutical-and-numab-therapeutics-collaborate-on-inflammatory-bowel-disease-treatment.html</guid>
		</item>	
				<item>
			<title>South Korean Firm Alteogen enters into an agreement with Japan behemoth Daiichi Sankyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/25188/south-korean-firm-alteogen-enters-into-an-agreement-with-japan-behemoth-daiichi-sankyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25188/south-korean-firm-alteogen-enters-into-an-agreement-with-japan-behemoth-daiichi-sankyo.html</link>
			<pubDate>Mon, 11 Nov 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25188/south-korean-firm-alteogen-enters-into-an-agreement-with-japan-behemoth-daiichi-sankyo.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT Fund invests $4 M to advance diagnostics and treatments for NTDs and malaria</title>
			<atom:link href="https://biospectrumasia.com/news/50/25179/japans-ghit-fund-invests-4-m-to-advance-diagnostics-and-treatments-for-ntds-and-malaria.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25179/japans-ghit-fund-invests-4-m-to-advance-diagnostics-and-treatments-for-ntds-and-malaria.html</link>
			<pubDate>Fri, 08 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_8_11_2024_164552_www_freepik_com-25179.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25179/japans-ghit-fund-invests-4-m-to-advance-diagnostics-and-treatments-for-ntds-and-malaria.html</guid>
		</item>	
				<item>
			<title>Inocras and Summit Pharma International Corp collaborate to transform clinical genomics in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/25163/inocras-and-summit-pharma-international-corp-collaborate-to-transform-clinical-genomics-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25163/inocras-and-summit-pharma-international-corp-collaborate-to-transform-clinical-genomics-in-japan.html</link>
			<pubDate>Wed, 06 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wgs-25163.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25163/inocras-and-summit-pharma-international-corp-collaborate-to-transform-clinical-genomics-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan Agency for Medical Research and Development picks Eisai&#039;s venture capital to strengthen program for pharma startup ecosystem</title>
			<atom:link href="https://biospectrumasia.com/news/50/25156/japan-agency-for-medical-research-and-development-picks-eisais-venture-capital-to-strengthen-program-for-pharma-startup-ecosystem.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25156/japan-agency-for-medical-research-and-development-picks-eisais-venture-capital-to-strengthen-program-for-pharma-startup-ecosystem.html</link>
			<pubDate>Tue, 05 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dd2-25156.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25156/japan-agency-for-medical-research-and-development-picks-eisais-venture-capital-to-strengthen-program-for-pharma-startup-ecosystem.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu Corp partners with US-based Sepragen marking entry into biopharma market</title>
			<atom:link href="https://biospectrumasia.com/news/50/25150/japans-shimadzu-corp-partners-with-us-based-sepragen-marking-entry-into-biopharma-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25150/japans-shimadzu-corp-partners-with-us-based-sepragen-marking-entry-into-biopharma-market.html</link>
			<pubDate>Mon, 04 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_11_2024_114723_sepragen_com-25150.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25150/japans-shimadzu-corp-partners-with-us-based-sepragen-marking-entry-into-biopharma-market.html</guid>
		</item>	
				<item>
			<title>Japanese researchers discover key to preventing neurodegeneration in Parkinson&#039;s and related disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/25146/japanese-researchers-discover-key-to-preventing-neurodegeneration-in-parkinsons-and-related-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25146/japanese-researchers-discover-key-to-preventing-neurodegeneration-in-parkinsons-and-related-disorders.html</link>
			<pubDate>Fri, 01 Nov 2024 07:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25146/japanese-researchers-discover-key-to-preventing-neurodegeneration-in-parkinsons-and-related-disorders.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s I Peace announces new iPSC lines to reduce immune rejection risk for US population</title>
			<atom:link href="https://biospectrumasia.com/news/50/25144/japans-i-peace-announces-new-ipsc-lines-to-reduce-immune-rejection-risk-for-us-population.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25144/japans-i-peace-announces-new-ipsc-lines-to-reduce-immune-rejection-risk-for-us-population.html</link>
			<pubDate>Fri, 01 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-25144.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25144/japans-i-peace-announces-new-ipsc-lines-to-reduce-immune-rejection-risk-for-us-population.html</guid>
		</item>	
				<item>
			<title>Breakthroughs and Global Innovation as MEDICAL JAPAN TOKYO 2024 Achieves Resounding Success</title>
			<atom:link href="https://biospectrumasia.com/news/50/25115/breakthroughs-and-global-innovation-as-medical-japan-tokyo-2024-achieves-resounding-success.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25115/breakthroughs-and-global-innovation-as-medical-japan-tokyo-2024-achieves-resounding-success.html</link>
			<pubDate>Wed, 30 Oct 2024 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mjt_photo_1-25115.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25115/breakthroughs-and-global-innovation-as-medical-japan-tokyo-2024-achieves-resounding-success.html</guid>
		</item>	
				<item>
			<title>Shimadzu releases CellTune software for supporting optimisation of cell culture conditions</title>
			<atom:link href="https://biospectrumasia.com/news/50/25105/shimadzu-releases-celltune-software-for-supporting-optimisation-of-cell-culture-conditions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25105/shimadzu-releases-celltune-software-for-supporting-optimisation-of-cell-culture-conditions.html</link>
			<pubDate>Tue, 29 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cell-25105.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25105/shimadzu-releases-celltune-software-for-supporting-optimisation-of-cell-culture-conditions.html</guid>
		</item>	
				<item>
			<title>First-of-its-kind research collaboration for Takeda and Boston Medical Center to decarbonise the healthcare value chain</title>
			<atom:link href="https://biospectrumasia.com/news/50/25090/first-of-its-kind-research-collaboration-for-takeda-and-boston-medical-center-to-decarbonise-the-healthcare-value-chain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25090/first-of-its-kind-research-collaboration-for-takeda-and-boston-medical-center-to-decarbonise-the-healthcare-value-chain.html</link>
			<pubDate>Thu, 24 Oct 2024 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/decarb-25090.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25090/first-of-its-kind-research-collaboration-for-takeda-and-boston-medical-center-to-decarbonise-the-healthcare-value-chain.html</guid>
		</item>	
				<item>
			<title>Joint venture company established in Japan to incubate early drug discovery programs</title>
			<atom:link href="https://biospectrumasia.com/news/50/25056/joint-venture-company-established-in-japan-to-incubate-early-drug-discovery-programs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25056/joint-venture-company-established-in-japan-to-incubate-early-drug-discovery-programs.html</link>
			<pubDate>Tue, 22 Oct 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25056/joint-venture-company-established-in-japan-to-incubate-early-drug-discovery-programs.html</guid>
		</item>	
				<item>
			<title>JETRO partners with Mayo Clinic to boost US market access for Japanese companies </title>
			<atom:link href="https://biospectrumasia.com/news/50/25082/jetro-partners-with-mayo-clinic-to-boost-us-market-access-for-japanese-companies-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25082/jetro-partners-with-mayo-clinic-to-boost-us-market-access-for-japanese-companies-.html</link>
			<pubDate>Tue, 22 Oct 2024 20:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25082/jetro-partners-with-mayo-clinic-to-boost-us-market-access-for-japanese-companies-.html</guid>
		</item>	
				<item>
			<title>Japanese med tech leader Terumo announces strategic outsourcing partnership with Namsa</title>
			<atom:link href="https://biospectrumasia.com/news/50/25064/japanese-med-tech-leader-terumo-announces-strategic-outsourcing-partnership-with-namsa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25064/japanese-med-tech-leader-terumo-announces-strategic-outsourcing-partnership-with-namsa.html</link>
			<pubDate>Wed, 16 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_10_2024_183610_namsa_com-25064.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25064/japanese-med-tech-leader-terumo-announces-strategic-outsourcing-partnership-with-namsa.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Honkuwa Pharma opens up new chapter in innovative pharmaceutical R&amp;D technologies</title>
			<atom:link href="https://biospectrumasia.com/news/50/25051/japans-honkuwa-pharma-opens-up-new-chapter-in-innovative-pharmaceutical-rd-technologies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25051/japans-honkuwa-pharma-opens-up-new-chapter-in-innovative-pharmaceutical-rd-technologies.html</link>
			<pubDate>Tue, 15 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_10_2024_12841_www_media_outreach_com-25051.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25051/japans-honkuwa-pharma-opens-up-new-chapter-in-innovative-pharmaceutical-rd-technologies.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono Pharma inks $700 M ADC deal with Korean firm LigaChem Biosciences</title>
			<atom:link href="https://biospectrumasia.com/news/50/25047/japans-ono-pharma-inks-700-m-adc-deal-with-korean-firm-ligachem-biosciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25047/japans-ono-pharma-inks-700-m-adc-deal-with-korean-firm-ligachem-biosciences.html</link>
			<pubDate>Mon, 14 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/adc-25047.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25047/japans-ono-pharma-inks-700-m-adc-deal-with-korean-firm-ligachem-biosciences.html</guid>
		</item>	
				<item>
			<title>Japanese startup Alpha Fusion accelerates astatine-based drug discovery with Series B funding</title>
			<atom:link href="https://biospectrumasia.com/news/50/25042/japanese-startup-alpha-fusion-accelerates-astatine-based-drug-discovery-with-series-b-funding.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25042/japanese-startup-alpha-fusion-accelerates-astatine-based-drug-discovery-with-series-b-funding.html</link>
			<pubDate>Sun, 13 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ddd-25042.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25042/japanese-startup-alpha-fusion-accelerates-astatine-based-drug-discovery-with-series-b-funding.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas and UK-based AviadoBio ink billion dollar deal for gene therapy targeting frontotemporal dementia </title>
			<atom:link href="https://biospectrumasia.com/news/50/25026/japans-astellas-and-uk-based-aviadobio-ink-billion-dollar-deal-for-gene-therapy-targeting-frontotemporal-dementia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25026/japans-astellas-and-uk-based-aviadobio-ink-billion-dollar-deal-for-gene-therapy-targeting-frontotemporal-dementia-.html</link>
			<pubDate>Thu, 10 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dem-25026.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25026/japans-astellas-and-uk-based-aviadobio-ink-billion-dollar-deal-for-gene-therapy-targeting-frontotemporal-dementia-.html</guid>
		</item>	
				<item>
			<title>Eisai&#039;s gout drug approved in Thailand</title>
			<atom:link href="https://biospectrumasia.com/news/50/25025/eisais-gout-drug-approved-in-thailand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25025/eisais-gout-drug-approved-in-thailand.html</link>
			<pubDate>Wed, 09 Oct 2024 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25025/eisais-gout-drug-approved-in-thailand.html</guid>
		</item>	
				<item>
			<title>Lifebit and Flatiron Health advances cancer care in Japan through real-world data</title>
			<atom:link href="https://biospectrumasia.com/news/50/25021/lifebit-and-flatiron-health-advances-cancer-care-in-japan-through-real-world-data.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25021/lifebit-and-flatiron-health-advances-cancer-care-in-japan-through-real-world-data.html</link>
			<pubDate>Wed, 09 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dh1-25021.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25021/lifebit-and-flatiron-health-advances-cancer-care-in-japan-through-real-world-data.html</guid>
		</item>	
				<item>
			<title>Japanese startup Rege Nephro raises Â¥ 22.5 B to accelerate kidney disease therapy trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/25009/japanese-startup-rege-nephro-raises-22-5-b-to-accelerate-kidney-disease-therapy-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25009/japanese-startup-rege-nephro-raises-22-5-b-to-accelerate-kidney-disease-therapy-trials.html</link>
			<pubDate>Tue, 08 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/startup-25009.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25009/japanese-startup-rege-nephro-raises-22-5-b-to-accelerate-kidney-disease-therapy-trials.html</guid>
		</item>	
				<item>
			<title>DKSH and Kyowa Kirin partner to improve patient access in six APAC markets</title>
			<atom:link href="https://biospectrumasia.com/news/50/25010/dksh-and-kyowa-kirin-partner-to-improve-patient-access-in-six-apac-markets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/25010/dksh-and-kyowa-kirin-partner-to-improve-patient-access-in-six-apac-markets.html</link>
			<pubDate>Mon, 07 Oct 2024 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/25010/dksh-and-kyowa-kirin-partner-to-improve-patient-access-in-six-apac-markets.html</guid>
		</item>	
				<item>
			<title>Nxera Pharma enters new commercial partnership with Shionogi for insomnia drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24997/nxera-pharma-enters-new-commercial-partnership-with-shionogi-for-insomnia-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24997/nxera-pharma-enters-new-commercial-partnership-with-shionogi-for-insomnia-drug-in-japan.html</link>
			<pubDate>Thu, 03 Oct 2024 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24997/nxera-pharma-enters-new-commercial-partnership-with-shionogi-for-insomnia-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Curium inks strategic partnership with PeptiDream for prostate cancer theranostics in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24989/curium-inks-strategic-partnership-with-peptidream-for-prostate-cancer-theranostics-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24989/curium-inks-strategic-partnership-with-peptidream-for-prostate-cancer-theranostics-in-japan.html</link>
			<pubDate>Thu, 03 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-24989.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24989/curium-inks-strategic-partnership-with-peptidream-for-prostate-cancer-theranostics-in-japan.html</guid>
		</item>	
				<item>
			<title>Terumo Asia Holdings unveils Terumo Asia Skill Lab with the expansion of Singapore office</title>
			<atom:link href="https://biospectrumasia.com/news/50/24986/terumo-asia-holdings-unveils-terumo-asia-skill-lab-with-the-expansion-of-singapore-office.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24986/terumo-asia-holdings-unveils-terumo-asia-skill-lab-with-the-expansion-of-singapore-office.html</link>
			<pubDate>Wed, 02 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dfd-24986.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24986/terumo-asia-holdings-unveils-terumo-asia-skill-lab-with-the-expansion-of-singapore-office.html</guid>
		</item>	
				<item>
			<title>Nxera Pharma appoints Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/24974/nxera-pharma-appoints-makoto-sugita-as-chief-medical-officer-and-president-of-nxera-pharma-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24974/nxera-pharma-appoints-makoto-sugita-as-chief-medical-officer-and-president-of-nxera-pharma-japan-.html</link>
			<pubDate>Tue, 01 Oct 2024 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24974/nxera-pharma-appoints-makoto-sugita-as-chief-medical-officer-and-president-of-nxera-pharma-japan-.html</guid>
		</item>	
				<item>
			<title>Japanese medtech firm Olympus introduces new imaging platform VISERA S</title>
			<atom:link href="https://biospectrumasia.com/news/50/24970/japanese-medtech-firm-olympus-introduces-new-imaging-platform-visera-s.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24970/japanese-medtech-firm-olympus-introduces-new-imaging-platform-visera-s.html</link>
			<pubDate>Tue, 01 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_9_2024_222136_www_acnnewswire_com-24970.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24970/japanese-medtech-firm-olympus-introduces-new-imaging-platform-visera-s.html</guid>
		</item>	
				<item>
			<title>Japan approves Boston Scientific&#039;s FARAPULSE Pulsed Field Ablation System</title>
			<atom:link href="https://biospectrumasia.com/news/50/24964/japan-approves-boston-scientifics-farapulse-pulsed-field-ablation-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24964/japan-approves-boston-scientifics-farapulse-pulsed-field-ablation-system.html</link>
			<pubDate>Sun, 29 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_29_9_2024_222643_www_bostonscientific_com-24964.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24964/japan-approves-boston-scientifics-farapulse-pulsed-field-ablation-system.html</guid>
		</item>	
				<item>
			<title>Nxera Pharma receives approval of insomnia drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24939/nxera-pharma-receives-approval-of-insomnia-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24939/nxera-pharma-receives-approval-of-insomnia-drug-in-japan.html</link>
			<pubDate>Tue, 24 Sep 2024 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_24_9_2024_231919_-24939.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24939/nxera-pharma-receives-approval-of-insomnia-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda Pharma provides over $32 M for five new global CSR partnerships</title>
			<atom:link href="https://biospectrumasia.com/news/50/24918/japans-takeda-pharma-provides-over-32-m-for-five-new-global-csr-partnerships.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24918/japans-takeda-pharma-provides-over-32-m-for-five-new-global-csr-partnerships.html</link>
			<pubDate>Fri, 20 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/invest-24918.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24918/japans-takeda-pharma-provides-over-32-m-for-five-new-global-csr-partnerships.html</guid>
		</item>	
				<item>
			<title>Japanese biotech Axcelead DDP and Lilly Enter into Research and Collaboration Agreement</title>
			<atom:link href="https://biospectrumasia.com/news/50/24914/japanese-biotech-axcelead-ddp-and-lilly-enter-into-research-and-collaboration-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24914/japanese-biotech-axcelead-ddp-and-lilly-enter-into-research-and-collaboration-agreement.html</link>
			<pubDate>Thu, 19 Sep 2024 20:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24914/japanese-biotech-axcelead-ddp-and-lilly-enter-into-research-and-collaboration-agreement.html</guid>
		</item>	
				<item>
			<title>Japan-based analytical instrument firm Shimadzu begins operations in Mexico</title>
			<atom:link href="https://biospectrumasia.com/news/50/24909/japan-based-analytical-instrument-firm-shimadzu-begins-operations-in-mexico.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24909/japan-based-analytical-instrument-firm-shimadzu-begins-operations-in-mexico.html</link>
			<pubDate>Wed, 18 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shimadzu-24909.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24909/japan-based-analytical-instrument-firm-shimadzu-begins-operations-in-mexico.html</guid>
		</item>	
				<item>
			<title>Rigaku develops new solution to accelerate biopharmaceutical R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/50/24899/rigaku-develops-new-solution-to-accelerate-biopharmaceutical-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24899/rigaku-develops-new-solution-to-accelerate-biopharmaceutical-rd.html</link>
			<pubDate>Tue, 17 Sep 2024 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24899/rigaku-develops-new-solution-to-accelerate-biopharmaceutical-rd.html</guid>
		</item>	
				<item>
			<title>Japan approves iRhythm Technologies&#039; AI-based ECG monitoring system</title>
			<atom:link href="https://biospectrumasia.com/news/50/24896/japan-approves-irhythm-technologies-ai-based-ecg-monitoring-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24896/japan-approves-irhythm-technologies-ai-based-ecg-monitoring-system.html</link>
			<pubDate>Tue, 17 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_17_9_2024_22449_www_irhythmtech_com-24896.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24896/japan-approves-irhythm-technologies-ai-based-ecg-monitoring-system.html</guid>
		</item>	
				<item>
			<title>Japan approves self-amplifying mRNA COVID-19 vaccine for protection against JN.1 strain</title>
			<atom:link href="https://biospectrumasia.com/news/50/24884/japan-approves-self-amplifying-mrna-covid-19-vaccine-for-protection-against-jn-1-strain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24884/japan-approves-self-amplifying-mrna-covid-19-vaccine-for-protection-against-jn-1-strain.html</link>
			<pubDate>Fri, 13 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_13_9_2024_192839_-24884.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24884/japan-approves-self-amplifying-mrna-covid-19-vaccine-for-protection-against-jn-1-strain.html</guid>
		</item>	
				<item>
			<title>French firm Osivax grants rights to KM Biologics to develop and market influenza vaccine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24861/french-firm-osivax-grants-rights-to-km-biologics-to-develop-and-market-influenza-vaccine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24861/french-firm-osivax-grants-rights-to-km-biologics-to-develop-and-market-influenza-vaccine-in-japan.html</link>
			<pubDate>Tue, 10 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vaxi-24861.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24861/french-firm-osivax-grants-rights-to-km-biologics-to-develop-and-market-influenza-vaccine-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan-based Takara Bio launches large-scale qPCR system to advance broad surveillance of antimicrobial resistance</title>
			<atom:link href="https://biospectrumasia.com/news/50/24852/japan-based-takara-bio-launches-large-scale-qpcr-system-to-advance-broad-surveillance-of-antimicrobial-resistance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24852/japan-based-takara-bio-launches-large-scale-qpcr-system-to-advance-broad-surveillance-of-antimicrobial-resistance.html</link>
			<pubDate>Fri, 06 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/plate-24852.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24852/japan-based-takara-bio-launches-large-scale-qpcr-system-to-advance-broad-surveillance-of-antimicrobial-resistance.html</guid>
		</item>	
				<item>
			<title>US-based Rigel inks $162.5 M oncology deal with Kissei for Japan, Korea and Taiwan markets</title>
			<atom:link href="https://biospectrumasia.com/news/50/24842/us-based-rigel-inks-162-5-m-oncology-deal-with-kissei-for-japan-korea-and-taiwan-markets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24842/us-based-rigel-inks-162-5-m-oncology-deal-with-kissei-for-japan-korea-and-taiwan-markets.html</link>
			<pubDate>Thu, 05 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/part-24842.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24842/us-based-rigel-inks-162-5-m-oncology-deal-with-kissei-for-japan-korea-and-taiwan-markets.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Rigaku Corp develops solution to accelerate biopharmaceutical R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/50/24837/japans-rigaku-corp-develops-solution-to-accelerate-biopharmaceutical-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24837/japans-rigaku-corp-develops-solution-to-accelerate-biopharmaceutical-rd.html</link>
			<pubDate>Wed, 04 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-24837.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24837/japans-rigaku-corp-develops-solution-to-accelerate-biopharmaceutical-rd.html</guid>
		</item>	
				<item>
			<title>ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort</title>
			<atom:link href="https://biospectrumasia.com/news/50/24824/thinkcyte-secures-32-million-in-series-c-funding-to-drive-global-expansion-of-visionsort.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24824/thinkcyte-secures-32-million-in-series-c-funding-to-drive-global-expansion-of-visionsort.html</link>
			<pubDate>Tue, 03 Sep 2024 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24824/thinkcyte-secures-32-million-in-series-c-funding-to-drive-global-expansion-of-visionsort.html</guid>
		</item>	
				<item>
			<title>PHC in Japan introduces new prototype cell expansion system to support cell and gene therapy manufacturing</title>
			<atom:link href="https://biospectrumasia.com/news/50/24807/phc-in-japan-introduces-new-prototype-cell-expansion-system-to-support-cell-and-gene-therapy-manufacturing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24807/phc-in-japan-introduces-new-prototype-cell-expansion-system-to-support-cell-and-gene-therapy-manufacturing.html</link>
			<pubDate>Mon, 02 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image_new-24807.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24807/phc-in-japan-introduces-new-prototype-cell-expansion-system-to-support-cell-and-gene-therapy-manufacturing.html</guid>
		</item>	
				<item>
			<title>Rebooting Japan&#039;s biotech growth engine</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/24797/rebooting-japans-biotech-growth-engine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/24797/rebooting-japans-biotech-growth-engine.html</link>
			<pubDate>Sun, 01 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jp-24797.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/24797/rebooting-japans-biotech-growth-engine.html</guid>
		</item>	
				<item>
			<title>Boosting Japan&#039;s Biotech Ecosystem </title>
			<atom:link href="https://biospectrumasia.com/opinion/50/24798/boosting-japans-biotech-ecosystem-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/24798/boosting-japans-biotech-ecosystem-.html</link>
			<pubDate>Sun, 01 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/andrew-24798.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/24798/boosting-japans-biotech-ecosystem-.html</guid>
		</item>	
				<item>
			<title>Advancing Japan&#039;s Biotech Ecosystem: Current Initiatives and Future Outlook</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/24799/advancing-japans-biotech-ecosystem-current-initiatives-and-future-outlook.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/24799/advancing-japans-biotech-ecosystem-current-initiatives-and-future-outlook.html</link>
			<pubDate>Sun, 01 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kikuo_yasui_coo_director_of_the_board_heartseed_inc_-24799.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/24799/advancing-japans-biotech-ecosystem-current-initiatives-and-future-outlook.html</guid>
		</item>	
				<item>
			<title>Strategies for Success in Japan&#039;s Biotech Ecosystem</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/24800/strategies-for-success-in-japans-biotech-ecosystem.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/24800/strategies-for-success-in-japans-biotech-ecosystem.html</link>
			<pubDate>Sun, 01 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stefan_1024x768-24800.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/24800/strategies-for-success-in-japans-biotech-ecosystem.html</guid>
		</item>	
				<item>
			<title>Antibody Engineering &amp; Therapeutics Asia 2024: A Premier Gathering for Cutting-Edge Antibody Research and Innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/24858/antibody-engineering-therapeutics-asia-2024-a-premier-gathering-for-cutting-edge-antibody-research-and-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24858/antibody-engineering-therapeutics-asia-2024-a-premier-gathering-for-cutting-edge-antibody-research-and-innovation.html</link>
			<pubDate>Sun, 01 Sep 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image_1_-24858.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24858/antibody-engineering-therapeutics-asia-2024-a-premier-gathering-for-cutting-edge-antibody-research-and-innovation.html</guid>
		</item>	
				<item>
			<title>Kaneka completes construction of medical device plant in Hokkaido, Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24794/kaneka-completes-construction-of-medical-device-plant-in-hokkaido-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24794/kaneka-completes-construction-of-medical-device-plant-in-hokkaido-japan.html</link>
			<pubDate>Fri, 30 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_8_2024_124430_mms_businesswire_com-24794.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24794/kaneka-completes-construction-of-medical-device-plant-in-hokkaido-japan.html</guid>
		</item>	
				<item>
			<title>Hitachi and Gencurix enter into partnership to expand cancer molecular diagnostics biz in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24789/hitachi-and-gencurix-enter-into-partnership-to-expand-cancer-molecular-diagnostics-biz-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24789/hitachi-and-gencurix-enter-into-partnership-to-expand-cancer-molecular-diagnostics-biz-in-japan.html</link>
			<pubDate>Thu, 29 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer2-24789.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24789/hitachi-and-gencurix-enter-into-partnership-to-expand-cancer-molecular-diagnostics-biz-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese medtech firm Olympus extends advanced bipolar surgical energy portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/50/24777/japanese-medtech-firm-olympus-extends-advanced-bipolar-surgical-energy-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24777/japanese-medtech-firm-olympus-extends-advanced-bipolar-surgical-energy-portfolio.html</link>
			<pubDate>Tue, 27 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_27_8_2024_111956_mma_prnewswire_com-24777.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24777/japanese-medtech-firm-olympus-extends-advanced-bipolar-surgical-energy-portfolio.html</guid>
		</item>	
				<item>
			<title>Fujitsu tackles â€˜drug loss&#039; in Japan through ecosystem to accelerate digitalization of clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/24775/fujitsu-tackles-drug-loss-in-japan-through-ecosystem-to-accelerate-digitalization-of-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24775/fujitsu-tackles-drug-loss-in-japan-through-ecosystem-to-accelerate-digitalization-of-clinical-trials.html</link>
			<pubDate>Mon, 26 Aug 2024 16:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24775/fujitsu-tackles-drug-loss-in-japan-through-ecosystem-to-accelerate-digitalization-of-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Hitachi High-Tech launches new tabletop microscopes with enhanced usability</title>
			<atom:link href="https://biospectrumasia.com/news/50/24762/hitachi-high-tech-launches-new-tabletop-microscopes-with-enhanced-usability.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24762/hitachi-high-tech-launches-new-tabletop-microscopes-with-enhanced-usability.html</link>
			<pubDate>Sat, 24 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_24_8_2024_18245_mail_google_com-24762.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24762/hitachi-high-tech-launches-new-tabletop-microscopes-with-enhanced-usability.html</guid>
		</item>	
				<item>
			<title>Rakuten Medical Announces New Management Team to Drive the Next Phase of Growth and Innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/24759/rakuten-medical-announces-new-management-team-to-drive-the-next-phase-of-growth-and-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24759/rakuten-medical-announces-new-management-team-to-drive-the-next-phase-of-growth-and-innovation.html</link>
			<pubDate>Thu, 22 Aug 2024 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24759/rakuten-medical-announces-new-management-team-to-drive-the-next-phase-of-growth-and-innovation.html</guid>
		</item>	
				<item>
			<title>Tokyo Medical and Dental University, Celaid Therapeutics partner for CGT </title>
			<atom:link href="https://biospectrumasia.com/news/50/24753/tokyo-medical-and-dental-university-celaid-therapeutics-partner-for-cgt-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24753/tokyo-medical-and-dental-university-celaid-therapeutics-partner-for-cgt-.html</link>
			<pubDate>Wed, 21 Aug 2024 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24753/tokyo-medical-and-dental-university-celaid-therapeutics-partner-for-cgt-.html</guid>
		</item>	
				<item>
			<title>Otsuka launches DTx for Depression in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/24743/otsuka-launches-dtx-for-depression-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24743/otsuka-launches-dtx-for-depression-in-us.html</link>
			<pubDate>Mon, 19 Aug 2024 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24743/otsuka-launches-dtx-for-depression-in-us.html</guid>
		</item>	
				<item>
			<title>Nanoform and Takeda Collaborate on Pre-Clinical Development of Innovative Plasma-Derived Therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/24733/nanoform-and-takeda-collaborate-on-pre-clinical-development-of-innovative-plasma-derived-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24733/nanoform-and-takeda-collaborate-on-pre-clinical-development-of-innovative-plasma-derived-therapies.html</link>
			<pubDate>Fri, 16 Aug 2024 20:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24733/nanoform-and-takeda-collaborate-on-pre-clinical-development-of-innovative-plasma-derived-therapies.html</guid>
		</item>	
				<item>
			<title>MEDICAL JAPAN 2024 TOKYO Expands Horizons with New Trade Fairs and Comprehensive Healthcare  Coverage</title>
			<atom:link href="https://biospectrumasia.com/news/50/24729/medical-japan-2024-tokyo-expands-horizons-with-new-trade-fairs-and-comprehensive-healthcare-coverage.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24729/medical-japan-2024-tokyo-expands-horizons-with-new-trade-fairs-and-comprehensive-healthcare-coverage.html</link>
			<pubDate>Wed, 14 Aug 2024 16:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24729/medical-japan-2024-tokyo-expands-horizons-with-new-trade-fairs-and-comprehensive-healthcare-coverage.html</guid>
		</item>	
				<item>
			<title>FDA approves first and only prescription digital therapeutic for depression  </title>
			<atom:link href="https://biospectrumasia.com/news/50/24721/fda-approves-first-and-only-prescription-digital-therapeutic-for-depression-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24721/fda-approves-first-and-only-prescription-digital-therapeutic-for-depression-.html</link>
			<pubDate>Tue, 13 Aug 2024 21:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24721/fda-approves-first-and-only-prescription-digital-therapeutic-for-depression-.html</guid>
		</item>	
				<item>
			<title>Aevice Health secures $7M Seed Plus funding to expand remote monitoring for chronic respiratory disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/24717/aevice-health-secures-7m-seed-plus-funding-to-expand-remote-monitoring-for-chronic-respiratory-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24717/aevice-health-secures-7m-seed-plus-funding-to-expand-remote-monitoring-for-chronic-respiratory-disease.html</link>
			<pubDate>Mon, 12 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-24717.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24717/aevice-health-secures-7m-seed-plus-funding-to-expand-remote-monitoring-for-chronic-respiratory-disease.html</guid>
		</item>	
				<item>
			<title>Eisai inks a $1.5 billion deal with SEED Therapeutics for molecular degraders</title>
			<atom:link href="https://biospectrumasia.com/news/50/24711/eisai-inks-a-1-5-billion-deal-with-seed-therapeutics-for-molecular-degraders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24711/eisai-inks-a-1-5-billion-deal-with-seed-therapeutics-for-molecular-degraders.html</link>
			<pubDate>Fri, 09 Aug 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24711/eisai-inks-a-1-5-billion-deal-with-seed-therapeutics-for-molecular-degraders.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo and Merck ink $170 M deal to commercialise cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/24696/daiichi-sankyo-and-merck-ink-170-m-deal-to-commercialise-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24696/daiichi-sankyo-and-merck-ink-170-m-deal-to-commercialise-cancer-drug.html</link>
			<pubDate>Thu, 08 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-24696.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24696/daiichi-sankyo-and-merck-ink-170-m-deal-to-commercialise-cancer-drug.html</guid>
		</item>	
				<item>
			<title>NEC Bio &amp; AGC Biologics announce collaboration to manufacture personalised cancer vaccines</title>
			<atom:link href="https://biospectrumasia.com/news/50/24707/nec-bio-agc-biologics-announce-collaboration-to-manufacture-personalised-cancer-vaccines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24707/nec-bio-agc-biologics-announce-collaboration-to-manufacture-personalised-cancer-vaccines.html</link>
			<pubDate>Wed, 07 Aug 2024 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24707/nec-bio-agc-biologics-announce-collaboration-to-manufacture-personalised-cancer-vaccines.html</guid>
		</item>	
				<item>
			<title>Kyorin,  EVerMed ink option deal for respiratory disease treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/24699/kyorin-evermed-ink-option-deal-for-respiratory-disease-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24699/kyorin-evermed-ink-option-deal-for-respiratory-disease-treatment.html</link>
			<pubDate>Wed, 07 Aug 2024 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24699/kyorin-evermed-ink-option-deal-for-respiratory-disease-treatment.html</guid>
		</item>	
				<item>
			<title>Japanese medtech firm Terumo establishes corporate venture capital to support innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/24691/japanese-medtech-firm-terumo-establishes-corporate-venture-capital-to-support-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24691/japanese-medtech-firm-terumo-establishes-corporate-venture-capital-to-support-innovation.html</link>
			<pubDate>Tue, 06 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/terumo-24691.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24691/japanese-medtech-firm-terumo-establishes-corporate-venture-capital-to-support-innovation.html</guid>
		</item>	
				<item>
			<title>DKSH and Kyowa Kirin Forge Strategic Partnership Across Asia-Pacific</title>
			<atom:link href="https://biospectrumasia.com/news/50/24686/dksh-and-kyowa-kirin-forge-strategic-partnership-across-asia-pacific.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24686/dksh-and-kyowa-kirin-forge-strategic-partnership-across-asia-pacific.html</link>
			<pubDate>Mon, 05 Aug 2024 20:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24686/dksh-and-kyowa-kirin-forge-strategic-partnership-across-asia-pacific.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka Pharma acquires American biotech startup Jnana Therapeutics for $1.1 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/24681/japans-otsuka-pharma-acquires-american-biotech-startup-jnana-therapeutics-for-1-1-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24681/japans-otsuka-pharma-acquires-american-biotech-startup-jnana-therapeutics-for-1-1-b.html</link>
			<pubDate>Mon, 05 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_5_8_2024_133614_www_jnanatx_com-24681.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24681/japans-otsuka-pharma-acquires-american-biotech-startup-jnana-therapeutics-for-1-1-b.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s pharma firm Kyowa Kirin announces sustainable biz strategy for APAC region</title>
			<atom:link href="https://biospectrumasia.com/news/50/24676/japans-pharma-firm-kyowa-kirin-announces-sustainable-biz-strategy-for-apac-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24676/japans-pharma-firm-kyowa-kirin-announces-sustainable-biz-strategy-for-apac-region.html</link>
			<pubDate>Fri, 02 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-24676.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24676/japans-pharma-firm-kyowa-kirin-announces-sustainable-biz-strategy-for-apac-region.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Hitachi High-Tech acquires majority interest in American firm Nabsys</title>
			<atom:link href="https://biospectrumasia.com/news/50/24678/japans-hitachi-high-tech-acquires-majority-interest-in-american-firm-nabsys.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24678/japans-hitachi-high-tech-acquires-majority-interest-in-american-firm-nabsys.html</link>
			<pubDate>Thu, 01 Aug 2024 02:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24678/japans-hitachi-high-tech-acquires-majority-interest-in-american-firm-nabsys.html</guid>
		</item>	
				<item>
			<title>Biogen, Beckman Coulter and Fujirebio to develop new tests for tau pathology in Alzheimer&#039;s</title>
			<atom:link href="https://biospectrumasia.com/news/50/24659/biogen-beckman-coulter-and-fujirebio-to-develop-new-tests-for-tau-pathology-in-alzheimers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24659/biogen-beckman-coulter-and-fujirebio-to-develop-new-tests-for-tau-pathology-in-alzheimers.html</link>
			<pubDate>Wed, 31 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ad-24659.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24659/biogen-beckman-coulter-and-fujirebio-to-develop-new-tests-for-tau-pathology-in-alzheimers.html</guid>
		</item>	
				<item>
			<title>AstraZeneca partners with Japanese startup United Immunity for drug delivery tech research</title>
			<atom:link href="https://biospectrumasia.com/news/50/24651/astrazeneca-partners-with-japanese-startup-united-immunity-for-drug-delivery-tech-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24651/astrazeneca-partners-with-japanese-startup-united-immunity-for-drug-delivery-tech-research.html</link>
			<pubDate>Tue, 30 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dd-24651.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24651/astrazeneca-partners-with-japanese-startup-united-immunity-for-drug-delivery-tech-research.html</guid>
		</item>	
				<item>
			<title>Merck inks MoU with Japanese biotech startup Gene Therapy Research  Institution</title>
			<atom:link href="https://biospectrumasia.com/news/50/24628/merck-inks-mou-with-japanese-biotech-startup-gene-therapy-research-institution.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24628/merck-inks-mou-with-japanese-biotech-startup-gene-therapy-research-institution.html</link>
			<pubDate>Fri, 26 Jul 2024 16:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gt-24628.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24628/merck-inks-mou-with-japanese-biotech-startup-gene-therapy-research-institution.html</guid>
		</item>	
				<item>
			<title>Eisai and EcoNaviSta to build dementia ecosystem in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24620/eisai-and-econavista-to-build-dementia-ecosystem-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24620/eisai-and-econavista-to-build-dementia-ecosystem-in-japan.html</link>
			<pubDate>Thu, 25 Jul 2024 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dem-24620.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24620/eisai-and-econavista-to-build-dementia-ecosystem-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan-based Fujifilm expands health screening service business in Mongolia</title>
			<atom:link href="https://biospectrumasia.com/news/50/24615/japan-based-fujifilm-expands-health-screening-service-business-in-mongolia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24615/japan-based-fujifilm-expands-health-screening-service-business-in-mongolia.html</link>
			<pubDate>Wed, 24 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nura-24615.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24615/japan-based-fujifilm-expands-health-screening-service-business-in-mongolia.html</guid>
		</item>	
				<item>
			<title>Eisai partners with Sato Pharma to commercialise anti-fungal agent fosravuconazole in Asia, Oceania</title>
			<atom:link href="https://biospectrumasia.com/news/50/24609/eisai-partners-with-sato-pharma-to-commercialise-anti-fungal-agent-fosravuconazole-in-asia-oceania.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24609/eisai-partners-with-sato-pharma-to-commercialise-anti-fungal-agent-fosravuconazole-in-asia-oceania.html</link>
			<pubDate>Tue, 23 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_23_7_2024_133045_-24609.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24609/eisai-partners-with-sato-pharma-to-commercialise-anti-fungal-agent-fosravuconazole-in-asia-oceania.html</guid>
		</item>	
				<item>
			<title>Astellas and Osaka University to develop pluripotent stem cell-derived cartilage organoid cell therapy in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24601/astellas-and-osaka-university-to-develop-pluripotent-stem-cell-derived-cartilage-organoid-cell-therapy-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24601/astellas-and-osaka-university-to-develop-pluripotent-stem-cell-derived-cartilage-organoid-cell-therapy-in-japan.html</link>
			<pubDate>Mon, 22 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-24601.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24601/astellas-and-osaka-university-to-develop-pluripotent-stem-cell-derived-cartilage-organoid-cell-therapy-in-japan.html</guid>
		</item>	
				<item>
			<title>Ubie and the American Kidney Fund Collaborate to Speed Early Diagnosis and Education for Kidney Disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/24595/ubie-and-the-american-kidney-fund-collaborate-to-speed-early-diagnosis-and-education-for-kidney-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24595/ubie-and-the-american-kidney-fund-collaborate-to-speed-early-diagnosis-and-education-for-kidney-disease.html</link>
			<pubDate>Fri, 19 Jul 2024 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24595/ubie-and-the-american-kidney-fund-collaborate-to-speed-early-diagnosis-and-education-for-kidney-disease.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nipro Corp invests $398 M into new medical device manufacturing facility in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/24591/japans-nipro-corp-invests-398-m-into-new-medical-device-manufacturing-facility-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24591/japans-nipro-corp-invests-398-m-into-new-medical-device-manufacturing-facility-in-us.html</link>
			<pubDate>Thu, 18 Jul 2024 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_19_7_2024_53555_www_nipro_group_com-24591.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24591/japans-nipro-corp-invests-398-m-into-new-medical-device-manufacturing-facility-in-us.html</guid>
		</item>	
				<item>
			<title>VitalLife and Bumrungrad International Hospital in Thailand launches NEC&#039;s FonesVisuas Test</title>
			<atom:link href="https://biospectrumasia.com/news/50/24587/vitallife-and-bumrungrad-international-hospital-in-thailand-launches-necs-fonesvisuas-test.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24587/vitallife-and-bumrungrad-international-hospital-in-thailand-launches-necs-fonesvisuas-test.html</link>
			<pubDate>Thu, 18 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image001_1_-24587.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24587/vitallife-and-bumrungrad-international-hospital-in-thailand-launches-necs-fonesvisuas-test.html</guid>
		</item>	
				<item>
			<title>Renalys Pharma Closes Â¥6.0Bn Series A Financing to Advance Kidney Disease Treatments Across Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/24583/renalys-pharma-closes-6-0bn-series-a-financing-to-advance-kidney-disease-treatments-across-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24583/renalys-pharma-closes-6-0bn-series-a-financing-to-advance-kidney-disease-treatments-across-asia.html</link>
			<pubDate>Wed, 17 Jul 2024 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24583/renalys-pharma-closes-6-0bn-series-a-financing-to-advance-kidney-disease-treatments-across-asia.html</guid>
		</item>	
				<item>
			<title>Researchers from Japan discover new enzyme with promising antibacterial activity</title>
			<atom:link href="https://biospectrumasia.com/news/50/24568/researchers-from-japan-discover-new-enzyme-with-promising-antibacterial-activity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24568/researchers-from-japan-discover-new-enzyme-with-promising-antibacterial-activity.html</link>
			<pubDate>Mon, 15 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-24568.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24568/researchers-from-japan-discover-new-enzyme-with-promising-antibacterial-activity.html</guid>
		</item>	
				<item>
			<title>Shimadzu partners with Tescan Group to launch Scanning Electron Microscopes in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24559/shimadzu-partners-with-tescan-group-to-launch-scanning-electron-microscopes-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24559/shimadzu-partners-with-tescan-group-to-launch-scanning-electron-microscopes-in-japan.html</link>
			<pubDate>Fri, 12 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tescan-24559.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24559/shimadzu-partners-with-tescan-group-to-launch-scanning-electron-microscopes-in-japan.html</guid>
		</item>	
				<item>
			<title>Mitsubishi to promote Moderna&#039;s mRNA respiratory vaccine portfolio in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24548/mitsubishi-to-promote-modernas-mrna-respiratory-vaccine-portfolio-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24548/mitsubishi-to-promote-modernas-mrna-respiratory-vaccine-portfolio-in-japan.html</link>
			<pubDate>Wed, 10 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vax-24548.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24548/mitsubishi-to-promote-modernas-mrna-respiratory-vaccine-portfolio-in-japan.html</guid>
		</item>	
				<item>
			<title>TMS partners with Hokkaido University in Japan to develop treatment for spinal cord injury</title>
			<atom:link href="https://biospectrumasia.com/news/50/24542/tms-partners-with-hokkaido-university-in-japan-to-develop-treatment-for-spinal-cord-injury.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24542/tms-partners-with-hokkaido-university-in-japan-to-develop-treatment-for-spinal-cord-injury.html</link>
			<pubDate>Tue, 09 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sc-24542.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24542/tms-partners-with-hokkaido-university-in-japan-to-develop-treatment-for-spinal-cord-injury.html</guid>
		</item>	
				<item>
			<title>Shimadzu, Shionogi unveil international wastewater-based epidemiology lab at University of Tokyo, Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24529/shimadzu-shionogi-unveil-international-wastewater-based-epidemiology-lab-at-university-of-tokyo-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24529/shimadzu-shionogi-unveil-international-wastewater-based-epidemiology-lab-at-university-of-tokyo-japan.html</link>
			<pubDate>Fri, 05 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/water-24529.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24529/shimadzu-shionogi-unveil-international-wastewater-based-epidemiology-lab-at-university-of-tokyo-japan.html</guid>
		</item>	
				<item>
			<title>BE Health set to connect Taiwanese and Japanese biotech startups</title>
			<atom:link href="https://biospectrumasia.com/news/50/24525/be-health-set-to-connect-taiwanese-and-japanese-biotech-startups.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24525/be-health-set-to-connect-taiwanese-and-japanese-biotech-startups.html</link>
			<pubDate>Wed, 03 Jul 2024 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24525/be-health-set-to-connect-taiwanese-and-japanese-biotech-startups.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Eisai terminates ADC manufacturing pact with BMS</title>
			<atom:link href="https://biospectrumasia.com/news/50/24514/japans-eisai-terminates-adc-manufacturing-pact-with-bms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24514/japans-eisai-terminates-adc-manufacturing-pact-with-bms.html</link>
			<pubDate>Wed, 03 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-24514.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24514/japans-eisai-terminates-adc-manufacturing-pact-with-bms.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s SoftBank Group establishes JV with Tempus for AI-based healthcare advancements</title>
			<atom:link href="https://biospectrumasia.com/news/50/24512/japans-softbank-group-establishes-jv-with-tempus-for-ai-based-healthcare-advancements.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24512/japans-softbank-group-establishes-jv-with-tempus-for-ai-based-healthcare-advancements.html</link>
			<pubDate>Tue, 02 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ai_med-24512.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24512/japans-softbank-group-establishes-jv-with-tempus-for-ai-based-healthcare-advancements.html</guid>
		</item>	
				<item>
			<title>Eisai&#039;s Alzheimer&#039;s drug launched in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/24506/eisais-alzheimers-drug-launched-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24506/eisais-alzheimers-drug-launched-in-china.html</link>
			<pubDate>Fri, 28 Jun 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24506/eisais-alzheimers-drug-launched-in-china.html</guid>
		</item>	
				<item>
			<title>Nxera Pharma gets $10 million from AbbVie for neurological diseases </title>
			<atom:link href="https://biospectrumasia.com/news/50/24497/nxera-pharma-gets-10-million-from-abbvie-for-neurological-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24497/nxera-pharma-gets-10-million-from-abbvie-for-neurological-diseases-.html</link>
			<pubDate>Thu, 27 Jun 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24497/nxera-pharma-gets-10-million-from-abbvie-for-neurological-diseases-.html</guid>
		</item>	
				<item>
			<title>Israel&#039;s Medasense partners with Nihon Kohden for distribution of pain monitoring device in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24490/israels-medasense-partners-with-nihon-kohden-for-distribution-of-pain-monitoring-device-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24490/israels-medasense-partners-with-nihon-kohden-for-distribution-of-pain-monitoring-device-in-japan.html</link>
			<pubDate>Thu, 27 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/meda-24490.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24490/israels-medasense-partners-with-nihon-kohden-for-distribution-of-pain-monitoring-device-in-japan.html</guid>
		</item>	
				<item>
			<title>Ono invests $1 million to advance cancer research and education</title>
			<atom:link href="https://biospectrumasia.com/news/50/24482/ono-invests-1-million-to-advance-cancer-research-and-education.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24482/ono-invests-1-million-to-advance-cancer-research-and-education.html</link>
			<pubDate>Tue, 25 Jun 2024 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24482/ono-invests-1-million-to-advance-cancer-research-and-education.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s NX Group partners with Iceland-based Controlant for real-time monitoring of pharma supplies</title>
			<atom:link href="https://biospectrumasia.com/news/50/24479/japans-nx-group-partners-with-iceland-based-controlant-for-real-time-monitoring-of-pharma-supplies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24479/japans-nx-group-partners-with-iceland-based-controlant-for-real-time-monitoring-of-pharma-supplies.html</link>
			<pubDate>Tue, 25 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-24479.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24479/japans-nx-group-partners-with-iceland-based-controlant-for-real-time-monitoring-of-pharma-supplies.html</guid>
		</item>	
				<item>
			<title>Japan approves first post-transplant anti- cytomegalovirus infection treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/24475/japan-approves-first-post-transplant-anti-cytomegalovirus-infection-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24475/japan-approves-first-post-transplant-anti-cytomegalovirus-infection-treatment.html</link>
			<pubDate>Mon, 24 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_24_6_2024_17815_-24475.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24475/japan-approves-first-post-transplant-anti-cytomegalovirus-infection-treatment.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Healios inks stem cells production deal with Astellas Pharma for $8 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/24463/japans-healios-inks-stem-cells-production-deal-with-astellas-pharma-for-8-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24463/japans-healios-inks-stem-cells-production-deal-with-astellas-pharma-for-8-m.html</link>
			<pubDate>Fri, 21 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem_cell-24463.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24463/japans-healios-inks-stem-cells-production-deal-with-astellas-pharma-for-8-m.html</guid>
		</item>	
				<item>
			<title>Mitsubishi sells its European business to french firm Ethypharm</title>
			<atom:link href="https://biospectrumasia.com/news/50/24457/mitsubishi-sells-its-european-business-to-french-firm-ethypharm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24457/mitsubishi-sells-its-european-business-to-french-firm-ethypharm.html</link>
			<pubDate>Wed, 19 Jun 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24457/mitsubishi-sells-its-european-business-to-french-firm-ethypharm.html</guid>
		</item>	
				<item>
			<title>Japanese study reveals promising drug target for treating osteoporosis</title>
			<atom:link href="https://biospectrumasia.com/news/50/24449/japanese-study-reveals-promising-drug-target-for-treating-osteoporosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24449/japanese-study-reveals-promising-drug-target-for-treating-osteoporosis.html</link>
			<pubDate>Tue, 18 Jun 2024 21:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24449/japanese-study-reveals-promising-drug-target-for-treating-osteoporosis.html</guid>
		</item>	
				<item>
			<title>Mirxes secures grant of S$172k to develop novel cancer screening test in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24444/mirxes-secures-grant-of-s172k-to-develop-novel-cancer-screening-test-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24444/mirxes-secures-grant-of-s172k-to-develop-novel-cancer-screening-test-in-japan.html</link>
			<pubDate>Tue, 18 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_200010311-24444.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24444/mirxes-secures-grant-of-s172k-to-develop-novel-cancer-screening-test-in-japan.html</guid>
		</item>	
				<item>
			<title>Kissei grants Korean rights for GnRH antagonist Linzagolix to JW Pharmaceutical </title>
			<atom:link href="https://biospectrumasia.com/news/50/24429/kissei-grants-korean-rights-for-gnrh-antagonist-linzagolix-to-jw-pharmaceutical-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24429/kissei-grants-korean-rights-for-gnrh-antagonist-linzagolix-to-jw-pharmaceutical-.html</link>
			<pubDate>Thu, 13 Jun 2024 14:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24429/kissei-grants-korean-rights-for-gnrh-antagonist-linzagolix-to-jw-pharmaceutical-.html</guid>
		</item>	
				<item>
			<title>Kyowa Kirin invests $530m in new US biologics manufacturing facility</title>
			<atom:link href="https://biospectrumasia.com/news/50/24414/kyowa-kirin-invests-530m-in-new-us-biologics-manufacturing-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24414/kyowa-kirin-invests-530m-in-new-us-biologics-manufacturing-facility.html</link>
			<pubDate>Tue, 11 Jun 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24414/kyowa-kirin-invests-530m-in-new-us-biologics-manufacturing-facility.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi inks â‚¬400 M deal with French firm Cilcare to address hearing loss</title>
			<atom:link href="https://biospectrumasia.com/news/50/24407/japans-shionogi-inks-400-m-deal-with-french-firm-cilcare-to-address-hearing-loss.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24407/japans-shionogi-inks-400-m-deal-with-french-firm-cilcare-to-address-hearing-loss.html</link>
			<pubDate>Mon, 10 Jun 2024 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hear-24407.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24407/japans-shionogi-inks-400-m-deal-with-french-firm-cilcare-to-address-hearing-loss.html</guid>
		</item>	
				<item>
			<title>Maruho Licenses Amenalief Rights in 10 ASEAN States to Singapore&#039;s Hyphen Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/24399/maruho-licenses-amenalief-rights-in-10-asean-states-to-singapores-hyphen-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24399/maruho-licenses-amenalief-rights-in-10-asean-states-to-singapores-hyphen-pharma.html</link>
			<pubDate>Fri, 07 Jun 2024 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24399/maruho-licenses-amenalief-rights-in-10-asean-states-to-singapores-hyphen-pharma.html</guid>
		</item>	
				<item>
			<title>Japan-based Shimadzu acquires all shares of Zef Scientific Inc.</title>
			<atom:link href="https://biospectrumasia.com/news/50/24401/japan-based-shimadzu-acquires-all-shares-of-zef-scientific-inc-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24401/japan-based-shimadzu-acquires-all-shares-of-zef-scientific-inc-.html</link>
			<pubDate>Fri, 07 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_7_6_2024_182957_www_shimadzu_com-24401.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24401/japan-based-shimadzu-acquires-all-shares-of-zef-scientific-inc-.html</guid>
		</item>	
				<item>
			<title>Shionogi to open antimicrobial R&amp;D Center in the US</title>
			<atom:link href="https://biospectrumasia.com/news/50/24393/shionogi-to-open-antimicrobial-rd-center-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24393/shionogi-to-open-antimicrobial-rd-center-in-the-us.html</link>
			<pubDate>Thu, 06 Jun 2024 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24393/shionogi-to-open-antimicrobial-rd-center-in-the-us.html</guid>
		</item>	
				<item>
			<title>Singapore-Japan team finds common virus that triggers growth of nasopharyngeal cancer </title>
			<atom:link href="https://biospectrumasia.com/news/50/24390/singapore-japan-team-finds-common-virus-that-triggers-growth-of-nasopharyngeal-cancer-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24390/singapore-japan-team-finds-common-virus-that-triggers-growth-of-nasopharyngeal-cancer-.html</link>
			<pubDate>Thu, 06 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ntu-24390.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24390/singapore-japan-team-finds-common-virus-that-triggers-growth-of-nasopharyngeal-cancer-.html</guid>
		</item>	
				<item>
			<title>Eisai expands venture investment to 4 billion yen to accelerate drug discovery innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/24372/eisai-expands-venture-investment-to-4-billion-yen-to-accelerate-drug-discovery-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24372/eisai-expands-venture-investment-to-4-billion-yen-to-accelerate-drug-discovery-innovation.html</link>
			<pubDate>Tue, 04 Jun 2024 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24372/eisai-expands-venture-investment-to-4-billion-yen-to-accelerate-drug-discovery-innovation.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Asahi Kasei to establish facility in US and launch plasmid DNA business</title>
			<atom:link href="https://biospectrumasia.com/news/50/24366/japans-asahi-kasei-to-establish-facility-in-us-and-launch-plasmid-dna-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24366/japans-asahi-kasei-to-establish-facility-in-us-and-launch-plasmid-dna-business.html</link>
			<pubDate>Tue, 04 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ak-24366.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24366/japans-asahi-kasei-to-establish-facility-in-us-and-launch-plasmid-dna-business.html</guid>
		</item>	
				<item>
			<title>Fujitsu Japan and Juntendo University launch Medical Digital Resilience Research Course</title>
			<atom:link href="https://biospectrumasia.com/news/50/24358/fujitsu-japan-and-juntendo-university-launch-medical-digital-resilience-research-course.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24358/fujitsu-japan-and-juntendo-university-launch-medical-digital-resilience-research-course.html</link>
			<pubDate>Mon, 03 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/disas-24358.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24358/fujitsu-japan-and-juntendo-university-launch-medical-digital-resilience-research-course.html</guid>
		</item>	
				<item>
			<title>Kaken to transfer bispecific antibody IP to J&amp;J for $138 million</title>
			<atom:link href="https://biospectrumasia.com/news/50/24356/kaken-to-transfer-bispecific-antibody-ip-to-jj-for-138-million.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24356/kaken-to-transfer-bispecific-antibody-ip-to-jj-for-138-million.html</link>
			<pubDate>Fri, 31 May 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24356/kaken-to-transfer-bispecific-antibody-ip-to-jj-for-138-million.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu announces release of LCMS-TQ RX Series High-Performance LCMS</title>
			<atom:link href="https://biospectrumasia.com/news/50/24348/japans-shimadzu-announces-release-of-lcms-tq-rx-series-high-performance-lcms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24348/japans-shimadzu-announces-release-of-lcms-tq-rx-series-high-performance-lcms.html</link>
			<pubDate>Fri, 31 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_5_2024_142431_www_shimadzu_com-24348.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24348/japans-shimadzu-announces-release-of-lcms-tq-rx-series-high-performance-lcms.html</guid>
		</item>	
				<item>
			<title>Shionogi&#039;s Qpex Biopharma gets $10M from US government to advance AMR drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/24346/shionogis-qpex-biopharma-gets-10m-from-us-government-to-advance-amr-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24346/shionogis-qpex-biopharma-gets-10m-from-us-government-to-advance-amr-drugs.html</link>
			<pubDate>Thu, 30 May 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24346/shionogis-qpex-biopharma-gets-10m-from-us-government-to-advance-amr-drugs.html</guid>
		</item>	
				<item>
			<title>Teijin announces launch of novel cardiovascular surgical patch in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24336/teijin-announces-launch-of-novel-cardiovascular-surgical-patch-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24336/teijin-announces-launch-of-novel-cardiovascular-surgical-patch-in-japan.html</link>
			<pubDate>Thu, 30 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patch-24336.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24336/teijin-announces-launch-of-novel-cardiovascular-surgical-patch-in-japan.html</guid>
		</item>	
				<item>
			<title>Shionogi launches novel antibiotic Fetroja in Taiwan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24335/shionogi-launches-novel-antibiotic-fetroja-in-taiwan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24335/shionogi-launches-novel-antibiotic-fetroja-in-taiwan.html</link>
			<pubDate>Wed, 29 May 2024 20:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24335/shionogi-launches-novel-antibiotic-fetroja-in-taiwan.html</guid>
		</item>	
				<item>
			<title> Asahi Kasei to acquire Swedish firm Calliditas Therapeutics AB for JBP 174 billion</title>
			<atom:link href="https://biospectrumasia.com/news/50/24328/-asahi-kasei-to-acquire-swedish-firm-calliditas-therapeutics-ab-for-jbp-174-billion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24328/-asahi-kasei-to-acquire-swedish-firm-calliditas-therapeutics-ab-for-jbp-174-billion.html</link>
			<pubDate>Tue, 28 May 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24328/-asahi-kasei-to-acquire-swedish-firm-calliditas-therapeutics-ab-for-jbp-174-billion.html</guid>
		</item>	
				<item>
			<title>Astatine to emerge as Japan-originated therapy for prostate cancer patients </title>
			<atom:link href="https://biospectrumasia.com/news/50/24317/astatine-to-emerge-as-japan-originated-therapy-for-prostate-cancer-patients-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24317/astatine-to-emerge-as-japan-originated-therapy-for-prostate-cancer-patients-.html</link>
			<pubDate>Tue, 28 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-24317.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24317/astatine-to-emerge-as-japan-originated-therapy-for-prostate-cancer-patients-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Hitachi High-Tech extends partnership with Roche for diagnostic testing</title>
			<atom:link href="https://biospectrumasia.com/news/50/24304/japans-hitachi-high-tech-extends-partnership-with-roche-for-diagnostic-testing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24304/japans-hitachi-high-tech-extends-partnership-with-roche-for-diagnostic-testing.html</link>
			<pubDate>Mon, 27 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_27_5_2024_113829_diagnostics_roche_com-24304.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24304/japans-hitachi-high-tech-extends-partnership-with-roche-for-diagnostic-testing.html</guid>
		</item>	
				<item>
			<title>Asahi Kasei completes construction of third assembly plant for Planova virus removal filters in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24307/asahi-kasei-completes-construction-of-third-assembly-plant-for-planova-virus-removal-filters-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24307/asahi-kasei-completes-construction-of-third-assembly-plant-for-planova-virus-removal-filters-in-japan.html</link>
			<pubDate>Mon, 27 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the_completion_ceremony_on_may_24-24307.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24307/asahi-kasei-completes-construction-of-third-assembly-plant-for-planova-virus-removal-filters-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda inks $1.2 billion deal with China&#039;s Degron for molecular glue</title>
			<atom:link href="https://biospectrumasia.com/news/50/24296/takeda-inks-1-2-billion-deal-with-chinas-degron-for-molecular-glue.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24296/takeda-inks-1-2-billion-deal-with-chinas-degron-for-molecular-glue.html</link>
			<pubDate>Fri, 24 May 2024 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24296/takeda-inks-1-2-billion-deal-with-chinas-degron-for-molecular-glue.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu announces release of new liquid chromatograph software</title>
			<atom:link href="https://biospectrumasia.com/news/50/24298/japans-shimadzu-announces-release-of-new-liquid-chromatograph-software.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24298/japans-shimadzu-announces-release-of-new-liquid-chromatograph-software.html</link>
			<pubDate>Fri, 24 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_24_5_2024_222116_-24298.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24298/japans-shimadzu-announces-release-of-new-liquid-chromatograph-software.html</guid>
		</item>	
				<item>
			<title>Japanese pharma firm Daiichi Sankyo sets up new research sites in US, Germany</title>
			<atom:link href="https://biospectrumasia.com/news/50/24290/japanese-pharma-firm-daiichi-sankyo-sets-up-new-research-sites-in-us-germany.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24290/japanese-pharma-firm-daiichi-sankyo-sets-up-new-research-sites-in-us-germany.html</link>
			<pubDate>Thu, 23 May 2024 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-24290.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24290/japanese-pharma-firm-daiichi-sankyo-sets-up-new-research-sites-in-us-germany.html</guid>
		</item>	
				<item>
			<title>Metoject subcutaneous injection pen launches in Japan for rheumatic arthritis treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/24283/metoject-subcutaneous-injection-pen-launches-in-japan-for-rheumatic-arthritis-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24283/metoject-subcutaneous-injection-pen-launches-in-japan-for-rheumatic-arthritis-treatment.html</link>
			<pubDate>Wed, 22 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_22_5_2024_144837_mail_google_com-24283.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24283/metoject-subcutaneous-injection-pen-launches-in-japan-for-rheumatic-arthritis-treatment.html</guid>
		</item>	
				<item>
			<title>Astellas partners with Yaskawa to create innovative cell therapy ecosystem in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24274/astellas-partners-with-yaskawa-to-create-innovative-cell-therapy-ecosystem-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24274/astellas-partners-with-yaskawa-to-create-innovative-cell-therapy-ecosystem-in-japan.html</link>
			<pubDate>Tue, 21 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yaskawa-24274.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24274/astellas-partners-with-yaskawa-to-create-innovative-cell-therapy-ecosystem-in-japan.html</guid>
		</item>	
				<item>
			<title>&quot;Japan&#039;s success in digital health is attributed to the collaborative efforts between the government, private sector, and academic institutions&quot;</title>
			<atom:link href="https://biospectrumasia.com/news/50/24271/japans-success-in-digital-health-is-attributed-to-the-collaborative-efforts-between-the-government-private-sector-and-academic-institutions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24271/japans-success-in-digital-health-is-attributed-to-the-collaborative-efforts-between-the-government-private-sector-and-academic-institutions.html</link>
			<pubDate>Mon, 20 May 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dave-24271.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24271/japans-success-in-digital-health-is-attributed-to-the-collaborative-efforts-between-the-government-private-sector-and-academic-institutions.html</guid>
		</item>	
				<item>
			<title>WHO prequalifies Takeda&#039;s dengue vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/24263/who-prequalifies-takedas-dengue-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24263/who-prequalifies-takedas-dengue-vaccine.html</link>
			<pubDate>Sun, 19 May 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24263/who-prequalifies-takedas-dengue-vaccine.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s HOYA Group to distribute AI-assisted lesion detection device in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/24258/japans-hoya-group-to-distribute-ai-assisted-lesion-detection-device-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24258/japans-hoya-group-to-distribute-ai-assisted-lesion-detection-device-in-us.html</link>
			<pubDate>Sat, 18 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_5_2024_172419_magentiq_com-24258.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24258/japans-hoya-group-to-distribute-ai-assisted-lesion-detection-device-in-us.html</guid>
		</item>	
				<item>
			<title>AC Immune and Takeda Pharma ink $2.1 B deal for immunotherapy to delay Alzheimer&#039;s progression</title>
			<atom:link href="https://biospectrumasia.com/news/50/24230/ac-immune-and-takeda-pharma-ink-2-1-b-deal-for-immunotherapy-to-delay-alzheimers-progression.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24230/ac-immune-and-takeda-pharma-ink-2-1-b-deal-for-immunotherapy-to-delay-alzheimers-progression.html</link>
			<pubDate>Wed, 15 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-24230.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24230/ac-immune-and-takeda-pharma-ink-2-1-b-deal-for-immunotherapy-to-delay-alzheimers-progression.html</guid>
		</item>	
				<item>
			<title>OrthAlign launches handheld technology for knee arthroplasty in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24236/orthalign-launches-handheld-technology-for-knee-arthroplasty-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24236/orthalign-launches-handheld-technology-for-knee-arthroplasty-in-japan.html</link>
			<pubDate>Tue, 14 May 2024 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24236/orthalign-launches-handheld-technology-for-knee-arthroplasty-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi announces $150 M deal to develop first oral therapy for Pompe Disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/24225/japans-shionogi-announces-150-m-deal-to-develop-first-oral-therapy-for-pompe-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24225/japans-shionogi-announces-150-m-deal-to-develop-first-oral-therapy-for-pompe-disease.html</link>
			<pubDate>Mon, 13 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pill-24225.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24225/japans-shionogi-announces-150-m-deal-to-develop-first-oral-therapy-for-pompe-disease.html</guid>
		</item>	
				<item>
			<title>Japan Kidney Association and Renalys Pharma form collaborative agreement to overcome kidney disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/24202/japan-kidney-association-and-renalys-pharma-form-collaborative-agreement-to-overcome-kidney-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24202/japan-kidney-association-and-renalys-pharma-form-collaborative-agreement-to-overcome-kidney-disease.html</link>
			<pubDate>Fri, 10 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_10_5_2024_143952_renalys_com-24202.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24202/japan-kidney-association-and-renalys-pharma-form-collaborative-agreement-to-overcome-kidney-disease.html</guid>
		</item>	
				<item>
			<title>Lilly partners with Mitsubishi for obesity drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24211/lilly-partners-with-mitsubishi-for-obesity-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24211/lilly-partners-with-mitsubishi-for-obesity-drug-in-japan.html</link>
			<pubDate>Thu, 09 May 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24211/lilly-partners-with-mitsubishi-for-obesity-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT invests $10.8 M to develop new drugs for malaria &amp; NTDs</title>
			<atom:link href="https://biospectrumasia.com/news/50/24216/japans-ghit-invests-10-8-m-to-develop-new-drugs-for-malaria-ntds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24216/japans-ghit-invests-10-8-m-to-develop-new-drugs-for-malaria-ntds.html</link>
			<pubDate>Thu, 09 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dd-24216.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24216/japans-ghit-invests-10-8-m-to-develop-new-drugs-for-malaria-ntds.html</guid>
		</item>	
				<item>
			<title>Astellas and Poseida Therapeutics ink a $50 million deal to develop novel allogeneic cell therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/24192/astellas-and-poseida-therapeutics-ink-a-50-million-deal-to-develop-novel-allogeneic-cell-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24192/astellas-and-poseida-therapeutics-ink-a-50-million-deal-to-develop-novel-allogeneic-cell-therapies.html</link>
			<pubDate>Tue, 07 May 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24192/astellas-and-poseida-therapeutics-ink-a-50-million-deal-to-develop-novel-allogeneic-cell-therapies.html</guid>
		</item>	
				<item>
			<title>Takara Bio launches first commercial dissolvable microfluidic lentiviral transduction enhancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/24188/takara-bio-launches-first-commercial-dissolvable-microfluidic-lentiviral-transduction-enhancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24188/takara-bio-launches-first-commercial-dissolvable-microfluidic-lentiviral-transduction-enhancer.html</link>
			<pubDate>Tue, 07 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-24188.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24188/takara-bio-launches-first-commercial-dissolvable-microfluidic-lentiviral-transduction-enhancer.html</guid>
		</item>	
				<item>
			<title>Japan approves AI-powered surgical visualisation tool Eureka Î±</title>
			<atom:link href="https://biospectrumasia.com/news/50/24169/japan-approves-ai-powered-surgical-visualisation-tool-eureka-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24169/japan-approves-ai-powered-surgical-visualisation-tool-eureka-.html</link>
			<pubDate>Fri, 03 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image-24169.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24169/japan-approves-ai-powered-surgical-visualisation-tool-eureka-.html</guid>
		</item>	
				<item>
			<title>Japan-based PeptiDream inks $2.71 B deal with Novartis</title>
			<atom:link href="https://biospectrumasia.com/news/50/24163/japan-based-peptidream-inks-2-71-b-deal-with-novartis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24163/japan-based-peptidream-inks-2-71-b-deal-with-novartis.html</link>
			<pubDate>Thu, 02 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_309940142-24163.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24163/japan-based-peptidream-inks-2-71-b-deal-with-novartis.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s ONO to acquire US based Deciphera Pharmaceuticals for $2.4 billion </title>
			<atom:link href="https://biospectrumasia.com/news/50/24147/japans-ono-to-acquire-us-based-deciphera-pharmaceuticals-for-2-4-billion-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24147/japans-ono-to-acquire-us-based-deciphera-pharmaceuticals-for-2-4-billion-.html</link>
			<pubDate>Tue, 30 Apr 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24147/japans-ono-to-acquire-us-based-deciphera-pharmaceuticals-for-2-4-billion-.html</guid>
		</item>	
				<item>
			<title>US based Câ‚‚N Diagnostics expands Alzheimer&#039;s diagnostics into Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24144/us-based-cn-diagnostics-expands-alzheimers-diagnostics-into-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24144/us-based-cn-diagnostics-expands-alzheimers-diagnostics-into-japan.html</link>
			<pubDate>Tue, 30 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lab-24144.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24144/us-based-cn-diagnostics-expands-alzheimers-diagnostics-into-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Yokogawa helps to revolutionise Single-Cell Lipidomics</title>
			<atom:link href="https://biospectrumasia.com/news/50/24139/japans-yokogawa-helps-to-revolutionise-single-cell-lipidomics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24139/japans-yokogawa-helps-to-revolutionise-single-cell-lipidomics.html</link>
			<pubDate>Mon, 29 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_29_4_2024_131515_-24139.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24139/japans-yokogawa-helps-to-revolutionise-single-cell-lipidomics.html</guid>
		</item>	
				<item>
			<title>PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono</title>
			<atom:link href="https://biospectrumasia.com/news/50/24133/prism-biolab-enters-into-a-joint-research-and-licensing-agreement-with-ono.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24133/prism-biolab-enters-into-a-joint-research-and-licensing-agreement-with-ono.html</link>
			<pubDate>Thu, 25 Apr 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24133/prism-biolab-enters-into-a-joint-research-and-licensing-agreement-with-ono.html</guid>
		</item>	
				<item>
			<title>Japanese Foundation for Cancer Research collaborates with Takeda Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/24119/japanese-foundation-for-cancer-research-collaborates-with-takeda-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24119/japanese-foundation-for-cancer-research-collaborates-with-takeda-pharma.html</link>
			<pubDate>Wed, 24 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-24119.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24119/japanese-foundation-for-cancer-research-collaborates-with-takeda-pharma.html</guid>
		</item>	
				<item>
			<title>Takeda, Astellas and Sumitomo to establish JV for drug discovery programmes in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24112/takeda-astellas-and-sumitomo-to-establish-jv-for-drug-discovery-programmes-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24112/takeda-astellas-and-sumitomo-to-establish-jv-for-drug-discovery-programmes-in-japan.html</link>
			<pubDate>Tue, 23 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pill-24112.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24112/takeda-astellas-and-sumitomo-to-establish-jv-for-drug-discovery-programmes-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu establishes Supersulfides Life Science Co-Creation Research Centre in partnership with Tohoku University</title>
			<atom:link href="https://biospectrumasia.com/news/50/24107/japans-shimadzu-establishes-supersulfides-life-science-co-creation-research-centre-in-partnership-with-tohoku-university.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24107/japans-shimadzu-establishes-supersulfides-life-science-co-creation-research-centre-in-partnership-with-tohoku-university.html</link>
			<pubDate>Mon, 22 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lab-24107.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24107/japans-shimadzu-establishes-supersulfides-life-science-co-creation-research-centre-in-partnership-with-tohoku-university.html</guid>
		</item>	
				<item>
			<title>Takeda inks $1.2 billion deal with Kumquat for immuno-oncology program</title>
			<atom:link href="https://biospectrumasia.com/news/50/24101/takeda-inks-1-2-billion-deal-with-kumquat-for-immuno-oncology-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24101/takeda-inks-1-2-billion-deal-with-kumquat-for-immuno-oncology-program.html</link>
			<pubDate>Fri, 19 Apr 2024 20:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24101/takeda-inks-1-2-billion-deal-with-kumquat-for-immuno-oncology-program.html</guid>
		</item>	
				<item>
			<title>Eisai&#039;s antiepileptic drug Fycompa injection formulation launches in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24098/eisais-antiepileptic-drug-fycompa-injection-formulation-launches-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24098/eisais-antiepileptic-drug-fycompa-injection-formulation-launches-in-japan.html</link>
			<pubDate>Thu, 18 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_4_2024_105542_www_eisai_com-24098.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24098/eisais-antiepileptic-drug-fycompa-injection-formulation-launches-in-japan.html</guid>
		</item>	
				<item>
			<title>Taiwan approves Japan-based Shionogi&#039;s influenza drug for paediatric use </title>
			<atom:link href="https://biospectrumasia.com/news/50/24092/taiwan-approves-japan-based-shionogis-influenza-drug-for-paediatric-use-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24092/taiwan-approves-japan-based-shionogis-influenza-drug-for-paediatric-use-.html</link>
			<pubDate>Wed, 17 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/flu-24092.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24092/taiwan-approves-japan-based-shionogis-influenza-drug-for-paediatric-use-.html</guid>
		</item>	
				<item>
			<title>BC Platforms and NTT launch Japanese precision medicine platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/24083/bc-platforms-and-ntt-launch-japanese-precision-medicine-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24083/bc-platforms-and-ntt-launch-japanese-precision-medicine-platform.html</link>
			<pubDate>Mon, 15 Apr 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24083/bc-platforms-and-ntt-launch-japanese-precision-medicine-platform.html</guid>
		</item>	
				<item>
			<title>Nanoform partners with CBC to bring best-in-class nanomedicine technology to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24081/nanoform-partners-with-cbc-to-bring-best-in-class-nanomedicine-technology-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24081/nanoform-partners-with-cbc-to-bring-best-in-class-nanomedicine-technology-to-japan.html</link>
			<pubDate>Mon, 15 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nano-24081.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24081/nanoform-partners-with-cbc-to-bring-best-in-class-nanomedicine-technology-to-japan.html</guid>
		</item>	
				<item>
			<title>World Orphan Drug Alliance expands to Japan &amp; South Korea </title>
			<atom:link href="https://biospectrumasia.com/news/50/24071/world-orphan-drug-alliance-expands-to-japan-south-korea-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24071/world-orphan-drug-alliance-expands-to-japan-south-korea-.html</link>
			<pubDate>Fri, 12 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drugs-24071.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24071/world-orphan-drug-alliance-expands-to-japan-south-korea-.html</guid>
		</item>	
				<item>
			<title>ãƒ‡ãƒ¥ãƒãƒ³ã¯ STARLIMS ã‚’ä½¿ç”¨ã—ã¦ ç ”ç©¶é–‹ç™ºãƒ©ãƒœã§ã®è©¦é¨“ã‚’çµ±åˆã—ã¾ã—ãŸ</title>
			<atom:link href="https://biospectrumasia.com/news/50/24125/-starlims-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24125/-starlims-.html</link>
			<pubDate>Thu, 11 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/starlims_biospectrum_1_-24125.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24125/-starlims-.html</guid>
		</item>	
				<item>
			<title>Japanese researchers develop a new method in mRNA engineering to advanced therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/24074/japanese-researchers-develop-a-new-method-in-mrna-engineering-to-advanced-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24074/japanese-researchers-develop-a-new-method-in-mrna-engineering-to-advanced-therapies.html</link>
			<pubDate>Wed, 10 Apr 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24074/japanese-researchers-develop-a-new-method-in-mrna-engineering-to-advanced-therapies.html</guid>
		</item>	
				<item>
			<title>Canon starts clinical research with Hiroshima University in Japan on photon-counting computed tomography</title>
			<atom:link href="https://biospectrumasia.com/news/50/24068/canon-starts-clinical-research-with-hiroshima-university-in-japan-on-photon-counting-computed-tomography.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24068/canon-starts-clinical-research-with-hiroshima-university-in-japan-on-photon-counting-computed-tomography.html</link>
			<pubDate>Wed, 10 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/canon-24068.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24068/canon-starts-clinical-research-with-hiroshima-university-in-japan-on-photon-counting-computed-tomography.html</guid>
		</item>	
				<item>
			<title>French sales subsidiary of Japanese pharma firm Eisai divests rights of neurology drugs for â‚¬ 56.5 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/24059/french-sales-subsidiary-of-japanese-pharma-firm-eisai-divests-rights-of-neurology-drugs-for-56-5-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24059/french-sales-subsidiary-of-japanese-pharma-firm-eisai-divests-rights-of-neurology-drugs-for-56-5-m.html</link>
			<pubDate>Tue, 09 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-24059.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24059/french-sales-subsidiary-of-japanese-pharma-firm-eisai-divests-rights-of-neurology-drugs-for-56-5-m.html</guid>
		</item>	
				<item>
			<title>Japanese firms Mitsui &amp; Rohto Pharma buy Singapore-based consumer healthcare brand for Â¥88 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/24052/japanese-firms-mitsui-rohto-pharma-buy-singapore-based-consumer-healthcare-brand-for-88-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24052/japanese-firms-mitsui-rohto-pharma-buy-singapore-based-consumer-healthcare-brand-for-88-b.html</link>
			<pubDate>Mon, 08 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tcm-24052.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24052/japanese-firms-mitsui-rohto-pharma-buy-singapore-based-consumer-healthcare-brand-for-88-b.html</guid>
		</item>	
				<item>
			<title>Japan-based Shimadzu acquires California X-ray Imaging Services</title>
			<atom:link href="https://biospectrumasia.com/news/50/24045/japan-based-shimadzu-acquires-california-x-ray-imaging-services.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24045/japan-based-shimadzu-acquires-california-x-ray-imaging-services.html</link>
			<pubDate>Fri, 05 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shi-24045.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24045/japan-based-shimadzu-acquires-california-x-ray-imaging-services.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s NS Pharma &amp; UK-based MiNA Therapeutics lay focus on rare diseases of Central Nervous System</title>
			<atom:link href="https://biospectrumasia.com/news/50/24044/japans-ns-pharma-uk-based-mina-therapeutics-lay-focus-on-rare-diseases-of-central-nervous-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24044/japans-ns-pharma-uk-based-mina-therapeutics-lay-focus-on-rare-diseases-of-central-nervous-system.html</link>
			<pubDate>Thu, 04 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ns-24044.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24044/japans-ns-pharma-uk-based-mina-therapeutics-lay-focus-on-rare-diseases-of-central-nervous-system.html</guid>
		</item>	
				<item>
			<title>Asahi Kasei Medical and AW Technologies enter exclusive distribution agreement for TrachFlush in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/24036/asahi-kasei-medical-and-aw-technologies-enter-exclusive-distribution-agreement-for-trachflush-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24036/asahi-kasei-medical-and-aw-technologies-enter-exclusive-distribution-agreement-for-trachflush-in-japan.html</link>
			<pubDate>Wed, 03 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2024_04_asahi_kasei_medical_and_aw_technologies_enter_exclusive_distribution_agreement_for_trachflush_in_japan_akc-24036.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24036/asahi-kasei-medical-and-aw-technologies-enter-exclusive-distribution-agreement-for-trachflush-in-japan.html</guid>
		</item>	
				<item>
			<title>Aculys Pharma appoints Takeda Veteran as New CEO</title>
			<atom:link href="https://biospectrumasia.com/news/50/24032/aculys-pharma-appoints-takeda-veteran-as-new-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24032/aculys-pharma-appoints-takeda-veteran-as-new-ceo.html</link>
			<pubDate>Tue, 02 Apr 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24032/aculys-pharma-appoints-takeda-veteran-as-new-ceo.html</guid>
		</item>	
				<item>
			<title>Nxera Pharma is the new name for Sosei Group</title>
			<atom:link href="https://biospectrumasia.com/news/50/24025/nxera-pharma-is-the-new-name-for-sosei-group.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24025/nxera-pharma-is-the-new-name-for-sosei-group.html</link>
			<pubDate>Mon, 01 Apr 2024 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24025/nxera-pharma-is-the-new-name-for-sosei-group.html</guid>
		</item>	
				<item>
			<title>Eisai to divest rights for Merislon and Myonal in Japan to Kaken Pharma for Â¥ 3.8 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/24010/eisai-to-divest-rights-for-merislon-and-myonal-in-japan-to-kaken-pharma-for-3-8-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24010/eisai-to-divest-rights-for-merislon-and-myonal-in-japan-to-kaken-pharma-for-3-8-b.html</link>
			<pubDate>Fri, 29 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/54-24010.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24010/eisai-to-divest-rights-for-merislon-and-myonal-in-japan-to-kaken-pharma-for-3-8-b.html</guid>
		</item>	
				<item>
			<title>Japanese pharma firms Eli Lilly, Nippon Shinyaku join hands to strengthen haematologic oncology field</title>
			<atom:link href="https://biospectrumasia.com/news/50/24004/japanese-pharma-firms-eli-lilly-nippon-shinyaku-join-hands-to-strengthen-haematologic-oncology-field.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/24004/japanese-pharma-firms-eli-lilly-nippon-shinyaku-join-hands-to-strengthen-haematologic-oncology-field.html</link>
			<pubDate>Thu, 28 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/blood-24004.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/24004/japanese-pharma-firms-eli-lilly-nippon-shinyaku-join-hands-to-strengthen-haematologic-oncology-field.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s NTT and Olympus begin world&#039;s first joint demo experiment of cloud endoscopy system</title>
			<atom:link href="https://biospectrumasia.com/news/50/23996/japans-ntt-and-olympus-begin-worlds-first-joint-demo-experiment-of-cloud-endoscopy-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23996/japans-ntt-and-olympus-begin-worlds-first-joint-demo-experiment-of-cloud-endoscopy-system.html</link>
			<pubDate>Wed, 27 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/olympus-23996.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23996/japans-ntt-and-olympus-begin-worlds-first-joint-demo-experiment-of-cloud-endoscopy-system.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu releases Nexera FV ultra high performance liquid chromatograph for online analysis</title>
			<atom:link href="https://biospectrumasia.com/news/50/23990/japans-shimadzu-releases-nexera-fv-ultra-high-performance-liquid-chromatograph-for-online-analysis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23990/japans-shimadzu-releases-nexera-fv-ultra-high-performance-liquid-chromatograph-for-online-analysis.html</link>
			<pubDate>Tue, 26 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_26_3_2024_121621_www_shimadzu_com-23990.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23990/japans-shimadzu-releases-nexera-fv-ultra-high-performance-liquid-chromatograph-for-online-analysis.html</guid>
		</item>	
				<item>
			<title>NEC and TMDU in Japan use AI to assist self-care for chronic lower back pain</title>
			<atom:link href="https://biospectrumasia.com/news/50/23979/nec-and-tmdu-in-japan-use-ai-to-assist-self-care-for-chronic-lower-back-pain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23979/nec-and-tmdu-in-japan-use-ai-to-assist-self-care-for-chronic-lower-back-pain.html</link>
			<pubDate>Fri, 22 Mar 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lower_back_pain-23979.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23979/nec-and-tmdu-in-japan-use-ai-to-assist-self-care-for-chronic-lower-back-pain.html</guid>
		</item>	
				<item>
			<title>Japan injects $5 M to enhance digital health services in Latin America and the Caribbean</title>
			<atom:link href="https://biospectrumasia.com/news/50/23971/japan-injects-5-m-to-enhance-digital-health-services-in-latin-america-and-the-caribbean.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23971/japan-injects-5-m-to-enhance-digital-health-services-in-latin-america-and-the-caribbean.html</link>
			<pubDate>Thu, 21 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_133503068-23971.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23971/japan-injects-5-m-to-enhance-digital-health-services-in-latin-america-and-the-caribbean.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shonan iPark commences collaboration with KBIOHealth in South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/23962/japans-shonan-ipark-commences-collaboration-with-kbiohealth-in-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23962/japans-shonan-ipark-commences-collaboration-with-kbiohealth-in-south-korea.html</link>
			<pubDate>Wed, 20 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kbio-23962.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23962/japans-shonan-ipark-commences-collaboration-with-kbiohealth-in-south-korea.html</guid>
		</item>	
				<item>
			<title>STARLIMS and INFOCOM launch partnership in Japan.</title>
			<atom:link href="https://biospectrumasia.com/news/50/23954/starlims-and-infocom-launch-partnership-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23954/starlims-and-infocom-launch-partnership-in-japan-.html</link>
			<pubDate>Tue, 19 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/news_post_thumbnail-23954.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23954/starlims-and-infocom-launch-partnership-in-japan-.html</guid>
		</item>	
				<item>
			<title>Takeda Hospital Group allies with TriNetX Network to revolutionize medical care in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23955/takeda-hospital-group-allies-with-trinetx-network-to-revolutionize-medical-care-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23955/takeda-hospital-group-allies-with-trinetx-network-to-revolutionize-medical-care-in-japan.html</link>
			<pubDate>Tue, 19 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hand_medical_glove_pointing_virtual_screen_medical_technology_53876_104200-23955.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23955/takeda-hospital-group-allies-with-trinetx-network-to-revolutionize-medical-care-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus rescinds purchase of Korean gastrointestinal stent firm Taewoong Medical </title>
			<atom:link href="https://biospectrumasia.com/news/50/23941/japans-olympus-rescinds-purchase-of-korean-gastrointestinal-stent-firm-taewoong-medical-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23941/japans-olympus-rescinds-purchase-of-korean-gastrointestinal-stent-firm-taewoong-medical-.html</link>
			<pubDate>Fri, 15 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_144799030-23941.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23941/japans-olympus-rescinds-purchase-of-korean-gastrointestinal-stent-firm-taewoong-medical-.html</guid>
		</item>	
				<item>
			<title>Takeda announces new president of Japan Pharma Business Unit</title>
			<atom:link href="https://biospectrumasia.com/news/50/23934/takeda-announces-new-president-of-japan-pharma-business-unit.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23934/takeda-announces-new-president-of-japan-pharma-business-unit.html</link>
			<pubDate>Thu, 14 Mar 2024 20:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23934/takeda-announces-new-president-of-japan-pharma-business-unit.html</guid>
		</item>	
				<item>
			<title>Japanese electronics company Ricoh enters into CRISPR/Cas9 license agreement with ERS Genomics</title>
			<atom:link href="https://biospectrumasia.com/news/50/23927/japanese-electronics-company-ricoh-enters-into-crispr-cas9-license-agreement-with-ers-genomics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23927/japanese-electronics-company-ricoh-enters-into-crispr-cas9-license-agreement-with-ers-genomics.html</link>
			<pubDate>Wed, 13 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene-23927.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23927/japanese-electronics-company-ricoh-enters-into-crispr-cas9-license-agreement-with-ers-genomics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sosei Heptares inks â‚¬750 M deal with Boehringer Ingelheim for schizophrenia treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/23913/japans-sosei-heptares-inks-750-m-deal-with-boehringer-ingelheim-for-schizophrenia-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23913/japans-sosei-heptares-inks-750-m-deal-with-boehringer-ingelheim-for-schizophrenia-treatment.html</link>
			<pubDate>Tue, 12 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sz-23913.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23913/japans-sosei-heptares-inks-750-m-deal-with-boehringer-ingelheim-for-schizophrenia-treatment.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Casio launches Uterocervical Observation Camera in the US, Au and NZ</title>
			<atom:link href="https://biospectrumasia.com/news/50/23919/japans-casio-launches-uterocervical-observation-camera-in-the-us-au-and-nz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23919/japans-casio-launches-uterocervical-observation-camera-in-the-us-au-and-nz.html</link>
			<pubDate>Tue, 12 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cst_100m_with_dz_c100_attached-23919.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23919/japans-casio-launches-uterocervical-observation-camera-in-the-us-au-and-nz.html</guid>
		</item>	
				<item>
			<title>Beckman Coulter expands collaboration with Fujirebio for neurodegenerative disease assays</title>
			<atom:link href="https://biospectrumasia.com/news/50/23920/beckman-coulter-expands-collaboration-with-fujirebio-for-neurodegenerative-disease-assays.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23920/beckman-coulter-expands-collaboration-with-fujirebio-for-neurodegenerative-disease-assays.html</link>
			<pubDate>Tue, 12 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/beck-23920.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23920/beckman-coulter-expands-collaboration-with-fujirebio-for-neurodegenerative-disease-assays.html</guid>
		</item>	
				<item>
			<title>CPHI Japan 2024 to see more than 20% year-on-year rise</title>
			<atom:link href="https://biospectrumasia.com/news/50/23921/cphi-japan-2024-to-see-more-than-20-year-on-year-rise.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23921/cphi-japan-2024-to-see-more-than-20-year-on-year-rise.html</link>
			<pubDate>Tue, 12 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jp-23921.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23921/cphi-japan-2024-to-see-more-than-20-year-on-year-rise.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kyowa Kirin invests $200 M to build first North American pharma manufacturing operation</title>
			<atom:link href="https://biospectrumasia.com/news/50/23904/japans-kyowa-kirin-invests-200-m-to-build-first-north-american-pharma-manufacturing-operation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23904/japans-kyowa-kirin-invests-200-m-to-build-first-north-american-pharma-manufacturing-operation.html</link>
			<pubDate>Mon, 11 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-23904.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23904/japans-kyowa-kirin-invests-200-m-to-build-first-north-american-pharma-manufacturing-operation.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nagasaki University and Shionogi extend industry-academia partnership to eliminate malaria</title>
			<atom:link href="https://biospectrumasia.com/news/50/23909/japans-nagasaki-university-and-shionogi-extend-industry-academia-partnership-to-eliminate-malaria.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23909/japans-nagasaki-university-and-shionogi-extend-industry-academia-partnership-to-eliminate-malaria.html</link>
			<pubDate>Mon, 11 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20240308_2-23909.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23909/japans-nagasaki-university-and-shionogi-extend-industry-academia-partnership-to-eliminate-malaria.html</guid>
		</item>	
				<item>
			<title>Ono secures cancer drug License from South Korea&#039;s NEX-I</title>
			<atom:link href="https://biospectrumasia.com/news/50/23895/ono-secures-cancer-drug-license-from-south-koreas-nex-i.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23895/ono-secures-cancer-drug-license-from-south-koreas-nex-i.html</link>
			<pubDate>Fri, 08 Mar 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23895/ono-secures-cancer-drug-license-from-south-koreas-nex-i.html</guid>
		</item>	
				<item>
			<title>Shionogi, Nagasaki University enter new phase of Malaria collaboration </title>
			<atom:link href="https://biospectrumasia.com/news/50/23881/shionogi-nagasaki-university-enter-new-phase-of-malaria-collaboration-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23881/shionogi-nagasaki-university-enter-new-phase-of-malaria-collaboration-.html</link>
			<pubDate>Thu, 07 Mar 2024 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23881/shionogi-nagasaki-university-enter-new-phase-of-malaria-collaboration-.html</guid>
		</item>	
				<item>
			<title>Japanese firm Eisai invests $15 M in US-based C2N Diagnostics to simplify Alzheimer&#039;s detection</title>
			<atom:link href="https://biospectrumasia.com/news/50/23878/japanese-firm-eisai-invests-15-m-in-us-based-c2n-diagnostics-to-simplify-alzheimers-detection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23878/japanese-firm-eisai-invests-15-m-in-us-based-c2n-diagnostics-to-simplify-alzheimers-detection.html</link>
			<pubDate>Wed, 06 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ad-23878.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23878/japanese-firm-eisai-invests-15-m-in-us-based-c2n-diagnostics-to-simplify-alzheimers-detection.html</guid>
		</item>	
				<item>
			<title>Nippon Express acquires stake in Japanese startup expanding 3D-printed prosthetics biz</title>
			<atom:link href="https://biospectrumasia.com/news/50/23880/nippon-express-acquires-stake-in-japanese-startup-expanding-3d-printed-prosthetics-biz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23880/nippon-express-acquires-stake-in-japanese-startup-expanding-3d-printed-prosthetics-biz.html</link>
			<pubDate>Wed, 06 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/limb-23880.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23880/nippon-express-acquires-stake-in-japanese-startup-expanding-3d-printed-prosthetics-biz.html</guid>
		</item>	
				<item>
			<title>Shionogi and Osaka University establish a new joint research lab on long COVID</title>
			<atom:link href="https://biospectrumasia.com/news/50/23876/shionogi-and-osaka-university-establish-a-new-joint-research-lab-on-long-covid.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23876/shionogi-and-osaka-university-establish-a-new-joint-research-lab-on-long-covid.html</link>
			<pubDate>Tue, 05 Mar 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23876/shionogi-and-osaka-university-establish-a-new-joint-research-lab-on-long-covid.html</guid>
		</item>	
				<item>
			<title>Toyoda Gosei invests in Japanese startup developing urine test kits for early cancer detection</title>
			<atom:link href="https://biospectrumasia.com/news/50/23864/toyoda-gosei-invests-in-japanese-startup-developing-urine-test-kits-for-early-cancer-detection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23864/toyoda-gosei-invests-in-japanese-startup-developing-urine-test-kits-for-early-cancer-detection.html</link>
			<pubDate>Tue, 05 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/test-23864.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23864/toyoda-gosei-invests-in-japanese-startup-developing-urine-test-kits-for-early-cancer-detection.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s NEC forges clinical development of Neoantigen Cancer Vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/23867/japans-nec-forges-clinical-development-of-neoantigen-cancer-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23867/japans-nec-forges-clinical-development-of-neoantigen-cancer-vaccine.html</link>
			<pubDate>Tue, 05 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/istockphoto_1220059380_2048x2048_transformed-23867.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23867/japans-nec-forges-clinical-development-of-neoantigen-cancer-vaccine.html</guid>
		</item>	
				<item>
			<title>Taiho licenses rights to China Pharma&#039;s lung cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/23859/taiho-licenses-rights-to-china-pharmas-lung-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23859/taiho-licenses-rights-to-china-pharmas-lung-cancer-drug.html</link>
			<pubDate>Mon, 04 Mar 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23859/taiho-licenses-rights-to-china-pharmas-lung-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Medigene AG expands patent portfolio in Japan for iM-TCR Technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/23855/medigene-ag-expands-patent-portfolio-in-japan-for-im-tcr-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23855/medigene-ag-expands-patent-portfolio-in-japan-for-im-tcr-technology.html</link>
			<pubDate>Mon, 04 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik_8-23855.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23855/medigene-ag-expands-patent-portfolio-in-japan-for-im-tcr-technology.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka Pharma enters into $30 M investment contract with AN Venture Partners</title>
			<atom:link href="https://biospectrumasia.com/news/50/23837/japans-otsuka-pharma-enters-into-30-m-investment-contract-with-an-venture-partners.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23837/japans-otsuka-pharma-enters-into-30-m-investment-contract-with-an-venture-partners.html</link>
			<pubDate>Fri, 01 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bio-23837.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23837/japans-otsuka-pharma-enters-into-30-m-investment-contract-with-an-venture-partners.html</guid>
		</item>	
				<item>
			<title>&quot;One example of success is the development of a potential new paediatric treatment for schistosomiasis&quot; </title>
			<atom:link href="https://biospectrumasia.com/opinion/50/23847/one-example-of-success-is-the-development-of-a-potential-new-paediatric-treatment-for-schistosomiasis-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/23847/one-example-of-success-is-the-development-of-a-potential-new-paediatric-treatment-for-schistosomiasis-.html</link>
			<pubDate>Fri, 01 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ghit-23847.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/23847/one-example-of-success-is-the-development-of-a-potential-new-paediatric-treatment-for-schistosomiasis-.html</guid>
		</item>	
				<item>
			<title>Shionogi and Osaka University unveils a new joint research lab to review anti-COVID-19 drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/23848/shionogi-and-osaka-university-unveils-a-new-joint-research-lab-to-review-anti-covid-19-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23848/shionogi-and-osaka-university-unveils-a-new-joint-research-lab-to-review-anti-covid-19-drug.html</link>
			<pubDate>Fri, 01 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/depositphotos5-23848.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23848/shionogi-and-osaka-university-unveils-a-new-joint-research-lab-to-review-anti-covid-19-drug.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo invests â‚¬1B in Germany site, expanding into innovation centre </title>
			<atom:link href="https://biospectrumasia.com/news/50/23822/japans-daiichi-sankyo-invests-1b-in-germany-site-expanding-into-innovation-centre-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23822/japans-daiichi-sankyo-invests-1b-in-germany-site-expanding-into-innovation-centre-.html</link>
			<pubDate>Thu, 29 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dc-23822.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23822/japans-daiichi-sankyo-invests-1b-in-germany-site-expanding-into-innovation-centre-.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Chemical shuts down regenerative Medicine development</title>
			<atom:link href="https://biospectrumasia.com/news/50/23821/mitsubishi-chemical-shuts-down-regenerative-medicine-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23821/mitsubishi-chemical-shuts-down-regenerative-medicine-development.html</link>
			<pubDate>Wed, 28 Feb 2024 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23821/mitsubishi-chemical-shuts-down-regenerative-medicine-development.html</guid>
		</item>	
				<item>
			<title>Ono partners with InveniAI to identify novel therapeutic targets</title>
			<atom:link href="https://biospectrumasia.com/news/50/23778/ono-partners-with-inveniai-to-identify-novel-therapeutic-targets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23778/ono-partners-with-inveniai-to-identify-novel-therapeutic-targets.html</link>
			<pubDate>Tue, 27 Feb 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23778/ono-partners-with-inveniai-to-identify-novel-therapeutic-targets.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda accelerates dengue vaccine access through manufacturing partnership with Biological E in India</title>
			<atom:link href="https://biospectrumasia.com/news/50/23807/japans-takeda-accelerates-dengue-vaccine-access-through-manufacturing-partnership-with-biological-e-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23807/japans-takeda-accelerates-dengue-vaccine-access-through-manufacturing-partnership-with-biological-e-in-india.html</link>
			<pubDate>Tue, 27 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vaccine-23807.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23807/japans-takeda-accelerates-dengue-vaccine-access-through-manufacturing-partnership-with-biological-e-in-india.html</guid>
		</item>	
				<item>
			<title>Ligand, Eisai receives approval in Japan for antiepileptic injection </title>
			<atom:link href="https://biospectrumasia.com/news/50/23803/ligand-eisai-receives-approval-in-japan-for-antiepileptic-injection-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23803/ligand-eisai-receives-approval-in-japan-for-antiepileptic-injection-.html</link>
			<pubDate>Mon, 26 Feb 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23803/ligand-eisai-receives-approval-in-japan-for-antiepileptic-injection-.html</guid>
		</item>	
				<item>
			<title>Astellas hires new Chief to lead US operations </title>
			<atom:link href="https://biospectrumasia.com/news/50/23794/astellas-hires-new-chief-to-lead-us-operations-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23794/astellas-hires-new-chief-to-lead-us-operations-.html</link>
			<pubDate>Thu, 22 Feb 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23794/astellas-hires-new-chief-to-lead-us-operations-.html</guid>
		</item>	
				<item>
			<title>Researchers in Japan reveal mechanism of drug reactivating tumor suppressors</title>
			<atom:link href="https://biospectrumasia.com/news/50/23785/researchers-in-japan-reveal-mechanism-of-drug-reactivating-tumor-suppressors.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23785/researchers-in-japan-reveal-mechanism-of-drug-reactivating-tumor-suppressors.html</link>
			<pubDate>Wed, 21 Feb 2024 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23785/researchers-in-japan-reveal-mechanism-of-drug-reactivating-tumor-suppressors.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma inks oncology deal worth $800 M with US-based biotech startup Kelonia</title>
			<atom:link href="https://biospectrumasia.com/news/50/23766/japans-astellas-pharma-inks-oncology-deal-worth-800-m-with-us-based-biotech-startup-kelonia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23766/japans-astellas-pharma-inks-oncology-deal-worth-800-m-with-us-based-biotech-startup-kelonia.html</link>
			<pubDate>Tue, 20 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-23766.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23766/japans-astellas-pharma-inks-oncology-deal-worth-800-m-with-us-based-biotech-startup-kelonia.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nanophoton strengthens Bruker&#039;s portfolio of molecular microscopy research solutions</title>
			<atom:link href="https://biospectrumasia.com/news/50/23767/japans-nanophoton-strengthens-brukers-portfolio-of-molecular-microscopy-research-solutions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23767/japans-nanophoton-strengthens-brukers-portfolio-of-molecular-microscopy-research-solutions.html</link>
			<pubDate>Mon, 19 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/micro-23767.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23767/japans-nanophoton-strengthens-brukers-portfolio-of-molecular-microscopy-research-solutions.html</guid>
		</item>	
				<item>
			<title>Japan approves Metoject Methotrexate Autoinjector pen for rheumatoid arthritis</title>
			<atom:link href="https://biospectrumasia.com/news/50/23758/japan-approves-metoject-methotrexate-autoinjector-pen-for-rheumatoid-arthritis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23758/japan-approves-metoject-methotrexate-autoinjector-pen-for-rheumatoid-arthritis.html</link>
			<pubDate>Fri, 16 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/metoject_pen_schachtel_15mg_group_resize-23758.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23758/japan-approves-metoject-methotrexate-autoinjector-pen-for-rheumatoid-arthritis.html</guid>
		</item>	
				<item>
			<title>US Centers for Disease Control and Prevention opens new East Asia and Pacific office in Tokyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/23759/us-centers-for-disease-control-and-prevention-opens-new-east-asia-and-pacific-office-in-tokyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23759/us-centers-for-disease-control-and-prevention-opens-new-east-asia-and-pacific-office-in-tokyo.html</link>
			<pubDate>Fri, 16 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cdc-23759.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23759/us-centers-for-disease-control-and-prevention-opens-new-east-asia-and-pacific-office-in-tokyo.html</guid>
		</item>	
				<item>
			<title>Japan first in world to approve Dupixent for chronic spontaneous urticaria</title>
			<atom:link href="https://biospectrumasia.com/news/50/23762/japan-first-in-world-to-approve-dupixent-for-chronic-spontaneous-urticaria.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23762/japan-first-in-world-to-approve-dupixent-for-chronic-spontaneous-urticaria.html</link>
			<pubDate>Fri, 16 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/csu-23762.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23762/japan-first-in-world-to-approve-dupixent-for-chronic-spontaneous-urticaria.html</guid>
		</item>	
				<item>
			<title>European firm Iktos opens a subsidiary in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23755/european-firm-iktos-opens-a-subsidiary-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23755/european-firm-iktos-opens-a-subsidiary-in-japan.html</link>
			<pubDate>Thu, 15 Feb 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23755/european-firm-iktos-opens-a-subsidiary-in-japan.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s STARmed accelerates global market entry of medtech products through Olympus in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23751/koreas-starmed-accelerates-global-market-entry-of-medtech-products-through-olympus-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23751/koreas-starmed-accelerates-global-market-entry-of-medtech-products-through-olympus-in-japan.html</link>
			<pubDate>Thu, 15 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medtech-23751.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23751/koreas-starmed-accelerates-global-market-entry-of-medtech-products-through-olympus-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda, Dundee and Cambridge reunite in fight against dementia</title>
			<atom:link href="https://biospectrumasia.com/news/50/23742/takeda-dundee-and-cambridge-reunite-in-fight-against-dementia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23742/takeda-dundee-and-cambridge-reunite-in-fight-against-dementia.html</link>
			<pubDate>Wed, 14 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dementia-23742.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23742/takeda-dundee-and-cambridge-reunite-in-fight-against-dementia.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu announces development of new technology to improve healthy life expectancy</title>
			<atom:link href="https://biospectrumasia.com/news/50/23741/japans-shimadzu-announces-development-of-new-technology-to-improve-healthy-life-expectancy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23741/japans-shimadzu-announces-development-of-new-technology-to-improve-healthy-life-expectancy.html</link>
			<pubDate>Tue, 13 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shim-23741.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23741/japans-shimadzu-announces-development-of-new-technology-to-improve-healthy-life-expectancy.html</guid>
		</item>	
				<item>
			<title>BridgeBio Pharma and Kyowa Kirin ink $100 M deal for skeletal dysplasias treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23715/bridgebio-pharma-and-kyowa-kirin-ink-100-m-deal-for-skeletal-dysplasias-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23715/bridgebio-pharma-and-kyowa-kirin-ink-100-m-deal-for-skeletal-dysplasias-treatment-in-japan.html</link>
			<pubDate>Mon, 12 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bonediseases_share-23715.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23715/bridgebio-pharma-and-kyowa-kirin-ink-100-m-deal-for-skeletal-dysplasias-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Sysmex and Hitachi partner to develop new genetic testing systems</title>
			<atom:link href="https://biospectrumasia.com/news/50/23725/sysmex-and-hitachi-partner-to-develop-new-genetic-testing-systems.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23725/sysmex-and-hitachi-partner-to-develop-new-genetic-testing-systems.html</link>
			<pubDate>Thu, 08 Feb 2024 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23725/sysmex-and-hitachi-partner-to-develop-new-genetic-testing-systems.html</guid>
		</item>	
				<item>
			<title>ZimVie launches Next-Generation TSXÂ® dental Implant in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23717/zimvie-launches-next-generation-tsx-dental-implant-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23717/zimvie-launches-next-generation-tsx-dental-implant-in-japan.html</link>
			<pubDate>Thu, 08 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tsx_implant_hero_clear-23717.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23717/zimvie-launches-next-generation-tsx-dental-implant-in-japan.html</guid>
		</item>	
				<item>
			<title>Sysmex and Hitachi High-Tech to collaboratively develop New Genetic Testing Systems</title>
			<atom:link href="https://biospectrumasia.com/news/50/23718/sysmex-and-hitachi-high-tech-to-collaboratively-develop-new-genetic-testing-systems.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23718/sysmex-and-hitachi-high-tech-to-collaboratively-develop-new-genetic-testing-systems.html</link>
			<pubDate>Thu, 08 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dna_abstract_technology_background_35029_558-23718.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23718/sysmex-and-hitachi-high-tech-to-collaboratively-develop-new-genetic-testing-systems.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Chugai to position Singapore subsidiary as permanent global drug discovery research centre</title>
			<atom:link href="https://biospectrumasia.com/news/50/23677/japans-chugai-to-position-singapore-subsidiary-as-permanent-global-drug-discovery-research-centre.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23677/japans-chugai-to-position-singapore-subsidiary-as-permanent-global-drug-discovery-research-centre.html</link>
			<pubDate>Mon, 05 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibody-23677.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23677/japans-chugai-to-position-singapore-subsidiary-as-permanent-global-drug-discovery-research-centre.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda Pharma inks haematology deal worth $300 M with US-based Protagonist Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/23672/japans-takeda-pharma-inks-haematology-deal-worth-300-m-with-us-based-protagonist-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23672/japans-takeda-pharma-inks-haematology-deal-worth-300-m-with-us-based-protagonist-therapeutics.html</link>
			<pubDate>Fri, 02 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/haem-23672.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23672/japans-takeda-pharma-inks-haematology-deal-worth-300-m-with-us-based-protagonist-therapeutics.html</guid>
		</item>	
				<item>
			<title>Renalys Pharma to bring innovative medicines to Japan and other countries in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/23639/renalys-pharma-to-bring-innovative-medicines-to-japan-and-other-countries-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23639/renalys-pharma-to-bring-innovative-medicines-to-japan-and-other-countries-in-asia.html</link>
			<pubDate>Tue, 30 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications_342462_1920-23639.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23639/renalys-pharma-to-bring-innovative-medicines-to-japan-and-other-countries-in-asia.html</guid>
		</item>	
				<item>
			<title>Shionogi inks a deal with Niremia Collective to fund well-being tech startups</title>
			<atom:link href="https://biospectrumasia.com/news/50/23634/shionogi-inks-a-deal-with-niremia-collective-to-fund-well-being-tech-startups.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23634/shionogi-inks-a-deal-with-niremia-collective-to-fund-well-being-tech-startups.html</link>
			<pubDate>Sun, 28 Jan 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23634/shionogi-inks-a-deal-with-niremia-collective-to-fund-well-being-tech-startups.html</guid>
		</item>	
				<item>
			<title>Nikon builds new research hubs in US &amp; Japan to support for drug discovery and innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/23632/nikon-builds-new-research-hubs-in-us-japan-to-support-for-drug-discovery-and-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23632/nikon-builds-new-research-hubs-in-us-japan-to-support-for-drug-discovery-and-innovation.html</link>
			<pubDate>Fri, 26 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nikon-23632.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23632/nikon-builds-new-research-hubs-in-us-japan-to-support-for-drug-discovery-and-innovation.html</guid>
		</item>	
				<item>
			<title>Japan-based PRISM BioLab raises Â¥ 1.5 B to advance technologies for protein-protein interactions</title>
			<atom:link href="https://biospectrumasia.com/news/50/23620/japan-based-prism-biolab-raises-1-5-b-to-advance-technologies-for-protein-protein-interactions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23620/japan-based-prism-biolab-raises-1-5-b-to-advance-technologies-for-protein-protein-interactions.html</link>
			<pubDate>Thu, 25 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/32-23620.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23620/japan-based-prism-biolab-raises-1-5-b-to-advance-technologies-for-protein-protein-interactions.html</guid>
		</item>	
				<item>
			<title>Japanese biotech startup RevolKa to create highly functional proteins by using AI-driven platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/23613/japanese-biotech-startup-revolka-to-create-highly-functional-proteins-by-using-ai-driven-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23613/japanese-biotech-startup-revolka-to-create-highly-functional-proteins-by-using-ai-driven-platform.html</link>
			<pubDate>Wed, 24 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-23613.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23613/japanese-biotech-startup-revolka-to-create-highly-functional-proteins-by-using-ai-driven-platform.html</guid>
		</item>	
				<item>
			<title>First-ever treatment for ultra-rare rapid-aging disease Progeria receives approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23608/first-ever-treatment-for-ultra-rare-rapid-aging-disease-progeria-receives-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23608/first-ever-treatment-for-ultra-rare-rapid-aging-disease-progeria-receives-approval-in-japan.html</link>
			<pubDate>Mon, 22 Jan 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23608/first-ever-treatment-for-ultra-rare-rapid-aging-disease-progeria-receives-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>Fujirebio &amp; Agappe ink business collaboration for CLIA based immunoassay products</title>
			<atom:link href="https://biospectrumasia.com/news/50/23604/fujirebio-agappe-ink-business-collaboration-for-clia-based-immunoassay-products.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23604/fujirebio-agappe-ink-business-collaboration-for-clia-based-immunoassay-products.html</link>
			<pubDate>Mon, 22 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/press_meet_1-23604.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23604/fujirebio-agappe-ink-business-collaboration-for-clia-based-immunoassay-products.html</guid>
		</item>	
				<item>
			<title>Quantum-Si introduces world&#039;s first next-generation protein sequencer in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23599/quantum-si-introduces-worlds-first-next-generation-protein-sequencer-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23599/quantum-si-introduces-worlds-first-next-generation-protein-sequencer-in-japan.html</link>
			<pubDate>Fri, 19 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/qua-23599.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23599/quantum-si-introduces-worlds-first-next-generation-protein-sequencer-in-japan.html</guid>
		</item>	
				<item>
			<title>Epicore Biosystems scales personalised hydration wearable across Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/23592/epicore-biosystems-scales-personalised-hydration-wearable-across-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23592/epicore-biosystems-scales-personalised-hydration-wearable-across-asia.html</link>
			<pubDate>Thu, 18 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wear-23592.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23592/epicore-biosystems-scales-personalised-hydration-wearable-across-asia.html</guid>
		</item>	
				<item>
			<title>Parexel and Japanese Foundation for Cancer Research announce strategic alliance</title>
			<atom:link href="https://biospectrumasia.com/news/50/23589/parexel-and-japanese-foundation-for-cancer-research-announce-strategic-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23589/parexel-and-japanese-foundation-for-cancer-research-announce-strategic-alliance.html</link>
			<pubDate>Wed, 17 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-23589.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23589/parexel-and-japanese-foundation-for-cancer-research-announce-strategic-alliance.html</guid>
		</item>	
				<item>
			<title>DOCOMO&#039;s new AI generates images of predicted changes in the brain</title>
			<atom:link href="https://biospectrumasia.com/news/50/23587/docomos-new-ai-generates-images-of-predicted-changes-in-the-brain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23587/docomos-new-ai-generates-images-of-predicted-changes-in-the-brain.html</link>
			<pubDate>Tue, 16 Jan 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23587/docomos-new-ai-generates-images-of-predicted-changes-in-the-brain.html</guid>
		</item>	
				<item>
			<title>Japan-based Canon and Olympus enter into commercial alliance for endoscopic ultrasound systems</title>
			<atom:link href="https://biospectrumasia.com/news/50/23576/japan-based-canon-and-olympus-enter-into-commercial-alliance-for-endoscopic-ultrasound-systems.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23576/japan-based-canon-and-olympus-enter-into-commercial-alliance-for-endoscopic-ultrasound-systems.html</link>
			<pubDate>Tue, 16 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-23576.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23576/japan-based-canon-and-olympus-enter-into-commercial-alliance-for-endoscopic-ultrasound-systems.html</guid>
		</item>	
				<item>
			<title>Korean FUST Lab&#039;s DEBREXÂ Nano-Emulsion/Dispersion equipment enters JapanÂ market</title>
			<atom:link href="https://biospectrumasia.com/news/50/23582/korean-fust-labs-debrexnano-emulsion-dispersion-equipment-enters-japanmarket.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23582/korean-fust-labs-debrexnano-emulsion-dispersion-equipment-enters-japanmarket.html</link>
			<pubDate>Tue, 16 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image__1-23582.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23582/korean-fust-labs-debrexnano-emulsion-dispersion-equipment-enters-japanmarket.html</guid>
		</item>	
				<item>
			<title>Shionogi, NTT Data to build DTx distribution platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/23557/shionogi-ntt-data-to-build-dtx-distribution-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23557/shionogi-ntt-data-to-build-dtx-distribution-platform.html</link>
			<pubDate>Wed, 10 Jan 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23557/shionogi-ntt-data-to-build-dtx-distribution-platform.html</guid>
		</item>	
				<item>
			<title>Japan approves first at-home migraine treatment in the form of Neurolief&#039;s neuromodulation device</title>
			<atom:link href="https://biospectrumasia.com/news/50/23552/japan-approves-first-at-home-migraine-treatment-in-the-form-of-neuroliefs-neuromodulation-device.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23552/japan-approves-first-at-home-migraine-treatment-in-the-form-of-neuroliefs-neuromodulation-device.html</link>
			<pubDate>Wed, 10 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neuro-23552.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23552/japan-approves-first-at-home-migraine-treatment-in-the-form-of-neuroliefs-neuromodulation-device.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu automates coating processes of medical systems components</title>
			<atom:link href="https://biospectrumasia.com/news/50/23530/japans-shimadzu-automates-coating-processes-of-medical-systems-components.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23530/japans-shimadzu-automates-coating-processes-of-medical-systems-components.html</link>
			<pubDate>Fri, 05 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shimadzu-23530.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23530/japans-shimadzu-automates-coating-processes-of-medical-systems-components.html</guid>
		</item>	
				<item>
			<title>Japa&#039;s Teijin signs joint R&amp;D agreement with US based Garwood Medical Devices</title>
			<atom:link href="https://biospectrumasia.com/news/50/23538/japas-teijin-signs-joint-rd-agreement-with-us-based-garwood-medical-devices.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23538/japas-teijin-signs-joint-rd-agreement-with-us-based-garwood-medical-devices.html</link>
			<pubDate>Thu, 04 Jan 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23538/japas-teijin-signs-joint-rd-agreement-with-us-based-garwood-medical-devices.html</guid>
		</item>	
				<item>
			<title>South Korea&#039; Ildong seeks license to produce Shionogi&#039;s Ensitrelvir </title>
			<atom:link href="https://biospectrumasia.com/news/50/23534/south-korea-ildong-seeks-license-to-produce-shionogis-ensitrelvir-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23534/south-korea-ildong-seeks-license-to-produce-shionogis-ensitrelvir-.html</link>
			<pubDate>Tue, 02 Jan 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23534/south-korea-ildong-seeks-license-to-produce-shionogis-ensitrelvir-.html</guid>
		</item>	
				<item>
			<title>Japan introduces world&#039;s first machine learning model to screen Alzheimer&#039;s disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/23528/japan-introduces-worlds-first-machine-learning-model-to-screen-alzheimers-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23528/japan-introduces-worlds-first-machine-learning-model-to-screen-alzheimers-disease.html</link>
			<pubDate>Tue, 02 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ad-23528.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23528/japan-introduces-worlds-first-machine-learning-model-to-screen-alzheimers-disease.html</guid>
		</item>	
				<item>
			<title>Japan-Germany collaboration for cancer research to design novel immunotherapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/23515/japan-germany-collaboration-for-cancer-research-to-design-novel-immunotherapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23515/japan-germany-collaboration-for-cancer-research-to-design-novel-immunotherapies.html</link>
			<pubDate>Thu, 28 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23515.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23515/japan-germany-collaboration-for-cancer-research-to-design-novel-immunotherapies.html</guid>
		</item>	
				<item>
			<title>AGC invests 50 Billion Yen to expand biopharmaceutical CDMO capability in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23510/agc-invests-50-billion-yen-to-expand-biopharmaceutical-cdmo-capability-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23510/agc-invests-50-billion-yen-to-expand-biopharmaceutical-cdmo-capability-in-japan.html</link>
			<pubDate>Tue, 26 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cdmo-23510.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23510/agc-invests-50-billion-yen-to-expand-biopharmaceutical-cdmo-capability-in-japan.html</guid>
		</item>	
				<item>
			<title>Biocon Biologics partners with Sandoz for  distribution of Adalimumab biosimilar in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23512/biocon-biologics-partners-with-sandoz-for-distribution-of-adalimumab-biosimilar-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23512/biocon-biologics-partners-with-sandoz-for-distribution-of-adalimumab-biosimilar-in-japan.html</link>
			<pubDate>Fri, 22 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23512.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23512/biocon-biologics-partners-with-sandoz-for-distribution-of-adalimumab-biosimilar-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono Pharma enters into research collaboration with UK Dementia Research Institute</title>
			<atom:link href="https://biospectrumasia.com/news/50/23504/japans-ono-pharma-enters-into-research-collaboration-with-uk-dementia-research-institute.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23504/japans-ono-pharma-enters-into-research-collaboration-with-uk-dementia-research-institute.html</link>
			<pubDate>Thu, 21 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-23504.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23504/japans-ono-pharma-enters-into-research-collaboration-with-uk-dementia-research-institute.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu releases new gas chromatograph mass spectrometer</title>
			<atom:link href="https://biospectrumasia.com/news/50/23494/japans-shimadzu-releases-new-gas-chromatograph-mass-spectrometer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23494/japans-shimadzu-releases-new-gas-chromatograph-mass-spectrometer.html</link>
			<pubDate>Tue, 19 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gc-23494.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23494/japans-shimadzu-releases-new-gas-chromatograph-mass-spectrometer.html</guid>
		</item>	
				<item>
			<title>BioCheetah to commercialise ELISA bladder cancer diagnostic in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23472/biocheetah-to-commercialise-elisa-bladder-cancer-diagnostic-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23472/biocheetah-to-commercialise-elisa-bladder-cancer-diagnostic-in-japan.html</link>
			<pubDate>Fri, 15 Dec 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23472/biocheetah-to-commercialise-elisa-bladder-cancer-diagnostic-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan-based GHIT Fund invests $8.8 M in new drug development projects for malaria</title>
			<atom:link href="https://biospectrumasia.com/news/50/23469/japan-based-ghit-fund-invests-8-8-m-in-new-drug-development-projects-for-malaria.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23469/japan-based-ghit-fund-invests-8-8-m-in-new-drug-development-projects-for-malaria.html</link>
			<pubDate>Fri, 15 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23469.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23469/japan-based-ghit-fund-invests-8-8-m-in-new-drug-development-projects-for-malaria.html</guid>
		</item>	
				<item>
			<title>Torii gets exclusive rights for Japan to develop, market and distribute ALK&#039;s allergy immunotherapy drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/23468/torii-gets-exclusive-rights-for-japan-to-develop-market-and-distribute-alks-allergy-immunotherapy-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23468/torii-gets-exclusive-rights-for-japan-to-develop-market-and-distribute-alks-allergy-immunotherapy-drug-.html</link>
			<pubDate>Thu, 14 Dec 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23468/torii-gets-exclusive-rights-for-japan-to-develop-market-and-distribute-alks-allergy-immunotherapy-drug-.html</guid>
		</item>	
				<item>
			<title>LEQEMBI to launch in Japan for Alzheimer&#039;s disease on December 20</title>
			<atom:link href="https://biospectrumasia.com/news/50/23459/leqembi-to-launch-in-japan-for-alzheimers-disease-on-december-20.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23459/leqembi-to-launch-in-japan-for-alzheimers-disease-on-december-20.html</link>
			<pubDate>Wed, 13 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-23459.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23459/leqembi-to-launch-in-japan-for-alzheimers-disease-on-december-20.html</guid>
		</item>	
				<item>
			<title>French firm Depixus collaborates with Japan&#039;s Daiichi Sankyo to accelerate RNA-targeted drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/23452/french-firm-depixus-collaborates-with-japans-daiichi-sankyo-to-accelerate-rna-targeted-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23452/french-firm-depixus-collaborates-with-japans-daiichi-sankyo-to-accelerate-rna-targeted-drug-discovery.html</link>
			<pubDate>Tue, 12 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dep-23452.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23452/french-firm-depixus-collaborates-with-japans-daiichi-sankyo-to-accelerate-rna-targeted-drug-discovery.html</guid>
		</item>	
				<item>
			<title>GMP cell CDMO I Peace obtains accreditation as ISO 17025: 2017 compliant</title>
			<atom:link href="https://biospectrumasia.com/news/50/23447/gmp-cell-cdmo-i-peace-obtains-accreditation-as-iso-17025-2017-compliant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23447/gmp-cell-cdmo-i-peace-obtains-accreditation-as-iso-17025-2017-compliant.html</link>
			<pubDate>Mon, 11 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23447.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23447/gmp-cell-cdmo-i-peace-obtains-accreditation-as-iso-17025-2017-compliant.html</guid>
		</item>	
				<item>
			<title>Kaneka acquires Japan Medical Device Technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/23440/kaneka-acquires-japan-medical-device-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23440/kaneka-acquires-japan-medical-device-technology.html</link>
			<pubDate>Fri, 08 Dec 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23440/kaneka-acquires-japan-medical-device-technology.html</guid>
		</item>	
				<item>
			<title>Fujifilm invests $200 M into cell therapy development and manufacturing capabilities in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/23437/fujifilm-invests-200-m-into-cell-therapy-development-and-manufacturing-capabilities-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23437/fujifilm-invests-200-m-into-cell-therapy-development-and-manufacturing-capabilities-in-us.html</link>
			<pubDate>Fri, 08 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23437.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23437/fujifilm-invests-200-m-into-cell-therapy-development-and-manufacturing-capabilities-in-us.html</guid>
		</item>	
				<item>
			<title>Sosei Group&#039;s CNS drug receives marketing approval in South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/23435/sosei-groups-cns-drug-receives-marketing-approval-in-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23435/sosei-groups-cns-drug-receives-marketing-approval-in-south-korea.html</link>
			<pubDate>Thu, 07 Dec 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23435/sosei-groups-cns-drug-receives-marketing-approval-in-south-korea.html</guid>
		</item>	
				<item>
			<title>Synplogen and Ginkgo Bioworks to boost DNA manufacturing and gene therapy platform services in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23432/synplogen-and-ginkgo-bioworks-to-boost-dna-manufacturing-and-gene-therapy-platform-services-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23432/synplogen-and-ginkgo-bioworks-to-boost-dna-manufacturing-and-gene-therapy-platform-services-in-japan.html</link>
			<pubDate>Thu, 07 Dec 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23432/synplogen-and-ginkgo-bioworks-to-boost-dna-manufacturing-and-gene-therapy-platform-services-in-japan.html</guid>
		</item>	
				<item>
			<title>India&#039;s Dr. Bhatia Medical Coaching Institute partners with Japan-based M3, Inc</title>
			<atom:link href="https://biospectrumasia.com/news/50/23434/indias-dr-bhatia-medical-coaching-institute-partners-with-japan-based-m3-inc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23434/indias-dr-bhatia-medical-coaching-institute-partners-with-japan-based-m3-inc.html</link>
			<pubDate>Thu, 07 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/m3-23434.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23434/indias-dr-bhatia-medical-coaching-institute-partners-with-japan-based-m3-inc.html</guid>
		</item>	
				<item>
			<title>Shionogi partners with Life Science VC AN Venture Partners</title>
			<atom:link href="https://biospectrumasia.com/news/50/23423/shionogi-partners-with-life-science-vc-an-venture-partners.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23423/shionogi-partners-with-life-science-vc-an-venture-partners.html</link>
			<pubDate>Tue, 05 Dec 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23423/shionogi-partners-with-life-science-vc-an-venture-partners.html</guid>
		</item>	
				<item>
			<title>Japanese pharma firm Eisai partners with Thailand Health Ministry for dementia treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/23420/japanese-pharma-firm-eisai-partners-with-thailand-health-ministry-for-dementia-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23420/japanese-pharma-firm-eisai-partners-with-thailand-health-ministry-for-dementia-treatment.html</link>
			<pubDate>Mon, 04 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23420.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23420/japanese-pharma-firm-eisai-partners-with-thailand-health-ministry-for-dementia-treatment.html</guid>
		</item>	
				<item>
			<title>India&#039;s Meril Life Sciences inks pact with Japan Lifeline for global expansion</title>
			<atom:link href="https://biospectrumasia.com/news/50/23443/indias-meril-life-sciences-inks-pact-with-japan-lifeline-for-global-expansion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23443/indias-meril-life-sciences-inks-pact-with-japan-lifeline-for-global-expansion.html</link>
			<pubDate>Sat, 02 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-23443.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23443/indias-meril-life-sciences-inks-pact-with-japan-lifeline-for-global-expansion.html</guid>
		</item>	
				<item>
			<title>Fujirebio and Sysmex expand partnership into the field of neurodegenerative diseases </title>
			<atom:link href="https://biospectrumasia.com/news/50/23413/fujirebio-and-sysmex-expand-partnership-into-the-field-of-neurodegenerative-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23413/fujirebio-and-sysmex-expand-partnership-into-the-field-of-neurodegenerative-diseases-.html</link>
			<pubDate>Fri, 01 Dec 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23413/fujirebio-and-sysmex-expand-partnership-into-the-field-of-neurodegenerative-diseases-.html</guid>
		</item>	
				<item>
			<title>Ascendis Pharma announces $70 million strategic partnership with Teijin in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23408/ascendis-pharma-announces-70-million-strategic-partnership-with-teijin-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23408/ascendis-pharma-announces-70-million-strategic-partnership-with-teijin-in-japan.html</link>
			<pubDate>Thu, 30 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23408/ascendis-pharma-announces-70-million-strategic-partnership-with-teijin-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese firm PRISM BioLab inks $660 M drug discovery pact with Eli Lilly</title>
			<atom:link href="https://biospectrumasia.com/news/50/23404/japanese-firm-prism-biolab-inks-660-m-drug-discovery-pact-with-eli-lilly.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23404/japanese-firm-prism-biolab-inks-660-m-drug-discovery-pact-with-eli-lilly.html</link>
			<pubDate>Thu, 30 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-23404.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23404/japanese-firm-prism-biolab-inks-660-m-drug-discovery-pact-with-eli-lilly.html</guid>
		</item>	
				<item>
			<title>US based biotech Amylyx establishes Japan subsidiary</title>
			<atom:link href="https://biospectrumasia.com/news/50/23397/us-based-biotech-amylyx-establishes-japan-subsidiary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23397/us-based-biotech-amylyx-establishes-japan-subsidiary.html</link>
			<pubDate>Tue, 28 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23397/us-based-biotech-amylyx-establishes-japan-subsidiary.html</guid>
		</item>	
				<item>
			<title>Sumitomo Pharma wins NMPA approval for an antibiotic drug for pneumonia</title>
			<atom:link href="https://biospectrumasia.com/news/50/23395/sumitomo-pharma-wins-nmpa-approval-for-an-antibiotic-drug-for-pneumonia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23395/sumitomo-pharma-wins-nmpa-approval-for-an-antibiotic-drug-for-pneumonia.html</link>
			<pubDate>Mon, 27 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23395/sumitomo-pharma-wins-nmpa-approval-for-an-antibiotic-drug-for-pneumonia.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Alfresa inks a deal to introduce Japanese pharmaceuticals and medical devices into the Chinese market</title>
			<atom:link href="https://biospectrumasia.com/news/50/23376/japans-alfresa-inks-a-deal-to-introduce-japanese-pharmaceuticals-and-medical-devices-into-the-chinese-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23376/japans-alfresa-inks-a-deal-to-introduce-japanese-pharmaceuticals-and-medical-devices-into-the-chinese-market.html</link>
			<pubDate>Thu, 23 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23376/japans-alfresa-inks-a-deal-to-introduce-japanese-pharmaceuticals-and-medical-devices-into-the-chinese-market.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo to supply omicron XBB.1.5-adapted COVID-19 vaccine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23359/daiichi-sankyo-to-supply-omicron-xbb-1-5-adapted-covid-19-vaccine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23359/daiichi-sankyo-to-supply-omicron-xbb-1-5-adapted-covid-19-vaccine-in-japan.html</link>
			<pubDate>Wed, 22 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_171044057-23359.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23359/daiichi-sankyo-to-supply-omicron-xbb-1-5-adapted-covid-19-vaccine-in-japan.html</guid>
		</item>	
				<item>
			<title>Partnership in Japan for for mRNA drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/50/23349/partnership-in-japan-for-for-mrna-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23349/partnership-in-japan-for-for-mrna-drug-discovery-research.html</link>
			<pubDate>Mon, 20 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23349/partnership-in-japan-for-for-mrna-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma buys US-based startup Propella Therapeutics for $175 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/23337/japans-astellas-pharma-buys-us-based-startup-propella-therapeutics-for-175-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23337/japans-astellas-pharma-buys-us-based-startup-propella-therapeutics-for-175-m.html</link>
			<pubDate>Mon, 20 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-23337.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23337/japans-astellas-pharma-buys-us-based-startup-propella-therapeutics-for-175-m.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujitsu delivers advanced technology to US-based startup for treating delirium</title>
			<atom:link href="https://biospectrumasia.com/news/50/23342/japans-fujitsu-delivers-advanced-technology-to-us-based-startup-for-treating-delirium.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23342/japans-fujitsu-delivers-advanced-technology-to-us-based-startup-for-treating-delirium.html</link>
			<pubDate>Mon, 20 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-23342.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23342/japans-fujitsu-delivers-advanced-technology-to-us-based-startup-for-treating-delirium.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma &amp; University of Tsukuba partner to create new drug discovery startups</title>
			<atom:link href="https://biospectrumasia.com/news/50/23333/japans-astellas-pharma-university-of-tsukuba-partner-to-create-new-drug-discovery-startups.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23333/japans-astellas-pharma-university-of-tsukuba-partner-to-create-new-drug-discovery-startups.html</link>
			<pubDate>Fri, 17 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-23333.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23333/japans-astellas-pharma-university-of-tsukuba-partner-to-create-new-drug-discovery-startups.html</guid>
		</item>	
				<item>
			<title>Japan-Korea partnership to propel growth of advanced biotechnology sector</title>
			<atom:link href="https://biospectrumasia.com/news/50/23327/japan-korea-partnership-to-propel-growth-of-advanced-biotechnology-sector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23327/japan-korea-partnership-to-propel-growth-of-advanced-biotechnology-sector.html</link>
			<pubDate>Thu, 16 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23327.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23327/japan-korea-partnership-to-propel-growth-of-advanced-biotechnology-sector.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujitsu inks agreement with Spain to advance regional healthcare cybersecurity ecosystem</title>
			<atom:link href="https://biospectrumasia.com/news/50/23324/japans-fujitsu-inks-agreement-with-spain-to-advance-regional-healthcare-cybersecurity-ecosystem.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23324/japans-fujitsu-inks-agreement-with-spain-to-advance-regional-healthcare-cybersecurity-ecosystem.html</link>
			<pubDate>Wed, 15 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-23324.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23324/japans-fujitsu-inks-agreement-with-spain-to-advance-regional-healthcare-cybersecurity-ecosystem.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ajinomoto to acquire US based Forge Biologics for $620 million</title>
			<atom:link href="https://biospectrumasia.com/news/50/23316/japans-ajinomoto-to-acquire-us-based-forge-biologics-for-620-million.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23316/japans-ajinomoto-to-acquire-us-based-forge-biologics-for-620-million.html</link>
			<pubDate>Tue, 14 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23316/japans-ajinomoto-to-acquire-us-based-forge-biologics-for-620-million.html</guid>
		</item>	
				<item>
			<title>Takeda gets FDA approval for first and only treatment for a rare disease cTTP </title>
			<atom:link href="https://biospectrumasia.com/news/50/23314/takeda-gets-fda-approval-for-first-and-only-treatment-for-a-rare-disease-cttp-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23314/takeda-gets-fda-approval-for-first-and-only-treatment-for-a-rare-disease-cttp-.html</link>
			<pubDate>Mon, 13 Nov 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23314/takeda-gets-fda-approval-for-first-and-only-treatment-for-a-rare-disease-cttp-.html</guid>
		</item>	
				<item>
			<title>Mitsubishi licenses neuropsychiatric drug to Dutch startup Kynexis</title>
			<atom:link href="https://biospectrumasia.com/news/50/23297/mitsubishi-licenses-neuropsychiatric-drug-to-dutch-startup-kynexis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23297/mitsubishi-licenses-neuropsychiatric-drug-to-dutch-startup-kynexis.html</link>
			<pubDate>Thu, 09 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23297/mitsubishi-licenses-neuropsychiatric-drug-to-dutch-startup-kynexis.html</guid>
		</item>	
				<item>
			<title>FDA approves first renal denervation system for the treatment of hypertension</title>
			<atom:link href="https://biospectrumasia.com/news/50/23293/fda-approves-first-renal-denervation-system-for-the-treatment-of-hypertension.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23293/fda-approves-first-renal-denervation-system-for-the-treatment-of-hypertension.html</link>
			<pubDate>Wed, 08 Nov 2023 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23293/fda-approves-first-renal-denervation-system-for-the-treatment-of-hypertension.html</guid>
		</item>	
				<item>
			<title>Chugai transfers rights of anti-cancer drug to Cheplapharm</title>
			<atom:link href="https://biospectrumasia.com/news/50/23280/chugai-transfers-rights-of-anti-cancer-drug-to-cheplapharm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23280/chugai-transfers-rights-of-anti-cancer-drug-to-cheplapharm.html</link>
			<pubDate>Tue, 07 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23280/chugai-transfers-rights-of-anti-cancer-drug-to-cheplapharm.html</guid>
		</item>	
				<item>
			<title>Japan-Singapore partnership to accelerate innovation in drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/23279/japan-singapore-partnership-to-accelerate-innovation-in-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23279/japan-singapore-partnership-to-accelerate-innovation-in-drug-discovery.html</link>
			<pubDate>Tue, 07 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23279.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23279/japan-singapore-partnership-to-accelerate-innovation-in-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Masahiro Kato steps in as Managing Director of Daiichi Sankyo Europe</title>
			<atom:link href="https://biospectrumasia.com/news/50/23283/masahiro-kato-steps-in-as-managing-director-of-daiichi-sankyo-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23283/masahiro-kato-steps-in-as-managing-director-of-daiichi-sankyo-europe.html</link>
			<pubDate>Tue, 07 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ds-23283.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23283/masahiro-kato-steps-in-as-managing-director-of-daiichi-sankyo-europe.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT Fund and Medicines Patent Pool strengthen ties to improve access to medicines</title>
			<atom:link href="https://biospectrumasia.com/news/50/23272/japans-ghit-fund-and-medicines-patent-pool-strengthen-ties-to-improve-access-to-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23272/japans-ghit-fund-and-medicines-patent-pool-strengthen-ties-to-improve-access-to-medicines.html</link>
			<pubDate>Mon, 06 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-23272.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23272/japans-ghit-fund-and-medicines-patent-pool-strengthen-ties-to-improve-access-to-medicines.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi establishes JV with US-based Apnimed to treat sleep disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/23261/japans-shionogi-establishes-jv-with-us-based-apnimed-to-treat-sleep-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23261/japans-shionogi-establishes-jv-with-us-based-apnimed-to-treat-sleep-disorders.html</link>
			<pubDate>Fri, 03 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23261.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23261/japans-shionogi-establishes-jv-with-us-based-apnimed-to-treat-sleep-disorders.html</guid>
		</item>	
				<item>
			<title>Shionogi, Mochida partner for insomnia treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23255/shionogi-mochida-partner-for-insomnia-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23255/shionogi-mochida-partner-for-insomnia-treatment-in-japan.html</link>
			<pubDate>Thu, 02 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23255/shionogi-mochida-partner-for-insomnia-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s pharmaceutical firm Daiichi Sankyo to merge 2 wholly-owned subsidiaries</title>
			<atom:link href="https://biospectrumasia.com/news/50/23249/japans-pharmaceutical-firm-daiichi-sankyo-to-merge-2-wholly-owned-subsidiaries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23249/japans-pharmaceutical-firm-daiichi-sankyo-to-merge-2-wholly-owned-subsidiaries.html</link>
			<pubDate>Thu, 02 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23249.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23249/japans-pharmaceutical-firm-daiichi-sankyo-to-merge-2-wholly-owned-subsidiaries.html</guid>
		</item>	
				<item>
			<title>Japan takes major step forward in advancing autologous cardiac regenerative medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/23259/japan-takes-major-step-forward-in-advancing-autologous-cardiac-regenerative-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23259/japan-takes-major-step-forward-in-advancing-autologous-cardiac-regenerative-medicine.html</link>
			<pubDate>Thu, 02 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-23259.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23259/japan-takes-major-step-forward-in-advancing-autologous-cardiac-regenerative-medicine.html</guid>
		</item>	
				<item>
			<title>AnHeart Therapeutics signs $40 M deal with Nippon Kayaku for cancer treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23241/anheart-therapeutics-signs-40-m-deal-with-nippon-kayaku-for-cancer-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23241/anheart-therapeutics-signs-40-m-deal-with-nippon-kayaku-for-cancer-treatment-in-japan.html</link>
			<pubDate>Tue, 31 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-23241.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23241/anheart-therapeutics-signs-40-m-deal-with-nippon-kayaku-for-cancer-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sumitomo grants AlphaNavi rights to neuropathic pain therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/23235/japans-sumitomo-grants-alphanavi-rights-to-neuropathic-pain-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23235/japans-sumitomo-grants-alphanavi-rights-to-neuropathic-pain-therapy.html</link>
			<pubDate>Mon, 30 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pain-23235.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23235/japans-sumitomo-grants-alphanavi-rights-to-neuropathic-pain-therapy.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Yakult transfers marketing authorisation of cancer drug Elplat to Takata</title>
			<atom:link href="https://biospectrumasia.com/news/50/23222/japans-yakult-transfers-marketing-authorisation-of-cancer-drug-elplat-to-takata.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23222/japans-yakult-transfers-marketing-authorisation-of-cancer-drug-elplat-to-takata.html</link>
			<pubDate>Fri, 27 Oct 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-23222.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23222/japans-yakult-transfers-marketing-authorisation-of-cancer-drug-elplat-to-takata.html</guid>
		</item>	
				<item>
			<title>Japanese doctors start adopting generative AI</title>
			<atom:link href="https://biospectrumasia.com/news/50/23211/japanese-doctors-start-adopting-generative-ai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23211/japanese-doctors-start-adopting-generative-ai.html</link>
			<pubDate>Thu, 26 Oct 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23211/japanese-doctors-start-adopting-generative-ai.html</guid>
		</item>	
				<item>
			<title>Mithra to receive â‚¬ 2.5 M from Fuji Pharma for dysmenorrhea treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23203/mithra-to-receive-2-5-m-from-fuji-pharma-for-dysmenorrhea-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23203/mithra-to-receive-2-5-m-from-fuji-pharma-for-dysmenorrhea-treatment-in-japan.html</link>
			<pubDate>Wed, 25 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-23203.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23203/mithra-to-receive-2-5-m-from-fuji-pharma-for-dysmenorrhea-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan-based Shimadzu unveils integrated system for urine volume measurement</title>
			<atom:link href="https://biospectrumasia.com/news/50/23186/japan-based-shimadzu-unveils-integrated-system-for-urine-volume-measurement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23186/japan-based-shimadzu-unveils-integrated-system-for-urine-volume-measurement.html</link>
			<pubDate>Mon, 23 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-23186.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23186/japan-based-shimadzu-unveils-integrated-system-for-urine-volume-measurement.html</guid>
		</item>	
				<item>
			<title>Smith+Nephew introduces REGENETEN Bioinductive Implant in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23170/smithnephew-introduces-regeneten-bioinductive-implant-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23170/smithnephew-introduces-regeneten-bioinductive-implant-in-japan.html</link>
			<pubDate>Fri, 20 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-23170.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23170/smithnephew-introduces-regeneten-bioinductive-implant-in-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo and Merck announce global deal worth billion dollars to develop antibody drug conjugates</title>
			<atom:link href="https://biospectrumasia.com/news/50/23179/daiichi-sankyo-and-merck-announce-global-deal-worth-billion-dollars-to-develop-antibody-drug-conjugates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23179/daiichi-sankyo-and-merck-announce-global-deal-worth-billion-dollars-to-develop-antibody-drug-conjugates.html</link>
			<pubDate>Fri, 20 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-23179.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23179/daiichi-sankyo-and-merck-announce-global-deal-worth-billion-dollars-to-develop-antibody-drug-conjugates.html</guid>
		</item>	
				<item>
			<title>Japanese firms Fujitsu and TOPPAN Holdings collaborate to expand medical big data business</title>
			<atom:link href="https://biospectrumasia.com/news/50/23176/japanese-firms-fujitsu-and-toppan-holdings-collaborate-to-expand-medical-big-data-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23176/japanese-firms-fujitsu-and-toppan-holdings-collaborate-to-expand-medical-big-data-business.html</link>
			<pubDate>Thu, 19 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/data-23176.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23176/japanese-firms-fujitsu-and-toppan-holdings-collaborate-to-expand-medical-big-data-business.html</guid>
		</item>	
				<item>
			<title>BioJapan 2023 showcases automation revolutionizing cell therapy and regenerative medicine industry</title>
			<atom:link href="https://biospectrumasia.com/news/50/23172/biojapan-2023-showcases-automation-revolutionizing-cell-therapy-and-regenerative-medicine-industry.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23172/biojapan-2023-showcases-automation-revolutionizing-cell-therapy-and-regenerative-medicine-industry.html</link>
			<pubDate>Wed, 18 Oct 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23172/biojapan-2023-showcases-automation-revolutionizing-cell-therapy-and-regenerative-medicine-industry.html</guid>
		</item>	
				<item>
			<title>Japan accelerates open innovation and enhance life science ecosystem</title>
			<atom:link href="https://biospectrumasia.com/news/50/23150/japan-accelerates-open-innovation-and-enhance-life-science-ecosystem.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23150/japan-accelerates-open-innovation-and-enhance-life-science-ecosystem.html</link>
			<pubDate>Tue, 17 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-23150.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23150/japan-accelerates-open-innovation-and-enhance-life-science-ecosystem.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT joins hands with Institut Pasteur de Dakar in Africa to develop new diagnostics &amp; vaccines</title>
			<atom:link href="https://biospectrumasia.com/news/50/23153/japans-ghit-joins-hands-with-institut-pasteur-de-dakar-in-africa-to-develop-new-diagnostics-vaccines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23153/japans-ghit-joins-hands-with-institut-pasteur-de-dakar-in-africa-to-develop-new-diagnostics-vaccines.html</link>
			<pubDate>Mon, 16 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23153.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23153/japans-ghit-joins-hands-with-institut-pasteur-de-dakar-in-africa-to-develop-new-diagnostics-vaccines.html</guid>
		</item>	
				<item>
			<title>Singapore and Japan join forces in pioneering telesurgery trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/23146/singapore-and-japan-join-forces-in-pioneering-telesurgery-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23146/singapore-and-japan-join-forces-in-pioneering-telesurgery-trial.html</link>
			<pubDate>Fri, 13 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-23146.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23146/singapore-and-japan-join-forces-in-pioneering-telesurgery-trial.html</guid>
		</item>	
				<item>
			<title>Japanese firm Mitsui invests $8 M in US-based clinical intelligence startup Lokavant</title>
			<atom:link href="https://biospectrumasia.com/news/50/23128/japanese-firm-mitsui-invests-8-m-in-us-based-clinical-intelligence-startup-lokavant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23128/japanese-firm-mitsui-invests-8-m-in-us-based-clinical-intelligence-startup-lokavant.html</link>
			<pubDate>Tue, 10 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ct-23128.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23128/japanese-firm-mitsui-invests-8-m-in-us-based-clinical-intelligence-startup-lokavant.html</guid>
		</item>	
				<item>
			<title>Japan-based Fujitsu and RIKEN develop AI drug discovery technology utilising generative AI </title>
			<atom:link href="https://biospectrumasia.com/news/50/23137/japan-based-fujitsu-and-riken-develop-ai-drug-discovery-technology-utilising-generative-ai-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23137/japan-based-fujitsu-and-riken-develop-ai-drug-discovery-technology-utilising-generative-ai-.html</link>
			<pubDate>Tue, 10 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-23137.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23137/japan-based-fujitsu-and-riken-develop-ai-drug-discovery-technology-utilising-generative-ai-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kyushu University signs strategic partnership agreement with GSK</title>
			<atom:link href="https://biospectrumasia.com/news/50/23118/japans-kyushu-university-signs-strategic-partnership-agreement-with-gsk.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23118/japans-kyushu-university-signs-strategic-partnership-agreement-with-gsk.html</link>
			<pubDate>Mon, 09 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_309940142-23118.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23118/japans-kyushu-university-signs-strategic-partnership-agreement-with-gsk.html</guid>
		</item>	
				<item>
			<title>Japanese firm Kyowa Kirin to acquire UK-based startup Orchard Therapeutics for $477 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/23115/japanese-firm-kyowa-kirin-to-acquire-uk-based-startup-orchard-therapeutics-for-477-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23115/japanese-firm-kyowa-kirin-to-acquire-uk-based-startup-orchard-therapeutics-for-477-m.html</link>
			<pubDate>Fri, 06 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23115.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23115/japanese-firm-kyowa-kirin-to-acquire-uk-based-startup-orchard-therapeutics-for-477-m.html</guid>
		</item>	
				<item>
			<title>ARCALIS awarded additional financial grants from Japanese Government</title>
			<atom:link href="https://biospectrumasia.com/news/50/23112/arcalis-awarded-additional-financial-grants-from-japanese-government.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23112/arcalis-awarded-additional-financial-grants-from-japanese-government.html</link>
			<pubDate>Thu, 05 Oct 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23112/arcalis-awarded-additional-financial-grants-from-japanese-government.html</guid>
		</item>	
				<item>
			<title>WHO recommends Japanese firm Takeda&#039;s dengue vaccine for children aged 6 to 16 yrs</title>
			<atom:link href="https://biospectrumasia.com/news/50/23103/who-recommends-japanese-firm-takedas-dengue-vaccine-for-children-aged-6-to-16-yrs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23103/who-recommends-japanese-firm-takedas-dengue-vaccine-for-children-aged-6-to-16-yrs.html</link>
			<pubDate>Wed, 04 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vax-23103.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23103/who-recommends-japanese-firm-takedas-dengue-vaccine-for-children-aged-6-to-16-yrs.html</guid>
		</item>	
				<item>
			<title>Chugai&#039;s enspryng launched in Taiwan as first indication for Neuromyelitis Optica Spectrum Disorder (NMOSD)</title>
			<atom:link href="https://biospectrumasia.com/news/50/23099/chugais-enspryng-launched-in-taiwan-as-first-indication-for-neuromyelitis-optica-spectrum-disorder-nmosd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23099/chugais-enspryng-launched-in-taiwan-as-first-indication-for-neuromyelitis-optica-spectrum-disorder-nmosd.html</link>
			<pubDate>Tue, 03 Oct 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23099/chugais-enspryng-launched-in-taiwan-as-first-indication-for-neuromyelitis-optica-spectrum-disorder-nmosd.html</guid>
		</item>	
				<item>
			<title>Singapore-based Vela Diagnostics collaborates with SRL for product distribution in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23092/singapore-based-vela-diagnostics-collaborates-with-srl-for-product-distribution-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23092/singapore-based-vela-diagnostics-collaborates-with-srl-for-product-distribution-in-japan.html</link>
			<pubDate>Tue, 03 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_211842661-23092.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23092/singapore-based-vela-diagnostics-collaborates-with-srl-for-product-distribution-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus names Dr John de Csepel as Chief Medical Officer</title>
			<atom:link href="https://biospectrumasia.com/news/50/23097/japans-olympus-names-dr-john-de-csepel-as-chief-medical-officer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23097/japans-olympus-names-dr-john-de-csepel-as-chief-medical-officer.html</link>
			<pubDate>Tue, 03 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-23097.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23097/japans-olympus-names-dr-john-de-csepel-as-chief-medical-officer.html</guid>
		</item>	
				<item>
			<title>Fujitsu and iSurgery launch bone health promotion project in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23061/fujitsu-and-isurgery-launch-bone-health-promotion-project-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23061/fujitsu-and-isurgery-launch-bone-health-promotion-project-in-japan.html</link>
			<pubDate>Fri, 29 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-23061.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23061/fujitsu-and-isurgery-launch-bone-health-promotion-project-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan approves GSK&#039;s Arexvy, country&#039;s first RSV vaccine for adults</title>
			<atom:link href="https://biospectrumasia.com/news/50/23067/japan-approves-gsks-arexvy-countrys-first-rsv-vaccine-for-adults.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23067/japan-approves-gsks-arexvy-countrys-first-rsv-vaccine-for-adults.html</link>
			<pubDate>Wed, 27 Sep 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_06_19_at_10_15_50_pm-23067.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23067/japan-approves-gsks-arexvy-countrys-first-rsv-vaccine-for-adults.html</guid>
		</item>	
				<item>
			<title>Inventiva and Hepalys Pharma to develop and commercialize NASH drug in Japan and South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/23069/inventiva-and-hepalys-pharma-to-develop-and-commercialize-nash-drug-in-japan-and-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23069/inventiva-and-hepalys-pharma-to-develop-and-commercialize-nash-drug-in-japan-and-south-korea.html</link>
			<pubDate>Wed, 27 Sep 2023 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23069/inventiva-and-hepalys-pharma-to-develop-and-commercialize-nash-drug-in-japan-and-south-korea.html</guid>
		</item>	
				<item>
			<title>Japan approves Eisai and Biogen&#039;s Alzheimer&#039;s drug LEQEMBI</title>
			<atom:link href="https://biospectrumasia.com/news/50/23058/japan-approves-eisai-and-biogens-alzheimers-drug-leqembi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23058/japan-approves-eisai-and-biogens-alzheimers-drug-leqembi.html</link>
			<pubDate>Mon, 25 Sep 2023 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23058/japan-approves-eisai-and-biogens-alzheimers-drug-leqembi.html</guid>
		</item>	
				<item>
			<title>BioCurate and Takeda renew alliance to accelerate discoveries of new drugs and therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/23054/biocurate-and-takeda-renew-alliance-to-accelerate-discoveries-of-new-drugs-and-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23054/biocurate-and-takeda-renew-alliance-to-accelerate-discoveries-of-new-drugs-and-therapeutics.html</link>
			<pubDate>Sun, 24 Sep 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23054/biocurate-and-takeda-renew-alliance-to-accelerate-discoveries-of-new-drugs-and-therapeutics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PeptiDream inks $40 M deal with Genentech for novel peptide-radioisotope drug conjugates</title>
			<atom:link href="https://biospectrumasia.com/news/50/23042/japans-peptidream-inks-40-m-deal-with-genentech-for-novel-peptide-radioisotope-drug-conjugates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23042/japans-peptidream-inks-40-m-deal-with-genentech-for-novel-peptide-radioisotope-drug-conjugates.html</link>
			<pubDate>Wed, 20 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-23042.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23042/japans-peptidream-inks-40-m-deal-with-genentech-for-novel-peptide-radioisotope-drug-conjugates.html</guid>
		</item>	
				<item>
			<title>Japanese medtech startup Medmain to expand to US</title>
			<atom:link href="https://biospectrumasia.com/news/50/23039/japanese-medtech-startup-medmain-to-expand-to-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23039/japanese-medtech-startup-medmain-to-expand-to-us.html</link>
			<pubDate>Tue, 19 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/med-23039.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23039/japanese-medtech-startup-medmain-to-expand-to-us.html</guid>
		</item>	
				<item>
			<title>Japanese pharma firm Astellas to invest more than â‚¬330 M in Ireland facility</title>
			<atom:link href="https://biospectrumasia.com/news/50/23030/japanese-pharma-firm-astellas-to-invest-more-than-330-m-in-ireland-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23030/japanese-pharma-firm-astellas-to-invest-more-than-330-m-in-ireland-facility.html</link>
			<pubDate>Mon, 18 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ireland-23030.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23030/japanese-pharma-firm-astellas-to-invest-more-than-330-m-in-ireland-facility.html</guid>
		</item>	
				<item>
			<title>Japan to develop brain bio-digital twin technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/23024/japan-to-develop-brain-bio-digital-twin-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23024/japan-to-develop-brain-bio-digital-twin-technology.html</link>
			<pubDate>Fri, 15 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-23024.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23024/japan-to-develop-brain-bio-digital-twin-technology.html</guid>
		</item>	
				<item>
			<title>Buzzreach and Oncoshot spearhead clinical trial advancements in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/23016/buzzreach-and-oncoshot-spearhead-clinical-trial-advancements-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23016/buzzreach-and-oncoshot-spearhead-clinical-trial-advancements-in-japan.html</link>
			<pubDate>Thu, 14 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-23016.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23016/buzzreach-and-oncoshot-spearhead-clinical-trial-advancements-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda Pharma commits $30+ M in five new global CSR partnerships</title>
			<atom:link href="https://biospectrumasia.com/news/50/23012/japans-takeda-pharma-commits-30-m-in-five-new-global-csr-partnerships.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23012/japans-takeda-pharma-commits-30-m-in-five-new-global-csr-partnerships.html</link>
			<pubDate>Wed, 13 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-23012.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23012/japans-takeda-pharma-commits-30-m-in-five-new-global-csr-partnerships.html</guid>
		</item>	
				<item>
			<title>Eisai establishes new digital business company to build dementia ecosystem</title>
			<atom:link href="https://biospectrumasia.com/news/50/23000/eisai-establishes-new-digital-business-company-to-build-dementia-ecosystem.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/23000/eisai-establishes-new-digital-business-company-to-build-dementia-ecosystem.html</link>
			<pubDate>Tue, 12 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-23000.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/23000/eisai-establishes-new-digital-business-company-to-build-dementia-ecosystem.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka Pharma inks $1.5 B deal to develop novel AAV gene therapies for ocular diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/22999/japans-otsuka-pharma-inks-1-5-b-deal-to-develop-novel-aav-gene-therapies-for-ocular-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22999/japans-otsuka-pharma-inks-1-5-b-deal-to-develop-novel-aav-gene-therapies-for-ocular-diseases.html</link>
			<pubDate>Mon, 11 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-22999.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22999/japans-otsuka-pharma-inks-1-5-b-deal-to-develop-novel-aav-gene-therapies-for-ocular-diseases.html</guid>
		</item>	
				<item>
			<title>Shimadzu announces release of Japan&#039;s first infectious disease management support system</title>
			<atom:link href="https://biospectrumasia.com/news/50/22994/shimadzu-announces-release-of-japans-first-infectious-disease-management-support-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22994/shimadzu-announces-release-of-japans-first-infectious-disease-management-support-system.html</link>
			<pubDate>Sat, 09 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22994.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22994/shimadzu-announces-release-of-japans-first-infectious-disease-management-support-system.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Maruho gets Asian rights for hyperhidrosis wipe medication</title>
			<atom:link href="https://biospectrumasia.com/news/50/22992/japans-maruho-gets-asian-rights-for-hyperhidrosis-wipe-medication.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22992/japans-maruho-gets-asian-rights-for-hyperhidrosis-wipe-medication.html</link>
			<pubDate>Fri, 08 Sep 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22992/japans-maruho-gets-asian-rights-for-hyperhidrosis-wipe-medication.html</guid>
		</item>	
				<item>
			<title>Partnership in Japan to develop novel imaging device for human brain</title>
			<atom:link href="https://biospectrumasia.com/news/50/22985/partnership-in-japan-to-develop-novel-imaging-device-for-human-brain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22985/partnership-in-japan-to-develop-novel-imaging-device-for-human-brain.html</link>
			<pubDate>Thu, 07 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22985.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22985/partnership-in-japan-to-develop-novel-imaging-device-for-human-brain.html</guid>
		</item>	
				<item>
			<title>Bristol Myers Squibb inks $50 M deal to treat immune-mediated diseases in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/22981/bristol-myers-squibb-inks-50-m-deal-to-treat-immune-mediated-diseases-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22981/bristol-myers-squibb-inks-50-m-deal-to-treat-immune-mediated-diseases-in-asia.html</link>
			<pubDate>Wed, 06 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-22981.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22981/bristol-myers-squibb-inks-50-m-deal-to-treat-immune-mediated-diseases-in-asia.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s RaQalia introduces GERD drug Tegoprazan in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/50/22972/japans-raqalia-introduces-gerd-drug-tegoprazan-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22972/japans-raqalia-introduces-gerd-drug-tegoprazan-in-singapore.html</link>
			<pubDate>Tue, 05 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22972.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22972/japans-raqalia-introduces-gerd-drug-tegoprazan-in-singapore.html</guid>
		</item>	
				<item>
			<title>Japanese pharma firm Otsuka buys Mindset Pharma for CAD 80 M to strengthen pipeline in neurological disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/22966/japanese-pharma-firm-otsuka-buys-mindset-pharma-for-cad-80-m-to-strengthen-pipeline-in-neurological-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22966/japanese-pharma-firm-otsuka-buys-mindset-pharma-for-cad-80-m-to-strengthen-pipeline-in-neurological-disorders.html</link>
			<pubDate>Mon, 04 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-22966.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22966/japanese-pharma-firm-otsuka-buys-mindset-pharma-for-cad-80-m-to-strengthen-pipeline-in-neurological-disorders.html</guid>
		</item>	
				<item>
			<title>â€œPolicies that help to add value to the R&amp;D ecosystem are essential to empower Indian medical device sectorâ€</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/22931/policies-that-help-to-add-value-to-the-rd-ecosystem-are-essential-to-empower-indian-medical-device-sector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/22931/policies-that-help-to-add-value-to-the-rd-ecosystem-are-essential-to-empower-indian-medical-device-sector.html</link>
			<pubDate>Fri, 01 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/omron-22931.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/22931/policies-that-help-to-add-value-to-the-rd-ecosystem-are-essential-to-empower-indian-medical-device-sector.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono Pharma partners with Twist Bioscience to discover novel antibodies for autoimmune diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/22953/japans-ono-pharma-partners-with-twist-bioscience-to-discover-novel-antibodies-for-autoimmune-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22953/japans-ono-pharma-partners-with-twist-bioscience-to-discover-novel-antibodies-for-autoimmune-diseases.html</link>
			<pubDate>Thu, 31 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_795297598-22953.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22953/japans-ono-pharma-partners-with-twist-bioscience-to-discover-novel-antibodies-for-autoimmune-diseases.html</guid>
		</item>	
				<item>
			<title>Shionogi launches pediatric antibiotic drug in China </title>
			<atom:link href="https://biospectrumasia.com/news/50/22949/shionogi-launches-pediatric-antibiotic-drug-in-china-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22949/shionogi-launches-pediatric-antibiotic-drug-in-china-.html</link>
			<pubDate>Wed, 30 Aug 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22949/shionogi-launches-pediatric-antibiotic-drug-in-china-.html</guid>
		</item>	
				<item>
			<title>Taiho to license French firm&#039;s targeted cancer drug in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/22928/taiho-to-license-french-firms-targeted-cancer-drug-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22928/taiho-to-license-french-firms-targeted-cancer-drug-in-asia.html</link>
			<pubDate>Tue, 29 Aug 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22928/taiho-to-license-french-firms-targeted-cancer-drug-in-asia.html</guid>
		</item>	
				<item>
			<title>Israel&#039;s Cybellum to help improve medical device cybersecurity for Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22934/israels-cybellum-to-help-improve-medical-device-cybersecurity-for-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22934/israels-cybellum-to-help-improve-medical-device-cybersecurity-for-japan.html</link>
			<pubDate>Tue, 29 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/43-22934.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22934/israels-cybellum-to-help-improve-medical-device-cybersecurity-for-japan.html</guid>
		</item>	
				<item>
			<title>ImmunoGen &amp; Takeda ink oncology deal worth $34 M in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22921/immunogen-takeda-ink-oncology-deal-worth-34-m-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22921/immunogen-takeda-ink-oncology-deal-worth-34-m-in-japan.html</link>
			<pubDate>Mon, 28 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-22921.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22921/immunogen-takeda-ink-oncology-deal-worth-34-m-in-japan.html</guid>
		</item>	
				<item>
			<title>BostonGene, NEC and JIP form Joint Venture in Japan to advance personalised medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/22916/bostongene-nec-and-jip-form-joint-venture-in-japan-to-advance-personalised-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22916/bostongene-nec-and-jip-form-joint-venture-in-japan-to-advance-personalised-medicine.html</link>
			<pubDate>Fri, 25 Aug 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_171043553-22916.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22916/bostongene-nec-and-jip-form-joint-venture-in-japan-to-advance-personalised-medicine.html</guid>
		</item>	
				<item>
			<title>PeptiGrowth inks a deal for the development of novel synthetic peptide based growth factor</title>
			<atom:link href="https://biospectrumasia.com/news/50/22910/peptigrowth-inks-a-deal-for-the-development-of-novel-synthetic-peptide-based-growth-factor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22910/peptigrowth-inks-a-deal-for-the-development-of-novel-synthetic-peptide-based-growth-factor.html</link>
			<pubDate>Thu, 24 Aug 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22910/peptigrowth-inks-a-deal-for-the-development-of-novel-synthetic-peptide-based-growth-factor.html</guid>
		</item>	
				<item>
			<title>Japan to design universal vaccines targeting tropical infectious diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/22894/japan-to-design-universal-vaccines-targeting-tropical-infectious-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22894/japan-to-design-universal-vaccines-targeting-tropical-infectious-diseases.html</link>
			<pubDate>Mon, 21 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-22894.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22894/japan-to-design-universal-vaccines-targeting-tropical-infectious-diseases.html</guid>
		</item>	
				<item>
			<title>Nippon Express opens new logistics centre in Ireland</title>
			<atom:link href="https://biospectrumasia.com/news/50/22883/nippon-express-opens-new-logistics-centre-in-ireland.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22883/nippon-express-opens-new-logistics-centre-in-ireland.html</link>
			<pubDate>Thu, 17 Aug 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22883/nippon-express-opens-new-logistics-centre-in-ireland.html</guid>
		</item>	
				<item>
			<title>Japanese govt injects $115 M to enhance mRNA manufacturing</title>
			<atom:link href="https://biospectrumasia.com/news/50/22879/japanese-govt-injects-115-m-to-enhance-mrna-manufacturing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22879/japanese-govt-injects-115-m-to-enhance-mrna-manufacturing.html</link>
			<pubDate>Wed, 16 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/230719_037_raf_low-22879.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22879/japanese-govt-injects-115-m-to-enhance-mrna-manufacturing.html</guid>
		</item>	
				<item>
			<title>Otsuka Unit Astex, expands $35 million drug discovery collaboration with Merck</title>
			<atom:link href="https://biospectrumasia.com/news/50/22870/otsuka-unit-astex-expands-35-million-drug-discovery-collaboration-with-merck.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22870/otsuka-unit-astex-expands-35-million-drug-discovery-collaboration-with-merck.html</link>
			<pubDate>Fri, 11 Aug 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22870/otsuka-unit-astex-expands-35-million-drug-discovery-collaboration-with-merck.html</guid>
		</item>	
				<item>
			<title>Astellas to open new life sciences facility in the US</title>
			<atom:link href="https://biospectrumasia.com/news/50/22862/astellas-to-open-new-life-sciences-facility-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22862/astellas-to-open-new-life-sciences-facility-in-the-us.html</link>
			<pubDate>Thu, 10 Aug 2023 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22862/astellas-to-open-new-life-sciences-facility-in-the-us.html</guid>
		</item>	
				<item>
			<title>Pharmanovia appoints new GM for Korea &amp; Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22845/pharmanovia-appoints-new-gm-for-korea-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22845/pharmanovia-appoints-new-gm-for-korea-japan.html</link>
			<pubDate>Wed, 09 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/korea-22845.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22845/pharmanovia-appoints-new-gm-for-korea-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu releases mass spectrometers for R&amp;D of pharmaceuticals</title>
			<atom:link href="https://biospectrumasia.com/news/50/22847/japans-shimadzu-releases-mass-spectrometers-for-rd-of-pharmaceuticals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22847/japans-shimadzu-releases-mass-spectrometers-for-rd-of-pharmaceuticals.html</link>
			<pubDate>Wed, 09 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mass-22847.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22847/japans-shimadzu-releases-mass-spectrometers-for-rd-of-pharmaceuticals.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma invests $50 M for redefining cancer cell therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/22852/japans-astellas-pharma-invests-50-m-for-redefining-cancer-cell-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22852/japans-astellas-pharma-invests-50-m-for-redefining-cancer-cell-therapy.html</link>
			<pubDate>Tue, 08 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22852.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22852/japans-astellas-pharma-invests-50-m-for-redefining-cancer-cell-therapy.html</guid>
		</item>	
				<item>
			<title>Japan approves Shionogi&#039;s stable supply plan for antibiotics drugs </title>
			<atom:link href="https://biospectrumasia.com/news/50/22831/japan-approves-shionogis-stable-supply-plan-for-antibiotics-drugs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22831/japan-approves-shionogis-stable-supply-plan-for-antibiotics-drugs-.html</link>
			<pubDate>Thu, 03 Aug 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22831/japan-approves-shionogis-stable-supply-plan-for-antibiotics-drugs-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Toyo Ink Group invests in US-based VLP Therapeutics to accelerate vaccine development</title>
			<atom:link href="https://biospectrumasia.com/news/50/22833/japans-toyo-ink-group-invests-in-us-based-vlp-therapeutics-to-accelerate-vaccine-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22833/japans-toyo-ink-group-invests-in-us-based-vlp-therapeutics-to-accelerate-vaccine-development.html</link>
			<pubDate>Thu, 03 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-22833.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22833/japans-toyo-ink-group-invests-in-us-based-vlp-therapeutics-to-accelerate-vaccine-development.html</guid>
		</item>	
				<item>
			<title>Israel&#039;s MediWound announces launch of biologic drug NexoBrid in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22823/israels-mediwound-announces-launch-of-biologic-drug-nexobrid-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22823/israels-mediwound-announces-launch-of-biologic-drug-nexobrid-in-japan.html</link>
			<pubDate>Wed, 02 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medi-22823.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22823/israels-mediwound-announces-launch-of-biologic-drug-nexobrid-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese pharma firm Mitsubishi launches Dyskinesia drug in Thailand </title>
			<atom:link href="https://biospectrumasia.com/news/50/22819/japanese-pharma-firm-mitsubishi-launches-dyskinesia-drug-in-thailand-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22819/japanese-pharma-firm-mitsubishi-launches-dyskinesia-drug-in-thailand-.html</link>
			<pubDate>Tue, 01 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22819.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22819/japanese-pharma-firm-mitsubishi-launches-dyskinesia-drug-in-thailand-.html</guid>
		</item>	
				<item>
			<title>French firm Roquette buys Japan-based Qualicaps to reinforce global position in pharma industry</title>
			<atom:link href="https://biospectrumasia.com/news/50/22807/french-firm-roquette-buys-japan-based-qualicaps-to-reinforce-global-position-in-pharma-industry.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22807/french-firm-roquette-buys-japan-based-qualicaps-to-reinforce-global-position-in-pharma-industry.html</link>
			<pubDate>Mon, 31 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-22807.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22807/french-firm-roquette-buys-japan-based-qualicaps-to-reinforce-global-position-in-pharma-industry.html</guid>
		</item>	
				<item>
			<title>Japanese firms ink Â¥20.6 B deal to discover novel targeted protein degraders</title>
			<atom:link href="https://biospectrumasia.com/news/50/22788/japanese-firms-ink-20-6-b-deal-to-discover-novel-targeted-protein-degraders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22788/japanese-firms-ink-20-6-b-deal-to-discover-novel-targeted-protein-degraders.html</link>
			<pubDate>Thu, 27 Jul 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-22788.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22788/japanese-firms-ink-20-6-b-deal-to-discover-novel-targeted-protein-degraders.html</guid>
		</item>	
				<item>
			<title>Japanese startup AI Medical Service teams up with Stanford Medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/22792/japanese-startup-ai-medical-service-teams-up-with-stanford-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22792/japanese-startup-ai-medical-service-teams-up-with-stanford-medicine.html</link>
			<pubDate>Thu, 27 Jul 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oip-22792.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22792/japanese-startup-ai-medical-service-teams-up-with-stanford-medicine.html</guid>
		</item>	
				<item>
			<title>Japan produces world&#039;s first report on brain activation by Plasmacluster Technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/22783/japan-produces-worlds-first-report-on-brain-activation-by-plasmacluster-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22783/japan-produces-worlds-first-report-on-brain-activation-by-plasmacluster-technology.html</link>
			<pubDate>Wed, 26 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/22-22783.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22783/japan-produces-worlds-first-report-on-brain-activation-by-plasmacluster-technology.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Omron Healthcare breaks ground on new manufacturing plant in India</title>
			<atom:link href="https://biospectrumasia.com/news/50/22778/japans-omron-healthcare-breaks-ground-on-new-manufacturing-plant-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22778/japans-omron-healthcare-breaks-ground-on-new-manufacturing-plant-in-india.html</link>
			<pubDate>Tue, 25 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/omron-22778.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22778/japans-omron-healthcare-breaks-ground-on-new-manufacturing-plant-in-india.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares buys Idorsia&#039;s pharma business in Japan and Korea for JPY65 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/22766/sosei-heptares-buys-idorsias-pharma-business-in-japan-and-korea-for-jpy65-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22766/sosei-heptares-buys-idorsias-pharma-business-in-japan-and-korea-for-jpy65-b.html</link>
			<pubDate>Mon, 24 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-22766.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22766/sosei-heptares-buys-idorsias-pharma-business-in-japan-and-korea-for-jpy65-b.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus announces project in Kenya for diagnosis of gastrointestinal diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/22763/japans-olympus-announces-project-in-kenya-for-diagnosis-of-gastrointestinal-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22763/japans-olympus-announces-project-in-kenya-for-diagnosis-of-gastrointestinal-diseases.html</link>
			<pubDate>Fri, 21 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22763.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22763/japans-olympus-announces-project-in-kenya-for-diagnosis-of-gastrointestinal-diseases.html</guid>
		</item>	
				<item>
			<title>Japan unveils wearable sensor for measuring sweat lactate levels during exercise</title>
			<atom:link href="https://biospectrumasia.com/news/50/22751/japan-unveils-wearable-sensor-for-measuring-sweat-lactate-levels-during-exercise.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22751/japan-unveils-wearable-sensor-for-measuring-sweat-lactate-levels-during-exercise.html</link>
			<pubDate>Thu, 20 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sweat-22751.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22751/japan-unveils-wearable-sensor-for-measuring-sweat-lactate-levels-during-exercise.html</guid>
		</item>	
				<item>
			<title>Thailand gives nod to Meiji Pharma&#039;s REMITCH for hemodialysis patients</title>
			<atom:link href="https://biospectrumasia.com/news/50/22762/thailand-gives-nod-to-meiji-pharmas-remitch-for-hemodialysis-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22762/thailand-gives-nod-to-meiji-pharmas-remitch-for-hemodialysis-patients.html</link>
			<pubDate>Thu, 20 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-22762.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22762/thailand-gives-nod-to-meiji-pharmas-remitch-for-hemodialysis-patients.html</guid>
		</item>	
				<item>
			<title>Fujifilm to reorganise Medical Systems Group Companies in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22746/fujifilm-to-reorganise-medical-systems-group-companies-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22746/fujifilm-to-reorganise-medical-systems-group-companies-in-japan.html</link>
			<pubDate>Wed, 19 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22746.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22746/fujifilm-to-reorganise-medical-systems-group-companies-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese researchers explore RNase as a treatment for autoimmune diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/22744/japanese-researchers-explore-rnase-as-a-treatment-for-autoimmune-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22744/japanese-researchers-explore-rnase-as-a-treatment-for-autoimmune-diseases.html</link>
			<pubDate>Tue, 18 Jul 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22744/japanese-researchers-explore-rnase-as-a-treatment-for-autoimmune-diseases.html</guid>
		</item>	
				<item>
			<title>Japan-based Fujirebio partners with Beckman Coulter to bolster access to blood-based Alzheimer&#039;s Disease test </title>
			<atom:link href="https://biospectrumasia.com/news/50/22740/japan-based-fujirebio-partners-with-beckman-coulter-to-bolster-access-to-blood-based-alzheimers-disease-test-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22740/japan-based-fujirebio-partners-with-beckman-coulter-to-bolster-access-to-blood-based-alzheimers-disease-test-.html</link>
			<pubDate>Tue, 18 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_212432119-22740.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22740/japan-based-fujirebio-partners-with-beckman-coulter-to-bolster-access-to-blood-based-alzheimers-disease-test-.html</guid>
		</item>	
				<item>
			<title>Japan-based Chugai Pharma and Omron focus on automation for drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/50/22736/japan-based-chugai-pharma-and-omron-focus-on-automation-for-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22736/japan-based-chugai-pharma-and-omron-focus-on-automation-for-drug-discovery-research.html</link>
			<pubDate>Mon, 17 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/32-22736.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22736/japan-based-chugai-pharma-and-omron-focus-on-automation-for-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s RaQualia Pharma initiates sale of GERD drug in Indonesia</title>
			<atom:link href="https://biospectrumasia.com/news/50/22719/japans-raqualia-pharma-initiates-sale-of-gerd-drug-in-indonesia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22719/japans-raqualia-pharma-initiates-sale-of-gerd-drug-in-indonesia.html</link>
			<pubDate>Fri, 14 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-22719.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22719/japans-raqualia-pharma-initiates-sale-of-gerd-drug-in-indonesia.html</guid>
		</item>	
				<item>
			<title>Japanese research increases effectiveness of cancer detection tests using urine</title>
			<atom:link href="https://biospectrumasia.com/news/50/22713/japanese-research-increases-effectiveness-of-cancer-detection-tests-using-urine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22713/japanese-research-increases-effectiveness-of-cancer-detection-tests-using-urine.html</link>
			<pubDate>Wed, 12 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-22713.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22713/japanese-research-increases-effectiveness-of-cancer-detection-tests-using-urine.html</guid>
		</item>	
				<item>
			<title>Japan designs world&#039;s first immuno-chromatography kit for extracellular vesicles</title>
			<atom:link href="https://biospectrumasia.com/news/50/22710/japan-designs-worlds-first-immuno-chromatography-kit-for-extracellular-vesicles.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22710/japan-designs-worlds-first-immuno-chromatography-kit-for-extracellular-vesicles.html</link>
			<pubDate>Tue, 11 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/55-22710.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22710/japan-designs-worlds-first-immuno-chromatography-kit-for-extracellular-vesicles.html</guid>
		</item>	
				<item>
			<title>US FDA approves Japanese pharma firm Eisai&#039;s  treatment of Alzheimer&#039;s Disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/22696/us-fda-approves-japanese-pharma-firm-eisais-treatment-of-alzheimers-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22696/us-fda-approves-japanese-pharma-firm-eisais-treatment-of-alzheimers-disease.html</link>
			<pubDate>Mon, 10 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-22696.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22696/us-fda-approves-japanese-pharma-firm-eisais-treatment-of-alzheimers-disease.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Pentax Medical establishes manufacturing, R&amp;D centre in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/22704/japans-pentax-medical-establishes-manufacturing-rd-centre-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22704/japans-pentax-medical-establishes-manufacturing-rd-centre-in-china.html</link>
			<pubDate>Mon, 10 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pentax-22704.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22704/japans-pentax-medical-establishes-manufacturing-rd-centre-in-china.html</guid>
		</item>	
				<item>
			<title>Japan strengthens global pandemic preparedness and response</title>
			<atom:link href="https://biospectrumasia.com/news/50/22698/japan-strengthens-global-pandemic-preparedness-and-response.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22698/japan-strengthens-global-pandemic-preparedness-and-response.html</link>
			<pubDate>Fri, 07 Jul 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22698.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22698/japan-strengthens-global-pandemic-preparedness-and-response.html</guid>
		</item>	
				<item>
			<title>Japan-UK collaboration to develop digital solutions for dementia</title>
			<atom:link href="https://biospectrumasia.com/news/50/22658/japan-uk-collaboration-to-develop-digital-solutions-for-dementia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22658/japan-uk-collaboration-to-develop-digital-solutions-for-dementia.html</link>
			<pubDate>Thu, 06 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dem-22658.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22658/japan-uk-collaboration-to-develop-digital-solutions-for-dementia.html</guid>
		</item>	
				<item>
			<title>Eisai transfers economic rights for breast cancer drug to Canadian firm DRI Healthcare</title>
			<atom:link href="https://biospectrumasia.com/news/50/22682/eisai-transfers-economic-rights-for-breast-cancer-drug-to-canadian-firm-dri-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22682/eisai-transfers-economic-rights-for-breast-cancer-drug-to-canadian-firm-dri-healthcare.html</link>
			<pubDate>Tue, 04 Jul 2023 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22682/eisai-transfers-economic-rights-for-breast-cancer-drug-to-canadian-firm-dri-healthcare.html</guid>
		</item>	
				<item>
			<title>Hitachi collaborates with Mass General Brigham for R&amp;D in regenerative medicine and GCT </title>
			<atom:link href="https://biospectrumasia.com/news/50/22689/hitachi-collaborates-with-mass-general-brigham-for-rd-in-regenerative-medicine-and-gct-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22689/hitachi-collaborates-with-mass-general-brigham-for-rd-in-regenerative-medicine-and-gct-.html</link>
			<pubDate>Tue, 04 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_representation_dna_2_-22689.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22689/hitachi-collaborates-with-mass-general-brigham-for-rd-in-regenerative-medicine-and-gct-.html</guid>
		</item>	
				<item>
			<title>â€œThe interest of companies in biobanks has significantly increased but investments have not yet been realisedâ€ </title>
			<atom:link href="https://biospectrumasia.com/news/50/22673/the-interest-of-companies-in-biobanks-has-significantly-increased-but-investments-have-not-yet-been-realised-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22673/the-interest-of-companies-in-biobanks-has-significantly-increased-but-investments-have-not-yet-been-realised-.html</link>
			<pubDate>Mon, 03 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-22673.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22673/the-interest-of-companies-in-biobanks-has-significantly-increased-but-investments-have-not-yet-been-realised-.html</guid>
		</item>	
				<item>
			<title>Astellas, Mitsui to open innovation hub</title>
			<atom:link href="https://biospectrumasia.com/news/50/22656/astellas-mitsui-to-open-innovation-hub.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22656/astellas-mitsui-to-open-innovation-hub.html</link>
			<pubDate>Fri, 30 Jun 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22656/astellas-mitsui-to-open-innovation-hub.html</guid>
		</item>	
				<item>
			<title>Taiho, Kyushu University to advance covalent drugs </title>
			<atom:link href="https://biospectrumasia.com/news/50/22649/taiho-kyushu-university-to-advance-covalent-drugs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22649/taiho-kyushu-university-to-advance-covalent-drugs-.html</link>
			<pubDate>Thu, 29 Jun 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22649/taiho-kyushu-university-to-advance-covalent-drugs-.html</guid>
		</item>	
				<item>
			<title>Japan approves updated indication for GSK&#039;s Shingrix vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/22645/japan-approves-updated-indication-for-gsks-shingrix-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22645/japan-approves-updated-indication-for-gsks-shingrix-vaccine.html</link>
			<pubDate>Wed, 28 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22645.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22645/japan-approves-updated-indication-for-gsks-shingrix-vaccine.html</guid>
		</item>	
				<item>
			<title>Shionogi to acquire US based Qpex Biopharma for approx $40 million</title>
			<atom:link href="https://biospectrumasia.com/news/50/22640/shionogi-to-acquire-us-based-qpex-biopharma-for-approx-40-million.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22640/shionogi-to-acquire-us-based-qpex-biopharma-for-approx-40-million.html</link>
			<pubDate>Tue, 27 Jun 2023 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22640/shionogi-to-acquire-us-based-qpex-biopharma-for-approx-40-million.html</guid>
		</item>	
				<item>
			<title>ASLAN Pharmaceuticals inks a deal with Zenyaku Kogyo for the development and commercialization of Eblasakimab in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22632/aslan-pharmaceuticals-inks-a-deal-with-zenyaku-kogyo-for-the-development-and-commercialization-of-eblasakimab-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22632/aslan-pharmaceuticals-inks-a-deal-with-zenyaku-kogyo-for-the-development-and-commercialization-of-eblasakimab-in-japan.html</link>
			<pubDate>Mon, 26 Jun 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22632/aslan-pharmaceuticals-inks-a-deal-with-zenyaku-kogyo-for-the-development-and-commercialization-of-eblasakimab-in-japan.html</guid>
		</item>	
				<item>
			<title>Australian startup Psylo advances depression treatment with Japanese pharma firm Daiichi Sankyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/22625/australian-startup-psylo-advances-depression-treatment-with-japanese-pharma-firm-daiichi-sankyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22625/australian-startup-psylo-advances-depression-treatment-with-japanese-pharma-firm-daiichi-sankyo.html</link>
			<pubDate>Fri, 23 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-22625.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22625/australian-startup-psylo-advances-depression-treatment-with-japanese-pharma-firm-daiichi-sankyo.html</guid>
		</item>	
				<item>
			<title>US-based Biolinq to commercialise new-gen glucose monitoring products in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22614/us-based-biolinq-to-commercialise-new-gen-glucose-monitoring-products-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22614/us-based-biolinq-to-commercialise-new-gen-glucose-monitoring-products-in-japan.html</link>
			<pubDate>Wed, 21 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22614.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22614/us-based-biolinq-to-commercialise-new-gen-glucose-monitoring-products-in-japan.html</guid>
		</item>	
				<item>
			<title>Pistoia Alliance partners with Matador to enable pharma R&amp;D in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22611/pistoia-alliance-partners-with-matador-to-enable-pharma-rd-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22611/pistoia-alliance-partners-with-matador-to-enable-pharma-rd-in-japan.html</link>
			<pubDate>Tue, 20 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-22611.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22611/pistoia-alliance-partners-with-matador-to-enable-pharma-rd-in-japan.html</guid>
		</item>	
				<item>
			<title>US-based startup Cullgen inks billion-dollar deal with Japanese pharma firm Astellas</title>
			<atom:link href="https://biospectrumasia.com/news/50/22598/us-based-startup-cullgen-inks-billion-dollar-deal-with-japanese-pharma-firm-astellas.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22598/us-based-startup-cullgen-inks-billion-dollar-deal-with-japanese-pharma-firm-astellas.html</link>
			<pubDate>Mon, 19 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-22598.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22598/us-based-startup-cullgen-inks-billion-dollar-deal-with-japanese-pharma-firm-astellas.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PHC Holdings Corp fully acquires SciMed (Asia) in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/50/22596/japans-phc-holdings-corp-fully-acquires-scimed-asia-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22596/japans-phc-holdings-corp-fully-acquires-scimed-asia-in-singapore.html</link>
			<pubDate>Fri, 16 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/phc-22596.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22596/japans-phc-holdings-corp-fully-acquires-scimed-asia-in-singapore.html</guid>
		</item>	
				<item>
			<title>India&#039;s Wellthy Therapeutics adds Beyond Next Ventures as investor, expands into Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22587/indias-wellthy-therapeutics-adds-beyond-next-ventures-as-investor-expands-into-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22587/indias-wellthy-therapeutics-adds-beyond-next-ventures-as-investor-expands-into-japan.html</link>
			<pubDate>Thu, 15 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22587.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22587/indias-wellthy-therapeutics-adds-beyond-next-ventures-as-investor-expands-into-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu acquires French software company Biomaneo to expand sales of mass spectrometers</title>
			<atom:link href="https://biospectrumasia.com/news/50/22585/japans-shimadzu-acquires-french-software-company-biomaneo-to-expand-sales-of-mass-spectrometers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22585/japans-shimadzu-acquires-french-software-company-biomaneo-to-expand-sales-of-mass-spectrometers.html</link>
			<pubDate>Wed, 14 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-22585.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22585/japans-shimadzu-acquires-french-software-company-biomaneo-to-expand-sales-of-mass-spectrometers.html</guid>
		</item>	
				<item>
			<title>Astellas Pharma and Kate Therapeutics inks a deal for rare disease gene therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/22578/astellas-pharma-and-kate-therapeutics-inks-a-deal-for-rare-disease-gene-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22578/astellas-pharma-and-kate-therapeutics-inks-a-deal-for-rare-disease-gene-therapy.html</link>
			<pubDate>Mon, 12 Jun 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22578/astellas-pharma-and-kate-therapeutics-inks-a-deal-for-rare-disease-gene-therapy.html</guid>
		</item>	
				<item>
			<title>Fujifilm to enhance presence in Asia for biologics and advanced therapies contract services</title>
			<atom:link href="https://biospectrumasia.com/news/50/22577/fujifilm-to-enhance-presence-in-asia-for-biologics-and-advanced-therapies-contract-services.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22577/fujifilm-to-enhance-presence-in-asia-for-biologics-and-advanced-therapies-contract-services.html</link>
			<pubDate>Mon, 12 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fuji-22577.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22577/fujifilm-to-enhance-presence-in-asia-for-biologics-and-advanced-therapies-contract-services.html</guid>
		</item>	
				<item>
			<title>Japanese firm Shimadzu invests in ChromaCode for developing scalable PCR technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/22561/japanese-firm-shimadzu-invests-in-chromacode-for-developing-scalable-pcr-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22561/japanese-firm-shimadzu-invests-in-chromacode-for-developing-scalable-pcr-technology.html</link>
			<pubDate>Thu, 08 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_104108189-22561.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22561/japanese-firm-shimadzu-invests-in-chromacode-for-developing-scalable-pcr-technology.html</guid>
		</item>	
				<item>
			<title>Japan approves first gene panel testing system for Inherited Retinal Dystrophy</title>
			<atom:link href="https://biospectrumasia.com/news/50/22550/japan-approves-first-gene-panel-testing-system-for-inherited-retinal-dystrophy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22550/japan-approves-first-gene-panel-testing-system-for-inherited-retinal-dystrophy.html</link>
			<pubDate>Wed, 07 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22550.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22550/japan-approves-first-gene-panel-testing-system-for-inherited-retinal-dystrophy.html</guid>
		</item>	
				<item>
			<title>Medtech firm Olympus to establish digital excellence centres in Hamburg, Boston and Tokyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/22553/medtech-firm-olympus-to-establish-digital-excellence-centres-in-hamburg-boston-and-tokyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22553/medtech-firm-olympus-to-establish-digital-excellence-centres-in-hamburg-boston-and-tokyo.html</link>
			<pubDate>Tue, 06 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22553.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22553/medtech-firm-olympus-to-establish-digital-excellence-centres-in-hamburg-boston-and-tokyo.html</guid>
		</item>	
				<item>
			<title>CSL Behring launches HAE Diary app for Hereditary Angioedema (HAE) Patients in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22546/csl-behring-launches-hae-diary-app-for-hereditary-angioedema-hae-patients-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22546/csl-behring-launches-hae-diary-app-for-hereditary-angioedema-hae-patients-in-japan.html</link>
			<pubDate>Mon, 05 Jun 2023 13:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22546/csl-behring-launches-hae-diary-app-for-hereditary-angioedema-hae-patients-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan-based Fujifilm introduces first-of-its-kind human iPSC-derived blood-brain barrier isogenic kit</title>
			<atom:link href="https://biospectrumasia.com/news/50/22541/japan-based-fujifilm-introduces-first-of-its-kind-human-ipsc-derived-blood-brain-barrier-isogenic-kit.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22541/japan-based-fujifilm-introduces-first-of-its-kind-human-ipsc-derived-blood-brain-barrier-isogenic-kit.html</link>
			<pubDate>Mon, 05 Jun 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-22541.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22541/japan-based-fujifilm-introduces-first-of-its-kind-human-ipsc-derived-blood-brain-barrier-isogenic-kit.html</guid>
		</item>	
				<item>
			<title>InDex Pharma inks $50 M deal with Viatris Japan treatment of ulcerative colitis</title>
			<atom:link href="https://biospectrumasia.com/news/50/22533/index-pharma-inks-50-m-deal-with-viatris-japan-treatment-of-ulcerative-colitis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22533/index-pharma-inks-50-m-deal-with-viatris-japan-treatment-of-ulcerative-colitis.html</link>
			<pubDate>Thu, 01 Jun 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-22533.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22533/index-pharma-inks-50-m-deal-with-viatris-japan-treatment-of-ulcerative-colitis.html</guid>
		</item>	
				<item>
			<title>Chugai to invest over Â¥ 50 B to build new biomanufacturing facilities in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22531/chugai-to-invest-over-50-b-to-build-new-biomanufacturing-facilities-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22531/chugai-to-invest-over-50-b-to-build-new-biomanufacturing-facilities-in-japan.html</link>
			<pubDate>Thu, 01 Jun 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22531.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22531/chugai-to-invest-over-50-b-to-build-new-biomanufacturing-facilities-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Meiji Seika Pharma expands CMO business in India </title>
			<atom:link href="https://biospectrumasia.com/news/50/22525/japans-meiji-seika-pharma-expands-cmo-business-in-india-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22525/japans-meiji-seika-pharma-expands-cmo-business-in-india-.html</link>
			<pubDate>Wed, 31 May 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22525.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22525/japans-meiji-seika-pharma-expands-cmo-business-in-india-.html</guid>
		</item>	
				<item>
			<title>Lunit and Japan National Cancer Center Hospital East partner in AI pathology </title>
			<atom:link href="https://biospectrumasia.com/news/50/22520/lunit-and-japan-national-cancer-center-hospital-east-partner-in-ai-pathology-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22520/lunit-and-japan-national-cancer-center-hospital-east-partner-in-ai-pathology-.html</link>
			<pubDate>Wed, 31 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/32-22520.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22520/lunit-and-japan-national-cancer-center-hospital-east-partner-in-ai-pathology-.html</guid>
		</item>	
				<item>
			<title>Chugai&#039;s FoundationOne Liquid gets approval as companion diagnostics in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22519/chugais-foundationone-liquid-gets-approval-as-companion-diagnostics-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22519/chugais-foundationone-liquid-gets-approval-as-companion-diagnostics-in-japan.html</link>
			<pubDate>Tue, 30 May 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22519/chugais-foundationone-liquid-gets-approval-as-companion-diagnostics-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu signs comprehensive collaboration agreement with Osaka University</title>
			<atom:link href="https://biospectrumasia.com/news/50/22491/japans-shimadzu-signs-comprehensive-collaboration-agreement-with-osaka-university.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22491/japans-shimadzu-signs-comprehensive-collaboration-agreement-with-osaka-university.html</link>
			<pubDate>Mon, 29 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22491.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22491/japans-shimadzu-signs-comprehensive-collaboration-agreement-with-osaka-university.html</guid>
		</item>	
				<item>
			<title>Astellas to sell its European manufacturing plant to Delpharm</title>
			<atom:link href="https://biospectrumasia.com/news/50/22504/astellas-to-sell-its-european-manufacturing-plant-to-delpharm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22504/astellas-to-sell-its-european-manufacturing-plant-to-delpharm.html</link>
			<pubDate>Fri, 26 May 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22504/astellas-to-sell-its-european-manufacturing-plant-to-delpharm.html</guid>
		</item>	
				<item>
			<title>Japan govt injects $200M to support third phase operations of GHIT Fund</title>
			<atom:link href="https://biospectrumasia.com/news/50/22495/japan-govt-injects-200m-to-support-third-phase-operations-of-ghit-fund.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22495/japan-govt-injects-200m-to-support-third-phase-operations-of-ghit-fund.html</link>
			<pubDate>Fri, 26 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22495.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22495/japan-govt-injects-200m-to-support-third-phase-operations-of-ghit-fund.html</guid>
		</item>	
				<item>
			<title>Catalent adds new cryogenic capabilities at Japan facility to support cell &amp; gene therapy development</title>
			<atom:link href="https://biospectrumasia.com/news/50/22492/catalent-adds-new-cryogenic-capabilities-at-japan-facility-to-support-cell-gene-therapy-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22492/catalent-adds-new-cryogenic-capabilities-at-japan-facility-to-support-cell-gene-therapy-development.html</link>
			<pubDate>Thu, 25 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/catalent-22492.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22492/catalent-adds-new-cryogenic-capabilities-at-japan-facility-to-support-cell-gene-therapy-development.html</guid>
		</item>	
				<item>
			<title>US-based startup KSQ inks immuno-oncology deal worth $510 M with Japan&#039;s Takeda Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/22467/us-based-startup-ksq-inks-immuno-oncology-deal-worth-510-m-with-japans-takeda-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22467/us-based-startup-ksq-inks-immuno-oncology-deal-worth-510-m-with-japans-takeda-pharma.html</link>
			<pubDate>Fri, 19 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-22467.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22467/us-based-startup-ksq-inks-immuno-oncology-deal-worth-510-m-with-japans-takeda-pharma.html</guid>
		</item>	
				<item>
			<title>Biodrug Design Accelerator platform launches in Japan to accelerate peptide drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/50/22453/biodrug-design-accelerator-platform-launches-in-japan-to-accelerate-peptide-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22453/biodrug-design-accelerator-platform-launches-in-japan-to-accelerate-peptide-drug-discovery-research.html</link>
			<pubDate>Thu, 18 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22453.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22453/biodrug-design-accelerator-platform-launches-in-japan-to-accelerate-peptide-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>Cybersecurity: The Next Frontier for Protecting Patient Safety</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/22464/cybersecurity-the-next-frontier-for-protecting-patient-safety.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/22464/cybersecurity-the-next-frontier-for-protecting-patient-safety.html</link>
			<pubDate>Thu, 18 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vijay_higher_res-22464.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/22464/cybersecurity-the-next-frontier-for-protecting-patient-safety.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma enters into cancer research collaboration with Sony Corporation</title>
			<atom:link href="https://biospectrumasia.com/news/50/22452/japans-astellas-pharma-enters-into-cancer-research-collaboration-with-sony-corporation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22452/japans-astellas-pharma-enters-into-cancer-research-collaboration-with-sony-corporation.html</link>
			<pubDate>Wed, 17 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22452.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22452/japans-astellas-pharma-enters-into-cancer-research-collaboration-with-sony-corporation.html</guid>
		</item>	
				<item>
			<title>Japan suggests language analysis to detect early onset of Parkinson&#039;s disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/22437/japan-suggests-language-analysis-to-detect-early-onset-of-parkinsons-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22437/japan-suggests-language-analysis-to-detect-early-onset-of-parkinsons-disease.html</link>
			<pubDate>Mon, 15 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/43-22437.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22437/japan-suggests-language-analysis-to-detect-early-onset-of-parkinsons-disease.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka Pharma gets US FDA nod for drug to treat agitation during Alzheimer&#039;s</title>
			<atom:link href="https://biospectrumasia.com/news/50/22431/japans-otsuka-pharma-gets-us-fda-nod-for-drug-to-treat-agitation-during-alzheimers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22431/japans-otsuka-pharma-gets-us-fda-nod-for-drug-to-treat-agitation-during-alzheimers.html</link>
			<pubDate>Fri, 12 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22431.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22431/japans-otsuka-pharma-gets-us-fda-nod-for-drug-to-treat-agitation-during-alzheimers.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT Fund secures $24 M pledge from Bill &amp; Melinda Gates Foundation over 3 yrs</title>
			<atom:link href="https://biospectrumasia.com/news/50/22416/japans-ghit-fund-secures-24-m-pledge-from-bill-melinda-gates-foundation-over-3-yrs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22416/japans-ghit-fund-secures-24-m-pledge-from-bill-melinda-gates-foundation-over-3-yrs.html</link>
			<pubDate>Wed, 10 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-22416.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22416/japans-ghit-fund-secures-24-m-pledge-from-bill-melinda-gates-foundation-over-3-yrs.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/22413/japans-eisai-inks-2-b-oncology-deal-with-china-based-startup-bliss-biopharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22413/japans-eisai-inks-2-b-oncology-deal-with-china-based-startup-bliss-biopharma.html</link>
			<pubDate>Mon, 08 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-22413.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22413/japans-eisai-inks-2-b-oncology-deal-with-china-based-startup-bliss-biopharma.html</guid>
		</item>	
				<item>
			<title>Japanese startup Ubie expands rare diseases partnership with Takeda </title>
			<atom:link href="https://biospectrumasia.com/news/50/22401/japanese-startup-ubie-expands-rare-diseases-partnership-with-takeda-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22401/japanese-startup-ubie-expands-rare-diseases-partnership-with-takeda-.html</link>
			<pubDate>Fri, 05 May 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/32-22401.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22401/japanese-startup-ubie-expands-rare-diseases-partnership-with-takeda-.html</guid>
		</item>	
				<item>
			<title>Precision Oncology Is Redefining Cancer Care At All Stages Of The Disease </title>
			<atom:link href="https://biospectrumasia.com/opinion/50/22396/precision-oncology-is-redefining-cancer-care-at-all-stages-of-the-disease-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/22396/precision-oncology-is-redefining-cancer-care-at-all-stages-of-the-disease-.html</link>
			<pubDate>Thu, 04 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/guardant_health_amea_j_simranjit_singh_ceo_headshot_-22396.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/22396/precision-oncology-is-redefining-cancer-care-at-all-stages-of-the-disease-.html</guid>
		</item>	
				<item>
			<title>FDA approves Otsuka&#039;s ABILIFY for schizophrenia and bipolar disorder </title>
			<atom:link href="https://biospectrumasia.com/news/50/22375/fda-approves-otsukas-abilify-for-schizophrenia-and-bipolar-disorder-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22375/fda-approves-otsukas-abilify-for-schizophrenia-and-bipolar-disorder-.html</link>
			<pubDate>Tue, 02 May 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22375/fda-approves-otsukas-abilify-for-schizophrenia-and-bipolar-disorder-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma acquires US-based Iveric Bio for $5.9 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/22364/japans-astellas-pharma-acquires-us-based-iveric-bio-for-5-9-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22364/japans-astellas-pharma-acquires-us-based-iveric-bio-for-5-9-b.html</link>
			<pubDate>Mon, 01 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22364.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22364/japans-astellas-pharma-acquires-us-based-iveric-bio-for-5-9-b.html</guid>
		</item>	
				<item>
			<title>US firm Healint announces AI-based study of migraine diagnosis in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22357/us-firm-healint-announces-ai-based-study-of-migraine-diagnosis-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22357/us-firm-healint-announces-ai-based-study-of-migraine-diagnosis-in-japan.html</link>
			<pubDate>Fri, 28 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mig-22357.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22357/us-firm-healint-announces-ai-based-study-of-migraine-diagnosis-in-japan.html</guid>
		</item>	
				<item>
			<title>Taiwan approves Japan-based Chugai Pharma&#039;s drug for COVID-19 treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/22342/taiwan-approves-japan-based-chugai-pharmas-drug-for-covid-19-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22342/taiwan-approves-japan-based-chugai-pharmas-drug-for-covid-19-treatment.html</link>
			<pubDate>Wed, 26 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22342.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22342/taiwan-approves-japan-based-chugai-pharmas-drug-for-covid-19-treatment.html</guid>
		</item>	
				<item>
			<title>Medtech firm Murata Vios plans to expand to Middle East, Europe &amp; Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22350/medtech-firm-murata-vios-plans-to-expand-to-middle-east-europe-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22350/medtech-firm-murata-vios-plans-to-expand-to-middle-east-europe-japan.html</link>
			<pubDate>Wed, 26 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amiy-22350.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22350/medtech-firm-murata-vios-plans-to-expand-to-middle-east-europe-japan.html</guid>
		</item>	
				<item>
			<title>Qiagen launches QIAstat-Dx in Japan with respiratory panel for syndromic testing</title>
			<atom:link href="https://biospectrumasia.com/news/50/22337/qiagen-launches-qiastat-dx-in-japan-with-respiratory-panel-for-syndromic-testing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22337/qiagen-launches-qiastat-dx-in-japan-with-respiratory-panel-for-syndromic-testing.html</link>
			<pubDate>Tue, 25 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/qiagen-22337.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22337/qiagen-launches-qiastat-dx-in-japan-with-respiratory-panel-for-syndromic-testing.html</guid>
		</item>	
				<item>
			<title>Nippon Express opens pharma logistics centre in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/22318/nippon-express-opens-pharma-logistics-centre-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22318/nippon-express-opens-pharma-logistics-centre-in-us.html</link>
			<pubDate>Fri, 21 Apr 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22318.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22318/nippon-express-opens-pharma-logistics-centre-in-us.html</guid>
		</item>	
				<item>
			<title>Eli Lilly and Mitsubishi Tanabe launch new diabetes treatment in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/22316/eli-lilly-and-mitsubishi-tanabe-launch-new-diabetes-treatment-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22316/eli-lilly-and-mitsubishi-tanabe-launch-new-diabetes-treatment-in-japan-.html</link>
			<pubDate>Fri, 21 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-22316.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22316/eli-lilly-and-mitsubishi-tanabe-launch-new-diabetes-treatment-in-japan-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shin Nippon Biomedical Labs buys American firm Satsuma Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/22305/japans-shin-nippon-biomedical-labs-buys-american-firm-satsuma-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22305/japans-shin-nippon-biomedical-labs-buys-american-firm-satsuma-pharma.html</link>
			<pubDate>Thu, 20 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22305.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22305/japans-shin-nippon-biomedical-labs-buys-american-firm-satsuma-pharma.html</guid>
		</item>	
				<item>
			<title>Shimadzu unveils tool to evaluate thermal stability of nucleic acid pharmaceuticals</title>
			<atom:link href="https://biospectrumasia.com/news/50/22297/shimadzu-unveils-tool-to-evaluate-thermal-stability-of-nucleic-acid-pharmaceuticals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22297/shimadzu-unveils-tool-to-evaluate-thermal-stability-of-nucleic-acid-pharmaceuticals.html</link>
			<pubDate>Tue, 18 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-22297.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22297/shimadzu-unveils-tool-to-evaluate-thermal-stability-of-nucleic-acid-pharmaceuticals.html</guid>
		</item>	
				<item>
			<title>Japan further promotes medical applications of induced pluripotent stem cells</title>
			<atom:link href="https://biospectrumasia.com/news/50/22283/japan-further-promotes-medical-applications-of-induced-pluripotent-stem-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22283/japan-further-promotes-medical-applications-of-induced-pluripotent-stem-cells.html</link>
			<pubDate>Fri, 14 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22283.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22283/japan-further-promotes-medical-applications-of-induced-pluripotent-stem-cells.html</guid>
		</item>	
				<item>
			<title>US-based Establishment Labs launches breast aesthetics technology in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22275/us-based-establishment-labs-launches-breast-aesthetics-technology-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22275/us-based-establishment-labs-launches-breast-aesthetics-technology-in-japan.html</link>
			<pubDate>Thu, 13 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22275.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22275/us-based-establishment-labs-launches-breast-aesthetics-technology-in-japan.html</guid>
		</item>	
				<item>
			<title>UK-based medtech firm Smith+Nephew brings new technology into Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/22267/uk-based-medtech-firm-smithnephew-brings-new-technology-into-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22267/uk-based-medtech-firm-smithnephew-brings-new-technology-into-japan-.html</link>
			<pubDate>Wed, 12 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medtech-22267.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22267/uk-based-medtech-firm-smithnephew-brings-new-technology-into-japan-.html</guid>
		</item>	
				<item>
			<title>Don&#039;t Let Clinical Supply Risks Derail Your Success: Join Our Webinar</title>
			<atom:link href="https://biospectrumasia.com/news/50/22272/dont-let-clinical-supply-risks-derail-your-success-join-our-webinar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22272/dont-let-clinical-supply-risks-derail-your-success-join-our-webinar.html</link>
			<pubDate>Wed, 12 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2023_04_12_at_10_25_48_am-22272.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22272/dont-let-clinical-supply-risks-derail-your-success-join-our-webinar.html</guid>
		</item>	
				<item>
			<title>JCR, Sumitomo enter into copromotion pact for Izcargo in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22258/jcr-sumitomo-enter-into-copromotion-pact-for-izcargo-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22258/jcr-sumitomo-enter-into-copromotion-pact-for-izcargo-in-japan.html</link>
			<pubDate>Mon, 10 Apr 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22258/jcr-sumitomo-enter-into-copromotion-pact-for-izcargo-in-japan.html</guid>
		</item>	
				<item>
			<title>Shimadzu launches corporate venture capital to invest in startups</title>
			<atom:link href="https://biospectrumasia.com/news/50/22263/shimadzu-launches-corporate-venture-capital-to-invest-in-startups.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22263/shimadzu-launches-corporate-venture-capital-to-invest-in-startups.html</link>
			<pubDate>Mon, 10 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22263.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22263/shimadzu-launches-corporate-venture-capital-to-invest-in-startups.html</guid>
		</item>	
				<item>
			<title>Japan-based EIZO Corporation launches new subsidiary in India to meet healthcare needs</title>
			<atom:link href="https://biospectrumasia.com/news/50/22264/japan-based-eizo-corporation-launches-new-subsidiary-in-india-to-meet-healthcare-needs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22264/japan-based-eizo-corporation-launches-new-subsidiary-in-india-to-meet-healthcare-needs.html</link>
			<pubDate>Mon, 10 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22264.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22264/japan-based-eizo-corporation-launches-new-subsidiary-in-india-to-meet-healthcare-needs.html</guid>
		</item>	
				<item>
			<title>Eisai invests Â¥ 8.5 B to revamp Tsukuba Research Laboratories in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22244/eisai-invests-8-5-b-to-revamp-tsukuba-research-laboratories-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22244/eisai-invests-8-5-b-to-revamp-tsukuba-research-laboratories-in-japan.html</link>
			<pubDate>Sat, 08 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22244.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22244/eisai-invests-8-5-b-to-revamp-tsukuba-research-laboratories-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu to develop integrated platform for lipid analysis</title>
			<atom:link href="https://biospectrumasia.com/news/50/22253/japans-shimadzu-to-develop-integrated-platform-for-lipid-analysis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22253/japans-shimadzu-to-develop-integrated-platform-for-lipid-analysis.html</link>
			<pubDate>Sat, 08 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-22253.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22253/japans-shimadzu-to-develop-integrated-platform-for-lipid-analysis.html</guid>
		</item>	
				<item>
			<title>CEPI appoints Dr Yasuhiro Suzuki to the Board</title>
			<atom:link href="https://biospectrumasia.com/news/50/22255/cepi-appoints-dr-yasuhiro-suzuki-to-the-board.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22255/cepi-appoints-dr-yasuhiro-suzuki-to-the-board.html</link>
			<pubDate>Sat, 08 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/suzuki-22255.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22255/cepi-appoints-dr-yasuhiro-suzuki-to-the-board.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PHC Corporation to work on non-melanoma skin cancer detection</title>
			<atom:link href="https://biospectrumasia.com/news/50/22227/japans-phc-corporation-to-work-on-non-melanoma-skin-cancer-detection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22227/japans-phc-corporation-to-work-on-non-melanoma-skin-cancer-detection.html</link>
			<pubDate>Wed, 05 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22227.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22227/japans-phc-corporation-to-work-on-non-melanoma-skin-cancer-detection.html</guid>
		</item>	
				<item>
			<title>AGC Biologics inks exosome agreement with Jikei University in Japan for Idiopathic Pulmonary Fibrosis project</title>
			<atom:link href="https://biospectrumasia.com/news/50/22224/agc-biologics-inks-exosome-agreement-with-jikei-university-in-japan-for-idiopathic-pulmonary-fibrosis-project.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22224/agc-biologics-inks-exosome-agreement-with-jikei-university-in-japan-for-idiopathic-pulmonary-fibrosis-project.html</link>
			<pubDate>Tue, 04 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/exo-22224.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22224/agc-biologics-inks-exosome-agreement-with-jikei-university-in-japan-for-idiopathic-pulmonary-fibrosis-project.html</guid>
		</item>	
				<item>
			<title>Japanese firm Takeda Pharma inks $415 M deal for celiac disease research</title>
			<atom:link href="https://biospectrumasia.com/news/50/22214/japanese-firm-takeda-pharma-inks-415-m-deal-for-celiac-disease-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22214/japanese-firm-takeda-pharma-inks-415-m-deal-for-celiac-disease-research.html</link>
			<pubDate>Mon, 03 Apr 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/celiac-22214.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22214/japanese-firm-takeda-pharma-inks-415-m-deal-for-celiac-disease-research.html</guid>
		</item>	
				<item>
			<title>Fujifilm transfers EMR related business to PHC Holdings&#039; subsidiary in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22203/fujifilm-transfers-emr-related-business-to-phc-holdings-subsidiary-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22203/fujifilm-transfers-emr-related-business-to-phc-holdings-subsidiary-in-japan.html</link>
			<pubDate>Mon, 03 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_133503068-22203.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22203/fujifilm-transfers-emr-related-business-to-phc-holdings-subsidiary-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s NEC establishes European subsidiaries for strengthening global AI drug development biz</title>
			<atom:link href="https://biospectrumasia.com/news/50/22201/japans-nec-establishes-european-subsidiaries-for-strengthening-global-ai-drug-development-biz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22201/japans-nec-establishes-european-subsidiaries-for-strengthening-global-ai-drug-development-biz.html</link>
			<pubDate>Fri, 31 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22201.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22201/japans-nec-establishes-european-subsidiaries-for-strengthening-global-ai-drug-development-biz.html</guid>
		</item>	
				<item>
			<title>Eppendorf adds digital documentation to connected electronic pipette system</title>
			<atom:link href="https://biospectrumasia.com/news/50/22212/eppendorf-adds-digital-documentation-to-connected-electronic-pipette-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22212/eppendorf-adds-digital-documentation-to-connected-electronic-pipette-system.html</link>
			<pubDate>Fri, 31 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eppendorf_se_press_image_pipette_manager_2-22212.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22212/eppendorf-adds-digital-documentation-to-connected-electronic-pipette-system.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kaken Pharma inks drug discovery collaboration with bitBiome for infectious diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/22187/japans-kaken-pharma-inks-drug-discovery-collaboration-with-bitbiome-for-infectious-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22187/japans-kaken-pharma-inks-drug-discovery-collaboration-with-bitbiome-for-infectious-diseases.html</link>
			<pubDate>Thu, 30 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-22187.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22187/japans-kaken-pharma-inks-drug-discovery-collaboration-with-bitbiome-for-infectious-diseases.html</guid>
		</item>	
				<item>
			<title>International dementia research collaboration to address key health challenge in Australia and Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22188/international-dementia-research-collaboration-to-address-key-health-challenge-in-australia-and-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22188/international-dementia-research-collaboration-to-address-key-health-challenge-in-australia-and-japan.html</link>
			<pubDate>Thu, 30 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dem-22188.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22188/international-dementia-research-collaboration-to-address-key-health-challenge-in-australia-and-japan.html</guid>
		</item>	
				<item>
			<title>GHIT fund in Japan invests $2.9 M for treatment of neglected tropical diseases </title>
			<atom:link href="https://biospectrumasia.com/news/50/22189/ghit-fund-in-japan-invests-2-9-m-for-treatment-of-neglected-tropical-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22189/ghit-fund-in-japan-invests-2-9-m-for-treatment-of-neglected-tropical-diseases-.html</link>
			<pubDate>Thu, 30 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ntd-22189.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22189/ghit-fund-in-japan-invests-2-9-m-for-treatment-of-neglected-tropical-diseases-.html</guid>
		</item>	
				<item>
			<title>Astellas and Roche to develop integrated diabetes self-management solution in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22182/astellas-and-roche-to-develop-integrated-diabetes-self-management-solution-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22182/astellas-and-roche-to-develop-integrated-diabetes-self-management-solution-in-japan.html</link>
			<pubDate>Wed, 29 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-22182.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22182/astellas-and-roche-to-develop-integrated-diabetes-self-management-solution-in-japan.html</guid>
		</item>	
				<item>
			<title>Fujitsu launches new cloud-based platform for healthcare sector in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22172/fujitsu-launches-new-cloud-based-platform-for-healthcare-sector-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22172/fujitsu-launches-new-cloud-based-platform-for-healthcare-sector-in-japan.html</link>
			<pubDate>Tue, 28 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22172.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22172/fujitsu-launches-new-cloud-based-platform-for-healthcare-sector-in-japan.html</guid>
		</item>	
				<item>
			<title>Taiwanese startup Health2Sync adds more data points to Japan&#039;s personal health record initiative</title>
			<atom:link href="https://biospectrumasia.com/news/50/22175/taiwanese-startup-health2sync-adds-more-data-points-to-japans-personal-health-record-initiative.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22175/taiwanese-startup-health2sync-adds-more-data-points-to-japans-personal-health-record-initiative.html</link>
			<pubDate>Tue, 28 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mallya-22175.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22175/taiwanese-startup-health2sync-adds-more-data-points-to-japans-personal-health-record-initiative.html</guid>
		</item>	
				<item>
			<title>Takeda to invest Â¥100 B in new facility for plasma-derived therapies in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22161/takeda-to-invest-100-b-in-new-facility-for-plasma-derived-therapies-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22161/takeda-to-invest-100-b-in-new-facility-for-plasma-derived-therapies-in-japan.html</link>
			<pubDate>Mon, 27 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/plasma-22161.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22161/takeda-to-invest-100-b-in-new-facility-for-plasma-derived-therapies-in-japan.html</guid>
		</item>	
				<item>
			<title>Ono Pharma&#039;s Opdivo gets South Korean approval for 1st line esophageal cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/22153/ono-pharmas-opdivo-gets-south-korean-approval-for-1st-line-esophageal-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22153/ono-pharmas-opdivo-gets-south-korean-approval-for-1st-line-esophageal-cancer.html</link>
			<pubDate>Fri, 24 Mar 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22153/ono-pharmas-opdivo-gets-south-korean-approval-for-1st-line-esophageal-cancer.html</guid>
		</item>	
				<item>
			<title>Japanese startup Jolly Good and Harvard University collaborate on medical VR content</title>
			<atom:link href="https://biospectrumasia.com/news/50/22148/japanese-startup-jolly-good-and-harvard-university-collaborate-on-medical-vr-content.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22148/japanese-startup-jolly-good-and-harvard-university-collaborate-on-medical-vr-content.html</link>
			<pubDate>Fri, 24 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jolly-22148.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22148/japanese-startup-jolly-good-and-harvard-university-collaborate-on-medical-vr-content.html</guid>
		</item>	
				<item>
			<title>Japan to provide comprehensive end-to-end linen management services to hospitals in India</title>
			<atom:link href="https://biospectrumasia.com/news/50/22129/japan-to-provide-comprehensive-end-to-end-linen-management-services-to-hospitals-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22129/japan-to-provide-comprehensive-end-to-end-linen-management-services-to-hospitals-in-india.html</link>
			<pubDate>Tue, 21 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-22129.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22129/japan-to-provide-comprehensive-end-to-end-linen-management-services-to-hospitals-in-india.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s dengue vaccine receives first approval  in Latin America</title>
			<atom:link href="https://biospectrumasia.com/news/50/22108/takedas-dengue-vaccine-receives-first-approval-in-latin-america.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22108/takedas-dengue-vaccine-receives-first-approval-in-latin-america.html</link>
			<pubDate>Wed, 15 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22108.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22108/takedas-dengue-vaccine-receives-first-approval-in-latin-america.html</guid>
		</item>	
				<item>
			<title>GHIT Fund invests Â¥ 260 M for new malaria drug development by Japanese firms</title>
			<atom:link href="https://biospectrumasia.com/news/50/22094/ghit-fund-invests-260-m-for-new-malaria-drug-development-by-japanese-firms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22094/ghit-fund-invests-260-m-for-new-malaria-drug-development-by-japanese-firms.html</link>
			<pubDate>Mon, 13 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22094.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22094/ghit-fund-invests-260-m-for-new-malaria-drug-development-by-japanese-firms.html</guid>
		</item>	
				<item>
			<title>AriBio &amp; Fujirebio to advance biomarker development for Alzheimer&#039;s Disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/22084/aribio-fujirebio-to-advance-biomarker-development-for-alzheimers-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22084/aribio-fujirebio-to-advance-biomarker-development-for-alzheimers-disease.html</link>
			<pubDate>Fri, 10 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22084.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22084/aribio-fujirebio-to-advance-biomarker-development-for-alzheimers-disease.html</guid>
		</item>	
				<item>
			<title>Japanese firm Sumitomo invests in radiopharmaceutical startup Alpha Fusion</title>
			<atom:link href="https://biospectrumasia.com/news/50/22079/japanese-firm-sumitomo-invests-in-radiopharmaceutical-startup-alpha-fusion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22079/japanese-firm-sumitomo-invests-in-radiopharmaceutical-startup-alpha-fusion.html</link>
			<pubDate>Thu, 09 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-22079.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22079/japanese-firm-sumitomo-invests-in-radiopharmaceutical-startup-alpha-fusion.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Teijin Pharma inks $230 M deal with Novartis for kidney diseases treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/22070/japans-teijin-pharma-inks-230-m-deal-with-novartis-for-kidney-diseases-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22070/japans-teijin-pharma-inks-230-m-deal-with-novartis-for-kidney-diseases-treatment.html</link>
			<pubDate>Wed, 08 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kidney-22070.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22070/japans-teijin-pharma-inks-230-m-deal-with-novartis-for-kidney-diseases-treatment.html</guid>
		</item>	
				<item>
			<title>Kyorin licenses vibegron to Sumitomo Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/22067/kyorin-licenses-vibegron-to-sumitomo-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22067/kyorin-licenses-vibegron-to-sumitomo-pharma.html</link>
			<pubDate>Tue, 07 Mar 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22067/kyorin-licenses-vibegron-to-sumitomo-pharma.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Saitama Medical University International Medical Center joins the TriNetX Network to study rare diseases </title>
			<atom:link href="https://biospectrumasia.com/news/50/22066/japans-saitama-medical-university-international-medical-center-joins-the-trinetx-network-to-study-rare-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22066/japans-saitama-medical-university-international-medical-center-joins-the-trinetx-network-to-study-rare-diseases-.html</link>
			<pubDate>Tue, 07 Mar 2023 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22066/japans-saitama-medical-university-international-medical-center-joins-the-trinetx-network-to-study-rare-diseases-.html</guid>
		</item>	
				<item>
			<title>Japan discovers potential treatment of autoimmune diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/22053/japan-discovers-potential-treatment-of-autoimmune-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22053/japan-discovers-potential-treatment-of-autoimmune-diseases.html</link>
			<pubDate>Tue, 07 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-22053.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22053/japan-discovers-potential-treatment-of-autoimmune-diseases.html</guid>
		</item>	
				<item>
			<title>Medical Technology Association of India recommends Japan as â€œChina+1 alternative in MedTech Importsâ€</title>
			<atom:link href="https://biospectrumasia.com/news/50/22041/medical-technology-association-of-india-recommends-japan-as-china1-alternative-in-medtech-imports.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22041/medical-technology-association-of-india-recommends-japan-as-china1-alternative-in-medtech-imports.html</link>
			<pubDate>Fri, 03 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22041.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22041/medical-technology-association-of-india-recommends-japan-as-china1-alternative-in-medtech-imports.html</guid>
		</item>	
				<item>
			<title>Biogen terminates multiple sclerosis (MS) pact with Eisai in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22042/biogen-terminates-multiple-sclerosis-ms-pact-with-eisai-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22042/biogen-terminates-multiple-sclerosis-ms-pact-with-eisai-in-japan.html</link>
			<pubDate>Fri, 03 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22042.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22042/biogen-terminates-multiple-sclerosis-ms-pact-with-eisai-in-japan.html</guid>
		</item>	
				<item>
			<title>C2i Genomics, Riken Genesis expand AI-powered cancer detection technology across Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/22049/c2i-genomics-riken-genesis-expand-ai-powered-cancer-detection-technology-across-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22049/c2i-genomics-riken-genesis-expand-ai-powered-cancer-detection-technology-across-japan.html</link>
			<pubDate>Fri, 03 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-22049.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22049/c2i-genomics-riken-genesis-expand-ai-powered-cancer-detection-technology-across-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT strengthens ties with Unitaid to improve access to critical health tools</title>
			<atom:link href="https://biospectrumasia.com/news/50/22035/japans-ghit-strengthens-ties-with-unitaid-to-improve-access-to-critical-health-tools.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22035/japans-ghit-strengthens-ties-with-unitaid-to-improve-access-to-critical-health-tools.html</link>
			<pubDate>Thu, 02 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22035.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22035/japans-ghit-strengthens-ties-with-unitaid-to-improve-access-to-critical-health-tools.html</guid>
		</item>	
				<item>
			<title>Japanese researchers identify three intestinal bacteria found in dementia with Lewy bodies</title>
			<atom:link href="https://biospectrumasia.com/news/50/22029/japanese-researchers-identify-three-intestinal-bacteria-found-in-dementia-with-lewy-bodies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22029/japanese-researchers-identify-three-intestinal-bacteria-found-in-dementia-with-lewy-bodies.html</link>
			<pubDate>Wed, 01 Mar 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22029/japanese-researchers-identify-three-intestinal-bacteria-found-in-dementia-with-lewy-bodies.html</guid>
		</item>	
				<item>
			<title>Deprecated Yen attracts renewed international interest in Japanese pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/22030/deprecated-yen-attracts-renewed-international-interest-in-japanese-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22030/deprecated-yen-attracts-renewed-international-interest-in-japanese-pharma.html</link>
			<pubDate>Wed, 01 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cphi-22030.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22030/deprecated-yen-attracts-renewed-international-interest-in-japanese-pharma.html</guid>
		</item>	
				<item>
			<title>Japanese firm Mitsui &amp; Co. invests in American health tech company Koios Medical</title>
			<atom:link href="https://biospectrumasia.com/news/50/22022/japanese-firm-mitsui-co-invests-in-american-health-tech-company-koios-medical.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22022/japanese-firm-mitsui-co-invests-in-american-health-tech-company-koios-medical.html</link>
			<pubDate>Tue, 28 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22022.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22022/japanese-firm-mitsui-co-invests-in-american-health-tech-company-koios-medical.html</guid>
		</item>	
				<item>
			<title>Ono inks a deal with Cue Biopharma for autoimmune candidate </title>
			<atom:link href="https://biospectrumasia.com/news/50/22016/ono-inks-a-deal-with-cue-biopharma-for-autoimmune-candidate-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22016/ono-inks-a-deal-with-cue-biopharma-for-autoimmune-candidate-.html</link>
			<pubDate>Mon, 27 Feb 2023 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22016/ono-inks-a-deal-with-cue-biopharma-for-autoimmune-candidate-.html</guid>
		</item>	
				<item>
			<title>Japan bags new opportunity to improve healthcare system</title>
			<atom:link href="https://biospectrumasia.com/news/50/22011/japan-bags-new-opportunity-to-improve-healthcare-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22011/japan-bags-new-opportunity-to-improve-healthcare-system.html</link>
			<pubDate>Mon, 27 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-22011.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22011/japan-bags-new-opportunity-to-improve-healthcare-system.html</guid>
		</item>	
				<item>
			<title>Taiwan approves Ono Pharma&#039;s non-small cell lung cancer drug with chemotherapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/22000/taiwan-approves-ono-pharmas-non-small-cell-lung-cancer-drug-with-chemotherapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22000/taiwan-approves-ono-pharmas-non-small-cell-lung-cancer-drug-with-chemotherapy.html</link>
			<pubDate>Fri, 24 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-22000.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22000/taiwan-approves-ono-pharmas-non-small-cell-lung-cancer-drug-with-chemotherapy.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus buys Korean gastrointestinal stent firm Taewoong Medical for $370 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/22004/japans-olympus-buys-korean-gastrointestinal-stent-firm-taewoong-medical-for-370-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/22004/japans-olympus-buys-korean-gastrointestinal-stent-firm-taewoong-medical-for-370-m.html</link>
			<pubDate>Fri, 24 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stent-22004.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/22004/japans-olympus-buys-korean-gastrointestinal-stent-firm-taewoong-medical-for-370-m.html</guid>
		</item>	
				<item>
			<title>Ajinomoto Bio-Pharma Services successfully develops highly functional ancestral RNA ligase </title>
			<atom:link href="https://biospectrumasia.com/news/50/21994/ajinomoto-bio-pharma-services-successfully-develops-highly-functional-ancestral-rna-ligase-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21994/ajinomoto-bio-pharma-services-successfully-develops-highly-functional-ancestral-rna-ligase-.html</link>
			<pubDate>Thu, 23 Feb 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21994/ajinomoto-bio-pharma-services-successfully-develops-highly-functional-ancestral-rna-ligase-.html</guid>
		</item>	
				<item>
			<title>Japanese firms Teijin and Axcelead establish joint venture for drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/50/21980/japanese-firms-teijin-and-axcelead-establish-joint-venture-for-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21980/japanese-firms-teijin-and-axcelead-establish-joint-venture-for-drug-discovery-research.html</link>
			<pubDate>Thu, 23 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_309940142-21980.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21980/japanese-firms-teijin-and-axcelead-establish-joint-venture-for-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>3H Medi Solution to expand delivery of decentralized clinical trials in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21987/3h-medi-solution-to-expand-delivery-of-decentralized-clinical-trials-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21987/3h-medi-solution-to-expand-delivery-of-decentralized-clinical-trials-in-japan.html</link>
			<pubDate>Wed, 22 Feb 2023 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21987/3h-medi-solution-to-expand-delivery-of-decentralized-clinical-trials-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese pharma firm Eisai dissolves joint venture with Italy&#039;s Bracco Imaging</title>
			<atom:link href="https://biospectrumasia.com/news/50/21976/japanese-pharma-firm-eisai-dissolves-joint-venture-with-italys-bracco-imaging.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21976/japanese-pharma-firm-eisai-dissolves-joint-venture-with-italys-bracco-imaging.html</link>
			<pubDate>Tue, 21 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_172626641-21976.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21976/japanese-pharma-firm-eisai-dissolves-joint-venture-with-italys-bracco-imaging.html</guid>
		</item>	
				<item>
			<title>Capricor Therapeutics inks $100 M deal with Nippon Shinyaku for DMD treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21964/capricor-therapeutics-inks-100-m-deal-with-nippon-shinyaku-for-dmd-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21964/capricor-therapeutics-inks-100-m-deal-with-nippon-shinyaku-for-dmd-treatment-in-japan.html</link>
			<pubDate>Mon, 20 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21964.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21964/capricor-therapeutics-inks-100-m-deal-with-nippon-shinyaku-for-dmd-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan approves Susmed&#039;s insomnia app</title>
			<atom:link href="https://biospectrumasia.com/news/50/21972/japan-approves-susmeds-insomnia-app.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21972/japan-approves-susmeds-insomnia-app.html</link>
			<pubDate>Sun, 19 Feb 2023 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21972/japan-approves-susmeds-insomnia-app.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GAIA BioMedicine inks a cancer therapeutics deal with French firm TreeFrog Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/21956/japans-gaia-biomedicine-inks-a-cancer-therapeutics-deal-with-french-firm-treefrog-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21956/japans-gaia-biomedicine-inks-a-cancer-therapeutics-deal-with-french-firm-treefrog-therapeutics.html</link>
			<pubDate>Thu, 16 Feb 2023 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21956/japans-gaia-biomedicine-inks-a-cancer-therapeutics-deal-with-french-firm-treefrog-therapeutics.html</guid>
		</item>	
				<item>
			<title>Fujifilm explores stem cells therapy for meniscus injuries</title>
			<atom:link href="https://biospectrumasia.com/news/50/21940/fujifilm-explores-stem-cells-therapy-for-meniscus-injuries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21940/fujifilm-explores-stem-cells-therapy-for-meniscus-injuries.html</link>
			<pubDate>Tue, 14 Feb 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21940/fujifilm-explores-stem-cells-therapy-for-meniscus-injuries.html</guid>
		</item>	
				<item>
			<title>Japan develops method to design new peptide therapeutics for combating antibiotic resistance</title>
			<atom:link href="https://biospectrumasia.com/news/50/21934/japan-develops-method-to-design-new-peptide-therapeutics-for-combating-antibiotic-resistance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21934/japan-develops-method-to-design-new-peptide-therapeutics-for-combating-antibiotic-resistance.html</link>
			<pubDate>Mon, 13 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-21934.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21934/japan-develops-method-to-design-new-peptide-therapeutics-for-combating-antibiotic-resistance.html</guid>
		</item>	
				<item>
			<title>Takeda completes acquisition of Nimbus Therapeutics&#039; TYK2 program subsidiary</title>
			<atom:link href="https://biospectrumasia.com/news/50/21928/takeda-completes-acquisition-of-nimbus-therapeutics-tyk2-program-subsidiary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21928/takeda-completes-acquisition-of-nimbus-therapeutics-tyk2-program-subsidiary.html</link>
			<pubDate>Fri, 10 Feb 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21928/takeda-completes-acquisition-of-nimbus-therapeutics-tyk2-program-subsidiary.html</guid>
		</item>	
				<item>
			<title>Japan develops world&#039;s first optical computing AI algorithm inspired by human brain </title>
			<atom:link href="https://biospectrumasia.com/news/50/21916/japan-develops-worlds-first-optical-computing-ai-algorithm-inspired-by-human-brain-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21916/japan-develops-worlds-first-optical-computing-ai-algorithm-inspired-by-human-brain-.html</link>
			<pubDate>Thu, 09 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-21916.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21916/japan-develops-worlds-first-optical-computing-ai-algorithm-inspired-by-human-brain-.html</guid>
		</item>	
				<item>
			<title>Astellas Pharma announces change of President and CEO</title>
			<atom:link href="https://biospectrumasia.com/news/50/21913/astellas-pharma-announces-change-of-president-and-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21913/astellas-pharma-announces-change-of-president-and-ceo.html</link>
			<pubDate>Wed, 08 Feb 2023 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astelllas-21913.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21913/astellas-pharma-announces-change-of-president-and-ceo.html</guid>
		</item>	
				<item>
			<title>Japan &amp; Kenya develop biometric-based vaccination management system for newborns</title>
			<atom:link href="https://biospectrumasia.com/news/50/21907/japan-kenya-develop-biometric-based-vaccination-management-system-for-newborns.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21907/japan-kenya-develop-biometric-based-vaccination-management-system-for-newborns.html</link>
			<pubDate>Wed, 08 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kenya-21907.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21907/japan-kenya-develop-biometric-based-vaccination-management-system-for-newborns.html</guid>
		</item>	
				<item>
			<title>Takeda gets USFDA approval for paediatric heart drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/21894/takeda-gets-usfda-approval-for-paediatric-heart-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21894/takeda-gets-usfda-approval-for-paediatric-heart-drug.html</link>
			<pubDate>Mon, 06 Feb 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21894/takeda-gets-usfda-approval-for-paediatric-heart-drug.html</guid>
		</item>	
				<item>
			<title>Japanese firm Mitsubishi Tanabe stops commercialisation of COVID-19 vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/21885/japanese-firm-mitsubishi-tanabe-stops-commercialisation-of-covid-19-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21885/japanese-firm-mitsubishi-tanabe-stops-commercialisation-of-covid-19-vaccine.html</link>
			<pubDate>Mon, 06 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-21885.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21885/japanese-firm-mitsubishi-tanabe-stops-commercialisation-of-covid-19-vaccine.html</guid>
		</item>	
				<item>
			<title>Invivoscribe appoints Masato Sasaki as General Manager of LabPMM, GK (Japan)</title>
			<atom:link href="https://biospectrumasia.com/news/50/21879/invivoscribe-appoints-masato-sasaki-as-general-manager-of-labpmm-gk-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21879/invivoscribe-appoints-masato-sasaki-as-general-manager-of-labpmm-gk-japan.html</link>
			<pubDate>Thu, 02 Feb 2023 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-21879.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21879/invivoscribe-appoints-masato-sasaki-as-general-manager-of-labpmm-gk-japan.html</guid>
		</item>	
				<item>
			<title>Japanese pharma firm Shionogi launches anti-bacterial drug in Denmark</title>
			<atom:link href="https://biospectrumasia.com/news/50/21874/japanese-pharma-firm-shionogi-launches-anti-bacterial-drug-in-denmark.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21874/japanese-pharma-firm-shionogi-launches-anti-bacterial-drug-in-denmark.html</link>
			<pubDate>Thu, 02 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shionogi-21874.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21874/japanese-pharma-firm-shionogi-launches-anti-bacterial-drug-in-denmark.html</guid>
		</item>	
				<item>
			<title>Japan-based Daiichi Sankyo announces new President and COO</title>
			<atom:link href="https://biospectrumasia.com/news/50/21869/japan-based-daiichi-sankyo-announces-new-president-and-coo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21869/japan-based-daiichi-sankyo-announces-new-president-and-coo.html</link>
			<pubDate>Wed, 01 Feb 2023 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sankyo-21869.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21869/japan-based-daiichi-sankyo-announces-new-president-and-coo.html</guid>
		</item>	
				<item>
			<title>Eisai&#039;s Lecanemab earns priority review in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21864/eisais-lecanemab-earns-priority-review-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21864/eisais-lecanemab-earns-priority-review-in-japan.html</link>
			<pubDate>Tue, 31 Jan 2023 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21864/eisais-lecanemab-earns-priority-review-in-japan.html</guid>
		</item>	
				<item>
			<title>US FDA lifts clinical hold of Astellas&#039; Pompe gene therapy </title>
			<atom:link href="https://biospectrumasia.com/news/50/21855/us-fda-lifts-clinical-hold-of-astellas-pompe-gene-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21855/us-fda-lifts-clinical-hold-of-astellas-pompe-gene-therapy-.html</link>
			<pubDate>Mon, 30 Jan 2023 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21855/us-fda-lifts-clinical-hold-of-astellas-pompe-gene-therapy-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono Pharma acquires multiple oncology programmes from US-based KSQ Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/21848/japans-ono-pharma-acquires-multiple-oncology-programmes-from-us-based-ksq-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21848/japans-ono-pharma-acquires-multiple-oncology-programmes-from-us-based-ksq-therapeutics.html</link>
			<pubDate>Mon, 30 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21848.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21848/japans-ono-pharma-acquires-multiple-oncology-programmes-from-us-based-ksq-therapeutics.html</guid>
		</item>	
				<item>
			<title>Shimadzu opens door to biomolecular imaging with new compact MALDI-TOF solution</title>
			<atom:link href="https://biospectrumasia.com/news/50/21839/shimadzu-opens-door-to-biomolecular-imaging-with-new-compact-maldi-tof-solution.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21839/shimadzu-opens-door-to-biomolecular-imaging-with-new-compact-maldi-tof-solution.html</link>
			<pubDate>Thu, 26 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/maldi-21839.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21839/shimadzu-opens-door-to-biomolecular-imaging-with-new-compact-maldi-tof-solution.html</guid>
		</item>	
				<item>
			<title>Aculys Pharma and Four H initiate research collaboration using wearable devices to study sleep disorders in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21831/aculys-pharma-and-four-h-initiate-research-collaboration-using-wearable-devices-to-study-sleep-disorders-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21831/aculys-pharma-and-four-h-initiate-research-collaboration-using-wearable-devices-to-study-sleep-disorders-in-japan.html</link>
			<pubDate>Wed, 25 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21831.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21831/aculys-pharma-and-four-h-initiate-research-collaboration-using-wearable-devices-to-study-sleep-disorders-in-japan.html</guid>
		</item>	
				<item>
			<title>Sandoz to acquire rights of antifungal agent Mycamine from Japanese firm Astellas</title>
			<atom:link href="https://biospectrumasia.com/news/50/21823/sandoz-to-acquire-rights-of-antifungal-agent-mycamine-from-japanese-firm-astellas.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21823/sandoz-to-acquire-rights-of-antifungal-agent-mycamine-from-japanese-firm-astellas.html</link>
			<pubDate>Tue, 24 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fungal_21823-21823.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21823/sandoz-to-acquire-rights-of-antifungal-agent-mycamine-from-japanese-firm-astellas.html</guid>
		</item>	
				<item>
			<title>Takeda inks oncology deal worth $730 M with Hutchmed to improve cancer treatment outside China</title>
			<atom:link href="https://biospectrumasia.com/news/50/21816/takeda-inks-oncology-deal-worth-730-m-with-hutchmed-to-improve-cancer-treatment-outside-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21816/takeda-inks-oncology-deal-worth-730-m-with-hutchmed-to-improve-cancer-treatment-outside-china.html</link>
			<pubDate>Mon, 23 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oip-21816.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21816/takeda-inks-oncology-deal-worth-730-m-with-hutchmed-to-improve-cancer-treatment-outside-china.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono invests $1.5 Million in US&#039; Repare Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/21808/japans-ono-invests-1-5-million-in-us-repare-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21808/japans-ono-invests-1-5-million-in-us-repare-therapeutics.html</link>
			<pubDate>Fri, 20 Jan 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21808/japans-ono-invests-1-5-million-in-us-repare-therapeutics.html</guid>
		</item>	
				<item>
			<title>Japanese firm Fuji Pharma expands partnership with Alvotech for new biosimilar candidate</title>
			<atom:link href="https://biospectrumasia.com/news/50/21793/japanese-firm-fuji-pharma-expands-partnership-with-alvotech-for-new-biosimilar-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21793/japanese-firm-fuji-pharma-expands-partnership-with-alvotech-for-new-biosimilar-candidate.html</link>
			<pubDate>Thu, 19 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-21793.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21793/japanese-firm-fuji-pharma-expands-partnership-with-alvotech-for-new-biosimilar-candidate.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kaneka expands GMP manufacturing capacity for mRNA to Europe</title>
			<atom:link href="https://biospectrumasia.com/news/50/21798/japans-kaneka-expands-gmp-manufacturing-capacity-for-mrna-to-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21798/japans-kaneka-expands-gmp-manufacturing-capacity-for-mrna-to-europe.html</link>
			<pubDate>Thu, 19 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/assortment_vaccination_elements_covid19_23_2148880533-21798.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21798/japans-kaneka-expands-gmp-manufacturing-capacity-for-mrna-to-europe.html</guid>
		</item>	
				<item>
			<title>Eisai launches subsidiary operations to boost business activities in Israel</title>
			<atom:link href="https://biospectrumasia.com/news/50/21799/eisai-launches-subsidiary-operations-to-boost-business-activities-in-israel.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21799/eisai-launches-subsidiary-operations-to-boost-business-activities-in-israel.html</link>
			<pubDate>Thu, 19 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/multi_colored_pills_capsules_lie_table_syringe_injection_scattered_drugs_167684_78-21799.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21799/eisai-launches-subsidiary-operations-to-boost-business-activities-in-israel.html</guid>
		</item>	
				<item>
			<title>FDA approves Eisai&#039;s Alzheimer&#039;s drug under the accelerated approval pathway</title>
			<atom:link href="https://biospectrumasia.com/news/50/21772/fda-approves-eisais-alzheimers-drug-under-the-accelerated-approval-pathway.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21772/fda-approves-eisais-alzheimers-drug-under-the-accelerated-approval-pathway.html</link>
			<pubDate>Mon, 16 Jan 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21772/fda-approves-eisais-alzheimers-drug-under-the-accelerated-approval-pathway.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma inks $340 M worth deal to advance gene therapy portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/50/21770/japans-astellas-pharma-inks-340-m-worth-deal-to-advance-gene-therapy-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21770/japans-astellas-pharma-inks-340-m-worth-deal-to-advance-gene-therapy-portfolio.html</link>
			<pubDate>Mon, 16 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_146497574-21770.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21770/japans-astellas-pharma-inks-340-m-worth-deal-to-advance-gene-therapy-portfolio.html</guid>
		</item>	
				<item>
			<title>Otsuka and SchrÃ¶dinger announce single-target, drug discovery partnership in neurology</title>
			<atom:link href="https://biospectrumasia.com/news/50/21762/otsuka-and-schrdinger-announce-single-target-drug-discovery-partnership-in-neurology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21762/otsuka-and-schrdinger-announce-single-target-drug-discovery-partnership-in-neurology.html</link>
			<pubDate>Fri, 13 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21762.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21762/otsuka-and-schrdinger-announce-single-target-drug-discovery-partnership-in-neurology.html</guid>
		</item>	
				<item>
			<title>Ajinomoto and Exelixis partner to develop novel antibody-drug conjugates for cancer treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/21749/ajinomoto-and-exelixis-partner-to-develop-novel-antibody-drug-conjugates-for-cancer-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21749/ajinomoto-and-exelixis-partner-to-develop-novel-antibody-drug-conjugates-for-cancer-treatment.html</link>
			<pubDate>Wed, 11 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ajino-21749.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21749/ajinomoto-and-exelixis-partner-to-develop-novel-antibody-drug-conjugates-for-cancer-treatment.html</guid>
		</item>	
				<item>
			<title>Nippon Shinyaku opens new drug discovery center in the US</title>
			<atom:link href="https://biospectrumasia.com/news/50/21742/nippon-shinyaku-opens-new-drug-discovery-center-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21742/nippon-shinyaku-opens-new-drug-discovery-center-in-the-us.html</link>
			<pubDate>Tue, 10 Jan 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21742/nippon-shinyaku-opens-new-drug-discovery-center-in-the-us.html</guid>
		</item>	
				<item>
			<title>Moderna buys Japanese startup OriCiro for $85M</title>
			<atom:link href="https://biospectrumasia.com/news/50/21717/moderna-buys-japanese-startup-oriciro-for-85m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21717/moderna-buys-japanese-startup-oriciro-for-85m.html</link>
			<pubDate>Mon, 09 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/atos_1068x712-21717.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21717/moderna-buys-japanese-startup-oriciro-for-85m.html</guid>
		</item>	
				<item>
			<title>Spruce Biosciences, Kaken Pharmaceutical to develop and commercialize Tildacerfont for CAH in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21730/spruce-biosciences-kaken-pharmaceutical-to-develop-and-commercialize-tildacerfont-for-cah-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21730/spruce-biosciences-kaken-pharmaceutical-to-develop-and-commercialize-tildacerfont-for-cah-in-japan.html</link>
			<pubDate>Sat, 07 Jan 2023 14:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21730/spruce-biosciences-kaken-pharmaceutical-to-develop-and-commercialize-tildacerfont-for-cah-in-japan.html</guid>
		</item>	
				<item>
			<title>&quot;Crovalimab could potentially become the first global drug originating from Singapore&quot;</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/21722/crovalimab-could-potentially-become-the-first-global-drug-originating-from-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/21722/crovalimab-could-potentially-become-the-first-global-drug-originating-from-singapore.html</link>
			<pubDate>Fri, 06 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chugai-21722.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/21722/crovalimab-could-potentially-become-the-first-global-drug-originating-from-singapore.html</guid>
		</item>	
				<item>
			<title>Kitakyushu General Hospital in Japan advances use of digital laparoscopic platform </title>
			<atom:link href="https://biospectrumasia.com/news/50/21711/kitakyushu-general-hospital-in-japan-advances-use-of-digital-laparoscopic-platform-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21711/kitakyushu-general-hospital-in-japan-advances-use-of-digital-laparoscopic-platform-.html</link>
			<pubDate>Thu, 05 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21711.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21711/kitakyushu-general-hospital-in-japan-advances-use-of-digital-laparoscopic-platform-.html</guid>
		</item>	
				<item>
			<title>AstraZeneca&#039;s cancer drug approved in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/21699/astrazenecas-cancer-drug-approved-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21699/astrazenecas-cancer-drug-approved-in-japan-.html</link>
			<pubDate>Mon, 02 Jan 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21699/astrazenecas-cancer-drug-approved-in-japan-.html</guid>
		</item>	
				<item>
			<title>KKR to acquire Japan&#039;s Bushu Pharmaceuticals</title>
			<atom:link href="https://biospectrumasia.com/news/50/21694/kkr-to-acquire-japans-bushu-pharmaceuticals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21694/kkr-to-acquire-japans-bushu-pharmaceuticals.html</link>
			<pubDate>Fri, 30 Dec 2022 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21694/kkr-to-acquire-japans-bushu-pharmaceuticals.html</guid>
		</item>	
				<item>
			<title>Japanese startup Veritas In Silico inks new partnership for mRNA-targeted small molecule drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/21690/japanese-startup-veritas-in-silico-inks-new-partnership-for-mrna-targeted-small-molecule-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21690/japanese-startup-veritas-in-silico-inks-new-partnership-for-mrna-targeted-small-molecule-drug-discovery.html</link>
			<pubDate>Fri, 30 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21690.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21690/japanese-startup-veritas-in-silico-inks-new-partnership-for-mrna-targeted-small-molecule-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japanese pharma firm PeptiDream inks $3 B worth deals for novel peptide drug conjugates</title>
			<atom:link href="https://biospectrumasia.com/news/50/21685/japanese-pharma-firm-peptidream-inks-3-b-worth-deals-for-novel-peptide-drug-conjugates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21685/japanese-pharma-firm-peptidream-inks-3-b-worth-deals-for-novel-peptide-drug-conjugates.html</link>
			<pubDate>Wed, 28 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-21685.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21685/japanese-pharma-firm-peptidream-inks-3-b-worth-deals-for-novel-peptide-drug-conjugates.html</guid>
		</item>	
				<item>
			<title>Fujifilm to acquire Inspirata&#039;s digital pathology business</title>
			<atom:link href="https://biospectrumasia.com/news/50/21688/fujifilm-to-acquire-inspiratas-digital-pathology-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21688/fujifilm-to-acquire-inspiratas-digital-pathology-business.html</link>
			<pubDate>Wed, 28 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21688.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21688/fujifilm-to-acquire-inspiratas-digital-pathology-business.html</guid>
		</item>	
				<item>
			<title>Lightnix decided to participate as a partner company in i2.JP led by AstraZeneca</title>
			<atom:link href="https://biospectrumasia.com/news/50/21677/lightnix-decided-to-participate-as-a-partner-company-in-i2-jp-led-by-astrazeneca.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21677/lightnix-decided-to-participate-as-a-partner-company-in-i2-jp-led-by-astrazeneca.html</link>
			<pubDate>Mon, 26 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21677/lightnix-decided-to-participate-as-a-partner-company-in-i2-jp-led-by-astrazeneca.html</guid>
		</item>	
				<item>
			<title>Japan approves manufacturing and marketing of Adtralza for atopic dermatitis treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/21679/japan-approves-manufacturing-and-marketing-of-adtralza-for-atopic-dermatitis-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21679/japan-approves-manufacturing-and-marketing-of-adtralza-for-atopic-dermatitis-treatment.html</link>
			<pubDate>Mon, 26 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21679.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21679/japan-approves-manufacturing-and-marketing-of-adtralza-for-atopic-dermatitis-treatment.html</guid>
		</item>	
				<item>
			<title>Yescarta now approved in Japan for treatment of relapsed/refractory large B-cell lymphoma</title>
			<atom:link href="https://biospectrumasia.com/news/50/21671/yescarta-now-approved-in-japan-for-treatment-of-relapsed-refractory-large-b-cell-lymphoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21671/yescarta-now-approved-in-japan-for-treatment-of-relapsed-refractory-large-b-cell-lymphoma.html</link>
			<pubDate>Fri, 23 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21671/yescarta-now-approved-in-japan-for-treatment-of-relapsed-refractory-large-b-cell-lymphoma.html</guid>
		</item>	
				<item>
			<title>Japanese pharma sector takes steps to reduce environmental burden in packaging</title>
			<atom:link href="https://biospectrumasia.com/news/50/21667/japanese-pharma-sector-takes-steps-to-reduce-environmental-burden-in-packaging.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21667/japanese-pharma-sector-takes-steps-to-reduce-environmental-burden-in-packaging.html</link>
			<pubDate>Fri, 23 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-21667.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21667/japanese-pharma-sector-takes-steps-to-reduce-environmental-burden-in-packaging.html</guid>
		</item>	
				<item>
			<title>Japan approves Sysmex&#039;s assay kit for detection of Alzheimer&#039;s </title>
			<atom:link href="https://biospectrumasia.com/news/50/21675/japan-approves-sysmexs-assay-kit-for-detection-of-alzheimers-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21675/japan-approves-sysmexs-assay-kit-for-detection-of-alzheimers-.html</link>
			<pubDate>Fri, 23 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21675.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21675/japan-approves-sysmexs-assay-kit-for-detection-of-alzheimers-.html</guid>
		</item>	
				<item>
			<title>Takeda, IIF, and Mitsubishi further develop Shonan iPark in Japan to enhance life sciences ecosystem</title>
			<atom:link href="https://biospectrumasia.com/news/50/21659/takeda-iif-and-mitsubishi-further-develop-shonan-ipark-in-japan-to-enhance-life-sciences-ecosystem.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21659/takeda-iif-and-mitsubishi-further-develop-shonan-ipark-in-japan-to-enhance-life-sciences-ecosystem.html</link>
			<pubDate>Thu, 22 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ground_signboard_min_16_9-21659.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21659/takeda-iif-and-mitsubishi-further-develop-shonan-ipark-in-japan-to-enhance-life-sciences-ecosystem.html</guid>
		</item>	
				<item>
			<title>Daiichi launches blood cancer drug in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/21658/daiichi-launches-blood-cancer-drug-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21658/daiichi-launches-blood-cancer-drug-in-japan-.html</link>
			<pubDate>Wed, 21 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21658/daiichi-launches-blood-cancer-drug-in-japan-.html</guid>
		</item>	
				<item>
			<title>Enhertu approved in the EU </title>
			<atom:link href="https://biospectrumasia.com/news/50/21650/enhertu-approved-in-the-eu-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21650/enhertu-approved-in-the-eu-.html</link>
			<pubDate>Tue, 20 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21650/enhertu-approved-in-the-eu-.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares &amp; Eli Lilly ink $730 M deal for treatment of diabetes and metabolic diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/21636/sosei-heptares-eli-lilly-ink-730-m-deal-for-treatment-of-diabetes-and-metabolic-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21636/sosei-heptares-eli-lilly-ink-730-m-deal-for-treatment-of-diabetes-and-metabolic-diseases.html</link>
			<pubDate>Tue, 20 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-21636.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21636/sosei-heptares-eli-lilly-ink-730-m-deal-for-treatment-of-diabetes-and-metabolic-diseases.html</guid>
		</item>	
				<item>
			<title>Tanaka makes equity contribution for establishing medical venture ecosystem in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21647/tanaka-makes-equity-contribution-for-establishing-medical-venture-ecosystem-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21647/tanaka-makes-equity-contribution-for-establishing-medical-venture-ecosystem-in-japan.html</link>
			<pubDate>Tue, 20 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicine_expenses_healthcare_medicine_health_insurance_stethoscope_money_dollars_banknote_blood_test_tubes_73110_9049-21647.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21647/tanaka-makes-equity-contribution-for-establishing-medical-venture-ecosystem-in-japan.html</guid>
		</item>	
				<item>
			<title>South Korea&#039;s Neurophet&#039;s enters Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21637/south-koreas-neurophets-enters-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21637/south-koreas-neurophets-enters-japan.html</link>
			<pubDate>Mon, 19 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21637/south-koreas-neurophets-enters-japan.html</guid>
		</item>	
				<item>
			<title>Japanese firm Eisai partners with Washington University for treatment of neuro diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/21629/japanese-firm-eisai-partners-with-washington-university-for-treatment-of-neuro-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21629/japanese-firm-eisai-partners-with-washington-university-for-treatment-of-neuro-diseases.html</link>
			<pubDate>Mon, 19 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/32-21629.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21629/japanese-firm-eisai-partners-with-washington-university-for-treatment-of-neuro-diseases.html</guid>
		</item>	
				<item>
			<title>Sumitomo Pharma divests LUNESTA to Woodward Pharma Services LLC</title>
			<atom:link href="https://biospectrumasia.com/news/50/21622/sumitomo-pharma-divests-lunesta-to-woodward-pharma-services-llc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21622/sumitomo-pharma-divests-lunesta-to-woodward-pharma-services-llc.html</link>
			<pubDate>Fri, 16 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21622/sumitomo-pharma-divests-lunesta-to-woodward-pharma-services-llc.html</guid>
		</item>	
				<item>
			<title>Japan-based Ono Pharma inks multi target R&amp;D deal with UK&#039;s PrecisionLife </title>
			<atom:link href="https://biospectrumasia.com/news/50/21614/japan-based-ono-pharma-inks-multi-target-rd-deal-with-uks-precisionlife-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21614/japan-based-ono-pharma-inks-multi-target-rd-deal-with-uks-precisionlife-.html</link>
			<pubDate>Fri, 16 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21614.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21614/japan-based-ono-pharma-inks-multi-target-rd-deal-with-uks-precisionlife-.html</guid>
		</item>	
				<item>
			<title>Fujifilm invests in PhenoVista Biosciences to develop stem cells-based assay services</title>
			<atom:link href="https://biospectrumasia.com/news/50/21612/fujifilm-invests-in-phenovista-biosciences-to-develop-stem-cells-based-assay-services.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21612/fujifilm-invests-in-phenovista-biosciences-to-develop-stem-cells-based-assay-services.html</link>
			<pubDate>Thu, 15 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21612.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21612/fujifilm-invests-in-phenovista-biosciences-to-develop-stem-cells-based-assay-services.html</guid>
		</item>	
				<item>
			<title>Takeda inks deal worth $6 B with US-based Nimbus Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/21597/takeda-inks-deal-worth-6-b-with-us-based-nimbus-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21597/takeda-inks-deal-worth-6-b-with-us-based-nimbus-therapeutics.html</link>
			<pubDate>Wed, 14 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21597.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21597/takeda-inks-deal-worth-6-b-with-us-based-nimbus-therapeutics.html</guid>
		</item>	
				<item>
			<title>GI CELL enters agreement with Optieum Biotechnologies</title>
			<atom:link href="https://biospectrumasia.com/news/50/21596/gi-cell-enters-agreement-with-optieum-biotechnologies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21596/gi-cell-enters-agreement-with-optieum-biotechnologies.html</link>
			<pubDate>Tue, 13 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21596/gi-cell-enters-agreement-with-optieum-biotechnologies.html</guid>
		</item>	
				<item>
			<title>Japanese government buys additional quantity of COVID-19 drug Xocova from Shionogi</title>
			<atom:link href="https://biospectrumasia.com/news/50/21592/japanese-government-buys-additional-quantity-of-covid-19-drug-xocova-from-shionogi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21592/japanese-government-buys-additional-quantity-of-covid-19-drug-xocova-from-shionogi.html</link>
			<pubDate>Tue, 13 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/free-21592.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21592/japanese-government-buys-additional-quantity-of-covid-19-drug-xocova-from-shionogi.html</guid>
		</item>	
				<item>
			<title>Japanese healthcare startup Ubie raises $45 M in series C round</title>
			<atom:link href="https://biospectrumasia.com/news/50/21603/japanese-healthcare-startup-ubie-raises-45-m-in-series-c-round.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21603/japanese-healthcare-startup-ubie-raises-45-m-in-series-c-round.html</link>
			<pubDate>Tue, 13 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/22-21603.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21603/japanese-healthcare-startup-ubie-raises-45-m-in-series-c-round.html</guid>
		</item>	
				<item>
			<title>Chugai and Towa launch edirol tablet for osteoporosis treatment in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/21590/chugai-and-towa-launch-edirol-tablet-for-osteoporosis-treatment-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21590/chugai-and-towa-launch-edirol-tablet-for-osteoporosis-treatment-in-japan-.html</link>
			<pubDate>Mon, 12 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21590.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21590/chugai-and-towa-launch-edirol-tablet-for-osteoporosis-treatment-in-japan-.html</guid>
		</item>	
				<item>
			<title>Kite and Daiichi Sankyo modify CAR T-Cell therapy licensing agreement in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21566/kite-and-daiichi-sankyo-modify-car-t-cell-therapy-licensing-agreement-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21566/kite-and-daiichi-sankyo-modify-car-t-cell-therapy-licensing-agreement-in-japan.html</link>
			<pubDate>Thu, 08 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21566/kite-and-daiichi-sankyo-modify-car-t-cell-therapy-licensing-agreement-in-japan.html</guid>
		</item>	
				<item>
			<title>Kyowa Kirin Rlaunches automated injection device of G-Lasta in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21550/kyowa-kirin-rlaunches-automated-injection-device-of-g-lasta-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21550/kyowa-kirin-rlaunches-automated-injection-device-of-g-lasta-in-japan.html</link>
			<pubDate>Wed, 07 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21550/kyowa-kirin-rlaunches-automated-injection-device-of-g-lasta-in-japan.html</guid>
		</item>	
				<item>
			<title> Kyowa Kirin scraps zandelisib development</title>
			<atom:link href="https://biospectrumasia.com/news/50/21544/-kyowa-kirin-scraps-zandelisib-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21544/-kyowa-kirin-scraps-zandelisib-development.html</link>
			<pubDate>Tue, 06 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21544/-kyowa-kirin-scraps-zandelisib-development.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Global Health Innovative Technology Fund secures $20 M pledge from Wellcome</title>
			<atom:link href="https://biospectrumasia.com/news/50/21534/japans-global-health-innovative-technology-fund-secures-20-m-pledge-from-wellcome.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21534/japans-global-health-innovative-technology-fund-secures-20-m-pledge-from-wellcome.html</link>
			<pubDate>Tue, 06 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_142053856-21534.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21534/japans-global-health-innovative-technology-fund-secures-20-m-pledge-from-wellcome.html</guid>
		</item>	
				<item>
			<title>Olympus backs Japan govt&#039;s project for dissemination of endoscopic AI diagnosis in Vietnam</title>
			<atom:link href="https://biospectrumasia.com/news/50/21546/olympus-backs-japan-govts-project-for-dissemination-of-endoscopic-ai-diagnosis-in-vietnam.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21546/olympus-backs-japan-govts-project-for-dissemination-of-endoscopic-ai-diagnosis-in-vietnam.html</link>
			<pubDate>Tue, 06 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/low_olympus20221206-21546.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21546/olympus-backs-japan-govts-project-for-dissemination-of-endoscopic-ai-diagnosis-in-vietnam.html</guid>
		</item>	
				<item>
			<title>Olympus Asia Pacific Innovation Programme to identify medtech innovators</title>
			<atom:link href="https://biospectrumasia.com/news/50/21529/olympus-asia-pacific-innovation-programme-to-identify-medtech-innovators.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21529/olympus-asia-pacific-innovation-programme-to-identify-medtech-innovators.html</link>
			<pubDate>Mon, 05 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21529.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21529/olympus-asia-pacific-innovation-programme-to-identify-medtech-innovators.html</guid>
		</item>	
				<item>
			<title>Healios to provide universal donor cells to Sumitomo Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/21525/healios-to-provide-universal-donor-cells-to-sumitomo-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21525/healios-to-provide-universal-donor-cells-to-sumitomo-pharma.html</link>
			<pubDate>Fri, 02 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21525/healios-to-provide-universal-donor-cells-to-sumitomo-pharma.html</guid>
		</item>	
				<item>
			<title>Moderna partners with Japanese startup Allm for digital therapeutics </title>
			<atom:link href="https://biospectrumasia.com/news/50/21522/moderna-partners-with-japanese-startup-allm-for-digital-therapeutics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21522/moderna-partners-with-japanese-startup-allm-for-digital-therapeutics-.html</link>
			<pubDate>Thu, 01 Dec 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21522/moderna-partners-with-japanese-startup-allm-for-digital-therapeutics-.html</guid>
		</item>	
				<item>
			<title>SanBio partners with Keio University for Alzheimer&#039;s Cure</title>
			<atom:link href="https://biospectrumasia.com/news/50/21517/sanbio-partners-with-keio-university-for-alzheimers-cure.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21517/sanbio-partners-with-keio-university-for-alzheimers-cure.html</link>
			<pubDate>Wed, 30 Nov 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21517/sanbio-partners-with-keio-university-for-alzheimers-cure.html</guid>
		</item>	
				<item>
			<title> Japanese pharma firm Kyowa Kirin announces joint venture with Germany&#039;s GrÃ¼nenthal</title>
			<atom:link href="https://biospectrumasia.com/news/50/21513/-japanese-pharma-firm-kyowa-kirin-announces-joint-venture-with-germanys-grnenthal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21513/-japanese-pharma-firm-kyowa-kirin-announces-joint-venture-with-germanys-grnenthal.html</link>
			<pubDate>Tue, 29 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-21513.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21513/-japanese-pharma-firm-kyowa-kirin-announces-joint-venture-with-germanys-grnenthal.html</guid>
		</item>	
				<item>
			<title>GARDP and Mitsubishi Tanabe Pharma Corporation announce partnership in search for new antibiotics</title>
			<atom:link href="https://biospectrumasia.com/news/50/21502/gardp-and-mitsubishi-tanabe-pharma-corporation-announce-partnership-in-search-for-new-antibiotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21502/gardp-and-mitsubishi-tanabe-pharma-corporation-announce-partnership-in-search-for-new-antibiotics.html</link>
			<pubDate>Mon, 28 Nov 2022 20:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21502/gardp-and-mitsubishi-tanabe-pharma-corporation-announce-partnership-in-search-for-new-antibiotics.html</guid>
		</item>	
				<item>
			<title>GARDP and Sumitomo Pharma announce partnership in search for new antibiotics</title>
			<atom:link href="https://biospectrumasia.com/news/50/21488/gardp-and-sumitomo-pharma-announce-partnership-in-search-for-new-antibiotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21488/gardp-and-sumitomo-pharma-announce-partnership-in-search-for-new-antibiotics.html</link>
			<pubDate>Thu, 24 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/anti-21488.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21488/gardp-and-sumitomo-pharma-announce-partnership-in-search-for-new-antibiotics.html</guid>
		</item>	
				<item>
			<title>Japan to develop first blood biomarker-based diagnostic workflow for dementia </title>
			<atom:link href="https://biospectrumasia.com/news/50/21475/japan-to-develop-first-blood-biomarker-based-diagnostic-workflow-for-dementia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21475/japan-to-develop-first-blood-biomarker-based-diagnostic-workflow-for-dementia-.html</link>
			<pubDate>Tue, 22 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/12-21475.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21475/japan-to-develop-first-blood-biomarker-based-diagnostic-workflow-for-dementia-.html</guid>
		</item>	
				<item>
			<title>Japan starts joint trials for millimeter-wave sensor to detect falls of elderly patients</title>
			<atom:link href="https://biospectrumasia.com/news/50/21471/japan-starts-joint-trials-for-millimeter-wave-sensor-to-detect-falls-of-elderly-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21471/japan-starts-joint-trials-for-millimeter-wave-sensor-to-detect-falls-of-elderly-patients.html</link>
			<pubDate>Mon, 21 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-21471.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21471/japan-starts-joint-trials-for-millimeter-wave-sensor-to-detect-falls-of-elderly-patients.html</guid>
		</item>	
				<item>
			<title>Japan commercialises world&#039;s first test for early-stage pancreatic cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/21456/japan-commercialises-worlds-first-test-for-early-stage-pancreatic-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21456/japan-commercialises-worlds-first-test-for-early-stage-pancreatic-cancer.html</link>
			<pubDate>Thu, 17 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21456.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21456/japan-commercialises-worlds-first-test-for-early-stage-pancreatic-cancer.html</guid>
		</item>	
				<item>
			<title>EU approves Takeda&#039;s CMV drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/21446/eu-approves-takedas-cmv-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21446/eu-approves-takedas-cmv-drug.html</link>
			<pubDate>Wed, 16 Nov 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21446/eu-approves-takedas-cmv-drug.html</guid>
		</item>	
				<item>
			<title>Chugai extends R&amp;D collaboration in Singapore earmarking S$282M over next 5 years</title>
			<atom:link href="https://biospectrumasia.com/company-results/50/21452/chugai-extends-rd-collaboration-in-singapore-earmarking-s282m-over-next-5-years.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/50/21452/chugai-extends-rd-collaboration-in-singapore-earmarking-s282m-over-next-5-years.html</link>
			<pubDate>Wed, 16 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_6_-21452.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/50/21452/chugai-extends-rd-collaboration-in-singapore-earmarking-s282m-over-next-5-years.html</guid>
		</item>	
				<item>
			<title>Daiichi and AZ&#039;s Enhertu recommended for approval in the EU  </title>
			<atom:link href="https://biospectrumasia.com/news/50/21437/daiichi-and-azs-enhertu-recommended-for-approval-in-the-eu-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21437/daiichi-and-azs-enhertu-recommended-for-approval-in-the-eu-.html</link>
			<pubDate>Tue, 15 Nov 2022 21:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21437/daiichi-and-azs-enhertu-recommended-for-approval-in-the-eu-.html</guid>
		</item>	
				<item>
			<title>Ono Pharma inks neuro drug discovery collaboration with Captor Therapeutics </title>
			<atom:link href="https://biospectrumasia.com/news/50/21441/ono-pharma-inks-neuro-drug-discovery-collaboration-with-captor-therapeutics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21441/ono-pharma-inks-neuro-drug-discovery-collaboration-with-captor-therapeutics-.html</link>
			<pubDate>Tue, 15 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-21441.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21441/ono-pharma-inks-neuro-drug-discovery-collaboration-with-captor-therapeutics-.html</guid>
		</item>	
				<item>
			<title>Otsuka ends gene therapy collaboraton with Takara Bio</title>
			<atom:link href="https://biospectrumasia.com/news/50/21430/otsuka-ends-gene-therapy-collaboraton-with-takara-bio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21430/otsuka-ends-gene-therapy-collaboraton-with-takara-bio.html</link>
			<pubDate>Mon, 14 Nov 2022 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/term-21430.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21430/otsuka-ends-gene-therapy-collaboraton-with-takara-bio.html</guid>
		</item>	
				<item>
			<title>GHIT Fund in Japan invests Â¥ 790 M for product development of Neglected Tropical Diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/21425/ghit-fund-in-japan-invests-790-m-for-product-development-of-neglected-tropical-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21425/ghit-fund-in-japan-invests-790-m-for-product-development-of-neglected-tropical-diseases.html</link>
			<pubDate>Mon, 14 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-21425.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21425/ghit-fund-in-japan-invests-790-m-for-product-development-of-neglected-tropical-diseases.html</guid>
		</item>	
				<item>
			<title>Kirin Holdings and Kao explore link between visceral fat and immunology</title>
			<atom:link href="https://biospectrumasia.com/news/50/21420/kirin-holdings-and-kao-explore-link-between-visceral-fat-and-immunology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21420/kirin-holdings-and-kao-explore-link-between-visceral-fat-and-immunology.html</link>
			<pubDate>Fri, 11 Nov 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21420/kirin-holdings-and-kao-explore-link-between-visceral-fat-and-immunology.html</guid>
		</item>	
				<item>
			<title>Japan explores use of robotic technology to help people with disabilities</title>
			<atom:link href="https://biospectrumasia.com/news/50/21413/japan-explores-use-of-robotic-technology-to-help-people-with-disabilities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21413/japan-explores-use-of-robotic-technology-to-help-people-with-disabilities.html</link>
			<pubDate>Thu, 10 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-21413.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21413/japan-explores-use-of-robotic-technology-to-help-people-with-disabilities.html</guid>
		</item>	
				<item>
			<title>Kyowa Kirin announce changes in leadership positions </title>
			<atom:link href="https://biospectrumasia.com/news/50/21403/kyowa-kirin-announce-changes-in-leadership-positions-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21403/kyowa-kirin-announce-changes-in-leadership-positions-.html</link>
			<pubDate>Wed, 09 Nov 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-21403.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21403/kyowa-kirin-announce-changes-in-leadership-positions-.html</guid>
		</item>	
				<item>
			<title>Japan-based Shionogi invests  Â¥100 M in stroke recovery technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/21406/japan-based-shionogi-invests-100-m-in-stroke-recovery-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21406/japan-based-shionogi-invests-100-m-in-stroke-recovery-technology.html</link>
			<pubDate>Wed, 09 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stroke-21406.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21406/japan-based-shionogi-invests-100-m-in-stroke-recovery-technology.html</guid>
		</item>	
				<item>
			<title>Canon launches first domestic X-ray CT system with photon-counting detector</title>
			<atom:link href="https://biospectrumasia.com/news/50/21386/canon-launches-first-domestic-x-ray-ct-system-with-photon-counting-detector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21386/canon-launches-first-domestic-x-ray-ct-system-with-photon-counting-detector.html</link>
			<pubDate>Mon, 07 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21386.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21386/canon-launches-first-domestic-x-ray-ct-system-with-photon-counting-detector.html</guid>
		</item>	
				<item>
			<title>CureApp, World&#039;s first digital therapeutics app for hypertension receives insurance coverage in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/21381/cureapp-worlds-first-digital-therapeutics-app-for-hypertension-receives-insurance-coverage-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21381/cureapp-worlds-first-digital-therapeutics-app-for-hypertension-receives-insurance-coverage-in-japan-.html</link>
			<pubDate>Fri, 04 Nov 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21381/cureapp-worlds-first-digital-therapeutics-app-for-hypertension-receives-insurance-coverage-in-japan-.html</guid>
		</item>	
				<item>
			<title>Ono Pharmaceutical inks immuno-oncology partnership with Memo Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/21375/ono-pharmaceutical-inks-immuno-oncology-partnership-with-memo-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21375/ono-pharmaceutical-inks-immuno-oncology-partnership-with-memo-therapeutics.html</link>
			<pubDate>Fri, 04 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-21375.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21375/ono-pharmaceutical-inks-immuno-oncology-partnership-with-memo-therapeutics.html</guid>
		</item>	
				<item>
			<title>I Peace partners with the California Institute for Regenerative Medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/21357/i-peace-partners-with-the-california-institute-for-regenerative-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21357/i-peace-partners-with-the-california-institute-for-regenerative-medicine.html</link>
			<pubDate>Thu, 03 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21357.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21357/i-peace-partners-with-the-california-institute-for-regenerative-medicine.html</guid>
		</item>	
				<item>
			<title>Terumo invests Â¥15 B to expand CDMO services outside Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21346/terumo-invests-15-b-to-expand-cdmo-services-outside-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21346/terumo-invests-15-b-to-expand-cdmo-services-outside-japan.html</link>
			<pubDate>Tue, 01 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21346.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21346/terumo-invests-15-b-to-expand-cdmo-services-outside-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus appoints Stefan Kaufmann as CEO </title>
			<atom:link href="https://biospectrumasia.com/news/50/21339/japans-olympus-appoints-stefan-kaufmann-as-ceo-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21339/japans-olympus-appoints-stefan-kaufmann-as-ceo-.html</link>
			<pubDate>Mon, 31 Oct 2022 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21339/japans-olympus-appoints-stefan-kaufmann-as-ceo-.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk to commercialise Mallya smart sensors in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21318/novo-nordisk-to-commercialise-mallya-smart-sensors-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21318/novo-nordisk-to-commercialise-mallya-smart-sensors-in-japan.html</link>
			<pubDate>Fri, 28 Oct 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-21318.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21318/novo-nordisk-to-commercialise-mallya-smart-sensors-in-japan.html</guid>
		</item>	
				<item>
			<title>The BEES-HAUS Cell Therapy, Tested With Cell Engraftment by Urologists at the Edogawa Hospital in Japan, Has The Potential to Stop Recurrence of Urethral Stricture</title>
			<atom:link href="https://biospectrumasia.com/news/50/21323/the-bees-haus-cell-therapy-tested-with-cell-engraftment-by-urologists-at-the-edogawa-hospital-in-japan-has-the-potential-to-stop-recurrence-of-urethral-stricture.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21323/the-bees-haus-cell-therapy-tested-with-cell-engraftment-by-urologists-at-the-edogawa-hospital-in-japan-has-the-potential-to-stop-recurrence-of-urethral-stricture.html</link>
			<pubDate>Fri, 28 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-21323.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21323/the-bees-haus-cell-therapy-tested-with-cell-engraftment-by-urologists-at-the-edogawa-hospital-in-japan-has-the-potential-to-stop-recurrence-of-urethral-stricture.html</guid>
		</item>	
				<item>
			<title>FUJIFILM to enable GMP manufacturing of cell and exosome therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/21314/fujifilm-to-enable-gmp-manufacturing-of-cell-and-exosome-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21314/fujifilm-to-enable-gmp-manufacturing-of-cell-and-exosome-therapies.html</link>
			<pubDate>Thu, 27 Oct 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21314/fujifilm-to-enable-gmp-manufacturing-of-cell-and-exosome-therapies.html</guid>
		</item>	
				<item>
			<title>Japan-based Sumitovant Biopharma to acquire Myovant Sciences for $1.7 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/21304/japan-based-sumitovant-biopharma-to-acquire-myovant-sciences-for-1-7-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21304/japan-based-sumitovant-biopharma-to-acquire-myovant-sciences-for-1-7-b.html</link>
			<pubDate>Thu, 27 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21304.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21304/japan-based-sumitovant-biopharma-to-acquire-myovant-sciences-for-1-7-b.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma invests $50 M to support gene therapy programmes of Taysha</title>
			<atom:link href="https://biospectrumasia.com/news/50/21292/japans-astellas-pharma-invests-50-m-to-support-gene-therapy-programmes-of-taysha.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21292/japans-astellas-pharma-invests-50-m-to-support-gene-therapy-programmes-of-taysha.html</link>
			<pubDate>Tue, 25 Oct 2022 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-21292.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21292/japans-astellas-pharma-invests-50-m-to-support-gene-therapy-programmes-of-taysha.html</guid>
		</item>	
				<item>
			<title>Takeda enters new collaboration to develop first-in-class celiac disease therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/21287/takeda-enters-new-collaboration-to-develop-first-in-class-celiac-disease-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21287/takeda-enters-new-collaboration-to-develop-first-in-class-celiac-disease-therapy.html</link>
			<pubDate>Sat, 22 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21287.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21287/takeda-enters-new-collaboration-to-develop-first-in-class-celiac-disease-therapy.html</guid>
		</item>	
				<item>
			<title>Olympus announces leadership succession plan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21289/olympus-announces-leadership-succession-plan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21289/olympus-announces-leadership-succession-plan.html</link>
			<pubDate>Sat, 22 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/33-21289.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21289/olympus-announces-leadership-succession-plan.html</guid>
		</item>	
				<item>
			<title>Takara Bio, BioExcel Diagnostics to develop wide-coverage infectious disease detection panels</title>
			<atom:link href="https://biospectrumasia.com/news/50/21269/takara-bio-bioexcel-diagnostics-to-develop-wide-coverage-infectious-disease-detection-panels.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21269/takara-bio-bioexcel-diagnostics-to-develop-wide-coverage-infectious-disease-detection-panels.html</link>
			<pubDate>Wed, 19 Oct 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_104108189-21269.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21269/takara-bio-bioexcel-diagnostics-to-develop-wide-coverage-infectious-disease-detection-panels.html</guid>
		</item>	
				<item>
			<title>Japanese firm introduces new RNA editing technology </title>
			<atom:link href="https://biospectrumasia.com/news/50/21264/japanese-firm-introduces-new-rna-editing-technology-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21264/japanese-firm-introduces-new-rna-editing-technology-.html</link>
			<pubDate>Tue, 18 Oct 2022 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_146497574-21264.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21264/japanese-firm-introduces-new-rna-editing-technology-.html</guid>
		</item>	
				<item>
			<title>Biocon out-licenses two biosimilar assets for commercialization in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21247/biocon-out-licenses-two-biosimilar-assets-for-commercialization-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21247/biocon-out-licenses-two-biosimilar-assets-for-commercialization-in-japan.html</link>
			<pubDate>Mon, 17 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-21247.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21247/biocon-out-licenses-two-biosimilar-assets-for-commercialization-in-japan.html</guid>
		</item>	
				<item>
			<title>Philips expands ClarifEye AR surgical navigation solution rollout in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21295/philips-expands-clarifeye-ar-surgical-navigation-solution-rollout-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21295/philips-expands-clarifeye-ar-surgical-navigation-solution-rollout-in-japan.html</link>
			<pubDate>Mon, 17 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/44-21295.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21295/philips-expands-clarifeye-ar-surgical-navigation-solution-rollout-in-japan.html</guid>
		</item>	
				<item>
			<title>Sanofi sells manufacturing site in Japan to CDMO Adragos Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/21245/sanofi-sells-manufacturing-site-in-japan-to-cdmo-adragos-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21245/sanofi-sells-manufacturing-site-in-japan-to-cdmo-adragos-pharma.html</link>
			<pubDate>Fri, 14 Oct 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-21245.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21245/sanofi-sells-manufacturing-site-in-japan-to-cdmo-adragos-pharma.html</guid>
		</item>	
				<item>
			<title>Japan reiterates commitment to HIV vaccine development with a $10.5 million contribution to IAVI</title>
			<atom:link href="https://biospectrumasia.com/news/50/21213/japan-reiterates-commitment-to-hiv-vaccine-development-with-a-10-5-million-contribution-to-iavi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21213/japan-reiterates-commitment-to-hiv-vaccine-development-with-a-10-5-million-contribution-to-iavi.html</link>
			<pubDate>Tue, 11 Oct 2022 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21213/japan-reiterates-commitment-to-hiv-vaccine-development-with-a-10-5-million-contribution-to-iavi.html</guid>
		</item>	
				<item>
			<title>Japan approves CathWorks device for coronary artery disease patients</title>
			<atom:link href="https://biospectrumasia.com/news/50/21205/japan-approves-cathworks-device-for-coronary-artery-disease-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21205/japan-approves-cathworks-device-for-coronary-artery-disease-patients.html</link>
			<pubDate>Mon, 10 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21205.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21205/japan-approves-cathworks-device-for-coronary-artery-disease-patients.html</guid>
		</item>	
				<item>
			<title>Fujifilm to establish first Bio-CDMO site in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21225/fujifilm-to-establish-first-bio-cdmo-site-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21225/fujifilm-to-establish-first-bio-cdmo-site-in-japan.html</link>
			<pubDate>Mon, 10 Oct 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21225.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21225/fujifilm-to-establish-first-bio-cdmo-site-in-japan.html</guid>
		</item>	
				<item>
			<title>Olympus introduces new endoscopic ultrasound processor</title>
			<atom:link href="https://biospectrumasia.com/news/50/21196/olympus-introduces-new-endoscopic-ultrasound-processor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21196/olympus-introduces-new-endoscopic-ultrasound-processor.html</link>
			<pubDate>Fri, 07 Oct 2022 02:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-21196.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21196/olympus-introduces-new-endoscopic-ultrasound-processor.html</guid>
		</item>	
				<item>
			<title>Eisai strengthens R&amp;D function for injectable drug formulations in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21189/eisai-strengthens-rd-function-for-injectable-drug-formulations-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21189/eisai-strengthens-rd-function-for-injectable-drug-formulations-in-japan.html</link>
			<pubDate>Thu, 06 Oct 2022 02:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21189.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21189/eisai-strengthens-rd-function-for-injectable-drug-formulations-in-japan.html</guid>
		</item>	
				<item>
			<title>DentalMonitoring expands into Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21175/dentalmonitoring-expands-into-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21175/dentalmonitoring-expands-into-japan.html</link>
			<pubDate>Tue, 04 Oct 2022 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21175.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21175/dentalmonitoring-expands-into-japan.html</guid>
		</item>	
				<item>
			<title>Hyperthermia system made in Japan helping cancer patients in Vietnam</title>
			<atom:link href="https://biospectrumasia.com/news/50/21162/hyperthermia-system-made-in-japan-helping-cancer-patients-in-vietnam.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21162/hyperthermia-system-made-in-japan-helping-cancer-patients-in-vietnam.html</link>
			<pubDate>Mon, 03 Oct 2022 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21162.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21162/hyperthermia-system-made-in-japan-helping-cancer-patients-in-vietnam.html</guid>
		</item>	
				<item>
			<title>Japan approves AstraZeneca&#039;s Tezspire for severe asthma treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/21150/japan-approves-astrazenecas-tezspire-for-severe-asthma-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21150/japan-approves-astrazenecas-tezspire-for-severe-asthma-treatment.html</link>
			<pubDate>Fri, 30 Sep 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21150.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21150/japan-approves-astrazenecas-tezspire-for-severe-asthma-treatment.html</guid>
		</item>	
				<item>
			<title>Takeda strengthens healthcare systems to meet patients&#039; need for plasma-derived therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/21147/takeda-strengthens-healthcare-systems-to-meet-patients-need-for-plasma-derived-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21147/takeda-strengthens-healthcare-systems-to-meet-patients-need-for-plasma-derived-therapies.html</link>
			<pubDate>Fri, 30 Sep 2022 02:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21147.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21147/takeda-strengthens-healthcare-systems-to-meet-patients-need-for-plasma-derived-therapies.html</guid>
		</item>	
				<item>
			<title>Fujifilm receives regulatory approval for latest generation Endoscopic Ultrasound</title>
			<atom:link href="https://biospectrumasia.com/news/50/21127/fujifilm-receives-regulatory-approval-for-latest-generation-endoscopic-ultrasound.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21127/fujifilm-receives-regulatory-approval-for-latest-generation-endoscopic-ultrasound.html</link>
			<pubDate>Thu, 29 Sep 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-21127.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21127/fujifilm-receives-regulatory-approval-for-latest-generation-endoscopic-ultrasound.html</guid>
		</item>	
				<item>
			<title>Japanese firm Olympus launches THUNDERBEAT energy device for open surgery</title>
			<atom:link href="https://biospectrumasia.com/news/50/21130/japanese-firm-olympus-launches-thunderbeat-energy-device-for-open-surgery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21130/japanese-firm-olympus-launches-thunderbeat-energy-device-for-open-surgery.html</link>
			<pubDate>Wed, 28 Sep 2022 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/7-21130.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21130/japanese-firm-olympus-launches-thunderbeat-energy-device-for-open-surgery.html</guid>
		</item>	
				<item>
			<title>Japan approves subcutaneous injection formulation for rheumatoid arthritis</title>
			<atom:link href="https://biospectrumasia.com/news/50/21116/japan-approves-subcutaneous-injection-formulation-for-rheumatoid-arthritis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21116/japan-approves-subcutaneous-injection-formulation-for-rheumatoid-arthritis.html</link>
			<pubDate>Wed, 28 Sep 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21116.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21116/japan-approves-subcutaneous-injection-formulation-for-rheumatoid-arthritis.html</guid>
		</item>	
				<item>
			<title>Japan approves CAR-T therapy for relapsed or refractory multiple myeloma </title>
			<atom:link href="https://biospectrumasia.com/news/50/21141/japan-approves-car-t-therapy-for-relapsed-or-refractory-multiple-myeloma-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21141/japan-approves-car-t-therapy-for-relapsed-or-refractory-multiple-myeloma-.html</link>
			<pubDate>Wed, 28 Sep 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21141.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21141/japan-approves-car-t-therapy-for-relapsed-or-refractory-multiple-myeloma-.html</guid>
		</item>	
				<item>
			<title>Fujitsu, Tohoku University embark on strategic alliance for preventive healthcare</title>
			<atom:link href="https://biospectrumasia.com/news/50/21114/fujitsu-tohoku-university-embark-on-strategic-alliance-for-preventive-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21114/fujitsu-tohoku-university-embark-on-strategic-alliance-for-preventive-healthcare.html</link>
			<pubDate>Tue, 27 Sep 2022 03:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21114.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21114/fujitsu-tohoku-university-embark-on-strategic-alliance-for-preventive-healthcare.html</guid>
		</item>	
				<item>
			<title>Japan gets its first AAHRPP credited organisation </title>
			<atom:link href="https://biospectrumasia.com/news/50/21109/japan-gets-its-first-aahrpp-credited-organisation-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21109/japan-gets-its-first-aahrpp-credited-organisation-.html</link>
			<pubDate>Mon, 26 Sep 2022 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21109/japan-gets-its-first-aahrpp-credited-organisation-.html</guid>
		</item>	
				<item>
			<title>Shionogi to launch business involving brain activation through sound stimulation</title>
			<atom:link href="https://biospectrumasia.com/news/50/21105/shionogi-to-launch-business-involving-brain-activation-through-sound-stimulation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21105/shionogi-to-launch-business-involving-brain-activation-through-sound-stimulation.html</link>
			<pubDate>Mon, 26 Sep 2022 03:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21105.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21105/shionogi-to-launch-business-involving-brain-activation-through-sound-stimulation.html</guid>
		</item>	
				<item>
			<title>Advanced peripheral mechanical thrombectomy technology to enter Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21094/advanced-peripheral-mechanical-thrombectomy-technology-to-enter-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21094/advanced-peripheral-mechanical-thrombectomy-technology-to-enter-japan.html</link>
			<pubDate>Fri, 23 Sep 2022 01:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-21094.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21094/advanced-peripheral-mechanical-thrombectomy-technology-to-enter-japan.html</guid>
		</item>	
				<item>
			<title>Peli BioThermal opens new service centre in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21086/peli-biothermal-opens-new-service-centre-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21086/peli-biothermal-opens-new-service-centre-in-japan.html</link>
			<pubDate>Thu, 22 Sep 2022 01:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21086.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21086/peli-biothermal-opens-new-service-centre-in-japan.html</guid>
		</item>	
				<item>
			<title>Indian firm Excelra expands scientific products footprint in Japanese market</title>
			<atom:link href="https://biospectrumasia.com/news/50/21084/indian-firm-excelra-expands-scientific-products-footprint-in-japanese-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21084/indian-firm-excelra-expands-scientific-products-footprint-in-japanese-market.html</link>
			<pubDate>Wed, 21 Sep 2022 04:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_281615630-21084.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21084/indian-firm-excelra-expands-scientific-products-footprint-in-japanese-market.html</guid>
		</item>	
				<item>
			<title>Smith+Nephew launches hip replacement surgery tool in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21072/smithnephew-launches-hip-replacement-surgery-tool-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21072/smithnephew-launches-hip-replacement-surgery-tool-in-japan.html</link>
			<pubDate>Tue, 20 Sep 2022 01:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-21072.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21072/smithnephew-launches-hip-replacement-surgery-tool-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus launches new surgical visualization platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/21067/japans-olympus-launches-new-surgical-visualization-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21067/japans-olympus-launches-new-surgical-visualization-platform.html</link>
			<pubDate>Mon, 19 Sep 2022 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21067/japans-olympus-launches-new-surgical-visualization-platform.html</guid>
		</item>	
				<item>
			<title>Japanese firm Olympus unveils new surgical visualisation platform for endoscopy</title>
			<atom:link href="https://biospectrumasia.com/news/50/21048/japanese-firm-olympus-unveils-new-surgical-visualisation-platform-for-endoscopy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21048/japanese-firm-olympus-unveils-new-surgical-visualisation-platform-for-endoscopy.html</link>
			<pubDate>Thu, 15 Sep 2022 01:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ve3_system-21048.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21048/japanese-firm-olympus-unveils-new-surgical-visualisation-platform-for-endoscopy.html</guid>
		</item>	
				<item>
			<title>Nippon&#039;s Japan center is GDP compliant  </title>
			<atom:link href="https://biospectrumasia.com/news/50/21041/nippons-japan-center-is-gdp-compliant-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21041/nippons-japan-center-is-gdp-compliant-.html</link>
			<pubDate>Wed, 14 Sep 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21041/nippons-japan-center-is-gdp-compliant-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Cellusion and China&#039;s Celregen to work on regenerative therapy for greater China region </title>
			<atom:link href="https://biospectrumasia.com/news/50/21023/japans-cellusion-and-chinas-celregen-to-work-on-regenerative-therapy-for-greater-china-region-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21023/japans-cellusion-and-chinas-celregen-to-work-on-regenerative-therapy-for-greater-china-region-.html</link>
			<pubDate>Mon, 12 Sep 2022 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21023/japans-cellusion-and-chinas-celregen-to-work-on-regenerative-therapy-for-greater-china-region-.html</guid>
		</item>	
				<item>
			<title>Life science tech firm MGI unveils state-of-the-art demo lab in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/21017/life-science-tech-firm-mgi-unveils-state-of-the-art-demo-lab-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/21017/life-science-tech-firm-mgi-unveils-state-of-the-art-demo-lab-in-japan.html</link>
			<pubDate>Fri, 09 Sep 2022 03:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21017.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/21017/life-science-tech-firm-mgi-unveils-state-of-the-art-demo-lab-in-japan.html</guid>
		</item>	
				<item>
			<title>Teijin Pharma receives additional approval in Japan for abaloparatide acetate as treatment for osteoporosis</title>
			<atom:link href="https://biospectrumasia.com/news/50/20993/teijin-pharma-receives-additional-approval-in-japan-for-abaloparatide-acetate-as-treatment-for-osteoporosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20993/teijin-pharma-receives-additional-approval-in-japan-for-abaloparatide-acetate-as-treatment-for-osteoporosis.html</link>
			<pubDate>Tue, 06 Sep 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20993/teijin-pharma-receives-additional-approval-in-japan-for-abaloparatide-acetate-as-treatment-for-osteoporosis.html</guid>
		</item>	
				<item>
			<title>Prospection partners with Japanese firm Medical Data Vision to improve patient care</title>
			<atom:link href="https://biospectrumasia.com/news/50/20989/prospection-partners-with-japanese-firm-medical-data-vision-to-improve-patient-care.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20989/prospection-partners-with-japanese-firm-medical-data-vision-to-improve-patient-care.html</link>
			<pubDate>Tue, 06 Sep 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_171674909-20989.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20989/prospection-partners-with-japanese-firm-medical-data-vision-to-improve-patient-care.html</guid>
		</item>	
				<item>
			<title>Fujitsu, Tsuda University launch joint research on healthcare services in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20959/fujitsu-tsuda-university-launch-joint-research-on-healthcare-services-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20959/fujitsu-tsuda-university-launch-joint-research-on-healthcare-services-in-japan.html</link>
			<pubDate>Tue, 30 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/33-20959.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20959/fujitsu-tsuda-university-launch-joint-research-on-healthcare-services-in-japan.html</guid>
		</item>	
				<item>
			<title>Shimadzu unveils near-infrared light imaging system to enhance drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/50/20947/shimadzu-unveils-near-infrared-light-imaging-system-to-enhance-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20947/shimadzu-unveils-near-infrared-light-imaging-system-to-enhance-drug-discovery-research.html</link>
			<pubDate>Mon, 29 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/55-20947.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20947/shimadzu-unveils-near-infrared-light-imaging-system-to-enhance-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>Japan gives nod to breast cancer drug by AstraZeneca and Merck</title>
			<atom:link href="https://biospectrumasia.com/news/50/20940/japan-gives-nod-to-breast-cancer-drug-by-astrazeneca-and-merck.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20940/japan-gives-nod-to-breast-cancer-drug-by-astrazeneca-and-merck.html</link>
			<pubDate>Fri, 26 Aug 2022 03:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/55-20940.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20940/japan-gives-nod-to-breast-cancer-drug-by-astrazeneca-and-merck.html</guid>
		</item>	
				<item>
			<title>Lupin and I&#039;rom partner to make denosumab biosimilar available in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20927/lupin-and-irom-partner-to-make-denosumab-biosimilar-available-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20927/lupin-and-irom-partner-to-make-denosumab-biosimilar-available-in-japan.html</link>
			<pubDate>Thu, 25 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/22-20927.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20927/lupin-and-irom-partner-to-make-denosumab-biosimilar-available-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai builds real-world evidence for blood-based assays for cognitive impairment</title>
			<atom:link href="https://biospectrumasia.com/news/50/20925/eisai-builds-real-world-evidence-for-blood-based-assays-for-cognitive-impairment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20925/eisai-builds-real-world-evidence-for-blood-based-assays-for-cognitive-impairment.html</link>
			<pubDate>Wed, 24 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_200010311-20925.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20925/eisai-builds-real-world-evidence-for-blood-based-assays-for-cognitive-impairment.html</guid>
		</item>	
				<item>
			<title>Ubie secures $26.2 M to fuel business growth in Japan &amp; US</title>
			<atom:link href="https://biospectrumasia.com/news/50/20911/ubie-secures-26-2-m-to-fuel-business-growth-in-japan-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20911/ubie-secures-26-2-m-to-fuel-business-growth-in-japan-us.html</link>
			<pubDate>Mon, 22 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-20911.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20911/ubie-secures-26-2-m-to-fuel-business-growth-in-japan-us.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s CureApp, Sawai Group partner for DTx solution in NASH field </title>
			<atom:link href="https://biospectrumasia.com/news/50/20896/japans-cureapp-sawai-group-partner-for-dtx-solution-in-nash-field-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20896/japans-cureapp-sawai-group-partner-for-dtx-solution-in-nash-field-.html</link>
			<pubDate>Fri, 19 Aug 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20896.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20896/japans-cureapp-sawai-group-partner-for-dtx-solution-in-nash-field-.html</guid>
		</item>	
				<item>
			<title>Carlyle acquires significant minority stake in Japanese startup CureApp</title>
			<atom:link href="https://biospectrumasia.com/news/50/20894/carlyle-acquires-significant-minority-stake-in-japanese-startup-cureapp.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20894/carlyle-acquires-significant-minority-stake-in-japanese-startup-cureapp.html</link>
			<pubDate>Thu, 18 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_171674909-20894.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20894/carlyle-acquires-significant-minority-stake-in-japanese-startup-cureapp.html</guid>
		</item>	
				<item>
			<title> Vuzix tests smart glasses for emergency medical care in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/20885/-vuzix-tests-smart-glasses-for-emergency-medical-care-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20885/-vuzix-tests-smart-glasses-for-emergency-medical-care-in-japan-.html</link>
			<pubDate>Wed, 17 Aug 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20885.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20885/-vuzix-tests-smart-glasses-for-emergency-medical-care-in-japan-.html</guid>
		</item>	
				<item>
			<title>Japan approves Chugai Pharma&#039;s osteoporosis drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/20877/japan-approves-chugai-pharmas-osteoporosis-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20877/japan-approves-chugai-pharmas-osteoporosis-drug.html</link>
			<pubDate>Tue, 16 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/33-20877.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20877/japan-approves-chugai-pharmas-osteoporosis-drug.html</guid>
		</item>	
				<item>
			<title>Verizon Business to transform Astellas Pharma&#039;s global network infra</title>
			<atom:link href="https://biospectrumasia.com/news/50/20849/verizon-business-to-transform-astellas-pharmas-global-network-infra.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20849/verizon-business-to-transform-astellas-pharmas-global-network-infra.html</link>
			<pubDate>Wed, 10 Aug 2022 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20849.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20849/verizon-business-to-transform-astellas-pharmas-global-network-infra.html</guid>
		</item>	
				<item>
			<title>Eisai, LIFENET to build ecosystem for reducing medical care burden in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20846/eisai-lifenet-to-build-ecosystem-for-reducing-medical-care-burden-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20846/eisai-lifenet-to-build-ecosystem-for-reducing-medical-care-burden-in-japan.html</link>
			<pubDate>Tue, 09 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_133533590-20846.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20846/eisai-lifenet-to-build-ecosystem-for-reducing-medical-care-burden-in-japan.html</guid>
		</item>	
				<item>
			<title>Astellas Pharma puts forth new management structure</title>
			<atom:link href="https://biospectrumasia.com/news/50/20837/astellas-pharma-puts-forth-new-management-structure.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20837/astellas-pharma-puts-forth-new-management-structure.html</link>
			<pubDate>Mon, 08 Aug 2022 13:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_148575200-20837.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20837/astellas-pharma-puts-forth-new-management-structure.html</guid>
		</item>	
				<item>
			<title>GrÃ¼nenthal licenses-out osteoarthritis pain treatment to Shionogi in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/20820/grnenthal-licenses-out-osteoarthritis-pain-treatment-to-shionogi-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20820/grnenthal-licenses-out-osteoarthritis-pain-treatment-to-shionogi-in-japan-.html</link>
			<pubDate>Thu, 04 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-20820.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20820/grnenthal-licenses-out-osteoarthritis-pain-treatment-to-shionogi-in-japan-.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares and AbbVie enter new multi-target collaboration worth $1.2 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/20816/sosei-heptares-and-abbvie-enter-new-multi-target-collaboration-worth-1-2-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20816/sosei-heptares-and-abbvie-enter-new-multi-target-collaboration-worth-1-2-b.html</link>
			<pubDate>Wed, 03 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-20816.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20816/sosei-heptares-and-abbvie-enter-new-multi-target-collaboration-worth-1-2-b.html</guid>
		</item>	
				<item>
			<title>Shionogi begins phase 3 study in Japan of Akili&#039;s digital treatment in children with ADHD</title>
			<atom:link href="https://biospectrumasia.com/news/50/20810/shionogi-begins-phase-3-study-in-japan-of-akilis-digital-treatment-in-children-with-adhd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20810/shionogi-begins-phase-3-study-in-japan-of-akilis-digital-treatment-in-children-with-adhd.html</link>
			<pubDate>Tue, 02 Aug 2022 17:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20810/shionogi-begins-phase-3-study-in-japan-of-akilis-digital-treatment-in-children-with-adhd.html</guid>
		</item>	
				<item>
			<title>Eisai appoints former Lilly exec as Alzheimer&#039;s commercial lead</title>
			<atom:link href="https://biospectrumasia.com/news/50/20798/eisai-appoints-former-lilly-exec-as-alzheimers-commercial-lead.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20798/eisai-appoints-former-lilly-exec-as-alzheimers-commercial-lead.html</link>
			<pubDate>Mon, 01 Aug 2022 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20798/eisai-appoints-former-lilly-exec-as-alzheimers-commercial-lead.html</guid>
		</item>	
				<item>
			<title>Japan approves Novavax&#039;s COVID-19 vaccine for adolescents</title>
			<atom:link href="https://biospectrumasia.com/news/50/20773/japan-approves-novavaxs-covid-19-vaccine-for-adolescents.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20773/japan-approves-novavaxs-covid-19-vaccine-for-adolescents.html</link>
			<pubDate>Thu, 28 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-20773.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20773/japan-approves-novavaxs-covid-19-vaccine-for-adolescents.html</guid>
		</item>	
				<item>
			<title>Otsuka implement digital cell tech for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/20761/otsuka-implement-digital-cell-tech-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20761/otsuka-implement-digital-cell-tech-for-drug-discovery.html</link>
			<pubDate>Tue, 26 Jul 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20761/otsuka-implement-digital-cell-tech-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Shimadzu lays focus on diagnostic aid technology for depression using blood tests</title>
			<atom:link href="https://biospectrumasia.com/news/50/20764/shimadzu-lays-focus-on-diagnostic-aid-technology-for-depression-using-blood-tests.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20764/shimadzu-lays-focus-on-diagnostic-aid-technology-for-depression-using-blood-tests.html</link>
			<pubDate>Tue, 26 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-20764.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20764/shimadzu-lays-focus-on-diagnostic-aid-technology-for-depression-using-blood-tests.html</guid>
		</item>	
				<item>
			<title>Kyowa Kirin axes Parkinson&#039;s drug development</title>
			<atom:link href="https://biospectrumasia.com/news/50/20751/kyowa-kirin-axes-parkinsons-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20751/kyowa-kirin-axes-parkinsons-drug-development.html</link>
			<pubDate>Mon, 25 Jul 2022 21:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20751/kyowa-kirin-axes-parkinsons-drug-development.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sosei partners with Cancer Research UK for cancer trials   </title>
			<atom:link href="https://biospectrumasia.com/news/50/20739/japans-sosei-partners-with-cancer-research-uk-for-cancer-trials-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20739/japans-sosei-partners-with-cancer-research-uk-for-cancer-trials-.html</link>
			<pubDate>Fri, 22 Jul 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20739/japans-sosei-partners-with-cancer-research-uk-for-cancer-trials-.html</guid>
		</item>	
				<item>
			<title>Japan-based Astellas Pharma to open new biotech campus in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/20744/japan-based-astellas-pharma-to-open-new-biotech-campus-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20744/japan-based-astellas-pharma-to-open-new-biotech-campus-in-us.html</link>
			<pubDate>Fri, 22 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-20744.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20744/japan-based-astellas-pharma-to-open-new-biotech-campus-in-us.html</guid>
		</item>	
				<item>
			<title>FDA grants orphan drug status to Sumitomo brain cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/20716/fda-grants-orphan-drug-status-to-sumitomo-brain-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20716/fda-grants-orphan-drug-status-to-sumitomo-brain-cancer-drug-.html</link>
			<pubDate>Tue, 19 Jul 2022 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20716/fda-grants-orphan-drug-status-to-sumitomo-brain-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Heidelberg Pharma inks deal worth â‚¬ 105 M with Japan&#039;s Chiome Bioscience</title>
			<atom:link href="https://biospectrumasia.com/news/50/20696/heidelberg-pharma-inks-deal-worth-105-m-with-japans-chiome-bioscience.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20696/heidelberg-pharma-inks-deal-worth-105-m-with-japans-chiome-bioscience.html</link>
			<pubDate>Mon, 18 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-20696.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20696/heidelberg-pharma-inks-deal-worth-105-m-with-japans-chiome-bioscience.html</guid>
		</item>	
				<item>
			<title>Japanese startup Elix introduces &#039;all-in-one&#039; platform for AI drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/20698/japanese-startup-elix-introduces-all-in-one-platform-for-ai-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20698/japanese-startup-elix-introduces-all-in-one-platform-for-ai-drug-discovery.html</link>
			<pubDate>Fri, 15 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-20698.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20698/japanese-startup-elix-introduces-all-in-one-platform-for-ai-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan-based 3D-printed prosthetic legs maker Instalimb raises Â¥ 445 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/20680/japan-based-3d-printed-prosthetic-legs-maker-instalimb-raises-445-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20680/japan-based-3d-printed-prosthetic-legs-maker-instalimb-raises-445-m.html</link>
			<pubDate>Wed, 13 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/instalimb-20680.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20680/japan-based-3d-printed-prosthetic-legs-maker-instalimb-raises-445-m.html</guid>
		</item>	
				<item>
			<title>Aculys Pharma, SUSMED to conduct world&#039;s first clinical trial using blockchain</title>
			<atom:link href="https://biospectrumasia.com/news/50/20685/aculys-pharma-susmed-to-conduct-worlds-first-clinical-trial-using-blockchain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20685/aculys-pharma-susmed-to-conduct-worlds-first-clinical-trial-using-blockchain.html</link>
			<pubDate>Wed, 13 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_133503068-20685.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20685/aculys-pharma-susmed-to-conduct-worlds-first-clinical-trial-using-blockchain.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe to sell Lilly&#039;s tirzepatide in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20674/mitsubishi-tanabe-to-sell-lillys-tirzepatide-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20674/mitsubishi-tanabe-to-sell-lillys-tirzepatide-in-japan.html</link>
			<pubDate>Tue, 12 Jul 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20674/mitsubishi-tanabe-to-sell-lillys-tirzepatide-in-japan.html</guid>
		</item>	
				<item>
			<title>Fujitsu develops new technology for accurately estimating postures of human body</title>
			<atom:link href="https://biospectrumasia.com/news/50/20670/fujitsu-develops-new-technology-for-accurately-estimating-postures-of-human-body.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20670/fujitsu-develops-new-technology-for-accurately-estimating-postures-of-human-body.html</link>
			<pubDate>Mon, 11 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20670.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20670/fujitsu-develops-new-technology-for-accurately-estimating-postures-of-human-body.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi seeks China approval for COVID-19 treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/20666/japans-shionogi-seeks-china-approval-for-covid-19-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20666/japans-shionogi-seeks-china-approval-for-covid-19-treatment.html</link>
			<pubDate>Fri, 08 Jul 2022 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-20666.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20666/japans-shionogi-seeks-china-approval-for-covid-19-treatment.html</guid>
		</item>	
				<item>
			<title>Eli Lilly Japan inks deal with Mitsubishi Tanabe for diabetes treatment </title>
			<atom:link href="https://biospectrumasia.com/news/50/20657/eli-lilly-japan-inks-deal-with-mitsubishi-tanabe-for-diabetes-treatment-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20657/eli-lilly-japan-inks-deal-with-mitsubishi-tanabe-for-diabetes-treatment-.html</link>
			<pubDate>Thu, 07 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-20657.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20657/eli-lilly-japan-inks-deal-with-mitsubishi-tanabe-for-diabetes-treatment-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma partners with Mogrify to address sensorineural hearing loss</title>
			<atom:link href="https://biospectrumasia.com/news/50/20646/japans-astellas-pharma-partners-with-mogrify-to-address-sensorineural-hearing-loss.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20646/japans-astellas-pharma-partners-with-mogrify-to-address-sensorineural-hearing-loss.html</link>
			<pubDate>Wed, 06 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20646.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20646/japans-astellas-pharma-partners-with-mogrify-to-address-sensorineural-hearing-loss.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s EditForce &amp; Mitsubishi ink gene therapy deal for Â¥20 B  </title>
			<atom:link href="https://biospectrumasia.com/news/50/20638/japans-editforce-mitsubishi-ink-gene-therapy-deal-for-20-b-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20638/japans-editforce-mitsubishi-ink-gene-therapy-deal-for-20-b-.html</link>
			<pubDate>Tue, 05 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-20638.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20638/japans-editforce-mitsubishi-ink-gene-therapy-deal-for-20-b-.html</guid>
		</item>	
				<item>
			<title>Richard Fabian named Chief Executive Officer of FUJIFILM Sonosite</title>
			<atom:link href="https://biospectrumasia.com/news/50/20627/richard-fabian-named-chief-executive-officer-of-fujifilm-sonosite.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20627/richard-fabian-named-chief-executive-officer-of-fujifilm-sonosite.html</link>
			<pubDate>Mon, 04 Jul 2022 21:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1517670491138-20627.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20627/richard-fabian-named-chief-executive-officer-of-fujifilm-sonosite.html</guid>
		</item>	
				<item>
			<title>Fujifilm invests $1.6 B to expand global offering of cell culture manufacturing services</title>
			<atom:link href="https://biospectrumasia.com/news/50/20630/fujifilm-invests-1-6-b-to-expand-global-offering-of-cell-culture-manufacturing-services.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20630/fujifilm-invests-1-6-b-to-expand-global-offering-of-cell-culture-manufacturing-services.html</link>
			<pubDate>Mon, 04 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_162650075-20630.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20630/fujifilm-invests-1-6-b-to-expand-global-offering-of-cell-culture-manufacturing-services.html</guid>
		</item>	
				<item>
			<title>Generian and Astellas to discover and develop novel small molecules For undruggable targets</title>
			<atom:link href="https://biospectrumasia.com/news/50/20616/generian-and-astellas-to-discover-and-develop-novel-small-molecules-for-undruggable-targets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20616/generian-and-astellas-to-discover-and-develop-novel-small-molecules-for-undruggable-targets.html</link>
			<pubDate>Fri, 01 Jul 2022 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20616/generian-and-astellas-to-discover-and-develop-novel-small-molecules-for-undruggable-targets.html</guid>
		</item>	
				<item>
			<title>Catalent expands primary packaging capabilities in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20596/catalent-expands-primary-packaging-capabilities-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20596/catalent-expands-primary-packaging-capabilities-in-japan.html</link>
			<pubDate>Fri, 01 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed_9_-20596.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20596/catalent-expands-primary-packaging-capabilities-in-japan.html</guid>
		</item>	
				<item>
			<title>Novel AI-driven automation platform enables optimization of laboratory protocols</title>
			<atom:link href="https://biospectrumasia.com/news/50/20621/novel-ai-driven-automation-platform-enables-optimization-of-laboratory-protocols.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20621/novel-ai-driven-automation-platform-enables-optimization-of-laboratory-protocols.html</link>
			<pubDate>Fri, 01 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik87654321-20621.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20621/novel-ai-driven-automation-platform-enables-optimization-of-laboratory-protocols.html</guid>
		</item>	
				<item>
			<title>Astellas and Sutro Biopharma partner to advance novel immunostimulatory antibody-drug conjugates (iADCs)</title>
			<atom:link href="https://biospectrumasia.com/news/50/20605/astellas-and-sutro-biopharma-partner-to-advance-novel-immunostimulatory-antibody-drug-conjugates-iadcs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20605/astellas-and-sutro-biopharma-partner-to-advance-novel-immunostimulatory-antibody-drug-conjugates-iadcs.html</link>
			<pubDate>Thu, 30 Jun 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20605/astellas-and-sutro-biopharma-partner-to-advance-novel-immunostimulatory-antibody-drug-conjugates-iadcs.html</guid>
		</item>	
				<item>
			<title>Labcorp plans expansion in Japan through BML collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/50/20590/labcorp-plans-expansion-in-japan-through-bml-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20590/labcorp-plans-expansion-in-japan-through-bml-collaboration.html</link>
			<pubDate>Wed, 29 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20590.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20590/labcorp-plans-expansion-in-japan-through-bml-collaboration.html</guid>
		</item>	
				<item>
			<title>Sanofi partners with Health2Sync for diabetes management in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20580/sanofi-partners-with-health2sync-for-diabetes-management-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20580/sanofi-partners-with-health2sync-for-diabetes-management-in-japan.html</link>
			<pubDate>Tue, 28 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_171674909-20580.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20580/sanofi-partners-with-health2sync-for-diabetes-management-in-japan.html</guid>
		</item>	
				<item>
			<title>KYORIN partners with CellGenTech for Fabry Disease </title>
			<atom:link href="https://biospectrumasia.com/news/50/20570/kyorin-partners-with-cellgentech-for-fabry-disease-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20570/kyorin-partners-with-cellgentech-for-fabry-disease-.html</link>
			<pubDate>Mon, 27 Jun 2022 20:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20570/kyorin-partners-with-cellgentech-for-fabry-disease-.html</guid>
		</item>	
				<item>
			<title>Japan discovers new type of bone repairing material</title>
			<atom:link href="https://biospectrumasia.com/news/50/20575/japan-discovers-new-type-of-bone-repairing-material.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20575/japan-discovers-new-type-of-bone-repairing-material.html</link>
			<pubDate>Mon, 27 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20575.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20575/japan-discovers-new-type-of-bone-repairing-material.html</guid>
		</item>	
				<item>
			<title>Japan-based Fujirebio acquires ADx Neurosciences for â‚¬40 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/20562/japan-based-fujirebio-acquires-adx-neurosciences-for-40-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20562/japan-based-fujirebio-acquires-adx-neurosciences-for-40-m.html</link>
			<pubDate>Fri, 24 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-20562.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20562/japan-based-fujirebio-acquires-adx-neurosciences-for-40-m.html</guid>
		</item>	
				<item>
			<title>Fujitsu, Salesforce start collaboration on healthcare solutions for Japan market</title>
			<atom:link href="https://biospectrumasia.com/news/50/20551/fujitsu-salesforce-start-collaboration-on-healthcare-solutions-for-japan-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20551/fujitsu-salesforce-start-collaboration-on-healthcare-solutions-for-japan-market.html</link>
			<pubDate>Thu, 23 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-20551.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20551/fujitsu-salesforce-start-collaboration-on-healthcare-solutions-for-japan-market.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nippon Express launches new service for vaccine transport </title>
			<atom:link href="https://biospectrumasia.com/news/50/20545/japans-nippon-express-launches-new-service-for-vaccine-transport-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20545/japans-nippon-express-launches-new-service-for-vaccine-transport-.html</link>
			<pubDate>Tue, 21 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4-20545.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20545/japans-nippon-express-launches-new-service-for-vaccine-transport-.html</guid>
		</item>	
				<item>
			<title>Saint-Gobain Life Sciences expands manufacturing capacity in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/20518/saint-gobain-life-sciences-expands-manufacturing-capacity-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20518/saint-gobain-life-sciences-expands-manufacturing-capacity-in-japan-.html</link>
			<pubDate>Fri, 17 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20518.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20518/saint-gobain-life-sciences-expands-manufacturing-capacity-in-japan-.html</guid>
		</item>	
				<item>
			<title>Shionogi expands access to Cefiderocol in 135 countries to treat bacterial infections</title>
			<atom:link href="https://biospectrumasia.com/news/50/20509/shionogi-expands-access-to-cefiderocol-in-135-countries-to-treat-bacterial-infections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20509/shionogi-expands-access-to-cefiderocol-in-135-countries-to-treat-bacterial-infections.html</link>
			<pubDate>Wed, 15 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-20509.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20509/shionogi-expands-access-to-cefiderocol-in-135-countries-to-treat-bacterial-infections.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s dengue vaccine proves protection through 4.5 yrs of clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/20513/takedas-dengue-vaccine-proves-protection-through-4-5-yrs-of-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20513/takedas-dengue-vaccine-proves-protection-through-4-5-yrs-of-clinical-trials.html</link>
			<pubDate>Wed, 15 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20513.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20513/takedas-dengue-vaccine-proves-protection-through-4-5-yrs-of-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Shimadzu Medical Systems announces release of new angiography system</title>
			<atom:link href="https://biospectrumasia.com/news/50/20493/shimadzu-medical-systems-announces-release-of-new-angiography-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20493/shimadzu-medical-systems-announces-release-of-new-angiography-system.html</link>
			<pubDate>Mon, 13 Jun 2022 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20493/shimadzu-medical-systems-announces-release-of-new-angiography-system.html</guid>
		</item>	
				<item>
			<title>Nippon Express launches ultra-low temp-controlled pharma logistics service </title>
			<atom:link href="https://biospectrumasia.com/news/50/20475/nippon-express-launches-ultra-low-temp-controlled-pharma-logistics-service-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20475/nippon-express-launches-ultra-low-temp-controlled-pharma-logistics-service-.html</link>
			<pubDate>Mon, 13 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20475.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20475/nippon-express-launches-ultra-low-temp-controlled-pharma-logistics-service-.html</guid>
		</item>	
				<item>
			<title>Shimadzu releases high-performance LCMS-2050</title>
			<atom:link href="https://biospectrumasia.com/news/50/20763/shimadzu-releases-high-performance-lcms-2050.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20763/shimadzu-releases-high-performance-lcms-2050.html</link>
			<pubDate>Sat, 11 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-20763.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20763/shimadzu-releases-high-performance-lcms-2050.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas opens office in Saudi Arabia</title>
			<atom:link href="https://biospectrumasia.com/news/50/20476/japans-astellas-opens-office-in-saudi-arabia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20476/japans-astellas-opens-office-in-saudi-arabia.html</link>
			<pubDate>Fri, 10 Jun 2022 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20476/japans-astellas-opens-office-in-saudi-arabia.html</guid>
		</item>	
				<item>
			<title>Major milestone for secondary fracture prevention announced in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20465/major-milestone-for-secondary-fracture-prevention-announced-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20465/major-milestone-for-secondary-fracture-prevention-announced-in-japan.html</link>
			<pubDate>Fri, 10 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20465.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20465/major-milestone-for-secondary-fracture-prevention-announced-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Marubeni invests in Lunatus, a Middle East healthcare turnkey solutions provider</title>
			<atom:link href="https://biospectrumasia.com/news/50/20461/japans-marubeni-invests-in-lunatus-a-middle-east-healthcare-turnkey-solutions-provider.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20461/japans-marubeni-invests-in-lunatus-a-middle-east-healthcare-turnkey-solutions-provider.html</link>
			<pubDate>Thu, 09 Jun 2022 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20461/japans-marubeni-invests-in-lunatus-a-middle-east-healthcare-turnkey-solutions-provider.html</guid>
		</item>	
				<item>
			<title>Japanese startup LUCA Science raises $30.3 M in Series B funding </title>
			<atom:link href="https://biospectrumasia.com/news/50/20436/japanese-startup-luca-science-raises-30-3-m-in-series-b-funding-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20436/japanese-startup-luca-science-raises-30-3-m-in-series-b-funding-.html</link>
			<pubDate>Mon, 06 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20436.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20436/japanese-startup-luca-science-raises-30-3-m-in-series-b-funding-.html</guid>
		</item>	
				<item>
			<title>Megakaryon Corporation starts first-in-human trial of Allogenic Human iPSC-Derived HLA Homozygous Platelets (MEG-002)</title>
			<atom:link href="https://biospectrumasia.com/news/50/20428/megakaryon-corporation-starts-first-in-human-trial-of-allogenic-human-ipsc-derived-hla-homozygous-platelets-meg-002.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20428/megakaryon-corporation-starts-first-in-human-trial-of-allogenic-human-ipsc-derived-hla-homozygous-platelets-meg-002.html</link>
			<pubDate>Fri, 03 Jun 2022 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20428/megakaryon-corporation-starts-first-in-human-trial-of-allogenic-human-ipsc-derived-hla-homozygous-platelets-meg-002.html</guid>
		</item>	
				<item>
			<title>Biogen and Samsung Bioepis&#039; BYOOVIZ (ranibizumab-nuna) launches in the United States</title>
			<atom:link href="https://biospectrumasia.com/news/50/20429/biogen-and-samsung-bioepis-byooviz-ranibizumab-nuna-launches-in-the-united-states.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20429/biogen-and-samsung-bioepis-byooviz-ranibizumab-nuna-launches-in-the-united-states.html</link>
			<pubDate>Fri, 03 Jun 2022 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20429/biogen-and-samsung-bioepis-byooviz-ranibizumab-nuna-launches-in-the-united-states.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo to commercialise mRNA vaccine against COVID-19 in 2022</title>
			<atom:link href="https://biospectrumasia.com/news/50/20434/japans-daiichi-sankyo-to-commercialise-mrna-vaccine-against-covid-19-in-2022.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20434/japans-daiichi-sankyo-to-commercialise-mrna-vaccine-against-covid-19-in-2022.html</link>
			<pubDate>Fri, 03 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/13-20434.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20434/japans-daiichi-sankyo-to-commercialise-mrna-vaccine-against-covid-19-in-2022.html</guid>
		</item>	
				<item>
			<title>Japan approves ViiV Healthcare&#039;s combination drug for HIV </title>
			<atom:link href="https://biospectrumasia.com/news/50/20415/japan-approves-viiv-healthcares-combination-drug-for-hiv-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20415/japan-approves-viiv-healthcares-combination-drug-for-hiv-.html</link>
			<pubDate>Thu, 02 Jun 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20415.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20415/japan-approves-viiv-healthcares-combination-drug-for-hiv-.html</guid>
		</item>	
				<item>
			<title>Moderna to become marketing authorization holder in Japan for Spikevax COVID-19 Vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/20406/moderna-to-become-marketing-authorization-holder-in-japan-for-spikevax-covid-19-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20406/moderna-to-become-marketing-authorization-holder-in-japan-for-spikevax-covid-19-vaccine.html</link>
			<pubDate>Thu, 02 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_117541078-20406.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20406/moderna-to-become-marketing-authorization-holder-in-japan-for-spikevax-covid-19-vaccine.html</guid>
		</item>	
				<item>
			<title>Astellas and GO Therapeutics partner to develop novel antibodies for Immuno-Oncology</title>
			<atom:link href="https://biospectrumasia.com/news/50/20407/astellas-and-go-therapeutics-partner-to-develop-novel-antibodies-for-immuno-oncology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20407/astellas-and-go-therapeutics-partner-to-develop-novel-antibodies-for-immuno-oncology.html</link>
			<pubDate>Wed, 01 Jun 2022 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20407/astellas-and-go-therapeutics-partner-to-develop-novel-antibodies-for-immuno-oncology.html</guid>
		</item>	
				<item>
			<title>Eurofins enhances clinical and biopharma services in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20396/eurofins-enhances-clinical-and-biopharma-services-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20396/eurofins-enhances-clinical-and-biopharma-services-in-japan.html</link>
			<pubDate>Tue, 31 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-20396.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20396/eurofins-enhances-clinical-and-biopharma-services-in-japan.html</guid>
		</item>	
				<item>
			<title>Chugai launches Vabysmo Intravitreal Injection in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/20379/chugai-launches-vabysmo-intravitreal-injection-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20379/chugai-launches-vabysmo-intravitreal-injection-in-japan-.html</link>
			<pubDate>Fri, 27 May 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20379/chugai-launches-vabysmo-intravitreal-injection-in-japan-.html</guid>
		</item>	
				<item>
			<title>Otsuka partners with Ai-Brainscience&#039;s for cognitive test app in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20361/otsuka-partners-with-ai-brainsciences-for-cognitive-test-app-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20361/otsuka-partners-with-ai-brainsciences-for-cognitive-test-app-in-japan.html</link>
			<pubDate>Wed, 25 May 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20361/otsuka-partners-with-ai-brainsciences-for-cognitive-test-app-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan launches new treatment for chronic constipation</title>
			<atom:link href="https://biospectrumasia.com/news/50/20367/japan-launches-new-treatment-for-chronic-constipation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20367/japan-launches-new-treatment-for-chronic-constipation.html</link>
			<pubDate>Wed, 25 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-20367.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20367/japan-launches-new-treatment-for-chronic-constipation.html</guid>
		</item>	
				<item>
			<title>Japan develops desktop-sized air-curtain to inactivate coronavirus particles</title>
			<atom:link href="https://biospectrumasia.com/news/50/20368/japan-develops-desktop-sized-air-curtain-to-inactivate-coronavirus-particles.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20368/japan-develops-desktop-sized-air-curtain-to-inactivate-coronavirus-particles.html</link>
			<pubDate>Wed, 25 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-20368.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20368/japan-develops-desktop-sized-air-curtain-to-inactivate-coronavirus-particles.html</guid>
		</item>	
				<item>
			<title>Mitsubishi announces FDA approval of RADICAVA ORS (edaravone) for the treatment of ALS</title>
			<atom:link href="https://biospectrumasia.com/news/50/20353/mitsubishi-announces-fda-approval-of-radicava-ors-edaravone-for-the-treatment-of-als.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20353/mitsubishi-announces-fda-approval-of-radicava-ors-edaravone-for-the-treatment-of-als.html</link>
			<pubDate>Tue, 24 May 2022 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20353/mitsubishi-announces-fda-approval-of-radicava-ors-edaravone-for-the-treatment-of-als.html</guid>
		</item>	
				<item>
			<title>Otsuka Pharmaceutical terminates agreement with Akebia Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/20346/otsuka-pharmaceutical-terminates-agreement-with-akebia-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20346/otsuka-pharmaceutical-terminates-agreement-with-akebia-therapeutics.html</link>
			<pubDate>Mon, 23 May 2022 17:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20346/otsuka-pharmaceutical-terminates-agreement-with-akebia-therapeutics.html</guid>
		</item>	
				<item>
			<title>Japan sets new model case of personalised healthcare based on wearable tracking devices</title>
			<atom:link href="https://biospectrumasia.com/news/50/20350/japan-sets-new-model-case-of-personalised-healthcare-based-on-wearable-tracking-devices.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20350/japan-sets-new-model-case-of-personalised-healthcare-based-on-wearable-tracking-devices.html</link>
			<pubDate>Mon, 23 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20350.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20350/japan-sets-new-model-case-of-personalised-healthcare-based-on-wearable-tracking-devices.html</guid>
		</item>	
				<item>
			<title>Kyowa Kirin to build new biopharma API building</title>
			<atom:link href="https://biospectrumasia.com/news/50/20329/kyowa-kirin-to-build-new-biopharma-api-building.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20329/kyowa-kirin-to-build-new-biopharma-api-building.html</link>
			<pubDate>Fri, 20 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-20329.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20329/kyowa-kirin-to-build-new-biopharma-api-building.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT advances global fight against infectious diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/20335/japans-ghit-advances-global-fight-against-infectious-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20335/japans-ghit-advances-global-fight-against-infectious-diseases.html</link>
			<pubDate>Thu, 19 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_142053856-20335.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20335/japans-ghit-advances-global-fight-against-infectious-diseases.html</guid>
		</item>	
				<item>
			<title>LUCA Science and Kyowa Kirin announce joint research agreement on mitochondrial disease treatment with novel mitochondria modality</title>
			<atom:link href="https://biospectrumasia.com/news/50/20313/luca-science-and-kyowa-kirin-announce-joint-research-agreement-on-mitochondrial-disease-treatment-with-novel-mitochondria-modality.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20313/luca-science-and-kyowa-kirin-announce-joint-research-agreement-on-mitochondrial-disease-treatment-with-novel-mitochondria-modality.html</link>
			<pubDate>Wed, 18 May 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20313/luca-science-and-kyowa-kirin-announce-joint-research-agreement-on-mitochondrial-disease-treatment-with-novel-mitochondria-modality.html</guid>
		</item>	
				<item>
			<title>Limaca Medical and HekaBio announce partnership</title>
			<atom:link href="https://biospectrumasia.com/news/50/20307/limaca-medical-and-hekabio-announce-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20307/limaca-medical-and-hekabio-announce-partnership.html</link>
			<pubDate>Tue, 17 May 2022 17:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-20307.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20307/limaca-medical-and-hekabio-announce-partnership.html</guid>
		</item>	
				<item>
			<title>Japanese firms initiate joint research on next-gen IT drug discovery technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/20302/japanese-firms-initiate-joint-research-on-next-gen-it-drug-discovery-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20302/japanese-firms-initiate-joint-research-on-next-gen-it-drug-discovery-technology.html</link>
			<pubDate>Tue, 17 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_rendering_medical_artificial_intelligence_robot_31965_5171-20302.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20302/japanese-firms-initiate-joint-research-on-next-gen-it-drug-discovery-technology.html</guid>
		</item>	
				<item>
			<title>Japanese life science research market secures Protein Footprinting Products </title>
			<atom:link href="https://biospectrumasia.com/news/50/20303/japanese-life-science-research-market-secures-protein-footprinting-products-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20303/japanese-life-science-research-market-secures-protein-footprinting-products-.html</link>
			<pubDate>Tue, 17 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the_flash_oxidation_fox_system_for_hrpf_analysis-20303.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20303/japanese-life-science-research-market-secures-protein-footprinting-products-.html</guid>
		</item>	
				<item>
			<title>Novo Holdings, Shionogi offer treatment for invasive fungal infections in Europe and Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/20293/novo-holdings-shionogi-offer-treatment-for-invasive-fungal-infections-in-europe-and-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20293/novo-holdings-shionogi-offer-treatment-for-invasive-fungal-infections-in-europe-and-asia.html</link>
			<pubDate>Mon, 16 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20293.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20293/novo-holdings-shionogi-offer-treatment-for-invasive-fungal-infections-in-europe-and-asia.html</guid>
		</item>	
				<item>
			<title>I Peace accelerates allogeneic iPSC-derived cell therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/20280/i-peace-accelerates-allogeneic-ipsc-derived-cell-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20280/i-peace-accelerates-allogeneic-ipsc-derived-cell-therapies.html</link>
			<pubDate>Thu, 12 May 2022 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20280/i-peace-accelerates-allogeneic-ipsc-derived-cell-therapies.html</guid>
		</item>	
				<item>
			<title>Cullinan Oncology and Taiho Pharmaceutical to develop and commercialize CLN-081/TAS6417 </title>
			<atom:link href="https://biospectrumasia.com/news/50/20279/cullinan-oncology-and-taiho-pharmaceutical-to-develop-and-commercialize-cln-081-tas6417-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20279/cullinan-oncology-and-taiho-pharmaceutical-to-develop-and-commercialize-cln-081-tas6417-.html</link>
			<pubDate>Thu, 12 May 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20279/cullinan-oncology-and-taiho-pharmaceutical-to-develop-and-commercialize-cln-081-tas6417-.html</guid>
		</item>	
				<item>
			<title>Crown Bioscience to provide preclinical and translational services in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20276/crown-bioscience-to-provide-preclinical-and-translational-services-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20276/crown-bioscience-to-provide-preclinical-and-translational-services-in-japan.html</link>
			<pubDate>Thu, 12 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_135415067-20276.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20276/crown-bioscience-to-provide-preclinical-and-translational-services-in-japan.html</guid>
		</item>	
				<item>
			<title>Eiger BioPharmaceuticals and AnGes partner for regulatory approval and commercialization of Zokinvy (lonafarnib) in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20269/eiger-biopharmaceuticals-and-anges-partner-for-regulatory-approval-and-commercialization-of-zokinvy-lonafarnib-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20269/eiger-biopharmaceuticals-and-anges-partner-for-regulatory-approval-and-commercialization-of-zokinvy-lonafarnib-in-japan.html</link>
			<pubDate>Wed, 11 May 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20269/eiger-biopharmaceuticals-and-anges-partner-for-regulatory-approval-and-commercialization-of-zokinvy-lonafarnib-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai submits biologics license application for Alzheimer&#039;s drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/20260/eisai-submits-biologics-license-application-for-alzheimers-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20260/eisai-submits-biologics-license-application-for-alzheimers-drug.html</link>
			<pubDate>Tue, 10 May 2022 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20260/eisai-submits-biologics-license-application-for-alzheimers-drug.html</guid>
		</item>	
				<item>
			<title>Japan-based Hitachi advances molecular diagnostics and precision medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/20262/japan-based-hitachi-advances-molecular-diagnostics-and-precision-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20262/japan-based-hitachi-advances-molecular-diagnostics-and-precision-medicine.html</link>
			<pubDate>Tue, 10 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_146497574-20262.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20262/japan-based-hitachi-advances-molecular-diagnostics-and-precision-medicine.html</guid>
		</item>	
				<item>
			<title>ExoCoBio receives Japanese patent for alleviating dermatitis with exosome-based medicines</title>
			<atom:link href="https://biospectrumasia.com/news/50/20255/exocobio-receives-japanese-patent-for-alleviating-dermatitis-with-exosome-based-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20255/exocobio-receives-japanese-patent-for-alleviating-dermatitis-with-exosome-based-medicines.html</link>
			<pubDate>Mon, 09 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20255.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20255/exocobio-receives-japanese-patent-for-alleviating-dermatitis-with-exosome-based-medicines.html</guid>
		</item>	
				<item>
			<title>Takeda opens plant in Ireland </title>
			<atom:link href="https://biospectrumasia.com/news/50/20240/takeda-opens-plant-in-ireland-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20240/takeda-opens-plant-in-ireland-.html</link>
			<pubDate>Fri, 06 May 2022 19:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20240/takeda-opens-plant-in-ireland-.html</guid>
		</item>	
				<item>
			<title>CureApp receives world-first approval of digital therapeutic app for hypertension</title>
			<atom:link href="https://biospectrumasia.com/news/50/20242/cureapp-receives-world-first-approval-of-digital-therapeutic-app-for-hypertension.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20242/cureapp-receives-world-first-approval-of-digital-therapeutic-app-for-hypertension.html</link>
			<pubDate>Fri, 06 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20242.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20242/cureapp-receives-world-first-approval-of-digital-therapeutic-app-for-hypertension.html</guid>
		</item>	
				<item>
			<title>Aurion Biotech raises $120 million</title>
			<atom:link href="https://biospectrumasia.com/news/50/20230/aurion-biotech-raises-120-million.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20230/aurion-biotech-raises-120-million.html</link>
			<pubDate>Thu, 05 May 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-20230.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20230/aurion-biotech-raises-120-million.html</guid>
		</item>	
				<item>
			<title>Jazz Pharma and Sumitomo Pharma to develop therapies for sleep disorders </title>
			<atom:link href="https://biospectrumasia.com/news/50/20226/jazz-pharma-and-sumitomo-pharma-to-develop-therapies-for-sleep-disorders-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20226/jazz-pharma-and-sumitomo-pharma-to-develop-therapies-for-sleep-disorders-.html</link>
			<pubDate>Thu, 05 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20226.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20226/jazz-pharma-and-sumitomo-pharma-to-develop-therapies-for-sleep-disorders-.html</guid>
		</item>	
				<item>
			<title>Japanese population projected to live longer without dementia: Study</title>
			<atom:link href="https://biospectrumasia.com/news/50/20221/japanese-population-projected-to-live-longer-without-dementia-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20221/japanese-population-projected-to-live-longer-without-dementia-study.html</link>
			<pubDate>Wed, 04 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_240098272-20221.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20221/japanese-population-projected-to-live-longer-without-dementia-study.html</guid>
		</item>	
				<item>
			<title>Incyte and Maruho lay focus on inflammatory dermatologic diseases in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20207/incyte-and-maruho-lay-focus-on-inflammatory-dermatologic-diseases-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20207/incyte-and-maruho-lay-focus-on-inflammatory-dermatologic-diseases-in-japan.html</link>
			<pubDate>Tue, 03 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-20207.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20207/incyte-and-maruho-lay-focus-on-inflammatory-dermatologic-diseases-in-japan.html</guid>
		</item>	
				<item>
			<title>Healion Bio, FUJIFILM Toyama co-explore promising COVID-19 oral antiviral drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/20198/healion-bio-fujifilm-toyama-co-explore-promising-covid-19-oral-antiviral-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20198/healion-bio-fujifilm-toyama-co-explore-promising-covid-19-oral-antiviral-drug.html</link>
			<pubDate>Fri, 29 Apr 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-20198.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20198/healion-bio-fujifilm-toyama-co-explore-promising-covid-19-oral-antiviral-drug.html</guid>
		</item>	
				<item>
			<title>ViGeneron, Daiichi Sankyo to develop novel gene therapy for prevalent eye diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/20202/vigeneron-daiichi-sankyo-to-develop-novel-gene-therapy-for-prevalent-eye-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20202/vigeneron-daiichi-sankyo-to-develop-novel-gene-therapy-for-prevalent-eye-diseases.html</link>
			<pubDate>Fri, 29 Apr 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-20202.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20202/vigeneron-daiichi-sankyo-to-develop-novel-gene-therapy-for-prevalent-eye-diseases.html</guid>
		</item>	
				<item>
			<title>Japan deploys AI technology for detecting pancreatic cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/20195/japan-deploys-ai-technology-for-detecting-pancreatic-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20195/japan-deploys-ai-technology-for-detecting-pancreatic-cancer.html</link>
			<pubDate>Fri, 29 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_133503068-20195.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20195/japan-deploys-ai-technology-for-detecting-pancreatic-cancer.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sumitomo Pharma takes license to CRISPR/Cas9 patent portfolio from ERS Genomics</title>
			<atom:link href="https://biospectrumasia.com/news/50/20186/japans-sumitomo-pharma-takes-license-to-crispr-cas9-patent-portfolio-from-ers-genomics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20186/japans-sumitomo-pharma-takes-license-to-crispr-cas9-patent-portfolio-from-ers-genomics.html</link>
			<pubDate>Thu, 28 Apr 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-20186.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20186/japans-sumitomo-pharma-takes-license-to-crispr-cas9-patent-portfolio-from-ers-genomics.html</guid>
		</item>	
				<item>
			<title>Shionogi&#039;s COVID-19 antiviral drug shows rapid virus clearance</title>
			<atom:link href="https://biospectrumasia.com/news/50/20187/shionogis-covid-19-antiviral-drug-shows-rapid-virus-clearance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20187/shionogis-covid-19-antiviral-drug-shows-rapid-virus-clearance.html</link>
			<pubDate>Thu, 28 Apr 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_31369030-20187.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20187/shionogis-covid-19-antiviral-drug-shows-rapid-virus-clearance.html</guid>
		</item>	
				<item>
			<title>Softbank invests in Japanese startup AI Medical Service Inc </title>
			<atom:link href="https://biospectrumasia.com/news/50/20179/softbank-invests-in-japanese-startup-ai-medical-service-inc-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20179/softbank-invests-in-japanese-startup-ai-medical-service-inc-.html</link>
			<pubDate>Wed, 27 Apr 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20179.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20179/softbank-invests-in-japanese-startup-ai-medical-service-inc-.html</guid>
		</item>	
				<item>
			<title>University of Tokyo, Astellas further advance development of innovative medicines</title>
			<atom:link href="https://biospectrumasia.com/news/50/20173/university-of-tokyo-astellas-further-advance-development-of-innovative-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20173/university-of-tokyo-astellas-further-advance-development-of-innovative-medicines.html</link>
			<pubDate>Wed, 27 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-20173.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20173/university-of-tokyo-astellas-further-advance-development-of-innovative-medicines.html</guid>
		</item>	
				<item>
			<title>Ubie, Japanese HealthTech Startup, launches AI-powered symptom checker in the US </title>
			<atom:link href="https://biospectrumasia.com/news/50/20161/ubie-japanese-healthtech-startup-launches-ai-powered-symptom-checker-in-the-us-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20161/ubie-japanese-healthtech-startup-launches-ai-powered-symptom-checker-in-the-us-.html</link>
			<pubDate>Tue, 26 Apr 2022 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_171674909-20161.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20161/ubie-japanese-healthtech-startup-launches-ai-powered-symptom-checker-in-the-us-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Asahi Kasei Medical to acquire US-based CDMO Bionova Scientific</title>
			<atom:link href="https://biospectrumasia.com/news/50/20151/japans-asahi-kasei-medical-to-acquire-us-based-cdmo-bionova-scientific.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20151/japans-asahi-kasei-medical-to-acquire-us-based-cdmo-bionova-scientific.html</link>
			<pubDate>Mon, 25 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-20151.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20151/japans-asahi-kasei-medical-to-acquire-us-based-cdmo-bionova-scientific.html</guid>
		</item>	
				<item>
			<title>NTT DATA begins offering vitals measurement service with a smartphone</title>
			<atom:link href="https://biospectrumasia.com/news/50/20141/ntt-data-begins-offering-vitals-measurement-service-with-a-smartphone.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20141/ntt-data-begins-offering-vitals-measurement-service-with-a-smartphone.html</link>
			<pubDate>Fri, 22 Apr 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20141/ntt-data-begins-offering-vitals-measurement-service-with-a-smartphone.html</guid>
		</item>	
				<item>
			<title>Idorsia&#039;s first commercial product now available for patients in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20130/idorsias-first-commercial-product-now-available-for-patients-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20130/idorsias-first-commercial-product-now-available-for-patients-in-japan.html</link>
			<pubDate>Thu, 21 Apr 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20130/idorsias-first-commercial-product-now-available-for-patients-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan offers early detection of dementia using AI vocal biomarkers</title>
			<atom:link href="https://biospectrumasia.com/news/50/20135/japan-offers-early-detection-of-dementia-using-ai-vocal-biomarkers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20135/japan-offers-early-detection-of-dementia-using-ai-vocal-biomarkers.html</link>
			<pubDate>Thu, 21 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20135.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20135/japan-offers-early-detection-of-dementia-using-ai-vocal-biomarkers.html</guid>
		</item>	
				<item>
			<title>Pangaea Data joins AstraZeneca Japan&#039;s Healthcare Innovation Network</title>
			<atom:link href="https://biospectrumasia.com/news/50/20123/pangaea-data-joins-astrazeneca-japans-healthcare-innovation-network.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20123/pangaea-data-joins-astrazeneca-japans-healthcare-innovation-network.html</link>
			<pubDate>Wed, 20 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_131746163-20123.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20123/pangaea-data-joins-astrazeneca-japans-healthcare-innovation-network.html</guid>
		</item>	
				<item>
			<title>Japan approves Novavax&#039;s COVID-19 vaccine for primary and booster immunisation</title>
			<atom:link href="https://biospectrumasia.com/news/50/20113/japan-approves-novavaxs-covid-19-vaccine-for-primary-and-booster-immunisation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20113/japan-approves-novavaxs-covid-19-vaccine-for-primary-and-booster-immunisation.html</link>
			<pubDate>Tue, 19 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_06_19_at_10_15_50_pm-20113.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20113/japan-approves-novavaxs-covid-19-vaccine-for-primary-and-booster-immunisation.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PHC receives first EU-MDR certification</title>
			<atom:link href="https://biospectrumasia.com/news/50/20100/japans-phc-receives-first-eu-mdr-certification.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20100/japans-phc-receives-first-eu-mdr-certification.html</link>
			<pubDate>Mon, 18 Apr 2022 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-20100.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20100/japans-phc-receives-first-eu-mdr-certification.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kaneka releases new PCR detection kits for Omicron and Occult Omicron variants</title>
			<atom:link href="https://biospectrumasia.com/news/50/20103/japans-kaneka-releases-new-pcr-detection-kits-for-omicron-and-occult-omicron-variants.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20103/japans-kaneka-releases-new-pcr-detection-kits-for-omicron-and-occult-omicron-variants.html</link>
			<pubDate>Mon, 18 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_104108189-20103.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20103/japans-kaneka-releases-new-pcr-detection-kits-for-omicron-and-occult-omicron-variants.html</guid>
		</item>	
				<item>
			<title>Japan develops photocatalyst for antiviral coating against COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/20095/japan-develops-photocatalyst-for-antiviral-coating-against-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20095/japan-develops-photocatalyst-for-antiviral-coating-against-covid-19.html</link>
			<pubDate>Fri, 15 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/22-20095.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20095/japan-develops-photocatalyst-for-antiviral-coating-against-covid-19.html</guid>
		</item>	
				<item>
			<title>Takeda partners with Engitix to to develop new anti-fibrotic therapies </title>
			<atom:link href="https://biospectrumasia.com/news/50/20086/takeda-partners-with-engitix-to-to-develop-new-anti-fibrotic-therapies-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20086/takeda-partners-with-engitix-to-to-develop-new-anti-fibrotic-therapies-.html</link>
			<pubDate>Thu, 14 Apr 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-20086.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20086/takeda-partners-with-engitix-to-to-develop-new-anti-fibrotic-therapies-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujifilm announces positive results of AI-based study on Alzheimer&#039;s detection</title>
			<atom:link href="https://biospectrumasia.com/news/50/20088/japans-fujifilm-announces-positive-results-of-ai-based-study-on-alzheimers-detection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20088/japans-fujifilm-announces-positive-results-of-ai-based-study-on-alzheimers-detection.html</link>
			<pubDate>Thu, 14 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20088.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20088/japans-fujifilm-announces-positive-results-of-ai-based-study-on-alzheimers-detection.html</guid>
		</item>	
				<item>
			<title>Mitsui partners with TriNetX to expand global research network in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20078/mitsui-partners-with-trinetx-to-expand-global-research-network-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20078/mitsui-partners-with-trinetx-to-expand-global-research-network-in-japan.html</link>
			<pubDate>Wed, 13 Apr 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-20078.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20078/mitsui-partners-with-trinetx-to-expand-global-research-network-in-japan.html</guid>
		</item>	
				<item>
			<title>Osaka University, Shimadzu, SIGMAXYZ collaborate for 3D bioprinting in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/20072/osaka-university-shimadzu-sigmaxyz-collaborate-for-3d-bioprinting-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20072/osaka-university-shimadzu-sigmaxyz-collaborate-for-3d-bioprinting-in-japan.html</link>
			<pubDate>Wed, 13 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20072.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20072/osaka-university-shimadzu-sigmaxyz-collaborate-for-3d-bioprinting-in-japan.html</guid>
		</item>	
				<item>
			<title>Ardelyx and Kyowa Kirin amend license agreement for Tenapanor</title>
			<atom:link href="https://biospectrumasia.com/news/50/20065/ardelyx-and-kyowa-kirin-amend-license-agreement-for-tenapanor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20065/ardelyx-and-kyowa-kirin-amend-license-agreement-for-tenapanor.html</link>
			<pubDate>Tue, 12 Apr 2022 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-20065.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20065/ardelyx-and-kyowa-kirin-amend-license-agreement-for-tenapanor.html</guid>
		</item>	
				<item>
			<title>PENTAX Medical appoints Dr Klaus Mergener as Chief Medical Officer </title>
			<atom:link href="https://biospectrumasia.com/news/50/20049/pentax-medical-appoints-dr-klaus-mergener-as-chief-medical-officer-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20049/pentax-medical-appoints-dr-klaus-mergener-as-chief-medical-officer-.html</link>
			<pubDate>Mon, 11 Apr 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drmergener-20049.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20049/pentax-medical-appoints-dr-klaus-mergener-as-chief-medical-officer-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda teams up with Evozyne to develop next-gen gene therapies </title>
			<atom:link href="https://biospectrumasia.com/news/50/20053/japans-takeda-teams-up-with-evozyne-to-develop-next-gen-gene-therapies-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20053/japans-takeda-teams-up-with-evozyne-to-develop-next-gen-gene-therapies-.html</link>
			<pubDate>Mon, 11 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_146497574-20053.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20053/japans-takeda-teams-up-with-evozyne-to-develop-next-gen-gene-therapies-.html</guid>
		</item>	
				<item>
			<title>AGC to expand synthetic pharmaceutical production base in Spain</title>
			<atom:link href="https://biospectrumasia.com/news/50/20039/agc-to-expand-synthetic-pharmaceutical-production-base-in-spain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20039/agc-to-expand-synthetic-pharmaceutical-production-base-in-spain.html</link>
			<pubDate>Fri, 08 Apr 2022 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-20039.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20039/agc-to-expand-synthetic-pharmaceutical-production-base-in-spain.html</guid>
		</item>	
				<item>
			<title>CEPI partners with Japan&#039;s NEC Group for AI-designed betacoronavirus vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/20038/cepi-partners-with-japans-nec-group-for-ai-designed-betacoronavirus-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20038/cepi-partners-with-japans-nec-group-for-ai-designed-betacoronavirus-vaccine.html</link>
			<pubDate>Fri, 08 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-20038.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20038/cepi-partners-with-japans-nec-group-for-ai-designed-betacoronavirus-vaccine.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi accelerates R&amp;D for data-driven innovation in pharmaceuticals</title>
			<atom:link href="https://biospectrumasia.com/news/50/20023/japans-shionogi-accelerates-rd-for-data-driven-innovation-in-pharmaceuticals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20023/japans-shionogi-accelerates-rd-for-data-driven-innovation-in-pharmaceuticals.html</link>
			<pubDate>Thu, 07 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_281615630-20023.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20023/japans-shionogi-accelerates-rd-for-data-driven-innovation-in-pharmaceuticals.html</guid>
		</item>	
				<item>
			<title>Iktos, Teijin Pharma to co-develop new technology for small molecule drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/20010/iktos-teijin-pharma-to-co-develop-new-technology-for-small-molecule-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20010/iktos-teijin-pharma-to-co-develop-new-technology-for-small-molecule-drug-discovery.html</link>
			<pubDate>Wed, 06 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-20010.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20010/iktos-teijin-pharma-to-co-develop-new-technology-for-small-molecule-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Chugai, Halozyme Therapeutics partner for ENHANZE Technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/20002/chugai-halozyme-therapeutics-partner-for-enhanze-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/20002/chugai-halozyme-therapeutics-partner-for-enhanze-technology.html</link>
			<pubDate>Mon, 04 Apr 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-20002.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/20002/chugai-halozyme-therapeutics-partner-for-enhanze-technology.html</guid>
		</item>	
				<item>
			<title>Otsuka and Akebia seek USFDA approval for renal anemia drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/19988/otsuka-and-akebia-seek-usfda-approval-for-renal-anemia-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19988/otsuka-and-akebia-seek-usfda-approval-for-renal-anemia-drug-.html</link>
			<pubDate>Fri, 01 Apr 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-19988.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19988/otsuka-and-akebia-seek-usfda-approval-for-renal-anemia-drug-.html</guid>
		</item>	
				<item>
			<title>HOYA Group appoints Rainer Burkard as global president of PENTAX Medical </title>
			<atom:link href="https://biospectrumasia.com/news/50/19985/hoya-group-appoints-rainer-burkard-as-global-president-of-pentax-medical-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19985/hoya-group-appoints-rainer-burkard-as-global-president-of-pentax-medical-.html</link>
			<pubDate>Fri, 01 Apr 2022 23:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19985.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19985/hoya-group-appoints-rainer-burkard-as-global-president-of-pentax-medical-.html</guid>
		</item>	
				<item>
			<title>Terumo and Glooko collaborate on new solution for diabetes data sharing</title>
			<atom:link href="https://biospectrumasia.com/news/50/19975/terumo-and-glooko-collaborate-on-new-solution-for-diabetes-data-sharing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19975/terumo-and-glooko-collaborate-on-new-solution-for-diabetes-data-sharing.html</link>
			<pubDate>Thu, 31 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19975.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19975/terumo-and-glooko-collaborate-on-new-solution-for-diabetes-data-sharing.html</guid>
		</item>	
				<item>
			<title>Japan grants marketing authorisation to Sanofi&#039;s rare disease drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/19966/japan-grants-marketing-authorisation-to-sanofis-rare-disease-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19966/japan-grants-marketing-authorisation-to-sanofis-rare-disease-drug.html</link>
			<pubDate>Wed, 30 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19966.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19966/japan-grants-marketing-authorisation-to-sanofis-rare-disease-drug.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s TAKHZYRO (lanadelumab) approved in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/19962/takedas-takhzyro-lanadelumab-approved-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19962/takedas-takhzyro-lanadelumab-approved-in-japan-.html</link>
			<pubDate>Tue, 29 Mar 2022 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19962.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19962/takedas-takhzyro-lanadelumab-approved-in-japan-.html</guid>
		</item>	
				<item>
			<title>Japan approves Tarlige tablets for treatment of patients with neuropathic pain</title>
			<atom:link href="https://biospectrumasia.com/news/50/19964/japan-approves-tarlige-tablets-for-treatment-of-patients-with-neuropathic-pain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19964/japan-approves-tarlige-tablets-for-treatment-of-patients-with-neuropathic-pain.html</link>
			<pubDate>Tue, 29 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-19964.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19964/japan-approves-tarlige-tablets-for-treatment-of-patients-with-neuropathic-pain.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s Health2Sync partners with Novo Nordisk Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/19952/taiwans-health2sync-partners-with-novo-nordisk-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19952/taiwans-health2sync-partners-with-novo-nordisk-pharma.html</link>
			<pubDate>Mon, 28 Mar 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_171674909-19952.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19952/taiwans-health2sync-partners-with-novo-nordisk-pharma.html</guid>
		</item>	
				<item>
			<title>Hyperflex balloon catheter by Endovastec receives marketing approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19946/hyperflex-balloon-catheter-by-endovastec-receives-marketing-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19946/hyperflex-balloon-catheter-by-endovastec-receives-marketing-approval-in-japan.html</link>
			<pubDate>Mon, 28 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19946.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19946/hyperflex-balloon-catheter-by-endovastec-receives-marketing-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>TANAKA develops gold shell nanoparticles using high dispersion stability</title>
			<atom:link href="https://biospectrumasia.com/news/50/19944/tanaka-develops-gold-shell-nanoparticles-using-high-dispersion-stability.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19944/tanaka-develops-gold-shell-nanoparticles-using-high-dispersion-stability.html</link>
			<pubDate>Sat, 26 Mar 2022 17:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nano_particles-19944.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19944/tanaka-develops-gold-shell-nanoparticles-using-high-dispersion-stability.html</guid>
		</item>	
				<item>
			<title>Japan verifies use of AI for retrosynthetic analysis in pharma applications</title>
			<atom:link href="https://biospectrumasia.com/news/50/19941/japan-verifies-use-of-ai-for-retrosynthetic-analysis-in-pharma-applications.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19941/japan-verifies-use-of-ai-for-retrosynthetic-analysis-in-pharma-applications.html</link>
			<pubDate>Fri, 25 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-19941.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19941/japan-verifies-use-of-ai-for-retrosynthetic-analysis-in-pharma-applications.html</guid>
		</item>	
				<item>
			<title>Fujifilm buys Shenandoah Biotechnology to strengthen life sciences biz</title>
			<atom:link href="https://biospectrumasia.com/news/50/19924/fujifilm-buys-shenandoah-biotechnology-to-strengthen-life-sciences-biz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19924/fujifilm-buys-shenandoah-biotechnology-to-strengthen-life-sciences-biz.html</link>
			<pubDate>Wed, 23 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_162650075-19924.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19924/fujifilm-buys-shenandoah-biotechnology-to-strengthen-life-sciences-biz.html</guid>
		</item>	
				<item>
			<title>Japan identifies tissue-specific exosome marker candidates from blood</title>
			<atom:link href="https://biospectrumasia.com/news/50/19906/japan-identifies-tissue-specific-exosome-marker-candidates-from-blood.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19906/japan-identifies-tissue-specific-exosome-marker-candidates-from-blood.html</link>
			<pubDate>Tue, 22 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-19906.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19906/japan-identifies-tissue-specific-exosome-marker-candidates-from-blood.html</guid>
		</item>	
				<item>
			<title>Biogen and Eisai amend collaboration agreements on Alzheimer&#039;s disease treatments</title>
			<atom:link href="https://biospectrumasia.com/news/50/19898/biogen-and-eisai-amend-collaboration-agreements-on-alzheimers-disease-treatments.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19898/biogen-and-eisai-amend-collaboration-agreements-on-alzheimers-disease-treatments.html</link>
			<pubDate>Mon, 21 Mar 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-19898.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19898/biogen-and-eisai-amend-collaboration-agreements-on-alzheimers-disease-treatments.html</guid>
		</item>	
				<item>
			<title>Singapore-based NDR Medical expands APAC presence</title>
			<atom:link href="https://biospectrumasia.com/news/50/19875/singapore-based-ndr-medical-expands-apac-presence.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19875/singapore-based-ndr-medical-expands-apac-presence.html</link>
			<pubDate>Thu, 17 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image002_2_-19875.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19875/singapore-based-ndr-medical-expands-apac-presence.html</guid>
		</item>	
				<item>
			<title>Astellas&#039; menopause drug fails in Asia trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/19868/astellas-menopause-drug-fails-in-asia-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19868/astellas-menopause-drug-fails-in-asia-trial.html</link>
			<pubDate>Wed, 16 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-19868.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19868/astellas-menopause-drug-fails-in-asia-trial.html</guid>
		</item>	
				<item>
			<title>Guardant Health receives regulatory approval for Guardant360 CDx in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/19853/guardant-health-receives-regulatory-approval-for-guardant360-cdx-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19853/guardant-health-receives-regulatory-approval-for-guardant360-cdx-in-japan-.html</link>
			<pubDate>Tue, 15 Mar 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19853/guardant-health-receives-regulatory-approval-for-guardant360-cdx-in-japan-.html</guid>
		</item>	
				<item>
			<title>Innovations in APAC have become cornerstone of future development of IVD</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/19850/innovations-in-apac-have-become-cornerstone-of-future-development-of-ivd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/19850/innovations-in-apac-have-become-cornerstone-of-future-development-of-ivd.html</link>
			<pubDate>Tue, 15 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kyon_soonpil_kosea_j-19850.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/19850/innovations-in-apac-have-become-cornerstone-of-future-development-of-ivd.html</guid>
		</item>	
				<item>
			<title>Fujifilm terminates ph III enrolment for Avigan drug trial in Japan due to omicron variant</title>
			<atom:link href="https://biospectrumasia.com/news/50/19862/fujifilm-terminates-ph-iii-enrolment-for-avigan-drug-trial-in-japan-due-to-omicron-variant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19862/fujifilm-terminates-ph-iii-enrolment-for-avigan-drug-trial-in-japan-due-to-omicron-variant.html</link>
			<pubDate>Tue, 15 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-19862.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19862/fujifilm-terminates-ph-iii-enrolment-for-avigan-drug-trial-in-japan-due-to-omicron-variant.html</guid>
		</item>	
				<item>
			<title>Japan approves Guardant Health&#039;s liquid biopsy test for tumour mutation profiling</title>
			<atom:link href="https://biospectrumasia.com/news/50/19847/japan-approves-guardant-healths-liquid-biopsy-test-for-tumour-mutation-profiling.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19847/japan-approves-guardant-healths-liquid-biopsy-test-for-tumour-mutation-profiling.html</link>
			<pubDate>Mon, 14 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/test-19847.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19847/japan-approves-guardant-healths-liquid-biopsy-test-for-tumour-mutation-profiling.html</guid>
		</item>	
				<item>
			<title>Japan develops artificial retinal device that mimics human optical illusions</title>
			<atom:link href="https://biospectrumasia.com/news/50/19835/japan-develops-artificial-retinal-device-that-mimics-human-optical-illusions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19835/japan-develops-artificial-retinal-device-that-mimics-human-optical-illusions.html</link>
			<pubDate>Fri, 11 Mar 2022 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rh74a-19835.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19835/japan-develops-artificial-retinal-device-that-mimics-human-optical-illusions.html</guid>
		</item>	
				<item>
			<title>Japanese startup launches english version of hands-on medical VR </title>
			<atom:link href="https://biospectrumasia.com/news/50/19822/japanese-startup-launches-english-version-of-hands-on-medical-vr-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19822/japanese-startup-launches-english-version-of-hands-on-medical-vr-.html</link>
			<pubDate>Thu, 10 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/english_version_hands_on_medical_vr_developed_exhibiting_at_sxsw_2022-19822.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19822/japanese-startup-launches-english-version-of-hands-on-medical-vr-.html</guid>
		</item>	
				<item>
			<title>Japan unveils Well-BeingX to shape future of wellness</title>
			<atom:link href="https://biospectrumasia.com/news/50/19816/japan-unveils-well-beingx-to-shape-future-of-wellness.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19816/japan-unveils-well-beingx-to-shape-future-of-wellness.html</link>
			<pubDate>Wed, 09 Mar 2022 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_171674909-19816.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19816/japan-unveils-well-beingx-to-shape-future-of-wellness.html</guid>
		</item>	
				<item>
			<title> Shionogi files for approval of COVID-19 drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19810/-shionogi-files-for-approval-of-covid-19-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19810/-shionogi-files-for-approval-of-covid-19-drug-in-japan.html</link>
			<pubDate>Tue, 08 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image-19810.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19810/-shionogi-files-for-approval-of-covid-19-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan uses supercomputer and AI to shed light on drug resistance in cancer treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/19797/japan-uses-supercomputer-and-ai-to-shed-light-on-drug-resistance-in-cancer-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19797/japan-uses-supercomputer-and-ai-to-shed-light-on-drug-resistance-in-cancer-treatment.html</link>
			<pubDate>Mon, 07 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-19797.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19797/japan-uses-supercomputer-and-ai-to-shed-light-on-drug-resistance-in-cancer-treatment.html</guid>
		</item>	
				<item>
			<title>Japan pledges $300 M to CEPI&#039;s pandemic preparedness plan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19752/japan-pledges-300-m-to-cepis-pandemic-preparedness-plan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19752/japan-pledges-300-m-to-cepis-pandemic-preparedness-plan.html</link>
			<pubDate>Mon, 28 Feb 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/12-19752.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19752/japan-pledges-300-m-to-cepis-pandemic-preparedness-plan.html</guid>
		</item>	
				<item>
			<title>Alvotech, Fuji Pharma expand partnership for additional biosimilar candidate in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19746/alvotech-fuji-pharma-expand-partnership-for-additional-biosimilar-candidate-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19746/alvotech-fuji-pharma-expand-partnership-for-additional-biosimilar-candidate-in-japan.html</link>
			<pubDate>Thu, 24 Feb 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications_342462_1920-19746.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19746/alvotech-fuji-pharma-expand-partnership-for-additional-biosimilar-candidate-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan proposes framework for conducting ethical research on brain organoids</title>
			<atom:link href="https://biospectrumasia.com/news/50/19740/japan-proposes-framework-for-conducting-ethical-research-on-brain-organoids.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19740/japan-proposes-framework-for-conducting-ethical-research-on-brain-organoids.html</link>
			<pubDate>Wed, 23 Feb 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/12-19740.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19740/japan-proposes-framework-for-conducting-ethical-research-on-brain-organoids.html</guid>
		</item>	
				<item>
			<title>Japan uses network models to help understand spread of new COVID-19 variants</title>
			<atom:link href="https://biospectrumasia.com/news/50/19736/japan-uses-network-models-to-help-understand-spread-of-new-covid-19-variants.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19736/japan-uses-network-models-to-help-understand-spread-of-new-covid-19-variants.html</link>
			<pubDate>Tue, 22 Feb 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/getty-19736.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19736/japan-uses-network-models-to-help-understand-spread-of-new-covid-19-variants.html</guid>
		</item>	
				<item>
			<title>Japan fabricates polymer-DNA gel that could be used in tissue regeneration and robotics</title>
			<atom:link href="https://biospectrumasia.com/news/50/19721/japan-fabricates-polymer-dna-gel-that-could-be-used-in-tissue-regeneration-and-robotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19721/japan-fabricates-polymer-dna-gel-that-could-be-used-in-tissue-regeneration-and-robotics.html</link>
			<pubDate>Thu, 17 Feb 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_10052-19721.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19721/japan-fabricates-polymer-dna-gel-that-could-be-used-in-tissue-regeneration-and-robotics.html</guid>
		</item>	
				<item>
			<title>Japan discovers host immune-dependent novel anti-coronavirus antibody</title>
			<atom:link href="https://biospectrumasia.com/news/50/19717/japan-discovers-host-immune-dependent-novel-anti-coronavirus-antibody.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19717/japan-discovers-host-immune-dependent-novel-anti-coronavirus-antibody.html</link>
			<pubDate>Wed, 16 Feb 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-19717.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19717/japan-discovers-host-immune-dependent-novel-anti-coronavirus-antibody.html</guid>
		</item>	
				<item>
			<title>Japan-based Fujifilm introduces life sciences strategic investment fund</title>
			<atom:link href="https://biospectrumasia.com/news/50/19706/japan-based-fujifilm-introduces-life-sciences-strategic-investment-fund.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19706/japan-based-fujifilm-introduces-life-sciences-strategic-investment-fund.html</link>
			<pubDate>Mon, 14 Feb 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-19706.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19706/japan-based-fujifilm-introduces-life-sciences-strategic-investment-fund.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sharp Naturizer sanitizer solution proves effectiveness against COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/19699/japans-sharp-naturizer-sanitizer-solution-proves-effectiveness-against-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19699/japans-sharp-naturizer-sanitizer-solution-proves-effectiveness-against-covid-19.html</link>
			<pubDate>Thu, 10 Feb 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image-19699.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19699/japans-sharp-naturizer-sanitizer-solution-proves-effectiveness-against-covid-19.html</guid>
		</item>	
				<item>
			<title>Japanese firms ink new business partnership worth Â¥5 B for mental healthcare</title>
			<atom:link href="https://biospectrumasia.com/news/50/19656/japanese-firms-ink-new-business-partnership-worth-5-b-for-mental-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19656/japanese-firms-ink-new-business-partnership-worth-5-b-for-mental-healthcare.html</link>
			<pubDate>Wed, 02 Feb 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-19656.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19656/japanese-firms-ink-new-business-partnership-worth-5-b-for-mental-healthcare.html</guid>
		</item>	
				<item>
			<title>Japan grants patent to Anixa Biosciences for ovarian cancer vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/19652/japan-grants-patent-to-anixa-biosciences-for-ovarian-cancer-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19652/japan-grants-patent-to-anixa-biosciences-for-ovarian-cancer-vaccine.html</link>
			<pubDate>Tue, 01 Feb 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vaccine-19652.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19652/japan-grants-patent-to-anixa-biosciences-for-ovarian-cancer-vaccine.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo starts trial for mRNA vaccine as booster dose in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19647/daiichi-sankyo-starts-trial-for-mrna-vaccine-as-booster-dose-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19647/daiichi-sankyo-starts-trial-for-mrna-vaccine-as-booster-dose-in-japan.html</link>
			<pubDate>Mon, 31 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_06_19_at_10_15_50_pm-19647.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19647/daiichi-sankyo-starts-trial-for-mrna-vaccine-as-booster-dose-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujifilm buys Atara&#039;s T-cell manufacturing facility for $100 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/19635/japans-fujifilm-buys-ataras-t-cell-manufacturing-facility-for-100-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19635/japans-fujifilm-buys-ataras-t-cell-manufacturing-facility-for-100-m.html</link>
			<pubDate>Thu, 27 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_135415067-19635.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19635/japans-fujifilm-buys-ataras-t-cell-manufacturing-facility-for-100-m.html</guid>
		</item>	
				<item>
			<title>Illumina collaborates with National Cancer Center Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19629/illumina-collaborates-with-national-cancer-center-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19629/illumina-collaborates-with-national-cancer-center-japan.html</link>
			<pubDate>Tue, 25 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-19629.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19629/illumina-collaborates-with-national-cancer-center-japan.html</guid>
		</item>	
				<item>
			<title>Japan approves VYVGART for treatment of generalised Myasthenia Gravis</title>
			<atom:link href="https://biospectrumasia.com/news/50/19616/japan-approves-vyvgart-for-treatment-of-generalised-myasthenia-gravis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19616/japan-approves-vyvgart-for-treatment-of-generalised-myasthenia-gravis.html</link>
			<pubDate>Thu, 20 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-19616.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19616/japan-approves-vyvgart-for-treatment-of-generalised-myasthenia-gravis.html</guid>
		</item>	
				<item>
			<title>IQVIA releases emerging biotech/biopharma trends to watch for in 2022</title>
			<atom:link href="https://biospectrumasia.com/news/50/19605/iqvia-releases-emerging-biotech-biopharma-trends-to-watch-for-in-2022.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19605/iqvia-releases-emerging-biotech-biopharma-trends-to-watch-for-in-2022.html</link>
			<pubDate>Wed, 19 Jan 2022 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicines-19605.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19605/iqvia-releases-emerging-biotech-biopharma-trends-to-watch-for-in-2022.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo divests certain cardiovascular products, shifting focus to oncology</title>
			<atom:link href="https://biospectrumasia.com/news/50/19608/japans-daiichi-sankyo-divests-certain-cardiovascular-products-shifting-focus-to-oncology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19608/japans-daiichi-sankyo-divests-certain-cardiovascular-products-shifting-focus-to-oncology.html</link>
			<pubDate>Wed, 19 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_144799030-19608.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19608/japans-daiichi-sankyo-divests-certain-cardiovascular-products-shifting-focus-to-oncology.html</guid>
		</item>	
				<item>
			<title>Japan approves MicroPort CRM&#039;s Alizea Bluetooth Pacemaker</title>
			<atom:link href="https://biospectrumasia.com/news/50/19593/japan-approves-microport-crms-alizea-bluetooth-pacemaker.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19593/japan-approves-microport-crms-alizea-bluetooth-pacemaker.html</link>
			<pubDate>Mon, 17 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pacemaker-19593.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19593/japan-approves-microport-crms-alizea-bluetooth-pacemaker.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda buys Adaptate Biotherapeutics to strengthen immuno-oncology portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/50/19572/japans-takeda-buys-adaptate-biotherapeutics-to-strengthen-immuno-oncology-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19572/japans-takeda-buys-adaptate-biotherapeutics-to-strengthen-immuno-oncology-portfolio.html</link>
			<pubDate>Tue, 11 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19572.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19572/japans-takeda-buys-adaptate-biotherapeutics-to-strengthen-immuno-oncology-portfolio.html</guid>
		</item>	
				<item>
			<title>Japan develops cancer therapy using on-site synthesis of anti-cancer drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/19565/japan-develops-cancer-therapy-using-on-site-synthesis-of-anti-cancer-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19565/japan-develops-cancer-therapy-using-on-site-synthesis-of-anti-cancer-drugs.html</link>
			<pubDate>Mon, 10 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19565.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19565/japan-develops-cancer-therapy-using-on-site-synthesis-of-anti-cancer-drugs.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka Pharma invests in development of psychedelic medicines</title>
			<atom:link href="https://biospectrumasia.com/news/50/19561/japans-otsuka-pharma-invests-in-development-of-psychedelic-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19561/japans-otsuka-pharma-invests-in-development-of-psychedelic-medicines.html</link>
			<pubDate>Fri, 07 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications_342462_1920-19561.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19561/japans-otsuka-pharma-invests-in-development-of-psychedelic-medicines.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu enters into &#039;smart cells&#039; field with new investment</title>
			<atom:link href="https://biospectrumasia.com/news/50/19556/japans-shimadzu-enters-into-smart-cells-field-with-new-investment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19556/japans-shimadzu-enters-into-smart-cells-field-with-new-investment.html</link>
			<pubDate>Thu, 06 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2022_01_06_at_12_25_01_pm-19556.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19556/japans-shimadzu-enters-into-smart-cells-field-with-new-investment.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PRISM BioLab partners with Roche and Genentech for drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/50/19548/japans-prism-biolab-partners-with-roche-and-genentech-for-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19548/japans-prism-biolab-partners-with-roche-and-genentech-for-drug-discovery-research.html</link>
			<pubDate>Wed, 05 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-19548.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19548/japans-prism-biolab-partners-with-roche-and-genentech-for-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>Japan opts for drug repurposing to stop dementia</title>
			<atom:link href="https://biospectrumasia.com/news/50/19532/japan-opts-for-drug-repurposing-to-stop-dementia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19532/japan-opts-for-drug-repurposing-to-stop-dementia.html</link>
			<pubDate>Sat, 01 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19532.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19532/japan-opts-for-drug-repurposing-to-stop-dementia.html</guid>
		</item>	
				<item>
			<title>Japan-funded study explores antibodies to neutralise omicron</title>
			<atom:link href="https://biospectrumasia.com/news/50/19529/japan-funded-study-explores-antibodies-to-neutralise-omicron.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19529/japan-funded-study-explores-antibodies-to-neutralise-omicron.html</link>
			<pubDate>Tue, 28 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_795297598-19529.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19529/japan-funded-study-explores-antibodies-to-neutralise-omicron.html</guid>
		</item>	
				<item>
			<title>Merck and Ridgeback&#039;s COVID-19 pill receives â€˜special approval&#039; in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19523/merck-and-ridgebacks-covid-19-pill-receives-special-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19523/merck-and-ridgebacks-covid-19-pill-receives-special-approval-in-japan.html</link>
			<pubDate>Mon, 27 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19523.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19523/merck-and-ridgebacks-covid-19-pill-receives-special-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai to market Gilead&#039;s rheumatoid arthritis drug in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/19516/eisai-to-market-gileads-rheumatoid-arthritis-drug-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19516/eisai-to-market-gileads-rheumatoid-arthritis-drug-in-asia.html</link>
			<pubDate>Thu, 23 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19516.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19516/eisai-to-market-gileads-rheumatoid-arthritis-drug-in-asia.html</guid>
		</item>	
				<item>
			<title>Japan approves booster shot for Moderna COVID-19 vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/19501/japan-approves-booster-shot-for-moderna-covid-19-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19501/japan-approves-booster-shot-for-moderna-covid-19-vaccine.html</link>
			<pubDate>Mon, 20 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_171044057-19501.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19501/japan-approves-booster-shot-for-moderna-covid-19-vaccine.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s NEC teams up with BostonGene to improve cancer care</title>
			<atom:link href="https://biospectrumasia.com/news/50/19492/japans-nec-teams-up-with-bostongene-to-improve-cancer-care.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19492/japans-nec-teams-up-with-bostongene-to-improve-cancer-care.html</link>
			<pubDate>Thu, 16 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-19492.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19492/japans-nec-teams-up-with-bostongene-to-improve-cancer-care.html</guid>
		</item>	
				<item>
			<title>Japan launches R&amp;D of VR therapy for chronic pain</title>
			<atom:link href="https://biospectrumasia.com/news/50/19484/japan-launches-rd-of-vr-therapy-for-chronic-pain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19484/japan-launches-rd-of-vr-therapy-for-chronic-pain.html</link>
			<pubDate>Wed, 15 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_12_15_at_11_29_33_am-19484.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19484/japan-launches-rd-of-vr-therapy-for-chronic-pain.html</guid>
		</item>	
				<item>
			<title>Japan-based Shimadzu releases six new models of analytical balances</title>
			<atom:link href="https://biospectrumasia.com/news/50/19481/japan-based-shimadzu-releases-six-new-models-of-analytical-balances.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19481/japan-based-shimadzu-releases-six-new-models-of-analytical-balances.html</link>
			<pubDate>Tue, 14 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_12_14_at_12_32_19_pm-19481.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19481/japan-based-shimadzu-releases-six-new-models-of-analytical-balances.html</guid>
		</item>	
				<item>
			<title>Eurofins enhances clinical and COVID-19 testing offering in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19470/eurofins-enhances-clinical-and-covid-19-testing-offering-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19470/eurofins-enhances-clinical-and-covid-19-testing-offering-in-japan.html</link>
			<pubDate>Fri, 10 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_200010311-19470.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19470/eurofins-enhances-clinical-and-covid-19-testing-offering-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan uses atomic force microscopy to study SARS-CoV-2 entry mechanism</title>
			<atom:link href="https://biospectrumasia.com/news/50/19465/japan-uses-atomic-force-microscopy-to-study-sars-cov-2-entry-mechanism.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19465/japan-uses-atomic-force-microscopy-to-study-sars-cov-2-entry-mechanism.html</link>
			<pubDate>Thu, 09 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19465.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19465/japan-uses-atomic-force-microscopy-to-study-sars-cov-2-entry-mechanism.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi to develop COVID-19 recombinant protein-based vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/19460/japans-shionogi-to-develop-covid-19-recombinant-protein-based-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19460/japans-shionogi-to-develop-covid-19-recombinant-protein-based-vaccine.html</link>
			<pubDate>Wed, 08 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_117541078-19460.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19460/japans-shionogi-to-develop-covid-19-recombinant-protein-based-vaccine.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus plans sharper focus on medical business</title>
			<atom:link href="https://biospectrumasia.com/news/50/19452/japans-olympus-plans-sharper-focus-on-medical-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19452/japans-olympus-plans-sharper-focus-on-medical-business.html</link>
			<pubDate>Tue, 07 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_12_07_at_12_37_21_pm-19452.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19452/japans-olympus-plans-sharper-focus-on-medical-business.html</guid>
		</item>	
				<item>
			<title>Olympus strenghtens its medical business polices targeting chronic diseases</title>
			<atom:link href="https://biospectrumasia.com/company-results/50/19453/olympus-strenghtens-its-medical-business-polices-targeting-chronic-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/50/19453/olympus-strenghtens-its-medical-business-polices-targeting-chronic-diseases.html</link>
			<pubDate>Tue, 07 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/computer_screen_with_molecule_model_background_two_lab_workers_whitecoats_masks_gloves_studying_online_information_274679_13741_1_-19453.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/50/19453/olympus-strenghtens-its-medical-business-polices-targeting-chronic-diseases.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo establishes new subsidiaries in Australia, Canada, and Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/50/19440/daiichi-sankyo-establishes-new-subsidiaries-in-australia-canada-and-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19440/daiichi-sankyo-establishes-new-subsidiaries-in-australia-canada-and-singapore.html</link>
			<pubDate>Fri, 03 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications_342462_1920-19440.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19440/daiichi-sankyo-establishes-new-subsidiaries-in-australia-canada-and-singapore.html</guid>
		</item>	
				<item>
			<title>GenScript, BioComo accelerate novel intranasal SARS-CoV-2 vaccine development in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19435/genscript-biocomo-accelerate-novel-intranasal-sars-cov-2-vaccine-development-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19435/genscript-biocomo-accelerate-novel-intranasal-sars-cov-2-vaccine-development-in-japan.html</link>
			<pubDate>Thu, 02 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19435.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19435/genscript-biocomo-accelerate-novel-intranasal-sars-cov-2-vaccine-development-in-japan.html</guid>
		</item>	
				<item>
			<title>Q-Sera takes rapid serum blood collection tube technology to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19426/q-sera-takes-rapid-serum-blood-collection-tube-technology-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19426/q-sera-takes-rapid-serum-blood-collection-tube-technology-to-japan.html</link>
			<pubDate>Wed, 01 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19426.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19426/q-sera-takes-rapid-serum-blood-collection-tube-technology-to-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s OriCiro Genomics launches new enzymatic DNA synthesis tool</title>
			<atom:link href="https://biospectrumasia.com/news/50/19416/japans-oriciro-genomics-launches-new-enzymatic-dna-synthesis-tool.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19416/japans-oriciro-genomics-launches-new-enzymatic-dna-synthesis-tool.html</link>
			<pubDate>Tue, 30 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19416.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19416/japans-oriciro-genomics-launches-new-enzymatic-dna-synthesis-tool.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Canon introduces deep-learning reconstruction for cardiac CT scans</title>
			<atom:link href="https://biospectrumasia.com/news/50/19410/japans-canon-introduces-deep-learning-reconstruction-for-cardiac-ct-scans.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19410/japans-canon-introduces-deep-learning-reconstruction-for-cardiac-ct-scans.html</link>
			<pubDate>Mon, 29 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_11_29_at_4_19_23_pm-19410.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19410/japans-canon-introduces-deep-learning-reconstruction-for-cardiac-ct-scans.html</guid>
		</item>	
				<item>
			<title>Japan connects hepatitis C treatment with reduction in liver cancer progression</title>
			<atom:link href="https://biospectrumasia.com/news/50/19399/japan-connects-hepatitis-c-treatment-with-reduction-in-liver-cancer-progression.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19399/japan-connects-hepatitis-c-treatment-with-reduction-in-liver-cancer-progression.html</link>
			<pubDate>Thu, 25 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-19399.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19399/japan-connects-hepatitis-c-treatment-with-reduction-in-liver-cancer-progression.html</guid>
		</item>	
				<item>
			<title>Amgen, Bushu Pharma expand supply chain partnership across JAPAC</title>
			<atom:link href="https://biospectrumasia.com/news/50/19391/amgen-bushu-pharma-expand-supply-chain-partnership-across-japac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19391/amgen-bushu-pharma-expand-supply-chain-partnership-across-japac.html</link>
			<pubDate>Wed, 24 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_135415067-19391.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19391/amgen-bushu-pharma-expand-supply-chain-partnership-across-japac.html</guid>
		</item>	
				<item>
			<title>Japan finds risk factors associated with waning immunity of Pfizer vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/19381/japan-finds-risk-factors-associated-with-waning-immunity-of-pfizer-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19381/japan-finds-risk-factors-associated-with-waning-immunity-of-pfizer-vaccine.html</link>
			<pubDate>Mon, 22 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_06_19_at_10_15_50_pm-19381.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19381/japan-finds-risk-factors-associated-with-waning-immunity-of-pfizer-vaccine.html</guid>
		</item>	
				<item>
			<title>Japan-based Terumo Corp to expand diabetes care offerings</title>
			<atom:link href="https://biospectrumasia.com/news/50/19367/japan-based-terumo-corp-to-expand-diabetes-care-offerings.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19367/japan-based-terumo-corp-to-expand-diabetes-care-offerings.html</link>
			<pubDate>Thu, 18 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_11_18_at_1_26_54_pm-19367.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19367/japan-based-terumo-corp-to-expand-diabetes-care-offerings.html</guid>
		</item>	
				<item>
			<title>First integration of health management app and CGM data in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19358/first-integration-of-health-management-app-and-cgm-data-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19358/first-integration-of-health-management-app-and-cgm-data-in-japan.html</link>
			<pubDate>Wed, 17 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_171674909-19358.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19358/first-integration-of-health-management-app-and-cgm-data-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan to buy 1.6M courses of Merck&#039;s COVID-19 pill</title>
			<atom:link href="https://biospectrumasia.com/news/50/19339/japan-to-buy-1-6m-courses-of-mercks-covid-19-pill.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19339/japan-to-buy-1-6m-courses-of-mercks-covid-19-pill.html</link>
			<pubDate>Thu, 11 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_11_11_at_11_50_39_am-19339.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19339/japan-to-buy-1-6m-courses-of-mercks-covid-19-pill.html</guid>
		</item>	
				<item>
			<title>Onlab Bio Dementia calls for Japanese and global startups</title>
			<atom:link href="https://biospectrumasia.com/news/50/19315/onlab-bio-dementia-calls-for-japanese-and-global-startups.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19315/onlab-bio-dementia-calls-for-japanese-and-global-startups.html</link>
			<pubDate>Mon, 08 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_148575200-19315.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19315/onlab-bio-dementia-calls-for-japanese-and-global-startups.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT Fund invests $6.6M in new partnerships for life-saving drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/19311/japans-ghit-fund-invests-6-6m-in-new-partnerships-for-life-saving-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19311/japans-ghit-fund-invests-6-6m-in-new-partnerships-for-life-saving-drugs.html</link>
			<pubDate>Fri, 05 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19311.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19311/japans-ghit-fund-invests-6-6m-in-new-partnerships-for-life-saving-drugs.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Yokogawa announces new acquisition to build bioprocess solutions</title>
			<atom:link href="https://biospectrumasia.com/news/50/19307/japans-yokogawa-announces-new-acquisition-to-build-bioprocess-solutions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19307/japans-yokogawa-announces-new-acquisition-to-build-bioprocess-solutions.html</link>
			<pubDate>Wed, 03 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_104108189-19307.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19307/japans-yokogawa-announces-new-acquisition-to-build-bioprocess-solutions.html</guid>
		</item>	
				<item>
			<title>Japan offers new treatment option for brain cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/19296/japan-offers-new-treatment-option-for-brain-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19296/japan-offers-new-treatment-option-for-brain-cancer.html</link>
			<pubDate>Tue, 02 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-19296.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19296/japan-offers-new-treatment-option-for-brain-cancer.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s venture capitalism elevates deep-tech startups in Southeast Asia region</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/19297/japans-venture-capitalism-elevates-deep-tech-startups-in-southeast-asia-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/19297/japans-venture-capitalism-elevates-deep-tech-startups-in-southeast-asia-region.html</link>
			<pubDate>Tue, 02 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiki_kumamoto-19297.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/19297/japans-venture-capitalism-elevates-deep-tech-startups-in-southeast-asia-region.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda makes new deal to accelerate gamma-delta T cell-based therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/19276/japans-takeda-makes-new-deal-to-accelerate-gamma-delta-t-cell-based-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19276/japans-takeda-makes-new-deal-to-accelerate-gamma-delta-t-cell-based-therapies.html</link>
			<pubDate>Thu, 28 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_212432119-19276.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19276/japans-takeda-makes-new-deal-to-accelerate-gamma-delta-t-cell-based-therapies.html</guid>
		</item>	
				<item>
			<title>Japan proposes drug cocktail to stop SARS-CoV-2 infection of stem cells</title>
			<atom:link href="https://biospectrumasia.com/news/50/19270/japan-proposes-drug-cocktail-to-stop-sars-cov-2-infection-of-stem-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19270/japan-proposes-drug-cocktail-to-stop-sars-cov-2-infection-of-stem-cells.html</link>
			<pubDate>Wed, 27 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-19270.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19270/japan-proposes-drug-cocktail-to-stop-sars-cov-2-infection-of-stem-cells.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo to commercialize mRNA COVID-19 vaccine in Japan within 2022</title>
			<atom:link href="https://biospectrumasia.com/news/50/19266/daiichi-sankyo-to-commercialize-mrna-covid-19-vaccine-in-japan-within-2022.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19266/daiichi-sankyo-to-commercialize-mrna-covid-19-vaccine-in-japan-within-2022.html</link>
			<pubDate>Tue, 26 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_117541078-19266.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19266/daiichi-sankyo-to-commercialize-mrna-covid-19-vaccine-in-japan-within-2022.html</guid>
		</item>	
				<item>
			<title>Japan brings highly sensitive bio-technology to detect SARS-CoV-2</title>
			<atom:link href="https://biospectrumasia.com/news/50/19258/japan-brings-highly-sensitive-bio-technology-to-detect-sars-cov-2.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19258/japan-brings-highly-sensitive-bio-technology-to-detect-sars-cov-2.html</link>
			<pubDate>Mon, 25 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19258.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19258/japan-brings-highly-sensitive-bio-technology-to-detect-sars-cov-2.html</guid>
		</item>	
				<item>
			<title>Fujitsu to offer AI-based personalised cancer treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19250/fujitsu-to-offer-ai-based-personalised-cancer-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19250/fujitsu-to-offer-ai-based-personalised-cancer-treatment-in-japan.html</link>
			<pubDate>Fri, 22 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19250.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19250/fujitsu-to-offer-ai-based-personalised-cancer-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan emphasises on escalating global anxiety and depression crisis</title>
			<atom:link href="https://biospectrumasia.com/news/50/19233/japan-emphasises-on-escalating-global-anxiety-and-depression-crisis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19233/japan-emphasises-on-escalating-global-anxiety-and-depression-crisis.html</link>
			<pubDate>Tue, 19 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19233.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19233/japan-emphasises-on-escalating-global-anxiety-and-depression-crisis.html</guid>
		</item>	
				<item>
			<title>Japan identifies molecules for building stronger antibodies</title>
			<atom:link href="https://biospectrumasia.com/news/50/19219/japan-identifies-molecules-for-building-stronger-antibodies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19219/japan-identifies-molecules-for-building-stronger-antibodies.html</link>
			<pubDate>Fri, 15 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_795297598-19219.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19219/japan-identifies-molecules-for-building-stronger-antibodies.html</guid>
		</item>	
				<item>
			<title>Japan develops ML-based screening tool for cervical myelopathy</title>
			<atom:link href="https://biospectrumasia.com/news/50/19205/japan-develops-ml-based-screening-tool-for-cervical-myelopathy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19205/japan-develops-ml-based-screening-tool-for-cervical-myelopathy.html</link>
			<pubDate>Wed, 13 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_10_13_at_2_17_08_pm-19205.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19205/japan-develops-ml-based-screening-tool-for-cervical-myelopathy.html</guid>
		</item>	
				<item>
			<title>Fujitsu and University of Tokyo Hospital embark joint AI  R&amp;D for heart disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/19188/fujitsu-and-university-of-tokyo-hospital-embark-joint-ai-rd-for-heart-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19188/fujitsu-and-university-of-tokyo-hospital-embark-joint-ai-rd-for-heart-disease.html</link>
			<pubDate>Mon, 11 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik456457-19188.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19188/fujitsu-and-university-of-tokyo-hospital-embark-joint-ai-rd-for-heart-disease.html</guid>
		</item>	
				<item>
			<title>Mass spec technology by Shimadzu unveils novel approach for immunotherapy success </title>
			<atom:link href="https://biospectrumasia.com/news/50/19189/mass-spec-technology-by-shimadzu-unveils-novel-approach-for-immunotherapy-success-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19189/mass-spec-technology-by-shimadzu-unveils-novel-approach-for-immunotherapy-success-.html</link>
			<pubDate>Mon, 11 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19189.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19189/mass-spec-technology-by-shimadzu-unveils-novel-approach-for-immunotherapy-success-.html</guid>
		</item>	
				<item>
			<title>Catalent Opens New Full-Service Clinical Supply Facility in Shiga, Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19187/catalent-opens-new-full-service-clinical-supply-facility-in-shiga-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19187/catalent-opens-new-full-service-clinical-supply-facility-in-shiga-japan.html</link>
			<pubDate>Sun, 10 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shiga_1080x810_1-19187.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19187/catalent-opens-new-full-service-clinical-supply-facility-in-shiga-japan.html</guid>
		</item>	
				<item>
			<title>Japan identifies emerging infectious disease caused by new &#039;nairovirus&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/50/19185/japan-identifies-emerging-infectious-disease-caused-by-new-nairovirus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19185/japan-identifies-emerging-infectious-disease-caused-by-new-nairovirus.html</link>
			<pubDate>Fri, 08 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-19185.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19185/japan-identifies-emerging-infectious-disease-caused-by-new-nairovirus.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus sets-up corporate venture capital fund</title>
			<atom:link href="https://biospectrumasia.com/news/50/19162/japans-olympus-sets-up-corporate-venture-capital-fund.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19162/japans-olympus-sets-up-corporate-venture-capital-fund.html</link>
			<pubDate>Tue, 05 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19162.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19162/japans-olympus-sets-up-corporate-venture-capital-fund.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujifilm promotes industrial application of iPS cell-derived regenerative medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/19154/japans-fujifilm-promotes-industrial-application-of-ips-cell-derived-regenerative-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19154/japans-fujifilm-promotes-industrial-application-of-ips-cell-derived-regenerative-medicine.html</link>
			<pubDate>Mon, 04 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19154.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19154/japans-fujifilm-promotes-industrial-application-of-ips-cell-derived-regenerative-medicine.html</guid>
		</item>	
				<item>
			<title>Israel&#039;s CytoReason introduces AI clinical drug development platform to Japan&#039;s pharma market</title>
			<atom:link href="https://biospectrumasia.com/news/50/19155/israels-cytoreason-introduces-ai-clinical-drug-development-platform-to-japans-pharma-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19155/israels-cytoreason-introduces-ai-clinical-drug-development-platform-to-japans-pharma-market.html</link>
			<pubDate>Thu, 30 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_rendering_medical_artificial_intelligence_robot_31965_5171-19155.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19155/israels-cytoreason-introduces-ai-clinical-drug-development-platform-to-japans-pharma-market.html</guid>
		</item>	
				<item>
			<title>&quot;Stem cell-based therapeutics poised to become mainstream optionâ€</title>
			<atom:link href="https://biospectrumasia.com/news/50/19140/stem-cell-based-therapeutics-poised-to-become-mainstream-option.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19140/stem-cell-based-therapeutics-poised-to-become-mainstream-option.html</link>
			<pubDate>Fri, 01 Oct 2021 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/koji_s_photo-19140.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19140/stem-cell-based-therapeutics-poised-to-become-mainstream-option.html</guid>
		</item>	
				<item>
			<title>Japan to commercialize next-gen Hunter Syndrome therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/19147/japan-to-commercialize-next-gen-hunter-syndrome-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19147/japan-to-commercialize-next-gen-hunter-syndrome-therapy.html</link>
			<pubDate>Fri, 01 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-19147.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19147/japan-to-commercialize-next-gen-hunter-syndrome-therapy.html</guid>
		</item>	
				<item>
			<title>New osteoporotic bone loss kit enters Japanese market</title>
			<atom:link href="https://biospectrumasia.com/news/50/19135/new-osteoporotic-bone-loss-kit-enters-japanese-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19135/new-osteoporotic-bone-loss-kit-enters-japanese-market.html</link>
			<pubDate>Thu, 30 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_240098272-19135.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19135/new-osteoporotic-bone-loss-kit-enters-japanese-market.html</guid>
		</item>	
				<item>
			<title>Aptamer brings Optimer binders-based technology for Japanese scientists</title>
			<atom:link href="https://biospectrumasia.com/news/50/19119/aptamer-brings-optimer-binders-based-technology-for-japanese-scientists.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19119/aptamer-brings-optimer-binders-based-technology-for-japanese-scientists.html</link>
			<pubDate>Tue, 28 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_104108189-19119.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19119/aptamer-brings-optimer-binders-based-technology-for-japanese-scientists.html</guid>
		</item>	
				<item>
			<title>Japan approves first orally administered therapy for rare autoimmune renal disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/19109/japan-approves-first-orally-administered-therapy-for-rare-autoimmune-renal-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19109/japan-approves-first-orally-administered-therapy-for-rare-autoimmune-renal-disease.html</link>
			<pubDate>Mon, 27 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19109.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19109/japan-approves-first-orally-administered-therapy-for-rare-autoimmune-renal-disease.html</guid>
		</item>	
				<item>
			<title>Japan approves first and only antibody-drug conjugate (ADC) to treat Urothelial Cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/19111/japan-approves-first-and-only-antibody-drug-conjugate-adc-to-treat-urothelial-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19111/japan-approves-first-and-only-antibody-drug-conjugate-adc-to-treat-urothelial-cancer.html</link>
			<pubDate>Mon, 27 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik235-19111.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19111/japan-approves-first-and-only-antibody-drug-conjugate-adc-to-treat-urothelial-cancer.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda Pharma picks new partners to help strengthen health systems in LMICs</title>
			<atom:link href="https://biospectrumasia.com/news/50/19085/japans-takeda-pharma-picks-new-partners-to-help-strengthen-health-systems-in-lmics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19085/japans-takeda-pharma-picks-new-partners-to-help-strengthen-health-systems-in-lmics.html</link>
			<pubDate>Thu, 23 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_197722757-19085.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19085/japans-takeda-pharma-picks-new-partners-to-help-strengthen-health-systems-in-lmics.html</guid>
		</item>	
				<item>
			<title>Japan sets eyes on rare pediatric liver diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/19082/japan-sets-eyes-on-rare-pediatric-liver-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19082/japan-sets-eyes-on-rare-pediatric-liver-diseases.html</link>
			<pubDate>Wed, 22 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-19082.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19082/japan-sets-eyes-on-rare-pediatric-liver-diseases.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus unveils advanced bipolar surgical energy products</title>
			<atom:link href="https://biospectrumasia.com/news/50/19076/japans-olympus-unveils-advanced-bipolar-surgical-energy-products.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19076/japans-olympus-unveils-advanced-bipolar-surgical-energy-products.html</link>
			<pubDate>Tue, 21 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_09_21_at_12_19_37_pm-19076.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19076/japans-olympus-unveils-advanced-bipolar-surgical-energy-products.html</guid>
		</item>	
				<item>
			<title>Innovative home dialysis therapies to support Japan&#039;s growing needs</title>
			<atom:link href="https://biospectrumasia.com/news/50/19065/innovative-home-dialysis-therapies-to-support-japans-growing-needs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19065/innovative-home-dialysis-therapies-to-support-japans-growing-needs.html</link>
			<pubDate>Fri, 17 Sep 2021 02:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/img_ttl_dialysis_sp-19065.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19065/innovative-home-dialysis-therapies-to-support-japans-growing-needs.html</guid>
		</item>	
				<item>
			<title>Japan finds molecular code that powers up cancer-fighting immune cells</title>
			<atom:link href="https://biospectrumasia.com/news/50/19043/japan-finds-molecular-code-that-powers-up-cancer-fighting-immune-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19043/japan-finds-molecular-code-that-powers-up-cancer-fighting-immune-cells.html</link>
			<pubDate>Wed, 15 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/04_blog_tumor_cell_l-19043.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19043/japan-finds-molecular-code-that-powers-up-cancer-fighting-immune-cells.html</guid>
		</item>	
				<item>
			<title>Kyowa Kirin addresses sepsis-associated acute kidney injury in Japanese population</title>
			<atom:link href="https://biospectrumasia.com/news/50/19028/kyowa-kirin-addresses-sepsis-associated-acute-kidney-injury-in-japanese-population.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19028/kyowa-kirin-addresses-sepsis-associated-acute-kidney-injury-in-japanese-population.html</link>
			<pubDate>Tue, 14 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image-19028.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19028/kyowa-kirin-addresses-sepsis-associated-acute-kidney-injury-in-japanese-population.html</guid>
		</item>	
				<item>
			<title>French firm Poxel launches type 2 diabetes drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/19009/french-firm-poxel-launches-type-2-diabetes-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19009/french-firm-poxel-launches-type-2-diabetes-drug-in-japan.html</link>
			<pubDate>Fri, 10 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/which_medications_are_best_for_anxiety_disorders_1440x810-19009.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19009/french-firm-poxel-launches-type-2-diabetes-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>US-based CLRO firm Advanced Clinical continues APAC expansion</title>
			<atom:link href="https://biospectrumasia.com/news/50/19001/us-based-clro-firm-advanced-clinical-continues-apac-expansion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19001/us-based-clro-firm-advanced-clinical-continues-apac-expansion.html</link>
			<pubDate>Thu, 09 Sep 2021 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-19001.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19001/us-based-clro-firm-advanced-clinical-continues-apac-expansion.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s TANAKA holdings encourage overseas medical startups by investment opportunities</title>
			<atom:link href="https://biospectrumasia.com/news/50/19004/japans-tanaka-holdings-encourage-overseas-medical-startups-by-investment-opportunities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/19004/japans-tanaka-holdings-encourage-overseas-medical-startups-by-investment-opportunities.html</link>
			<pubDate>Thu, 09 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stethoscope_calculator_money_cash_medical_data_concept_health_care_costs_medical_insurance_132358_3738-19004.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/19004/japans-tanaka-holdings-encourage-overseas-medical-startups-by-investment-opportunities.html</guid>
		</item>	
				<item>
			<title>Japan buys 150 M doses of Novavax COVID-19 vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/18987/japan-buys-150-m-doses-of-novavax-covid-19-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18987/japan-buys-150-m-doses-of-novavax-covid-19-vaccine.html</link>
			<pubDate>Wed, 08 Sep 2021 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/getty_1290225107_covid19vaccineproductionline_scaled_e1615918414858-18987.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18987/japan-buys-150-m-doses-of-novavax-covid-19-vaccine.html</guid>
		</item>	
				<item>
			<title>Japan to benefit from personalized stem cell banking service expansion by I Peace</title>
			<atom:link href="https://biospectrumasia.com/news/50/18990/japan-to-benefit-from-personalized-stem-cell-banking-service-expansion-by-i-peace.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18990/japan-to-benefit-from-personalized-stem-cell-banking-service-expansion-by-i-peace.html</link>
			<pubDate>Wed, 08 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/embryonic_stem_cells_cellular_therapy_151689_32-18990.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18990/japan-to-benefit-from-personalized-stem-cell-banking-service-expansion-by-i-peace.html</guid>
		</item>	
				<item>
			<title>Japan lays focus on early detection of heart diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/18969/japan-lays-focus-on-early-detection-of-heart-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18969/japan-lays-focus-on-early-detection-of-heart-diseases.html</link>
			<pubDate>Mon, 06 Sep 2021 02:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_09_06_at_11_14_48_am-18969.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18969/japan-lays-focus-on-early-detection-of-heart-diseases.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujifilm sells radiopharma biz to PeptiDream for 30.5 billion yen</title>
			<atom:link href="https://biospectrumasia.com/news/50/18964/japans-fujifilm-sells-radiopharma-biz-to-peptidream-for-30-5-billion-yen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18964/japans-fujifilm-sells-radiopharma-biz-to-peptidream-for-30-5-billion-yen.html</link>
			<pubDate>Fri, 03 Sep 2021 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-18964.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18964/japans-fujifilm-sells-radiopharma-biz-to-peptidream-for-30-5-billion-yen.html</guid>
		</item>	
				<item>
			<title>Rapid acceleration of medical education in Japan using virtual reality</title>
			<atom:link href="https://biospectrumasia.com/news/50/18956/rapid-acceleration-of-medical-education-in-japan-using-virtual-reality.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18956/rapid-acceleration-of-medical-education-in-japan-using-virtual-reality.html</link>
			<pubDate>Thu, 02 Sep 2021 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_09_02_at_6_56_02_pm-18956.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18956/rapid-acceleration-of-medical-education-in-japan-using-virtual-reality.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s REPROCELL to boost its GMP iPSC - Master Cell Bank (MCB) manufacturing service</title>
			<atom:link href="https://biospectrumasia.com/news/50/18949/japans-reprocell-to-boost-its-gmp-ipsc-master-cell-bank-mcb-manufacturing-service.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18949/japans-reprocell-to-boost-its-gmp-ipsc-master-cell-bank-mcb-manufacturing-service.html</link>
			<pubDate>Thu, 02 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_illustration_dna_molecule_its_structure_concept_human_genome_92790_825-18949.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18949/japans-reprocell-to-boost-its-gmp-ipsc-master-cell-bank-mcb-manufacturing-service.html</guid>
		</item>	
				<item>
			<title>Eli Lilly Japan, Daiichi Sankyo ink pact to commercialise migraine drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/18943/eli-lilly-japan-daiichi-sankyo-ink-pact-to-commercialise-migraine-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18943/eli-lilly-japan-daiichi-sankyo-ink-pact-to-commercialise-migraine-drug.html</link>
			<pubDate>Wed, 01 Sep 2021 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicines-18943.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18943/eli-lilly-japan-daiichi-sankyo-ink-pact-to-commercialise-migraine-drug.html</guid>
		</item>	
				<item>
			<title>Japan to distribute hyperuricemia drug in five ASEAN countries</title>
			<atom:link href="https://biospectrumasia.com/news/50/18937/japan-to-distribute-hyperuricemia-drug-in-five-asean-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18937/japan-to-distribute-hyperuricemia-drug-in-five-asean-countries.html</link>
			<pubDate>Tue, 31 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/doctor_showing_model_kidney_pills_healthcare_concept_253401_5039-18937.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18937/japan-to-distribute-hyperuricemia-drug-in-five-asean-countries.html</guid>
		</item>	
				<item>
			<title>Japan suggests DNA deletion to treat mitochondrial diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/18931/japan-suggests-dna-deletion-to-treat-mitochondrial-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18931/japan-suggests-dna-deletion-to-treat-mitochondrial-diseases.html</link>
			<pubDate>Mon, 30 Aug 2021 05:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_146497574-18931.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18931/japan-suggests-dna-deletion-to-treat-mitochondrial-diseases.html</guid>
		</item>	
				<item>
			<title>Shimadzu contributes to PCR screening tests for COVID-19 mutant strains in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/18915/shimadzu-contributes-to-pcr-screening-tests-for-covid-19-mutant-strains-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18915/shimadzu-contributes-to-pcr-screening-tests-for-covid-19-mutant-strains-in-japan.html</link>
			<pubDate>Fri, 27 Aug 2021 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_08_27_at_11_07_35_am-18915.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18915/shimadzu-contributes-to-pcr-screening-tests-for-covid-19-mutant-strains-in-japan.html</guid>
		</item>	
				<item>
			<title>Cryoport, Mitsubishi Logistics Corp to bring temperature-controlled supply chain solutions to APAC region</title>
			<atom:link href="https://biospectrumasia.com/news/50/18911/cryoport-mitsubishi-logistics-corp-to-bring-temperature-controlled-supply-chain-solutions-to-apac-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18911/cryoport-mitsubishi-logistics-corp-to-bring-temperature-controlled-supply-chain-solutions-to-apac-region.html</link>
			<pubDate>Thu, 26 Aug 2021 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cyroport-18911.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18911/cryoport-mitsubishi-logistics-corp-to-bring-temperature-controlled-supply-chain-solutions-to-apac-region.html</guid>
		</item>	
				<item>
			<title>Japan to leverage advanced IoT technology for flatfoot patients</title>
			<atom:link href="https://biospectrumasia.com/news/50/18904/japan-to-leverage-advanced-iot-technology-for-flatfoot-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18904/japan-to-leverage-advanced-iot-technology-for-flatfoot-patients.html</link>
			<pubDate>Thu, 26 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/imgonline_com_ua_twotoone_sedydbmqo54-18904.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18904/japan-to-leverage-advanced-iot-technology-for-flatfoot-patients.html</guid>
		</item>	
				<item>
			<title>Japan invents organ-on-a-chip imaging tool to visualize cell functions</title>
			<atom:link href="https://biospectrumasia.com/news/50/18877/japan-invents-organ-on-a-chip-imaging-tool-to-visualize-cell-functions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18877/japan-invents-organ-on-a-chip-imaging-tool-to-visualize-cell-functions.html</link>
			<pubDate>Mon, 23 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20210820_research_microphysiological_system_pic1-18877.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18877/japan-invents-organ-on-a-chip-imaging-tool-to-visualize-cell-functions.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu, HORIBA release LC-Raman System for multi-R&amp;D applications</title>
			<atom:link href="https://biospectrumasia.com/news/50/18859/japans-shimadzu-horiba-release-lc-raman-system-for-multi-rd-applications.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18859/japans-shimadzu-horiba-release-lc-raman-system-for-multi-rd-applications.html</link>
			<pubDate>Thu, 19 Aug 2021 08:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_08_19_at_11_00_16_am-18859.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18859/japans-shimadzu-horiba-release-lc-raman-system-for-multi-rd-applications.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s digital trade elites gather to create business opportunities in Japanese market</title>
			<atom:link href="https://biospectrumasia.com/news/50/18829/taiwans-digital-trade-elites-gather-to-create-business-opportunities-in-japanese-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18829/taiwans-digital-trade-elites-gather-to-create-business-opportunities-in-japanese-market.html</link>
			<pubDate>Mon, 16 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_1_-18829.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18829/taiwans-digital-trade-elites-gather-to-create-business-opportunities-in-japanese-market.html</guid>
		</item>	
				<item>
			<title>Fujifilm launches AI-powered chest X-ray in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/18813/fujifilm-launches-ai-powered-chest-x-ray-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18813/fujifilm-launches-ai-powered-chest-x-ray-in-japan.html</link>
			<pubDate>Fri, 13 Aug 2021 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/9_20_homepage_photo_1024x684-18813.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18813/fujifilm-launches-ai-powered-chest-x-ray-in-japan.html</guid>
		</item>	
				<item>
			<title>FDA approves combination therapy for Advanced Renal Cell Carcinoma (RCC)</title>
			<atom:link href="https://biospectrumasia.com/news/50/18808/fda-approves-combination-therapy-for-advanced-renal-cell-carcinoma-rcc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18808/fda-approves-combination-therapy-for-advanced-renal-cell-carcinoma-rcc.html</link>
			<pubDate>Thu, 12 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicine_light_protected_bottle_36049_404-18808.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18808/fda-approves-combination-therapy-for-advanced-renal-cell-carcinoma-rcc.html</guid>
		</item>	
				<item>
			<title>Japan reveals adverse events following COVID-19 vaccination in youngsters</title>
			<atom:link href="https://biospectrumasia.com/news/50/18797/japan-reveals-adverse-events-following-covid-19-vaccination-in-youngsters.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18797/japan-reveals-adverse-events-following-covid-19-vaccination-in-youngsters.html</link>
			<pubDate>Wed, 11 Aug 2021 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/8-18797.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18797/japan-reveals-adverse-events-following-covid-19-vaccination-in-youngsters.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka Pharma receives $17.8 M grant for TB drug trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/18786/japans-otsuka-pharma-receives-17-8-m-grant-for-tb-drug-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18786/japans-otsuka-pharma-receives-17-8-m-grant-for-tb-drug-trial.html</link>
			<pubDate>Tue, 10 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-18786.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18786/japans-otsuka-pharma-receives-17-8-m-grant-for-tb-drug-trial.html</guid>
		</item>	
				<item>
			<title>Healx&#039;s AI-platform to create world&#039;s most detailed rare disease biomedical knowledge graph</title>
			<atom:link href="https://biospectrumasia.com/news/50/18790/healxs-ai-platform-to-create-worlds-most-detailed-rare-disease-biomedical-knowledge-graph.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18790/healxs-ai-platform-to-create-worlds-most-detailed-rare-disease-biomedical-knowledge-graph.html</link>
			<pubDate>Tue, 10 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/adobestock_182431295_convertedv5_2x-18790.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18790/healxs-ai-platform-to-create-worlds-most-detailed-rare-disease-biomedical-knowledge-graph.html</guid>
		</item>	
				<item>
			<title>Mr. Ryoichi Tanaka Joins Telix Japan as Chief Operating Officer</title>
			<atom:link href="https://biospectrumasia.com/news/50/18762/mr-ryoichi-tanaka-joins-telix-japan-as-chief-operating-officer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18762/mr-ryoichi-tanaka-joins-telix-japan-as-chief-operating-officer.html</link>
			<pubDate>Fri, 06 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2e2df01811646f2be55a5d11c7b03614-18762.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18762/mr-ryoichi-tanaka-joins-telix-japan-as-chief-operating-officer.html</guid>
		</item>	
				<item>
			<title>Taiwanese firm to manufacture Japanese generic drug to strengthen synergy</title>
			<atom:link href="https://biospectrumasia.com/news/50/18768/taiwanese-firm-to-manufacture-japanese-generic-drug-to-strengthen-synergy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18768/taiwanese-firm-to-manufacture-japanese-generic-drug-to-strengthen-synergy.html</link>
			<pubDate>Fri, 06 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/close_up_pharmacist_man_hand_shaking_counter_with_patient_customer_42708_27-18768.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18768/taiwanese-firm-to-manufacture-japanese-generic-drug-to-strengthen-synergy.html</guid>
		</item>	
				<item>
			<title>Japan builds mathematical simulator to guide COVID-19 isolation policies</title>
			<atom:link href="https://biospectrumasia.com/news/50/18746/japan-builds-mathematical-simulator-to-guide-covid-19-isolation-policies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18746/japan-builds-mathematical-simulator-to-guide-covid-19-isolation-policies.html</link>
			<pubDate>Wed, 04 Aug 2021 08:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/https___d1e00ek4ebabms_cloudfront_net_production_04e8897c_2260_4651_964b_cbebac65da9a-18746.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18746/japan-builds-mathematical-simulator-to-guide-covid-19-isolation-policies.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Chugai Pharma unveils comprehensive genomic profiling test for cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/18736/japans-chugai-pharma-unveils-comprehensive-genomic-profiling-test-for-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18736/japans-chugai-pharma-unveils-comprehensive-genomic-profiling-test-for-cancer.html</link>
			<pubDate>Tue, 03 Aug 2021 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene-18736.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18736/japans-chugai-pharma-unveils-comprehensive-genomic-profiling-test-for-cancer.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda launches new biopharma venture for norovirus vaccine candidate</title>
			<atom:link href="https://biospectrumasia.com/news/50/18707/japans-takeda-launches-new-biopharma-venture-for-norovirus-vaccine-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18707/japans-takeda-launches-new-biopharma-venture-for-norovirus-vaccine-candidate.html</link>
			<pubDate>Fri, 30 Jul 2021 09:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/istock_157317886-18707.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18707/japans-takeda-launches-new-biopharma-venture-for-norovirus-vaccine-candidate.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PHC Corp offers medicated refrigerated storage solutions</title>
			<atom:link href="https://biospectrumasia.com/news/50/18700/japans-phc-corp-offers-medicated-refrigerated-storage-solutions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18700/japans-phc-corp-offers-medicated-refrigerated-storage-solutions.html</link>
			<pubDate>Thu, 29 Jul 2021 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_07_29_at_12_29_24_pm-18700.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18700/japans-phc-corp-offers-medicated-refrigerated-storage-solutions.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shimadzu unveils device for measuring amyloid peptides in blood</title>
			<atom:link href="https://biospectrumasia.com/news/50/18685/japans-shimadzu-unveils-device-for-measuring-amyloid-peptides-in-blood.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18685/japans-shimadzu-unveils-device-for-measuring-amyloid-peptides-in-blood.html</link>
			<pubDate>Wed, 28 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bachem_website_post_1200x800px2-18685.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18685/japans-shimadzu-unveils-device-for-measuring-amyloid-peptides-in-blood.html</guid>
		</item>	
				<item>
			<title>Japan uses quantum physics to destroy cancer cells</title>
			<atom:link href="https://biospectrumasia.com/news/50/18677/japan-uses-quantum-physics-to-destroy-cancer-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18677/japan-uses-quantum-physics-to-destroy-cancer-cells.html</link>
			<pubDate>Tue, 27 Jul 2021 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_07_27_at_11_34_19_am-18677.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18677/japan-uses-quantum-physics-to-destroy-cancer-cells.html</guid>
		</item>	
				<item>
			<title>Japan develops 20-min test to detect antibodies against SARS-CoV-2</title>
			<atom:link href="https://biospectrumasia.com/news/50/18672/japan-develops-20-min-test-to-detect-antibodies-against-sars-cov-2.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18672/japan-develops-20-min-test-to-detect-antibodies-against-sars-cov-2.html</link>
			<pubDate>Mon, 26 Jul 2021 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_104108189-18672.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18672/japan-develops-20-min-test-to-detect-antibodies-against-sars-cov-2.html</guid>
		</item>	
				<item>
			<title>Takeda expands Moderna&#039;s COVID-19 vaccine supply in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/18643/takeda-expands-modernas-covid-19-vaccine-supply-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18643/takeda-expands-modernas-covid-19-vaccine-supply-in-japan.html</link>
			<pubDate>Wed, 21 Jul 2021 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/moderna_ramps_up_covid_19_vaccine_supply_to_3_billion_doses_in_2022-18643.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18643/takeda-expands-modernas-covid-19-vaccine-supply-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese startup OriCiro raises Â¥1 B to advance cell-free DNA technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/18640/japanese-startup-oriciro-raises-1-b-to-advance-cell-free-dna-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18640/japanese-startup-oriciro-raises-1-b-to-advance-cell-free-dna-technology.html</link>
			<pubDate>Wed, 21 Jul 2021 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/use_case_ask_your_donors_to_help_you_fund_raise_with_text_messaging_featured-18640.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18640/japanese-startup-oriciro-raises-1-b-to-advance-cell-free-dna-technology.html</guid>
		</item>	
				<item>
			<title>Japan approves Regeneron&#039;s antibody cocktail for COVID-19 treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/18628/japan-approves-regenerons-antibody-cocktail-for-covid-19-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18628/japan-approves-regenerons-antibody-cocktail-for-covid-19-treatment.html</link>
			<pubDate>Tue, 20 Jul 2021 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_795297598-18628.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18628/japan-approves-regenerons-antibody-cocktail-for-covid-19-treatment.html</guid>
		</item>	
				<item>
			<title>Product launches by Asian pharma cos can benefit antiviral drug makers in APAC: Graphical Research</title>
			<atom:link href="https://biospectrumasia.com/news/50/18620/product-launches-by-asian-pharma-cos-can-benefit-antiviral-drug-makers-in-apac-graphical-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18620/product-launches-by-asian-pharma-cos-can-benefit-antiviral-drug-makers-in-apac-graphical-research.html</link>
			<pubDate>Mon, 19 Jul 2021 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicines-18620.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18620/product-launches-by-asian-pharma-cos-can-benefit-antiviral-drug-makers-in-apac-graphical-research.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Topcon Healthcare acquires VISIA Imaging</title>
			<atom:link href="https://biospectrumasia.com/news/50/18608/japans-topcon-healthcare-acquires-visia-imaging.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18608/japans-topcon-healthcare-acquires-visia-imaging.html</link>
			<pubDate>Fri, 16 Jul 2021 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_07_16_at_11_55_15_am-18608.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18608/japans-topcon-healthcare-acquires-visia-imaging.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT Fund invests 97.4M yen in drug discovery project for TB</title>
			<atom:link href="https://biospectrumasia.com/news/50/18596/japans-ghit-fund-invests-97-4m-yen-in-drug-discovery-project-for-tb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18596/japans-ghit-fund-invests-97-4m-yen-in-drug-discovery-project-for-tb.html</link>
			<pubDate>Thu, 15 Jul 2021 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/science_funding_2_1-18596.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18596/japans-ghit-fund-invests-97-4m-yen-in-drug-discovery-project-for-tb.html</guid>
		</item>	
				<item>
			<title>NEC&#039;s AI tool aids in determining whether colorectal lesions are potentially neoplastic</title>
			<atom:link href="https://biospectrumasia.com/news/50/18594/necs-ai-tool-aids-in-determining-whether-colorectal-lesions-are-potentially-neoplastic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18594/necs-ai-tool-aids-in-determining-whether-colorectal-lesions-are-potentially-neoplastic.html</link>
			<pubDate>Thu, 15 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/low_necai-18594.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18594/necs-ai-tool-aids-in-determining-whether-colorectal-lesions-are-potentially-neoplastic.html</guid>
		</item>	
				<item>
			<title>Japan explores complex lipid metabolism networks for studying various diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/18588/japan-explores-complex-lipid-metabolism-networks-for-studying-various-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18588/japan-explores-complex-lipid-metabolism-networks-for-studying-various-diseases.html</link>
			<pubDate>Wed, 14 Jul 2021 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-18588.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18588/japan-explores-complex-lipid-metabolism-networks-for-studying-various-diseases.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PHC launches next-gen sequencer for advanced genomic medicine research</title>
			<atom:link href="https://biospectrumasia.com/news/50/18572/japans-phc-launches-next-gen-sequencer-for-advanced-genomic-medicine-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18572/japans-phc-launches-next-gen-sequencer-for-advanced-genomic-medicine-research.html</link>
			<pubDate>Tue, 13 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20210706en-18572.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18572/japans-phc-launches-next-gen-sequencer-for-advanced-genomic-medicine-research.html</guid>
		</item>	
				<item>
			<title>Japan sets COVID-19 drug trials up for success</title>
			<atom:link href="https://biospectrumasia.com/news/50/18559/japan-sets-covid-19-drug-trials-up-for-success.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18559/japan-sets-covid-19-drug-trials-up-for-success.html</link>
			<pubDate>Fri, 09 Jul 2021 17:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-18559.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18559/japan-sets-covid-19-drug-trials-up-for-success.html</guid>
		</item>	
				<item>
			<title>PHC Corp launches next-generation sequencer DNBSEQ series in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/18524/phc-corp-launches-next-generation-sequencer-dnbseq-series-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18524/phc-corp-launches-next-generation-sequencer-dnbseq-series-in-japan.html</link>
			<pubDate>Wed, 07 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_07_06_at_10_02_15_pm-18524.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18524/phc-corp-launches-next-generation-sequencer-dnbseq-series-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan harness potential of self-assembling peptides (SAPs) in intracellular spaces</title>
			<atom:link href="https://biospectrumasia.com/news/50/18531/japan-harness-potential-of-self-assembling-peptides-saps-in-intracellular-spaces.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18531/japan-harness-potential-of-self-assembling-peptides-saps-in-intracellular-spaces.html</link>
			<pubDate>Wed, 07 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/infographic_advances_in_intracellular_spaces_with_de_novo_designed_peptide-18531.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18531/japan-harness-potential-of-self-assembling-peptides-saps-in-intracellular-spaces.html</guid>
		</item>	
				<item>
			<title>SE Asia&#039;s Austrianova secures significant investment from Japan&#039;s Real Tech Fund </title>
			<atom:link href="https://biospectrumasia.com/news/50/18532/se-asias-austrianova-secures-significant-investment-from-japans-real-tech-fund-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18532/se-asias-austrianova-secures-significant-investment-from-japans-real-tech-fund-.html</link>
			<pubDate>Wed, 07 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/page2image7187840_1_-18532.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18532/se-asias-austrianova-secures-significant-investment-from-japans-real-tech-fund-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujifilm invests Â¥90 B to increase capacity for biologics</title>
			<atom:link href="https://biospectrumasia.com/news/50/18513/japans-fujifilm-invests-90-b-to-increase-capacity-for-biologics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18513/japans-fujifilm-invests-90-b-to-increase-capacity-for-biologics.html</link>
			<pubDate>Tue, 06 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_135415067-18513.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18513/japans-fujifilm-invests-90-b-to-increase-capacity-for-biologics.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares partners InveniAI to launch multi-target AI-powered drug discovery platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/18521/sosei-heptares-partners-inveniai-to-launch-multi-target-ai-powered-drug-discovery-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18521/sosei-heptares-partners-inveniai-to-launch-multi-target-ai-powered-drug-discovery-platform.html</link>
			<pubDate>Tue, 06 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fmcna-18521.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18521/sosei-heptares-partners-inveniai-to-launch-multi-target-ai-powered-drug-discovery-platform.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sysmex Corp teams up with QIAGEN for global cancer companion diagnostics</title>
			<atom:link href="https://biospectrumasia.com/news/50/18491/japans-sysmex-corp-teams-up-with-qiagen-for-global-cancer-companion-diagnostics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18491/japans-sysmex-corp-teams-up-with-qiagen-for-global-cancer-companion-diagnostics.html</link>
			<pubDate>Fri, 02 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_211842661-18491.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18491/japans-sysmex-corp-teams-up-with-qiagen-for-global-cancer-companion-diagnostics.html</guid>
		</item>	
				<item>
			<title>Scientists propose repurposing anti-malarial drug Mefloquine to fight COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/18498/scientists-propose-repurposing-anti-malarial-drug-mefloquine-to-fight-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18498/scientists-propose-repurposing-anti-malarial-drug-mefloquine-to-fight-covid-19.html</link>
			<pubDate>Fri, 02 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharmaceutical_researcher_finds_solution_coronavirus_concept_medical_research_207634_24-18498.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18498/scientists-propose-repurposing-anti-malarial-drug-mefloquine-to-fight-covid-19.html</guid>
		</item>	
				<item>
			<title>Japan plans data scientist training program for pharma industry</title>
			<atom:link href="https://biospectrumasia.com/news/50/18462/japan-plans-data-scientist-training-program-for-pharma-industry.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18462/japan-plans-data-scientist-training-program-for-pharma-industry.html</link>
			<pubDate>Tue, 29 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug_discovery_pharma_data_science_scaled-18462.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18462/japan-plans-data-scientist-training-program-for-pharma-industry.html</guid>
		</item>	
				<item>
			<title>Japanese startup B dot Medical promotes spread of proton therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/18457/japanese-startup-b-dot-medical-promotes-spread-of-proton-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18457/japanese-startup-b-dot-medical-promotes-spread-of-proton-therapy.html</link>
			<pubDate>Mon, 28 Jun 2021 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_06_28_at_3_08_23_pm-18457.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18457/japanese-startup-b-dot-medical-promotes-spread-of-proton-therapy.html</guid>
		</item>	
				<item>
			<title>Japan aims to prevent CVDs using AI and home measurement data</title>
			<atom:link href="https://biospectrumasia.com/news/50/18440/japan-aims-to-prevent-cvds-using-ai-and-home-measurement-data.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18440/japan-aims-to-prevent-cvds-using-ai-and-home-measurement-data.html</link>
			<pubDate>Fri, 25 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_06_24_at_11_06_41_pm-18440.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18440/japan-aims-to-prevent-cvds-using-ai-and-home-measurement-data.html</guid>
		</item>	
				<item>
			<title>Takara Bio grants BioNTech a commercial patents license of CAR T-cell Therapy drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/18447/takara-bio-grants-biontech-a-commercial-patents-license-of-car-t-cell-therapy-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18447/takara-bio-grants-biontech-a-commercial-patents-license-of-car-t-cell-therapy-drug.html</link>
			<pubDate>Fri, 25 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/white_dna_structure_abstract_pill_drug_isolated_white_background_3d_rendering_46370_3881-18447.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18447/takara-bio-grants-biontech-a-commercial-patents-license-of-car-t-cell-therapy-drug.html</guid>
		</item>	
				<item>
			<title>Japanese healthcare firms to find potential startup partners at virtual convention</title>
			<atom:link href="https://biospectrumasia.com/news/50/18431/japanese-healthcare-firms-to-find-potential-startup-partners-at-virtual-convention.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18431/japanese-healthcare-firms-to-find-potential-startup-partners-at-virtual-convention.html</link>
			<pubDate>Thu, 24 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_06_23_at_10_39_10_pm-18431.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18431/japanese-healthcare-firms-to-find-potential-startup-partners-at-virtual-convention.html</guid>
		</item>	
				<item>
			<title>Fujitsu Japan deploys world&#039;s fastest supercomputer for COVID-19 therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/18417/fujitsu-japan-deploys-worlds-fastest-supercomputer-for-covid-19-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18417/fujitsu-japan-deploys-worlds-fastest-supercomputer-for-covid-19-therapies.html</link>
			<pubDate>Tue, 22 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/depositphotos0-18417.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18417/fujitsu-japan-deploys-worlds-fastest-supercomputer-for-covid-19-therapies.html</guid>
		</item>	
				<item>
			<title>Rakuten Medical, Shimadzu to develop photoimmunotherapy-based medical device</title>
			<atom:link href="https://biospectrumasia.com/news/50/18392/rakuten-medical-shimadzu-to-develop-photoimmunotherapy-based-medical-device.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18392/rakuten-medical-shimadzu-to-develop-photoimmunotherapy-based-medical-device.html</link>
			<pubDate>Fri, 18 Jun 2021 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-18392.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18392/rakuten-medical-shimadzu-to-develop-photoimmunotherapy-based-medical-device.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo discontinues development of Nafamostat in Japan for COVID-19 treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/18382/daiichi-sankyo-discontinues-development-of-nafamostat-in-japan-for-covid-19-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18382/daiichi-sankyo-discontinues-development-of-nafamostat-in-japan-for-covid-19-treatment.html</link>
			<pubDate>Wed, 16 Jun 2021 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_104108189-18382.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18382/daiichi-sankyo-discontinues-development-of-nafamostat-in-japan-for-covid-19-treatment.html</guid>
		</item>	
				<item>
			<title>Japan demonstrates ability of chlorine dioxide aqueous solution to combat SARS-CoV-2</title>
			<atom:link href="https://biospectrumasia.com/news/50/18358/japan-demonstrates-ability-of-chlorine-dioxide-aqueous-solution-to-combat-sars-cov-2.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18358/japan-demonstrates-ability-of-chlorine-dioxide-aqueous-solution-to-combat-sars-cov-2.html</link>
			<pubDate>Fri, 11 Jun 2021 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-18358.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18358/japan-demonstrates-ability-of-chlorine-dioxide-aqueous-solution-to-combat-sars-cov-2.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Eisai helps Alzheimer&#039;s patients access ADUHELM post-FDA approval</title>
			<atom:link href="https://biospectrumasia.com/news/50/18316/japans-eisai-helps-alzheimers-patients-access-aduhelm-post-fda-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18316/japans-eisai-helps-alzheimers-patients-access-aduhelm-post-fda-approval.html</link>
			<pubDate>Tue, 08 Jun 2021 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/robina_weermeijer_ihfopazzjhm_unsplash_scaled-18316.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18316/japans-eisai-helps-alzheimers-patients-access-aduhelm-post-fda-approval.html</guid>
		</item>	
				<item>
			<title>Japan hosts Gavi COVAX AMC summit virtual event securing $2.4 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/18308/japan-hosts-gavi-covax-amc-summit-virtual-event-securing-2-4-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18308/japan-hosts-gavi-covax-amc-summit-virtual-event-securing-2-4-b.html</link>
			<pubDate>Mon, 07 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gavi_1_-18308.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18308/japan-hosts-gavi-covax-amc-summit-virtual-event-securing-2-4-b.html</guid>
		</item>	
				<item>
			<title>Countries, health partners discuss efforts to curb COVID-19 in WHO South-East Asia Region</title>
			<atom:link href="https://biospectrumasia.com/news/50/18291/countries-health-partners-discuss-efforts-to-curb-covid-19-in-who-south-east-asia-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18291/countries-health-partners-discuss-efforts-to-curb-covid-19-in-who-south-east-asia-region.html</link>
			<pubDate>Thu, 03 Jun 2021 17:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_133533590-18291.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18291/countries-health-partners-discuss-efforts-to-curb-covid-19-in-who-south-east-asia-region.html</guid>
		</item>	
				<item>
			<title>Shimadzu and Shionogi partner to explore wastewater viral infections</title>
			<atom:link href="https://biospectrumasia.com/news/50/18281/shimadzu-and-shionogi-partner-to-explore-wastewater-viral-infections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18281/shimadzu-and-shionogi-partner-to-explore-wastewater-viral-infections.html</link>
			<pubDate>Thu, 03 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_researcher_tries_find_solution_virus_concept_viruses_bacteria_research_207634_9-18281.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18281/shimadzu-and-shionogi-partner-to-explore-wastewater-viral-infections.html</guid>
		</item>	
				<item>
			<title>Eisai ties up with ITO EN to support people living with dementia</title>
			<atom:link href="https://biospectrumasia.com/news/50/18282/eisai-ties-up-with-ito-en-to-support-people-living-with-dementia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18282/eisai-ties-up-with-ito-en-to-support-people-living-with-dementia.html</link>
			<pubDate>Wed, 02 Jun 2021 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dementia-18282.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18282/eisai-ties-up-with-ito-en-to-support-people-living-with-dementia.html</guid>
		</item>	
				<item>
			<title>Japan takes step forward towards treating hereditary deafness</title>
			<atom:link href="https://biospectrumasia.com/news/50/18263/japan-takes-step-forward-towards-treating-hereditary-deafness.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18263/japan-takes-step-forward-towards-treating-hereditary-deafness.html</link>
			<pubDate>Mon, 31 May 2021 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/249285_2200_732x549-18263.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18263/japan-takes-step-forward-towards-treating-hereditary-deafness.html</guid>
		</item>	
				<item>
			<title>Fujitsu Japan revamps Electronic Medical Record System for clinics</title>
			<atom:link href="https://biospectrumasia.com/news/50/18258/fujitsu-japan-revamps-electronic-medical-record-system-for-clinics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18258/fujitsu-japan-revamps-electronic-medical-record-system-for-clinics.html</link>
			<pubDate>Mon, 31 May 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/doctor_mask_works_computer_medical_equipment_emergency_department_395899_36-18258.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18258/fujitsu-japan-revamps-electronic-medical-record-system-for-clinics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujifilm launches SARS-CoV-2 mutation kit to detect Indian variant</title>
			<atom:link href="https://biospectrumasia.com/news/50/18249/japans-fujifilm-launches-sars-cov-2-mutation-kit-to-detect-indian-variant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18249/japans-fujifilm-launches-sars-cov-2-mutation-kit-to-detect-indian-variant.html</link>
			<pubDate>Fri, 28 May 2021 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_211842661-18249.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18249/japans-fujifilm-launches-sars-cov-2-mutation-kit-to-detect-indian-variant.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares and Pfizer collaborate for multi-target drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/18213/sosei-heptares-and-pfizer-collaborate-for-multi-target-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18213/sosei-heptares-and-pfizer-collaborate-for-multi-target-drug-discovery.html</link>
			<pubDate>Mon, 24 May 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik_7-18213.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18213/sosei-heptares-and-pfizer-collaborate-for-multi-target-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japanese firmsÂ toÂ developÂ novel AI-based cell analyzers and testing techniques</title>
			<atom:link href="https://biospectrumasia.com/news/50/18189/japanese-firmstodevelopnovel-ai-based-cell-analyzers-and-testing-techniques.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18189/japanese-firmstodevelopnovel-ai-based-cell-analyzers-and-testing-techniques.html</link>
			<pubDate>Fri, 14 May 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik8-18189.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18189/japanese-firmstodevelopnovel-ai-based-cell-analyzers-and-testing-techniques.html</guid>
		</item>	
				<item>
			<title>Mitsubishi&#039;s air purification filtering technology can inactivate SARS-CoV-2</title>
			<atom:link href="https://biospectrumasia.com/news/50/18177/mitsubishis-air-purification-filtering-technology-can-inactivate-sars-cov-2.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18177/mitsubishis-air-purification-filtering-technology-can-inactivate-sars-cov-2.html</link>
			<pubDate>Thu, 13 May 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pm_2_5_air_filteration_virus_protection_3_layers_filter_34230_489-18177.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18177/mitsubishis-air-purification-filtering-technology-can-inactivate-sars-cov-2.html</guid>
		</item>	
				<item>
			<title>Japan aids India with oxygen generation plants</title>
			<atom:link href="https://biospectrumasia.com/news/50/18170/japan-aids-india-with-oxygen-generation-plants.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18170/japan-aids-india-with-oxygen-generation-plants.html</link>
			<pubDate>Tue, 11 May 2021 17:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oxygen-18170.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18170/japan-aids-india-with-oxygen-generation-plants.html</guid>
		</item>	
				<item>
			<title>Japan secures supply of investigational antibody cocktail for COVID-19 treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/18165/japan-secures-supply-of-investigational-antibody-cocktail-for-covid-19-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18165/japan-secures-supply-of-investigational-antibody-cocktail-for-covid-19-treatment.html</link>
			<pubDate>Tue, 11 May 2021 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications_342462_1920-18165.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18165/japan-secures-supply-of-investigational-antibody-cocktail-for-covid-19-treatment.html</guid>
		</item>	
				<item>
			<title>Pfizer, BioNTech to help vaccinate athletes at 2020 Tokyo Games</title>
			<atom:link href="https://biospectrumasia.com/news/50/18149/pfizer-biontech-to-help-vaccinate-athletes-at-2020-tokyo-games.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18149/pfizer-biontech-to-help-vaccinate-athletes-at-2020-tokyo-games.html</link>
			<pubDate>Fri, 07 May 2021 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_05_07_at_3_10_41_pm-18149.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18149/pfizer-biontech-to-help-vaccinate-athletes-at-2020-tokyo-games.html</guid>
		</item>	
				<item>
			<title>Japan-based NEC to develop biosensor for detecting SARS-CoV-2 in open spaces</title>
			<atom:link href="https://biospectrumasia.com/news/50/18134/japan-based-nec-to-develop-biosensor-for-detecting-sars-cov-2-in-open-spaces.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18134/japan-based-nec-to-develop-biosensor-for-detecting-sars-cov-2-in-open-spaces.html</link>
			<pubDate>Thu, 06 May 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/graphic_illustration_coronavirus_disease_pandemic_dark_background_181624_23747-18134.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18134/japan-based-nec-to-develop-biosensor-for-detecting-sars-cov-2-in-open-spaces.html</guid>
		</item>	
				<item>
			<title>Tiziana seeks partner in Asia to enhance hepatocellular carcinoma treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/18130/tiziana-seeks-partner-in-asia-to-enhance-hepatocellular-carcinoma-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18130/tiziana-seeks-partner-in-asia-to-enhance-hepatocellular-carcinoma-treatment.html</link>
			<pubDate>Wed, 05 May 2021 15:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-18130.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18130/tiziana-seeks-partner-in-asia-to-enhance-hepatocellular-carcinoma-treatment.html</guid>
		</item>	
				<item>
			<title>Japan lays focus on improving brain health</title>
			<atom:link href="https://biospectrumasia.com/news/50/18113/japan-lays-focus-on-improving-brain-health.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18113/japan-lays-focus-on-improving-brain-health.html</link>
			<pubDate>Mon, 03 May 2021 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_240098272-18113.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18113/japan-lays-focus-on-improving-brain-health.html</guid>
		</item>	
				<item>
			<title>CPhI Japan highlights cell &amp; gene therapies, digital innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/18100/cphi-japan-highlights-cell-gene-therapies-digital-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18100/cphi-japan-highlights-cell-gene-therapies-digital-innovation.html</link>
			<pubDate>Fri, 30 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/big_sight_hi_res-18100.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18100/cphi-japan-highlights-cell-gene-therapies-digital-innovation.html</guid>
		</item>	
				<item>
			<title>Elusive protein complex can be the key to treat chromosomal disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/18109/elusive-protein-complex-can-be-the-key-to-treat-chromosomal-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18109/elusive-protein-complex-can-be-the-key-to-treat-chromosomal-disorders.html</link>
			<pubDate>Fri, 30 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/figure_elusive_protein_complex_could_hold_the_key_to_treating_chromosomal_disorders-18109.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18109/elusive-protein-complex-can-be-the-key-to-treat-chromosomal-disorders.html</guid>
		</item>	
				<item>
			<title>Japan offers support to new specialty pharmaceutical manufacturers</title>
			<atom:link href="https://biospectrumasia.com/news/50/18081/japan-offers-support-to-new-specialty-pharmaceutical-manufacturers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18081/japan-offers-support-to-new-specialty-pharmaceutical-manufacturers.html</link>
			<pubDate>Wed, 28 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/health_care_icon_pattern_medical_innovation_background_115579_230_1_-18081.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18081/japan-offers-support-to-new-specialty-pharmaceutical-manufacturers.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo to market hypercholesterolemia treatment in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/18072/daiichi-sankyo-to-market-hypercholesterolemia-treatment-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18072/daiichi-sankyo-to-market-hypercholesterolemia-treatment-in-asia.html</link>
			<pubDate>Tue, 27 Apr 2021 09:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_04_27_at_11_00_20_am-18072.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18072/daiichi-sankyo-to-market-hypercholesterolemia-treatment-in-asia.html</guid>
		</item>	
				<item>
			<title>UK&#039;s Ergomed expands pharmacovigilance business operations in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/18063/uks-ergomed-expands-pharmacovigilance-business-operations-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18063/uks-ergomed-expands-pharmacovigilance-business-operations-in-japan-.html</link>
			<pubDate>Mon, 26 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepikw4t-18063.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18063/uks-ergomed-expands-pharmacovigilance-business-operations-in-japan-.html</guid>
		</item>	
				<item>
			<title>Japan provides thermography camera in Kenya to prevent COVID-19 spread</title>
			<atom:link href="https://biospectrumasia.com/news/50/18051/japan-provides-thermography-camera-in-kenya-to-prevent-covid-19-spread.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18051/japan-provides-thermography-camera-in-kenya-to-prevent-covid-19-spread.html</link>
			<pubDate>Fri, 23 Apr 2021 14:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2301_01-18051.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18051/japan-provides-thermography-camera-in-kenya-to-prevent-covid-19-spread.html</guid>
		</item>	
				<item>
			<title>International collaboration to develop iPSMA SPECT imaging for prostate cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/18047/international-collaboration-to-develop-ipsma-spect-imaging-for-prostate-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18047/international-collaboration-to-develop-ipsma-spect-imaging-for-prostate-cancer.html</link>
			<pubDate>Fri, 23 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/launch_of_the_noble_registry_1-18047.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18047/international-collaboration-to-develop-ipsma-spect-imaging-for-prostate-cancer.html</guid>
		</item>	
				<item>
			<title>Fujifilm initiates new Ph III trial of Avigan for COVID-19 treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/18030/fujifilm-initiates-new-ph-iii-trial-of-avigan-for-covid-19-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18030/fujifilm-initiates-new-ph-iii-trial-of-avigan-for-covid-19-treatment-in-japan.html</link>
			<pubDate>Wed, 21 Apr 2021 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_31369030-18030.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18030/fujifilm-initiates-new-ph-iii-trial-of-avigan-for-covid-19-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Terumo boosts global plasma collection and delivery platform with CSL</title>
			<atom:link href="https://biospectrumasia.com/news/50/18023/japans-terumo-boosts-global-plasma-collection-and-delivery-platform-with-csl.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18023/japans-terumo-boosts-global-plasma-collection-and-delivery-platform-with-csl.html</link>
			<pubDate>Tue, 20 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/terumobct_2019_0185-18023.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18023/japans-terumo-boosts-global-plasma-collection-and-delivery-platform-with-csl.html</guid>
		</item>	
				<item>
			<title>ITOCHU to launch biomass power generation business inÂ Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/18009/itochu-to-launch-biomass-power-generation-business-injapan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18009/itochu-to-launch-biomass-power-generation-business-injapan.html</link>
			<pubDate>Mon, 19 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/news_210415_1_2-18009.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18009/itochu-to-launch-biomass-power-generation-business-injapan.html</guid>
		</item>	
				<item>
			<title>Japan invents novel cell therapy for type I diabetes mellitus</title>
			<atom:link href="https://biospectrumasia.com/news/50/17990/japan-invents-novel-cell-therapy-for-type-i-diabetes-mellitus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17990/japan-invents-novel-cell-therapy-for-type-i-diabetes-mellitus.html</link>
			<pubDate>Fri, 16 Apr 2021 05:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1691026993_1_16558_17333-17990.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17990/japan-invents-novel-cell-therapy-for-type-i-diabetes-mellitus.html</guid>
		</item>	
				<item>
			<title>Japan boosts native life science biz via virtual access for global audience</title>
			<atom:link href="https://biospectrumasia.com/news/50/18001/japan-boosts-native-life-science-biz-via-virtual-access-for-global-audience.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18001/japan-boosts-native-life-science-biz-via-virtual-access-for-global-audience.html</link>
			<pubDate>Fri, 16 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1618492505520_1_-18001.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18001/japan-boosts-native-life-science-biz-via-virtual-access-for-global-audience.html</guid>
		</item>	
				<item>
			<title>Japaneseâ€“European research team discovers novel genetic mitochondrial disorder</title>
			<atom:link href="https://biospectrumasia.com/news/50/18006/japaneseeuropean-research-team-discovers-novel-genetic-mitochondrial-disorder.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/18006/japaneseeuropean-research-team-discovers-novel-genetic-mitochondrial-disorder.html</link>
			<pubDate>Mon, 19 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/technology_science_concept_dna_futuristic_monitor_background_3d_rendering_142243_5-18006.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/18006/japaneseeuropean-research-team-discovers-novel-genetic-mitochondrial-disorder.html</guid>
		</item>	
				<item>
			<title>Japanese NHI price listing triggers $15 M milestone payment to BioCryst</title>
			<atom:link href="https://biospectrumasia.com/news/50/17989/japanese-nhi-price-listing-triggers-15-m-milestone-payment-to-biocryst.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17989/japanese-nhi-price-listing-triggers-15-m-milestone-payment-to-biocryst.html</link>
			<pubDate>Thu, 15 Apr 2021 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications_342462_1920-17989.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17989/japanese-nhi-price-listing-triggers-15-m-milestone-payment-to-biocryst.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher Amplitude Solution receives EUA from FDA</title>
			<atom:link href="https://biospectrumasia.com/news/50/17988/thermo-fisher-amplitude-solution-receives-eua-from-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17988/thermo-fisher-amplitude-solution-receives-eua-from-fda.html</link>
			<pubDate>Thu, 15 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thermo_fisher_scientific_amplitude_1_1_-17988.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17988/thermo-fisher-amplitude-solution-receives-eua-from-fda.html</guid>
		</item>	
				<item>
			<title>L Catterton announces JPY 20 B investment in healthcare firm PHC Holdings</title>
			<atom:link href="https://biospectrumasia.com/news/50/17977/l-catterton-announces-jpy-20-b-investment-in-healthcare-firm-phc-holdings.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17977/l-catterton-announces-jpy-20-b-investment-in-healthcare-firm-phc-holdings.html</link>
			<pubDate>Wed, 14 Apr 2021 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_04_14_at_12_18_19_pm-17977.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17977/l-catterton-announces-jpy-20-b-investment-in-healthcare-firm-phc-holdings.html</guid>
		</item>	
				<item>
			<title>Remiges Ventures launches new life science incubator</title>
			<atom:link href="https://biospectrumasia.com/news/50/17956/remiges-ventures-launches-new-life-science-incubator.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17956/remiges-ventures-launches-new-life-science-incubator.html</link>
			<pubDate>Fri, 09 Apr 2021 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_31369030-17956.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17956/remiges-ventures-launches-new-life-science-incubator.html</guid>
		</item>	
				<item>
			<title>Hitachi uses digital technology for creation of next-generation biopharmaceuticals</title>
			<atom:link href="https://biospectrumasia.com/news/50/17935/hitachi-uses-digital-technology-for-creation-of-next-generation-biopharmaceuticals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17935/hitachi-uses-digital-technology-for-creation-of-next-generation-biopharmaceuticals.html</link>
			<pubDate>Wed, 07 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_259174286-17935.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17935/hitachi-uses-digital-technology-for-creation-of-next-generation-biopharmaceuticals.html</guid>
		</item>	
				<item>
			<title>Japanese medical VR company Jolly Good to develop digital therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/17909/japanese-medical-vr-company-jolly-good-to-develop-digital-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17909/japanese-medical-vr-company-jolly-good-to-develop-digital-therapeutics.html</link>
			<pubDate>Mon, 05 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/national-17909.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17909/japanese-medical-vr-company-jolly-good-to-develop-digital-therapeutics.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo starts Ph 1 Trial for Nafamostat Inhalation Formulation to treat COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/17913/daiichi-sankyo-starts-ph-1-trial-for-nafamostat-inhalation-formulation-to-treat-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17913/daiichi-sankyo-starts-ph-1-trial-for-nafamostat-inhalation-formulation-to-treat-covid-19.html</link>
			<pubDate>Mon, 05 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-17913.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17913/daiichi-sankyo-starts-ph-1-trial-for-nafamostat-inhalation-formulation-to-treat-covid-19.html</guid>
		</item>	
				<item>
			<title>Fujifilm launches mutation detection kits for SARS-CoV-2</title>
			<atom:link href="https://biospectrumasia.com/news/50/17896/fujifilm-launches-mutation-detection-kits-for-sars-cov-2.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17896/fujifilm-launches-mutation-detection-kits-for-sars-cov-2.html</link>
			<pubDate>Fri, 02 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_212432119-17896.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17896/fujifilm-launches-mutation-detection-kits-for-sars-cov-2.html</guid>
		</item>	
				<item>
			<title>Japan holds AI-based nursing record support system demo</title>
			<atom:link href="https://biospectrumasia.com/news/50/17887/japan-holds-ai-based-nursing-record-support-system-demo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17887/japan-holds-ai-based-nursing-record-support-system-demo.html</link>
			<pubDate>Thu, 01 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/doctor_s_writing_working_laptop_computer_writing_prescription_clipboard_with_record_information_paper_4236_1457-17887.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17887/japan-holds-ai-based-nursing-record-support-system-demo.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo incurs 15 B yen loss after terminating vaccine biz with Sanofi</title>
			<atom:link href="https://biospectrumasia.com/news/50/17895/daiichi-sankyo-incurs-15-b-yen-loss-after-terminating-vaccine-biz-with-sanofi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17895/daiichi-sankyo-incurs-15-b-yen-loss-after-terminating-vaccine-biz-with-sanofi.html</link>
			<pubDate>Thu, 01 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_144799030-17895.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17895/daiichi-sankyo-incurs-15-b-yen-loss-after-terminating-vaccine-biz-with-sanofi.html</guid>
		</item>	
				<item>
			<title>KYORIN, Eisai to develop &amp; market drug for overactive bladder treatment in 4 ASEAN countries</title>
			<atom:link href="https://biospectrumasia.com/news/50/17886/kyorin-eisai-to-develop-market-drug-for-overactive-bladder-treatment-in-4-asean-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17886/kyorin-eisai-to-develop-market-drug-for-overactive-bladder-treatment-in-4-asean-countries.html</link>
			<pubDate>Wed, 31 Mar 2021 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_03_31_at_3_21_46_pm-17886.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17886/kyorin-eisai-to-develop-market-drug-for-overactive-bladder-treatment-in-4-asean-countries.html</guid>
		</item>	
				<item>
			<title>Eisai&#039;s Anti Cancer agent Lenvatinib-Pembrolizumab combo receives EMA in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17869/eisais-anti-cancer-agent-lenvatinib-pembrolizumab-combo-receives-ema-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17869/eisais-anti-cancer-agent-lenvatinib-pembrolizumab-combo-receives-ema-in-japan.html</link>
			<pubDate>Tue, 30 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/colorful_capsule_pills_stainless_steel_drug_tray_white_background_33867_24-17869.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17869/eisais-anti-cancer-agent-lenvatinib-pembrolizumab-combo-receives-ema-in-japan.html</guid>
		</item>	
				<item>
			<title>Toyoda Gosei invests in medical device development startup</title>
			<atom:link href="https://biospectrumasia.com/news/50/17870/toyoda-gosei-invests-in-medical-device-development-startup.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17870/toyoda-gosei-invests-in-medical-device-development-startup.html</link>
			<pubDate>Tue, 30 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_148575200-17870.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17870/toyoda-gosei-invests-in-medical-device-development-startup.html</guid>
		</item>	
				<item>
			<title>Japan studies Parkinson&#039;s disease with face-recognition software</title>
			<atom:link href="https://biospectrumasia.com/news/50/17864/japan-studies-parkinsons-disease-with-face-recognition-software.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17864/japan-studies-parkinsons-disease-with-face-recognition-software.html</link>
			<pubDate>Mon, 29 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-17864.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17864/japan-studies-parkinsons-disease-with-face-recognition-software.html</guid>
		</item>	
				<item>
			<title>Bright Peak Therapeutics and Ajinomoto to create novel immunocytokines</title>
			<atom:link href="https://biospectrumasia.com/news/50/17848/bright-peak-therapeutics-and-ajinomoto-to-create-novel-immunocytokines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17848/bright-peak-therapeutics-and-ajinomoto-to-create-novel-immunocytokines.html</link>
			<pubDate>Fri, 26 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/depositphotos-17848.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17848/bright-peak-therapeutics-and-ajinomoto-to-create-novel-immunocytokines.html</guid>
		</item>	
				<item>
			<title>Hitachi enters collaboration for data driven precision medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/17850/hitachi-enters-collaboration-for-data-driven-precision-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17850/hitachi-enters-collaboration-for-data-driven-precision-medicine.html</link>
			<pubDate>Fri, 26 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_131746163-17850.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17850/hitachi-enters-collaboration-for-data-driven-precision-medicine.html</guid>
		</item>	
				<item>
			<title>Japan enables access to electronic medical records via mobile phones</title>
			<atom:link href="https://biospectrumasia.com/news/50/17833/japan-enables-access-to-electronic-medical-records-via-mobile-phones.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17833/japan-enables-access-to-electronic-medical-records-via-mobile-phones.html</link>
			<pubDate>Thu, 25 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik235-17833.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17833/japan-enables-access-to-electronic-medical-records-via-mobile-phones.html</guid>
		</item>	
				<item>
			<title>CPhI Japan opens two-month long virtual event</title>
			<atom:link href="https://biospectrumasia.com/news/50/17821/cphi-japan-opens-two-month-long-virtual-event.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17821/cphi-japan-opens-two-month-long-virtual-event.html</link>
			<pubDate>Wed, 24 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cphijap2-17821.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17821/cphi-japan-opens-two-month-long-virtual-event.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo starts Ph 1/2 trial for mRNA COVID-19 vaccine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17819/daiichi-sankyo-starts-ph-1-2-trial-for-mrna-covid-19-vaccine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17819/daiichi-sankyo-starts-ph-1-2-trial-for-mrna-covid-19-vaccine-in-japan.html</link>
			<pubDate>Tue, 23 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_260662469-17819.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17819/daiichi-sankyo-starts-ph-1-2-trial-for-mrna-covid-19-vaccine-in-japan.html</guid>
		</item>	
				<item>
			<title>Novel DNA sensor can rapidly detect antibiotic-resistant pathogens</title>
			<atom:link href="https://biospectrumasia.com/news/50/17822/novel-dna-sensor-can-rapidly-detect-antibiotic-resistant-pathogens.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17822/novel-dna-sensor-can-rapidly-detect-antibiotic-resistant-pathogens.html</link>
			<pubDate>Tue, 23 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/figure_novel_dna_sensor_can_rapidly_detect_antibiotic_resistant_pathogens-17822.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17822/novel-dna-sensor-can-rapidly-detect-antibiotic-resistant-pathogens.html</guid>
		</item>	
				<item>
			<title>Eisai Medicine Innovation Technology Solutions to launch in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17809/eisai-medicine-innovation-technology-solutions-to-launch-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17809/eisai-medicine-innovation-technology-solutions-to-launch-in-japan.html</link>
			<pubDate>Mon, 22 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/assortment_vaccination_elements_covid19_23_2148880533-17809.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17809/eisai-medicine-innovation-technology-solutions-to-launch-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan designs less-invasive atomic force microscopy to visualize biomolecular systems</title>
			<atom:link href="https://biospectrumasia.com/news/50/17797/japan-designs-less-invasive-atomic-force-microscopy-to-visualize-biomolecular-systems.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17797/japan-designs-less-invasive-atomic-force-microscopy-to-visualize-biomolecular-systems.html</link>
			<pubDate>Fri, 19 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/modern_microscope_station_research_facility_87646_3734-17797.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17797/japan-designs-less-invasive-atomic-force-microscopy-to-visualize-biomolecular-systems.html</guid>
		</item>	
				<item>
			<title>Japan develops less-invasive atomic force microscopy</title>
			<atom:link href="https://biospectrumasia.com/news/50/17798/japan-develops-less-invasive-atomic-force-microscopy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17798/japan-develops-less-invasive-atomic-force-microscopy.html</link>
			<pubDate>Fri, 19 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_31369030-17798.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17798/japan-develops-less-invasive-atomic-force-microscopy.html</guid>
		</item>	
				<item>
			<title>Immune receptor protein could hold key to treatment of autoimmune diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/17794/immune-receptor-protein-could-hold-key-to-treatment-of-autoimmune-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17794/immune-receptor-protein-could-hold-key-to-treatment-of-autoimmune-diseases.html</link>
			<pubDate>Thu, 18 Mar 2021 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik_t_cell-17794.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17794/immune-receptor-protein-could-hold-key-to-treatment-of-autoimmune-diseases.html</guid>
		</item>	
				<item>
			<title>Fujitsu, NCC to create new services for clinical trials, drug development in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17786/fujitsu-ncc-to-create-new-services-for-clinical-trials-drug-development-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17786/fujitsu-ncc-to-create-new-services-for-clinical-trials-drug-development-in-japan.html</link>
			<pubDate>Thu, 18 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-17786.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17786/fujitsu-ncc-to-create-new-services-for-clinical-trials-drug-development-in-japan.html</guid>
		</item>	
				<item>
			<title>Epredia to distribute Paige Digital Pathology Software globally</title>
			<atom:link href="https://biospectrumasia.com/news/50/17793/epredia-to-distribute-paige-digital-pathology-software-globally.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17793/epredia-to-distribute-paige-digital-pathology-software-globally.html</link>
			<pubDate>Thu, 18 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/epredia-17793.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17793/epredia-to-distribute-paige-digital-pathology-software-globally.html</guid>
		</item>	
				<item>
			<title>Eisai aims for novel drug discovery for neurodegenerative disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/17778/eisai-aims-for-novel-drug-discovery-for-neurodegenerative-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17778/eisai-aims-for-novel-drug-discovery-for-neurodegenerative-disorders.html</link>
			<pubDate>Wed, 17 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_472971505_zpsttwkyiau_1000x480_2x-17778.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17778/eisai-aims-for-novel-drug-discovery-for-neurodegenerative-disorders.html</guid>
		</item>	
				<item>
			<title>Eisai, DZNE to create new therapeutic agents for neurodegenerative diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/17779/eisai-dzne-to-create-new-therapeutic-agents-for-neurodegenerative-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17779/eisai-dzne-to-create-new-therapeutic-agents-for-neurodegenerative-diseases.html</link>
			<pubDate>Wed, 17 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/depositphotos0-17779.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17779/eisai-dzne-to-create-new-therapeutic-agents-for-neurodegenerative-diseases.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo begins manufacture of the AstraZeneca COVID-19 Vaccine in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/17784/daiichi-sankyo-begins-manufacture-of-the-astrazeneca-covid-19-vaccine-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17784/daiichi-sankyo-begins-manufacture-of-the-astrazeneca-covid-19-vaccine-in-japan-.html</link>
			<pubDate>Wed, 17 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/img_thumbnail_01-17784.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17784/daiichi-sankyo-begins-manufacture-of-the-astrazeneca-covid-19-vaccine-in-japan-.html</guid>
		</item>	
				<item>
			<title>Takeda, IDT support manufacturing of J&amp;J&#039;s COVID-19 vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/17765/takeda-idt-support-manufacturing-of-jjs-covid-19-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17765/takeda-idt-support-manufacturing-of-jjs-covid-19-vaccine.html</link>
			<pubDate>Tue, 16 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/many_coronavirus_vaccines_lined_up_with_syringe_glass_table_with_reflections_blue_background_360032_44-17765.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17765/takeda-idt-support-manufacturing-of-jjs-covid-19-vaccine.html</guid>
		</item>	
				<item>
			<title>Fujitsu, Kyoto University build AI system to detect genetic disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/17744/fujitsu-kyoto-university-build-ai-system-to-detect-genetic-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17744/fujitsu-kyoto-university-build-ai-system-to-detect-genetic-disorders.html</link>
			<pubDate>Mon, 15 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biology_lab_46706_648-17744.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17744/fujitsu-kyoto-university-build-ai-system-to-detect-genetic-disorders.html</guid>
		</item>	
				<item>
			<title>Takeda to acquire Maverick Therapeutics for $525 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/17743/takeda-to-acquire-maverick-therapeutics-for-525-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17743/takeda-to-acquire-maverick-therapeutics-for-525-m.html</link>
			<pubDate>Fri, 12 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_307115906_web_17077-17743.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17743/takeda-to-acquire-maverick-therapeutics-for-525-m.html</guid>
		</item>	
				<item>
			<title>Setsuro Tech gets access to ERS Genomics&#039; CRISPR/Cas9 patent portfolio for Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17737/setsuro-tech-gets-access-to-ers-genomics-crispr-cas9-patent-portfolio-for-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17737/setsuro-tech-gets-access-to-ers-genomics-crispr-cas9-patent-portfolio-for-japan.html</link>
			<pubDate>Wed, 10 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/crispr_concept_human_genome_modification_medical_background_53562_10206-17737.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17737/setsuro-tech-gets-access-to-ers-genomics-crispr-cas9-patent-portfolio-for-japan.html</guid>
		</item>	
				<item>
			<title>AbbVie pips Gilead to dominate Japan&#039;s hepatitis C virus digital marketing space</title>
			<atom:link href="https://biospectrumasia.com/news/50/17732/abbvie-pips-gilead-to-dominate-japans-hepatitis-c-virus-digital-marketing-space.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17732/abbvie-pips-gilead-to-dominate-japans-hepatitis-c-virus-digital-marketing-space.html</link>
			<pubDate>Tue, 09 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed_1_-17732.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17732/abbvie-pips-gilead-to-dominate-japans-hepatitis-c-virus-digital-marketing-space.html</guid>
		</item>	
				<item>
			<title>Regenerative therapy to treat knee joint damages gets boost in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17735/regenerative-therapy-to-treat-knee-joint-damages-gets-boost-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17735/regenerative-therapy-to-treat-knee-joint-damages-gets-boost-in-japan.html</link>
			<pubDate>Tue, 09 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/edo_hp_ortho_team_bw_pr_08mar21-17735.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17735/regenerative-therapy-to-treat-knee-joint-damages-gets-boost-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda to import &amp; distribute Moderna&#039;s vaccine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17722/takeda-to-import-distribute-modernas-vaccine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17722/takeda-to-import-distribute-modernas-vaccine-in-japan.html</link>
			<pubDate>Mon, 08 Mar 2021 11:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vsccine_covid_16526-17722.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17722/takeda-to-import-distribute-modernas-vaccine-in-japan.html</guid>
		</item>	
				<item>
			<title>ERS Genomics inks licensing deal with Otsuka for CRISPR/Cas9 technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/17699/ers-genomics-inks-licensing-deal-with-otsuka-for-crispr-cas9-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17699/ers-genomics-inks-licensing-deal-with-otsuka-for-crispr-cas9-technology.html</link>
			<pubDate>Wed, 03 Mar 2021 12:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_104108189-17699.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17699/ers-genomics-inks-licensing-deal-with-otsuka-for-crispr-cas9-technology.html</guid>
		</item>	
				<item>
			<title>Olympus buys Israel&#039;s Medi-Tate to drive global urology business growth</title>
			<atom:link href="https://biospectrumasia.com/news/50/17670/olympus-buys-israels-medi-tate-to-drive-global-urology-business-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17670/olympus-buys-israels-medi-tate-to-drive-global-urology-business-growth.html</link>
			<pubDate>Tue, 02 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_162650075-17670.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17670/olympus-buys-israels-medi-tate-to-drive-global-urology-business-growth.html</guid>
		</item>	
				<item>
			<title>Harvard University, Kyowa Kirin collaborate for translational biomedical science</title>
			<atom:link href="https://biospectrumasia.com/news/50/17673/harvard-university-kyowa-kirin-collaborate-for-translational-biomedical-science.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17673/harvard-university-kyowa-kirin-collaborate-for-translational-biomedical-science.html</link>
			<pubDate>Mon, 01 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_200010311-17673.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17673/harvard-university-kyowa-kirin-collaborate-for-translational-biomedical-science.html</guid>
		</item>	
				<item>
			<title>Eisai&#039;s anti-Insomnia drug Dayvigo (Lemborexant) approved in Hong Kong</title>
			<atom:link href="https://biospectrumasia.com/news/50/17689/eisais-anti-insomnia-drug-dayvigo-lemborexant-approved-in-hong-kong.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17689/eisais-anti-insomnia-drug-dayvigo-lemborexant-approved-in-hong-kong.html</link>
			<pubDate>Mon, 01 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/202036_01-17689.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17689/eisais-anti-insomnia-drug-dayvigo-lemborexant-approved-in-hong-kong.html</guid>
		</item>	
				<item>
			<title>Takeda transfers assets of select diabetes products to Teijin Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/17674/takeda-transfers-assets-of-select-diabetes-products-to-teijin-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17674/takeda-transfers-assets-of-select-diabetes-products-to-teijin-pharma.html</link>
			<pubDate>Fri, 26 Feb 2021 19:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_307115906_web_17077-17674.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17674/takeda-transfers-assets-of-select-diabetes-products-to-teijin-pharma.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Polyplastics Group expands POM material portfolio for varied medical applications</title>
			<atom:link href="https://biospectrumasia.com/news/50/17668/japans-polyplastics-group-expands-pom-material-portfolio-for-varied-medical-applications.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17668/japans-polyplastics-group-expands-pom-material-portfolio-for-varied-medical-applications.html</link>
			<pubDate>Fri, 26 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/_prw_pi1fl_gb42p6vy-17668.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17668/japans-polyplastics-group-expands-pom-material-portfolio-for-varied-medical-applications.html</guid>
		</item>	
				<item>
			<title>Fujitsu unveils AI-powered physical rehabilitation solution</title>
			<atom:link href="https://biospectrumasia.com/news/50/17656/fujitsu-unveils-ai-powered-physical-rehabilitation-solution.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17656/fujitsu-unveils-ai-powered-physical-rehabilitation-solution.html</link>
			<pubDate>Thu, 25 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/imgonline_com_ua_twotoone_edwybkmbbcn5wli-17656.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17656/fujitsu-unveils-ai-powered-physical-rehabilitation-solution.html</guid>
		</item>	
				<item>
			<title>Terumo acquires all assets of Health Outcomes Sciences</title>
			<atom:link href="https://biospectrumasia.com/news/50/17655/terumo-acquires-all-assets-of-health-outcomes-sciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17655/terumo-acquires-all-assets-of-health-outcomes-sciences.html</link>
			<pubDate>Wed, 24 Feb 2021 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_271906976_3_-17655.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17655/terumo-acquires-all-assets-of-health-outcomes-sciences.html</guid>
		</item>	
				<item>
			<title>Innophys releases wearable work-assisting robotic suit &quot;MUSCLE SUIT Every&quot; in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/17643/innophys-releases-wearable-work-assisting-robotic-suit-muscle-suit-every-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17643/innophys-releases-wearable-work-assisting-robotic-suit-muscle-suit-every-in-china.html</link>
			<pubDate>Mon, 22 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/_prw_pi1fl_lui1im0t-17643.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17643/innophys-releases-wearable-work-assisting-robotic-suit-muscle-suit-every-in-china.html</guid>
		</item>	
				<item>
			<title>Japan develops methods for viruses and disease protein markers diagnosis</title>
			<atom:link href="https://biospectrumasia.com/news/50/17636/japan-develops-methods-for-viruses-and-disease-protein-markers-diagnosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17636/japan-develops-methods-for-viruses-and-disease-protein-markers-diagnosis.html</link>
			<pubDate>Fri, 19 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image_0-17636.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17636/japan-develops-methods-for-viruses-and-disease-protein-markers-diagnosis.html</guid>
		</item>	
				<item>
			<title>Yokogawa, Hirotsu Bio Science to widen use of N-NOSE cancer screening test</title>
			<atom:link href="https://biospectrumasia.com/news/50/17620/yokogawa-hirotsu-bio-science-to-widen-use-of-n-nose-cancer-screening-test.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17620/yokogawa-hirotsu-bio-science-to-widen-use-of-n-nose-cancer-screening-test.html</link>
			<pubDate>Thu, 18 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yokogawa_hbs_2-17620.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17620/yokogawa-hirotsu-bio-science-to-widen-use-of-n-nose-cancer-screening-test.html</guid>
		</item>	
				<item>
			<title>Japan discovers potential therapeutic stem cells to cure neurodegenerative disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/17616/japan-discovers-potential-therapeutic-stem-cells-to-cure-neurodegenerative-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17616/japan-discovers-potential-therapeutic-stem-cells-to-cure-neurodegenerative-disease.html</link>
			<pubDate>Wed, 17 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_medical_technology_design_male_figure_with_brain_highlighted_1048_10787_edited-17616.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17616/japan-discovers-potential-therapeutic-stem-cells-to-cure-neurodegenerative-disease.html</guid>
		</item>	
				<item>
			<title>Philippine partners JHPIA to support Covid-critical PPE and medical supplies</title>
			<atom:link href="https://biospectrumasia.com/news/50/17613/philippine-partners-jhpia-to-support-covid-critical-ppe-and-medical-supplies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17613/philippine-partners-jhpia-to-support-covid-critical-ppe-and-medical-supplies.html</link>
			<pubDate>Tue, 16 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/philippine_board_of_investments-17613.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17613/philippine-partners-jhpia-to-support-covid-critical-ppe-and-medical-supplies.html</guid>
		</item>	
				<item>
			<title>Mitsubishi&#039;s air purification technology potentially inactivates SARS-CoV-2</title>
			<atom:link href="https://biospectrumasia.com/news/50/17584/mitsubishis-air-purification-technology-potentially-inactivates-sars-cov-2.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17584/mitsubishis-air-purification-technology-potentially-inactivates-sars-cov-2.html</link>
			<pubDate>Wed, 10 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/virus_infection_bacteria_concept_background_premium_135814_97-17584.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17584/mitsubishis-air-purification-technology-potentially-inactivates-sars-cov-2.html</guid>
		</item>	
				<item>
			<title>Japan to offer Actemra for treating COVID-19 patients</title>
			<atom:link href="https://biospectrumasia.com/news/50/17576/japan-to-offer-actemra-for-treating-covid-19-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17576/japan-to-offer-actemra-for-treating-covid-19-patients.html</link>
			<pubDate>Tue, 09 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_160671770-17576.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17576/japan-to-offer-actemra-for-treating-covid-19-patients.html</guid>
		</item>	
				<item>
			<title>Olympus supports dissemination of endoscopic procedures for Colorectal Cancer in Russia</title>
			<atom:link href="https://biospectrumasia.com/news/50/17582/olympus-supports-dissemination-of-endoscopic-procedures-for-colorectal-cancer-in-russia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17582/olympus-supports-dissemination-of-endoscopic-procedures-for-colorectal-cancer-in-russia.html</link>
			<pubDate>Tue, 09 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/businessman_holding_medical_icon_connection_3d_rendering_110893_1484-17582.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17582/olympus-supports-dissemination-of-endoscopic-procedures-for-colorectal-cancer-in-russia.html</guid>
		</item>	
				<item>
			<title>Japan invests in development program for skin microbiome</title>
			<atom:link href="https://biospectrumasia.com/news/50/17563/japan-invests-in-development-program-for-skin-microbiome.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17563/japan-invests-in-development-program-for-skin-microbiome.html</link>
			<pubDate>Mon, 08 Feb 2021 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_15496-17563.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17563/japan-invests-in-development-program-for-skin-microbiome.html</guid>
		</item>	
				<item>
			<title>HORIBA acquires MedTest Holdings to expand laboratory chemistry offerings</title>
			<atom:link href="https://biospectrumasia.com/news/50/17538/horiba-acquires-medtest-holdings-to-expand-laboratory-chemistry-offerings.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17538/horiba-acquires-medtest-holdings-to-expand-laboratory-chemistry-offerings.html</link>
			<pubDate>Thu, 04 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_02_04_at_1_25_47_pm-17538.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17538/horiba-acquires-medtest-holdings-to-expand-laboratory-chemistry-offerings.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s TMDU, Fujitsu to develop management system for viral infections</title>
			<atom:link href="https://biospectrumasia.com/news/50/17530/japans-tmdu-fujitsu-to-develop-management-system-for-viral-infections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17530/japans-tmdu-fujitsu-to-develop-management-system-for-viral-infections.html</link>
			<pubDate>Wed, 03 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/futuristic_innovative_corona_covid_19_virus_doctor_wear_mask_virtual_digital_ai_infographic_data_tech_219644_51-17530.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17530/japans-tmdu-fujitsu-to-develop-management-system-for-viral-infections.html</guid>
		</item>	
				<item>
			<title>Olympus launches comprehensive educational platform for HCPs</title>
			<atom:link href="https://biospectrumasia.com/news/50/17516/olympus-launches-comprehensive-educational-platform-for-hcps.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17516/olympus-launches-comprehensive-educational-platform-for-hcps.html</link>
			<pubDate>Mon, 01 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_02_01_at_11_14_16_am-17516.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17516/olympus-launches-comprehensive-educational-platform-for-hcps.html</guid>
		</item>	
				<item>
			<title>Olympus bolsters surgical endoscopy capabilities with new acquisition</title>
			<atom:link href="https://biospectrumasia.com/news/50/17510/olympus-bolsters-surgical-endoscopy-capabilities-with-new-acquisition.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17510/olympus-bolsters-surgical-endoscopy-capabilities-with-new-acquisition.html</link>
			<pubDate>Fri, 29 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_01_29_at_11_40_44_am-17510.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17510/olympus-bolsters-surgical-endoscopy-capabilities-with-new-acquisition.html</guid>
		</item>	
				<item>
			<title>Japan supports precision prediction model for COVID-19 outcomes</title>
			<atom:link href="https://biospectrumasia.com/news/50/17500/japan-supports-precision-prediction-model-for-covid-19-outcomes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17500/japan-supports-precision-prediction-model-for-covid-19-outcomes.html</link>
			<pubDate>Thu, 28 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/coronavirus_covid_19_medical_test_vaccine_research_development_concept_31965_6475-17500.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17500/japan-supports-precision-prediction-model-for-covid-19-outcomes.html</guid>
		</item>	
				<item>
			<title>Casio&#039;s Dermocamera, a multifunctional device captures dermatological images</title>
			<atom:link href="https://biospectrumasia.com/news/50/17505/casios-dermocamera-a-multifunctional-device-captures-dermatological-images.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17505/casios-dermocamera-a-multifunctional-device-captures-dermatological-images.html</link>
			<pubDate>Thu, 28 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dz_1_0915-17505.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17505/casios-dermocamera-a-multifunctional-device-captures-dermatological-images.html</guid>
		</item>	
				<item>
			<title>Japanese firm unveils advanced cold field emission cryo-electron microscope</title>
			<atom:link href="https://biospectrumasia.com/news/50/17481/japanese-firm-unveils-advanced-cold-field-emission-cryo-electron-microscope.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17481/japanese-firm-unveils-advanced-cold-field-emission-cryo-electron-microscope.html</link>
			<pubDate>Mon, 25 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/210120133436_jem_3300-17481.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17481/japanese-firm-unveils-advanced-cold-field-emission-cryo-electron-microscope.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Nippon Express partners with China&#039;s Jointown Pharmaceutical Group Logistics</title>
			<atom:link href="https://biospectrumasia.com/news/50/17485/japans-nippon-express-partners-with-chinas-jointown-pharmaceutical-group-logistics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17485/japans-nippon-express-partners-with-chinas-jointown-pharmaceutical-group-logistics.html</link>
			<pubDate>Mon, 25 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/_prw_pi1fl_s40by2x6-17485.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17485/japans-nippon-express-partners-with-chinas-jointown-pharmaceutical-group-logistics.html</guid>
		</item>	
				<item>
			<title>Balancing digitalized healthcare services and data security</title>
			<atom:link href="https://biospectrumasia.com/news/50/17184/balancing-digitalized-healthcare-services-and-data-security.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17184/balancing-digitalized-healthcare-services-and-data-security.html</link>
			<pubDate>Wed, 20 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/george_lee_vice_president_asia_pacific_japan_rsa_2_-17184.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17184/balancing-digitalized-healthcare-services-and-data-security.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe &amp; Takeda to accelerate data-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/17457/mitsubishi-tanabe-takeda-to-accelerate-data-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17457/mitsubishi-tanabe-takeda-to-accelerate-data-driven-drug-discovery.html</link>
			<pubDate>Tue, 19 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medgadget-17457.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17457/mitsubishi-tanabe-takeda-to-accelerate-data-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Fujifilm injects $76M into manufacturing and innovation centre</title>
			<atom:link href="https://biospectrumasia.com/news/50/17439/fujifilm-injects-76m-into-manufacturing-and-innovation-centre.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17439/fujifilm-injects-76m-into-manufacturing-and-innovation-centre.html</link>
			<pubDate>Mon, 18 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ffd_ps_009-17439.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17439/fujifilm-injects-76m-into-manufacturing-and-innovation-centre.html</guid>
		</item>	
				<item>
			<title>Japan looking for comprehensive COVID-19 vaccination</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/17441/japan-looking-for-comprehensive-covid-19-vaccination.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/17441/japan-looking-for-comprehensive-covid-19-vaccination.html</link>
			<pubDate>Fri, 15 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed_2_-17441.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/17441/japan-looking-for-comprehensive-covid-19-vaccination.html</guid>
		</item>	
				<item>
			<title>KSQ Therapeutics and Takeda to develop and market novel Immuno-Oncology therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/17427/ksq-therapeutics-and-takeda-to-develop-and-market-novel-immuno-oncology-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17427/ksq-therapeutics-and-takeda-to-develop-and-market-novel-immuno-oncology-therapies.html</link>
			<pubDate>Thu, 14 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_2471-17427.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17427/ksq-therapeutics-and-takeda-to-develop-and-market-novel-immuno-oncology-therapies.html</guid>
		</item>	
				<item>
			<title>Chugai Pharma conducts digital transformation for manufacturing function</title>
			<atom:link href="https://biospectrumasia.com/news/50/17435/chugai-pharma-conducts-digital-transformation-for-manufacturing-function.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17435/chugai-pharma-conducts-digital-transformation-for-manufacturing-function.html</link>
			<pubDate>Thu, 14 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/e1-17435.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17435/chugai-pharma-conducts-digital-transformation-for-manufacturing-function.html</guid>
		</item>	
				<item>
			<title>NEC introduces WISE VISION Endoscopy in Europe and Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17418/nec-introduces-wise-vision-endoscopy-in-europe-and-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17418/nec-introduces-wise-vision-endoscopy-in-europe-and-japan.html</link>
			<pubDate>Wed, 13 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-17418.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17418/nec-introduces-wise-vision-endoscopy-in-europe-and-japan.html</guid>
		</item>	
				<item>
			<title>Avantor launches Japanese e-commerce website for life sciences industry</title>
			<atom:link href="https://biospectrumasia.com/news/50/17411/avantor-launches-japanese-e-commerce-website-for-life-sciences-industry.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17411/avantor-launches-japanese-e-commerce-website-for-life-sciences-industry.html</link>
			<pubDate>Tue, 12 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/introducing_the_new_avantor_edit_1920-17411.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17411/avantor-launches-japanese-e-commerce-website-for-life-sciences-industry.html</guid>
		</item>	
				<item>
			<title>Sosei and PharmEnable enter technology collaboration for AI-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/17412/sosei-and-pharmenable-enter-technology-collaboration-for-ai-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17412/sosei-and-pharmenable-enter-technology-collaboration-for-ai-driven-drug-discovery.html</link>
			<pubDate>Tue, 12 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_rendering_medical_artificial_intelligence_robot_31965_5171-17412.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17412/sosei-and-pharmenable-enter-technology-collaboration-for-ai-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Fujifilm injects $2B into large-scale cell culture manufacturing site in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/17384/fujifilm-injects-2b-into-large-scale-cell-culture-manufacturing-site-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17384/fujifilm-injects-2b-into-large-scale-cell-culture-manufacturing-site-in-us.html</link>
			<pubDate>Fri, 08 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstoc5k-17384.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17384/fujifilm-injects-2b-into-large-scale-cell-culture-manufacturing-site-in-us.html</guid>
		</item>	
				<item>
			<title>Olympus, Hitachi enter long-term collaboration for ultrasonic endoscopy system</title>
			<atom:link href="https://biospectrumasia.com/news/50/17378/olympus-hitachi-enter-long-term-collaboration-for-ultrasonic-endoscopy-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17378/olympus-hitachi-enter-long-term-collaboration-for-ultrasonic-endoscopy-system.html</link>
			<pubDate>Thu, 07 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/visera_elite_ii_screen_img_1200-17378.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17378/olympus-hitachi-enter-long-term-collaboration-for-ultrasonic-endoscopy-system.html</guid>
		</item>	
				<item>
			<title>Japan launches medical computer software for medical institutions and insurance pharmacies</title>
			<atom:link href="https://biospectrumasia.com/news/50/17383/japan-launches-medical-computer-software-for-medical-institutions-and-insurance-pharmacies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17383/japan-launches-medical-computer-software-for-medical-institutions-and-insurance-pharmacies.html</link>
			<pubDate>Thu, 07 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/photo_1_-17383.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17383/japan-launches-medical-computer-software-for-medical-institutions-and-insurance-pharmacies.html</guid>
		</item>	
				<item>
			<title>Fujifilm to invest $40M in innovative viral vector and advanced therapy facility</title>
			<atom:link href="https://biospectrumasia.com/news/50/17368/fujifilm-to-invest-40m-in-innovative-viral-vector-and-advanced-therapy-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17368/fujifilm-to-invest-40m-in-innovative-viral-vector-and-advanced-therapy-facility.html</link>
			<pubDate>Tue, 05 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_211842661-17368.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17368/fujifilm-to-invest-40m-in-innovative-viral-vector-and-advanced-therapy-facility.html</guid>
		</item>	
				<item>
			<title>Fujifilm applies for manufacturing and marketing approval for a SARS-CoV-2antigen test kit </title>
			<atom:link href="https://biospectrumasia.com/news/50/17358/fujifilm-applies-for-manufacturing-and-marketing-approval-for-a-sars-cov-2antigen-test-kit-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17358/fujifilm-applies-for-manufacturing-and-marketing-approval-for-a-sars-cov-2antigen-test-kit-.html</link>
			<pubDate>Mon, 04 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fgk-17358.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17358/fujifilm-applies-for-manufacturing-and-marketing-approval-for-a-sars-cov-2antigen-test-kit-.html</guid>
		</item>	
				<item>
			<title>Japan responds to new coronavirus variant</title>
			<atom:link href="https://biospectrumasia.com/news/50/17355/japan-responds-to-new-coronavirus-variant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17355/japan-responds-to-new-coronavirus-variant.html</link>
			<pubDate>Fri, 01 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20201228corona01-17355.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17355/japan-responds-to-new-coronavirus-variant.html</guid>
		</item>	
				<item>
			<title>Japan uses infrared radiation for detecting dental caries</title>
			<atom:link href="https://biospectrumasia.com/news/50/17333/japan-uses-infrared-radiation-for-detecting-dental-caries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17333/japan-uses-infrared-radiation-for-detecting-dental-caries.html</link>
			<pubDate>Thu, 31 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1691026993_1_16558-17333.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17333/japan-uses-infrared-radiation-for-detecting-dental-caries.html</guid>
		</item>	
				<item>
			<title>Urban China to have highest cases of NSCLC over next decade, predicts GlobalData</title>
			<atom:link href="https://biospectrumasia.com/news/50/17342/urban-china-to-have-highest-cases-of-nsclc-over-next-decade-predicts-globaldata.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17342/urban-china-to-have-highest-cases-of-nsclc-over-next-decade-predicts-globaldata.html</link>
			<pubDate>Wed, 30 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-17342.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17342/urban-china-to-have-highest-cases-of-nsclc-over-next-decade-predicts-globaldata.html</guid>
		</item>	
				<item>
			<title>Lynparza receives three new approvals for cancer treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17332/lynparza-receives-three-new-approvals-for-cancer-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17332/lynparza-receives-three-new-approvals-for-cancer-treatment-in-japan.html</link>
			<pubDate>Tue, 29 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/multi_colored_pills_capsules_lie_table_syringe_injection_scattered_drugs_167684_78-17332.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17332/lynparza-receives-three-new-approvals-for-cancer-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai strengthens in-house production function for anti-cancer drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/17325/eisai-strengthens-in-house-production-function-for-anti-cancer-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17325/eisai-strengthens-in-house-production-function-for-anti-cancer-drugs.html</link>
			<pubDate>Thu, 24 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/202085_2-17325.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17325/eisai-strengthens-in-house-production-function-for-anti-cancer-drugs.html</guid>
		</item>	
				<item>
			<title>Agilent receives approval for GenetiSure Dx Postnatal Assay in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17319/agilent-receives-approval-for-genetisure-dx-postnatal-assay-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17319/agilent-receives-approval-for-genetisure-dx-postnatal-assay-in-japan.html</link>
			<pubDate>Wed, 23 Dec 2020 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2020_12_23_at_5_52_25_pm-17319.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17319/agilent-receives-approval-for-genetisure-dx-postnatal-assay-in-japan.html</guid>
		</item>	
				<item>
			<title>NovoNordisk&#039;s Rybelsus could be a game-changer in Type 2 Diabetes</title>
			<atom:link href="https://biospectrumasia.com/news/50/17322/novonordisks-rybelsus-could-be-a-game-changer-in-type-2-diabetes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17322/novonordisks-rybelsus-could-be-a-game-changer-in-type-2-diabetes.html</link>
			<pubDate>Wed, 23 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/different_pills_remedy_treatment_diabet_147162_27-17322.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17322/novonordisks-rybelsus-could-be-a-game-changer-in-type-2-diabetes.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares and GSK target immune disorders of digestive system</title>
			<atom:link href="https://biospectrumasia.com/news/50/17300/sosei-heptares-and-gsk-target-immune-disorders-of-digestive-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17300/sosei-heptares-and-gsk-target-immune-disorders-of-digestive-system.html</link>
			<pubDate>Mon, 21 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik_2-17300.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17300/sosei-heptares-and-gsk-target-immune-disorders-of-digestive-system.html</guid>
		</item>	
				<item>
			<title>Fujitsu analyzes relationship b/w data in healthcare and allied sectors</title>
			<atom:link href="https://biospectrumasia.com/news/50/17288/fujitsu-analyzes-relationship-b-w-data-in-healthcare-and-allied-sectors.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17288/fujitsu-analyzes-relationship-b-w-data-in-healthcare-and-allied-sectors.html</link>
			<pubDate>Thu, 17 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/low_fujitsu121720-17288.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17288/fujitsu-analyzes-relationship-b-w-data-in-healthcare-and-allied-sectors.html</guid>
		</item>	
				<item>
			<title>Alvotech and Fuji Pharma extend biosimilar partnership in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17283/alvotech-and-fuji-pharma-extend-biosimilar-partnership-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17283/alvotech-and-fuji-pharma-extend-biosimilar-partnership-in-japan.html</link>
			<pubDate>Wed, 16 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/two_capsule_pills_33867_1173-17283.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17283/alvotech-and-fuji-pharma-extend-biosimilar-partnership-in-japan.html</guid>
		</item>	
				<item>
			<title>GlobalData reveals role of Japan&#039;s immunology market in branded digital marketing space</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/17279/globaldata-reveals-role-of-japans-immunology-market-in-branded-digital-marketing-space.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/17279/globaldata-reveals-role-of-japans-immunology-market-in-branded-digital-marketing-space.html</link>
			<pubDate>Tue, 15 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-17279.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/17279/globaldata-reveals-role-of-japans-immunology-market-in-branded-digital-marketing-space.html</guid>
		</item>	
				<item>
			<title>Whole-genome sequence data can now be transmitted in real-time by Quantum cryptography</title>
			<atom:link href="https://biospectrumasia.com/news/50/17271/whole-genome-sequence-data-can-now-be-transmitted-in-real-time-by-quantum-cryptography.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17271/whole-genome-sequence-data-can-now-be-transmitted-in-real-time-by-quantum-cryptography.html</link>
			<pubDate>Mon, 14 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands_robot_human_touching_dna_sequence_connecting_virtual_interface_future_127544_1139-17271.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17271/whole-genome-sequence-data-can-now-be-transmitted-in-real-time-by-quantum-cryptography.html</guid>
		</item>	
				<item>
			<title>GHIT invests 230 M Yen for developing malaria and chagas disease drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/17250/ghit-invests-230-m-yen-for-developing-malaria-and-chagas-disease-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17250/ghit-invests-230-m-yen-for-developing-malaria-and-chagas-disease-drugs.html</link>
			<pubDate>Fri, 11 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_31369030-17250.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17250/ghit-invests-230-m-yen-for-developing-malaria-and-chagas-disease-drugs.html</guid>
		</item>	
				<item>
			<title>Japan develops way to rapidly measure eye lens opacity</title>
			<atom:link href="https://biospectrumasia.com/news/50/17244/japan-develops-way-to-rapidly-measure-eye-lens-opacity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17244/japan-develops-way-to-rapidly-measure-eye-lens-opacity.html</link>
			<pubDate>Wed, 09 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/untitled-17244.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17244/japan-develops-way-to-rapidly-measure-eye-lens-opacity.html</guid>
		</item>	
				<item>
			<title>Olympus expands respiratory portfolio by acquiring Veran Medical Technologies</title>
			<atom:link href="https://biospectrumasia.com/news/50/17236/olympus-expands-respiratory-portfolio-by-acquiring-veran-medical-technologies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17236/olympus-expands-respiratory-portfolio-by-acquiring-veran-medical-technologies.html</link>
			<pubDate>Tue, 08 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_low_poly_human_healthy_lungs_virtual_laser_surgery_operation_hud_ui_display_future_technology_polygonal_medicine_disease_drug_treatment_blue_medicine_world_tuberculosis_day_illustration_115739-17236.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17236/olympus-expands-respiratory-portfolio-by-acquiring-veran-medical-technologies.html</guid>
		</item>	
				<item>
			<title>Japanese firm adopts blockchain to enhance clinical trials efficiencies</title>
			<atom:link href="https://biospectrumasia.com/news/50/17234/japanese-firm-adopts-blockchain-to-enhance-clinical-trials-efficiencies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17234/japanese-firm-adopts-blockchain-to-enhance-clinical-trials-efficiencies.html</link>
			<pubDate>Mon, 07 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/doctor_using_virtual_application_1134_652-17234.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17234/japanese-firm-adopts-blockchain-to-enhance-clinical-trials-efficiencies.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares, Biohaven ink $380M deal for treating CGRP-mediated disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/17212/sosei-heptares-biohaven-ink-380m-deal-for-treating-cgrp-mediated-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17212/sosei-heptares-biohaven-ink-380m-deal-for-treating-cgrp-mediated-disorders.html</link>
			<pubDate>Thu, 03 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_104108189-17212.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17212/sosei-heptares-biohaven-ink-380m-deal-for-treating-cgrp-mediated-disorders.html</guid>
		</item>	
				<item>
			<title>Takeda completes sale of select products to Celltrion for $278M</title>
			<atom:link href="https://biospectrumasia.com/news/50/17201/takeda-completes-sale-of-select-products-to-celltrion-for-278m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17201/takeda-completes-sale-of-select-products-to-celltrion-for-278m.html</link>
			<pubDate>Wed, 02 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-17201.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17201/takeda-completes-sale-of-select-products-to-celltrion-for-278m.html</guid>
		</item>	
				<item>
			<title>AstraZeneca&#039;s Forxiga approved in Japan for chronic heart failure</title>
			<atom:link href="https://biospectrumasia.com/news/50/17211/astrazenecas-forxiga-approved-in-japan-for-chronic-heart-failure.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17211/astrazenecas-forxiga-approved-in-japan-for-chronic-heart-failure.html</link>
			<pubDate>Wed, 02 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/high_angle_view_stethoscope_stitched_heart_medicines_yellow_backdrop_23_2148214053-17211.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17211/astrazenecas-forxiga-approved-in-japan-for-chronic-heart-failure.html</guid>
		</item>	
				<item>
			<title>Eisai and Wren Therapeutics collaborate for potential treatment of synucleinopathies</title>
			<atom:link href="https://biospectrumasia.com/news/50/17195/eisai-and-wren-therapeutics-collaborate-for-potential-treatment-of-synucleinopathies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17195/eisai-and-wren-therapeutics-collaborate-for-potential-treatment-of-synucleinopathies.html</link>
			<pubDate>Tue, 01 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_render_medical_background_with_brain_being_attacked_by_virus_cells_1048_6355-17195.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17195/eisai-and-wren-therapeutics-collaborate-for-potential-treatment-of-synucleinopathies.html</guid>
		</item>	
				<item>
			<title>Takeda makesÂ Nihon Pharma wholly owned subsidiary</title>
			<atom:link href="https://biospectrumasia.com/news/50/17180/takeda-makesnihon-pharma-wholly-owned-subsidiary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17180/takeda-makesnihon-pharma-wholly-owned-subsidiary.html</link>
			<pubDate>Thu, 26 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/close_up_pharmacist_man_hand_shaking_counter_with_patient_customer_42708_27-17180.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17180/takeda-makesnihon-pharma-wholly-owned-subsidiary.html</guid>
		</item>	
				<item>
			<title>Omron leads $65M investment round for AliveCor</title>
			<atom:link href="https://biospectrumasia.com/news/50/17170/omron-leads-65m-investment-round-for-alivecor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17170/omron-leads-65m-investment-round-for-alivecor.html</link>
			<pubDate>Wed, 25 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_16325-17170.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17170/omron-leads-65m-investment-round-for-alivecor.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujitsu drives digital transformation in hospitals and clinics</title>
			<atom:link href="https://biospectrumasia.com/news/50/17174/japans-fujitsu-drives-digital-transformation-in-hospitals-and-clinics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17174/japans-fujitsu-drives-digital-transformation-in-hospitals-and-clinics.html</link>
			<pubDate>Wed, 25 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/low_newsolutionuse_-17174.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17174/japans-fujitsu-drives-digital-transformation-in-hospitals-and-clinics.html</guid>
		</item>	
				<item>
			<title>Japan detects repetitive DNA sequence that causes health risks</title>
			<atom:link href="https://biospectrumasia.com/news/50/17165/japan-detects-repetitive-dna-sequence-that-causes-health-risks.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17165/japan-detects-repetitive-dna-sequence-that-causes-health-risks.html</link>
			<pubDate>Tue, 24 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nearinfrared-17165.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17165/japan-detects-repetitive-dna-sequence-that-causes-health-risks.html</guid>
		</item>	
				<item>
			<title>Sai Life Sciences opens representative office in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17157/sai-life-sciences-opens-representative-office-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17157/sai-life-sciences-opens-representative-office-in-japan.html</link>
			<pubDate>Fri, 20 Nov 2020 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/k9a2725_810x540-17157.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17157/sai-life-sciences-opens-representative-office-in-japan.html</guid>
		</item>	
				<item>
			<title>Hitachi launches &quot;treatment support for cancer drug therapy&quot; using AI interviews &amp; tablet robots</title>
			<atom:link href="https://biospectrumasia.com/news/50/17153/hitachi-launches-treatment-support-for-cancer-drug-therapy-using-ai-interviews-tablet-robots.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17153/hitachi-launches-treatment-support-for-cancer-drug-therapy-using-ai-interviews-tablet-robots.html</link>
			<pubDate>Fri, 20 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/therpy_video-17153.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17153/hitachi-launches-treatment-support-for-cancer-drug-therapy-using-ai-interviews-tablet-robots.html</guid>
		</item>	
				<item>
			<title>Gilead, Eisai launch rheumatoid arthritis drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17137/gilead-eisai-launch-rheumatoid-arthritis-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17137/gilead-eisai-launch-rheumatoid-arthritis-drug-in-japan.html</link>
			<pubDate>Thu, 19 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1487540663-17137.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17137/gilead-eisai-launch-rheumatoid-arthritis-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Takara Belmont develops new hair care system</title>
			<atom:link href="https://biospectrumasia.com/news/50/17135/takara-belmont-develops-new-hair-care-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17135/takara-belmont-develops-new-hair-care-system.html</link>
			<pubDate>Wed, 18 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hair_diagnosis-17135.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17135/takara-belmont-develops-new-hair-care-system.html</guid>
		</item>	
				<item>
			<title>Sumitomo Chemical accelerates next-gen biz utilizing synthetic biology</title>
			<atom:link href="https://biospectrumasia.com/news/50/17132/sumitomo-chemical-accelerates-next-gen-biz-utilizing-synthetic-biology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17132/sumitomo-chemical-accelerates-next-gen-biz-utilizing-synthetic-biology.html</link>
			<pubDate>Tue, 17 Nov 2020 13:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_296066270-17132.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17132/sumitomo-chemical-accelerates-next-gen-biz-utilizing-synthetic-biology.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo creates new biz unit for oncology</title>
			<atom:link href="https://biospectrumasia.com/news/50/17115/daiichi-sankyo-creates-new-biz-unit-for-oncology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17115/daiichi-sankyo-creates-new-biz-unit-for-oncology.html</link>
			<pubDate>Fri, 13 Nov 2020 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1464611949_4po7se_business_deal_13369-17115.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17115/daiichi-sankyo-creates-new-biz-unit-for-oncology.html</guid>
		</item>	
				<item>
			<title>Takeda, OrigiMed to develop genomic based clinical treatment platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/17108/takeda-origimed-to-develop-genomic-based-clinical-treatment-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17108/takeda-origimed-to-develop-genomic-based-clinical-treatment-platform.html</link>
			<pubDate>Thu, 12 Nov 2020 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda_origimed-17108.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17108/takeda-origimed-to-develop-genomic-based-clinical-treatment-platform.html</guid>
		</item>	
				<item>
			<title>Olympus brings procedure kits into endotherapy portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/50/17093/olympus-brings-procedure-kits-into-endotherapy-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17093/olympus-brings-procedure-kits-into-endotherapy-portfolio.html</link>
			<pubDate>Wed, 11 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/olympus_-17093.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17093/olympus-brings-procedure-kits-into-endotherapy-portfolio.html</guid>
		</item>	
				<item>
			<title>Fujitsu, TMDU leverage world&#039;s fastest supercomputer to perform cancer gene network analysis </title>
			<atom:link href="https://biospectrumasia.com/news/50/17094/fujitsu-tmdu-leverage-worlds-fastest-supercomputer-to-perform-cancer-gene-network-analysis-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17094/fujitsu-tmdu-leverage-worlds-fastest-supercomputer-to-perform-cancer-gene-network-analysis-.html</link>
			<pubDate>Tue, 10 Nov 2020 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2020_11_10_at_5_09_26_pm-17094.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17094/fujitsu-tmdu-leverage-worlds-fastest-supercomputer-to-perform-cancer-gene-network-analysis-.html</guid>
		</item>	
				<item>
			<title>Japanese firm develops urethane microfoam film for cell culture</title>
			<atom:link href="https://biospectrumasia.com/news/50/17080/japanese-firm-develops-urethane-microfoam-film-for-cell-culture.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17080/japanese-firm-develops-urethane-microfoam-film-for-cell-culture.html</link>
			<pubDate>Fri, 06 Nov 2020 16:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_wire_bsa-17080.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17080/japanese-firm-develops-urethane-microfoam-film-for-cell-culture.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s researcher&#039;s efficiently converts body heat to electricity</title>
			<atom:link href="https://biospectrumasia.com/news/50/17077/japans-researchers-efficiently-converts-body-heat-to-electricity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17077/japans-researchers-efficiently-converts-body-heat-to-electricity.html</link>
			<pubDate>Fri, 06 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thermocell_mechanism-17077.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17077/japans-researchers-efficiently-converts-body-heat-to-electricity.html</guid>
		</item>	
				<item>
			<title>Taiwan, Australia, Japan &amp; US stage GCTF virtual workshop on combating COVID-19 related crimes</title>
			<atom:link href="https://biospectrumasia.com/news/50/17059/taiwan-australia-japan-us-stage-gctf-virtual-workshop-on-combating-covid-19-related-crimes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17059/taiwan-australia-japan-us-stage-gctf-virtual-workshop-on-combating-covid-19-related-crimes.html</link>
			<pubDate>Wed, 04 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/img20201029164644722-17059.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17059/taiwan-australia-japan-us-stage-gctf-virtual-workshop-on-combating-covid-19-related-crimes.html</guid>
		</item>	
				<item>
			<title>Japan researchers uncover COVID-19&#039;s impact on the energy transition</title>
			<atom:link href="https://biospectrumasia.com/news/50/17062/japan-researchers-uncover-covid-19s-impact-on-the-energy-transition.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17062/japan-researchers-uncover-covid-19s-impact-on-the-energy-transition.html</link>
			<pubDate>Wed, 04 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/emission_pathways_and_targets_covid_19-17062.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17062/japan-researchers-uncover-covid-19s-impact-on-the-energy-transition.html</guid>
		</item>	
				<item>
			<title>Olympus announces acquisition of French orthopedics company</title>
			<atom:link href="https://biospectrumasia.com/news/50/17045/olympus-announces-acquisition-of-french-orthopedics-company.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17045/olympus-announces-acquisition-of-french-orthopedics-company.html</link>
			<pubDate>Tue, 03 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medtech-17045.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17045/olympus-announces-acquisition-of-french-orthopedics-company.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares and Aditum Bio to advance clinical program for neurological diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/17049/sosei-heptares-and-aditum-bio-to-advance-clinical-program-for-neurological-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17049/sosei-heptares-and-aditum-bio-to-advance-clinical-program-for-neurological-diseases.html</link>
			<pubDate>Tue, 03 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/el0siuvxeammbjo-17049.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17049/sosei-heptares-and-aditum-bio-to-advance-clinical-program-for-neurological-diseases.html</guid>
		</item>	
				<item>
			<title>Eli Lilly collaborates with Daiichi Sankyo for commercialisation of migraine drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17035/eli-lilly-collaborates-with-daiichi-sankyo-for-commercialisation-of-migraine-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17035/eli-lilly-collaborates-with-daiichi-sankyo-for-commercialisation-of-migraine-drug-in-japan.html</link>
			<pubDate>Mon, 02 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-17035.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17035/eli-lilly-collaborates-with-daiichi-sankyo-for-commercialisation-of-migraine-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda expands COVID-19 vaccine supply in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/17027/takeda-expands-covid-19-vaccine-supply-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17027/takeda-expands-covid-19-vaccine-supply-in-japan.html</link>
			<pubDate>Fri, 30 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bio_pharmaceutical_article_202001311018-17027.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17027/takeda-expands-covid-19-vaccine-supply-in-japan.html</guid>
		</item>	
				<item>
			<title>PHCNA, On-chip bring world&#039;s first damage-free microfluidic chip cell sorter </title>
			<atom:link href="https://biospectrumasia.com/news/50/17013/phcna-on-chip-bring-worlds-first-damage-free-microfluidic-chip-cell-sorter-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/17013/phcna-on-chip-bring-worlds-first-damage-free-microfluidic-chip-cell-sorter-.html</link>
			<pubDate>Wed, 28 Oct 2020 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chip-17013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/17013/phcna-on-chip-bring-worlds-first-damage-free-microfluidic-chip-cell-sorter-.html</guid>
		</item>	
				<item>
			<title>Eisai focuses on digital cognitive assessment technologies</title>
			<atom:link href="https://biospectrumasia.com/news/50/16995/eisai-focuses-on-digital-cognitive-assessment-technologies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16995/eisai-focuses-on-digital-cognitive-assessment-technologies.html</link>
			<pubDate>Tue, 27 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik76543-16995.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16995/eisai-focuses-on-digital-cognitive-assessment-technologies.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk procures Chugai&#039;sÂ Ab engineering technologies</title>
			<atom:link href="https://biospectrumasia.com/news/50/16997/novo-nordisk-procures-chugaisab-engineering-technologies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16997/novo-nordisk-procures-chugaisab-engineering-technologies.html</link>
			<pubDate>Mon, 26 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/virus_particles_background_concept_52683_41982-16997.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16997/novo-nordisk-procures-chugaisab-engineering-technologies.html</guid>
		</item>	
				<item>
			<title>Fujitsu initiates joint research to support remote health occupational system</title>
			<atom:link href="https://biospectrumasia.com/news/50/16984/fujitsu-initiates-joint-research-to-support-remote-health-occupational-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16984/fujitsu-initiates-joint-research-to-support-remote-health-occupational-system.html</link>
			<pubDate>Fri, 23 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/frepik23rweds-16984.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16984/fujitsu-initiates-joint-research-to-support-remote-health-occupational-system.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Casio to exhibit medical camera for global market at virtual.MEDICA 2020</title>
			<atom:link href="https://biospectrumasia.com/news/50/16983/japans-casio-to-exhibit-medical-camera-for-global-market-at-virtual-medica-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16983/japans-casio-to-exhibit-medical-camera-for-global-market-at-virtual-medica-2020.html</link>
			<pubDate>Thu, 22 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dz_s50_dz_d100_dz_image_viewer_1_-16983.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16983/japans-casio-to-exhibit-medical-camera-for-global-market-at-virtual-medica-2020.html</guid>
		</item>	
				<item>
			<title>BioNTech, Pfizer to initiate Ph 1/2 trial of COVID-19 mRNA vaccine candidate in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16971/biontech-pfizer-to-initiate-ph-1-2-trial-of-covid-19-mrna-vaccine-candidate-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16971/biontech-pfizer-to-initiate-ph-1-2-trial-of-covid-19-mrna-vaccine-candidate-in-japan.html</link>
			<pubDate>Wed, 21 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/front_view_vaccine_medical_concept_23_2148591500-16971.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16971/biontech-pfizer-to-initiate-ph-1-2-trial-of-covid-19-mrna-vaccine-candidate-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan pledges $130M to support global access to COVID-19 vaccines</title>
			<atom:link href="https://biospectrumasia.com/news/50/16973/japan-pledges-130m-to-support-global-access-to-covid-19-vaccines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16973/japan-pledges-130m-to-support-global-access-to-covid-19-vaccines.html</link>
			<pubDate>Wed, 21 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/imgonline_com_ua_twotoone_4z8qz8ae19-16973.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16973/japan-pledges-130m-to-support-global-access-to-covid-19-vaccines.html</guid>
		</item>	
				<item>
			<title>Astellas to present new roxadustat data in anemia of CKD at ASN kidney week </title>
			<atom:link href="https://biospectrumasia.com/news/50/16954/astellas-to-present-new-roxadustat-data-in-anemia-of-ckd-at-asn-kidney-week-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16954/astellas-to-present-new-roxadustat-data-in-anemia-of-ckd-at-asn-kidney-week-.html</link>
			<pubDate>Mon, 19 Oct 2020 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterst-16954.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16954/astellas-to-present-new-roxadustat-data-in-anemia-of-ckd-at-asn-kidney-week-.html</guid>
		</item>	
				<item>
			<title>Fujifilm includes additional indication for COVID-19 drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/16948/fujifilm-includes-additional-indication-for-covid-19-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16948/fujifilm-includes-additional-indication-for-covid-19-drug.html</link>
			<pubDate>Mon, 19 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3624300_061918_kgo_shutterstock_prescription_img_16976_17064-16948.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16948/fujifilm-includes-additional-indication-for-covid-19-drug.html</guid>
		</item>	
				<item>
			<title>SK Biopharma takes anti-seizure medication to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16940/sk-biopharma-takes-anti-seizure-medication-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16940/sk-biopharma-takes-anti-seizure-medication-to-japan.html</link>
			<pubDate>Fri, 16 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1685838_650-16940.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16940/sk-biopharma-takes-anti-seizure-medication-to-japan.html</guid>
		</item>	
				<item>
			<title>Pediatric indication for partial-onset seizures accepted in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/16944/pediatric-indication-for-partial-onset-seizures-accepted-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16944/pediatric-indication-for-partial-onset-seizures-accepted-in-china.html</link>
			<pubDate>Fri, 16 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/closeup_image_medicine_pills_144627_3793-16944.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16944/pediatric-indication-for-partial-onset-seizures-accepted-in-china.html</guid>
		</item>	
				<item>
			<title>Astellas, Seagen announce positive results in Ph 2 pivotal trial of PADCEV</title>
			<atom:link href="https://biospectrumasia.com/news/50/16922/astellas-seagen-announce-positive-results-in-ph-2-pivotal-trial-of-padcev.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16922/astellas-seagen-announce-positive-results-in-ph-2-pivotal-trial-of-padcev.html</link>
			<pubDate>Wed, 14 Oct 2020 18:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan_pharma-16922.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16922/astellas-seagen-announce-positive-results-in-ph-2-pivotal-trial-of-padcev.html</guid>
		</item>	
				<item>
			<title>Takeda accelerates digital transformation with Accenture and AWS</title>
			<atom:link href="https://biospectrumasia.com/news/50/16914/takeda-accelerates-digital-transformation-with-accenture-and-aws.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16914/takeda-accelerates-digital-transformation-with-accenture-and-aws.html</link>
			<pubDate>Wed, 14 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/depositphotos0-16914.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16914/takeda-accelerates-digital-transformation-with-accenture-and-aws.html</guid>
		</item>	
				<item>
			<title>Eisai collaborates with University of Tokyo for protein degradation drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/16904/eisai-collaborates-with-university-of-tokyo-for-protein-degradation-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16904/eisai-collaborates-with-university-of-tokyo-for-protein-degradation-drug-discovery.html</link>
			<pubDate>Tue, 13 Oct 2020 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_691546588-16904.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16904/eisai-collaborates-with-university-of-tokyo-for-protein-degradation-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Olympus launches ENDO-AID, an AI-powered platform for Its endoscopy system</title>
			<atom:link href="https://biospectrumasia.com/news/50/16907/olympus-launches-endo-aid-an-ai-powered-platform-for-its-endoscopy-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16907/olympus-launches-endo-aid-an-ai-powered-platform-for-its-endoscopy-system.html</link>
			<pubDate>Tue, 13 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/olympusendo_aid_554_1_-16907.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16907/olympus-launches-endo-aid-an-ai-powered-platform-for-its-endoscopy-system.html</guid>
		</item>	
				<item>
			<title>Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/16887/takeda-inks-deal-worth-1-04b-with-arrowhead-for-liver-disease-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16887/takeda-inks-deal-worth-1-04b-with-arrowhead-for-liver-disease-therapy.html</link>
			<pubDate>Mon, 12 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-16887.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16887/takeda-inks-deal-worth-1-04b-with-arrowhead-for-liver-disease-therapy.html</guid>
		</item>	
				<item>
			<title>Santen, Orbis to tackle increasing burden of eye diseases in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/16882/santen-orbis-to-tackle-increasing-burden-of-eye-diseases-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16882/santen-orbis-to-tackle-increasing-burden-of-eye-diseases-in-asia.html</link>
			<pubDate>Fri, 09 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_596799554-16882.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16882/santen-orbis-to-tackle-increasing-burden-of-eye-diseases-in-asia.html</guid>
		</item>	
				<item>
			<title>Fast-tracking innovation and transformative care to patients</title>
			<atom:link href="https://biospectrumasia.com/news/50/16893/fast-tracking-innovation-and-transformative-care-to-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16893/fast-tracking-innovation-and-transformative-care-to-patients.html</link>
			<pubDate>Fri, 09 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thomas_2dfd-16893.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16893/fast-tracking-innovation-and-transformative-care-to-patients.html</guid>
		</item>	
				<item>
			<title>Nagase increases rare amino acid productivity using Smart Cell technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/16868/nagase-increases-rare-amino-acid-productivity-using-smart-cell-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16868/nagase-increases-rare-amino-acid-productivity-using-smart-cell-technology.html</link>
			<pubDate>Thu, 08 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/modern_interior_brewery_barrels_pipes_factory_interior_179755_6431-16868.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16868/nagase-increases-rare-amino-acid-productivity-using-smart-cell-technology.html</guid>
		</item>	
				<item>
			<title>Eisai to involve jointly in COVID-19 drug discovery utilizing Eritoran and E6011</title>
			<atom:link href="https://biospectrumasia.com/news/50/16855/eisai-to-involve-jointly-in-covid-19-drug-discovery-utilizing-eritoran-and-e6011.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16855/eisai-to-involve-jointly-in-covid-19-drug-discovery-utilizing-eritoran-and-e6011.html</link>
			<pubDate>Wed, 07 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_researcher_tries_find_solution_virus_concept_viruses_bacteria_research_207634_9-16855.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16855/eisai-to-involve-jointly-in-covid-19-drug-discovery-utilizing-eritoran-and-e6011.html</guid>
		</item>	
				<item>
			<title>Transgene, NEC, BostonGene collaborate for ovarian and head &amp; neck cancers trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/16873/transgene-nec-bostongene-collaborate-for-ovarian-and-head-neck-cancers-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16873/transgene-nec-bostongene-collaborate-for-ovarian-and-head-neck-cancers-trials.html</link>
			<pubDate>Wed, 07 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/molecular_biologist_works_lab_87646_4184-16873.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16873/transgene-nec-bostongene-collaborate-for-ovarian-and-head-neck-cancers-trials.html</guid>
		</item>	
				<item>
			<title>Japan invents novel tool to alter gene activity in stem cells</title>
			<atom:link href="https://biospectrumasia.com/news/50/16853/japan-invents-novel-tool-to-alter-gene-activity-in-stem-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16853/japan-invents-novel-tool-to-alter-gene-activity-in-stem-cells.html</link>
			<pubDate>Tue, 06 Oct 2020 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/terahertzzap-16853.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16853/japan-invents-novel-tool-to-alter-gene-activity-in-stem-cells.html</guid>
		</item>	
				<item>
			<title>Shionogi partners with HanaVax for pneumonia vaccine candidate</title>
			<atom:link href="https://biospectrumasia.com/news/50/16845/shionogi-partners-with-hanavax-for-pneumonia-vaccine-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16845/shionogi-partners-with-hanavax-for-pneumonia-vaccine-candidate.html</link>
			<pubDate>Mon, 05 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/covid_coronavirus_curevac_mrna-16845.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16845/shionogi-partners-with-hanavax-for-pneumonia-vaccine-candidate.html</guid>
		</item>	
				<item>
			<title>OriCiro launches world&#039;s first cell-free circular DNA amplification technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/16830/oriciro-launches-worlds-first-cell-free-circular-dna-amplification-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16830/oriciro-launches-worlds-first-cell-free-circular-dna-amplification-technology.html</link>
			<pubDate>Fri, 02 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pixabay1-16830.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16830/oriciro-launches-worlds-first-cell-free-circular-dna-amplification-technology.html</guid>
		</item>	
				<item>
			<title>Shionogi examines mortality in patients with severe bacterial infections</title>
			<atom:link href="https://biospectrumasia.com/news/50/16837/shionogi-examines-mortality-in-patients-with-severe-bacterial-infections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16837/shionogi-examines-mortality-in-patients-with-severe-bacterial-infections.html</link>
			<pubDate>Thu, 01 Oct 2020 19:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amr-16837.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16837/shionogi-examines-mortality-in-patients-with-severe-bacterial-infections.html</guid>
		</item>	
				<item>
			<title>Aji Bio-Pharma, DNDi to develop treatment for cutaneous leishmaniasis infections</title>
			<atom:link href="https://biospectrumasia.com/news/50/16813/aji-bio-pharma-dndi-to-develop-treatment-for-cutaneous-leishmaniasis-infections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16813/aji-bio-pharma-dndi-to-develop-treatment-for-cutaneous-leishmaniasis-infections.html</link>
			<pubDate>Thu, 01 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels1688-16813.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16813/aji-bio-pharma-dndi-to-develop-treatment-for-cutaneous-leishmaniasis-infections.html</guid>
		</item>	
				<item>
			<title>Japan gathers genetic information for predicting COVID-19 severity</title>
			<atom:link href="https://biospectrumasia.com/news/50/16812/japan-gathers-genetic-information-for-predicting-covid-19-severity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16812/japan-gathers-genetic-information-for-predicting-covid-19-severity.html</link>
			<pubDate>Wed, 30 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image-16812.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16812/japan-gathers-genetic-information-for-predicting-covid-19-severity.html</guid>
		</item>	
				<item>
			<title>GHIT Fund infuses 1.37 B yen to develop new lifesaving drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/16805/ghit-fund-infuses-1-37-b-yen-to-develop-new-lifesaving-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16805/ghit-fund-infuses-1-37-b-yen-to-develop-new-lifesaving-drugs.html</link>
			<pubDate>Tue, 29 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/reasearchers_in_lab_700x420-16805.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16805/ghit-fund-infuses-1-37-b-yen-to-develop-new-lifesaving-drugs.html</guid>
		</item>	
				<item>
			<title>Japan approves Jyseleca for rheumatoid arthritis treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/16799/japan-approves-jyseleca-for-rheumatoid-arthritis-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16799/japan-approves-jyseleca-for-rheumatoid-arthritis-treatment.html</link>
			<pubDate>Mon, 28 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sex_specific_heart_medication_doses_needed_for_women-16799.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16799/japan-approves-jyseleca-for-rheumatoid-arthritis-treatment.html</guid>
		</item>	
				<item>
			<title>Sun Pharma launches plaque psoriasis drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16785/sun-pharma-launches-plaque-psoriasis-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16785/sun-pharma-launches-plaque-psoriasis-drug-in-japan.html</link>
			<pubDate>Thu, 24 Sep 2020 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/psoriasis-16785.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16785/sun-pharma-launches-plaque-psoriasis-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Hitachi Chemical adopts new name for global regenerative medicine biz</title>
			<atom:link href="https://biospectrumasia.com/news/50/16777/hitachi-chemical-adopts-new-name-for-global-regenerative-medicine-biz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16777/hitachi-chemical-adopts-new-name-for-global-regenerative-medicine-biz.html</link>
			<pubDate>Thu, 24 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1463056829-16777.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16777/hitachi-chemical-adopts-new-name-for-global-regenerative-medicine-biz.html</guid>
		</item>	
				<item>
			<title>Avigan shows promising results in treating COVID-19 patients in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16781/avigan-shows-promising-results-in-treating-covid-19-patients-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16781/avigan-shows-promising-results-in-treating-covid-19-patients-in-japan.html</link>
			<pubDate>Thu, 24 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1714108390_1595055139-16781.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16781/avigan-shows-promising-results-in-treating-covid-19-patients-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda inks evaluation agreement with Elektrofi</title>
			<atom:link href="https://biospectrumasia.com/news/50/16773/takeda-inks-evaluation-agreement-with-elektrofi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16773/takeda-inks-evaluation-agreement-with-elektrofi.html</link>
			<pubDate>Wed, 23 Sep 2020 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1114244621-16773.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16773/takeda-inks-evaluation-agreement-with-elektrofi.html</guid>
		</item>	
				<item>
			<title>Eisai receives EMA&#039;s CHMP approval for Antiepileptic agent Fycompa for pediatric use</title>
			<atom:link href="https://biospectrumasia.com/news/50/16769/eisai-receives-emas-chmp-approval-for-antiepileptic-agent-fycompa-for-pediatric-use.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16769/eisai-receives-emas-chmp-approval-for-antiepileptic-agent-fycompa-for-pediatric-use.html</link>
			<pubDate>Wed, 23 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepikliukyjhtgr-16769.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16769/eisai-receives-emas-chmp-approval-for-antiepileptic-agent-fycompa-for-pediatric-use.html</guid>
		</item>	
				<item>
			<title>Takeda to divest TachoSil for â‚¬350 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/16747/takeda-to-divest-tachosil-for-350-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16747/takeda-to-divest-tachosil-for-350-m.html</link>
			<pubDate>Fri, 18 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/divest__nattapol_sritongcom_sstock-16747.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16747/takeda-to-divest-tachosil-for-350-m.html</guid>
		</item>	
				<item>
			<title>VR startup in US brings immersive drug design software to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16741/vr-startup-in-us-brings-immersive-drug-design-software-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16741/vr-startup-in-us-brings-immersive-drug-design-software-to-japan.html</link>
			<pubDate>Thu, 17 Sep 2020 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_445337020-16741.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16741/vr-startup-in-us-brings-immersive-drug-design-software-to-japan.html</guid>
		</item>	
				<item>
			<title>Takeda opens new R&amp;D cell therapy manufacturing facility</title>
			<atom:link href="https://biospectrumasia.com/news/50/16730/takeda-opens-new-rd-cell-therapy-manufacturing-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16730/takeda-opens-new-rd-cell-therapy-manufacturing-facility.html</link>
			<pubDate>Wed, 16 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_684989701-16730.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16730/takeda-opens-new-rd-cell-therapy-manufacturing-facility.html</guid>
		</item>	
				<item>
			<title>TransEnterix opens surgical training centre in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16725/transenterix-opens-surgical-training-centre-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16725/transenterix-opens-surgical-training-centre-in-japan.html</link>
			<pubDate>Tue, 15 Sep 2020 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2020_09_15_at_12_01_24_pm-16725.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16725/transenterix-opens-surgical-training-centre-in-japan.html</guid>
		</item>	
				<item>
			<title>Nippon Express to supply pharmaceuticals worldwide</title>
			<atom:link href="https://biospectrumasia.com/news/50/16684/nippon-express-to-supply-pharmaceuticals-worldwide.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16684/nippon-express-to-supply-pharmaceuticals-worldwide.html</link>
			<pubDate>Thu, 10 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/_prw_pi2fl_szpza71o-16684.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16684/nippon-express-to-supply-pharmaceuticals-worldwide.html</guid>
		</item>	
				<item>
			<title>Takeda divests select non-core assets for $562 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/16681/takeda-divests-select-non-core-assets-for-562-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16681/takeda-divests-select-non-core-assets-for-562-m.html</link>
			<pubDate>Wed, 09 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_243274915-16681.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16681/takeda-divests-select-non-core-assets-for-562-m.html</guid>
		</item>	
				<item>
			<title>Japan develops novel test to tackle hospital acquired infections</title>
			<atom:link href="https://biospectrumasia.com/news/50/16668/japan-develops-novel-test-to-tackle-hospital-acquired-infections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16668/japan-develops-novel-test-to-tackle-hospital-acquired-infections.html</link>
			<pubDate>Tue, 08 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/news_medical_net-16668.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16668/japan-develops-novel-test-to-tackle-hospital-acquired-infections.html</guid>
		</item>	
				<item>
			<title>Japan uses virtual reality to improve physical, cognitive functions</title>
			<atom:link href="https://biospectrumasia.com/news/50/16658/japan-uses-virtual-reality-to-improve-physical-cognitive-functions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16658/japan-uses-virtual-reality-to-improve-physical-cognitive-functions.html</link>
			<pubDate>Mon, 07 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20200831_research_pr_burin_vr_pic2-16658.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16658/japan-uses-virtual-reality-to-improve-physical-cognitive-functions.html</guid>
		</item>	
				<item>
			<title>bitBiome raises 700M JPY to accelerate growth</title>
			<atom:link href="https://biospectrumasia.com/news/50/16641/bitbiome-raises-700m-jpy-to-accelerate-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16641/bitbiome-raises-700m-jpy-to-accelerate-growth.html</link>
			<pubDate>Fri, 04 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/12-16641.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16641/bitbiome-raises-700m-jpy-to-accelerate-growth.html</guid>
		</item>	
				<item>
			<title>Fujitsu, TSH embark on AI R&amp;D for COVID-19 diagnosis</title>
			<atom:link href="https://biospectrumasia.com/news/50/16645/fujitsu-tsh-embark-on-ai-rd-for-covid-19-diagnosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16645/fujitsu-tsh-embark-on-ai-rd-for-covid-19-diagnosis.html</link>
			<pubDate>Thu, 03 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2020_09_03_at_11_29_05_am-16645.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16645/fujitsu-tsh-embark-on-ai-rd-for-covid-19-diagnosis.html</guid>
		</item>	
				<item>
			<title>Japan designs method to create drugs â€œbuilding blocksâ€ for multiple diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/16652/japan-designs-method-to-create-drugs-building-blocks-for-multiple-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16652/japan-designs-method-to-create-drugs-building-blocks-for-multiple-diseases.html</link>
			<pubDate>Thu, 03 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/infographic_aug_06_2020_768x432_1_-16652.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16652/japan-designs-method-to-create-drugs-building-blocks-for-multiple-diseases.html</guid>
		</item>	
				<item>
			<title>INSIGHTEC receives reimbursement from Japan for treatment of parkinson&#039;s disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/16640/insightec-receives-reimbursement-from-japan-for-treatment-of-parkinsons-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16640/insightec-receives-reimbursement-from-japan-for-treatment-of-parkinsons-disease.html</link>
			<pubDate>Wed, 02 Sep 2020 11:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/parkinson-16640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16640/insightec-receives-reimbursement-from-japan-for-treatment-of-parkinsons-disease.html</guid>
		</item>	
				<item>
			<title>Hitachi builds management platform for regenerative medicines</title>
			<atom:link href="https://biospectrumasia.com/news/50/16638/hitachi-builds-management-platform-for-regenerative-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16638/hitachi-builds-management-platform-for-regenerative-medicines.html</link>
			<pubDate>Wed, 02 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_114690883-16638.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16638/hitachi-builds-management-platform-for-regenerative-medicines.html</guid>
		</item>	
				<item>
			<title>Propeller Health enters Japan for asthma medications</title>
			<atom:link href="https://biospectrumasia.com/news/50/16631/propeller-health-enters-japan-for-asthma-medications.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16631/propeller-health-enters-japan-for-asthma-medications.html</link>
			<pubDate>Tue, 01 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan_nvs_and_app-16631.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16631/propeller-health-enters-japan-for-asthma-medications.html</guid>
		</item>	
				<item>
			<title>Asia&#039;s first therapeutic app gets approval in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/16614/asias-first-therapeutic-app-gets-approval-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16614/asias-first-therapeutic-app-gets-approval-in-japan-.html</link>
			<pubDate>Fri, 28 Aug 2020 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/co_checker2-16614.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16614/asias-first-therapeutic-app-gets-approval-in-japan-.html</guid>
		</item>	
				<item>
			<title>Eisai launches skin care products</title>
			<atom:link href="https://biospectrumasia.com/news/50/16589/eisai-launches-skin-care-products.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16589/eisai-launches-skin-care-products.html</link>
			<pubDate>Thu, 27 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/low_eisaisahne-16589.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16589/eisai-launches-skin-care-products.html</guid>
		</item>	
				<item>
			<title>Graft versus host disease market to grow at 8.2% CAGR across 5 APAC markets in 10 years</title>
			<atom:link href="https://biospectrumasia.com/news/50/16604/graft-versus-host-disease-market-to-grow-at-8-2-cagr-across-5-apac-markets-in-10-years.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16604/graft-versus-host-disease-market-to-grow-at-8-2-cagr-across-5-apac-markets-in-10-years.html</link>
			<pubDate>Thu, 27 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels8908-16604.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16604/graft-versus-host-disease-market-to-grow-at-8-2-cagr-across-5-apac-markets-in-10-years.html</guid>
		</item>	
				<item>
			<title>Takeda divests consumer healthcare biz for JPY 242 B</title>
			<atom:link href="https://biospectrumasia.com/news/50/16578/takeda-divests-consumer-healthcare-biz-for-jpy-242-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16578/takeda-divests-consumer-healthcare-biz-for-jpy-242-b.html</link>
			<pubDate>Mon, 24 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16578.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16578/takeda-divests-consumer-healthcare-biz-for-jpy-242-b.html</guid>
		</item>	
				<item>
			<title>Japan studies inhibitory effect of hydroxy radicals on coronavirus</title>
			<atom:link href="https://biospectrumasia.com/news/50/16558/japan-studies-inhibitory-effect-of-hydroxy-radicals-on-coronavirus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16558/japan-studies-inhibitory-effect-of-hydroxy-radicals-on-coronavirus.html</link>
			<pubDate>Thu, 20 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1691026993_1-16558.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16558/japan-studies-inhibitory-effect-of-hydroxy-radicals-on-coronavirus.html</guid>
		</item>	
				<item>
			<title>Japan develops novel method to create several building blocks of pharmaceutical drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/16554/japan-develops-novel-method-to-create-several-building-blocks-of-pharmaceutical-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16554/japan-develops-novel-method-to-create-several-building-blocks-of-pharmaceutical-drugs.html</link>
			<pubDate>Wed, 19 Aug 2020 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/waseda-16554.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16554/japan-develops-novel-method-to-create-several-building-blocks-of-pharmaceutical-drugs.html</guid>
		</item>	
				<item>
			<title>AI accelerates drug repurposing to find potential COVID-19 therapies, says GlobalData</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/16565/ai-accelerates-drug-repurposing-to-find-potential-covid-19-therapies-says-globaldata.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/16565/ai-accelerates-drug-repurposing-to-find-potential-covid-19-therapies-says-globaldata.html</link>
			<pubDate>Wed, 19 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/depositphotos0-16565.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/16565/ai-accelerates-drug-repurposing-to-find-potential-covid-19-therapies-says-globaldata.html</guid>
		</item>	
				<item>
			<title>Chugai&#039;s Enspryng receives FDA approval for NMOSD </title>
			<atom:link href="https://biospectrumasia.com/news/50/16547/chugais-enspryng-receives-fda-approval-for-nmosd-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16547/chugais-enspryng-receives-fda-approval-for-nmosd-.html</link>
			<pubDate>Tue, 18 Aug 2020 16:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wiki-16547.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16547/chugais-enspryng-receives-fda-approval-for-nmosd-.html</guid>
		</item>	
				<item>
			<title>Isofol inks oncology deal with Solasia for $100M</title>
			<atom:link href="https://biospectrumasia.com/news/50/16541/isofol-inks-oncology-deal-with-solasia-for-100m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16541/isofol-inks-oncology-deal-with-solasia-for-100m.html</link>
			<pubDate>Tue, 18 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_577166482_1000x480_760x475_2x-16541.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16541/isofol-inks-oncology-deal-with-solasia-for-100m.html</guid>
		</item>	
				<item>
			<title>FUJIFILM and Novavax to manufacture COVID-19 Vaccine Candidate</title>
			<atom:link href="https://biospectrumasia.com/news/50/16548/fujifilm-and-novavax-to-manufacture-covid-19-vaccine-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16548/fujifilm-and-novavax-to-manufacture-covid-19-vaccine-candidate.html</link>
			<pubDate>Tue, 18 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vaccine_2-16548.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16548/fujifilm-and-novavax-to-manufacture-covid-19-vaccine-candidate.html</guid>
		</item>	
				<item>
			<title>Japan picks Daiichi Sankyo for COVID-19 vaccine supply</title>
			<atom:link href="https://biospectrumasia.com/news/50/16526/japan-picks-daiichi-sankyo-for-covid-19-vaccine-supply.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16526/japan-picks-daiichi-sankyo-for-covid-19-vaccine-supply.html</link>
			<pubDate>Mon, 17 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vsccine_covid-16526.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16526/japan-picks-daiichi-sankyo-for-covid-19-vaccine-supply.html</guid>
		</item>	
				<item>
			<title>OssDsign AB inks agreement with Muranaka Medical in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16496/ossdsign-ab-inks-agreement-with-muranaka-medical-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16496/ossdsign-ab-inks-agreement-with-muranaka-medical-in-japan.html</link>
			<pubDate>Fri, 14 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/demo_film-16496.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16496/ossdsign-ab-inks-agreement-with-muranaka-medical-in-japan.html</guid>
		</item>	
				<item>
			<title>PHC Holdings Corp infuses $50M into Senseonics</title>
			<atom:link href="https://biospectrumasia.com/news/50/16497/phc-holdings-corp-infuses-50m-into-senseonics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16497/phc-holdings-corp-infuses-50m-into-senseonics.html</link>
			<pubDate>Thu, 13 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eversense_cgm-16497.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16497/phc-holdings-corp-infuses-50m-into-senseonics.html</guid>
		</item>	
				<item>
			<title>Regeneus, Kyocera ink $19M deal for knee osteoarthritis treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/16493/regeneus-kyocera-ink-19m-deal-for-knee-osteoarthritis-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16493/regeneus-kyocera-ink-19m-deal-for-knee-osteoarthritis-treatment.html</link>
			<pubDate>Wed, 12 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem_cells_freepic-16493.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16493/regeneus-kyocera-ink-19m-deal-for-knee-osteoarthritis-treatment.html</guid>
		</item>	
				<item>
			<title>Jeol releases new scanning electron microscope</title>
			<atom:link href="https://biospectrumasia.com/news/50/16486/jeol-releases-new-scanning-electron-microscope.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16486/jeol-releases-new-scanning-electron-microscope.html</link>
			<pubDate>Tue, 11 Aug 2020 05:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/img_219894_1-16486.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16486/jeol-releases-new-scanning-electron-microscope.html</guid>
		</item>	
				<item>
			<title>Japan uses quantum technology for genomic medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/16469/japan-uses-quantum-technology-for-genomic-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16469/japan-uses-quantum-technology-for-genomic-medicine.html</link>
			<pubDate>Mon, 10 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/overview_of_the_demonstration_prnasia-16469.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16469/japan-uses-quantum-technology-for-genomic-medicine.html</guid>
		</item>	
				<item>
			<title>Takeda initiates I-SPY COVID Trial of 3 drugs in US with AbbVie and Amgen</title>
			<atom:link href="https://biospectrumasia.com/news/50/16491/takeda-initiates-i-spy-covid-trial-of-3-drugs-in-us-with-abbvie-and-amgen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16491/takeda-initiates-i-spy-covid-trial-of-3-drugs-in-us-with-abbvie-and-amgen.html</link>
			<pubDate>Mon, 10 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_science_laboratory_find_solution_coronavirus_concept_virus_bacteria_research_207634_17-16491.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16491/takeda-initiates-i-spy-covid-trial-of-3-drugs-in-us-with-abbvie-and-amgen.html</guid>
		</item>	
				<item>
			<title>Novavax, Takeda to develop COVID-19 vaccine candidate in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16480/novavax-takeda-to-develop-covid-19-vaccine-candidate-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16480/novavax-takeda-to-develop-covid-19-vaccine-candidate-in-japan.html</link>
			<pubDate>Fri, 07 Aug 2020 17:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image-16480.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16480/novavax-takeda-to-develop-covid-19-vaccine-candidate-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Olympus acquires Arc Medical Design to expand therapeutic device offerings</title>
			<atom:link href="https://biospectrumasia.com/news/50/16467/japans-olympus-acquires-arc-medical-design-to-expand-therapeutic-device-offerings.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16467/japans-olympus-acquires-arc-medical-design-to-expand-therapeutic-device-offerings.html</link>
			<pubDate>Fri, 07 Aug 2020 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/olympus_logo_logotype-16467.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16467/japans-olympus-acquires-arc-medical-design-to-expand-therapeutic-device-offerings.html</guid>
		</item>	
				<item>
			<title>Asahi Kasei to commercialize HA nanogel as pharmaceutical excipient</title>
			<atom:link href="https://biospectrumasia.com/news/50/16453/asahi-kasei-to-commercialize-ha-nanogel-as-pharmaceutical-excipient.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16453/asahi-kasei-to-commercialize-ha-nanogel-as-pharmaceutical-excipient.html</link>
			<pubDate>Fri, 07 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_wire_japan-16453.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16453/asahi-kasei-to-commercialize-ha-nanogel-as-pharmaceutical-excipient.html</guid>
		</item>	
				<item>
			<title>Regulations and geopolitics themes for Japanese companies to reduce dependence on China</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/16472/regulations-and-geopolitics-themes-for-japanese-companies-to-reduce-dependence-on-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/16472/regulations-and-geopolitics-themes-for-japanese-companies-to-reduce-dependence-on-china.html</link>
			<pubDate>Fri, 07 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed_1_-16472.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/16472/regulations-and-geopolitics-themes-for-japanese-companies-to-reduce-dependence-on-china.html</guid>
		</item>	
				<item>
			<title>World&#039;s first Quantum Cryptographic Communication Technology applied to Genomic Medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/16478/worlds-first-quantum-cryptographic-communication-technology-applied-to-genomic-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16478/worlds-first-quantum-cryptographic-communication-technology-applied-to-genomic-medicine.html</link>
			<pubDate>Fri, 07 Aug 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20200807_2879496_1_a-16478.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16478/worlds-first-quantum-cryptographic-communication-technology-applied-to-genomic-medicine.html</guid>
		</item>	
				<item>
			<title>Takeda announces results for first quarter of fiscal 2020</title>
			<atom:link href="https://biospectrumasia.com/news/50/16435/takeda-announces-results-for-first-quarter-of-fiscal-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16435/takeda-announces-results-for-first-quarter-of-fiscal-2020.html</link>
			<pubDate>Mon, 03 Aug 2020 15:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda_st-16435.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16435/takeda-announces-results-for-first-quarter-of-fiscal-2020.html</guid>
		</item>	
				<item>
			<title>Pfizer, BioNTech to supply 120M doses of COVID-19 vaccine to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16423/pfizer-biontech-to-supply-120m-doses-of-covid-19-vaccine-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16423/pfizer-biontech-to-supply-120m-doses-of-covid-19-vaccine-to-japan.html</link>
			<pubDate>Mon, 03 Aug 2020 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/file_20200214_11005_1l6czo1-16423.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16423/pfizer-biontech-to-supply-120m-doses-of-covid-19-vaccine-to-japan.html</guid>
		</item>	
				<item>
			<title>Novavax, Fujifilm to manufacture COVID-19 vaccine at large scale</title>
			<atom:link href="https://biospectrumasia.com/news/50/16403/novavax-fujifilm-to-manufacture-covid-19-vaccine-at-large-scale.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16403/novavax-fujifilm-to-manufacture-covid-19-vaccine-at-large-scale.html</link>
			<pubDate>Thu, 30 Jul 2020 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1489783262-16403.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16403/novavax-fujifilm-to-manufacture-covid-19-vaccine-at-large-scale.html</guid>
		</item>	
				<item>
			<title>Takeda receives U.S. FDA Breakthrough Therapy Designation for Pevonedistat </title>
			<atom:link href="https://biospectrumasia.com/news/50/16434/takeda-receives-u-s-fda-breakthrough-therapy-designation-for-pevonedistat-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16434/takeda-receives-u-s-fda-breakthrough-therapy-designation-for-pevonedistat-.html</link>
			<pubDate>Thu, 30 Jul 2020 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_2-16434.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16434/takeda-receives-u-s-fda-breakthrough-therapy-designation-for-pevonedistat-.html</guid>
		</item>	
				<item>
			<title>Japanese Beta Glucan recommended for clinical trial in COVID-19 patients</title>
			<atom:link href="https://biospectrumasia.com/news/50/16399/japanese-beta-glucan-recommended-for-clinical-trial-in-covid-19-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16399/japanese-beta-glucan-recommended-for-clinical-trial-in-covid-19-patients.html</link>
			<pubDate>Wed, 29 Jul 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nichi_glucan_image_01_29jul20-16399.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16399/japanese-beta-glucan-recommended-for-clinical-trial-in-covid-19-patients.html</guid>
		</item>	
				<item>
			<title>CPhI Japan announces 2021 postponement</title>
			<atom:link href="https://biospectrumasia.com/news/50/16395/cphi-japan-announces-2021-postponement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16395/cphi-japan-announces-2021-postponement.html</link>
			<pubDate>Tue, 28 Jul 2020 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/big_sight-16395.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16395/cphi-japan-announces-2021-postponement.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo signs deal with AstraZeneca for $6B</title>
			<atom:link href="https://biospectrumasia.com/news/50/16390/daiichi-sankyo-signs-deal-with-astrazeneca-for-6b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16390/daiichi-sankyo-signs-deal-with-astrazeneca-for-6b.html</link>
			<pubDate>Mon, 27 Jul 2020 16:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_621316742_1_3-16390.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16390/daiichi-sankyo-signs-deal-with-astrazeneca-for-6b.html</guid>
		</item>	
				<item>
			<title>Chugai, Biofourmis to develop objective assessment of pain using AI technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/16359/chugai-biofourmis-to-develop-objective-assessment-of-pain-using-ai-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16359/chugai-biofourmis-to-develop-objective-assessment-of-pain-using-ai-technology.html</link>
			<pubDate>Mon, 27 Jul 2020 05:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/frepik23rweds-16359.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16359/chugai-biofourmis-to-develop-objective-assessment-of-pain-using-ai-technology.html</guid>
		</item>	
				<item>
			<title>Hitachi Global Foundation to support infectious diseases research</title>
			<atom:link href="https://biospectrumasia.com/news/50/16347/hitachi-global-foundation-to-support-infectious-diseases-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16347/hitachi-global-foundation-to-support-infectious-diseases-research.html</link>
			<pubDate>Fri, 24 Jul 2020 07:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/37241347_1786552438105594_6010740583960674304_o-16347.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16347/hitachi-global-foundation-to-support-infectious-diseases-research.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo &amp; Gustave Roussy collaborate for oncology research</title>
			<atom:link href="https://biospectrumasia.com/news/50/16344/daiichi-sankyo-gustave-roussy-collaborate-for-oncology-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16344/daiichi-sankyo-gustave-roussy-collaborate-for-oncology-research.html</link>
			<pubDate>Thu, 23 Jul 2020 06:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_360472571_1_1_-16344.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16344/daiichi-sankyo-gustave-roussy-collaborate-for-oncology-research.html</guid>
		</item>	
				<item>
			<title>Takeda advances in Personalized Care for people with bleeding disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/16379/takeda-advances-in-personalized-care-for-people-with-bleeding-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16379/takeda-advances-in-personalized-care-for-people-with-bleeding-disorders.html</link>
			<pubDate>Thu, 23 Jul 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/researcher_bacteriological_genetic_laboratory_rubber_gloves_makes_blood_test_close_up_74906_2220-16379.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16379/takeda-advances-in-personalized-care-for-people-with-bleeding-disorders.html</guid>
		</item>	
				<item>
			<title>Japan enters into research collaboration with Canada</title>
			<atom:link href="https://biospectrumasia.com/news/50/16328/japan-enters-into-research-collaboration-with-canada.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16328/japan-enters-into-research-collaboration-with-canada.html</link>
			<pubDate>Tue, 21 Jul 2020 05:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_114687277_e1424737386142-16328.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16328/japan-enters-into-research-collaboration-with-canada.html</guid>
		</item>	
				<item>
			<title>FCNT initiates joint research with National Longevity Medical Research Center</title>
			<atom:link href="https://biospectrumasia.com/news/50/16320/fcnt-initiates-joint-research-with-national-longevity-medical-research-center.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16320/fcnt-initiates-joint-research-with-national-longevity-medical-research-center.html</link>
			<pubDate>Mon, 20 Jul 2020 06:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/elderly_woman_with_caregiver_needle_crafts_occupational_therapy_176124_122-16320.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16320/fcnt-initiates-joint-research-with-national-longevity-medical-research-center.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo announces participation in AMR action fund</title>
			<atom:link href="https://biospectrumasia.com/news/50/16307/daiichi-sankyo-announces-participation-in-amr-action-fund.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16307/daiichi-sankyo-announces-participation-in-amr-action-fund.html</link>
			<pubDate>Fri, 17 Jul 2020 06:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image_20170222_1319_1ogyhpk-16307.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16307/daiichi-sankyo-announces-participation-in-amr-action-fund.html</guid>
		</item>	
				<item>
			<title>Fujitsu established new company &quot;Fujitsu Japan Ltd.&quot;</title>
			<atom:link href="https://biospectrumasia.com/news/50/16321/fujitsu-established-new-company-fujitsu-japan-ltd-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16321/fujitsu-established-new-company-fujitsu-japan-ltd-.html</link>
			<pubDate>Fri, 17 Jul 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/120130_n7_screenhd-16321.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16321/fujitsu-established-new-company-fujitsu-japan-ltd-.html</guid>
		</item>	
				<item>
			<title>Terumo acquires Quirem Medical to enhance interventional oncology field</title>
			<atom:link href="https://biospectrumasia.com/news/50/16301/terumo-acquires-quirem-medical-to-enhance-interventional-oncology-field.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16301/terumo-acquires-quirem-medical-to-enhance-interventional-oncology-field.html</link>
			<pubDate>Thu, 16 Jul 2020 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepikw4t-16301.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16301/terumo-acquires-quirem-medical-to-enhance-interventional-oncology-field.html</guid>
		</item>	
				<item>
			<title>Eisai enters industry-academia-government joint research agreement</title>
			<atom:link href="https://biospectrumasia.com/news/50/16283/eisai-enters-industry-academia-government-joint-research-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16283/eisai-enters-industry-academia-government-joint-research-agreement.html</link>
			<pubDate>Wed, 15 Jul 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels97-16283.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16283/eisai-enters-industry-academia-government-joint-research-agreement.html</guid>
		</item>	
				<item>
			<title>PHC Group strengthens life sciences biz in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/16275/phc-group-strengthens-life-sciences-biz-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16275/phc-group-strengthens-life-sciences-biz-in-asia.html</link>
			<pubDate>Mon, 13 Jul 2020 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1562127415_2674-16275.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16275/phc-group-strengthens-life-sciences-biz-in-asia.html</guid>
		</item>	
				<item>
			<title>AVATAMED Partners CBmed in Europe on Precision Cancer Project</title>
			<atom:link href="https://biospectrumasia.com/news/50/16290/avatamed-partners-cbmed-in-europe-on-precision-cancer-project.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16290/avatamed-partners-cbmed-in-europe-on-precision-cancer-project.html</link>
			<pubDate>Mon, 13 Jul 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/webp_net_compress_image-16290.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16290/avatamed-partners-cbmed-in-europe-on-precision-cancer-project.html</guid>
		</item>	
				<item>
			<title>Aichi Cancer Center, NEC study advanced cancer immunotherapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/16239/aichi-cancer-center-nec-study-advanced-cancer-immunotherapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16239/aichi-cancer-center-nec-study-advanced-cancer-immunotherapy.html</link>
			<pubDate>Fri, 10 Jul 2020 06:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/microbiologists_working_modern_lab_1098_17092-16239.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16239/aichi-cancer-center-nec-study-advanced-cancer-immunotherapy.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher signs CDx agreement with Chugai Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/16267/thermo-fisher-signs-cdx-agreement-with-chugai-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16267/thermo-fisher-signs-cdx-agreement-with-chugai-pharma.html</link>
			<pubDate>Thu, 09 Jul 2020 04:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_12916-16267.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16267/thermo-fisher-signs-cdx-agreement-with-chugai-pharma.html</guid>
		</item>	
				<item>
			<title>Eisai launches anti-insomnia drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16235/eisai-launches-anti-insomnia-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16235/eisai-launches-anti-insomnia-drug-in-japan.html</link>
			<pubDate>Wed, 08 Jul 2020 04:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/000-16235.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16235/eisai-launches-anti-insomnia-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Hitachi, ThinkCyte focus on AI-driven cell analysis and sorting system</title>
			<atom:link href="https://biospectrumasia.com/news/50/16231/hitachi-thinkcyte-focus-on-ai-driven-cell-analysis-and-sorting-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16231/hitachi-thinkcyte-focus-on-ai-driven-cell-analysis-and-sorting-system.html</link>
			<pubDate>Tue, 07 Jul 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16231.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16231/hitachi-thinkcyte-focus-on-ai-driven-cell-analysis-and-sorting-system.html</guid>
		</item>	
				<item>
			<title>HOYA and Hitachi collaborate to supply Endoscopic Ultrasound Systems</title>
			<atom:link href="https://biospectrumasia.com/news/50/16246/hoya-and-hitachi-collaborate-to-supply-endoscopic-ultrasound-systems.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16246/hoya-and-hitachi-collaborate-to-supply-endoscopic-ultrasound-systems.html</link>
			<pubDate>Tue, 07 Jul 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik-16246.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16246/hoya-and-hitachi-collaborate-to-supply-endoscopic-ultrasound-systems.html</guid>
		</item>	
				<item>
			<title>Eisai receives approval for Parkinson&#039;s Disease Treatment Equfina in South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/16247/eisai-receives-approval-for-parkinsons-disease-treatment-equfina-in-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16247/eisai-receives-approval-for-parkinsons-disease-treatment-equfina-in-south-korea.html</link>
			<pubDate>Tue, 07 Jul 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/senior_man_sitting_wheelchair_taking_pills_85574_4150-16247.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16247/eisai-receives-approval-for-parkinsons-disease-treatment-equfina-in-south-korea.html</guid>
		</item>	
				<item>
			<title>Genesis Healthcare Ancestry Kit detects Asian genetic diversity and ancestral heritage</title>
			<atom:link href="https://biospectrumasia.com/news/50/16249/genesis-healthcare-ancestry-kit-detects-asian-genetic-diversity-and-ancestral-heritage.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16249/genesis-healthcare-ancestry-kit-detects-asian-genetic-diversity-and-ancestral-heritage.html</link>
			<pubDate>Tue, 07 Jul 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20200707_2850185_1-16249.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16249/genesis-healthcare-ancestry-kit-detects-asian-genetic-diversity-and-ancestral-heritage.html</guid>
		</item>	
				<item>
			<title>Eisai joins REMAP-CAP on innovative trial to combat COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/16222/eisai-joins-remap-cap-on-innovative-trial-to-combat-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16222/eisai-joins-remap-cap-on-innovative-trial-to-combat-covid-19.html</link>
			<pubDate>Mon, 06 Jul 2020 05:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16222.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16222/eisai-joins-remap-cap-on-innovative-trial-to-combat-covid-19.html</guid>
		</item>	
				<item>
			<title>Japan launches Fine Granule Formulation of Anti-epileptic Drug Fycompa</title>
			<atom:link href="https://biospectrumasia.com/news/50/16238/japan-launches-fine-granule-formulation-of-anti-epileptic-drug-fycompa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16238/japan-launches-fine-granule-formulation-of-anti-epileptic-drug-fycompa.html</link>
			<pubDate>Mon, 06 Jul 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yellow_capsules_blue_87646_1511-16238.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16238/japan-launches-fine-granule-formulation-of-anti-epileptic-drug-fycompa.html</guid>
		</item>	
				<item>
			<title>Fujifilm, Dr. Reddy and Global Response Aid to co-develop anti COVID-19 drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/16226/fujifilm-dr-reddy-and-global-response-aid-to-co-develop-anti-covid-19-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16226/fujifilm-dr-reddy-and-global-response-aid-to-co-develop-anti-covid-19-drug.html</link>
			<pubDate>Fri, 03 Jul 2020 07:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/top_view_assortment_medicine_table_23_2148529764-16226.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16226/fujifilm-dr-reddy-and-global-response-aid-to-co-develop-anti-covid-19-drug.html</guid>
		</item>	
				<item>
			<title>Japan begins research on vitals measurement headset</title>
			<atom:link href="https://biospectrumasia.com/news/50/16214/japan-begins-research-on-vitals-measurement-headset.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16214/japan-begins-research-on-vitals-measurement-headset.html</link>
			<pubDate>Fri, 03 Jul 2020 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/photo_58363-16214.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16214/japan-begins-research-on-vitals-measurement-headset.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo in discussion with AZ for COVID-19 vaccine supply</title>
			<atom:link href="https://biospectrumasia.com/news/50/16208/daiichi-sankyo-in-discussion-with-az-for-covid-19-vaccine-supply.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16208/daiichi-sankyo-in-discussion-with-az-for-covid-19-vaccine-supply.html</link>
			<pubDate>Thu, 02 Jul 2020 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16208.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16208/daiichi-sankyo-in-discussion-with-az-for-covid-19-vaccine-supply.html</guid>
		</item>	
				<item>
			<title>Japan reveals breakthrough research in cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/16201/japan-reveals-breakthrough-research-in-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16201/japan-reveals-breakthrough-research-in-cancer.html</link>
			<pubDate>Wed, 01 Jul 2020 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik_kvlmv-16201.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16201/japan-reveals-breakthrough-research-in-cancer.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher, Daiichi Sankyo to co-develop CDx for NSCLC</title>
			<atom:link href="https://biospectrumasia.com/news/50/16172/thermo-fisher-daiichi-sankyo-to-co-develop-cdx-for-nsclc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16172/thermo-fisher-daiichi-sankyo-to-co-develop-cdx-for-nsclc.html</link>
			<pubDate>Tue, 30 Jun 2020 08:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik786-16172.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16172/thermo-fisher-daiichi-sankyo-to-co-develop-cdx-for-nsclc.html</guid>
		</item>	
				<item>
			<title>Japan repurposes hypertension vaccine for COVID-19 treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/16187/japan-repurposes-hypertension-vaccine-for-covid-19-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16187/japan-repurposes-hypertension-vaccine-for-covid-19-treatment.html</link>
			<pubDate>Mon, 29 Jun 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik234-16187.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16187/japan-repurposes-hypertension-vaccine-for-covid-19-treatment.html</guid>
		</item>	
				<item>
			<title>Japan develops saliva test to detect COVID-19 in 30-min</title>
			<atom:link href="https://biospectrumasia.com/news/50/16174/japan-develops-saliva-test-to-detect-covid-19-in-30-min.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16174/japan-develops-saliva-test-to-detect-covid-19-in-30-min.html</link>
			<pubDate>Fri, 26 Jun 2020 05:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik_9_0-16174.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16174/japan-develops-saliva-test-to-detect-covid-19-in-30-min.html</guid>
		</item>	
				<item>
			<title>Santen, Orbis to develop training tools for eye care</title>
			<atom:link href="https://biospectrumasia.com/news/50/16155/santen-orbis-to-develop-training-tools-for-eye-care.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16155/santen-orbis-to-develop-training-tools-for-eye-care.html</link>
			<pubDate>Thu, 25 Jun 2020 09:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16155.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16155/santen-orbis-to-develop-training-tools-for-eye-care.html</guid>
		</item>	
				<item>
			<title>Japan develops breakthrough treatment for osteoarthritis</title>
			<atom:link href="https://biospectrumasia.com/news/50/16156/japan-develops-breakthrough-treatment-for-osteoarthritis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16156/japan-develops-breakthrough-treatment-for-osteoarthritis.html</link>
			<pubDate>Wed, 24 Jun 2020 08:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2020_06_19_at_1_04_11_pm-16156.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16156/japan-develops-breakthrough-treatment-for-osteoarthritis.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo to develop mRNA vaccine against COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/16159/daiichi-sankyo-to-develop-mrna-vaccine-against-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16159/daiichi-sankyo-to-develop-mrna-vaccine-against-covid-19.html</link>
			<pubDate>Tue, 23 Jun 2020 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16159.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16159/daiichi-sankyo-to-develop-mrna-vaccine-against-covid-19.html</guid>
		</item>	
				<item>
			<title>EIU launches APACÂ Economist Intelligence Unit report forÂ heartÂ ailments</title>
			<atom:link href="https://biospectrumasia.com/news/50/16164/eiu-launches-apaceconomist-intelligence-unit-report-forheartailments.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16164/eiu-launches-apaceconomist-intelligence-unit-report-forheartailments.html</link>
			<pubDate>Tue, 23 Jun 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepikk_sd-16164.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16164/eiu-launches-apaceconomist-intelligence-unit-report-forheartailments.html</guid>
		</item>	
				<item>
			<title>Cardiovascular disease (CVD) impact on Asia-Pacific markets</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/16165/cardiovascular-disease-cvd-impact-on-asia-pacific-markets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/16165/cardiovascular-disease-cvd-impact-on-asia-pacific-markets.html</link>
			<pubDate>Tue, 23 Jun 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepiksdf-16165.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/16165/cardiovascular-disease-cvd-impact-on-asia-pacific-markets.html</guid>
		</item>	
				<item>
			<title>Joimax develops partnership with Japan Medicalnext</title>
			<atom:link href="https://biospectrumasia.com/news/50/16153/joimax-develops-partnership-with-japan-medicalnext.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16153/joimax-develops-partnership-with-japan-medicalnext.html</link>
			<pubDate>Mon, 22 Jun 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2020_06_19_at_12_50_59_pm-16153.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16153/joimax-develops-partnership-with-japan-medicalnext.html</guid>
		</item>	
				<item>
			<title>Japan studies genetic differences of COVID-19 and SARS viruses</title>
			<atom:link href="https://biospectrumasia.com/news/50/16147/japan-studies-genetic-differences-of-covid-19-and-sars-viruses.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16147/japan-studies-genetic-differences-of-covid-19-and-sars-viruses.html</link>
			<pubDate>Fri, 19 Jun 2020 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16147.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16147/japan-studies-genetic-differences-of-covid-19-and-sars-viruses.html</guid>
		</item>	
				<item>
			<title>Takeda partners with Neurocrine Biosciences to focus on psychiatric disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/16136/takeda-partners-with-neurocrine-biosciences-to-focus-on-psychiatric-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16136/takeda-partners-with-neurocrine-biosciences-to-focus-on-psychiatric-disorders.html</link>
			<pubDate>Thu, 18 Jun 2020 08:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16136.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16136/takeda-partners-with-neurocrine-biosciences-to-focus-on-psychiatric-disorders.html</guid>
		</item>	
				<item>
			<title>Astellas develops science based exercise programs</title>
			<atom:link href="https://biospectrumasia.com/news/50/16120/astellas-develops-science-based-exercise-programs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16120/astellas-develops-science-based-exercise-programs.html</link>
			<pubDate>Tue, 16 Jun 2020 09:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16120.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16120/astellas-develops-science-based-exercise-programs.html</guid>
		</item>	
				<item>
			<title>Takeda to divest select APAC assets to Celltrion for $278M</title>
			<atom:link href="https://biospectrumasia.com/news/50/16113/takeda-to-divest-select-apac-assets-to-celltrion-for-278m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16113/takeda-to-divest-select-apac-assets-to-celltrion-for-278m.html</link>
			<pubDate>Mon, 15 Jun 2020 07:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16113.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16113/takeda-to-divest-select-apac-assets-to-celltrion-for-278m.html</guid>
		</item>	
				<item>
			<title>Fujifilm to invest 100B yen at Denmark site</title>
			<atom:link href="https://biospectrumasia.com/news/50/16102/fujifilm-to-invest-100b-yen-at-denmark-site.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16102/fujifilm-to-invest-100b-yen-at-denmark-site.html</link>
			<pubDate>Fri, 12 Jun 2020 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik0u-16102.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16102/fujifilm-to-invest-100b-yen-at-denmark-site.html</guid>
		</item>	
				<item>
			<title>AbbVie, Genmab enter $4B cancer immunotherapy partnership</title>
			<atom:link href="https://biospectrumasia.com/news/50/16105/abbvie-genmab-enter-4b-cancer-immunotherapy-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16105/abbvie-genmab-enter-4b-cancer-immunotherapy-partnership.html</link>
			<pubDate>Thu, 11 Jun 2020 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepiknever-16105.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16105/abbvie-genmab-enter-4b-cancer-immunotherapy-partnership.html</guid>
		</item>	
				<item>
			<title>Japan explores Nafamostat inhalation formulation for COVID-19 treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/16087/japan-explores-nafamostat-inhalation-formulation-for-covid-19-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16087/japan-explores-nafamostat-inhalation-formulation-for-covid-19-treatment.html</link>
			<pubDate>Wed, 10 Jun 2020 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16087.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16087/japan-explores-nafamostat-inhalation-formulation-for-covid-19-treatment.html</guid>
		</item>	
				<item>
			<title>Eisai takes Counter-Measures to tackle COVID-19 spread in Africa</title>
			<atom:link href="https://biospectrumasia.com/news/50/16089/eisai-takes-counter-measures-to-tackle-covid-19-spread-in-africa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16089/eisai-takes-counter-measures-to-tackle-covid-19-spread-in-africa.html</link>
			<pubDate>Wed, 10 Jun 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1200px_eisai_logo_svg-16089.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16089/eisai-takes-counter-measures-to-tackle-covid-19-spread-in-africa.html</guid>
		</item>	
				<item>
			<title>Healthtech startup Ubie raises $18.7M in Series B financing</title>
			<atom:link href="https://biospectrumasia.com/news/50/16071/healthtech-startup-ubie-raises-18-7m-in-series-b-financing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16071/healthtech-startup-ubie-raises-18-7m-in-series-b-financing.html</link>
			<pubDate>Tue, 09 Jun 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik254-16071.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16071/healthtech-startup-ubie-raises-18-7m-in-series-b-financing.html</guid>
		</item>	
				<item>
			<title>Healios establishes proprietary universal donor cell research line</title>
			<atom:link href="https://biospectrumasia.com/news/50/16066/healios-establishes-proprietary-universal-donor-cell-research-line.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16066/healios-establishes-proprietary-universal-donor-cell-research-line.html</link>
			<pubDate>Mon, 08 Jun 2020 07:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16066.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16066/healios-establishes-proprietary-universal-donor-cell-research-line.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo inks clinical research collaboration with Merck </title>
			<atom:link href="https://biospectrumasia.com/news/50/16052/daiichi-sankyo-inks-clinical-research-collaboration-with-merck-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16052/daiichi-sankyo-inks-clinical-research-collaboration-with-merck-.html</link>
			<pubDate>Thu, 04 Jun 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16052.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16052/daiichi-sankyo-inks-clinical-research-collaboration-with-merck-.html</guid>
		</item>	
				<item>
			<title>Eisai unveils new insomnia drug DAYVIGO</title>
			<atom:link href="https://biospectrumasia.com/news/50/16037/eisai-unveils-new-insomnia-drug-dayvigo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16037/eisai-unveils-new-insomnia-drug-dayvigo.html</link>
			<pubDate>Wed, 03 Jun 2020 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_1_-16037.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16037/eisai-unveils-new-insomnia-drug-dayvigo.html</guid>
		</item>	
				<item>
			<title>NCC Japan joins Illuminox Alliance Institutes network</title>
			<atom:link href="https://biospectrumasia.com/news/50/16030/ncc-japan-joins-illuminox-alliance-institutes-network.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16030/ncc-japan-joins-illuminox-alliance-institutes-network.html</link>
			<pubDate>Tue, 02 Jun 2020 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16030.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16030/ncc-japan-joins-illuminox-alliance-institutes-network.html</guid>
		</item>	
				<item>
			<title>Astellas receives approval for prostate cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/16017/astellas-receives-approval-for-prostate-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16017/astellas-receives-approval-for-prostate-cancer-drug.html</link>
			<pubDate>Mon, 01 Jun 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16017.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16017/astellas-receives-approval-for-prostate-cancer-drug.html</guid>
		</item>	
				<item>
			<title>XTANDI approved by Japan MHLW to treat Prostate Cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/16019/xtandi-approved-by-japan-mhlw-to-treat-prostate-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16019/xtandi-approved-by-japan-mhlw-to-treat-prostate-cancer.html</link>
			<pubDate>Sun, 31 May 2020 04:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik235-16019.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16019/xtandi-approved-by-japan-mhlw-to-treat-prostate-cancer.html</guid>
		</item>	
				<item>
			<title>Shinshu University, Toshiba develop tumor-tropic liposome technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/16012/shinshu-university-toshiba-develop-tumor-tropic-liposome-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16012/shinshu-university-toshiba-develop-tumor-tropic-liposome-technology.html</link>
			<pubDate>Fri, 29 May 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/site_logo_1-16012.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16012/shinshu-university-toshiba-develop-tumor-tropic-liposome-technology.html</guid>
		</item>	
				<item>
			<title>Takeda focuses on potential new therapies for COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/16007/takeda-focuses-on-potential-new-therapies-for-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16007/takeda-focuses-on-potential-new-therapies-for-covid-19.html</link>
			<pubDate>Thu, 28 May 2020 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16007.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16007/takeda-focuses-on-potential-new-therapies-for-covid-19.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo launches novel oncology medicine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/16004/daiichi-sankyo-launches-novel-oncology-medicine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/16004/daiichi-sankyo-launches-novel-oncology-medicine-in-japan.html</link>
			<pubDate>Wed, 27 May 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16004.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/16004/daiichi-sankyo-launches-novel-oncology-medicine-in-japan.html</guid>
		</item>	
				<item>
			<title>Fujifilm to use AI-based technology for COVID-19 diagnosis</title>
			<atom:link href="https://biospectrumasia.com/news/50/15997/fujifilm-to-use-ai-based-technology-for-covid-19-diagnosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15997/fujifilm-to-use-ai-based-technology-for-covid-19-diagnosis.html</link>
			<pubDate>Tue, 26 May 2020 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15997.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15997/fujifilm-to-use-ai-based-technology-for-covid-19-diagnosis.html</guid>
		</item>	
				<item>
			<title>AGC Biologics partners with Takara Bio in COVID-19 fight</title>
			<atom:link href="https://biospectrumasia.com/news/50/15983/agc-biologics-partners-with-takara-bio-in-covid-19-fight.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15983/agc-biologics-partners-with-takara-bio-in-covid-19-fight.html</link>
			<pubDate>Fri, 22 May 2020 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15983.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15983/agc-biologics-partners-with-takara-bio-in-covid-19-fight.html</guid>
		</item>	
				<item>
			<title>Cytiva, Takara Bio to scale up COVID-19 vaccine candidate</title>
			<atom:link href="https://biospectrumasia.com/news/50/15995/cytiva-takara-bio-to-scale-up-covid-19-vaccine-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15995/cytiva-takara-bio-to-scale-up-covid-19-vaccine-candidate.html</link>
			<pubDate>Thu, 21 May 2020 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15995.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15995/cytiva-takara-bio-to-scale-up-covid-19-vaccine-candidate.html</guid>
		</item>	
				<item>
			<title>Eisai to launch new Selbelle Premium Tablets and Fine Granules</title>
			<atom:link href="https://biospectrumasia.com/news/50/15960/eisai-to-launch-new-selbelle-premium-tablets-and-fine-granules.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15960/eisai-to-launch-new-selbelle-premium-tablets-and-fine-granules.html</link>
			<pubDate>Tue, 19 May 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_3850790-15960.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15960/eisai-to-launch-new-selbelle-premium-tablets-and-fine-granules.html</guid>
		</item>	
				<item>
			<title>Shionogi to develop prophylactic vaccine for COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/15955/shionogi-to-develop-prophylactic-vaccine-for-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15955/shionogi-to-develop-prophylactic-vaccine-for-covid-19.html</link>
			<pubDate>Mon, 18 May 2020 09:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15955.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15955/shionogi-to-develop-prophylactic-vaccine-for-covid-19.html</guid>
		</item>	
				<item>
			<title>Japan to design personalized cancer vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/15953/japan-to-design-personalized-cancer-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15953/japan-to-design-personalized-cancer-vaccine.html</link>
			<pubDate>Fri, 15 May 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik5634-15953.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15953/japan-to-design-personalized-cancer-vaccine.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo gets BTD for potential gastric cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/15929/daiichi-sankyo-gets-btd-for-potential-gastric-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15929/daiichi-sankyo-gets-btd-for-potential-gastric-cancer-drug.html</link>
			<pubDate>Wed, 13 May 2020 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15929.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15929/daiichi-sankyo-gets-btd-for-potential-gastric-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Japan approves Remdesivir to treat critically ill COVID-19 patients</title>
			<atom:link href="https://biospectrumasia.com/news/50/15937/japan-approves-remdesivir-to-treat-critically-ill-covid-19-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15937/japan-approves-remdesivir-to-treat-critically-ill-covid-19-patients.html</link>
			<pubDate>Wed, 13 May 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels9-15937.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15937/japan-approves-remdesivir-to-treat-critically-ill-covid-19-patients.html</guid>
		</item>	
				<item>
			<title>CoVIg-19 plasma alliance building strong momentum</title>
			<atom:link href="https://biospectrumasia.com/news/50/15913/covig-19-plasma-alliance-building-strong-momentum.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15913/covig-19-plasma-alliance-building-strong-momentum.html</link>
			<pubDate>Fri, 08 May 2020 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15913.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15913/covig-19-plasma-alliance-building-strong-momentum.html</guid>
		</item>	
				<item>
			<title>Hitachi opens First Europe based Proton Therapy system in Spain</title>
			<atom:link href="https://biospectrumasia.com/news/50/15915/hitachi-opens-first-europe-based-proton-therapy-system-in-spain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15915/hitachi-opens-first-europe-based-proton-therapy-system-in-spain.html</link>
			<pubDate>Fri, 08 May 2020 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_11892-15915.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15915/hitachi-opens-first-europe-based-proton-therapy-system-in-spain.html</guid>
		</item>	
				<item>
			<title>Ajinomoto inks manufacturing agreement for COVID-19 drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/15904/ajinomoto-inks-manufacturing-agreement-for-covid-19-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15904/ajinomoto-inks-manufacturing-agreement-for-covid-19-drug.html</link>
			<pubDate>Thu, 07 May 2020 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15904.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15904/ajinomoto-inks-manufacturing-agreement-for-covid-19-drug.html</guid>
		</item>	
				<item>
			<title>Astellas, Insilico Medicine bank on AI for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/15874/astellas-insilico-medicine-bank-on-ai-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15874/astellas-insilico-medicine-bank-on-ai-for-drug-discovery.html</link>
			<pubDate>Mon, 04 May 2020 08:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15874.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15874/astellas-insilico-medicine-bank-on-ai-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Harvard, Astellas establish strategic research alliance</title>
			<atom:link href="https://biospectrumasia.com/news/50/15875/harvard-astellas-establish-strategic-research-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15875/harvard-astellas-establish-strategic-research-alliance.html</link>
			<pubDate>Fri, 01 May 2020 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15875.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15875/harvard-astellas-establish-strategic-research-alliance.html</guid>
		</item>	
				<item>
			<title>Japan observes cross protection from COVID-19 by JEV</title>
			<atom:link href="https://biospectrumasia.com/news/50/15872/japan-observes-cross-protection-from-covid-19-by-jev.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15872/japan-observes-cross-protection-from-covid-19-by-jev.html</link>
			<pubDate>Thu, 30 Apr 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15872.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15872/japan-observes-cross-protection-from-covid-19-by-jev.html</guid>
		</item>	
				<item>
			<title>ProThera Bio, Takeda work towards treating acute inflammatory conditions</title>
			<atom:link href="https://biospectrumasia.com/news/50/15873/prothera-bio-takeda-work-towards-treating-acute-inflammatory-conditions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15873/prothera-bio-takeda-work-towards-treating-acute-inflammatory-conditions.html</link>
			<pubDate>Wed, 29 Apr 2020 14:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15873.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15873/prothera-bio-takeda-work-towards-treating-acute-inflammatory-conditions.html</guid>
		</item>	
				<item>
			<title>Takeda inks deal worth $670M with Orifarm</title>
			<atom:link href="https://biospectrumasia.com/news/50/15864/takeda-inks-deal-worth-670m-with-orifarm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15864/takeda-inks-deal-worth-670m-with-orifarm.html</link>
			<pubDate>Wed, 29 Apr 2020 05:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15864.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15864/takeda-inks-deal-worth-670m-with-orifarm.html</guid>
		</item>	
				<item>
			<title>Terumo donates $2.4 M for COVID-19 fight</title>
			<atom:link href="https://biospectrumasia.com/news/50/15856/terumo-donates-2-4-m-for-covid-19-fight.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15856/terumo-donates-2-4-m-for-covid-19-fight.html</link>
			<pubDate>Tue, 28 Apr 2020 07:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15856.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15856/terumo-donates-2-4-m-for-covid-19-fight.html</guid>
		</item>	
				<item>
			<title>Astellas acquires Nanna Therapeutics for Â£12 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/15854/astellas-acquires-nanna-therapeutics-for-12-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15854/astellas-acquires-nanna-therapeutics-for-12-m.html</link>
			<pubDate>Mon, 27 Apr 2020 07:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15854.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15854/astellas-acquires-nanna-therapeutics-for-12-m.html</guid>
		</item>	
				<item>
			<title>NEC designs blueprints for COVID-19 vaccines using AI</title>
			<atom:link href="https://biospectrumasia.com/news/50/15843/nec-designs-blueprints-for-covid-19-vaccines-using-ai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15843/nec-designs-blueprints-for-covid-19-vaccines-using-ai.html</link>
			<pubDate>Fri, 24 Apr 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15843.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15843/nec-designs-blueprints-for-covid-19-vaccines-using-ai.html</guid>
		</item>	
				<item>
			<title>Esperion &amp; Otsuka to develop treatment for hypercholesterolemia</title>
			<atom:link href="https://biospectrumasia.com/news/50/15836/esperion-otsuka-to-develop-treatment-for-hypercholesterolemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15836/esperion-otsuka-to-develop-treatment-for-hypercholesterolemia.html</link>
			<pubDate>Thu, 23 Apr 2020 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15836.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15836/esperion-otsuka-to-develop-treatment-for-hypercholesterolemia.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo to donate $1M for COVID-19 relief fund</title>
			<atom:link href="https://biospectrumasia.com/news/50/15808/daiichi-sankyo-to-donate-1m-for-covid-19-relief-fund.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15808/daiichi-sankyo-to-donate-1m-for-covid-19-relief-fund.html</link>
			<pubDate>Fri, 17 Apr 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15808.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15808/daiichi-sankyo-to-donate-1m-for-covid-19-relief-fund.html</guid>
		</item>	
				<item>
			<title>Fujifilm accelerates favipiravir production for COVID-19 treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/15801/fujifilm-accelerates-favipiravir-production-for-covid-19-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15801/fujifilm-accelerates-favipiravir-production-for-covid-19-treatment.html</link>
			<pubDate>Thu, 16 Apr 2020 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-15801.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15801/fujifilm-accelerates-favipiravir-production-for-covid-19-treatment.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo commences gene therapy research to restore vision</title>
			<atom:link href="https://biospectrumasia.com/news/50/15781/daiichi-sankyo-commences-gene-therapy-research-to-restore-vision.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15781/daiichi-sankyo-commences-gene-therapy-research-to-restore-vision.html</link>
			<pubDate>Tue, 14 Apr 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15781.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15781/daiichi-sankyo-commences-gene-therapy-research-to-restore-vision.html</guid>
		</item>	
				<item>
			<title>Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/15766/takeda-and-csl-behring-to-develop-potential-covid-19-hyperimmune-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15766/takeda-and-csl-behring-to-develop-potential-covid-19-hyperimmune-therapy.html</link>
			<pubDate>Fri, 10 Apr 2020 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/xconomy-15766.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15766/takeda-and-csl-behring-to-develop-potential-covid-19-hyperimmune-therapy.html</guid>
		</item>	
				<item>
			<title>Chugai starts Ph III trial of Actemra for COVID-19 pneumonia</title>
			<atom:link href="https://biospectrumasia.com/news/50/15763/chugai-starts-ph-iii-trial-of-actemra-for-covid-19-pneumonia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15763/chugai-starts-ph-iii-trial-of-actemra-for-covid-19-pneumonia.html</link>
			<pubDate>Fri, 10 Apr 2020 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15763.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15763/chugai-starts-ph-iii-trial-of-actemra-for-covid-19-pneumonia.html</guid>
		</item>	
				<item>
			<title>SanBio, Ocumension enter into biz alliance for treating eye diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/15731/sanbio-ocumension-enter-into-biz-alliance-for-treating-eye-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15731/sanbio-ocumension-enter-into-biz-alliance-for-treating-eye-diseases.html</link>
			<pubDate>Tue, 07 Apr 2020 05:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15731.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15731/sanbio-ocumension-enter-into-biz-alliance-for-treating-eye-diseases.html</guid>
		</item>	
				<item>
			<title>Jolly Good, NCCBTR collaborate for VR Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/15732/jolly-good-nccbtr-collaborate-for-vr-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15732/jolly-good-nccbtr-collaborate-for-vr-therapeutics.html</link>
			<pubDate>Mon, 06 Apr 2020 05:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15732.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15732/jolly-good-nccbtr-collaborate-for-vr-therapeutics.html</guid>
		</item>	
				<item>
			<title>Genesis Healthcare unveils new detection test for COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/15724/genesis-healthcare-unveils-new-detection-test-for-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15724/genesis-healthcare-unveils-new-detection-test-for-covid-19.html</link>
			<pubDate>Fri, 03 Apr 2020 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15724.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15724/genesis-healthcare-unveils-new-detection-test-for-covid-19.html</guid>
		</item>	
				<item>
			<title>Japan Coronavirus COVID-19 (2019-nCoV) Pandemic Dashboard : Daily Confirmed Cases </title>
			<atom:link href="https://biospectrumasia.com/news/50/15721/japan-coronavirus-covid-19-2019-ncov-pandemic-dashboard-daily-confirmed-cases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15721/japan-coronavirus-covid-19-2019-ncov-pandemic-dashboard-daily-confirmed-cases-.html</link>
			<pubDate>Fri, 03 Apr 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15721/japan-coronavirus-covid-19-2019-ncov-pandemic-dashboard-daily-confirmed-cases-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s MEXT awarded the A-PRAS certificate to Impact Science</title>
			<atom:link href="https://biospectrumasia.com/news/50/15710/japans-mext-awarded-the-a-pras-certificate-to-impact-science.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15710/japans-mext-awarded-the-a-pras-certificate-to-impact-science.html</link>
			<pubDate>Thu, 02 Apr 2020 02:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/impact_science_logo_3-15710.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15710/japans-mext-awarded-the-a-pras-certificate-to-impact-science.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo, Ultragenyx partner for gene therapy manufacturing technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/15702/daiichi-sankyo-ultragenyx-partner-for-gene-therapy-manufacturing-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15702/daiichi-sankyo-ultragenyx-partner-for-gene-therapy-manufacturing-technology.html</link>
			<pubDate>Wed, 01 Apr 2020 23:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15702.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15702/daiichi-sankyo-ultragenyx-partner-for-gene-therapy-manufacturing-technology.html</guid>
		</item>	
				<item>
			<title>GHIT Fund announces new investment of 3.29 B Yen </title>
			<atom:link href="https://biospectrumasia.com/news/50/15695/ghit-fund-announces-new-investment-of-3-29-b-yen-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15695/ghit-fund-announces-new-investment-of-3-29-b-yen-.html</link>
			<pubDate>Wed, 01 Apr 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15695.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15695/ghit-fund-announces-new-investment-of-3-29-b-yen-.html</guid>
		</item>	
				<item>
			<title>Hitachi to establish Lumada Data Science lab</title>
			<atom:link href="https://biospectrumasia.com/news/50/15684/hitachi-to-establish-lumada-data-science-lab.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15684/hitachi-to-establish-lumada-data-science-lab.html</link>
			<pubDate>Tue, 31 Mar 2020 04:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hitachivantara-15684.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15684/hitachi-to-establish-lumada-data-science-lab.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo ends influenza vaccine sales deal with Kitasato</title>
			<atom:link href="https://biospectrumasia.com/news/50/15675/daiichi-sankyo-ends-influenza-vaccine-sales-deal-with-kitasato.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15675/daiichi-sankyo-ends-influenza-vaccine-sales-deal-with-kitasato.html</link>
			<pubDate>Mon, 30 Mar 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15675.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15675/daiichi-sankyo-ends-influenza-vaccine-sales-deal-with-kitasato.html</guid>
		</item>	
				<item>
			<title>CG Oncology inks agreement with Kissei Pharma for $40M</title>
			<atom:link href="https://biospectrumasia.com/news/50/15672/cg-oncology-inks-agreement-with-kissei-pharma-for-40m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15672/cg-oncology-inks-agreement-with-kissei-pharma-for-40m.html</link>
			<pubDate>Fri, 27 Mar 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15672.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15672/cg-oncology-inks-agreement-with-kissei-pharma-for-40m.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo receives approval for new breast cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/15663/daiichi-sankyo-receives-approval-for-new-breast-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15663/daiichi-sankyo-receives-approval-for-new-breast-cancer-drug.html</link>
			<pubDate>Thu, 26 Mar 2020 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15663.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15663/daiichi-sankyo-receives-approval-for-new-breast-cancer-drug.html</guid>
		</item>	
				<item>
			<title>CytomX, Astellas to find cure for cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/15651/cytomx-astellas-to-find-cure-for-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15651/cytomx-astellas-to-find-cure-for-cancer.html</link>
			<pubDate>Wed, 25 Mar 2020 07:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands_1063442_1920-15651.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15651/cytomx-astellas-to-find-cure-for-cancer.html</guid>
		</item>	
				<item>
			<title>Eisai to launch digital tool  to assess brain health </title>
			<atom:link href="https://biospectrumasia.com/news/50/15642/eisai-to-launch-digital-tool-to-assess-brain-health-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15642/eisai-to-launch-digital-tool-to-assess-brain-health-.html</link>
			<pubDate>Tue, 24 Mar 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_257930-15642.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15642/eisai-to-launch-digital-tool-to-assess-brain-health-.html</guid>
		</item>	
				<item>
			<title>Gifu University, Astellas to create new treatments for bacterial infections</title>
			<atom:link href="https://biospectrumasia.com/news/50/15635/gifu-university-astellas-to-create-new-treatments-for-bacterial-infections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15635/gifu-university-astellas-to-create-new-treatments-for-bacterial-infections.html</link>
			<pubDate>Mon, 23 Mar 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15635.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15635/gifu-university-astellas-to-create-new-treatments-for-bacterial-infections.html</guid>
		</item>	
				<item>
			<title>Diagnostic biomarker for acute adult T-cell cancers discovered</title>
			<atom:link href="https://biospectrumasia.com/news/50/15644/diagnostic-biomarker-for-acute-adult-t-cell-cancers-discovered.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15644/diagnostic-biomarker-for-acute-adult-t-cell-cancers-discovered.html</link>
			<pubDate>Mon, 23 Mar 2020 05:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/national_cancer_institute-15644.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15644/diagnostic-biomarker-for-acute-adult-t-cell-cancers-discovered.html</guid>
		</item>	
				<item>
			<title>Eppendorf acquires centrifuge biz of Koki Holdings</title>
			<atom:link href="https://biospectrumasia.com/news/50/15626/eppendorf-acquires-centrifuge-biz-of-koki-holdings.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15626/eppendorf-acquires-centrifuge-biz-of-koki-holdings.html</link>
			<pubDate>Fri, 20 Mar 2020 05:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/key_visual_centrifuge_5920_r_lab_scene10_1l_bottle-15626.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15626/eppendorf-acquires-centrifuge-biz-of-koki-holdings.html</guid>
		</item>	
				<item>
			<title>Japan approves Novartis&#039; SMA drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/15622/japan-approves-novartis-sma-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15622/japan-approves-novartis-sma-drug-.html</link>
			<pubDate>Thu, 19 Mar 2020 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_2928254-15622.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15622/japan-approves-novartis-sma-drug-.html</guid>
		</item>	
				<item>
			<title>Fujifilm invests $83M to expand microbial production capacity</title>
			<atom:link href="https://biospectrumasia.com/news/50/15621/fujifilm-invests-83m-to-expand-microbial-production-capacity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15621/fujifilm-invests-83m-to-expand-microbial-production-capacity.html</link>
			<pubDate>Thu, 19 Mar 2020 10:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15621.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15621/fujifilm-invests-83m-to-expand-microbial-production-capacity.html</guid>
		</item>	
				<item>
			<title>Ribomic inks license agreement with Aju Pharma for AMD drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/15614/ribomic-inks-license-agreement-with-aju-pharma-for-amd-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15614/ribomic-inks-license-agreement-with-aju-pharma-for-amd-drug.html</link>
			<pubDate>Wed, 18 Mar 2020 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15614.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15614/ribomic-inks-license-agreement-with-aju-pharma-for-amd-drug.html</guid>
		</item>	
				<item>
			<title>Japan develops new strategy to treat oral cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/15604/japan-develops-new-strategy-to-treat-oral-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15604/japan-develops-new-strategy-to-treat-oral-cancer.html</link>
			<pubDate>Tue, 17 Mar 2020 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15604.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15604/japan-develops-new-strategy-to-treat-oral-cancer.html</guid>
		</item>	
				<item>
			<title>Heartseed collaborates with Itochu Chemical Frontier</title>
			<atom:link href="https://biospectrumasia.com/news/50/15579/heartseed-collaborates-with-itochu-chemical-frontier.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15579/heartseed-collaborates-with-itochu-chemical-frontier.html</link>
			<pubDate>Fri, 13 Mar 2020 09:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15579.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15579/heartseed-collaborates-with-itochu-chemical-frontier.html</guid>
		</item>	
				<item>
			<title>Japan to test AIM ImmunoTech&#039;s Ampligen for COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/15570/japan-to-test-aim-immunotechs-ampligen-for-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15570/japan-to-test-aim-immunotechs-ampligen-for-covid-19.html</link>
			<pubDate>Tue, 10 Mar 2020 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_15348-15570.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15570/japan-to-test-aim-immunotechs-ampligen-for-covid-19.html</guid>
		</item>	
				<item>
			<title>Nagase Medicals, Osaka University to work on drug delivery systems</title>
			<atom:link href="https://biospectrumasia.com/news/50/15551/nagase-medicals-osaka-university-to-work-on-drug-delivery-systems.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15551/nagase-medicals-osaka-university-to-work-on-drug-delivery-systems.html</link>
			<pubDate>Fri, 06 Mar 2020 09:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15551.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15551/nagase-medicals-osaka-university-to-work-on-drug-delivery-systems.html</guid>
		</item>	
				<item>
			<title>Takeda initiates development of Plasma-Derived Therapy for COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/50/15535/takeda-initiates-development-of-plasma-derived-therapy-for-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15535/takeda-initiates-development-of-plasma-derived-therapy-for-covid-19.html</link>
			<pubDate>Thu, 05 Mar 2020 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/coronavirus_blood_sample-15535.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15535/takeda-initiates-development-of-plasma-derived-therapy-for-covid-19.html</guid>
		</item>	
				<item>
			<title>Saki Corporation opens new factory in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/15531/saki-corporation-opens-new-factory-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15531/saki-corporation-opens-new-factory-in-japan.html</link>
			<pubDate>Wed, 04 Mar 2020 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15531.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15531/saki-corporation-opens-new-factory-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda to divest select assets to Hypera for $825M</title>
			<atom:link href="https://biospectrumasia.com/news/50/15529/takeda-to-divest-select-assets-to-hypera-for-825m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15529/takeda-to-divest-select-assets-to-hypera-for-825m.html</link>
			<pubDate>Tue, 03 Mar 2020 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15529.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15529/takeda-to-divest-select-assets-to-hypera-for-825m.html</guid>
		</item>	
				<item>
			<title>UCB, Daiichi Sankyo to offer new treatment option for epilepsy</title>
			<atom:link href="https://biospectrumasia.com/news/50/15523/ucb-daiichi-sankyo-to-offer-new-treatment-option-for-epilepsy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15523/ucb-daiichi-sankyo-to-offer-new-treatment-option-for-epilepsy.html</link>
			<pubDate>Mon, 02 Mar 2020 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15523.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15523/ucb-daiichi-sankyo-to-offer-new-treatment-option-for-epilepsy.html</guid>
		</item>	
				<item>
			<title>Takeda acquires PvP Biologics focusing on celiac disease treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/15517/takeda-acquires-pvp-biologics-focusing-on-celiac-disease-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15517/takeda-acquires-pvp-biologics-focusing-on-celiac-disease-treatment.html</link>
			<pubDate>Fri, 28 Feb 2020 09:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15517.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15517/takeda-acquires-pvp-biologics-focusing-on-celiac-disease-treatment.html</guid>
		</item>	
				<item>
			<title>Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/15500/eisai-fuji-yakuhin-to-work-on-hyperuricemia-and-gout-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15500/eisai-fuji-yakuhin-to-work-on-hyperuricemia-and-gout-treatment.html</link>
			<pubDate>Thu, 27 Feb 2020 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15500.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15500/eisai-fuji-yakuhin-to-work-on-hyperuricemia-and-gout-treatment.html</guid>
		</item>	
				<item>
			<title>Softbank leads $165 M funding for Karius</title>
			<atom:link href="https://biospectrumasia.com/news/50/15492/softbank-leads-165-m-funding-for-karius.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15492/softbank-leads-165-m-funding-for-karius.html</link>
			<pubDate>Wed, 26 Feb 2020 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15492.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15492/softbank-leads-165-m-funding-for-karius.html</guid>
		</item>	
				<item>
			<title>Eisai receives recognition for contribution towards liver diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/15483/eisai-receives-recognition-for-contribution-towards-liver-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15483/eisai-receives-recognition-for-contribution-towards-liver-diseases.html</link>
			<pubDate>Tue, 25 Feb 2020 06:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15483.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15483/eisai-receives-recognition-for-contribution-towards-liver-diseases.html</guid>
		</item>	
				<item>
			<title>Eisai&#039;s H3 Biomedicine appoints new CMO</title>
			<atom:link href="https://biospectrumasia.com/news/50/15482/eisais-h3-biomedicine-appoints-new-cmo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15482/eisais-h3-biomedicine-appoints-new-cmo.html</link>
			<pubDate>Mon, 24 Feb 2020 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/welcome_sign_2284312_1920-15482.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15482/eisais-h3-biomedicine-appoints-new-cmo.html</guid>
		</item>	
				<item>
			<title>BIO cancels Asia conference in Tokyo amid COVID-19 outbreak</title>
			<atom:link href="https://biospectrumasia.com/news/50/15476/bio-cancels-asia-conference-in-tokyo-amid-covid-19-outbreak.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15476/bio-cancels-asia-conference-in-tokyo-amid-covid-19-outbreak.html</link>
			<pubDate>Mon, 24 Feb 2020 05:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2020_02_23_at_5_51_38_pm-15476.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15476/bio-cancels-asia-conference-in-tokyo-amid-covid-19-outbreak.html</guid>
		</item>	
				<item>
			<title>BitOne enhances remote medical services with 5G technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/15457/bitone-enhances-remote-medical-services-with-5g-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15457/bitone-enhances-remote-medical-services-with-5g-technology.html</link>
			<pubDate>Wed, 19 Feb 2020 14:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15457.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15457/bitone-enhances-remote-medical-services-with-5g-technology.html</guid>
		</item>	
				<item>
			<title>Chugai receives Orphan Drug Designation for RG6042 </title>
			<atom:link href="https://biospectrumasia.com/news/50/15443/chugai-receives-orphan-drug-designation-for-rg6042-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15443/chugai-receives-orphan-drug-designation-for-rg6042-.html</link>
			<pubDate>Tue, 18 Feb 2020 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4458_brain_1296x728_header-15443.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15443/chugai-receives-orphan-drug-designation-for-rg6042-.html</guid>
		</item>	
				<item>
			<title>Researchers investigate cancer genomic landscape of Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/15442/researchers-investigate-cancer-genomic-landscape-of-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15442/researchers-investigate-cancer-genomic-landscape-of-japan.html</link>
			<pubDate>Mon, 17 Feb 2020 05:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15442.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15442/researchers-investigate-cancer-genomic-landscape-of-japan.html</guid>
		</item>	
				<item>
			<title>Japan explores muscular dystrophy associated cardiomyopathy</title>
			<atom:link href="https://biospectrumasia.com/news/50/15434/japan-explores-muscular-dystrophy-associated-cardiomyopathy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15434/japan-explores-muscular-dystrophy-associated-cardiomyopathy.html</link>
			<pubDate>Fri, 14 Feb 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15434.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15434/japan-explores-muscular-dystrophy-associated-cardiomyopathy.html</guid>
		</item>	
				<item>
			<title>Foundation Medicine &amp; Chugai announce partnership with NCC</title>
			<atom:link href="https://biospectrumasia.com/news/50/15427/foundation-medicine-chugai-announce-partnership-with-ncc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15427/foundation-medicine-chugai-announce-partnership-with-ncc.html</link>
			<pubDate>Thu, 13 Feb 2020 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15427.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15427/foundation-medicine-chugai-announce-partnership-with-ncc.html</guid>
		</item>	
				<item>
			<title>Nippon Shinyaku inks new agreement for prostate cancer treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/15419/nippon-shinyaku-inks-new-agreement-for-prostate-cancer-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15419/nippon-shinyaku-inks-new-agreement-for-prostate-cancer-treatment.html</link>
			<pubDate>Wed, 12 Feb 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15419.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15419/nippon-shinyaku-inks-new-agreement-for-prostate-cancer-treatment.html</guid>
		</item>	
				<item>
			<title>Japan suggests combined drug treatment for lung cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/15407/japan-suggests-combined-drug-treatment-for-lung-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15407/japan-suggests-combined-drug-treatment-for-lung-cancer.html</link>
			<pubDate>Tue, 11 Feb 2020 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/upper_body_944557_1280-15407.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15407/japan-suggests-combined-drug-treatment-for-lung-cancer.html</guid>
		</item>	
				<item>
			<title>Chugai collaborates with National Cancer Center</title>
			<atom:link href="https://biospectrumasia.com/news/50/15402/chugai-collaborates-with-national-cancer-center.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15402/chugai-collaborates-with-national-cancer-center.html</link>
			<pubDate>Mon, 10 Feb 2020 15:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15402.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15402/chugai-collaborates-with-national-cancer-center.html</guid>
		</item>	
				<item>
			<title>Santen, Verily to develop unique ophthalmic devices</title>
			<atom:link href="https://biospectrumasia.com/news/50/15396/santen-verily-to-develop-unique-ophthalmic-devices.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15396/santen-verily-to-develop-unique-ophthalmic-devices.html</link>
			<pubDate>Fri, 07 Feb 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15396.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15396/santen-verily-to-develop-unique-ophthalmic-devices.html</guid>
		</item>	
				<item>
			<title>Sumitomo Dainippon, Exscientia begin clinical study of AI based OCD drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/15362/sumitomo-dainippon-exscientia-begin-clinical-study-of-ai-based-ocd-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15362/sumitomo-dainippon-exscientia-begin-clinical-study-of-ai-based-ocd-drug.html</link>
			<pubDate>Mon, 03 Feb 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15362.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15362/sumitomo-dainippon-exscientia-begin-clinical-study-of-ai-based-ocd-drug.html</guid>
		</item>	
				<item>
			<title>AgeX accelerates hypoimmunogenic cells development in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/15342/agex-accelerates-hypoimmunogenic-cells-development-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15342/agex-accelerates-hypoimmunogenic-cells-development-in-japan.html</link>
			<pubDate>Fri, 31 Jan 2020 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/0-15342.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15342/agex-accelerates-hypoimmunogenic-cells-development-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan unveils herbal medicines to treat stomach disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/15347/japan-unveils-herbal-medicines-to-treat-stomach-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15347/japan-unveils-herbal-medicines-to-treat-stomach-disorders.html</link>
			<pubDate>Thu, 30 Jan 2020 16:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/0-15347.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15347/japan-unveils-herbal-medicines-to-treat-stomach-disorders.html</guid>
		</item>	
				<item>
			<title>Kitakyushu Hospital to initiate Senhance Digital Laparoscopy Program</title>
			<atom:link href="https://biospectrumasia.com/news/50/15344/kitakyushu-hospital-to-initiate-senhance-digital-laparoscopy-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15344/kitakyushu-hospital-to-initiate-senhance-digital-laparoscopy-program.html</link>
			<pubDate>Thu, 30 Jan 2020 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/0-15344.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15344/kitakyushu-hospital-to-initiate-senhance-digital-laparoscopy-program.html</guid>
		</item>	
				<item>
			<title>JT to market CORECTIM in Japan to treat atopic dermatitis</title>
			<atom:link href="https://biospectrumasia.com/news/50/15337/jt-to-market-corectim-in-japan-to-treat-atopic-dermatitis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15337/jt-to-market-corectim-in-japan-to-treat-atopic-dermatitis.html</link>
			<pubDate>Thu, 30 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15337.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15337/jt-to-market-corectim-in-japan-to-treat-atopic-dermatitis.html</guid>
		</item>	
				<item>
			<title>Eisai and PGDx jointly start R&amp;D of cancer genetics panel test </title>
			<atom:link href="https://biospectrumasia.com/news/50/15334/eisai-and-pgdx-jointly-start-rd-of-cancer-genetics-panel-test-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15334/eisai-and-pgdx-jointly-start-rd-of-cancer-genetics-panel-test-.html</link>
			<pubDate>Wed, 29 Jan 2020 11:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15334.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15334/eisai-and-pgdx-jointly-start-rd-of-cancer-genetics-panel-test-.html</guid>
		</item>	
				<item>
			<title>Eisai&#039;s DAYVIGO gets approval in Japan to treat insomnia</title>
			<atom:link href="https://biospectrumasia.com/news/50/15326/eisais-dayvigo-gets-approval-in-japan-to-treat-insomnia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15326/eisais-dayvigo-gets-approval-in-japan-to-treat-insomnia.html</link>
			<pubDate>Tue, 28 Jan 2020 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15326.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15326/eisais-dayvigo-gets-approval-in-japan-to-treat-insomnia.html</guid>
		</item>	
				<item>
			<title>Amgen Astellas Biopharma to become wholly owned Amgen affiliate</title>
			<atom:link href="https://biospectrumasia.com/news/50/15312/amgen-astellas-biopharma-to-become-wholly-owned-amgen-affiliate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15312/amgen-astellas-biopharma-to-become-wholly-owned-amgen-affiliate.html</link>
			<pubDate>Tue, 28 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15312.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15312/amgen-astellas-biopharma-to-become-wholly-owned-amgen-affiliate.html</guid>
		</item>	
				<item>
			<title>Eisai gets approval of anti-epileptic drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/15311/eisai-gets-approval-of-anti-epileptic-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15311/eisai-gets-approval-of-anti-epileptic-drug-in-japan.html</link>
			<pubDate>Mon, 27 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15311.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15311/eisai-gets-approval-of-anti-epileptic-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Sasakawa Health Foundation focuses on World Leprosy Day 2020</title>
			<atom:link href="https://biospectrumasia.com/news/50/15318/sasakawa-health-foundation-focuses-on-world-leprosy-day-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15318/sasakawa-health-foundation-focuses-on-world-leprosy-day-2020.html</link>
			<pubDate>Sat, 25 Jan 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15318.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15318/sasakawa-health-foundation-focuses-on-world-leprosy-day-2020.html</guid>
		</item>	
				<item>
			<title>Darolutamide gets marketing authorization in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/15301/darolutamide-gets-marketing-authorization-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15301/darolutamide-gets-marketing-authorization-in-japan.html</link>
			<pubDate>Fri, 24 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15301.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15301/darolutamide-gets-marketing-authorization-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan Ministry approves Propess for cervical ripening</title>
			<atom:link href="https://biospectrumasia.com/news/50/15303/japan-ministry-approves-propess-for-cervical-ripening.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15303/japan-ministry-approves-propess-for-cervical-ripening.html</link>
			<pubDate>Thu, 23 Jan 2020 15:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/0-15303.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15303/japan-ministry-approves-propess-for-cervical-ripening.html</guid>
		</item>	
				<item>
			<title>Poxel appoints industry leader Dr. David E. Moller as CSO</title>
			<atom:link href="https://biospectrumasia.com/news/50/15302/poxel-appoints-industry-leader-dr-david-e-moller-as-cso.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15302/poxel-appoints-industry-leader-dr-david-e-moller-as-cso.html</link>
			<pubDate>Thu, 23 Jan 2020 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/recruitment-15302.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15302/poxel-appoints-industry-leader-dr-david-e-moller-as-cso.html</guid>
		</item>	
				<item>
			<title>Hitachi Chemical inks pact with Ori Biotech</title>
			<atom:link href="https://biospectrumasia.com/news/50/15287/hitachi-chemical-inks-pact-with-ori-biotech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15287/hitachi-chemical-inks-pact-with-ori-biotech.html</link>
			<pubDate>Thu, 23 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15287.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15287/hitachi-chemical-inks-pact-with-ori-biotech.html</guid>
		</item>	
				<item>
			<title>Takeda announces liquidation of holding company</title>
			<atom:link href="https://biospectrumasia.com/news/50/15292/takeda-announces-liquidation-of-holding-company.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15292/takeda-announces-liquidation-of-holding-company.html</link>
			<pubDate>Wed, 22 Jan 2020 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-15292.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15292/takeda-announces-liquidation-of-holding-company.html</guid>
		</item>	
				<item>
			<title>PhoreMost, Otsuka collaborate for multi drug discovery projects</title>
			<atom:link href="https://biospectrumasia.com/news/50/15286/phoremost-otsuka-collaborate-for-multi-drug-discovery-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15286/phoremost-otsuka-collaborate-for-multi-drug-discovery-projects.html</link>
			<pubDate>Wed, 22 Jan 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15286.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15286/phoremost-otsuka-collaborate-for-multi-drug-discovery-projects.html</guid>
		</item>	
				<item>
			<title>Astellas invests Â¥10B to build new manufacturing facility</title>
			<atom:link href="https://biospectrumasia.com/news/50/15271/astellas-invests-10b-to-build-new-manufacturing-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15271/astellas-invests-10b-to-build-new-manufacturing-facility.html</link>
			<pubDate>Tue, 21 Jan 2020 06:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15271.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15271/astellas-invests-10b-to-build-new-manufacturing-facility.html</guid>
		</item>	
				<item>
			<title>ViiV Healthcare wins Japanese approval for Dovato to treat HIV-1</title>
			<atom:link href="https://biospectrumasia.com/news/50/15273/viiv-healthcare-wins-japanese-approval-for-dovato-to-treat-hiv-1.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15273/viiv-healthcare-wins-japanese-approval-for-dovato-to-treat-hiv-1.html</link>
			<pubDate>Mon, 20 Jan 2020 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hiv-15273.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15273/viiv-healthcare-wins-japanese-approval-for-dovato-to-treat-hiv-1.html</guid>
		</item>	
				<item>
			<title>Astellas completes acquisition of Audentes Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/15272/astellas-completes-acquisition-of-audentes-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15272/astellas-completes-acquisition-of-audentes-therapeutics.html</link>
			<pubDate>Mon, 20 Jan 2020 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-15272.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15272/astellas-completes-acquisition-of-audentes-therapeutics.html</guid>
		</item>	
				<item>
			<title>Astellas, Adaptimmune to develop CAR-T &amp; TCR T-cell therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/15257/astellas-adaptimmune-to-develop-car-t-tcr-t-cell-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15257/astellas-adaptimmune-to-develop-car-t-tcr-t-cell-therapies.html</link>
			<pubDate>Fri, 17 Jan 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15257.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15257/astellas-adaptimmune-to-develop-car-t-tcr-t-cell-therapies.html</guid>
		</item>	
				<item>
			<title>Charles River inks scientific collaboration with Takeda </title>
			<atom:link href="https://biospectrumasia.com/news/50/15259/charles-river-inks-scientific-collaboration-with-takeda-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15259/charles-river-inks-scientific-collaboration-with-takeda-.html</link>
			<pubDate>Thu, 16 Jan 2020 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15259.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15259/charles-river-inks-scientific-collaboration-with-takeda-.html</guid>
		</item>	
				<item>
			<title>ASKA, KinoPharma unite to treat cervical dysplasia</title>
			<atom:link href="https://biospectrumasia.com/news/50/15245/aska-kinopharma-unite-to-treat-cervical-dysplasia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15245/aska-kinopharma-unite-to-treat-cervical-dysplasia.html</link>
			<pubDate>Thu, 16 Jan 2020 06:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15245.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15245/aska-kinopharma-unite-to-treat-cervical-dysplasia.html</guid>
		</item>	
				<item>
			<title>Hitachi starts commercial manufacturing of Zynteglo</title>
			<atom:link href="https://biospectrumasia.com/news/50/15241/hitachi-starts-commercial-manufacturing-of-zynteglo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15241/hitachi-starts-commercial-manufacturing-of-zynteglo.html</link>
			<pubDate>Wed, 15 Jan 2020 06:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15241.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15241/hitachi-starts-commercial-manufacturing-of-zynteglo.html</guid>
		</item>	
				<item>
			<title>ERS Genomics licenses CRISPR gene editing technology to Daiichi Sankyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/15238/ers-genomics-licenses-crispr-gene-editing-technology-to-daiichi-sankyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15238/ers-genomics-licenses-crispr-gene-editing-technology-to-daiichi-sankyo.html</link>
			<pubDate>Tue, 14 Jan 2020 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15238.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15238/ers-genomics-licenses-crispr-gene-editing-technology-to-daiichi-sankyo.html</guid>
		</item>	
				<item>
			<title>FDA approves sNDA for Astellas&#039;s antifungal drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/15230/fda-approves-snda-for-astellass-antifungal-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15230/fda-approves-snda-for-astellass-antifungal-drug.html</link>
			<pubDate>Mon, 13 Jan 2020 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15230.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15230/fda-approves-snda-for-astellass-antifungal-drug.html</guid>
		</item>	
				<item>
			<title>Chugai signs licensing deal with Verastem for cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/15223/chugai-signs-licensing-deal-with-verastem-for-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15223/chugai-signs-licensing-deal-with-verastem-for-cancer-drug.html</link>
			<pubDate>Fri, 10 Jan 2020 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15223.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15223/chugai-signs-licensing-deal-with-verastem-for-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Huya Bioscience ropes in Meiji as distributor for Asian region</title>
			<atom:link href="https://biospectrumasia.com/news/50/15221/huya-bioscience-ropes-in-meiji-as-distributor-for-asian-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15221/huya-bioscience-ropes-in-meiji-as-distributor-for-asian-region.html</link>
			<pubDate>Fri, 10 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15221.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15221/huya-bioscience-ropes-in-meiji-as-distributor-for-asian-region.html</guid>
		</item>	
				<item>
			<title>Alma receives excellence award in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/15219/alma-receives-excellence-award-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15219/alma-receives-excellence-award-in-japan.html</link>
			<pubDate>Thu, 09 Jan 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15219.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15219/alma-receives-excellence-award-in-japan.html</guid>
		</item>	
				<item>
			<title>aTyr Pharma, Kyorin to work on interstitial lung diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/15195/atyr-pharma-kyorin-to-work-on-interstitial-lung-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15195/atyr-pharma-kyorin-to-work-on-interstitial-lung-diseases.html</link>
			<pubDate>Tue, 07 Jan 2020 06:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15195.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15195/atyr-pharma-kyorin-to-work-on-interstitial-lung-diseases.html</guid>
		</item>	
				<item>
			<title>Transgene, NEC initiate trials with AI-Powered Cancer Vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/15197/transgene-nec-initiate-trials-with-ai-powered-cancer-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15197/transgene-nec-initiate-trials-with-ai-powered-cancer-vaccine.html</link>
			<pubDate>Tue, 07 Jan 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/va-15197.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15197/transgene-nec-initiate-trials-with-ai-powered-cancer-vaccine.html</guid>
		</item>	
				<item>
			<title>Urovant inks $300M loan agreement with Sumitomo Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/15176/urovant-inks-300m-loan-agreement-with-sumitomo-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15176/urovant-inks-300m-loan-agreement-with-sumitomo-pharma.html</link>
			<pubDate>Thu, 02 Jan 2020 06:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15176.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15176/urovant-inks-300m-loan-agreement-with-sumitomo-pharma.html</guid>
		</item>	
				<item>
			<title>Japan develops new tumour-on-a-chip device</title>
			<atom:link href="https://biospectrumasia.com/news/50/15171/japan-develops-new-tumour-on-a-chip-device.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15171/japan-develops-new-tumour-on-a-chip-device.html</link>
			<pubDate>Wed, 01 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15171.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15171/japan-develops-new-tumour-on-a-chip-device.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo unveils drug for treating colorectal cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/15162/daiichi-sankyo-unveils-drug-for-treating-colorectal-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15162/daiichi-sankyo-unveils-drug-for-treating-colorectal-cancer.html</link>
			<pubDate>Tue, 31 Dec 2019 06:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15162.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15162/daiichi-sankyo-unveils-drug-for-treating-colorectal-cancer.html</guid>
		</item>	
				<item>
			<title>Astellas strengthens immuno-oncology portfolio by acquiring Xyphos</title>
			<atom:link href="https://biospectrumasia.com/news/50/15142/astellas-strengthens-immuno-oncology-portfolio-by-acquiring-xyphos.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15142/astellas-strengthens-immuno-oncology-portfolio-by-acquiring-xyphos.html</link>
			<pubDate>Fri, 27 Dec 2019 06:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15142.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15142/astellas-strengthens-immuno-oncology-portfolio-by-acquiring-xyphos.html</guid>
		</item>	
				<item>
			<title>USFDA approves Daiichi Sankyo and AstraZeneca&#039;s breast cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/15141/usfda-approves-daiichi-sankyo-and-astrazenecas-breast-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15141/usfda-approves-daiichi-sankyo-and-astrazenecas-breast-cancer-drug.html</link>
			<pubDate>Thu, 26 Dec 2019 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi_sankyo_enhertu_anchor_12-15141.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15141/usfda-approves-daiichi-sankyo-and-astrazenecas-breast-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Gilead, Eisai to co-promote drug in Japan for RA treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/15137/gilead-eisai-to-co-promote-drug-in-japan-for-ra-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15137/gilead-eisai-to-co-promote-drug-in-japan-for-ra-treatment.html</link>
			<pubDate>Thu, 26 Dec 2019 07:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15137.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15137/gilead-eisai-to-co-promote-drug-in-japan-for-ra-treatment.html</guid>
		</item>	
				<item>
			<title>Eisai gets USFDA nod for insomnia drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/15128/eisai-gets-usfda-nod-for-insomnia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15128/eisai-gets-usfda-nod-for-insomnia-drug.html</link>
			<pubDate>Tue, 24 Dec 2019 21:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_2928254-15128.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15128/eisai-gets-usfda-nod-for-insomnia-drug.html</guid>
		</item>	
				<item>
			<title>Towa to acquire Esteve&#039;s generic division for 320M euros</title>
			<atom:link href="https://biospectrumasia.com/news/50/15125/towa-to-acquire-esteves-generic-division-for-320m-euros.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15125/towa-to-acquire-esteves-generic-division-for-320m-euros.html</link>
			<pubDate>Tue, 24 Dec 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15125.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15125/towa-to-acquire-esteves-generic-division-for-320m-euros.html</guid>
		</item>	
				<item>
			<title>Takeda, Turnstone Biologics to develop novel viral immunotherapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/15106/takeda-turnstone-biologics-to-develop-novel-viral-immunotherapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15106/takeda-turnstone-biologics-to-develop-novel-viral-immunotherapies.html</link>
			<pubDate>Fri, 20 Dec 2019 07:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15106.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15106/takeda-turnstone-biologics-to-develop-novel-viral-immunotherapies.html</guid>
		</item>	
				<item>
			<title>Pentax Medical Remains Committed to Endoscopic Ultrasound Business</title>
			<atom:link href="https://biospectrumasia.com/news/50/15157/pentax-medical-remains-committed-to-endoscopic-ultrasound-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15157/pentax-medical-remains-committed-to-endoscopic-ultrasound-business.html</link>
			<pubDate>Thu, 19 Dec 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/global_aboutus_global_overview_akishima_office_05-15157.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15157/pentax-medical-remains-committed-to-endoscopic-ultrasound-business.html</guid>
		</item>	
				<item>
			<title>Pentax Medical Remains Committed to Endoscopic Ultrasound Business</title>
			<atom:link href="https://biospectrumasia.com/news/50/15158/pentax-medical-remains-committed-to-endoscopic-ultrasound-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15158/pentax-medical-remains-committed-to-endoscopic-ultrasound-business.html</link>
			<pubDate>Thu, 19 Dec 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/global_aboutus_global_overview_akishima_office_05-15158.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15158/pentax-medical-remains-committed-to-endoscopic-ultrasound-business.html</guid>
		</item>	
				<item>
			<title>FDA grants accelerated approval to Astellas&#039; and Seattle Genetics&#039; PADCEV</title>
			<atom:link href="https://biospectrumasia.com/news/50/15103/fda-grants-accelerated-approval-to-astellas-and-seattle-genetics-padcev.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15103/fda-grants-accelerated-approval-to-astellas-and-seattle-genetics-padcev.html</link>
			<pubDate>Thu, 19 Dec 2019 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda_approval-15103.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15103/fda-grants-accelerated-approval-to-astellas-and-seattle-genetics-padcev.html</guid>
		</item>	
				<item>
			<title>PHC Corporation makes investment in Kakehashi</title>
			<atom:link href="https://biospectrumasia.com/news/50/15097/phc-corporation-makes-investment-in-kakehashi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15097/phc-corporation-makes-investment-in-kakehashi.html</link>
			<pubDate>Thu, 19 Dec 2019 07:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dollar_currency_money_us_dollar_47344-15097.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15097/phc-corporation-makes-investment-in-kakehashi.html</guid>
		</item>	
				<item>
			<title>AMED awards 3 joint projects with A*STAR</title>
			<atom:link href="https://biospectrumasia.com/news/50/15095/amed-awards-3-joint-projects-with-astar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15095/amed-awards-3-joint-projects-with-astar.html</link>
			<pubDate>Wed, 18 Dec 2019 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15095.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15095/amed-awards-3-joint-projects-with-astar.html</guid>
		</item>	
				<item>
			<title>Pfizer, Astellas&#039; Xtandi Gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/15089/pfizer-astellas-xtandi-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15089/pfizer-astellas-xtandi-gets-fda-nod.html</link>
			<pubDate>Tue, 17 Dec 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/board_3700116_1920-15089.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15089/pfizer-astellas-xtandi-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>PENTAX Medical gets CE Mark for AI aided Polyp Detector</title>
			<atom:link href="https://biospectrumasia.com/news/50/15079/pentax-medical-gets-ce-mark-for-ai-aided-polyp-detector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15079/pentax-medical-gets-ce-mark-for-ai-aided-polyp-detector.html</link>
			<pubDate>Tue, 17 Dec 2019 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/0-15079.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15079/pentax-medical-gets-ce-mark-for-ai-aided-polyp-detector.html</guid>
		</item>	
				<item>
			<title>AstraZeneca, Daiichi Sankyo&#039;s trastuzumab shows promise in Phase II Trial </title>
			<atom:link href="https://biospectrumasia.com/news/50/15072/astrazeneca-daiichi-sankyos-trastuzumab-shows-promise-in-phase-ii-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15072/astrazeneca-daiichi-sankyos-trastuzumab-shows-promise-in-phase-ii-trial-.html</link>
			<pubDate>Mon, 16 Dec 2019 22:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/board_3700116_1920-15072.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15072/astrazeneca-daiichi-sankyos-trastuzumab-shows-promise-in-phase-ii-trial-.html</guid>
		</item>	
				<item>
			<title>Eisai presented research data on Eribulin (Halaven) at 42nd Annual SABCS2019</title>
			<atom:link href="https://biospectrumasia.com/news/50/15169/eisai-presented-research-data-on-eribulin-halaven-at-42nd-annual-sabcs2019.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15169/eisai-presented-research-data-on-eribulin-halaven-at-42nd-annual-sabcs2019.html</link>
			<pubDate>Mon, 16 Dec 2019 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/theepharmatechnicians-15169.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15169/eisai-presented-research-data-on-eribulin-halaven-at-42nd-annual-sabcs2019.html</guid>
		</item>	
				<item>
			<title>Eisai breaks ground for global drug discovery centre</title>
			<atom:link href="https://biospectrumasia.com/news/50/15070/eisai-breaks-ground-for-global-drug-discovery-centre.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15070/eisai-breaks-ground-for-global-drug-discovery-centre.html</link>
			<pubDate>Mon, 16 Dec 2019 07:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15070.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15070/eisai-breaks-ground-for-global-drug-discovery-centre.html</guid>
		</item>	
				<item>
			<title>FUJIFILM sets manufacturing facility for liposome formulation </title>
			<atom:link href="https://biospectrumasia.com/news/50/15055/fujifilm-sets-manufacturing-facility-for-liposome-formulation-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15055/fujifilm-sets-manufacturing-facility-for-liposome-formulation-.html</link>
			<pubDate>Thu, 12 Dec 2019 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15055.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15055/fujifilm-sets-manufacturing-facility-for-liposome-formulation-.html</guid>
		</item>	
				<item>
			<title>Solasia enters new license alliance with Maruho</title>
			<atom:link href="https://biospectrumasia.com/news/50/15051/solasia-enters-new-license-alliance-with-maruho.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15051/solasia-enters-new-license-alliance-with-maruho.html</link>
			<pubDate>Wed, 11 Dec 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15051.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15051/solasia-enters-new-license-alliance-with-maruho.html</guid>
		</item>	
				<item>
			<title>Takeda, Enzyre to develop diagnostic device for hemophilia patients</title>
			<atom:link href="https://biospectrumasia.com/news/50/15045/takeda-enzyre-to-develop-diagnostic-device-for-hemophilia-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15045/takeda-enzyre-to-develop-diagnostic-device-for-hemophilia-patients.html</link>
			<pubDate>Tue, 10 Dec 2019 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15045.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15045/takeda-enzyre-to-develop-diagnostic-device-for-hemophilia-patients.html</guid>
		</item>	
				<item>
			<title>Takeda presents Phase III Trial results in patients with amyloidosis</title>
			<atom:link href="https://biospectrumasia.com/news/50/15043/takeda-presents-phase-iii-trial-results-in-patients-with-amyloidosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15043/takeda-presents-phase-iii-trial-results-in-patients-with-amyloidosis.html</link>
			<pubDate>Mon, 09 Dec 2019 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical_study-15043.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15043/takeda-presents-phase-iii-trial-results-in-patients-with-amyloidosis.html</guid>
		</item>	
				<item>
			<title>Hitachi to provide CNAO with Proton Therapy System</title>
			<atom:link href="https://biospectrumasia.com/news/50/15039/hitachi-to-provide-cnao-with-proton-therapy-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15039/hitachi-to-provide-cnao-with-proton-therapy-system.html</link>
			<pubDate>Mon, 09 Dec 2019 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15039.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15039/hitachi-to-provide-cnao-with-proton-therapy-system.html</guid>
		</item>	
				<item>
			<title>BitBiome to analyse gut bacteria related to cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/15036/bitbiome-to-analyse-gut-bacteria-related-to-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15036/bitbiome-to-analyse-gut-bacteria-related-to-cancer.html</link>
			<pubDate>Fri, 06 Dec 2019 19:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15036.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15036/bitbiome-to-analyse-gut-bacteria-related-to-cancer.html</guid>
		</item>	
				<item>
			<title>Astellas to Acquire Audentes Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/15008/astellas-to-acquire-audentes-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15008/astellas-to-acquire-audentes-therapeutics.html</link>
			<pubDate>Tue, 03 Dec 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/people_woman_coffee_meeting-15008.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15008/astellas-to-acquire-audentes-therapeutics.html</guid>
		</item>	
				<item>
			<title>Astellas to acquire Audentes Therapeutics in a $3B deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/15004/astellas-to-acquire-audentes-therapeutics-in-a-3b-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15004/astellas-to-acquire-audentes-therapeutics-in-a-3b-deal.html</link>
			<pubDate>Tue, 03 Dec 2019 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15004.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15004/astellas-to-acquire-audentes-therapeutics-in-a-3b-deal.html</guid>
		</item>	
				<item>
			<title>Chugai Pharma&#039;s study on satralizumab published in The New England Journal of Medicine </title>
			<atom:link href="https://biospectrumasia.com/news/50/15000/chugai-pharmas-study-on-satralizumab-published-in-the-new-england-journal-of-medicine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/15000/chugai-pharmas-study-on-satralizumab-published-in-the-new-england-journal-of-medicine-.html</link>
			<pubDate>Mon, 02 Dec 2019 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ubwcaq8z1qwxuszlplu6xps9pjml8mpkcwjuysvs-15000.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/15000/chugai-pharmas-study-on-satralizumab-published-in-the-new-england-journal-of-medicine-.html</guid>
		</item>	
				<item>
			<title>Fujitsu Labs, ACC to advance cancer genomic medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/14992/fujitsu-labs-acc-to-advance-cancer-genomic-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14992/fujitsu-labs-acc-to-advance-cancer-genomic-medicine.html</link>
			<pubDate>Mon, 02 Dec 2019 07:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14992.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14992/fujitsu-labs-acc-to-advance-cancer-genomic-medicine.html</guid>
		</item>	
				<item>
			<title>Hitachi develops automation technology of 3D culture</title>
			<atom:link href="https://biospectrumasia.com/news/50/14982/hitachi-develops-automation-technology-of-3d-culture.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14982/hitachi-develops-automation-technology-of-3d-culture.html</link>
			<pubDate>Fri, 29 Nov 2019 06:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14982.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14982/hitachi-develops-automation-technology-of-3d-culture.html</guid>
		</item>	
				<item>
			<title>ONO Submits Supplemental Application for additional OpdivoÂ®</title>
			<atom:link href="https://biospectrumasia.com/news/50/14984/ono-submits-supplemental-application-for-additional-opdivo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14984/ono-submits-supplemental-application-for-additional-opdivo.html</link>
			<pubDate>Thu, 28 Nov 2019 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_2-14984.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14984/ono-submits-supplemental-application-for-additional-opdivo.html</guid>
		</item>	
				<item>
			<title>Ono Pharma seeks Japanese approval for tirabrutinib </title>
			<atom:link href="https://biospectrumasia.com/news/50/14985/ono-pharma-seeks-japanese-approval-for-tirabrutinib-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14985/ono-pharma-seeks-japanese-approval-for-tirabrutinib-.html</link>
			<pubDate>Thu, 28 Nov 2019 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biotech-14985.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14985/ono-pharma-seeks-japanese-approval-for-tirabrutinib-.html</guid>
		</item>	
				<item>
			<title>Ardelyx and Kyowa Kirin expand partnership</title>
			<atom:link href="https://biospectrumasia.com/news/50/14978/ardelyx-and-kyowa-kirin-expand-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14978/ardelyx-and-kyowa-kirin-expand-partnership.html</link>
			<pubDate>Thu, 28 Nov 2019 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/people_woman_coffee_meeting-14978.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14978/ardelyx-and-kyowa-kirin-expand-partnership.html</guid>
		</item>	
				<item>
			<title>Asahi Kasei collaborates with Woolsey Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/14977/asahi-kasei-collaborates-with-woolsey-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14977/asahi-kasei-collaborates-with-woolsey-pharma.html</link>
			<pubDate>Wed, 27 Nov 2019 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14977.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14977/asahi-kasei-collaborates-with-woolsey-pharma.html</guid>
		</item>	
				<item>
			<title>Eisai Launches First Amazon Alexa Skill Designed for Epileptic Children</title>
			<atom:link href="https://biospectrumasia.com/news/50/14968/eisai-launches-first-amazon-alexa-skill-designed-for-epileptic-children.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14968/eisai-launches-first-amazon-alexa-skill-designed-for-epileptic-children.html</link>
			<pubDate>Tue, 26 Nov 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_977296-14968.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14968/eisai-launches-first-amazon-alexa-skill-designed-for-epileptic-children.html</guid>
		</item>	
				<item>
			<title>Shionogi receives FDA approval for cUTI drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/14966/shionogi-receives-fda-approval-for-cuti-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14966/shionogi-receives-fda-approval-for-cuti-drug-.html</link>
			<pubDate>Tue, 26 Nov 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14966.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14966/shionogi-receives-fda-approval-for-cuti-drug-.html</guid>
		</item>	
				<item>
			<title>Eisai launches Parkinson&#039;s drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14948/eisai-launches-parkinsons-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14948/eisai-launches-parkinsons-drug-in-japan.html</link>
			<pubDate>Mon, 25 Nov 2019 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14948.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14948/eisai-launches-parkinsons-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Astellas and Welldoc collaborate for digital therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/14938/astellas-and-welldoc-collaborate-for-digital-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14938/astellas-and-welldoc-collaborate-for-digital-therapeutics.html</link>
			<pubDate>Fri, 22 Nov 2019 06:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14938.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14938/astellas-and-welldoc-collaborate-for-digital-therapeutics.html</guid>
		</item>	
				<item>
			<title>Japan grants ODD to Merck&#039;s investigational therapy Tepotinib </title>
			<atom:link href="https://biospectrumasia.com/news/50/14932/japan-grants-odd-to-mercks-investigational-therapy-tepotinib-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14932/japan-grants-odd-to-mercks-investigational-therapy-tepotinib-.html</link>
			<pubDate>Thu, 21 Nov 2019 06:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14932.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14932/japan-grants-odd-to-mercks-investigational-therapy-tepotinib-.html</guid>
		</item>	
				<item>
			<title>Toray signs pact with JICA to support infection control capacity</title>
			<atom:link href="https://biospectrumasia.com/news/50/14931/toray-signs-pact-with-jica-to-support-infection-control-capacity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14931/toray-signs-pact-with-jica-to-support-infection-control-capacity.html</link>
			<pubDate>Wed, 20 Nov 2019 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/protective_clothes-14931.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14931/toray-signs-pact-with-jica-to-support-infection-control-capacity.html</guid>
		</item>	
				<item>
			<title>Novartis to buy Aspen&#039;s Japanese operations </title>
			<atom:link href="https://biospectrumasia.com/news/50/14905/novartis-to-buy-aspens-japanese-operations-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14905/novartis-to-buy-aspens-japanese-operations-.html</link>
			<pubDate>Mon, 18 Nov 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/buy_2025564_1280-14905.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14905/novartis-to-buy-aspens-japanese-operations-.html</guid>
		</item>	
				<item>
			<title>Lupin bids goodbye to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14904/lupin-bids-goodbye-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14904/lupin-bids-goodbye-to-japan.html</link>
			<pubDate>Mon, 18 Nov 2019 17:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2019_11_18_at_9_07_44_pm-14904.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14904/lupin-bids-goodbye-to-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s FUJIFILM Diosynth to invest $55 million for gene therapy </title>
			<atom:link href="https://biospectrumasia.com/news/50/14906/japans-fujifilm-diosynth-to-invest-55-million-for-gene-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14906/japans-fujifilm-diosynth-to-invest-55-million-for-gene-therapy-.html</link>
			<pubDate>Mon, 18 Nov 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money_2696219_1920-14906.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14906/japans-fujifilm-diosynth-to-invest-55-million-for-gene-therapy-.html</guid>
		</item>	
				<item>
			<title>Clinical Trial of Boron Neutron Capture Therapy commences in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14903/clinical-trial-of-boron-neutron-capture-therapy-commences-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14903/clinical-trial-of-boron-neutron-capture-therapy-commences-in-japan.html</link>
			<pubDate>Mon, 18 Nov 2019 05:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14903.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14903/clinical-trial-of-boron-neutron-capture-therapy-commences-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda announces 12 new molecular entities </title>
			<atom:link href="https://biospectrumasia.com/news/50/14892/takeda-announces-12-new-molecular-entities-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14892/takeda-announces-12-new-molecular-entities-.html</link>
			<pubDate>Fri, 15 Nov 2019 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14892.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14892/takeda-announces-12-new-molecular-entities-.html</guid>
		</item>	
				<item>
			<title>NEC, VAXIMM to advance personalized neoantigen cancer vaccines</title>
			<atom:link href="https://biospectrumasia.com/news/50/14890/nec-vaximm-to-advance-personalized-neoantigen-cancer-vaccines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14890/nec-vaximm-to-advance-personalized-neoantigen-cancer-vaccines.html</link>
			<pubDate>Fri, 15 Nov 2019 08:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14890.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14890/nec-vaximm-to-advance-personalized-neoantigen-cancer-vaccines.html</guid>
		</item>	
				<item>
			<title>Yokogawa acquires nanopipette technology for life science applications </title>
			<atom:link href="https://biospectrumasia.com/news/50/14883/yokogawa-acquires-nanopipette-technology-for-life-science-applications-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14883/yokogawa-acquires-nanopipette-technology-for-life-science-applications-.html</link>
			<pubDate>Thu, 14 Nov 2019 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14883.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14883/yokogawa-acquires-nanopipette-technology-for-life-science-applications-.html</guid>
		</item>	
				<item>
			<title>Takeda, Anderson Cancer Center accelerate cell therapy </title>
			<atom:link href="https://biospectrumasia.com/news/50/14852/takeda-anderson-cancer-center-accelerate-cell-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14852/takeda-anderson-cancer-center-accelerate-cell-therapy-.html</link>
			<pubDate>Tue, 12 Nov 2019 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14852.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14852/takeda-anderson-cancer-center-accelerate-cell-therapy-.html</guid>
		</item>	
				<item>
			<title>Kayentis opens Japanese subsidiary </title>
			<atom:link href="https://biospectrumasia.com/news/50/14851/kayentis-opens-japanese-subsidiary-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14851/kayentis-opens-japanese-subsidiary-.html</link>
			<pubDate>Mon, 11 Nov 2019 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14851.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14851/kayentis-opens-japanese-subsidiary-.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk obtains worldwide licence to potential NASH candidate </title>
			<atom:link href="https://biospectrumasia.com/news/50/14853/novo-nordisk-obtains-worldwide-licence-to-potential-nash-candidate-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14853/novo-nordisk-obtains-worldwide-licence-to-potential-nash-candidate-.html</link>
			<pubDate>Fri, 08 Nov 2019 17:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14853.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14853/novo-nordisk-obtains-worldwide-licence-to-potential-nash-candidate-.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s Dengue vaccine candidate reveals protection in children</title>
			<atom:link href="https://biospectrumasia.com/news/50/14841/takedas-dengue-vaccine-candidate-reveals-protection-in-children.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14841/takedas-dengue-vaccine-candidate-reveals-protection-in-children.html</link>
			<pubDate>Fri, 08 Nov 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14841.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14841/takedas-dengue-vaccine-candidate-reveals-protection-in-children.html</guid>
		</item>	
				<item>
			<title>Fujitsu improves efficiency in Cancer Genomic Medicine in joint AI research</title>
			<atom:link href="https://biospectrumasia.com/news/50/14844/fujitsu-improves-efficiency-in-cancer-genomic-medicine-in-joint-ai-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14844/fujitsu-improves-efficiency-in-cancer-genomic-medicine-in-joint-ai-research.html</link>
			<pubDate>Fri, 08 Nov 2019 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/imgonline_com_ua_twotoone_fauwitmqgtjd-14844.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14844/fujitsu-improves-efficiency-in-cancer-genomic-medicine-in-joint-ai-research.html</guid>
		</item>	
				<item>
			<title>Hitachi collaborates with CLB to fight cancer using AI</title>
			<atom:link href="https://biospectrumasia.com/news/50/14838/hitachi-collaborates-with-clb-to-fight-cancer-using-ai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14838/hitachi-collaborates-with-clb-to-fight-cancer-using-ai.html</link>
			<pubDate>Thu, 07 Nov 2019 10:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14838.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14838/hitachi-collaborates-with-clb-to-fight-cancer-using-ai.html</guid>
		</item>	
				<item>
			<title>Olympus unveils corporate strategy</title>
			<atom:link href="https://biospectrumasia.com/news/50/14834/olympus-unveils-corporate-strategy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14834/olympus-unveils-corporate-strategy.html</link>
			<pubDate>Thu, 07 Nov 2019 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14834.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14834/olympus-unveils-corporate-strategy.html</guid>
		</item>	
				<item>
			<title>Takeda divests select products to STADA for $660M</title>
			<atom:link href="https://biospectrumasia.com/news/50/14825/takeda-divests-select-products-to-stada-for-660m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14825/takeda-divests-select-products-to-stada-for-660m.html</link>
			<pubDate>Wed, 06 Nov 2019 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14825.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14825/takeda-divests-select-products-to-stada-for-660m.html</guid>
		</item>	
				<item>
			<title>Fujifilm&#039;s rapid TB diagnostic kit receives recognition</title>
			<atom:link href="https://biospectrumasia.com/news/50/14811/fujifilms-rapid-tb-diagnostic-kit-receives-recognition.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14811/fujifilms-rapid-tb-diagnostic-kit-receives-recognition.html</link>
			<pubDate>Tue, 05 Nov 2019 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14811.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14811/fujifilms-rapid-tb-diagnostic-kit-receives-recognition.html</guid>
		</item>	
				<item>
			<title>Synthetic compound provides fast screening for potential drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/14808/synthetic-compound-provides-fast-screening-for-potential-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14808/synthetic-compound-provides-fast-screening-for-potential-drugs.html</link>
			<pubDate>Mon, 04 Nov 2019 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-14808.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14808/synthetic-compound-provides-fast-screening-for-potential-drugs.html</guid>
		</item>	
				<item>
			<title>Promethera Biosciences spreads business activity to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14805/promethera-biosciences-spreads-business-activity-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14805/promethera-biosciences-spreads-business-activity-to-japan.html</link>
			<pubDate>Mon, 04 Nov 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14805.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14805/promethera-biosciences-spreads-business-activity-to-japan.html</guid>
		</item>	
				<item>
			<title>Lobsor Pharma receives Japanese patent for APD solution</title>
			<atom:link href="https://biospectrumasia.com/news/50/14786/lobsor-pharma-receives-japanese-patent-for-apd-solution.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14786/lobsor-pharma-receives-japanese-patent-for-apd-solution.html</link>
			<pubDate>Fri, 01 Nov 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14786.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14786/lobsor-pharma-receives-japanese-patent-for-apd-solution.html</guid>
		</item>	
				<item>
			<title>EMA and FDA accept marketing applications for Chugai&#039;s Satralizumab </title>
			<atom:link href="https://biospectrumasia.com/news/50/14790/ema-and-fda-accept-marketing-applications-for-chugais-satralizumab-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14790/ema-and-fda-accept-marketing-applications-for-chugais-satralizumab-.html</link>
			<pubDate>Thu, 31 Oct 2019 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/elevation_of_eye_g_962777986_860x485-14790.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14790/ema-and-fda-accept-marketing-applications-for-chugais-satralizumab-.html</guid>
		</item>	
				<item>
			<title>Pandion, Astellas collaborate for pancreas targeted immunomodulators</title>
			<atom:link href="https://biospectrumasia.com/news/50/14787/pandion-astellas-collaborate-for-pancreas-targeted-immunomodulators.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14787/pandion-astellas-collaborate-for-pancreas-targeted-immunomodulators.html</link>
			<pubDate>Thu, 31 Oct 2019 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14787.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14787/pandion-astellas-collaborate-for-pancreas-targeted-immunomodulators.html</guid>
		</item>	
				<item>
			<title>Hitachi takes advanced Proton Therapy to the US</title>
			<atom:link href="https://biospectrumasia.com/news/50/14781/hitachi-takes-advanced-proton-therapy-to-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14781/hitachi-takes-advanced-proton-therapy-to-the-us.html</link>
			<pubDate>Thu, 31 Oct 2019 05:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed-14781.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14781/hitachi-takes-advanced-proton-therapy-to-the-us.html</guid>
		</item>	
				<item>
			<title>MIMS and Ashfield Communications combine operations in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14743/mims-and-ashfield-communications-combine-operations-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14743/mims-and-ashfield-communications-combine-operations-in-japan.html</link>
			<pubDate>Thu, 24 Oct 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14743.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14743/mims-and-ashfield-communications-combine-operations-in-japan.html</guid>
		</item>	
				<item>
			<title>Biogen plans regulatory filing for Aducanumab for Alzheimer&#039;s</title>
			<atom:link href="https://biospectrumasia.com/news/50/14748/biogen-plans-regulatory-filing-for-aducanumab-for-alzheimers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14748/biogen-plans-regulatory-filing-for-aducanumab-for-alzheimers.html</link>
			<pubDate>Wed, 23 Oct 2019 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alzeimer-14748.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14748/biogen-plans-regulatory-filing-for-aducanumab-for-alzheimers.html</guid>
		</item>	
				<item>
			<title>Rentschler Biopharma  to expand Japanese operation base</title>
			<atom:link href="https://biospectrumasia.com/news/50/14736/rentschler-biopharma-to-expand-japanese-operation-base.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14736/rentschler-biopharma-to-expand-japanese-operation-base.html</link>
			<pubDate>Wed, 23 Oct 2019 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14736.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14736/rentschler-biopharma-to-expand-japanese-operation-base.html</guid>
		</item>	
				<item>
			<title>Takeda acquires license for celiac disease therapy </title>
			<atom:link href="https://biospectrumasia.com/news/50/14735/takeda-acquires-license-for-celiac-disease-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14735/takeda-acquires-license-for-celiac-disease-therapy-.html</link>
			<pubDate>Tue, 22 Oct 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14735.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14735/takeda-acquires-license-for-celiac-disease-therapy-.html</guid>
		</item>	
				<item>
			<title>Trastuzumab deruxtecan gets FDA priority review to treat metastatic breast cancer </title>
			<atom:link href="https://biospectrumasia.com/news/50/14713/trastuzumab-deruxtecan-gets-fda-priority-review-to-treat-metastatic-breast-cancer-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14713/trastuzumab-deruxtecan-gets-fda-priority-review-to-treat-metastatic-breast-cancer-.html</link>
			<pubDate>Fri, 18 Oct 2019 11:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/breast_cancer-14713.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14713/trastuzumab-deruxtecan-gets-fda-priority-review-to-treat-metastatic-breast-cancer-.html</guid>
		</item>	
				<item>
			<title>Dr. Steven Rosenberg&#039;s achievements in cancer immunotherapy motivate young researchers</title>
			<atom:link href="https://biospectrumasia.com/news/50/14702/dr-steven-rosenbergs-achievements-in-cancer-immunotherapy-motivate-young-researchers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14702/dr-steven-rosenbergs-achievements-in-cancer-immunotherapy-motivate-young-researchers.html</link>
			<pubDate>Thu, 17 Oct 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ncrm_niche_2019_fcq_pr_pic_02ed_16oct19-14702.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14702/dr-steven-rosenbergs-achievements-in-cancer-immunotherapy-motivate-young-researchers.html</guid>
		</item>	
				<item>
			<title>Avidity Science acquires Edstrom Japan Ltd</title>
			<atom:link href="https://biospectrumasia.com/news/50/14703/avidity-science-acquires-edstrom-japan-ltd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14703/avidity-science-acquires-edstrom-japan-ltd.html</link>
			<pubDate>Thu, 17 Oct 2019 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition_2-14703.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14703/avidity-science-acquires-edstrom-japan-ltd.html</guid>
		</item>	
				<item>
			<title>Astellas transfers three products in Asia region to Daiichi Sankyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/14696/astellas-transfers-three-products-in-asia-region-to-daiichi-sankyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14696/astellas-transfers-three-products-in-asia-region-to-daiichi-sankyo.html</link>
			<pubDate>Thu, 17 Oct 2019 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-14696.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14696/astellas-transfers-three-products-in-asia-region-to-daiichi-sankyo.html</guid>
		</item>	
				<item>
			<title>Takeda divests select OTC to Acino for over $200M</title>
			<atom:link href="https://biospectrumasia.com/news/50/14691/takeda-divests-select-otc-to-acino-for-over-200m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14691/takeda-divests-select-otc-to-acino-for-over-200m.html</link>
			<pubDate>Wed, 16 Oct 2019 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14691.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14691/takeda-divests-select-otc-to-acino-for-over-200m.html</guid>
		</item>	
				<item>
			<title>Shionogi to develop treatment for mycobacterial diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/14673/shionogi-to-develop-treatment-for-mycobacterial-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14673/shionogi-to-develop-treatment-for-mycobacterial-diseases.html</link>
			<pubDate>Tue, 15 Oct 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14673.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14673/shionogi-to-develop-treatment-for-mycobacterial-diseases.html</guid>
		</item>	
				<item>
			<title>Canon Medical launches new division in Dubai, UAE</title>
			<atom:link href="https://biospectrumasia.com/news/50/14675/canon-medical-launches-new-division-in-dubai-uae.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14675/canon-medical-launches-new-division-in-dubai-uae.html</link>
			<pubDate>Mon, 14 Oct 2019 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_323705-14675.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14675/canon-medical-launches-new-division-in-dubai-uae.html</guid>
		</item>	
				<item>
			<title>Japanese firm advances diagnostic application of radiolabeling platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/14672/japanese-firm-advances-diagnostic-application-of-radiolabeling-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14672/japanese-firm-advances-diagnostic-application-of-radiolabeling-platform.html</link>
			<pubDate>Mon, 14 Oct 2019 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14672.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14672/japanese-firm-advances-diagnostic-application-of-radiolabeling-platform.html</guid>
		</item>	
				<item>
			<title>Japan issues GMP Certificate to Lupin&#039;s Mandideep facility</title>
			<atom:link href="https://biospectrumasia.com/news/50/14665/japan-issues-gmp-certificate-to-lupins-mandideep-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14665/japan-issues-gmp-certificate-to-lupins-mandideep-facility.html</link>
			<pubDate>Fri, 11 Oct 2019 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14665.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14665/japan-issues-gmp-certificate-to-lupins-mandideep-facility.html</guid>
		</item>	
				<item>
			<title>Viela Bio to develop autoimmune drug for nine Asian regions</title>
			<atom:link href="https://biospectrumasia.com/news/50/14663/viela-bio-to-develop-autoimmune-drug-for-nine-asian-regions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14663/viela-bio-to-develop-autoimmune-drug-for-nine-asian-regions.html</link>
			<pubDate>Fri, 11 Oct 2019 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14663.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14663/viela-bio-to-develop-autoimmune-drug-for-nine-asian-regions.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo launches new drug for AML treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/14661/daiichi-sankyo-launches-new-drug-for-aml-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14661/daiichi-sankyo-launches-new-drug-for-aml-treatment.html</link>
			<pubDate>Fri, 11 Oct 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14661.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14661/daiichi-sankyo-launches-new-drug-for-aml-treatment.html</guid>
		</item>	
				<item>
			<title>Shiseido acquires leading skincare brand</title>
			<atom:link href="https://biospectrumasia.com/news/50/14637/shiseido-acquires-leading-skincare-brand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14637/shiseido-acquires-leading-skincare-brand.html</link>
			<pubDate>Thu, 10 Oct 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14637.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14637/shiseido-acquires-leading-skincare-brand.html</guid>
		</item>	
				<item>
			<title>Gilead Sciences submits NDA to treat RA in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14650/gilead-sciences-submits-nda-to-treat-ra-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14650/gilead-sciences-submits-nda-to-treat-ra-in-japan.html</link>
			<pubDate>Wed, 09 Oct 2019 16:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rheumatoid_arthritis-14650.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14650/gilead-sciences-submits-nda-to-treat-ra-in-japan.html</guid>
		</item>	
				<item>
			<title>PHC, Kakehashi partner for healthcare IT solutions </title>
			<atom:link href="https://biospectrumasia.com/news/50/14643/phc-kakehashi-partner-for-healthcare-it-solutions-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14643/phc-kakehashi-partner-for-healthcare-it-solutions-.html</link>
			<pubDate>Wed, 09 Oct 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/people_woman_coffee_meeting-14643.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14643/phc-kakehashi-partner-for-healthcare-it-solutions-.html</guid>
		</item>	
				<item>
			<title>Bayer and RIKEN establish partnership for novel drug discovery </title>
			<atom:link href="https://biospectrumasia.com/news/50/14638/bayer-and-riken-establish-partnership-for-novel-drug-discovery-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14638/bayer-and-riken-establish-partnership-for-novel-drug-discovery-.html</link>
			<pubDate>Wed, 09 Oct 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/azemews_az-14638.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14638/bayer-and-riken-establish-partnership-for-novel-drug-discovery-.html</guid>
		</item>	
				<item>
			<title>Mik Japan launches new online drug store</title>
			<atom:link href="https://biospectrumasia.com/news/50/14635/mik-japan-launches-new-online-drug-store.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14635/mik-japan-launches-new-online-drug-store.html</link>
			<pubDate>Tue, 08 Oct 2019 14:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14635.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14635/mik-japan-launches-new-online-drug-store.html</guid>
		</item>	
				<item>
			<title>Japanese AI startup secures $42.9M in series B financing</title>
			<atom:link href="https://biospectrumasia.com/news/50/14631/japanese-ai-startup-secures-42-9m-in-series-b-financing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14631/japanese-ai-startup-secures-42-9m-in-series-b-financing.html</link>
			<pubDate>Tue, 08 Oct 2019 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14631.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14631/japanese-ai-startup-secures-42-9m-in-series-b-financing.html</guid>
		</item>	
				<item>
			<title>Rentschler Bio enhances collaboration in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14629/rentschler-bio-enhances-collaboration-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14629/rentschler-bio-enhances-collaboration-in-japan.html</link>
			<pubDate>Mon, 07 Oct 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14629.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14629/rentschler-bio-enhances-collaboration-in-japan.html</guid>
		</item>	
				<item>
			<title>Prometheus Biosciences, Takeda to develop targeted IBD therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/14620/prometheus-biosciences-takeda-to-develop-targeted-ibd-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14620/prometheus-biosciences-takeda-to-develop-targeted-ibd-therapies.html</link>
			<pubDate>Fri, 04 Oct 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14620.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14620/prometheus-biosciences-takeda-to-develop-targeted-ibd-therapies.html</guid>
		</item>	
				<item>
			<title>Moberg inks deal with Taisho for anti-fungal candidate</title>
			<atom:link href="https://biospectrumasia.com/news/50/14611/moberg-inks-deal-with-taisho-for-anti-fungal-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14611/moberg-inks-deal-with-taisho-for-anti-fungal-candidate.html</link>
			<pubDate>Thu, 03 Oct 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14611.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14611/moberg-inks-deal-with-taisho-for-anti-fungal-candidate.html</guid>
		</item>	
				<item>
			<title>MIMETAS and HUB to develop and promote Organoids-on-a-Chip</title>
			<atom:link href="https://biospectrumasia.com/news/50/14606/mimetas-and-hub-to-develop-and-promote-organoids-on-a-chip.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14606/mimetas-and-hub-to-develop-and-promote-organoids-on-a-chip.html</link>
			<pubDate>Wed, 02 Oct 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14606.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14606/mimetas-and-hub-to-develop-and-promote-organoids-on-a-chip.html</guid>
		</item>	
				<item>
			<title>Eisai to work with Tokio towards prevention of dementia</title>
			<atom:link href="https://biospectrumasia.com/news/50/14589/eisai-to-work-with-tokio-towards-prevention-of-dementia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14589/eisai-to-work-with-tokio-towards-prevention-of-dementia.html</link>
			<pubDate>Mon, 30 Sep 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14589.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14589/eisai-to-work-with-tokio-towards-prevention-of-dementia.html</guid>
		</item>	
				<item>
			<title>Eisai, Fronteo launch Coroban prediction system for inpatients</title>
			<atom:link href="https://biospectrumasia.com/news/50/14584/eisai-fronteo-launch-coroban-prediction-system-for-inpatients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14584/eisai-fronteo-launch-coroban-prediction-system-for-inpatients.html</link>
			<pubDate>Fri, 27 Sep 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14584.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14584/eisai-fronteo-launch-coroban-prediction-system-for-inpatients.html</guid>
		</item>	
				<item>
			<title>AGC Biologics appoints new General Manager for Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14575/agc-biologics-appoints-new-general-manager-for-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14575/agc-biologics-appoints-new-general-manager-for-japan.html</link>
			<pubDate>Thu, 26 Sep 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14575.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14575/agc-biologics-appoints-new-general-manager-for-japan.html</guid>
		</item>	
				<item>
			<title>Noven Announces Appointment of Dr. Naruhito Higo as CEO</title>
			<atom:link href="https://biospectrumasia.com/news/50/14564/noven-announces-appointment-of-dr-naruhito-higo-as-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14564/noven-announces-appointment-of-dr-naruhito-higo-as-ceo.html</link>
			<pubDate>Tue, 24 Sep 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/naruhito_higo-14564.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14564/noven-announces-appointment-of-dr-naruhito-higo-as-ceo.html</guid>
		</item>	
				<item>
			<title>Eisai, Meiji receive approval for Parkinson&#039;s drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/14547/eisai-meiji-receive-approval-for-parkinsons-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14547/eisai-meiji-receive-approval-for-parkinsons-drug.html</link>
			<pubDate>Tue, 24 Sep 2019 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14547.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14547/eisai-meiji-receive-approval-for-parkinsons-drug.html</guid>
		</item>	
				<item>
			<title>FDA Approves Merck &amp; Eisai&#039;s combination drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/14551/fda-approves-merck-eisais-combination-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14551/fda-approves-merck-eisais-combination-drug-.html</link>
			<pubDate>Mon, 23 Sep 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freestocks_org_nss2erzqwgw_unsplash-14551.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14551/fda-approves-merck-eisais-combination-drug-.html</guid>
		</item>	
				<item>
			<title>Takeda receives Ministry approval for depression drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/14546/takeda-receives-ministry-approval-for-depression-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14546/takeda-receives-ministry-approval-for-depression-drug.html</link>
			<pubDate>Mon, 23 Sep 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14546.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14546/takeda-receives-ministry-approval-for-depression-drug.html</guid>
		</item>	
				<item>
			<title>Kao named to the Dow Jones Sustainability World Index </title>
			<atom:link href="https://biospectrumasia.com/news/50/14538/kao-named-to-the-dow-jones-sustainability-world-index-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14538/kao-named-to-the-dow-jones-sustainability-world-index-.html</link>
			<pubDate>Fri, 20 Sep 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_684385_1_-14538.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14538/kao-named-to-the-dow-jones-sustainability-world-index-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Solasia set to start trials for Darinaparsin </title>
			<atom:link href="https://biospectrumasia.com/news/50/14535/japans-solasia-set-to-start-trials-for-darinaparsin-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14535/japans-solasia-set-to-start-trials-for-darinaparsin-.html</link>
			<pubDate>Fri, 20 Sep 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_1282270-14535.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14535/japans-solasia-set-to-start-trials-for-darinaparsin-.html</guid>
		</item>	
				<item>
			<title>Evrenzo gets approval in Japan to treat anemia associated with CKD </title>
			<atom:link href="https://biospectrumasia.com/news/50/14540/evrenzo-gets-approval-in-japan-to-treat-anemia-associated-with-ckd-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14540/evrenzo-gets-approval-in-japan-to-treat-anemia-associated-with-ckd-.html</link>
			<pubDate>Fri, 20 Sep 2019 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kedney-14540.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14540/evrenzo-gets-approval-in-japan-to-treat-anemia-associated-with-ckd-.html</guid>
		</item>	
				<item>
			<title>FDA approves combo drug to treat endometrial carcinoma</title>
			<atom:link href="https://biospectrumasia.com/news/50/14525/fda-approves-combo-drug-to-treat-endometrial-carcinoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14525/fda-approves-combo-drug-to-treat-endometrial-carcinoma.html</link>
			<pubDate>Thu, 19 Sep 2019 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_1-14525.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14525/fda-approves-combo-drug-to-treat-endometrial-carcinoma.html</guid>
		</item>	
				<item>
			<title>Toyobo to market RNA analysis kit based on RIKEN technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/14520/toyobo-to-market-rna-analysis-kit-based-on-riken-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14520/toyobo-to-market-rna-analysis-kit-based-on-riken-technology.html</link>
			<pubDate>Thu, 19 Sep 2019 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14520.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14520/toyobo-to-market-rna-analysis-kit-based-on-riken-technology.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe, Daiichi Sankyo tie alliance for ALS treatment agent</title>
			<atom:link href="https://biospectrumasia.com/news/50/14506/mitsubishi-tanabe-daiichi-sankyo-tie-alliance-for-als-treatment-agent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14506/mitsubishi-tanabe-daiichi-sankyo-tie-alliance-for-als-treatment-agent.html</link>
			<pubDate>Wed, 18 Sep 2019 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14506.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14506/mitsubishi-tanabe-daiichi-sankyo-tie-alliance-for-als-treatment-agent.html</guid>
		</item>	
				<item>
			<title>Seattle Genetics, Astellas gets USFDA priority review for Enfortumab Vedotin </title>
			<atom:link href="https://biospectrumasia.com/news/50/14503/seattle-genetics-astellas-gets-usfda-priority-review-for-enfortumab-vedotin-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14503/seattle-genetics-astellas-gets-usfda-priority-review-for-enfortumab-vedotin-.html</link>
			<pubDate>Tue, 17 Sep 2019 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/urothelial_cancer-14503.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14503/seattle-genetics-astellas-gets-usfda-priority-review-for-enfortumab-vedotin-.html</guid>
		</item>	
				<item>
			<title>Astellas, iota Biosciences enter into collaborative R&amp;D agreement</title>
			<atom:link href="https://biospectrumasia.com/news/50/14486/astellas-iota-biosciences-enter-into-collaborative-rd-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14486/astellas-iota-biosciences-enter-into-collaborative-rd-agreement.html</link>
			<pubDate>Tue, 17 Sep 2019 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14486.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14486/astellas-iota-biosciences-enter-into-collaborative-rd-agreement.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sumitomo Dainippon Pharma forms Strategic Alliance with Swiss  Roivant Sciences</title>
			<atom:link href="https://biospectrumasia.com/news/50/14484/japans-sumitomo-dainippon-pharma-forms-strategic-alliance-with-swiss-roivant-sciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14484/japans-sumitomo-dainippon-pharma-forms-strategic-alliance-with-swiss-roivant-sciences.html</link>
			<pubDate>Mon, 16 Sep 2019 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_1162968-14484.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14484/japans-sumitomo-dainippon-pharma-forms-strategic-alliance-with-swiss-roivant-sciences.html</guid>
		</item>	
				<item>
			<title>Eisai, Biogen discontinue clinical studies on AD drug candidate</title>
			<atom:link href="https://biospectrumasia.com/news/50/14480/eisai-biogen-discontinue-clinical-studies-on-ad-drug-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14480/eisai-biogen-discontinue-clinical-studies-on-ad-drug-candidate.html</link>
			<pubDate>Mon, 16 Sep 2019 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14480.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14480/eisai-biogen-discontinue-clinical-studies-on-ad-drug-candidate.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo Announces Launch of Cancer Pain Treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14466/daiichi-sankyo-announces-launch-of-cancer-pain-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14466/daiichi-sankyo-announces-launch-of-cancer-pain-treatment-in-japan.html</link>
			<pubDate>Fri, 13 Sep 2019 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freestocks_org_nss2erzqwgw_unsplash-14466.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14466/daiichi-sankyo-announces-launch-of-cancer-pain-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Astellas to accelerate early drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/14463/astellas-to-accelerate-early-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14463/astellas-to-accelerate-early-drug-discovery.html</link>
			<pubDate>Fri, 13 Sep 2019 11:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14463.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14463/astellas-to-accelerate-early-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab</title>
			<atom:link href="https://biospectrumasia.com/news/50/14455/chugai-presents-results-from-second-positive-global-phase-iii-clinical-study-of-satralizumab.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14455/chugai-presents-results-from-second-positive-global-phase-iii-clinical-study-of-satralizumab.html</link>
			<pubDate>Thu, 12 Sep 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_1282270-14455.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14455/chugai-presents-results-from-second-positive-global-phase-iii-clinical-study-of-satralizumab.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo brings new formulation for cancer pain treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/14453/daiichi-sankyo-brings-new-formulation-for-cancer-pain-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14453/daiichi-sankyo-brings-new-formulation-for-cancer-pain-treatment.html</link>
			<pubDate>Thu, 12 Sep 2019 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14453.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14453/daiichi-sankyo-brings-new-formulation-for-cancer-pain-treatment.html</guid>
		</item>	
				<item>
			<title>Japan allows human-embryo experiments</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/14437/japan-allows-human-embryo-experiments.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/14437/japan-allows-human-embryo-experiments.html</link>
			<pubDate>Tue, 10 Sep 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/louis_reed_pwckf7l4_no_unsplash-14437.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/14437/japan-allows-human-embryo-experiments.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo Advances [Fam-] Trastuzumab in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/14435/daiichi-sankyo-advances-fam-trastuzumab-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14435/daiichi-sankyo-advances-fam-trastuzumab-in-japan-.html</link>
			<pubDate>Tue, 10 Sep 2019 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kelly_sikkema_fvegjucmmzi_unsplash-14435.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14435/daiichi-sankyo-advances-fam-trastuzumab-in-japan-.html</guid>
		</item>	
				<item>
			<title>Eisai launches antimicrobial wet wipes</title>
			<atom:link href="https://biospectrumasia.com/news/50/14420/eisai-launches-antimicrobial-wet-wipes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14420/eisai-launches-antimicrobial-wet-wipes.html</link>
			<pubDate>Mon, 09 Sep 2019 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14420.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14420/eisai-launches-antimicrobial-wet-wipes.html</guid>
		</item>	
				<item>
			<title>Takeda issues US recall of NATPARA, a parathyroid hormone</title>
			<atom:link href="https://biospectrumasia.com/news/50/14421/takeda-issues-us-recall-of-natpara-a-parathyroid-hormone.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14421/takeda-issues-us-recall-of-natpara-a-parathyroid-hormone.html</link>
			<pubDate>Mon, 09 Sep 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/peoplespharmacy-14421.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14421/takeda-issues-us-recall-of-natpara-a-parathyroid-hormone.html</guid>
		</item>	
				<item>
			<title>BNV, Denso establish new medical IoT firm</title>
			<atom:link href="https://biospectrumasia.com/news/50/14416/bnv-denso-establish-new-medical-iot-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14416/bnv-denso-establish-new-medical-iot-firm.html</link>
			<pubDate>Mon, 09 Sep 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14416.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14416/bnv-denso-establish-new-medical-iot-firm.html</guid>
		</item>	
				<item>
			<title>Sumitomo Dainippon inks strategic collaboration with Roivant Sciences</title>
			<atom:link href="https://biospectrumasia.com/news/50/14413/sumitomo-dainippon-inks-strategic-collaboration-with-roivant-sciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14413/sumitomo-dainippon-inks-strategic-collaboration-with-roivant-sciences.html</link>
			<pubDate>Fri, 06 Sep 2019 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14413.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14413/sumitomo-dainippon-inks-strategic-collaboration-with-roivant-sciences.html</guid>
		</item>	
				<item>
			<title>Sanyo Chemical receives certification for innovative surgical sealant</title>
			<atom:link href="https://biospectrumasia.com/news/50/14412/sanyo-chemical-receives-certification-for-innovative-surgical-sealant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14412/sanyo-chemical-receives-certification-for-innovative-surgical-sealant.html</link>
			<pubDate>Fri, 06 Sep 2019 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14412.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14412/sanyo-chemical-receives-certification-for-innovative-surgical-sealant.html</guid>
		</item>	
				<item>
			<title>Eisai to develop cognitive function test with Cogstate</title>
			<atom:link href="https://biospectrumasia.com/news/50/14407/eisai-to-develop-cognitive-function-test-with-cogstate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14407/eisai-to-develop-cognitive-function-test-with-cogstate.html</link>
			<pubDate>Thu, 05 Sep 2019 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14407.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14407/eisai-to-develop-cognitive-function-test-with-cogstate.html</guid>
		</item>	
				<item>
			<title>Japan looks out for rapidly growing ASEAN ageing population</title>
			<atom:link href="https://biospectrumasia.com/news/50/14389/japan-looks-out-for-rapidly-growing-asean-ageing-population.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14389/japan-looks-out-for-rapidly-growing-asean-ageing-population.html</link>
			<pubDate>Wed, 04 Sep 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14389.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14389/japan-looks-out-for-rapidly-growing-asean-ageing-population.html</guid>
		</item>	
				<item>
			<title>Kyowa Kirin gets FDA nod for Parkinson&#039;s drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/14385/kyowa-kirin-gets-fda-nod-for-parkinsons-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14385/kyowa-kirin-gets-fda-nod-for-parkinsons-drug.html</link>
			<pubDate>Tue, 03 Sep 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14385.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14385/kyowa-kirin-gets-fda-nod-for-parkinsons-drug.html</guid>
		</item>	
				<item>
			<title>Invicro Appoints Hidenori Seshimo as Vice President of Biomarker Services, Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14364/invicro-appoints-hidenori-seshimo-as-vice-president-of-biomarker-services-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14364/invicro-appoints-hidenori-seshimo-as-vice-president-of-biomarker-services-japan.html</link>
			<pubDate>Fri, 30 Aug 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/seshimo_hidenori-14364.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14364/invicro-appoints-hidenori-seshimo-as-vice-president-of-biomarker-services-japan.html</guid>
		</item>	
				<item>
			<title>Eisai teams up with Merck to tackle NTDs in Kenya</title>
			<atom:link href="https://biospectrumasia.com/news/50/14345/eisai-teams-up-with-merck-to-tackle-ntds-in-kenya.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14345/eisai-teams-up-with-merck-to-tackle-ntds-in-kenya.html</link>
			<pubDate>Wed, 28 Aug 2019 10:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14345.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14345/eisai-teams-up-with-merck-to-tackle-ntds-in-kenya.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s BioWa extends partnership with Cantargia </title>
			<atom:link href="https://biospectrumasia.com/news/50/14327/japans-biowa-extends-partnership-with-cantargia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14327/japans-biowa-extends-partnership-with-cantargia-.html</link>
			<pubDate>Tue, 27 Aug 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14327.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14327/japans-biowa-extends-partnership-with-cantargia-.html</guid>
		</item>	
				<item>
			<title>Atonarp receives US$ 33 M from 5 investors to reinforce molecular diagnostic </title>
			<atom:link href="https://biospectrumasia.com/news/50/14329/atonarp-receives-us-33-m-from-5-investors-to-reinforce-molecular-diagnostic-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14329/atonarp-receives-us-33-m-from-5-investors-to-reinforce-molecular-diagnostic-.html</link>
			<pubDate>Mon, 26 Aug 2019 14:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14329.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14329/atonarp-receives-us-33-m-from-5-investors-to-reinforce-molecular-diagnostic-.html</guid>
		</item>	
				<item>
			<title>Atonarp Inc. completes $33M series C funding round</title>
			<atom:link href="https://biospectrumasia.com/news/50/14324/atonarp-inc-completes-33m-series-c-funding-round.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14324/atonarp-inc-completes-33m-series-c-funding-round.html</link>
			<pubDate>Mon, 26 Aug 2019 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14324.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14324/atonarp-inc-completes-33m-series-c-funding-round.html</guid>
		</item>	
				<item>
			<title>GSK submits first regulatory application for daprodustat in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/14302/gsk-submits-first-regulatory-application-for-daprodustat-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14302/gsk-submits-first-regulatory-application-for-daprodustat-in-japan-.html</link>
			<pubDate>Fri, 23 Aug 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/regulatory_1-14302.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14302/gsk-submits-first-regulatory-application-for-daprodustat-in-japan-.html</guid>
		</item>	
				<item>
			<title>Luye Pharma&#039;s anti-depression drug to start clinical trials in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14305/luye-pharmas-anti-depression-drug-to-start-clinical-trials-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14305/luye-pharmas-anti-depression-drug-to-start-clinical-trials-in-japan.html</link>
			<pubDate>Thu, 22 Aug 2019 16:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rdmag-14305.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14305/luye-pharmas-anti-depression-drug-to-start-clinical-trials-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda files NDA for subcutaneous formulation of Vedolizumab</title>
			<atom:link href="https://biospectrumasia.com/news/50/14293/takeda-files-nda-for-subcutaneous-formulation-of-vedolizumab.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14293/takeda-files-nda-for-subcutaneous-formulation-of-vedolizumab.html</link>
			<pubDate>Wed, 21 Aug 2019 17:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ulserative_colitis-14293.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14293/takeda-files-nda-for-subcutaneous-formulation-of-vedolizumab.html</guid>
		</item>	
				<item>
			<title>Japanese scientists develop 3D printed prosthetic hand</title>
			<atom:link href="https://biospectrumasia.com/news/50/14239/japanese-scientists-develop-3d-printed-prosthetic-hand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14239/japanese-scientists-develop-3d-printed-prosthetic-hand.html</link>
			<pubDate>Fri, 16 Aug 2019 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14239.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14239/japanese-scientists-develop-3d-printed-prosthetic-hand.html</guid>
		</item>	
				<item>
			<title>Shimadzu receives FDA clearance for FLUOROspeed X1</title>
			<atom:link href="https://biospectrumasia.com/news/50/14235/shimadzu-receives-fda-clearance-for-fluorospeed-x1.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14235/shimadzu-receives-fda-clearance-for-fluorospeed-x1.html</link>
			<pubDate>Wed, 14 Aug 2019 18:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_2_-14235.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14235/shimadzu-receives-fda-clearance-for-fluorospeed-x1.html</guid>
		</item>	
				<item>
			<title>OssDsign AB files regulatory approval for OssDsign Cranial in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/14201/ossdsign-ab-files-regulatory-approval-for-ossdsign-cranial-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14201/ossdsign-ab-files-regulatory-approval-for-ossdsign-cranial-in-japan.html</link>
			<pubDate>Mon, 12 Aug 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14201.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14201/ossdsign-ab-files-regulatory-approval-for-ossdsign-cranial-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai refreshes medical skin care product Sahne</title>
			<atom:link href="https://biospectrumasia.com/news/50/14200/eisai-refreshes-medical-skin-care-product-sahne.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14200/eisai-refreshes-medical-skin-care-product-sahne.html</link>
			<pubDate>Fri, 09 Aug 2019 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14200.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14200/eisai-refreshes-medical-skin-care-product-sahne.html</guid>
		</item>	
				<item>
			<title>Astellas Initiates Phase 3 Clinical Trials for Fezolinetant</title>
			<atom:link href="https://biospectrumasia.com/news/50/14176/astellas-initiates-phase-3-clinical-trials-for-fezolinetant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14176/astellas-initiates-phase-3-clinical-trials-for-fezolinetant.html</link>
			<pubDate>Thu, 08 Aug 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14176.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14176/astellas-initiates-phase-3-clinical-trials-for-fezolinetant.html</guid>
		</item>	
				<item>
			<title>Pola Orbis to create unique value in dermatology</title>
			<atom:link href="https://biospectrumasia.com/news/50/14167/pola-orbis-to-create-unique-value-in-dermatology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14167/pola-orbis-to-create-unique-value-in-dermatology.html</link>
			<pubDate>Wed, 07 Aug 2019 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14167.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14167/pola-orbis-to-create-unique-value-in-dermatology.html</guid>
		</item>	
				<item>
			<title>Nissui Pharma launches bacterial colony-counting service globally</title>
			<atom:link href="https://biospectrumasia.com/news/50/14166/nissui-pharma-launches-bacterial-colony-counting-service-globally.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14166/nissui-pharma-launches-bacterial-colony-counting-service-globally.html</link>
			<pubDate>Tue, 06 Aug 2019 18:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bacteria-14166.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14166/nissui-pharma-launches-bacterial-colony-counting-service-globally.html</guid>
		</item>	
				<item>
			<title>FDA Approves Daiichi Sankyo&#039;s TURALIOâ„¢ for Rare and Debilitating Tumor</title>
			<atom:link href="https://biospectrumasia.com/news/50/14159/fda-approves-daiichi-sankyos-turalio-for-rare-and-debilitating-tumor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14159/fda-approves-daiichi-sankyos-turalio-for-rare-and-debilitating-tumor.html</link>
			<pubDate>Tue, 06 Aug 2019 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-14159.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14159/fda-approves-daiichi-sankyos-turalio-for-rare-and-debilitating-tumor.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares, Takeda enter into multi-target partnership</title>
			<atom:link href="https://biospectrumasia.com/news/50/14151/sosei-heptares-takeda-enter-into-multi-target-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14151/sosei-heptares-takeda-enter-into-multi-target-partnership.html</link>
			<pubDate>Tue, 06 Aug 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14151.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14151/sosei-heptares-takeda-enter-into-multi-target-partnership.html</guid>
		</item>	
				<item>
			<title>FDA approves Daiichi Sankyo&#039;s TURALIO</title>
			<atom:link href="https://biospectrumasia.com/news/50/14155/fda-approves-daiichi-sankyos-turalio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14155/fda-approves-daiichi-sankyos-turalio.html</link>
			<pubDate>Mon, 05 Aug 2019 15:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/capsules-14155.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14155/fda-approves-daiichi-sankyos-turalio.html</guid>
		</item>	
				<item>
			<title>BactLAB bacterial colony-counting service now available globally</title>
			<atom:link href="https://biospectrumasia.com/news/50/14146/bactlab-bacterial-colony-counting-service-now-available-globally.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14146/bactlab-bacterial-colony-counting-service-now-available-globally.html</link>
			<pubDate>Mon, 05 Aug 2019 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/_bactlab_-14146.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14146/bactlab-bacterial-colony-counting-service-now-available-globally.html</guid>
		</item>	
				<item>
			<title>Rakuten Medical to further develop its photo-immunotherapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/14150/rakuten-medical-to-further-develop-its-photo-immunotherapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14150/rakuten-medical-to-further-develop-its-photo-immunotherapy.html</link>
			<pubDate>Mon, 05 Aug 2019 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/600600p677ednmaininvestment_min-14150.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14150/rakuten-medical-to-further-develop-its-photo-immunotherapy.html</guid>
		</item>	
				<item>
			<title>Morimoto Pharma unveils new Exposure Prevention Prefilled Syringe Kits</title>
			<atom:link href="https://biospectrumasia.com/news/50/14135/morimoto-pharma-unveils-new-exposure-prevention-prefilled-syringe-kits.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14135/morimoto-pharma-unveils-new-exposure-prevention-prefilled-syringe-kits.html</link>
			<pubDate>Mon, 05 Aug 2019 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gettyimages_117452568_58a9cac63df78c345b5f9bcb-14135.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14135/morimoto-pharma-unveils-new-exposure-prevention-prefilled-syringe-kits.html</guid>
		</item>	
				<item>
			<title>Sysmex gets Japanese manufacturing and marketing approval</title>
			<atom:link href="https://biospectrumasia.com/news/50/14140/sysmex-gets-japanese-manufacturing-and-marketing-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14140/sysmex-gets-japanese-manufacturing-and-marketing-approval.html</link>
			<pubDate>Fri, 02 Aug 2019 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diagnostic-14140.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14140/sysmex-gets-japanese-manufacturing-and-marketing-approval.html</guid>
		</item>	
				<item>
			<title>Fujifilm completes acquisition of Biogen&#039;s Manufacturing Site in Denmark</title>
			<atom:link href="https://biospectrumasia.com/news/50/14133/fujifilm-completes-acquisition-of-biogens-manufacturing-site-in-denmark.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14133/fujifilm-completes-acquisition-of-biogens-manufacturing-site-in-denmark.html</link>
			<pubDate>Fri, 02 Aug 2019 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_3_-14133.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14133/fujifilm-completes-acquisition-of-biogens-manufacturing-site-in-denmark.html</guid>
		</item>	
				<item>
			<title>Marken acquires PCX International to strengthen supply chain footprint</title>
			<atom:link href="https://biospectrumasia.com/news/50/14132/marken-acquires-pcx-international-to-strengthen-supply-chain-footprint.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14132/marken-acquires-pcx-international-to-strengthen-supply-chain-footprint.html</link>
			<pubDate>Fri, 02 Aug 2019 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14132.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14132/marken-acquires-pcx-international-to-strengthen-supply-chain-footprint.html</guid>
		</item>	
				<item>
			<title>Kyowa Kirin buys back Tivozanib rights from AVEO oncology</title>
			<atom:link href="https://biospectrumasia.com/news/50/14128/kyowa-kirin-buys-back-tivozanib-rights-from-aveo-oncology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14128/kyowa-kirin-buys-back-tivozanib-rights-from-aveo-oncology.html</link>
			<pubDate>Fri, 02 Aug 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14128.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14128/kyowa-kirin-buys-back-tivozanib-rights-from-aveo-oncology.html</guid>
		</item>	
				<item>
			<title>NEC acquires Norwegian Bioinformatics Company, OncoImmunity AS</title>
			<atom:link href="https://biospectrumasia.com/news/50/14129/nec-acquires-norwegian-bioinformatics-company-oncoimmunity-as.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14129/nec-acquires-norwegian-bioinformatics-company-oncoimmunity-as.html</link>
			<pubDate>Thu, 01 Aug 2019 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ien_eu-14129.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14129/nec-acquires-norwegian-bioinformatics-company-oncoimmunity-as.html</guid>
		</item>	
				<item>
			<title>Sun Pharma announces regulatory filing of Tildrakizumab in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/14125/sun-pharma-announces-regulatory-filing-of-tildrakizumab-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14125/sun-pharma-announces-regulatory-filing-of-tildrakizumab-in-japan-.html</link>
			<pubDate>Thu, 01 Aug 2019 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-14125.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14125/sun-pharma-announces-regulatory-filing-of-tildrakizumab-in-japan-.html</guid>
		</item>	
				<item>
			<title>Takeda, Pfizer terminate co-promotion of RA Drug Enbrel</title>
			<atom:link href="https://biospectrumasia.com/news/50/14104/takeda-pfizer-terminate-co-promotion-of-ra-drug-enbrel.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14104/takeda-pfizer-terminate-co-promotion-of-ra-drug-enbrel.html</link>
			<pubDate>Wed, 31 Jul 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14104.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14104/takeda-pfizer-terminate-co-promotion-of-ra-drug-enbrel.html</guid>
		</item>	
				<item>
			<title>NEC acquires OncoImmunity AS to empower personalized cancer immunotherapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/14095/nec-acquires-oncoimmunity-as-to-empower-personalized-cancer-immunotherapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14095/nec-acquires-oncoimmunity-as-to-empower-personalized-cancer-immunotherapy.html</link>
			<pubDate>Tue, 30 Jul 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14095.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14095/nec-acquires-oncoimmunity-as-to-empower-personalized-cancer-immunotherapy.html</guid>
		</item>	
				<item>
			<title>Scientists in Japan develop prosthetics for retinal stimulation</title>
			<atom:link href="https://biospectrumasia.com/news/50/14086/scientists-in-japan-develop-prosthetics-for-retinal-stimulation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14086/scientists-in-japan-develop-prosthetics-for-retinal-stimulation.html</link>
			<pubDate>Mon, 29 Jul 2019 10:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14086.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14086/scientists-in-japan-develop-prosthetics-for-retinal-stimulation.html</guid>
		</item>	
				<item>
			<title>Astellas submits biologics license application for Urothelial Cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/14079/astellas-submits-biologics-license-application-for-urothelial-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14079/astellas-submits-biologics-license-application-for-urothelial-cancer-drug.html</link>
			<pubDate>Fri, 26 Jul 2019 11:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14079.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14079/astellas-submits-biologics-license-application-for-urothelial-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Akebia submits new application for anemia drug in Japan   </title>
			<atom:link href="https://biospectrumasia.com/news/50/14050/akebia-submits-new-application-for-anemia-drug-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14050/akebia-submits-new-application-for-anemia-drug-in-japan-.html</link>
			<pubDate>Wed, 24 Jul 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14050.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14050/akebia-submits-new-application-for-anemia-drug-in-japan-.html</guid>
		</item>	
				<item>
			<title>Eisai, Merck receive breakthrough therapy designation from FDA</title>
			<atom:link href="https://biospectrumasia.com/news/50/14046/eisai-merck-receive-breakthrough-therapy-designation-from-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14046/eisai-merck-receive-breakthrough-therapy-designation-from-fda.html</link>
			<pubDate>Tue, 23 Jul 2019 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14046.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14046/eisai-merck-receive-breakthrough-therapy-designation-from-fda.html</guid>
		</item>	
				<item>
			<title>Bayer, BMS, Ono Pharma enter into clinical collaboration for colorectal cancer </title>
			<atom:link href="https://biospectrumasia.com/news/50/14031/bayer-bms-ono-pharma-enter-into-clinical-collaboration-for-colorectal-cancer-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14031/bayer-bms-ono-pharma-enter-into-clinical-collaboration-for-colorectal-cancer-.html</link>
			<pubDate>Mon, 22 Jul 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_treatment-14031.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14031/bayer-bms-ono-pharma-enter-into-clinical-collaboration-for-colorectal-cancer-.html</guid>
		</item>	
				<item>
			<title>Takeda, Kyoto University research collaboration develops further</title>
			<atom:link href="https://biospectrumasia.com/news/50/14011/takeda-kyoto-university-research-collaboration-develops-further.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14011/takeda-kyoto-university-research-collaboration-develops-further.html</link>
			<pubDate>Thu, 18 Jul 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14011.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14011/takeda-kyoto-university-research-collaboration-develops-further.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares teams up with Genentech for multi-target R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/50/14007/sosei-heptares-teams-up-with-genentech-for-multi-target-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/14007/sosei-heptares-teams-up-with-genentech-for-multi-target-rd.html</link>
			<pubDate>Wed, 17 Jul 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership-14007.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/14007/sosei-heptares-teams-up-with-genentech-for-multi-target-rd.html</guid>
		</item>	
				<item>
			<title>Kaneka launches takeover bid for 100% of AB-Biotics</title>
			<atom:link href="https://biospectrumasia.com/news/50/13999/kaneka-launches-takeover-bid-for-100-of-ab-biotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13999/kaneka-launches-takeover-bid-for-100-of-ab-biotics.html</link>
			<pubDate>Tue, 16 Jul 2019 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition_2-13999.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13999/kaneka-launches-takeover-bid-for-100-of-ab-biotics.html</guid>
		</item>	
				<item>
			<title>Eisai Centre for G2D2 commences operation towards dementia treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/13995/eisai-centre-for-g2d2-commences-operation-towards-dementia-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13995/eisai-centre-for-g2d2-commences-operation-towards-dementia-treatment.html</link>
			<pubDate>Tue, 16 Jul 2019 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13995.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13995/eisai-centre-for-g2d2-commences-operation-towards-dementia-treatment.html</guid>
		</item>	
				<item>
			<title>Japanese researchers use AI to design novel endoscopy</title>
			<atom:link href="https://biospectrumasia.com/news/50/13986/japanese-researchers-use-ai-to-design-novel-endoscopy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13986/japanese-researchers-use-ai-to-design-novel-endoscopy.html</link>
			<pubDate>Mon, 15 Jul 2019 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13986.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13986/japanese-researchers-use-ai-to-design-novel-endoscopy.html</guid>
		</item>	
				<item>
			<title>PHC launches medical integrated chart system for doctors</title>
			<atom:link href="https://biospectrumasia.com/news/50/13976/phc-launches-medical-integrated-chart-system-for-doctors.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13976/phc-launches-medical-integrated-chart-system-for-doctors.html</link>
			<pubDate>Fri, 12 Jul 2019 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13976.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13976/phc-launches-medical-integrated-chart-system-for-doctors.html</guid>
		</item>	
				<item>
			<title>CMIC joins Align Clinical CRO </title>
			<atom:link href="https://biospectrumasia.com/news/50/13954/cmic-joins-align-clinical-cro-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13954/cmic-joins-align-clinical-cro-.html</link>
			<pubDate>Wed, 10 Jul 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13954.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13954/cmic-joins-align-clinical-cro-.html</guid>
		</item>	
				<item>
			<title>Aerie Pharmaceuticals completes enrollment of the Netarsudil Ophthalmic Solution Phase 2 clinical trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/13949/aerie-pharmaceuticals-completes-enrollment-of-the-netarsudil-ophthalmic-solution-phase-2-clinical-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13949/aerie-pharmaceuticals-completes-enrollment-of-the-netarsudil-ophthalmic-solution-phase-2-clinical-trial.html</link>
			<pubDate>Tue, 09 Jul 2019 16:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13949/aerie-pharmaceuticals-completes-enrollment-of-the-netarsudil-ophthalmic-solution-phase-2-clinical-trial.html</guid>
		</item>	
				<item>
			<title>Eisai collaborates with University of Dundee for cancer drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/13936/eisai-collaborates-with-university-of-dundee-for-cancer-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13936/eisai-collaborates-with-university-of-dundee-for-cancer-drug-discovery.html</link>
			<pubDate>Tue, 09 Jul 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13936.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13936/eisai-collaborates-with-university-of-dundee-for-cancer-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Takeda announces results from Phase IIIb/IV clinical trial for ADYNOVATE</title>
			<atom:link href="https://biospectrumasia.com/news/50/13924/takeda-announces-results-from-phase-iiib-iv-clinical-trial-for-adynovate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13924/takeda-announces-results-from-phase-iiib-iv-clinical-trial-for-adynovate.html</link>
			<pubDate>Mon, 08 Jul 2019 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/results-13924.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13924/takeda-announces-results-from-phase-iiib-iv-clinical-trial-for-adynovate.html</guid>
		</item>	
				<item>
			<title>21st Interphex Week  Japan concludes in Tokyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/13914/21st-interphex-week-japan-concludes-in-tokyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13914/21st-interphex-week-japan-concludes-in-tokyo.html</link>
			<pubDate>Fri, 05 Jul 2019 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aomi_hall_3-13914.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13914/21st-interphex-week-japan-concludes-in-tokyo.html</guid>
		</item>	
				<item>
			<title>21st Interphex Week Japan: Making the event as one of the largest pharma industry events in Asia </title>
			<atom:link href="https://biospectrumasia.com/opinion/50/13915/21st-interphex-week-japan-making-the-event-as-one-of-the-largest-pharma-industry-events-in-asia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/13915/21st-interphex-week-japan-making-the-event-as-one-of-the-largest-pharma-industry-events-in-asia-.html</link>
			<pubDate>Fri, 05 Jul 2019 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2019_07_04_14_45_11_427-13915.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/13915/21st-interphex-week-japan-making-the-event-as-one-of-the-largest-pharma-industry-events-in-asia-.html</guid>
		</item>	
				<item>
			<title>Miraca and 7SBio announce strategic investment</title>
			<atom:link href="https://biospectrumasia.com/news/50/13884/miraca-and-7sbio-announce-strategic-investment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13884/miraca-and-7sbio-announce-strategic-investment.html</link>
			<pubDate>Thu, 04 Jul 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/legal_agreement-13884.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13884/miraca-and-7sbio-announce-strategic-investment.html</guid>
		</item>	
				<item>
			<title>INTERPHEX Japan puts up an impressive show</title>
			<atom:link href="https://biospectrumasia.com/news/50/13888/interphex-japan-puts-up-an-impressive-show.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13888/interphex-japan-puts-up-an-impressive-show.html</link>
			<pubDate>Thu, 04 Jul 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ipw_1-13888.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13888/interphex-japan-puts-up-an-impressive-show.html</guid>
		</item>	
				<item>
			<title>More than 600 Pharma / Cosmetics / Chemical &amp; Biotech executives attended Reed VIP Reception Party </title>
			<atom:link href="https://biospectrumasia.com/news/50/13901/more-than-600-pharma-cosmetics-chemical-biotech-executives-attended-reed-vip-reception-party-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13901/more-than-600-pharma-cosmetics-chemical-biotech-executives-attended-reed-vip-reception-party-.html</link>
			<pubDate>Thu, 04 Jul 2019 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/_mg_9925-13901.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13901/more-than-600-pharma-cosmetics-chemical-biotech-executives-attended-reed-vip-reception-party-.html</guid>
		</item>	
				<item>
			<title>Century Therapeutics launches with $250M financing for iPSC allogeneic cell therapy platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/13881/century-therapeutics-launches-with-250m-financing-for-ipsc-allogeneic-cell-therapy-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13881/century-therapeutics-launches-with-250m-financing-for-ipsc-allogeneic-cell-therapy-platform.html</link>
			<pubDate>Tue, 02 Jul 2019 14:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/page_image-13881.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13881/century-therapeutics-launches-with-250m-financing-for-ipsc-allogeneic-cell-therapy-platform.html</guid>
		</item>	
				<item>
			<title>Takeda sells Xiidra to Novartis</title>
			<atom:link href="https://biospectrumasia.com/news/50/13876/takeda-sells-xiidra-to-novartis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13876/takeda-sells-xiidra-to-novartis.html</link>
			<pubDate>Tue, 02 Jul 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eye_1132531_960_720-13876.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13876/takeda-sells-xiidra-to-novartis.html</guid>
		</item>	
				<item>
			<title>PHC Holdings completes acquisition deal with Thermo Fisher</title>
			<atom:link href="https://biospectrumasia.com/news/50/13863/phc-holdings-completes-acquisition-deal-with-thermo-fisher.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13863/phc-holdings-completes-acquisition-deal-with-thermo-fisher.html</link>
			<pubDate>Tue, 02 Jul 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition-13863.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13863/phc-holdings-completes-acquisition-deal-with-thermo-fisher.html</guid>
		</item>	
				<item>
			<title>PeptiDream announces new PDC collaboration with Novartis</title>
			<atom:link href="https://biospectrumasia.com/news/50/13848/peptidream-announces-new-pdc-collaboration-with-novartis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13848/peptidream-announces-new-pdc-collaboration-with-novartis.html</link>
			<pubDate>Fri, 28 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pciaw-13848.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13848/peptidream-announces-new-pdc-collaboration-with-novartis.html</guid>
		</item>	
				<item>
			<title>Takeda selects new partnerships for annual CSR programme</title>
			<atom:link href="https://biospectrumasia.com/news/50/13826/takeda-selects-new-partnerships-for-annual-csr-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13826/takeda-selects-new-partnerships-for-annual-csr-programme.html</link>
			<pubDate>Wed, 26 Jun 2019 16:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13826.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13826/takeda-selects-new-partnerships-for-annual-csr-programme.html</guid>
		</item>	
				<item>
			<title>Sommetrics completes study of new sleep apnea treatment in ethnic Japanese subjects</title>
			<atom:link href="https://biospectrumasia.com/news/50/13824/sommetrics-completes-study-of-new-sleep-apnea-treatment-in-ethnic-japanese-subjects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13824/sommetrics-completes-study-of-new-sleep-apnea-treatment-in-ethnic-japanese-subjects.html</link>
			<pubDate>Wed, 26 Jun 2019 15:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sleep-13824.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13824/sommetrics-completes-study-of-new-sleep-apnea-treatment-in-ethnic-japanese-subjects.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo, GE Healthcare sign marketing deal for four imaging agents</title>
			<atom:link href="https://biospectrumasia.com/news/50/13818/daiichi-sankyo-ge-healthcare-sign-marketing-deal-for-four-imaging-agents.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13818/daiichi-sankyo-ge-healthcare-sign-marketing-deal-for-four-imaging-agents.html</link>
			<pubDate>Wed, 26 Jun 2019 10:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13818.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13818/daiichi-sankyo-ge-healthcare-sign-marketing-deal-for-four-imaging-agents.html</guid>
		</item>	
				<item>
			<title>Gilead, Carna Biosciences announce R&amp;D collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/50/13812/gilead-carna-biosciences-announce-rd-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13812/gilead-carna-biosciences-announce-rd-collaboration.html</link>
			<pubDate>Tue, 25 Jun 2019 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13812.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13812/gilead-carna-biosciences-announce-rd-collaboration.html</guid>
		</item>	
				<item>
			<title>Shionogi concludes licensing agreements with Eddingpharm for Lusutrombopag</title>
			<atom:link href="https://biospectrumasia.com/news/50/13811/shionogi-concludes-licensing-agreements-with-eddingpharm-for-lusutrombopag.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13811/shionogi-concludes-licensing-agreements-with-eddingpharm-for-lusutrombopag.html</link>
			<pubDate>Tue, 25 Jun 2019 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement_4-13811.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13811/shionogi-concludes-licensing-agreements-with-eddingpharm-for-lusutrombopag.html</guid>
		</item>	
				<item>
			<title>Shionogi collaborates with Eddingpharm for TPO receptor agonist</title>
			<atom:link href="https://biospectrumasia.com/news/50/13791/shionogi-collaborates-with-eddingpharm-for-tpo-receptor-agonist.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13791/shionogi-collaborates-with-eddingpharm-for-tpo-receptor-agonist.html</link>
			<pubDate>Mon, 24 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13791.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13791/shionogi-collaborates-with-eddingpharm-for-tpo-receptor-agonist.html</guid>
		</item>	
				<item>
			<title>Ricoh announces strategic business partnership with Elixirgen Scientific</title>
			<atom:link href="https://biospectrumasia.com/news/50/13789/ricoh-announces-strategic-business-partnership-with-elixirgen-scientific.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13789/ricoh-announces-strategic-business-partnership-with-elixirgen-scientific.html</link>
			<pubDate>Fri, 21 Jun 2019 16:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collboration_3-13789.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13789/ricoh-announces-strategic-business-partnership-with-elixirgen-scientific.html</guid>
		</item>	
				<item>
			<title>Toray launches TORAYMYXIN in EU market</title>
			<atom:link href="https://biospectrumasia.com/news/50/13788/toray-launches-toraymyxin-in-eu-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13788/toray-launches-toraymyxin-in-eu-market.html</link>
			<pubDate>Fri, 21 Jun 2019 16:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/0-13788.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13788/toray-launches-toraymyxin-in-eu-market.html</guid>
		</item>	
				<item>
			<title>Myriad Genetics grants second manufacturing and marketing approval for BRACAnalysis Diagnostic System </title>
			<atom:link href="https://biospectrumasia.com/news/50/13785/myriad-genetics-grants-second-manufacturing-and-marketing-approval-for-bracanalysis-diagnostic-system-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13785/myriad-genetics-grants-second-manufacturing-and-marketing-approval-for-bracanalysis-diagnostic-system-.html</link>
			<pubDate>Fri, 21 Jun 2019 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approval-13785.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13785/myriad-genetics-grants-second-manufacturing-and-marketing-approval-for-bracanalysis-diagnostic-system-.html</guid>
		</item>	
				<item>
			<title>Eisai discovers new anti-cancer compound</title>
			<atom:link href="https://biospectrumasia.com/news/50/13774/eisai-discovers-new-anti-cancer-compound.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13774/eisai-discovers-new-anti-cancer-compound.html</link>
			<pubDate>Fri, 21 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13774.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13774/eisai-discovers-new-anti-cancer-compound.html</guid>
		</item>	
				<item>
			<title>Ricoh announces strategic business partnership with Elixirgen Scientific</title>
			<atom:link href="https://biospectrumasia.com/news/50/13769/ricoh-announces-strategic-business-partnership-with-elixirgen-scientific.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13769/ricoh-announces-strategic-business-partnership-with-elixirgen-scientific.html</link>
			<pubDate>Thu, 20 Jun 2019 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/home_equity_loan-13769.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13769/ricoh-announces-strategic-business-partnership-with-elixirgen-scientific.html</guid>
		</item>	
				<item>
			<title>Japan the first to approve Roche&#039;s personalised medicine Rozlytrek</title>
			<atom:link href="https://biospectrumasia.com/news/50/13749/japan-the-first-to-approve-roches-personalised-medicine-rozlytrek.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13749/japan-the-first-to-approve-roches-personalised-medicine-rozlytrek.html</link>
			<pubDate>Wed, 19 Jun 2019 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13749.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13749/japan-the-first-to-approve-roches-personalised-medicine-rozlytrek.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo&#039;s VANFLYTAÂ® receives approval for the treatment of Relapsed/Refractory FLT3-ITD AML</title>
			<atom:link href="https://biospectrumasia.com/news/50/13745/daiichi-sankyos-vanflyta-receives-approval-for-the-treatment-of-relapsed-refractory-flt3-itd-aml.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13745/daiichi-sankyos-vanflyta-receives-approval-for-the-treatment-of-relapsed-refractory-flt3-itd-aml.html</link>
			<pubDate>Tue, 18 Jun 2019 16:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-13745.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13745/daiichi-sankyos-vanflyta-receives-approval-for-the-treatment-of-relapsed-refractory-flt3-itd-aml.html</guid>
		</item>	
				<item>
			<title>Catalys Pacific to advance early-stage life sciences innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/13726/catalys-pacific-to-advance-early-stage-life-sciences-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13726/catalys-pacific-to-advance-early-stage-life-sciences-innovation.html</link>
			<pubDate>Tue, 18 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13726.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13726/catalys-pacific-to-advance-early-stage-life-sciences-innovation.html</guid>
		</item>	
				<item>
			<title>Teijin Pharma starts exclusive sale of TMS device in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/13724/teijin-pharma-starts-exclusive-sale-of-tms-device-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13724/teijin-pharma-starts-exclusive-sale-of-tms-device-in-japan.html</link>
			<pubDate>Mon, 17 Jun 2019 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13724.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13724/teijin-pharma-starts-exclusive-sale-of-tms-device-in-japan.html</guid>
		</item>	
				<item>
			<title>Terumo secures exclusive global rights to Orchestra BioMed&#039;s SEB</title>
			<atom:link href="https://biospectrumasia.com/news/50/13703/terumo-secures-exclusive-global-rights-to-orchestra-biomeds-seb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13703/terumo-secures-exclusive-global-rights-to-orchestra-biomeds-seb.html</link>
			<pubDate>Fri, 14 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/terumo-13703.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13703/terumo-secures-exclusive-global-rights-to-orchestra-biomeds-seb.html</guid>
		</item>	
				<item>
			<title>BiomX licenses novel targets for phage therapy program</title>
			<atom:link href="https://biospectrumasia.com/news/50/13688/biomx-licenses-novel-targets-for-phage-therapy-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13688/biomx-licenses-novel-targets-for-phage-therapy-program.html</link>
			<pubDate>Thu, 13 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13688.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13688/biomx-licenses-novel-targets-for-phage-therapy-program.html</guid>
		</item>	
				<item>
			<title>GT Apeiron Therapeuticsm Partners signs with Exscientia</title>
			<atom:link href="https://biospectrumasia.com/news/50/13691/gt-apeiron-therapeuticsm-partners-signs-with-exscientia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13691/gt-apeiron-therapeuticsm-partners-signs-with-exscientia.html</link>
			<pubDate>Wed, 12 Jun 2019 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ensuring_the_right_temperature_always_sealed_air_s_temperature_assurance_lab_in_singapore-13691.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13691/gt-apeiron-therapeuticsm-partners-signs-with-exscientia.html</guid>
		</item>	
				<item>
			<title>Acucela gets EMA approval for Emixustat to treat Stargardt disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/13686/acucela-gets-ema-approval-for-emixustat-to-treat-stargardt-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13686/acucela-gets-ema-approval-for-emixustat-to-treat-stargardt-disease.html</link>
			<pubDate>Tue, 11 Jun 2019 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eye_problem_1-13686.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13686/acucela-gets-ema-approval-for-emixustat-to-treat-stargardt-disease.html</guid>
		</item>	
				<item>
			<title>Hamamatsu Photonics develops novel 3D fluorescence scanner</title>
			<atom:link href="https://biospectrumasia.com/news/50/13670/hamamatsu-photonics-develops-novel-3d-fluorescence-scanner.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13670/hamamatsu-photonics-develops-novel-3d-fluorescence-scanner.html</link>
			<pubDate>Tue, 11 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_wire-13670.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13670/hamamatsu-photonics-develops-novel-3d-fluorescence-scanner.html</guid>
		</item>	
				<item>
			<title>Hamamatsu Photonics K.K. develops a novel 3D fluorescence scanning method</title>
			<atom:link href="https://biospectrumasia.com/news/50/13676/hamamatsu-photonics-k-k-develops-a-novel-3d-fluorescence-scanning-method.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13676/hamamatsu-photonics-k-k-develops-a-novel-3d-fluorescence-scanning-method.html</link>
			<pubDate>Mon, 10 Jun 2019 13:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/s_hl_zyncscan_pp_xx-13676.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13676/hamamatsu-photonics-k-k-develops-a-novel-3d-fluorescence-scanning-method.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares to receive new $3 million milestone payment from Pfizer</title>
			<atom:link href="https://biospectrumasia.com/news/50/13673/sosei-heptares-to-receive-new-3-million-milestone-payment-from-pfizer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13673/sosei-heptares-to-receive-new-3-million-milestone-payment-from-pfizer.html</link>
			<pubDate>Mon, 10 Jun 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition-13673.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13673/sosei-heptares-to-receive-new-3-million-milestone-payment-from-pfizer.html</guid>
		</item>	
				<item>
			<title>Otsuka Chemical acquires Cefixime business of Astellas Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/13634/otsuka-chemical-acquires-cefixime-business-of-astellas-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13634/otsuka-chemical-acquires-cefixime-business-of-astellas-pharma.html</link>
			<pubDate>Mon, 10 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13634.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13634/otsuka-chemical-acquires-cefixime-business-of-astellas-pharma.html</guid>
		</item>	
				<item>
			<title>A unique solution to boost immunization in developing countries</title>
			<atom:link href="https://biospectrumasia.com/news/50/13637/a-unique-solution-to-boost-immunization-in-developing-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13637/a-unique-solution-to-boost-immunization-in-developing-countries.html</link>
			<pubDate>Mon, 10 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13637.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13637/a-unique-solution-to-boost-immunization-in-developing-countries.html</guid>
		</item>	
				<item>
			<title>Parexel appoints Dr Makoto Sugita to lead its Japan organization</title>
			<atom:link href="https://biospectrumasia.com/news/50/13665/parexel-appoints-dr-makoto-sugita-to-lead-its-japan-organization.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13665/parexel-appoints-dr-makoto-sugita-to-lead-its-japan-organization.html</link>
			<pubDate>Fri, 07 Jun 2019 16:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13665.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13665/parexel-appoints-dr-makoto-sugita-to-lead-its-japan-organization.html</guid>
		</item>	
				<item>
			<title>Yokogawa takes strategic stake in Sensire to pursue collaboration in cold chain monitoring</title>
			<atom:link href="https://biospectrumasia.com/news/50/13658/yokogawa-takes-strategic-stake-in-sensire-to-pursue-collaboration-in-cold-chain-monitoring.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13658/yokogawa-takes-strategic-stake-in-sensire-to-pursue-collaboration-in-cold-chain-monitoring.html</link>
			<pubDate>Fri, 07 Jun 2019 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bw20190605005285_51990495_yokogawa_electric_sensire_pr_img-13658.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13658/yokogawa-takes-strategic-stake-in-sensire-to-pursue-collaboration-in-cold-chain-monitoring.html</guid>
		</item>	
				<item>
			<title>Otsuka Chemicals acquires the business of Cefixime from Astellas Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/13659/otsuka-chemicals-acquires-the-business-of-cefixime-from-astellas-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13659/otsuka-chemicals-acquires-the-business-of-cefixime-from-astellas-pharma.html</link>
			<pubDate>Fri, 07 Jun 2019 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition1-13659.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13659/otsuka-chemicals-acquires-the-business-of-cefixime-from-astellas-pharma.html</guid>
		</item>	
				<item>
			<title>Gavi, NEC, and Simprints signs MOU </title>
			<atom:link href="https://biospectrumasia.com/news/50/13655/gavi-nec-and-simprints-signs-mou-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13655/gavi-nec-and-simprints-signs-mou-.html</link>
			<pubDate>Fri, 07 Jun 2019 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mou3-13655.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13655/gavi-nec-and-simprints-signs-mou-.html</guid>
		</item>	
				<item>
			<title>FujiFilm Corp introduces novel, fully integrated continuous production system</title>
			<atom:link href="https://biospectrumasia.com/news/50/13647/fujifilm-corp-introduces-novel-fully-integrated-continuous-production-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13647/fujifilm-corp-introduces-novel-fully-integrated-continuous-production-system.html</link>
			<pubDate>Fri, 07 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13647.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13647/fujifilm-corp-introduces-novel-fully-integrated-continuous-production-system.html</guid>
		</item>	
				<item>
			<title>Takeda to discontinue trial in AL Amyloidosis</title>
			<atom:link href="https://biospectrumasia.com/news/50/13641/takeda-to-discontinue-trial-in-al-amyloidosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13641/takeda-to-discontinue-trial-in-al-amyloidosis.html</link>
			<pubDate>Thu, 06 Jun 2019 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13641/takeda-to-discontinue-trial-in-al-amyloidosis.html</guid>
		</item>	
				<item>
			<title>PeptiDream announces strategic partnership with drug-delivery expert PharmaIN</title>
			<atom:link href="https://biospectrumasia.com/news/50/13633/peptidream-announces-strategic-partnership-with-drug-delivery-expert-pharmain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13633/peptidream-announces-strategic-partnership-with-drug-delivery-expert-pharmain.html</link>
			<pubDate>Thu, 06 Jun 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13633.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13633/peptidream-announces-strategic-partnership-with-drug-delivery-expert-pharmain.html</guid>
		</item>	
				<item>
			<title>LPIXEL announces initiation of AI System development for cell evaluation with Astellas Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/13631/lpixel-announces-initiation-of-ai-system-development-for-cell-evaluation-with-astellas-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13631/lpixel-announces-initiation-of-ai-system-development-for-cell-evaluation-with-astellas-pharma.html</link>
			<pubDate>Wed, 05 Jun 2019 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/healthcare_big_data_1_-13631.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13631/lpixel-announces-initiation-of-ai-system-development-for-cell-evaluation-with-astellas-pharma.html</guid>
		</item>	
				<item>
			<title>Alecensa confirmed as a first-line therapy for patients with ALK-positive NSCLC</title>
			<atom:link href="https://biospectrumasia.com/news/50/13613/alecensa-confirmed-as-a-first-line-therapy-for-patients-with-alk-positive-nsclc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13613/alecensa-confirmed-as-a-first-line-therapy-for-patients-with-alk-positive-nsclc.html</link>
			<pubDate>Tue, 04 Jun 2019 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alecensa-13613.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13613/alecensa-confirmed-as-a-first-line-therapy-for-patients-with-alk-positive-nsclc.html</guid>
		</item>	
				<item>
			<title>Takeda Makes First Private Sector Pledge for Global Fund Replenishment</title>
			<atom:link href="https://biospectrumasia.com/news/50/13621/takeda-makes-first-private-sector-pledge-for-global-fund-replenishment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13621/takeda-makes-first-private-sector-pledge-for-global-fund-replenishment.html</link>
			<pubDate>Tue, 04 Jun 2019 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2_11-13621.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13621/takeda-makes-first-private-sector-pledge-for-global-fund-replenishment.html</guid>
		</item>	
				<item>
			<title>Parexel appoints Dr. Makoto Sugita to lead its Japan Organization </title>
			<atom:link href="https://biospectrumasia.com/news/50/13618/parexel-appoints-dr-makoto-sugita-to-lead-its-japan-organization-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13618/parexel-appoints-dr-makoto-sugita-to-lead-its-japan-organization-.html</link>
			<pubDate>Tue, 04 Jun 2019 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/recruitment-13618.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13618/parexel-appoints-dr-makoto-sugita-to-lead-its-japan-organization-.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher receives reimbursement coverage for Oncomine test</title>
			<atom:link href="https://biospectrumasia.com/news/50/13616/thermo-fisher-receives-reimbursement-coverage-for-oncomine-test.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13616/thermo-fisher-receives-reimbursement-coverage-for-oncomine-test.html</link>
			<pubDate>Tue, 04 Jun 2019 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13616.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13616/thermo-fisher-receives-reimbursement-coverage-for-oncomine-test.html</guid>
		</item>	
				<item>
			<title>Beam Therapeutics, Bio Palette to develop microbiome-related therapeutics in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/13592/beam-therapeutics-bio-palette-to-develop-microbiome-related-therapeutics-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13592/beam-therapeutics-bio-palette-to-develop-microbiome-related-therapeutics-in-asia.html</link>
			<pubDate>Mon, 03 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13592.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13592/beam-therapeutics-bio-palette-to-develop-microbiome-related-therapeutics-in-asia.html</guid>
		</item>	
				<item>
			<title>World&#039;s First Digital nicotine-dependent Treatment App from CureApp for higher sustained smoking cessation (CAR) rate</title>
			<atom:link href="https://biospectrumasia.com/news/50/13599/worlds-first-digital-nicotine-dependent-treatment-app-from-cureapp-for-higher-sustained-smoking-cessation-car-rate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13599/worlds-first-digital-nicotine-dependent-treatment-app-from-cureapp-for-higher-sustained-smoking-cessation-car-rate.html</link>
			<pubDate>Mon, 03 Jun 2019 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cure_app-13599.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13599/worlds-first-digital-nicotine-dependent-treatment-app-from-cureapp-for-higher-sustained-smoking-cessation-car-rate.html</guid>
		</item>	
				<item>
			<title>Scientists bioengineer human liver disease in the lab </title>
			<atom:link href="https://biospectrumasia.com/news/50/13594/scientists-bioengineer-human-liver-disease-in-the-lab-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13594/scientists-bioengineer-human-liver-disease-in-the-lab-.html</link>
			<pubDate>Fri, 31 May 2019 15:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13594.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13594/scientists-bioengineer-human-liver-disease-in-the-lab-.html</guid>
		</item>	
				<item>
			<title>Hitachi signs contract with HIMED to Deliver Particle Therapy System</title>
			<atom:link href="https://biospectrumasia.com/news/50/13582/hitachi-signs-contract-with-himed-to-deliver-particle-therapy-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13582/hitachi-signs-contract-with-himed-to-deliver-particle-therapy-system.html</link>
			<pubDate>Fri, 31 May 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eb5cd66dca913e25dcd6f01c9fc5b021-13582.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13582/hitachi-signs-contract-with-himed-to-deliver-particle-therapy-system.html</guid>
		</item>	
				<item>
			<title>PENTAX Medical launches MILES FOR HEALTH(TM) campaign</title>
			<atom:link href="https://biospectrumasia.com/news/50/13583/pentax-medical-launches-miles-for-healthtm-campaign.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13583/pentax-medical-launches-miles-for-healthtm-campaign.html</link>
			<pubDate>Thu, 30 May 2019 14:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_centre-13583.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13583/pentax-medical-launches-miles-for-healthtm-campaign.html</guid>
		</item>	
				<item>
			<title>Chugai Pharma aims to create high quality innovative drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/13576/chugai-pharma-aims-to-create-high-quality-innovative-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13576/chugai-pharma-aims-to-create-high-quality-innovative-drugs.html</link>
			<pubDate>Thu, 30 May 2019 11:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13576.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13576/chugai-pharma-aims-to-create-high-quality-innovative-drugs.html</guid>
		</item>	
				<item>
			<title>B dot Medical to develop ultra-compact proton cancer therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/13532/b-dot-medical-to-develop-ultra-compact-proton-cancer-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13532/b-dot-medical-to-develop-ultra-compact-proton-cancer-therapy.html</link>
			<pubDate>Tue, 28 May 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13532.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13532/b-dot-medical-to-develop-ultra-compact-proton-cancer-therapy.html</guid>
		</item>	
				<item>
			<title>Menicon launches holistic approach for myopia control management</title>
			<atom:link href="https://biospectrumasia.com/news/50/13537/menicon-launches-holistic-approach-for-myopia-control-management.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13537/menicon-launches-holistic-approach-for-myopia-control-management.html</link>
			<pubDate>Tue, 28 May 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13537.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13537/menicon-launches-holistic-approach-for-myopia-control-management.html</guid>
		</item>	
				<item>
			<title>Scientists develop technique for better detection of breast cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/13539/scientists-develop-technique-for-better-detection-of-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13539/scientists-develop-technique-for-better-detection-of-breast-cancer.html</link>
			<pubDate>Fri, 24 May 2019 16:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/okayama_university-13539.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13539/scientists-develop-technique-for-better-detection-of-breast-cancer.html</guid>
		</item>	
				<item>
			<title>Japanese Ministry approves Elekta Unity MR-linac for clinical use</title>
			<atom:link href="https://biospectrumasia.com/news/50/13534/japanese-ministry-approves-elekta-unity-mr-linac-for-clinical-use.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13534/japanese-ministry-approves-elekta-unity-mr-linac-for-clinical-use.html</link>
			<pubDate>Fri, 24 May 2019 15:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_2-13534.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13534/japanese-ministry-approves-elekta-unity-mr-linac-for-clinical-use.html</guid>
		</item>	
				<item>
			<title>Chugai&#039;s Actemra Intravenous Infusion receives additional approval for Adult Still&#039;s Disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/13527/chugais-actemra-intravenous-infusion-receives-additional-approval-for-adult-stills-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13527/chugais-actemra-intravenous-infusion-receives-additional-approval-for-adult-stills-disease.html</link>
			<pubDate>Fri, 24 May 2019 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approval-13527.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13527/chugais-actemra-intravenous-infusion-receives-additional-approval-for-adult-stills-disease.html</guid>
		</item>	
				<item>
			<title>Japan approves use of Elekta Unity MRI therapy system</title>
			<atom:link href="https://biospectrumasia.com/news/50/13524/japan-approves-use-of-elekta-unity-mri-therapy-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13524/japan-approves-use-of-elekta-unity-mri-therapy-system.html</link>
			<pubDate>Fri, 24 May 2019 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13524.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13524/japan-approves-use-of-elekta-unity-mri-therapy-system.html</guid>
		</item>	
				<item>
			<title>Eisai brings Novartis executive on oncology board</title>
			<atom:link href="https://biospectrumasia.com/news/50/13512/eisai-brings-novartis-executive-on-oncology-board.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13512/eisai-brings-novartis-executive-on-oncology-board.html</link>
			<pubDate>Thu, 23 May 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13512.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13512/eisai-brings-novartis-executive-on-oncology-board.html</guid>
		</item>	
				<item>
			<title>Takeda, Frazier Healthcare Partners to launch Phathom Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/13496/takeda-frazier-healthcare-partners-to-launch-phathom-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13496/takeda-frazier-healthcare-partners-to-launch-phathom-pharma.html</link>
			<pubDate>Tue, 21 May 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13496.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13496/takeda-frazier-healthcare-partners-to-launch-phathom-pharma.html</guid>
		</item>	
				<item>
			<title>Takeda announces results of Phase 3b VARSITY studies</title>
			<atom:link href="https://biospectrumasia.com/news/50/13493/takeda-announces-results-of-phase-3b-varsity-studies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13493/takeda-announces-results-of-phase-3b-varsity-studies.html</link>
			<pubDate>Mon, 20 May 2019 11:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13493/takeda-announces-results-of-phase-3b-varsity-studies.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo fails to hold up influenza vaccine project</title>
			<atom:link href="https://biospectrumasia.com/news/50/13491/daiichi-sankyo-fails-to-hold-up-influenza-vaccine-project.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13491/daiichi-sankyo-fails-to-hold-up-influenza-vaccine-project.html</link>
			<pubDate>Mon, 20 May 2019 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13491.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13491/daiichi-sankyo-fails-to-hold-up-influenza-vaccine-project.html</guid>
		</item>	
				<item>
			<title>Teijin and AMED to develop drugs for frail elders</title>
			<atom:link href="https://biospectrumasia.com/news/50/13471/teijin-and-amed-to-develop-drugs-for-frail-elders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13471/teijin-and-amed-to-develop-drugs-for-frail-elders.html</link>
			<pubDate>Fri, 17 May 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13471.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13471/teijin-and-amed-to-develop-drugs-for-frail-elders.html</guid>
		</item>	
				<item>
			<title>Eisai to present data on oncology pipeline and products</title>
			<atom:link href="https://biospectrumasia.com/news/50/13475/eisai-to-present-data-on-oncology-pipeline-and-products.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13475/eisai-to-present-data-on-oncology-pipeline-and-products.html</link>
			<pubDate>Thu, 16 May 2019 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_2-13475.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13475/eisai-to-present-data-on-oncology-pipeline-and-products.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo launches hypertension drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/13457/daiichi-sankyo-launches-hypertension-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13457/daiichi-sankyo-launches-hypertension-drug-in-japan.html</link>
			<pubDate>Wed, 15 May 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freestocks_org_126848-13457.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13457/daiichi-sankyo-launches-hypertension-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s BLA for Vedolizumab gets approval by U.S. FDA</title>
			<atom:link href="https://biospectrumasia.com/news/50/13460/takedas-bla-for-vedolizumab-gets-approval-by-u-s-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13460/takedas-bla-for-vedolizumab-gets-approval-by-u-s-fda.html</link>
			<pubDate>Tue, 14 May 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved1-13460.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13460/takedas-bla-for-vedolizumab-gets-approval-by-u-s-fda.html</guid>
		</item>	
				<item>
			<title>Eisai to sell anti-rheumatic injection in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/13443/eisai-to-sell-anti-rheumatic-injection-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13443/eisai-to-sell-anti-rheumatic-injection-in-japan.html</link>
			<pubDate>Tue, 14 May 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13443.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13443/eisai-to-sell-anti-rheumatic-injection-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda sells surgical patch to Ethicon for $400M</title>
			<atom:link href="https://biospectrumasia.com/news/50/13434/takeda-sells-surgical-patch-to-ethicon-for-400m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13434/takeda-sells-surgical-patch-to-ethicon-for-400m.html</link>
			<pubDate>Mon, 13 May 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13434.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13434/takeda-sells-surgical-patch-to-ethicon-for-400m.html</guid>
		</item>	
				<item>
			<title>Novartis to acquire Xiidra in a $5.3B deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/13423/novartis-to-acquire-xiidra-in-a-5-3b-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13423/novartis-to-acquire-xiidra-in-a-5-3b-deal.html</link>
			<pubDate>Fri, 10 May 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition_min-13423.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13423/novartis-to-acquire-xiidra-in-a-5-3b-deal.html</guid>
		</item>	
				<item>
			<title>Promethera Biosciences makes progress in HepaStem development programme</title>
			<atom:link href="https://biospectrumasia.com/news/50/13421/promethera-biosciences-makes-progress-in-hepastem-development-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13421/promethera-biosciences-makes-progress-in-hepastem-development-programme.html</link>
			<pubDate>Thu, 09 May 2019 02:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/labiotech_eu-13421.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13421/promethera-biosciences-makes-progress-in-hepastem-development-programme.html</guid>
		</item>	
				<item>
			<title>Promethera Biosciences completes â‚¬39.7 M Series D Financing</title>
			<atom:link href="https://biospectrumasia.com/news/50/13414/promethera-biosciences-completes-39-7-m-series-d-financing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13414/promethera-biosciences-completes-39-7-m-series-d-financing.html</link>
			<pubDate>Wed, 08 May 2019 15:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/series_a_funding-13414.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13414/promethera-biosciences-completes-39-7-m-series-d-financing.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo- AstraZeneca&#039;s breast cancer drug reveals positive response</title>
			<atom:link href="https://biospectrumasia.com/news/50/13412/daiichi-sankyo-astrazenecas-breast-cancer-drug-reveals-positive-response.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13412/daiichi-sankyo-astrazenecas-breast-cancer-drug-reveals-positive-response.html</link>
			<pubDate>Wed, 08 May 2019 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13412.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13412/daiichi-sankyo-astrazenecas-breast-cancer-drug-reveals-positive-response.html</guid>
		</item>	
				<item>
			<title>Eisai with UK DRI launches new Post-Doctoral programme  </title>
			<atom:link href="https://biospectrumasia.com/news/50/13406/eisai-with-uk-dri-launches-new-post-doctoral-programme-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13406/eisai-with-uk-dri-launches-new-post-doctoral-programme-.html</link>
			<pubDate>Wed, 08 May 2019 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13406.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13406/eisai-with-uk-dri-launches-new-post-doctoral-programme-.html</guid>
		</item>	
				<item>
			<title>Takeda collaborates with Skyhawk to develop solutions for neurodegenerative diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/13392/takeda-collaborates-with-skyhawk-to-develop-solutions-for-neurodegenerative-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13392/takeda-collaborates-with-skyhawk-to-develop-solutions-for-neurodegenerative-diseases.html</link>
			<pubDate>Tue, 07 May 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13392.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13392/takeda-collaborates-with-skyhawk-to-develop-solutions-for-neurodegenerative-diseases.html</guid>
		</item>	
				<item>
			<title>Takeda opens new global research center in San Diego</title>
			<atom:link href="https://biospectrumasia.com/news/50/13364/takeda-opens-new-global-research-center-in-san-diego.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13364/takeda-opens-new-global-research-center-in-san-diego.html</link>
			<pubDate>Fri, 03 May 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-13364.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13364/takeda-opens-new-global-research-center-in-san-diego.html</guid>
		</item>	
				<item>
			<title>Takeda announces Andrey Potapov as ICMEA Area Head </title>
			<atom:link href="https://biospectrumasia.com/news/50/13352/takeda-announces-andrey-potapov-as-icmea-area-head-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13352/takeda-announces-andrey-potapov-as-icmea-area-head-.html</link>
			<pubDate>Tue, 30 Apr 2019 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/_dsc0720-13352.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13352/takeda-announces-andrey-potapov-as-icmea-area-head-.html</guid>
		</item>	
				<item>
			<title>Japanese scientists reveal potential of technology to detect cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/13339/japanese-scientists-reveal-potential-of-technology-to-detect-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13339/japanese-scientists-reveal-potential-of-technology-to-detect-cancer.html</link>
			<pubDate>Mon, 29 Apr 2019 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13339.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13339/japanese-scientists-reveal-potential-of-technology-to-detect-cancer.html</guid>
		</item>	
				<item>
			<title>Santen, Glaukos collaborate for exclusive distribution of the MicroShunt in the U.S.</title>
			<atom:link href="https://biospectrumasia.com/news/50/13330/santen-glaukos-collaborate-for-exclusive-distribution-of-the-microshunt-in-the-u-s-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13330/santen-glaukos-collaborate-for-exclusive-distribution-of-the-microshunt-in-the-u-s-.html</link>
			<pubDate>Fri, 26 Apr 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration_2-13330.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13330/santen-glaukos-collaborate-for-exclusive-distribution-of-the-microshunt-in-the-u-s-.html</guid>
		</item>	
				<item>
			<title>Daiichi selects oncology candidate built on Zymeworks&#039; Bispecific platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/13328/daiichi-selects-oncology-candidate-built-on-zymeworks-bispecific-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13328/daiichi-selects-oncology-candidate-built-on-zymeworks-bispecific-platform.html</link>
			<pubDate>Fri, 26 Apr 2019 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collboration_3-13328.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13328/daiichi-selects-oncology-candidate-built-on-zymeworks-bispecific-platform.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo sells Its Nihonbashi building in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/13327/daiichi-sankyo-sells-its-nihonbashi-building-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13327/daiichi-sankyo-sells-its-nihonbashi-building-in-japan.html</link>
			<pubDate>Fri, 26 Apr 2019 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/finance-13327.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13327/daiichi-sankyo-sells-its-nihonbashi-building-in-japan.html</guid>
		</item>	
				<item>
			<title>Salix partners with Mitsubishi Tanabe Pharma to market IBD drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/13323/salix-partners-with-mitsubishi-tanabe-pharma-to-market-ibd-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13323/salix-partners-with-mitsubishi-tanabe-pharma-to-market-ibd-drug.html</link>
			<pubDate>Fri, 26 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13323.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13323/salix-partners-with-mitsubishi-tanabe-pharma-to-market-ibd-drug.html</guid>
		</item>	
				<item>
			<title>Velabs collaborates with Chiome for GPCR-Specific functional antibody screening</title>
			<atom:link href="https://biospectrumasia.com/news/50/13313/velabs-collaborates-with-chiome-for-gpcr-specific-functional-antibody-screening.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13313/velabs-collaborates-with-chiome-for-gpcr-specific-functional-antibody-screening.html</link>
			<pubDate>Wed, 24 Apr 2019 15:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibody_therapeutic-13313.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13313/velabs-collaborates-with-chiome-for-gpcr-specific-functional-antibody-screening.html</guid>
		</item>	
				<item>
			<title>LifeArc licenses lead stage molecules to Daiichi Sankyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/13304/lifearc-licenses-lead-stage-molecules-to-daiichi-sankyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13304/lifearc-licenses-lead-stage-molecules-to-daiichi-sankyo.html</link>
			<pubDate>Wed, 24 Apr 2019 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13304.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13304/lifearc-licenses-lead-stage-molecules-to-daiichi-sankyo.html</guid>
		</item>	
				<item>
			<title>Eisai selected as a Competitive IT Strategy Company 2019</title>
			<atom:link href="https://biospectrumasia.com/news/50/13303/eisai-selected-as-a-competitive-it-strategy-company-2019.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13303/eisai-selected-as-a-competitive-it-strategy-company-2019.html</link>
			<pubDate>Wed, 24 Apr 2019 10:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/strategy-13303.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13303/eisai-selected-as-a-competitive-it-strategy-company-2019.html</guid>
		</item>	
				<item>
			<title>ACT Genomics to provide cancer genomic profiling service </title>
			<atom:link href="https://biospectrumasia.com/news/50/13275/act-genomics-to-provide-cancer-genomic-profiling-service-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13275/act-genomics-to-provide-cancer-genomic-profiling-service-.html</link>
			<pubDate>Sun, 21 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_treatment-13275.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13275/act-genomics-to-provide-cancer-genomic-profiling-service-.html</guid>
		</item>	
				<item>
			<title>Nagasaki University, NEC initiate program on Global Health </title>
			<atom:link href="https://biospectrumasia.com/news/50/13268/nagasaki-university-nec-initiate-program-on-global-health-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13268/nagasaki-university-nec-initiate-program-on-global-health-.html</link>
			<pubDate>Thu, 18 Apr 2019 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ai_healthcare_jpg_2-13268.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13268/nagasaki-university-nec-initiate-program-on-global-health-.html</guid>
		</item>	
				<item>
			<title>Quantum dot imaging advances</title>
			<atom:link href="https://biospectrumasia.com/news/50/13261/quantum-dot-imaging-advances.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13261/quantum-dot-imaging-advances.html</link>
			<pubDate>Wed, 17 Apr 2019 11:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/infrared_quantum_dots-13261.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13261/quantum-dot-imaging-advances.html</guid>
		</item>	
				<item>
			<title>Fujifilm and Kyoto University jointly developed AI-based diagnostic support technology </title>
			<atom:link href="https://biospectrumasia.com/news/50/13256/fujifilm-and-kyoto-university-jointly-developed-ai-based-diagnostic-support-technology-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13256/fujifilm-and-kyoto-university-jointly-developed-ai-based-diagnostic-support-technology-.html</link>
			<pubDate>Tue, 16 Apr 2019 14:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/p4_lungsml0418_gi577938810-13256.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13256/fujifilm-and-kyoto-university-jointly-developed-ai-based-diagnostic-support-technology-.html</guid>
		</item>	
				<item>
			<title>Permobil to launch its new F-Series in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/13249/permobil-to-launch-its-new-f-series-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13249/permobil-to-launch-its-new-f-series-in-japan.html</link>
			<pubDate>Tue, 16 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13249.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13249/permobil-to-launch-its-new-f-series-in-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo launches Tarlige Tablets for pain treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/13246/daiichi-sankyo-launches-tarlige-tablets-for-pain-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13246/daiichi-sankyo-launches-tarlige-tablets-for-pain-treatment-in-japan.html</link>
			<pubDate>Mon, 15 Apr 2019 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_12228-13246.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13246/daiichi-sankyo-launches-tarlige-tablets-for-pain-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>Kaken Pharma, HitGen to develop a novel class of drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/13229/kaken-pharma-hitgen-to-develop-a-novel-class-of-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13229/kaken-pharma-hitgen-to-develop-a-novel-class-of-drugs.html</link>
			<pubDate>Fri, 12 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13229.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13229/kaken-pharma-hitgen-to-develop-a-novel-class-of-drugs.html</guid>
		</item>	
				<item>
			<title>Shionogi licenses Symproic to BioDelivery Sciences International Inc.</title>
			<atom:link href="https://biospectrumasia.com/news/50/13230/shionogi-licenses-symproic-to-biodelivery-sciences-international-inc-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13230/shionogi-licenses-symproic-to-biodelivery-sciences-international-inc-.html</link>
			<pubDate>Thu, 11 Apr 2019 11:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/handshake-13230.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13230/shionogi-licenses-symproic-to-biodelivery-sciences-international-inc-.html</guid>
		</item>	
				<item>
			<title>EdiGene raises $15 M in Series B funding</title>
			<atom:link href="https://biospectrumasia.com/news/50/13222/edigene-raises-15-m-in-series-b-funding.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13222/edigene-raises-15-m-in-series-b-funding.html</link>
			<pubDate>Thu, 11 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/funding1-13222.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13222/edigene-raises-15-m-in-series-b-funding.html</guid>
		</item>	
				<item>
			<title>Japan approves Rakuten Medical&#039;s ASP-1929 to treat cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/13214/japan-approves-rakuten-medicals-asp-1929-to-treat-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13214/japan-approves-rakuten-medicals-asp-1929-to-treat-cancer.html</link>
			<pubDate>Wed, 10 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_treatment-13214.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13214/japan-approves-rakuten-medicals-asp-1929-to-treat-cancer.html</guid>
		</item>	
				<item>
			<title>GeneDesign joins Ajinomoto Bio-pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/13210/genedesign-joins-ajinomoto-bio-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13210/genedesign-joins-ajinomoto-bio-pharma.html</link>
			<pubDate>Tue, 09 Apr 2019 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13210.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13210/genedesign-joins-ajinomoto-bio-pharma.html</guid>
		</item>	
				<item>
			<title>Japan grants Sakigake designation to Eisai&#039;s novel FGFR</title>
			<atom:link href="https://biospectrumasia.com/news/50/13201/japan-grants-sakigake-designation-to-eisais-novel-fgfr.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13201/japan-grants-sakigake-designation-to-eisais-novel-fgfr.html</link>
			<pubDate>Mon, 08 Apr 2019 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_2-13201.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13201/japan-grants-sakigake-designation-to-eisais-novel-fgfr.html</guid>
		</item>	
				<item>
			<title>Clinigen K.K., GC Pharma sign pact to market Hunterase ICV</title>
			<atom:link href="https://biospectrumasia.com/news/50/13183/clinigen-k-k-gc-pharma-sign-pact-to-market-hunterase-icv.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13183/clinigen-k-k-gc-pharma-sign-pact-to-market-hunterase-icv.html</link>
			<pubDate>Fri, 05 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-13183.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13183/clinigen-k-k-gc-pharma-sign-pact-to-market-hunterase-icv.html</guid>
		</item>	
				<item>
			<title>Japan approves first drug for ADA deficiency</title>
			<atom:link href="https://biospectrumasia.com/news/50/13178/japan-approves-first-drug-for-ada-deficiency.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13178/japan-approves-first-drug-for-ada-deficiency.html</link>
			<pubDate>Thu, 04 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13178.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13178/japan-approves-first-drug-for-ada-deficiency.html</guid>
		</item>	
				<item>
			<title>Chugai Pharma sells Ulcerlmin business to Fuji Chemical </title>
			<atom:link href="https://biospectrumasia.com/news/50/13161/chugai-pharma-sells-ulcerlmin-business-to-fuji-chemical-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13161/chugai-pharma-sells-ulcerlmin-business-to-fuji-chemical-.html</link>
			<pubDate>Wed, 03 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13161.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13161/chugai-pharma-sells-ulcerlmin-business-to-fuji-chemical-.html</guid>
		</item>	
				<item>
			<title>Takeda takes step towards EU Entyvio extension </title>
			<atom:link href="https://biospectrumasia.com/news/50/13162/takeda-takes-step-towards-eu-entyvio-extension-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13162/takeda-takes-step-towards-eu-entyvio-extension-.html</link>
			<pubDate>Tue, 02 Apr 2019 16:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_1_-13162.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13162/takeda-takes-step-towards-eu-entyvio-extension-.html</guid>
		</item>	
				<item>
			<title>Hitachi&#039;s Radiation Therapy Systems start operation in Nagamori Memorial Center </title>
			<atom:link href="https://biospectrumasia.com/news/50/13155/hitachis-radiation-therapy-systems-start-operation-in-nagamori-memorial-center-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13155/hitachis-radiation-therapy-systems-start-operation-in-nagamori-memorial-center-.html</link>
			<pubDate>Tue, 02 Apr 2019 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_1_-13155.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13155/hitachis-radiation-therapy-systems-start-operation-in-nagamori-memorial-center-.html</guid>
		</item>	
				<item>
			<title>GHIT selects joint research project on dengue by Chugai, A*STAR</title>
			<atom:link href="https://biospectrumasia.com/news/50/13152/ghit-selects-joint-research-project-on-dengue-by-chugai-astar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13152/ghit-selects-joint-research-project-on-dengue-by-chugai-astar.html</link>
			<pubDate>Tue, 02 Apr 2019 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13152.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13152/ghit-selects-joint-research-project-on-dengue-by-chugai-astar.html</guid>
		</item>	
				<item>
			<title>Takeda, StrideBio to advance novel gene therapies for neuro diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/13144/takeda-stridebio-to-advance-novel-gene-therapies-for-neuro-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13144/takeda-stridebio-to-advance-novel-gene-therapies-for-neuro-diseases.html</link>
			<pubDate>Mon, 01 Apr 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13144.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13144/takeda-stridebio-to-advance-novel-gene-therapies-for-neuro-diseases.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo, AstraZeneca sign $6.9M deal for cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/13136/daiichi-sankyo-astrazeneca-sign-6-9m-deal-for-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13136/daiichi-sankyo-astrazeneca-sign-6-9m-deal-for-cancer-drug.html</link>
			<pubDate>Fri, 29 Mar 2019 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13136.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13136/daiichi-sankyo-astrazeneca-sign-6-9m-deal-for-cancer-drug.html</guid>
		</item>	
				<item>
			<title>CPhI Japan sees Japanese R&amp;D reinvigorated with international partnerships proliferating</title>
			<atom:link href="https://biospectrumasia.com/news/50/13133/cphi-japan-sees-japanese-rd-reinvigorated-with-international-partnerships-proliferating.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13133/cphi-japan-sees-japanese-rd-reinvigorated-with-international-partnerships-proliferating.html</link>
			<pubDate>Fri, 29 Mar 2019 10:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13133.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13133/cphi-japan-sees-japanese-rd-reinvigorated-with-international-partnerships-proliferating.html</guid>
		</item>	
				<item>
			<title>Japan approves Gilead&#039;s Biktarvy to treat HIV-1 Infection</title>
			<atom:link href="https://biospectrumasia.com/news/50/13130/japan-approves-gileads-biktarvy-to-treat-hiv-1-infection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13130/japan-approves-gileads-biktarvy-to-treat-hiv-1-infection.html</link>
			<pubDate>Thu, 28 Mar 2019 16:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hiv-13130.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13130/japan-approves-gileads-biktarvy-to-treat-hiv-1-infection.html</guid>
		</item>	
				<item>
			<title>GHIT Fund announces new investment worth 2.86B Yen</title>
			<atom:link href="https://biospectrumasia.com/news/50/13122/ghit-fund-announces-new-investment-worth-2-86b-yen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13122/ghit-fund-announces-new-investment-worth-2-86b-yen.html</link>
			<pubDate>Thu, 28 Mar 2019 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13122.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13122/ghit-fund-announces-new-investment-worth-2-86b-yen.html</guid>
		</item>	
				<item>
			<title>Japan Health Ministry approves immunoglobulins to treat CIDP</title>
			<atom:link href="https://biospectrumasia.com/news/50/13119/japan-health-ministry-approves-immunoglobulins-to-treat-cidp.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13119/japan-health-ministry-approves-immunoglobulins-to-treat-cidp.html</link>
			<pubDate>Thu, 28 Mar 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cidp-13119.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13119/japan-health-ministry-approves-immunoglobulins-to-treat-cidp.html</guid>
		</item>	
				<item>
			<title>AbbVie gets the first global regulatory approval of SKYRIZI in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/13108/abbvie-gets-the-first-global-regulatory-approval-of-skyrizi-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13108/abbvie-gets-the-first-global-regulatory-approval-of-skyrizi-in-japan.html</link>
			<pubDate>Wed, 27 Mar 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13108.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13108/abbvie-gets-the-first-global-regulatory-approval-of-skyrizi-in-japan.html</guid>
		</item>	
				<item>
			<title>Lupin, YL Biologics receive PMDA approval for Etanercept biosimilar in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/13103/lupin-yl-biologics-receive-pmda-approval-for-etanercept-biosimilar-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13103/lupin-yl-biologics-receive-pmda-approval-for-etanercept-biosimilar-in-japan.html</link>
			<pubDate>Tue, 26 Mar 2019 11:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3b1a495d_2d29_4b2d_a6b2_21aed0776f1eimage22-13103.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13103/lupin-yl-biologics-receive-pmda-approval-for-etanercept-biosimilar-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai starts Phase III clinical trial for Alzheimer&#039;s drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/13086/eisai-starts-phase-iii-clinical-trial-for-alzheimers-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13086/eisai-starts-phase-iii-clinical-trial-for-alzheimers-drug.html</link>
			<pubDate>Mon, 25 Mar 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13086.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13086/eisai-starts-phase-iii-clinical-trial-for-alzheimers-drug.html</guid>
		</item>	
				<item>
			<title>Eisai to present latest research on Alzheimer&#039;s Disease / Dementia Pipeline </title>
			<atom:link href="https://biospectrumasia.com/news/50/13083/eisai-to-present-latest-research-on-alzheimers-disease-dementia-pipeline-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13083/eisai-to-present-latest-research-on-alzheimers-disease-dementia-pipeline-.html</link>
			<pubDate>Fri, 22 Mar 2019 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alzeimer-13083.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13083/eisai-to-present-latest-research-on-alzheimers-disease-dementia-pipeline-.html</guid>
		</item>	
				<item>
			<title>Biotech firm Spiber to develop artificial hair</title>
			<atom:link href="https://biospectrumasia.com/news/50/13075/biotech-firm-spiber-to-develop-artificial-hair.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13075/biotech-firm-spiber-to-develop-artificial-hair.html</link>
			<pubDate>Thu, 21 Mar 2019 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13075.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13075/biotech-firm-spiber-to-develop-artificial-hair.html</guid>
		</item>	
				<item>
			<title>Ono Pharma, twoXAR announce drug discovery research collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/50/13055/ono-pharma-twoxar-announce-drug-discovery-research-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13055/ono-pharma-twoxar-announce-drug-discovery-research-collaboration.html</link>
			<pubDate>Tue, 19 Mar 2019 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13055.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13055/ono-pharma-twoxar-announce-drug-discovery-research-collaboration.html</guid>
		</item>	
				<item>
			<title>Blackstone to acquire AYUMI Pharmaceutical</title>
			<atom:link href="https://biospectrumasia.com/news/50/13050/blackstone-to-acquire-ayumi-pharmaceutical.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13050/blackstone-to-acquire-ayumi-pharmaceutical.html</link>
			<pubDate>Mon, 18 Mar 2019 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13050.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13050/blackstone-to-acquire-ayumi-pharmaceutical.html</guid>
		</item>	
				<item>
			<title>Shimadzu incorporates AI in new chromatograph series</title>
			<atom:link href="https://biospectrumasia.com/news/50/13041/shimadzu-incorporates-ai-in-new-chromatograph-series.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13041/shimadzu-incorporates-ai-in-new-chromatograph-series.html</link>
			<pubDate>Fri, 15 Mar 2019 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13041.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13041/shimadzu-incorporates-ai-in-new-chromatograph-series.html</guid>
		</item>	
				<item>
			<title>Chugai&#039;s Hemlibra receives approval for severe Hemophilia A </title>
			<atom:link href="https://biospectrumasia.com/news/50/13040/chugais-hemlibra-receives-approval-for-severe-hemophilia-a-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13040/chugais-hemlibra-receives-approval-for-severe-hemophilia-a-.html</link>
			<pubDate>Fri, 15 Mar 2019 15:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hemophilia_credit_depositphotos-13040.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13040/chugais-hemlibra-receives-approval-for-severe-hemophilia-a-.html</guid>
		</item>	
				<item>
			<title>Aprecia, CMIC to bring 3DP pharmaceutical products to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/13038/aprecia-cmic-to-bring-3dp-pharmaceutical-products-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13038/aprecia-cmic-to-bring-3dp-pharmaceutical-products-to-japan.html</link>
			<pubDate>Fri, 15 Mar 2019 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13038.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13038/aprecia-cmic-to-bring-3dp-pharmaceutical-products-to-japan.html</guid>
		</item>	
				<item>
			<title>Fujifilm to acquire Biogen in a $890 M deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/13005/fujifilm-to-acquire-biogen-in-a-890-m-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13005/fujifilm-to-acquire-biogen-in-a-890-m-deal.html</link>
			<pubDate>Wed, 13 Mar 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-13005.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13005/fujifilm-to-acquire-biogen-in-a-890-m-deal.html</guid>
		</item>	
				<item>
			<title>FDA accepts NDA for Lemborexant to treat Insomnia</title>
			<atom:link href="https://biospectrumasia.com/news/50/13000/fda-accepts-nda-for-lemborexant-to-treat-insomnia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/13000/fda-accepts-nda-for-lemborexant-to-treat-insomnia.html</link>
			<pubDate>Tue, 12 Mar 2019 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sleep_wake_disorder-13000.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/13000/fda-accepts-nda-for-lemborexant-to-treat-insomnia.html</guid>
		</item>	
				<item>
			<title>Oncoceutics licenses rights for its anti-cancer compound to Ohara</title>
			<atom:link href="https://biospectrumasia.com/news/50/12998/oncoceutics-licenses-rights-for-its-anti-cancer-compound-to-ohara.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12998/oncoceutics-licenses-rights-for-its-anti-cancer-compound-to-ohara.html</link>
			<pubDate>Tue, 12 Mar 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12998.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12998/oncoceutics-licenses-rights-for-its-anti-cancer-compound-to-ohara.html</guid>
		</item>	
				<item>
			<title>In a first ever head-to-head biologic clinical study in Ulcerative Colitis Takeda&#039;s Entyvio demonstrates superior results compared to Humira</title>
			<atom:link href="https://biospectrumasia.com/news/50/12981/in-a-first-ever-head-to-head-biologic-clinical-study-in-ulcerative-colitis-takedas-entyvio-demonstrates-superior-results-compared-to-humira.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12981/in-a-first-ever-head-to-head-biologic-clinical-study-in-ulcerative-colitis-takedas-entyvio-demonstrates-superior-results-compared-to-humira.html</link>
			<pubDate>Mon, 11 Mar 2019 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda_pharma_200x200-12981.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12981/in-a-first-ever-head-to-head-biologic-clinical-study-in-ulcerative-colitis-takedas-entyvio-demonstrates-superior-results-compared-to-humira.html</guid>
		</item>	
				<item>
			<title>Akili, Shionogi to develop digital therapeutics in key Asian markets</title>
			<atom:link href="https://biospectrumasia.com/news/50/12978/akili-shionogi-to-develop-digital-therapeutics-in-key-asian-markets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12978/akili-shionogi-to-develop-digital-therapeutics-in-key-asian-markets.html</link>
			<pubDate>Mon, 11 Mar 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12978.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12978/akili-shionogi-to-develop-digital-therapeutics-in-key-asian-markets.html</guid>
		</item>	
				<item>
			<title>Santen to raise disease awareness during World Glaucoma Week</title>
			<atom:link href="https://biospectrumasia.com/news/50/12969/santen-to-raise-disease-awareness-during-world-glaucoma-week.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12969/santen-to-raise-disease-awareness-during-world-glaucoma-week.html</link>
			<pubDate>Fri, 08 Mar 2019 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12969.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12969/santen-to-raise-disease-awareness-during-world-glaucoma-week.html</guid>
		</item>	
				<item>
			<title>Eisai submits marketing authorization application for Insomnia drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/12963/eisai-submits-marketing-authorization-application-for-insomnia-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12963/eisai-submits-marketing-authorization-application-for-insomnia-drug-.html</link>
			<pubDate>Thu, 07 Mar 2019 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sleep_wake_disorder-12963.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12963/eisai-submits-marketing-authorization-application-for-insomnia-drug-.html</guid>
		</item>	
				<item>
			<title>Avita Medical to commercialize wounds treatment device in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12947/avita-medical-to-commercialize-wounds-treatment-device-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12947/avita-medical-to-commercialize-wounds-treatment-device-in-japan.html</link>
			<pubDate>Thu, 07 Mar 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12947.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12947/avita-medical-to-commercialize-wounds-treatment-device-in-japan.html</guid>
		</item>	
				<item>
			<title>Study: Inflammation in the brain enhances the side-effects of hypnotic medication</title>
			<atom:link href="https://biospectrumasia.com/news/50/12959/study-inflammation-in-the-brain-enhances-the-side-effects-of-hypnotic-medication.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12959/study-inflammation-in-the-brain-enhances-the-side-effects-of-hypnotic-medication.html</link>
			<pubDate>Wed, 06 Mar 2019 17:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-12959.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12959/study-inflammation-in-the-brain-enhances-the-side-effects-of-hypnotic-medication.html</guid>
		</item>	
				<item>
			<title>Scientists develop stem cell-derived kidney tubules in microfluidic chips</title>
			<atom:link href="https://biospectrumasia.com/news/50/12957/scientists-develop-stem-cell-derived-kidney-tubules-in-microfluidic-chips.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12957/scientists-develop-stem-cell-derived-kidney-tubules-in-microfluidic-chips.html</link>
			<pubDate>Wed, 06 Mar 2019 16:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientist-12957.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12957/scientists-develop-stem-cell-derived-kidney-tubules-in-microfluidic-chips.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk, Health2Sync collaborate for digital diabetes management</title>
			<atom:link href="https://biospectrumasia.com/news/50/12943/novo-nordisk-health2sync-collaborate-for-digital-diabetes-management.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12943/novo-nordisk-health2sync-collaborate-for-digital-diabetes-management.html</link>
			<pubDate>Tue, 05 Mar 2019 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12943.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12943/novo-nordisk-health2sync-collaborate-for-digital-diabetes-management.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk and Health2Sync bring digital diabetes management</title>
			<atom:link href="https://biospectrumasia.com/news/50/12952/novo-nordisk-and-health2sync-bring-digital-diabetes-management.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12952/novo-nordisk-and-health2sync-bring-digital-diabetes-management.html</link>
			<pubDate>Wed, 06 Mar 2019 12:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diabetes-12952.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12952/novo-nordisk-and-health2sync-bring-digital-diabetes-management.html</guid>
		</item>	
				<item>
			<title>Sagent Pharma acquires Raleigh manufacturing site</title>
			<atom:link href="https://biospectrumasia.com/news/50/12940/sagent-pharma-acquires-raleigh-manufacturing-site.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12940/sagent-pharma-acquires-raleigh-manufacturing-site.html</link>
			<pubDate>Tue, 05 Mar 2019 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12940.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12940/sagent-pharma-acquires-raleigh-manufacturing-site.html</guid>
		</item>	
				<item>
			<title>AGC completes acquisition of Malgrat Pharma Chemicals </title>
			<atom:link href="https://biospectrumasia.com/news/50/12931/agc-completes-acquisition-of-malgrat-pharma-chemicals-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12931/agc-completes-acquisition-of-malgrat-pharma-chemicals-.html</link>
			<pubDate>Mon, 04 Mar 2019 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12931.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12931/agc-completes-acquisition-of-malgrat-pharma-chemicals-.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher&#039;s oncomine test receives expanded approval</title>
			<atom:link href="https://biospectrumasia.com/news/50/12916/thermo-fishers-oncomine-test-receives-expanded-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12916/thermo-fishers-oncomine-test-receives-expanded-approval.html</link>
			<pubDate>Fri, 01 Mar 2019 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12916.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12916/thermo-fishers-oncomine-test-receives-expanded-approval.html</guid>
		</item>	
				<item>
			<title>CAC and rfxcel announce partnership for Pharmaceutical Traceability</title>
			<atom:link href="https://biospectrumasia.com/news/50/12905/cac-and-rfxcel-announce-partnership-for-pharmaceutical-traceability.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12905/cac-and-rfxcel-announce-partnership-for-pharmaceutical-traceability.html</link>
			<pubDate>Thu, 28 Feb 2019 09:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12905.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12905/cac-and-rfxcel-announce-partnership-for-pharmaceutical-traceability.html</guid>
		</item>	
				<item>
			<title>Eisai receives approval for an additional indication of HUMIRA </title>
			<atom:link href="https://biospectrumasia.com/news/50/12879/eisai-receives-approval-for-an-additional-indication-of-humira-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12879/eisai-receives-approval-for-an-additional-indication-of-humira-.html</link>
			<pubDate>Mon, 25 Feb 2019 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_29149_960_720-12879.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12879/eisai-receives-approval-for-an-additional-indication-of-humira-.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares initiates new clinical development programme</title>
			<atom:link href="https://biospectrumasia.com/news/50/12862/sosei-heptares-initiates-new-clinical-development-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12862/sosei-heptares-initiates-new-clinical-development-programme.html</link>
			<pubDate>Fri, 22 Feb 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12862.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12862/sosei-heptares-initiates-new-clinical-development-programme.html</guid>
		</item>	
				<item>
			<title>Japan second fastest pharma growth in 2019- CPhI Report</title>
			<atom:link href="https://biospectrumasia.com/news/50/12865/japan-second-fastest-pharma-growth-in-2019-cphi-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12865/japan-second-fastest-pharma-growth-in-2019-cphi-report.html</link>
			<pubDate>Thu, 21 Feb 2019 16:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12865.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12865/japan-second-fastest-pharma-growth-in-2019-cphi-report.html</guid>
		</item>	
				<item>
			<title>Generex Biotechnology Subsidiary granted approval for ECM hydrogel</title>
			<atom:link href="https://biospectrumasia.com/news/50/12859/generex-biotechnology-subsidiary-granted-approval-for-ecm-hydrogel.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12859/generex-biotechnology-subsidiary-granted-approval-for-ecm-hydrogel.html</link>
			<pubDate>Thu, 21 Feb 2019 11:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approval-12859.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12859/generex-biotechnology-subsidiary-granted-approval-for-ecm-hydrogel.html</guid>
		</item>	
				<item>
			<title>KCI launches ABTHERA Therapy in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12855/kci-launches-abthera-therapy-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12855/kci-launches-abthera-therapy-in-japan.html</link>
			<pubDate>Thu, 21 Feb 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12855.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12855/kci-launches-abthera-therapy-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai submits application in Europe to seek approval for Fycompa</title>
			<atom:link href="https://biospectrumasia.com/news/50/12802/eisai-submits-application-in-europe-to-seek-approval-for-fycompa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12802/eisai-submits-application-in-europe-to-seek-approval-for-fycompa.html</link>
			<pubDate>Fri, 15 Feb 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12802.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12802/eisai-submits-application-in-europe-to-seek-approval-for-fycompa.html</guid>
		</item>	
				<item>
			<title>Fujitsu launches healthcare personal service platform </title>
			<atom:link href="https://biospectrumasia.com/news/50/12806/fujitsu-launches-healthcare-personal-service-platform-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12806/fujitsu-launches-healthcare-personal-service-platform-.html</link>
			<pubDate>Thu, 14 Feb 2019 09:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12806.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12806/fujitsu-launches-healthcare-personal-service-platform-.html</guid>
		</item>	
				<item>
			<title>Researchers develop potential therapeutic model for Parkinson&#039;s disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/12788/researchers-develop-potential-therapeutic-model-for-parkinsons-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12788/researchers-develop-potential-therapeutic-model-for-parkinsons-disease.html</link>
			<pubDate>Tue, 12 Feb 2019 16:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neuro_disorder-12788.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12788/researchers-develop-potential-therapeutic-model-for-parkinsons-disease.html</guid>
		</item>	
				<item>
			<title>Takeda receives EC approval to extend the marketing authorization for ADCETRIS</title>
			<atom:link href="https://biospectrumasia.com/news/50/12783/takeda-receives-ec-approval-to-extend-the-marketing-authorization-for-adcetris.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12783/takeda-receives-ec-approval-to-extend-the-marketing-authorization-for-adcetris.html</link>
			<pubDate>Tue, 12 Feb 2019 13:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-12783.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12783/takeda-receives-ec-approval-to-extend-the-marketing-authorization-for-adcetris.html</guid>
		</item>	
				<item>
			<title>ROOT OF SKIN sells out for fifth consecutive time on QVC Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12778/root-of-skin-sells-out-for-fifth-consecutive-time-on-qvc-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12778/root-of-skin-sells-out-for-fifth-consecutive-time-on-qvc-japan.html</link>
			<pubDate>Tue, 12 Feb 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12778.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12778/root-of-skin-sells-out-for-fifth-consecutive-time-on-qvc-japan.html</guid>
		</item>	
				<item>
			<title>Optical Topography to timely diagnose Neurodevelopmental Disorders</title>
			<atom:link href="https://biospectrumasia.com/news/50/12769/optical-topography-to-timely-diagnose-neurodevelopmental-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12769/optical-topography-to-timely-diagnose-neurodevelopmental-disorders.html</link>
			<pubDate>Mon, 11 Feb 2019 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neuro_disorder-12769.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12769/optical-topography-to-timely-diagnose-neurodevelopmental-disorders.html</guid>
		</item>	
				<item>
			<title>Codexis signs enzyme supply agreement with Kyorin Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/12766/codexis-signs-enzyme-supply-agreement-with-kyorin-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12766/codexis-signs-enzyme-supply-agreement-with-kyorin-pharma.html</link>
			<pubDate>Mon, 11 Feb 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12766.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12766/codexis-signs-enzyme-supply-agreement-with-kyorin-pharma.html</guid>
		</item>	
				<item>
			<title>Kyowa Hakko Kirin initiates Ph 2 Clinical Study of Tenapanor</title>
			<atom:link href="https://biospectrumasia.com/news/50/12764/kyowa-hakko-kirin-initiates-ph-2-clinical-study-of-tenapanor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12764/kyowa-hakko-kirin-initiates-ph-2-clinical-study-of-tenapanor.html</link>
			<pubDate>Fri, 08 Feb 2019 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12764.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12764/kyowa-hakko-kirin-initiates-ph-2-clinical-study-of-tenapanor.html</guid>
		</item>	
				<item>
			<title>Eiger BioPharma gets patent protection for HDV drug in Europe and Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12763/eiger-biopharma-gets-patent-protection-for-hdv-drug-in-europe-and-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12763/eiger-biopharma-gets-patent-protection-for-hdv-drug-in-europe-and-japan.html</link>
			<pubDate>Fri, 08 Feb 2019 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12763.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12763/eiger-biopharma-gets-patent-protection-for-hdv-drug-in-europe-and-japan.html</guid>
		</item>	
				<item>
			<title>Roche &amp; Chugai join WFH aid programme</title>
			<atom:link href="https://biospectrumasia.com/news/50/12744/roche-chugai-join-wfh-aid-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12744/roche-chugai-join-wfh-aid-programme.html</link>
			<pubDate>Thu, 07 Feb 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12744.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12744/roche-chugai-join-wfh-aid-programme.html</guid>
		</item>	
				<item>
			<title>FALCO Bio, Promega kit obtains approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12737/falco-bio-promega-kit-obtains-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12737/falco-bio-promega-kit-obtains-approval-in-japan.html</link>
			<pubDate>Wed, 06 Feb 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12737.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12737/falco-bio-promega-kit-obtains-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>Taiho Pharma teams up with Cullinan Oncology</title>
			<atom:link href="https://biospectrumasia.com/news/50/12738/taiho-pharma-teams-up-with-cullinan-oncology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12738/taiho-pharma-teams-up-with-cullinan-oncology.html</link>
			<pubDate>Tue, 05 Feb 2019 23:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_3152586__340-12738.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12738/taiho-pharma-teams-up-with-cullinan-oncology.html</guid>
		</item>	
				<item>
			<title>Kaneka to invest 18.5% shares in medical device company</title>
			<atom:link href="https://biospectrumasia.com/news/50/12728/kaneka-to-invest-18-5-shares-in-medical-device-company.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12728/kaneka-to-invest-18-5-shares-in-medical-device-company.html</link>
			<pubDate>Tue, 05 Feb 2019 13:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/invest-12728.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12728/kaneka-to-invest-18-5-shares-in-medical-device-company.html</guid>
		</item>	
				<item>
			<title>Sosei announces collaboration with Medicxi </title>
			<atom:link href="https://biospectrumasia.com/news/50/12725/sosei-announces-collaboration-with-medicxi-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12725/sosei-announces-collaboration-with-medicxi-.html</link>
			<pubDate>Tue, 05 Feb 2019 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition_cover-12725.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12725/sosei-announces-collaboration-with-medicxi-.html</guid>
		</item>	
				<item>
			<title>Eisai, Purdue Pharma announce significant data of ph 3 clinical study</title>
			<atom:link href="https://biospectrumasia.com/news/50/12711/eisai-purdue-pharma-announce-significant-data-of-ph-3-clinical-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12711/eisai-purdue-pharma-announce-significant-data-of-ph-3-clinical-study.html</link>
			<pubDate>Mon, 04 Feb 2019 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12711.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12711/eisai-purdue-pharma-announce-significant-data-of-ph-3-clinical-study.html</guid>
		</item>	
				<item>
			<title>Positive CHMP opinion for Chugai&#039;s Hemlibra</title>
			<atom:link href="https://biospectrumasia.com/news/50/12719/positive-chmp-opinion-for-chugais-hemlibra.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12719/positive-chmp-opinion-for-chugais-hemlibra.html</link>
			<pubDate>Mon, 04 Feb 2019 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicine_296966__340-12719.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12719/positive-chmp-opinion-for-chugais-hemlibra.html</guid>
		</item>	
				<item>
			<title>Bayer ties up with Kyoto University for lung diseases treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/12706/bayer-ties-up-with-kyoto-university-for-lung-diseases-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12706/bayer-ties-up-with-kyoto-university-for-lung-diseases-treatment.html</link>
			<pubDate>Mon, 04 Feb 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12706.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12706/bayer-ties-up-with-kyoto-university-for-lung-diseases-treatment.html</guid>
		</item>	
				<item>
			<title>Researchers in Japan develop strategy to strengthen skeletal muscles</title>
			<atom:link href="https://biospectrumasia.com/news/50/12696/researchers-in-japan-develop-strategy-to-strengthen-skeletal-muscles.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12696/researchers-in-japan-develop-strategy-to-strengthen-skeletal-muscles.html</link>
			<pubDate>Fri, 01 Feb 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12696.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12696/researchers-in-japan-develop-strategy-to-strengthen-skeletal-muscles.html</guid>
		</item>	
				<item>
			<title>Hitachi to acquire apceth Biopharma </title>
			<atom:link href="https://biospectrumasia.com/news/50/12695/hitachi-to-acquire-apceth-biopharma-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12695/hitachi-to-acquire-apceth-biopharma-.html</link>
			<pubDate>Fri, 01 Feb 2019 10:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition_min-12695.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12695/hitachi-to-acquire-apceth-biopharma-.html</guid>
		</item>	
				<item>
			<title>Huadong Ningbo Medicine showcases its products at COSME TOKYO</title>
			<atom:link href="https://biospectrumasia.com/news/50/12677/huadong-ningbo-medicine-showcases-its-products-at-cosme-tokyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12677/huadong-ningbo-medicine-showcases-its-products-at-cosme-tokyo.html</link>
			<pubDate>Wed, 30 Jan 2019 17:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jap-12677.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12677/huadong-ningbo-medicine-showcases-its-products-at-cosme-tokyo.html</guid>
		</item>	
				<item>
			<title>NextPharma to acquire Santen&#039;s Tampere manufacturing facility</title>
			<atom:link href="https://biospectrumasia.com/news/50/12670/nextpharma-to-acquire-santens-tampere-manufacturing-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12670/nextpharma-to-acquire-santens-tampere-manufacturing-facility.html</link>
			<pubDate>Wed, 30 Jan 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12670.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12670/nextpharma-to-acquire-santens-tampere-manufacturing-facility.html</guid>
		</item>	
				<item>
			<title>Fujitsu launches SaaS solution tsClinical DDworks21/Trial Site</title>
			<atom:link href="https://biospectrumasia.com/news/50/12664/fujitsu-launches-saas-solution-tsclinical-ddworks21-trial-site.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12664/fujitsu-launches-saas-solution-tsclinical-ddworks21-trial-site.html</link>
			<pubDate>Tue, 29 Jan 2019 13:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12664.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12664/fujitsu-launches-saas-solution-tsclinical-ddworks21-trial-site.html</guid>
		</item>	
				<item>
			<title>WHO employs directors for Western Pacific and Southeast Asia regions</title>
			<atom:link href="https://biospectrumasia.com/news/50/12648/who-employs-directors-for-western-pacific-and-southeast-asia-regions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12648/who-employs-directors-for-western-pacific-and-southeast-asia-regions.html</link>
			<pubDate>Mon, 28 Jan 2019 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/recruit_jpg_2-12648.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12648/who-employs-directors-for-western-pacific-and-southeast-asia-regions.html</guid>
		</item>	
				<item>
			<title>Meiji Seika, Toray sign license agreement for antipuritic agent</title>
			<atom:link href="https://biospectrumasia.com/news/50/12630/meiji-seika-toray-sign-license-agreement-for-antipuritic-agent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12630/meiji-seika-toray-sign-license-agreement-for-antipuritic-agent.html</link>
			<pubDate>Fri, 25 Jan 2019 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12630.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12630/meiji-seika-toray-sign-license-agreement-for-antipuritic-agent.html</guid>
		</item>	
				<item>
			<title>Qiagen receives Japanese PMDA approval for cancer diagnostic kit</title>
			<atom:link href="https://biospectrumasia.com/news/50/12620/qiagen-receives-japanese-pmda-approval-for-cancer-diagnostic-kit.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12620/qiagen-receives-japanese-pmda-approval-for-cancer-diagnostic-kit.html</link>
			<pubDate>Thu, 24 Jan 2019 15:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12620.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12620/qiagen-receives-japanese-pmda-approval-for-cancer-diagnostic-kit.html</guid>
		</item>	
				<item>
			<title>Nipro to use FlowForma to automate field processes</title>
			<atom:link href="https://biospectrumasia.com/news/50/12621/nipro-to-use-flowforma-to-automate-field-processes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12621/nipro-to-use-flowforma-to-automate-field-processes.html</link>
			<pubDate>Thu, 24 Jan 2019 15:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/automation_2-12621.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12621/nipro-to-use-flowforma-to-automate-field-processes.html</guid>
		</item>	
				<item>
			<title>Polyplastics develops new DURACON(R) POM PM Series for healthcare industry</title>
			<atom:link href="https://biospectrumasia.com/news/50/12611/polyplastics-develops-new-duraconr-pom-pm-series-for-healthcare-industry.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12611/polyplastics-develops-new-duraconr-pom-pm-series-for-healthcare-industry.html</link>
			<pubDate>Wed, 23 Jan 2019 17:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/polyplastics-12611.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12611/polyplastics-develops-new-duraconr-pom-pm-series-for-healthcare-industry.html</guid>
		</item>	
				<item>
			<title>Eisai listed as Global 100 most sustainable corporation </title>
			<atom:link href="https://biospectrumasia.com/news/50/12594/eisai-listed-as-global-100-most-sustainable-corporation-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12594/eisai-listed-as-global-100-most-sustainable-corporation-.html</link>
			<pubDate>Tue, 22 Jan 2019 16:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/recognition_2-12594.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12594/eisai-listed-as-global-100-most-sustainable-corporation-.html</guid>
		</item>	
				<item>
			<title>Mechanical stress may affect normal bone development</title>
			<atom:link href="https://biospectrumasia.com/news/50/12585/mechanical-stress-may-affect-normal-bone-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12585/mechanical-stress-may-affect-normal-bone-development.html</link>
			<pubDate>Mon, 21 Jan 2019 17:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ortho_jpg_2-12585.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12585/mechanical-stress-may-affect-normal-bone-development.html</guid>
		</item>	
				<item>
			<title>Thyas signs a licensing agreement with iPS-AJ </title>
			<atom:link href="https://biospectrumasia.com/news/50/12572/thyas-signs-a-licensing-agreement-with-ips-aj-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12572/thyas-signs-a-licensing-agreement-with-ips-aj-.html</link>
			<pubDate>Fri, 18 Jan 2019 21:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement2-12572.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12572/thyas-signs-a-licensing-agreement-with-ips-aj-.html</guid>
		</item>	
				<item>
			<title>J&amp;J completes acquisition of Ci:z Holdings </title>
			<atom:link href="https://biospectrumasia.com/news/50/12566/jj-completes-acquisition-of-ciz-holdings-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12566/jj-completes-acquisition-of-ciz-holdings-.html</link>
			<pubDate>Fri, 18 Jan 2019 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/584_main-12566.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12566/jj-completes-acquisition-of-ciz-holdings-.html</guid>
		</item>	
				<item>
			<title>AIVITA gets IND nod for Phase 1B melanoma trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/12558/aivita-gets-ind-nod-for-phase-1b-melanoma-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12558/aivita-gets-ind-nod-for-phase-1b-melanoma-trial.html</link>
			<pubDate>Thu, 17 Jan 2019 13:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical_trial_2-12558.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12558/aivita-gets-ind-nod-for-phase-1b-melanoma-trial.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo to lead open innovation research on cell therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/12503/daiichi-sankyo-to-lead-open-innovation-research-on-cell-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12503/daiichi-sankyo-to-lead-open-innovation-research-on-cell-therapy.html</link>
			<pubDate>Fri, 11 Jan 2019 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12503.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12503/daiichi-sankyo-to-lead-open-innovation-research-on-cell-therapy.html</guid>
		</item>	
				<item>
			<title>Japan approves Amgen&#039;s osteoporosis drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/12502/japan-approves-amgens-osteoporosis-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12502/japan-approves-amgens-osteoporosis-drug.html</link>
			<pubDate>Thu, 10 Jan 2019 14:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12502.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12502/japan-approves-amgens-osteoporosis-drug.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo receives regulatory approval for hypertension tablets</title>
			<atom:link href="https://biospectrumasia.com/news/50/12493/daiichi-sankyo-receives-regulatory-approval-for-hypertension-tablets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12493/daiichi-sankyo-receives-regulatory-approval-for-hypertension-tablets.html</link>
			<pubDate>Thu, 10 Jan 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12493.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12493/daiichi-sankyo-receives-regulatory-approval-for-hypertension-tablets.html</guid>
		</item>	
				<item>
			<title>NapaJen Pharma closes $12.4M Series C financing</title>
			<atom:link href="https://biospectrumasia.com/news/50/12490/napajen-pharma-closes-12-4m-series-c-financing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12490/napajen-pharma-closes-12-4m-series-c-financing.html</link>
			<pubDate>Wed, 09 Jan 2019 16:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/financing_1_-12490.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12490/napajen-pharma-closes-12-4m-series-c-financing.html</guid>
		</item>	
				<item>
			<title>Takeda completes acquisition of Shire</title>
			<atom:link href="https://biospectrumasia.com/news/50/12474/takeda-completes-acquisition-of-shire.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12474/takeda-completes-acquisition-of-shire.html</link>
			<pubDate>Tue, 08 Jan 2019 15:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition-12474.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12474/takeda-completes-acquisition-of-shire.html</guid>
		</item>	
				<item>
			<title>Fujifilm to invest 10B Yen in Bio CDMO biz</title>
			<atom:link href="https://biospectrumasia.com/news/50/12469/fujifilm-to-invest-10b-yen-in-bio-cdmo-biz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12469/fujifilm-to-invest-10b-yen-in-bio-cdmo-biz.html</link>
			<pubDate>Tue, 08 Jan 2019 10:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12469.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12469/fujifilm-to-invest-10b-yen-in-bio-cdmo-biz.html</guid>
		</item>	
				<item>
			<title>Solasia initiates Phase III programme for PledOx</title>
			<atom:link href="https://biospectrumasia.com/news/50/12455/solasia-initiates-phase-iii-programme-for-pledox.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12455/solasia-initiates-phase-iii-programme-for-pledox.html</link>
			<pubDate>Mon, 07 Jan 2019 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinicaltrial_702x336-12455.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12455/solasia-initiates-phase-iii-programme-for-pledox.html</guid>
		</item>	
				<item>
			<title>Otsuka, Click Therapeutics to create therapy for mental illness</title>
			<atom:link href="https://biospectrumasia.com/news/50/12452/otsuka-click-therapeutics-to-create-therapy-for-mental-illness.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12452/otsuka-click-therapeutics-to-create-therapy-for-mental-illness.html</link>
			<pubDate>Mon, 07 Jan 2019 10:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12452.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12452/otsuka-click-therapeutics-to-create-therapy-for-mental-illness.html</guid>
		</item>	
				<item>
			<title>Takeda announces multiple cell therapy collaborations </title>
			<atom:link href="https://biospectrumasia.com/news/50/12440/takeda-announces-multiple-cell-therapy-collaborations-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12440/takeda-announces-multiple-cell-therapy-collaborations-.html</link>
			<pubDate>Fri, 04 Jan 2019 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration-12440.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12440/takeda-announces-multiple-cell-therapy-collaborations-.html</guid>
		</item>	
				<item>
			<title>Researchers discover laminin which can convert stem cells into retinal-like cells</title>
			<atom:link href="https://biospectrumasia.com/news/50/12416/researchers-discover-laminin-which-can-convert-stem-cells-into-retinal-like-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12416/researchers-discover-laminin-which-can-convert-stem-cells-into-retinal-like-cells.html</link>
			<pubDate>Wed, 02 Jan 2019 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eye-12416.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12416/researchers-discover-laminin-which-can-convert-stem-cells-into-retinal-like-cells.html</guid>
		</item>	
				<item>
			<title>MediPharm Labs declares its addition to HMMJ Index</title>
			<atom:link href="https://biospectrumasia.com/news/50/12403/medipharm-labs-declares-its-addition-to-hmmj-index.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12403/medipharm-labs-declares-its-addition-to-hmmj-index.html</link>
			<pubDate>Mon, 31 Dec 2018 16:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/canabis-12403.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12403/medipharm-labs-declares-its-addition-to-hmmj-index.html</guid>
		</item>	
				<item>
			<title>Taisho Pharmaceutical Holdings to purchase BMS&#039;s UPSA </title>
			<atom:link href="https://biospectrumasia.com/news/50/12395/taisho-pharmaceutical-holdings-to-purchase-bmss-upsa-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12395/taisho-pharmaceutical-holdings-to-purchase-bmss-upsa-.html</link>
			<pubDate>Sun, 30 Dec 2018 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/globalisation_1734176_960_720-12395.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12395/taisho-pharmaceutical-holdings-to-purchase-bmss-upsa-.html</guid>
		</item>	
				<item>
			<title>Foundation Medicine gets regulatory approval for its genomic profiling test in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12389/foundation-medicine-gets-regulatory-approval-for-its-genomic-profiling-test-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12389/foundation-medicine-gets-regulatory-approval-for-its-genomic-profiling-test-in-japan.html</link>
			<pubDate>Fri, 28 Dec 2018 15:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_1966719_960_720-12389.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12389/foundation-medicine-gets-regulatory-approval-for-its-genomic-profiling-test-in-japan.html</guid>
		</item>	
				<item>
			<title>Prevelance of colistin-resistance high in Vietnam: Research</title>
			<atom:link href="https://biospectrumasia.com/news/50/12387/prevelance-of-colistin-resistance-high-in-vietnam-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12387/prevelance-of-colistin-resistance-high-in-vietnam-research.html</link>
			<pubDate>Fri, 28 Dec 2018 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibiotic_sensitvity_and_resistance-12387.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12387/prevelance-of-colistin-resistance-high-in-vietnam-research.html</guid>
		</item>	
				<item>
			<title>Chugai obtains approval for Genomic Mutation Analysis Program </title>
			<atom:link href="https://biospectrumasia.com/news/50/12385/chugai-obtains-approval-for-genomic-mutation-analysis-program-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12385/chugai-obtains-approval-for-genomic-mutation-analysis-program-.html</link>
			<pubDate>Thu, 27 Dec 2018 17:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mutation_analysis_overview-12385.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12385/chugai-obtains-approval-for-genomic-mutation-analysis-program-.html</guid>
		</item>	
				<item>
			<title>Rakuten Aspyrian closes $284 Million Series C Financing for late-stage oncology pipeline</title>
			<atom:link href="https://biospectrumasia.com/news/50/12373/rakuten-aspyrian-closes-284-million-series-c-financing-for-late-stage-oncology-pipeline.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12373/rakuten-aspyrian-closes-284-million-series-c-financing-for-late-stage-oncology-pipeline.html</link>
			<pubDate>Wed, 26 Dec 2018 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money_1428594_960_720-12373.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12373/rakuten-aspyrian-closes-284-million-series-c-financing-for-late-stage-oncology-pipeline.html</guid>
		</item>	
				<item>
			<title>Mundipharma applies for marketing Remimazolam in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12363/mundipharma-applies-for-marketing-remimazolam-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12363/mundipharma-applies-for-marketing-remimazolam-in-japan.html</link>
			<pubDate>Fri, 21 Dec 2018 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12363.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12363/mundipharma-applies-for-marketing-remimazolam-in-japan.html</guid>
		</item>	
				<item>
			<title>Roivant Sciences, Daiichi Sankyo enter into broad pipeline partnership</title>
			<atom:link href="https://biospectrumasia.com/news/50/12351/roivant-sciences-daiichi-sankyo-enter-into-broad-pipeline-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12351/roivant-sciences-daiichi-sankyo-enter-into-broad-pipeline-partnership.html</link>
			<pubDate>Thu, 20 Dec 2018 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership_small_9065-12351.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12351/roivant-sciences-daiichi-sankyo-enter-into-broad-pipeline-partnership.html</guid>
		</item>	
				<item>
			<title>Ajinomoto and XL-protein unite to develop therapeutic compounds</title>
			<atom:link href="https://biospectrumasia.com/news/50/12345/ajinomoto-and-xl-protein-unite-to-develop-therapeutic-compounds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12345/ajinomoto-and-xl-protein-unite-to-develop-therapeutic-compounds.html</link>
			<pubDate>Wed, 19 Dec 2018 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/life_science_pharma-12345.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12345/ajinomoto-and-xl-protein-unite-to-develop-therapeutic-compounds.html</guid>
		</item>	
				<item>
			<title>Fuji Pharma Invests in Alvotech for $50M</title>
			<atom:link href="https://biospectrumasia.com/news/50/12344/fuji-pharma-invests-in-alvotech-for-50m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12344/fuji-pharma-invests-in-alvotech-for-50m.html</link>
			<pubDate>Wed, 19 Dec 2018 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/capsule_158568__340-12344.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12344/fuji-pharma-invests-in-alvotech-for-50m.html</guid>
		</item>	
				<item>
			<title>Study shows Stelara works superbly in Crohn&#039;s disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/12323/study-shows-stelara-works-superbly-in-crohns-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12323/study-shows-stelara-works-superbly-in-crohns-disease.html</link>
			<pubDate>Tue, 18 Dec 2018 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/crohn_disease-12323.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12323/study-shows-stelara-works-superbly-in-crohns-disease.html</guid>
		</item>	
				<item>
			<title>AIVITA Biomedical to sell skincare line in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/12317/aivita-biomedical-to-sell-skincare-line-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12317/aivita-biomedical-to-sell-skincare-line-in-japan-.html</link>
			<pubDate>Tue, 18 Dec 2018 11:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem_cell_therapy-12317.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12317/aivita-biomedical-to-sell-skincare-line-in-japan-.html</guid>
		</item>	
				<item>
			<title>Eisai signs pact with Eurofarma for anti-Obesity agent </title>
			<atom:link href="https://biospectrumasia.com/news/50/12300/eisai-signs-pact-with-eurofarma-for-anti-obesity-agent-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12300/eisai-signs-pact-with-eurofarma-for-anti-obesity-agent-.html</link>
			<pubDate>Mon, 17 Dec 2018 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/obesity_1_-12300.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12300/eisai-signs-pact-with-eurofarma-for-anti-obesity-agent-.html</guid>
		</item>	
				<item>
			<title>Luye Pharma submits its Parkinson&#039;s drug for clinical trial approval </title>
			<atom:link href="https://biospectrumasia.com/news/50/12287/luye-pharma-submits-its-parkinsons-drug-for-clinical-trial-approval-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12287/luye-pharma-submits-its-parkinsons-drug-for-clinical-trial-approval-.html</link>
			<pubDate>Thu, 13 Dec 2018 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/injection-12287.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12287/luye-pharma-submits-its-parkinsons-drug-for-clinical-trial-approval-.html</guid>
		</item>	
				<item>
			<title>GHIT Fund to invest $4.6M for new projects on drug development</title>
			<atom:link href="https://biospectrumasia.com/news/50/12284/ghit-fund-to-invest-4-6m-for-new-projects-on-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12284/ghit-fund-to-invest-4-6m-for-new-projects-on-drug-development.html</link>
			<pubDate>Thu, 13 Dec 2018 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12284.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12284/ghit-fund-to-invest-4-6m-for-new-projects-on-drug-development.html</guid>
		</item>	
				<item>
			<title>Eisai, Takeda and GARDP sign pact to develop novel antibiotics</title>
			<atom:link href="https://biospectrumasia.com/news/50/12283/eisai-takeda-and-gardp-sign-pact-to-develop-novel-antibiotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12283/eisai-takeda-and-gardp-sign-pact-to-develop-novel-antibiotics.html</link>
			<pubDate>Thu, 13 Dec 2018 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibiotics-12283.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12283/eisai-takeda-and-gardp-sign-pact-to-develop-novel-antibiotics.html</guid>
		</item>	
				<item>
			<title>Mundipharma to distribute Norspan in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12262/mundipharma-to-distribute-norspan-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12262/mundipharma-to-distribute-norspan-in-japan.html</link>
			<pubDate>Tue, 11 Dec 2018 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12262.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12262/mundipharma-to-distribute-norspan-in-japan.html</guid>
		</item>	
				<item>
			<title>HitGen, Mitsubishi Tanabe Pharma ink deal to foster drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/12266/hitgen-mitsubishi-tanabe-pharma-ink-deal-to-foster-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12266/hitgen-mitsubishi-tanabe-pharma-ink-deal-to-foster-drug-discovery.html</link>
			<pubDate>Tue, 11 Dec 2018 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/globalisation_1734176_960_720-12266.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12266/hitgen-mitsubishi-tanabe-pharma-ink-deal-to-foster-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Cabinet approves MoU between India, Japan for Healthcare and Wellness</title>
			<atom:link href="https://biospectrumasia.com/news/50/12248/cabinet-approves-mou-between-india-japan-for-healthcare-and-wellness.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12248/cabinet-approves-mou-between-india-japan-for-healthcare-and-wellness.html</link>
			<pubDate>Fri, 07 Dec 2018 16:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-12248.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12248/cabinet-approves-mou-between-india-japan-for-healthcare-and-wellness.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo shows updated Phase 1 Data for U3-1402 in cancer patient</title>
			<atom:link href="https://biospectrumasia.com/news/50/12236/daiichi-sankyo-shows-updated-phase-1-data-for-u3-1402-in-cancer-patient.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12236/daiichi-sankyo-shows-updated-phase-1-data-for-u3-1402-in-cancer-patient.html</link>
			<pubDate>Thu, 06 Dec 2018 15:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_1-12236.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12236/daiichi-sankyo-shows-updated-phase-1-data-for-u3-1402-in-cancer-patient.html</guid>
		</item>	
				<item>
			<title>AGC enters agreement to acquire Malgrat Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/12225/agc-enters-agreement-to-acquire-malgrat-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12225/agc-enters-agreement-to-acquire-malgrat-pharma.html</link>
			<pubDate>Wed, 05 Dec 2018 12:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition-12225.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12225/agc-enters-agreement-to-acquire-malgrat-pharma.html</guid>
		</item>	
				<item>
			<title>VSee Telehealth launches in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12223/vsee-telehealth-launches-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12223/vsee-telehealth-launches-in-japan.html</link>
			<pubDate>Wed, 05 Dec 2018 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12223.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12223/vsee-telehealth-launches-in-japan.html</guid>
		</item>	
				<item>
			<title>Researchers develop platelets in lab </title>
			<atom:link href="https://biospectrumasia.com/news/50/12201/researchers-develop-platelets-in-lab-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12201/researchers-develop-platelets-in-lab-.html</link>
			<pubDate>Fri, 30 Nov 2018 16:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/platelets_-12201.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12201/researchers-develop-platelets-in-lab-.html</guid>
		</item>	
				<item>
			<title>Sun Pharma acquires Japan&#039;s Pola Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/12194/sun-pharma-acquires-japans-pola-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12194/sun-pharma-acquires-japans-pola-pharma.html</link>
			<pubDate>Thu, 29 Nov 2018 22:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/capsule_158568__340-12194.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12194/sun-pharma-acquires-japans-pola-pharma.html</guid>
		</item>	
				<item>
			<title>AminoIndex risk screening: Catching cancer before it starts</title>
			<atom:link href="https://biospectrumasia.com/news/50/12192/aminoindex-risk-screening-catching-cancer-before-it-starts.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12192/aminoindex-risk-screening-catching-cancer-before-it-starts.html</link>
			<pubDate>Thu, 29 Nov 2018 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-12192.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12192/aminoindex-risk-screening-catching-cancer-before-it-starts.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo launches Trastuzumab Biosimilar in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12187/daiichi-sankyo-launches-trastuzumab-biosimilar-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12187/daiichi-sankyo-launches-trastuzumab-biosimilar-in-japan.html</link>
			<pubDate>Wed, 28 Nov 2018 22:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12187.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12187/daiichi-sankyo-launches-trastuzumab-biosimilar-in-japan.html</guid>
		</item>	
				<item>
			<title>Ono files for approval of ONO-7643 in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12189/ono-files-for-approval-of-ono-7643-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12189/ono-files-for-approval-of-ono-7643-in-japan.html</link>
			<pubDate>Wed, 28 Nov 2018 19:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fish_oil_1915424__340-12189.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12189/ono-files-for-approval-of-ono-7643-in-japan.html</guid>
		</item>	
				<item>
			<title>Sysmex, MolecularMD commence global partnership</title>
			<atom:link href="https://biospectrumasia.com/news/50/12180/sysmex-molecularmd-commence-global-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12180/sysmex-molecularmd-commence-global-partnership.html</link>
			<pubDate>Wed, 28 Nov 2018 14:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12180.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12180/sysmex-molecularmd-commence-global-partnership.html</guid>
		</item>	
				<item>
			<title>EC Approves Takeda&#039;s ALUNBRIG for ALK+ Non-Small Cell Lung Cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/12175/ec-approves-takedas-alunbrig-for-alk-non-small-cell-lung-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12175/ec-approves-takedas-alunbrig-for-alk-non-small-cell-lung-cancer.html</link>
			<pubDate>Wed, 28 Nov 2018 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lung_cancer-12175.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12175/ec-approves-takedas-alunbrig-for-alk-non-small-cell-lung-cancer.html</guid>
		</item>	
				<item>
			<title>Eisai to present new research on Eribulin at SABC Symposium</title>
			<atom:link href="https://biospectrumasia.com/news/50/12170/eisai-to-present-new-research-on-eribulin-at-sabc-symposium.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12170/eisai-to-present-new-research-on-eribulin-at-sabc-symposium.html</link>
			<pubDate>Tue, 27 Nov 2018 16:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_1-12170.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12170/eisai-to-present-new-research-on-eribulin-at-sabc-symposium.html</guid>
		</item>	
				<item>
			<title>Mitsui invests in Indian healthcare platform biz</title>
			<atom:link href="https://biospectrumasia.com/news/50/12150/mitsui-invests-in-indian-healthcare-platform-biz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12150/mitsui-invests-in-indian-healthcare-platform-biz.html</link>
			<pubDate>Mon, 26 Nov 2018 13:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/conference-12150.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12150/mitsui-invests-in-indian-healthcare-platform-biz.html</guid>
		</item>	
				<item>
			<title>Japan Govt. takes lead to collaborate Japanese Healthcare with Germany </title>
			<atom:link href="https://biospectrumasia.com/news/50/12141/japan-govt-takes-lead-to-collaborate-japanese-healthcare-with-germany-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12141/japan-govt-takes-lead-to-collaborate-japanese-healthcare-with-germany-.html</link>
			<pubDate>Fri, 23 Nov 2018 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration-12141.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12141/japan-govt-takes-lead-to-collaborate-japanese-healthcare-with-germany-.html</guid>
		</item>	
				<item>
			<title>Eisai to present latest data on Perampanel at AES annual meeting</title>
			<atom:link href="https://biospectrumasia.com/news/50/12137/eisai-to-present-latest-data-on-perampanel-at-aes-annual-meeting.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12137/eisai-to-present-latest-data-on-perampanel-at-aes-annual-meeting.html</link>
			<pubDate>Fri, 23 Nov 2018 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets-12137.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12137/eisai-to-present-latest-data-on-perampanel-at-aes-annual-meeting.html</guid>
		</item>	
				<item>
			<title>Takeda receives clearance from EC for proposed acquisition of Shire</title>
			<atom:link href="https://biospectrumasia.com/news/50/12136/takeda-receives-clearance-from-ec-for-proposed-acquisition-of-shire.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12136/takeda-receives-clearance-from-ec-for-proposed-acquisition-of-shire.html</link>
			<pubDate>Thu, 22 Nov 2018 16:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition_agreement_creative_commons-12136.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12136/takeda-receives-clearance-from-ec-for-proposed-acquisition-of-shire.html</guid>
		</item>	
				<item>
			<title>Alvotech, Fuji Pharma partner for biosimilars</title>
			<atom:link href="https://biospectrumasia.com/news/50/12109/alvotech-fuji-pharma-partner-for-biosimilars.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12109/alvotech-fuji-pharma-partner-for-biosimilars.html</link>
			<pubDate>Tue, 20 Nov 2018 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership_1_-12109.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12109/alvotech-fuji-pharma-partner-for-biosimilars.html</guid>
		</item>	
				<item>
			<title>Mundipharma to bring world&#039;s first gene therapy for knee osteoarthritis </title>
			<atom:link href="https://biospectrumasia.com/news/50/12096/mundipharma-to-bring-worlds-first-gene-therapy-for-knee-osteoarthritis-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12096/mundipharma-to-bring-worlds-first-gene-therapy-for-knee-osteoarthritis-.html</link>
			<pubDate>Mon, 19 Nov 2018 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/arthritis_knee-12096.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12096/mundipharma-to-bring-worlds-first-gene-therapy-for-knee-osteoarthritis-.html</guid>
		</item>	
				<item>
			<title>Karl Deisseroth receives Japan&#039;s Kyoto prize in advanced technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/12095/karl-deisseroth-receives-japans-kyoto-prize-in-advanced-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12095/karl-deisseroth-receives-japans-kyoto-prize-in-advanced-technology.html</link>
			<pubDate>Mon, 19 Nov 2018 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2_dr_karl_deisseroth_receives_prize-12095.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12095/karl-deisseroth-receives-japans-kyoto-prize-in-advanced-technology.html</guid>
		</item>	
				<item>
			<title>HeartFlow receives reimbursement approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/12093/heartflow-receives-reimbursement-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12093/heartflow-receives-reimbursement-approval-in-japan.html</link>
			<pubDate>Mon, 19 Nov 2018 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12093.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12093/heartflow-receives-reimbursement-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda sets target date to close $62B Shire deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/12057/takeda-sets-target-date-to-close-62b-shire-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12057/takeda-sets-target-date-to-close-62b-shire-deal.html</link>
			<pubDate>Mon, 12 Nov 2018 18:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2000px_logo_takeda_svg_1_-12057.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12057/takeda-sets-target-date-to-close-62b-shire-deal.html</guid>
		</item>	
				<item>
			<title>Philips, Allm to develop mobile diagnostic solutions</title>
			<atom:link href="https://biospectrumasia.com/news/50/12050/philips-allm-to-develop-mobile-diagnostic-solutions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12050/philips-allm-to-develop-mobile-diagnostic-solutions.html</link>
			<pubDate>Mon, 12 Nov 2018 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12050.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12050/philips-allm-to-develop-mobile-diagnostic-solutions.html</guid>
		</item>	
				<item>
			<title>Japan conducts world&#039;s first iPS cell transplant for Parkinson&#039;s</title>
			<atom:link href="https://biospectrumasia.com/news/50/12044/japan-conducts-worlds-first-ips-cell-transplant-for-parkinsons.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12044/japan-conducts-worlds-first-ips-cell-transplant-for-parkinsons.html</link>
			<pubDate>Sat, 10 Nov 2018 19:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12044.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12044/japan-conducts-worlds-first-ips-cell-transplant-for-parkinsons.html</guid>
		</item>	
				<item>
			<title>MEI Pharma, KHK to develop and commercialize ME-401</title>
			<atom:link href="https://biospectrumasia.com/news/50/12026/mei-pharma-khk-to-develop-and-commercialize-me-401.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12026/mei-pharma-khk-to-develop-and-commercialize-me-401.html</link>
			<pubDate>Mon, 05 Nov 2018 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12026.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12026/mei-pharma-khk-to-develop-and-commercialize-me-401.html</guid>
		</item>	
				<item>
			<title>HKSTP showcases Hong Kong&#039;s Innovation and Technology edge</title>
			<atom:link href="https://biospectrumasia.com/news/50/12008/hkstp-showcases-hong-kongs-innovation-and-technology-edge.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/12008/hkstp-showcases-hong-kongs-innovation-and-technology-edge.html</link>
			<pubDate>Fri, 02 Nov 2018 13:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-12008.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/12008/hkstp-showcases-hong-kongs-innovation-and-technology-edge.html</guid>
		</item>	
				<item>
			<title>Kissei buys exclusive rights of Tavalisse in Asian countries</title>
			<atom:link href="https://biospectrumasia.com/news/50/11997/kissei-buys-exclusive-rights-of-tavalisse-in-asian-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11997/kissei-buys-exclusive-rights-of-tavalisse-in-asian-countries.html</link>
			<pubDate>Thu, 01 Nov 2018 13:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills-11997.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11997/kissei-buys-exclusive-rights-of-tavalisse-in-asian-countries.html</guid>
		</item>	
				<item>
			<title>Green Science Alliance starts production of Chitin, Chitosan Nanofiber</title>
			<atom:link href="https://biospectrumasia.com/news/50/11982/green-science-alliance-starts-production-of-chitin-chitosan-nanofiber.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11982/green-science-alliance-starts-production-of-chitin-chitosan-nanofiber.html</link>
			<pubDate>Tue, 30 Oct 2018 14:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chitin_nanofibre-11982.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11982/green-science-alliance-starts-production-of-chitin-chitosan-nanofiber.html</guid>
		</item>	
				<item>
			<title>Mitsui Chemicals, Chitose Group launch novel open innovation initiative</title>
			<atom:link href="https://biospectrumasia.com/news/50/11981/mitsui-chemicals-chitose-group-launch-novel-open-innovation-initiative.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11981/mitsui-chemicals-chitose-group-launch-novel-open-innovation-initiative.html</link>
			<pubDate>Tue, 30 Oct 2018 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/innovation-11981.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11981/mitsui-chemicals-chitose-group-launch-novel-open-innovation-initiative.html</guid>
		</item>	
				<item>
			<title>NEC, Transgene collaborate for individualized cancer immunotherapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/11976/nec-transgene-collaborate-for-individualized-cancer-immunotherapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11976/nec-transgene-collaborate-for-individualized-cancer-immunotherapy.html</link>
			<pubDate>Tue, 30 Oct 2018 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nec-11976.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11976/nec-transgene-collaborate-for-individualized-cancer-immunotherapy.html</guid>
		</item>	
				<item>
			<title>Daiichi enters clinical collaboration with Merck, Pfizer</title>
			<atom:link href="https://biospectrumasia.com/news/50/11965/daiichi-enters-clinical-collaboration-with-merck-pfizer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11965/daiichi-enters-clinical-collaboration-with-merck-pfizer.html</link>
			<pubDate>Sat, 27 Oct 2018 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11965.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11965/daiichi-enters-clinical-collaboration-with-merck-pfizer.html</guid>
		</item>	
				<item>
			<title>Mesoblast licensee seeks expanded indication for stem cell product in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/11948/mesoblast-licensee-seeks-expanded-indication-for-stem-cell-product-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11948/mesoblast-licensee-seeks-expanded-indication-for-stem-cell-product-in-japan.html</link>
			<pubDate>Wed, 24 Oct 2018 19:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11948.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11948/mesoblast-licensee-seeks-expanded-indication-for-stem-cell-product-in-japan.html</guid>
		</item>	
				<item>
			<title>J &amp; J announces Offer to Acquire Ci:z Holdings Co., Ltd.</title>
			<atom:link href="https://biospectrumasia.com/news/50/11934/j-j-announces-offer-to-acquire-ciz-holdings-co-ltd-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11934/j-j-announces-offer-to-acquire-ciz-holdings-co-ltd-.html</link>
			<pubDate>Tue, 23 Oct 2018 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition-11934.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11934/j-j-announces-offer-to-acquire-ciz-holdings-co-ltd-.html</guid>
		</item>	
				<item>
			<title>Eisai, MSD start marketing activity for LENVIMA</title>
			<atom:link href="https://biospectrumasia.com/news/50/11929/eisai-msd-start-marketing-activity-for-lenvima.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11929/eisai-msd-start-marketing-activity-for-lenvima.html</link>
			<pubDate>Tue, 23 Oct 2018 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11929.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11929/eisai-msd-start-marketing-activity-for-lenvima.html</guid>
		</item>	
				<item>
			<title>Anaeropharma, Chugai come together to create Novel Oncology Drugs </title>
			<atom:link href="https://biospectrumasia.com/news/50/11920/anaeropharma-chugai-come-together-to-create-novel-oncology-drugs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11920/anaeropharma-chugai-come-together-to-create-novel-oncology-drugs-.html</link>
			<pubDate>Mon, 22 Oct 2018 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaborate-11920.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11920/anaeropharma-chugai-come-together-to-create-novel-oncology-drugs-.html</guid>
		</item>	
				<item>
			<title>Eisai discovers new compound to treat Parkinson&#039;s disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/11912/eisai-discovers-new-compound-to-treat-parkinsons-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11912/eisai-discovers-new-compound-to-treat-parkinsons-disease.html</link>
			<pubDate>Fri, 19 Oct 2018 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/parkinson-11912.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11912/eisai-discovers-new-compound-to-treat-parkinsons-disease.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo submits NDA in Japan for leukemia drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/11899/daiichi-sankyo-submits-nda-in-japan-for-leukemia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11899/daiichi-sankyo-submits-nda-in-japan-for-leukemia-drug.html</link>
			<pubDate>Wed, 17 Oct 2018 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11899.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11899/daiichi-sankyo-submits-nda-in-japan-for-leukemia-drug.html</guid>
		</item>	
				<item>
			<title>Eisai, Purdue Pharma declare positive results of SUNRISE 2 </title>
			<atom:link href="https://biospectrumasia.com/news/50/11898/eisai-purdue-pharma-declare-positive-results-of-sunrise-2-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11898/eisai-purdue-pharma-declare-positive-results-of-sunrise-2-.html</link>
			<pubDate>Wed, 17 Oct 2018 11:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sleep_disorders-11898.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11898/eisai-purdue-pharma-declare-positive-results-of-sunrise-2-.html</guid>
		</item>	
				<item>
			<title>Eisai signs pact with Eurofarma for anti-obesity agent </title>
			<atom:link href="https://biospectrumasia.com/news/50/11893/eisai-signs-pact-with-eurofarma-for-anti-obesity-agent-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11893/eisai-signs-pact-with-eurofarma-for-anti-obesity-agent-.html</link>
			<pubDate>Tue, 16 Oct 2018 18:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/obesity_1_-11893.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11893/eisai-signs-pact-with-eurofarma-for-anti-obesity-agent-.html</guid>
		</item>	
				<item>
			<title>Hitachi&#039;s heavy ion beam therapy system starts treatment at Osaka </title>
			<atom:link href="https://biospectrumasia.com/news/50/11892/hitachis-heavy-ion-beam-therapy-system-starts-treatment-at-osaka-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11892/hitachis-heavy-ion-beam-therapy-system-starts-treatment-at-osaka-.html</link>
			<pubDate>Tue, 16 Oct 2018 15:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11892.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11892/hitachis-heavy-ion-beam-therapy-system-starts-treatment-at-osaka-.html</guid>
		</item>	
				<item>
			<title>Innovus Pharma receives approval from Amazon for expansion in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/11885/innovus-pharma-receives-approval-from-amazon-for-expansion-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11885/innovus-pharma-receives-approval-from-amazon-for-expansion-in-japan.html</link>
			<pubDate>Mon, 15 Oct 2018 18:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fish_oil_1915424__340-11885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11885/innovus-pharma-receives-approval-from-amazon-for-expansion-in-japan.html</guid>
		</item>	
				<item>
			<title>GHIT Fund partners with Ono Pharmaceutical </title>
			<atom:link href="https://biospectrumasia.com/news/50/11883/ghit-fund-partners-with-ono-pharmaceutical-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11883/ghit-fund-partners-with-ono-pharmaceutical-.html</link>
			<pubDate>Mon, 15 Oct 2018 14:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/test_2-11883.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11883/ghit-fund-partners-with-ono-pharmaceutical-.html</guid>
		</item>	
				<item>
			<title>Scientists develop in vivo skin imaging technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/11878/scientists-develop-in-vivo-skin-imaging-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11878/scientists-develop-in-vivo-skin-imaging-technology.html</link>
			<pubDate>Sat, 13 Oct 2018 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11878.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11878/scientists-develop-in-vivo-skin-imaging-technology.html</guid>
		</item>	
				<item>
			<title>Novan expands business partnership with Sato in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/11852/novan-expands-business-partnership-with-sato-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11852/novan-expands-business-partnership-with-sato-in-japan.html</link>
			<pubDate>Wed, 10 Oct 2018 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership_jpg_1-11852.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11852/novan-expands-business-partnership-with-sato-in-japan.html</guid>
		</item>	
				<item>
			<title>GenAhead Bio, ERS Genomics enter into CRISPR/Cas9 license agreement</title>
			<atom:link href="https://biospectrumasia.com/news/50/11845/genahead-bio-ers-genomics-enter-into-crispr-cas9-license-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11845/genahead-bio-ers-genomics-enter-into-crispr-cas9-license-agreement.html</link>
			<pubDate>Tue, 09 Oct 2018 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11845.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11845/genahead-bio-ers-genomics-enter-into-crispr-cas9-license-agreement.html</guid>
		</item>	
				<item>
			<title>Novan inks $11M deal with Japanese firm</title>
			<atom:link href="https://biospectrumasia.com/news/50/11843/novan-inks-11m-deal-with-japanese-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11843/novan-inks-11m-deal-with-japanese-firm.html</link>
			<pubDate>Tue, 09 Oct 2018 16:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11843.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11843/novan-inks-11m-deal-with-japanese-firm.html</guid>
		</item>	
				<item>
			<title>Japan MHLW grants orphan designation to Axicabtagene Ciloleucel </title>
			<atom:link href="https://biospectrumasia.com/news/50/11835/japan-mhlw-grants-orphan-designation-to-axicabtagene-ciloleucel-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11835/japan-mhlw-grants-orphan-designation-to-axicabtagene-ciloleucel-.html</link>
			<pubDate>Mon, 08 Oct 2018 14:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11835.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11835/japan-mhlw-grants-orphan-designation-to-axicabtagene-ciloleucel-.html</guid>
		</item>	
				<item>
			<title>Orgenesis announces license agreement with HekaBio in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/11825/orgenesis-announces-license-agreement-with-hekabio-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11825/orgenesis-announces-license-agreement-with-hekabio-in-japan.html</link>
			<pubDate>Fri, 05 Oct 2018 01:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fish_oil_1915424__340-11825.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11825/orgenesis-announces-license-agreement-with-hekabio-in-japan.html</guid>
		</item>	
				<item>
			<title>Researchers develop rapid test for infectious diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/11817/researchers-develop-rapid-test-for-infectious-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11817/researchers-develop-rapid-test-for-infectious-diseases.html</link>
			<pubDate>Thu, 04 Oct 2018 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11817.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11817/researchers-develop-rapid-test-for-infectious-diseases.html</guid>
		</item>	
				<item>
			<title>Tasuku Honjo wins Nobel in medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/11806/tasuku-honjo-wins-nobel-in-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11806/tasuku-honjo-wins-nobel-in-medicine.html</link>
			<pubDate>Wed, 03 Oct 2018 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11806.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11806/tasuku-honjo-wins-nobel-in-medicine.html</guid>
		</item>	
				<item>
			<title>Eisai receives FDA approval for antiepileptic drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/11793/eisai-receives-fda-approval-for-antiepileptic-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11793/eisai-receives-fda-approval-for-antiepileptic-drug.html</link>
			<pubDate>Mon, 01 Oct 2018 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11793.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11793/eisai-receives-fda-approval-for-antiepileptic-drug.html</guid>
		</item>	
				<item>
			<title>GHIT Fund invests in innovative TB diagnostics tools</title>
			<atom:link href="https://biospectrumasia.com/news/50/11778/ghit-fund-invests-in-innovative-tb-diagnostics-tools.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11778/ghit-fund-invests-in-innovative-tb-diagnostics-tools.html</link>
			<pubDate>Thu, 27 Sep 2018 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11778.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11778/ghit-fund-invests-in-innovative-tb-diagnostics-tools.html</guid>
		</item>	
				<item>
			<title>PeptiDream announces agreement with Santen Pharmaceutical</title>
			<atom:link href="https://biospectrumasia.com/news/50/11772/peptidream-announces-agreement-with-santen-pharmaceutical.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11772/peptidream-announces-agreement-with-santen-pharmaceutical.html</link>
			<pubDate>Wed, 26 Sep 2018 15:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement_p-11772.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11772/peptidream-announces-agreement-with-santen-pharmaceutical.html</guid>
		</item>	
				<item>
			<title>Anaeropharma Science signs research agreement with Astellas</title>
			<atom:link href="https://biospectrumasia.com/news/50/11757/anaeropharma-science-signs-research-agreement-with-astellas.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11757/anaeropharma-science-signs-research-agreement-with-astellas.html</link>
			<pubDate>Tue, 25 Sep 2018 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11757.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11757/anaeropharma-science-signs-research-agreement-with-astellas.html</guid>
		</item>	
				<item>
			<title>Takeda gets positive CHMP opinion for ALUNBRIG</title>
			<atom:link href="https://biospectrumasia.com/news/50/11746/takeda-gets-positive-chmp-opinion-for-alunbrig.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11746/takeda-gets-positive-chmp-opinion-for-alunbrig.html</link>
			<pubDate>Mon, 24 Sep 2018 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hand_157251_960_720-11746.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11746/takeda-gets-positive-chmp-opinion-for-alunbrig.html</guid>
		</item>	
				<item>
			<title>Mylan, Fujifilm receive European marketing authorization for Hulio Biosimilar </title>
			<atom:link href="https://biospectrumasia.com/news/50/11743/mylan-fujifilm-receive-european-marketing-authorization-for-hulio-biosimilar-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11743/mylan-fujifilm-receive-european-marketing-authorization-for-hulio-biosimilar-.html</link>
			<pubDate>Mon, 24 Sep 2018 03:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_1049259__340-11743.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11743/mylan-fujifilm-receive-european-marketing-authorization-for-hulio-biosimilar-.html</guid>
		</item>	
				<item>
			<title>Medtronic starts Onyx ONE Clear study in Japan and US</title>
			<atom:link href="https://biospectrumasia.com/news/50/11691/medtronic-starts-onyx-one-clear-study-in-japan-and-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11691/medtronic-starts-onyx-one-clear-study-in-japan-and-us.html</link>
			<pubDate>Fri, 14 Sep 2018 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11691.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11691/medtronic-starts-onyx-one-clear-study-in-japan-and-us.html</guid>
		</item>	
				<item>
			<title>China approves Eisai&#039;s cancer drug Lenvima</title>
			<atom:link href="https://biospectrumasia.com/news/50/11652/china-approves-eisais-cancer-drug-lenvima.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11652/china-approves-eisais-cancer-drug-lenvima.html</link>
			<pubDate>Thu, 06 Sep 2018 18:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/checkbox_303113_960_720-11652.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11652/china-approves-eisais-cancer-drug-lenvima.html</guid>
		</item>	
				<item>
			<title>NEGTEC via crowdfunding portal promotes regenerative medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/11625/negtec-via-crowdfunding-portal-promotes-regenerative-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11625/negtec-via-crowdfunding-portal-promotes-regenerative-medicine.html</link>
			<pubDate>Tue, 04 Sep 2018 13:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/funding-11625.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11625/negtec-via-crowdfunding-portal-promotes-regenerative-medicine.html</guid>
		</item>	
				<item>
			<title>Chugai, Nippon Shinyaku bring Gazyva in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/11606/chugai-nippon-shinyaku-bring-gazyva-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11606/chugai-nippon-shinyaku-bring-gazyva-in-japan.html</link>
			<pubDate>Thu, 30 Aug 2018 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11606.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11606/chugai-nippon-shinyaku-bring-gazyva-in-japan.html</guid>
		</item>	
				<item>
			<title>Nissui Pharmaceutical Launches Colony Counter Service Based on AI Technology </title>
			<atom:link href="https://biospectrumasia.com/news/50/11597/nissui-pharmaceutical-launches-colony-counter-service-based-on-ai-technology-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11597/nissui-pharmaceutical-launches-colony-counter-service-based-on-ai-technology-.html</link>
			<pubDate>Thu, 30 Aug 2018 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/coffee_cup_hands_mug_samsung_smartphone_table_tablet_968474-11597.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11597/nissui-pharmaceutical-launches-colony-counter-service-based-on-ai-technology-.html</guid>
		</item>	
				<item>
			<title>Astellas announces approval of Linzess Tablets in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/11576/astellas-announces-approval-of-linzess-tablets-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11576/astellas-announces-approval-of-linzess-tablets-in-japan.html</link>
			<pubDate>Mon, 27 Aug 2018 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/capsule_158568__340-11576.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11576/astellas-announces-approval-of-linzess-tablets-in-japan.html</guid>
		</item>	
				<item>
			<title>Rakuten Aspyrian raises $150M in Series C Financing</title>
			<atom:link href="https://biospectrumasia.com/news/50/11572/rakuten-aspyrian-raises-150m-in-series-c-financing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11572/rakuten-aspyrian-raises-150m-in-series-c-financing.html</link>
			<pubDate>Mon, 27 Aug 2018 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/financing1-11572.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11572/rakuten-aspyrian-raises-150m-in-series-c-financing.html</guid>
		</item>	
				<item>
			<title>Eisai gets marketing approval from EC for LENVIMA </title>
			<atom:link href="https://biospectrumasia.com/news/50/11556/eisai-gets-marketing-approval-from-ec-for-lenvima-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11556/eisai-gets-marketing-approval-from-ec-for-lenvima-.html</link>
			<pubDate>Thu, 23 Aug 2018 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acne_jpg_2-11556.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11556/eisai-gets-marketing-approval-from-ec-for-lenvima-.html</guid>
		</item>	
				<item>
			<title>Tokyo to host Medtec Japan 2019 </title>
			<atom:link href="https://biospectrumasia.com/news/50/11548/tokyo-to-host-medtec-japan-2019-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11548/tokyo-to-host-medtec-japan-2019-.html</link>
			<pubDate>Wed, 22 Aug 2018 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_device-11548.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11548/tokyo-to-host-medtec-japan-2019-.html</guid>
		</item>	
				<item>
			<title>Shionogi submits NDA for INTUNIV</title>
			<atom:link href="https://biospectrumasia.com/news/50/11541/shionogi-submits-nda-for-intuniv.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11541/shionogi-submits-nda-for-intuniv.html</link>
			<pubDate>Tue, 21 Aug 2018 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11541.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11541/shionogi-submits-nda-for-intuniv.html</guid>
		</item>	
				<item>
			<title>Telix, Nihon collaborate on renal cancer imaging for Japanese market</title>
			<atom:link href="https://biospectrumasia.com/news/50/11533/telix-nihon-collaborate-on-renal-cancer-imaging-for-japanese-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11533/telix-nihon-collaborate-on-renal-cancer-imaging-for-japanese-market.html</link>
			<pubDate>Mon, 20 Aug 2018 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-11533.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11533/telix-nihon-collaborate-on-renal-cancer-imaging-for-japanese-market.html</guid>
		</item>	
				<item>
			<title>Eisai, Merck get FDA approval for LENVIMA capsules to treat HCC</title>
			<atom:link href="https://biospectrumasia.com/news/50/11520/eisai-merck-get-fda-approval-for-lenvima-capsules-to-treat-hcc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11520/eisai-merck-get-fda-approval-for-lenvima-capsules-to-treat-hcc.html</link>
			<pubDate>Fri, 17 Aug 2018 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/capsule-11520.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11520/eisai-merck-get-fda-approval-for-lenvima-capsules-to-treat-hcc.html</guid>
		</item>	
				<item>
			<title>Medtronic introduces IN.PACT Admiral DCB in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/11517/medtronic-introduces-in-pact-admiral-dcb-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11517/medtronic-introduces-in-pact-admiral-dcb-in-japan.html</link>
			<pubDate>Fri, 17 Aug 2018 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11517.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11517/medtronic-introduces-in-pact-admiral-dcb-in-japan.html</guid>
		</item>	
				<item>
			<title>Kaneka officially starts continuous manufacturing under GMP </title>
			<atom:link href="https://biospectrumasia.com/news/50/11506/kaneka-officially-starts-continuous-manufacturing-under-gmp-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11506/kaneka-officially-starts-continuous-manufacturing-under-gmp-.html</link>
			<pubDate>Tue, 14 Aug 2018 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kaneka-11506.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11506/kaneka-officially-starts-continuous-manufacturing-under-gmp-.html</guid>
		</item>	
				<item>
			<title>Kyowa Hakko Kirin announces results of Phase 3 trial of patients with Cutaneous T-cell Lymphoma</title>
			<atom:link href="https://biospectrumasia.com/news/50/11493/kyowa-hakko-kirin-announces-results-of-phase-3-trial-of-patients-with-cutaneous-t-cell-lymphoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11493/kyowa-hakko-kirin-announces-results-of-phase-3-trial-of-patients-with-cutaneous-t-cell-lymphoma.html</link>
			<pubDate>Mon, 13 Aug 2018 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical_trial_icon_2793430_960_720-11493.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11493/kyowa-hakko-kirin-announces-results-of-phase-3-trial-of-patients-with-cutaneous-t-cell-lymphoma.html</guid>
		</item>	
				<item>
			<title>A device to assist exact hemodialysis catheter placement</title>
			<atom:link href="https://biospectrumasia.com/news/50/11488/a-device-to-assist-exact-hemodialysis-catheter-placement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11488/a-device-to-assist-exact-hemodialysis-catheter-placement.html</link>
			<pubDate>Fri, 10 Aug 2018 17:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_devices-11488.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11488/a-device-to-assist-exact-hemodialysis-catheter-placement.html</guid>
		</item>	
				<item>
			<title>Takeda unite Ambys to treat serious liver disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/11483/takeda-unite-ambys-to-treat-serious-liver-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11483/takeda-unite-ambys-to-treat-serious-liver-disease.html</link>
			<pubDate>Fri, 10 Aug 2018 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership_22-11483.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11483/takeda-unite-ambys-to-treat-serious-liver-disease.html</guid>
		</item>	
				<item>
			<title>Qiagen, SRL to accelerate launch of companion diagnostics</title>
			<atom:link href="https://biospectrumasia.com/news/50/11445/qiagen-srl-to-accelerate-launch-of-companion-diagnostics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11445/qiagen-srl-to-accelerate-launch-of-companion-diagnostics.html</link>
			<pubDate>Fri, 03 Aug 2018 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11445.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11445/qiagen-srl-to-accelerate-launch-of-companion-diagnostics.html</guid>
		</item>	
				<item>
			<title>Eisai to market anti-Obesity agent in China through CY Biotech</title>
			<atom:link href="https://biospectrumasia.com/news/50/11412/eisai-to-market-anti-obesity-agent-in-china-through-cy-biotech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11412/eisai-to-market-anti-obesity-agent-in-china-through-cy-biotech.html</link>
			<pubDate>Tue, 31 Jul 2018 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11412.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11412/eisai-to-market-anti-obesity-agent-in-china-through-cy-biotech.html</guid>
		</item>	
				<item>
			<title>Eisai, Merck gets U.S. FDA breakthrough therapy designation for LENVIMA</title>
			<atom:link href="https://biospectrumasia.com/news/50/11410/eisai-merck-gets-u-s-fda-breakthrough-therapy-designation-for-lenvima.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11410/eisai-merck-gets-u-s-fda-breakthrough-therapy-designation-for-lenvima.html</link>
			<pubDate>Tue, 31 Jul 2018 11:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/breakthrough_-11410.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11410/eisai-merck-gets-u-s-fda-breakthrough-therapy-designation-for-lenvima.html</guid>
		</item>	
				<item>
			<title>Japan to lead human trial using stem cell to treat Parkinson&#039;s</title>
			<atom:link href="https://biospectrumasia.com/news/50/11408/japan-to-lead-human-trial-using-stem-cell-to-treat-parkinsons.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11408/japan-to-lead-human-trial-using-stem-cell-to-treat-parkinsons.html</link>
			<pubDate>Tue, 31 Jul 2018 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11408.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11408/japan-to-lead-human-trial-using-stem-cell-to-treat-parkinsons.html</guid>
		</item>	
				<item>
			<title>SanBio Receives $20 Million Grant From CIRM</title>
			<atom:link href="https://biospectrumasia.com/news/50/11399/sanbio-receives-20-million-grant-from-cirm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11399/sanbio-receives-20-million-grant-from-cirm.html</link>
			<pubDate>Mon, 30 Jul 2018 16:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/california_institute_for_regenerative_medicine-11399.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11399/sanbio-receives-20-million-grant-from-cirm.html</guid>
		</item>	
				<item>
			<title>Mylan, Fujifilm Kyowa Kirin Biologics declares positive CHMP opinion for Hulio</title>
			<atom:link href="https://biospectrumasia.com/news/50/11396/mylan-fujifilm-kyowa-kirin-biologics-declares-positive-chmp-opinion-for-hulio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11396/mylan-fujifilm-kyowa-kirin-biologics-declares-positive-chmp-opinion-for-hulio.html</link>
			<pubDate>Mon, 30 Jul 2018 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma_2-11396.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11396/mylan-fujifilm-kyowa-kirin-biologics-declares-positive-chmp-opinion-for-hulio.html</guid>
		</item>	
				<item>
			<title>Solasia Pharma announces approval of Sancusco in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/11387/solasia-pharma-announces-approval-of-sancusco-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11387/solasia-pharma-announces-approval-of-sancusco-in-china.html</link>
			<pubDate>Fri, 27 Jul 2018 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/black_1915459__340-11387.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11387/solasia-pharma-announces-approval-of-sancusco-in-china.html</guid>
		</item>	
				<item>
			<title>Takeda Announces Phase III Trial of ALUNBRIG For Lung Cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/11380/takeda-announces-phase-iii-trial-of-alunbrig-for-lung-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11380/takeda-announces-phase-iii-trial-of-alunbrig-for-lung-cancer.html</link>
			<pubDate>Thu, 26 Jul 2018 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-11380.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11380/takeda-announces-phase-iii-trial-of-alunbrig-for-lung-cancer.html</guid>
		</item>	
				<item>
			<title>Eisai, Biogen present Clinical study of Elenbecestat for Alzheimer&#039;s at AAIC 2018</title>
			<atom:link href="https://biospectrumasia.com/news/50/11375/eisai-biogen-present-clinical-study-of-elenbecestat-for-alzheimers-at-aaic-2018.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11375/eisai-biogen-present-clinical-study-of-elenbecestat-for-alzheimers-at-aaic-2018.html</link>
			<pubDate>Thu, 26 Jul 2018 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical_study_2-11375.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11375/eisai-biogen-present-clinical-study-of-elenbecestat-for-alzheimers-at-aaic-2018.html</guid>
		</item>	
				<item>
			<title>Terumo acquires China based Essen Tech</title>
			<atom:link href="https://biospectrumasia.com/news/50/11373/terumo-acquires-china-based-essen-tech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11373/terumo-acquires-china-based-essen-tech.html</link>
			<pubDate>Thu, 26 Jul 2018 10:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11373.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11373/terumo-acquires-china-based-essen-tech.html</guid>
		</item>	
				<item>
			<title>Oramed gets Japanese Patent for GLP-1 analog capsule</title>
			<atom:link href="https://biospectrumasia.com/news/50/11366/oramed-gets-japanese-patent-for-glp-1-analog-capsule.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11366/oramed-gets-japanese-patent-for-glp-1-analog-capsule.html</link>
			<pubDate>Tue, 24 Jul 2018 18:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patent-11366.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11366/oramed-gets-japanese-patent-for-glp-1-analog-capsule.html</guid>
		</item>	
				<item>
			<title>Researchers use AI to diagnose stomach cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/11357/researchers-use-ai-to-diagnose-stomach-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11357/researchers-use-ai-to-diagnose-stomach-cancer.html</link>
			<pubDate>Tue, 24 Jul 2018 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11357.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11357/researchers-use-ai-to-diagnose-stomach-cancer.html</guid>
		</item>	
				<item>
			<title>Eisai to bring NAILIN capsules in japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/11326/eisai-to-bring-nailin-capsules-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11326/eisai-to-bring-nailin-capsules-in-japan-.html</link>
			<pubDate>Thu, 19 Jul 2018 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/capsule-11326.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11326/eisai-to-bring-nailin-capsules-in-japan-.html</guid>
		</item>	
				<item>
			<title>Latest Data on Eisai&#039;s Alzheimer&#039;s disease to be presented at AAIC 2018</title>
			<atom:link href="https://biospectrumasia.com/news/50/11322/latest-data-on-eisais-alzheimers-disease-to-be-presented-at-aaic-2018.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11322/latest-data-on-eisais-alzheimers-disease-to-be-presented-at-aaic-2018.html</link>
			<pubDate>Thu, 19 Jul 2018 11:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alzheimer-11322.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11322/latest-data-on-eisais-alzheimers-disease-to-be-presented-at-aaic-2018.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka Pharma to acquire Visterra for $430 mn</title>
			<atom:link href="https://biospectrumasia.com/news/50/11318/japans-otsuka-pharma-to-acquire-visterra-for-430-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11318/japans-otsuka-pharma-to-acquire-visterra-for-430-mn.html</link>
			<pubDate>Wed, 18 Jul 2018 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/euro_1144835__340-11318.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11318/japans-otsuka-pharma-to-acquire-visterra-for-430-mn.html</guid>
		</item>	
				<item>
			<title>Ieon-nanodrugs announces collaboration with Takeda </title>
			<atom:link href="https://biospectrumasia.com/news/50/11309/ieon-nanodrugs-announces-collaboration-with-takeda-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11309/ieon-nanodrugs-announces-collaboration-with-takeda-.html</link>
			<pubDate>Tue, 17 Jul 2018 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration1-11309.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11309/ieon-nanodrugs-announces-collaboration-with-takeda-.html</guid>
		</item>	
				<item>
			<title>Otsuka acquires Visterra for $430 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/11274/otsuka-acquires-visterra-for-430-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11274/otsuka-acquires-visterra-for-430-m.html</link>
			<pubDate>Fri, 13 Jul 2018 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition1-11274.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11274/otsuka-acquires-visterra-for-430-m.html</guid>
		</item>	
				<item>
			<title>Takeda bags Japan&#039;s approval for ulcerative colitis drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/11239/takeda-bags-japans-approval-for-ulcerative-colitis-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11239/takeda-bags-japans-approval-for-ulcerative-colitis-drug.html</link>
			<pubDate>Fri, 06 Jul 2018 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11239.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11239/takeda-bags-japans-approval-for-ulcerative-colitis-drug.html</guid>
		</item>	
				<item>
			<title>Researchers in Japan devise method to produce steroid antibiotics</title>
			<atom:link href="https://biospectrumasia.com/news/50/11220/researchers-in-japan-devise-method-to-produce-steroid-antibiotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11220/researchers-in-japan-devise-method-to-produce-steroid-antibiotics.html</link>
			<pubDate>Thu, 05 Jul 2018 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11220.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11220/researchers-in-japan-devise-method-to-produce-steroid-antibiotics.html</guid>
		</item>	
				<item>
			<title>Philips powers first tele-intensive care eICU program in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/11213/philips-powers-first-tele-intensive-care-eicu-program-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11213/philips-powers-first-tele-intensive-care-eicu-program-in-japan.html</link>
			<pubDate>Wed, 04 Jul 2018 13:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hiroyuki_tsutsumi-11213.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11213/philips-powers-first-tele-intensive-care-eicu-program-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s farming sector may come to an end soon</title>
			<atom:link href="https://biospectrumasia.com/news/50/11183/japans-farming-sector-may-come-to-an-end-soon.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11183/japans-farming-sector-may-come-to-an-end-soon.html</link>
			<pubDate>Fri, 29 Jun 2018 17:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/far_eastern_agriculture-11183.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11183/japans-farming-sector-may-come-to-an-end-soon.html</guid>
		</item>	
				<item>
			<title>Nestle Japan to Expand its Healthcare Platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/11174/nestle-japan-to-expand-its-healthcare-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11174/nestle-japan-to-expand-its-healthcare-platform.html</link>
			<pubDate>Thu, 28 Jun 2018 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nestle2-11174.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11174/nestle-japan-to-expand-its-healthcare-platform.html</guid>
		</item>	
				<item>
			<title>PharmaMar, Chugai terminate License Agreement for Zepsyre</title>
			<atom:link href="https://biospectrumasia.com/news/50/11161/pharmamar-chugai-terminate-license-agreement-for-zepsyre.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11161/pharmamar-chugai-terminate-license-agreement-for-zepsyre.html</link>
			<pubDate>Wed, 27 Jun 2018 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/contract-11161.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11161/pharmamar-chugai-terminate-license-agreement-for-zepsyre.html</guid>
		</item>	
				<item>
			<title>Lupin, Nichi-Iko unite to market biosimilar Etanercept in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/11106/lupin-nichi-iko-unite-to-market-biosimilar-etanercept-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11106/lupin-nichi-iko-unite-to-market-biosimilar-etanercept-in-japan.html</link>
			<pubDate>Mon, 18 Jun 2018 13:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/joined_hands-11106.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11106/lupin-nichi-iko-unite-to-market-biosimilar-etanercept-in-japan.html</guid>
		</item>	
				<item>
			<title>Sage Therapeutics, Shionogi ink deal for MDD treatment </title>
			<atom:link href="https://biospectrumasia.com/news/50/11099/sage-therapeutics-shionogi-ink-deal-for-mdd-treatment-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11099/sage-therapeutics-shionogi-ink-deal-for-mdd-treatment-.html</link>
			<pubDate>Sun, 17 Jun 2018 22:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/euro_1144835__340-11099.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11099/sage-therapeutics-shionogi-ink-deal-for-mdd-treatment-.html</guid>
		</item>	
				<item>
			<title>AbbVie, Eisai launch auto-injector drug delivery pen</title>
			<atom:link href="https://biospectrumasia.com/news/50/11094/abbvie-eisai-launch-auto-injector-drug-delivery-pen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11094/abbvie-eisai-launch-auto-injector-drug-delivery-pen.html</link>
			<pubDate>Fri, 15 Jun 2018 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11094.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11094/abbvie-eisai-launch-auto-injector-drug-delivery-pen.html</guid>
		</item>	
				<item>
			<title>NirogStreet raises $ 300K from Japanese venture</title>
			<atom:link href="https://biospectrumasia.com/news/50/11083/nirogstreet-raises-300k-from-japanese-venture.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11083/nirogstreet-raises-300k-from-japanese-venture.html</link>
			<pubDate>Wed, 13 Jun 2018 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/funding-11083.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11083/nirogstreet-raises-300k-from-japanese-venture.html</guid>
		</item>	
				<item>
			<title>VistaGen nabs Japanese patent </title>
			<atom:link href="https://biospectrumasia.com/news/50/11069/vistagen-nabs-japanese-patent-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11069/vistagen-nabs-japanese-patent-.html</link>
			<pubDate>Tue, 12 Jun 2018 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-11069.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11069/vistagen-nabs-japanese-patent-.html</guid>
		</item>	
				<item>
			<title>Fluence Analytics announces partnership with Nihon Rufuto</title>
			<atom:link href="https://biospectrumasia.com/news/50/11058/fluence-analytics-announces-partnership-with-nihon-rufuto.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11058/fluence-analytics-announces-partnership-with-nihon-rufuto.html</link>
			<pubDate>Fri, 08 Jun 2018 17:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fluenceanalytics_logo-11058.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11058/fluence-analytics-announces-partnership-with-nihon-rufuto.html</guid>
		</item>	
				<item>
			<title>Verastem, Yakult Honsha Co. Ltd sign exclusive license agreement</title>
			<atom:link href="https://biospectrumasia.com/news/50/11053/verastem-yakult-honsha-co-ltd-sign-exclusive-license-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11053/verastem-yakult-honsha-co-ltd-sign-exclusive-license-agreement.html</link>
			<pubDate>Thu, 07 Jun 2018 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement_business_close_up_contract_data_deal_desk_document_916968-11053.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11053/verastem-yakult-honsha-co-ltd-sign-exclusive-license-agreement.html</guid>
		</item>	
				<item>
			<title>GHIT Fund names Hiroki Nakatani as Board Chair</title>
			<atom:link href="https://biospectrumasia.com/news/50/11050/ghit-fund-names-hiroki-nakatani-as-board-chair.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11050/ghit-fund-names-hiroki-nakatani-as-board-chair.html</link>
			<pubDate>Thu, 07 Jun 2018 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11050.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11050/ghit-fund-names-hiroki-nakatani-as-board-chair.html</guid>
		</item>	
				<item>
			<title>USFDA grants Priority Review to Astellas&#039;s NDA for Gilteritinib</title>
			<atom:link href="https://biospectrumasia.com/news/50/11028/usfda-grants-priority-review-to-astellass-nda-for-gilteritinib.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11028/usfda-grants-priority-review-to-astellass-nda-for-gilteritinib.html</link>
			<pubDate>Tue, 05 Jun 2018 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fish_oil_1915423__340-11028.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11028/usfda-grants-priority-review-to-astellass-nda-for-gilteritinib.html</guid>
		</item>	
				<item>
			<title>Scientists use RFID chips to track biological samples</title>
			<atom:link href="https://biospectrumasia.com/news/50/11004/scientists-use-rfid-chips-to-track-biological-samples.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/11004/scientists-use-rfid-chips-to-track-biological-samples.html</link>
			<pubDate>Fri, 01 Jun 2018 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11004.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/11004/scientists-use-rfid-chips-to-track-biological-samples.html</guid>
		</item>	
				<item>
			<title>Telix, Osaka University receive funding for alpha nuclide research</title>
			<atom:link href="https://biospectrumasia.com/news/50/10989/telix-osaka-university-receive-funding-for-alpha-nuclide-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10989/telix-osaka-university-receive-funding-for-alpha-nuclide-research.html</link>
			<pubDate>Thu, 31 May 2018 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_43_-10989.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10989/telix-osaka-university-receive-funding-for-alpha-nuclide-research.html</guid>
		</item>	
				<item>
			<title>Eisai, Merck provide Update on sNDA for Lenvatinib</title>
			<atom:link href="https://biospectrumasia.com/news/50/10965/eisai-merck-provide-update-on-snda-for-lenvatinib.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10965/eisai-merck-provide-update-on-snda-for-lenvatinib.html</link>
			<pubDate>Fri, 25 May 2018 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_1-10965.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10965/eisai-merck-provide-update-on-snda-for-lenvatinib.html</guid>
		</item>	
				<item>
			<title>Eisai, Purdue to present latest Clinical Data on Lemborexant </title>
			<atom:link href="https://biospectrumasia.com/news/50/10944/eisai-purdue-to-present-latest-clinical-data-on-lemborexant-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10944/eisai-purdue-to-present-latest-clinical-data-on-lemborexant-.html</link>
			<pubDate>Wed, 23 May 2018 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/insomnia-10944.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10944/eisai-purdue-to-present-latest-clinical-data-on-lemborexant-.html</guid>
		</item>	
				<item>
			<title>AstraZeneca submits sNDA in Japan for Forxiga in T1D</title>
			<atom:link href="https://biospectrumasia.com/news/50/10938/astrazeneca-submits-snda-in-japan-for-forxiga-in-t1d.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10938/astrazeneca-submits-snda-in-japan-for-forxiga-in-t1d.html</link>
			<pubDate>Tue, 22 May 2018 18:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_68_-10938.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10938/astrazeneca-submits-snda-in-japan-for-forxiga-in-t1d.html</guid>
		</item>	
				<item>
			<title>AstraZeneca submits sNDA for Forxiga in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/10936/astrazeneca-submits-snda-for-forxiga-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10936/astrazeneca-submits-snda-for-forxiga-in-japan.html</link>
			<pubDate>Tue, 22 May 2018 13:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hand_1106934_960_720-10936.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10936/astrazeneca-submits-snda-for-forxiga-in-japan.html</guid>
		</item>	
				<item>
			<title>Study shows new possibilities with cardiac T-high sensitive test</title>
			<atom:link href="https://biospectrumasia.com/news/50/10924/study-shows-new-possibilities-with-cardiac-t-high-sensitive-test.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10924/study-shows-new-possibilities-with-cardiac-t-high-sensitive-test.html</link>
			<pubDate>Mon, 21 May 2018 19:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_5_-10924.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10924/study-shows-new-possibilities-with-cardiac-t-high-sensitive-test.html</guid>
		</item>	
				<item>
			<title>Takeda Divests Techpool to Joint-Venture Partners in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/10922/takeda-divests-techpool-to-joint-venture-partners-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10922/takeda-divests-techpool-to-joint-venture-partners-in-china.html</link>
			<pubDate>Mon, 21 May 2018 14:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/euro_1144835__340-10922.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10922/takeda-divests-techpool-to-joint-venture-partners-in-china.html</guid>
		</item>	
				<item>
			<title>Japan approves stem cell based trials for heart treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/10892/japan-approves-stem-cell-based-trials-for-heart-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10892/japan-approves-stem-cell-based-trials-for-heart-treatment.html</link>
			<pubDate>Thu, 17 May 2018 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10892.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10892/japan-approves-stem-cell-based-trials-for-heart-treatment.html</guid>
		</item>	
				<item>
			<title>Platelet BioGenesis licenses induced pluripotent stem cell technology </title>
			<atom:link href="https://biospectrumasia.com/news/50/10870/platelet-biogenesis-licenses-induced-pluripotent-stem-cell-technology-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10870/platelet-biogenesis-licenses-induced-pluripotent-stem-cell-technology-.html</link>
			<pubDate>Mon, 14 May 2018 18:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/platelets-10870.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10870/platelet-biogenesis-licenses-induced-pluripotent-stem-cell-technology-.html</guid>
		</item>	
				<item>
			<title>Kaneka Corp. to appeal to Federal Court on Patent case</title>
			<atom:link href="https://biospectrumasia.com/news/50/10847/kaneka-corp-to-appeal-to-federal-court-on-patent-case.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10847/kaneka-corp-to-appeal-to-federal-court-on-patent-case.html</link>
			<pubDate>Thu, 10 May 2018 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kaneka-10847.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10847/kaneka-corp-to-appeal-to-federal-court-on-patent-case.html</guid>
		</item>	
				<item>
			<title>Aquinox, Astellas ink deal to develop and commercialize Rosiptor in APAC</title>
			<atom:link href="https://biospectrumasia.com/news/50/10845/aquinox-astellas-ink-deal-to-develop-and-commercialize-rosiptor-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10845/aquinox-astellas-ink-deal-to-develop-and-commercialize-rosiptor-in-apac.html</link>
			<pubDate>Thu, 10 May 2018 09:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/graph_163509__340-10845.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10845/aquinox-astellas-ink-deal-to-develop-and-commercialize-rosiptor-in-apac.html</guid>
		</item>	
				<item>
			<title>Takeda clinches $62B deal to drugmaker Shire</title>
			<atom:link href="https://biospectrumasia.com/news/50/10835/takeda-clinches-62b-deal-to-drugmaker-shire.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10835/takeda-clinches-62b-deal-to-drugmaker-shire.html</link>
			<pubDate>Tue, 08 May 2018 18:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_2_-10835.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10835/takeda-clinches-62b-deal-to-drugmaker-shire.html</guid>
		</item>	
				<item>
			<title>Ono Pharma submits marketing approval of metyrosine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/10800/ono-pharma-submits-marketing-approval-of-metyrosine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10800/ono-pharma-submits-marketing-approval-of-metyrosine-in-japan.html</link>
			<pubDate>Wed, 02 May 2018 17:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pheochromocytoma_1-10800.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10800/ono-pharma-submits-marketing-approval-of-metyrosine-in-japan.html</guid>
		</item>	
				<item>
			<title>Aspirin may suppress the impact of obesity on cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/10787/aspirin-may-suppress-the-impact-of-obesity-on-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10787/aspirin-may-suppress-the-impact-of-obesity-on-cancer.html</link>
			<pubDate>Mon, 30 Apr 2018 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aspirin-10787.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10787/aspirin-may-suppress-the-impact-of-obesity-on-cancer.html</guid>
		</item>	
				<item>
			<title>Takeda bids on Shire for $64-billion </title>
			<atom:link href="https://biospectrumasia.com/news/50/10783/takeda-bids-on-shire-for-64-billion-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10783/takeda-bids-on-shire-for-64-billion-.html</link>
			<pubDate>Fri, 27 Apr 2018 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition-10783.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10783/takeda-bids-on-shire-for-64-billion-.html</guid>
		</item>	
				<item>
			<title>Aska, Neopharma arm team up for Rs350 Cr venture</title>
			<atom:link href="https://biospectrumasia.com/news/50/10779/aska-neopharma-arm-team-up-for-rs350-cr-venture.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10779/aska-neopharma-arm-team-up-for-rs350-cr-venture.html</link>
			<pubDate>Fri, 27 Apr 2018 10:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10779.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10779/aska-neopharma-arm-team-up-for-rs350-cr-venture.html</guid>
		</item>	
				<item>
			<title>Japan, Taiwan high on measles alert</title>
			<atom:link href="https://biospectrumasia.com/news/50/10772/japan-taiwan-high-on-measles-alert.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10772/japan-taiwan-high-on-measles-alert.html</link>
			<pubDate>Thu, 26 Apr 2018 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10772.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10772/japan-taiwan-high-on-measles-alert.html</guid>
		</item>	
				<item>
			<title>Astellas sells certain U.S. research facilities to Gilead</title>
			<atom:link href="https://biospectrumasia.com/news/50/10727/astellas-sells-certain-u-s-research-facilities-to-gilead.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10727/astellas-sells-certain-u-s-research-facilities-to-gilead.html</link>
			<pubDate>Thu, 19 Apr 2018 22:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_31_-10727.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10727/astellas-sells-certain-u-s-research-facilities-to-gilead.html</guid>
		</item>	
				<item>
			<title>Allergan moves in as Shire rebuffs $63B Takeda bid</title>
			<atom:link href="https://biospectrumasia.com/news/50/10726/allergan-moves-in-as-shire-rebuffs-63b-takeda-bid.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10726/allergan-moves-in-as-shire-rebuffs-63b-takeda-bid.html</link>
			<pubDate>Thu, 19 Apr 2018 22:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/allergan_logo-10726.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10726/allergan-moves-in-as-shire-rebuffs-63b-takeda-bid.html</guid>
		</item>	
				<item>
			<title>Hitachi to carry out urine test for cancer detection</title>
			<atom:link href="https://biospectrumasia.com/news/50/10712/hitachi-to-carry-out-urine-test-for-cancer-detection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10712/hitachi-to-carry-out-urine-test-for-cancer-detection.html</link>
			<pubDate>Wed, 18 Apr 2018 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10712.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10712/hitachi-to-carry-out-urine-test-for-cancer-detection.html</guid>
		</item>	
				<item>
			<title>Fujitsu develops deep learning detection technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/10703/fujitsu-develops-deep-learning-detection-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10703/fujitsu-develops-deep-learning-detection-technology.html</link>
			<pubDate>Mon, 16 Apr 2018 16:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ai-10703.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10703/fujitsu-develops-deep-learning-detection-technology.html</guid>
		</item>	
				<item>
			<title>Researchers develop a compound to improve stroke patient recovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/10700/researchers-develop-a-compound-to-improve-stroke-patient-recovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10700/researchers-develop-a-compound-to-improve-stroke-patient-recovery.html</link>
			<pubDate>Mon, 16 Apr 2018 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research_2-10700.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10700/researchers-develop-a-compound-to-improve-stroke-patient-recovery.html</guid>
		</item>	
				<item>
			<title>Takeda looking for loans for Shire bid</title>
			<atom:link href="https://biospectrumasia.com/news/50/10671/takeda-looking-for-loans-for-shire-bid.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10671/takeda-looking-for-loans-for-shire-bid.html</link>
			<pubDate>Thu, 12 Apr 2018 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_2_-10671.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10671/takeda-looking-for-loans-for-shire-bid.html</guid>
		</item>	
				<item>
			<title>Hitachi&#039;s First Heavy Ion Therapy System to sell in Taiwan</title>
			<atom:link href="https://biospectrumasia.com/news/50/10608/hitachis-first-heavy-ion-therapy-system-to-sell-in-taiwan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10608/hitachis-first-heavy-ion-therapy-system-to-sell-in-taiwan.html</link>
			<pubDate>Wed, 04 Apr 2018 13:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hitachi_heavy_ion_system-10608.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10608/hitachis-first-heavy-ion-therapy-system-to-sell-in-taiwan.html</guid>
		</item>	
				<item>
			<title>Rhythm Pharma in-licenses PWS candidate from Takeda</title>
			<atom:link href="https://biospectrumasia.com/news/50/10602/rhythm-pharma-in-licenses-pws-candidate-from-takeda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10602/rhythm-pharma-in-licenses-pws-candidate-from-takeda.html</link>
			<pubDate>Tue, 03 Apr 2018 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_takeda_svg-10602.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10602/rhythm-pharma-in-licenses-pws-candidate-from-takeda.html</guid>
		</item>	
				<item>
			<title>Sekisui Medical acquires Veredus Labs</title>
			<atom:link href="https://biospectrumasia.com/news/50/10597/sekisui-medical-acquires-veredus-labs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10597/sekisui-medical-acquires-veredus-labs.html</link>
			<pubDate>Tue, 03 Apr 2018 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10597.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10597/sekisui-medical-acquires-veredus-labs.html</guid>
		</item>	
				<item>
			<title>Accuron divests Veredus Labs to Japanese diagnostic firm</title>
			<atom:link href="https://biospectrumasia.com/news/50/10596/accuron-divests-veredus-labs-to-japanese-diagnostic-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10596/accuron-divests-veredus-labs-to-japanese-diagnostic-firm.html</link>
			<pubDate>Tue, 03 Apr 2018 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_1012459__340-10596.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10596/accuron-divests-veredus-labs-to-japanese-diagnostic-firm.html</guid>
		</item>	
				<item>
			<title>Fujifilm to acquire 2 biotech units for $800M</title>
			<atom:link href="https://biospectrumasia.com/news/50/10585/fujifilm-to-acquire-2-biotech-units-for-800m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10585/fujifilm-to-acquire-2-biotech-units-for-800m.html</link>
			<pubDate>Sat, 31 Mar 2018 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10585.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10585/fujifilm-to-acquire-2-biotech-units-for-800m.html</guid>
		</item>	
				<item>
			<title>GHIT grants funds for malaria vaccine research</title>
			<atom:link href="https://biospectrumasia.com/news/50/10581/ghit-grants-funds-for-malaria-vaccine-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10581/ghit-grants-funds-for-malaria-vaccine-research.html</link>
			<pubDate>Fri, 30 Mar 2018 09:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10581.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10581/ghit-grants-funds-for-malaria-vaccine-research.html</guid>
		</item>	
				<item>
			<title>Eisai, Nichi-Iko Pharma enters strategic partnership</title>
			<atom:link href="https://biospectrumasia.com/news/50/10578/eisai-nichi-iko-pharma-enters-strategic-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10578/eisai-nichi-iko-pharma-enters-strategic-partnership.html</link>
			<pubDate>Thu, 29 Mar 2018 16:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership2-10578.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10578/eisai-nichi-iko-pharma-enters-strategic-partnership.html</guid>
		</item>	
				<item>
			<title>Innovation research on Cancer Hyperthermia Therapy </title>
			<atom:link href="https://biospectrumasia.com/news/50/10569/innovation-research-on-cancer-hyperthermia-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10569/innovation-research-on-cancer-hyperthermia-therapy-.html</link>
			<pubDate>Wed, 28 Mar 2018 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research_-10569.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10569/innovation-research-on-cancer-hyperthermia-therapy-.html</guid>
		</item>	
				<item>
			<title>Carna Bio, Sumitomo collaborate for neurological drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/10568/carna-bio-sumitomo-collaborate-for-neurological-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10568/carna-bio-sumitomo-collaborate-for-neurological-drug-discovery.html</link>
			<pubDate>Wed, 28 Mar 2018 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10568.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10568/carna-bio-sumitomo-collaborate-for-neurological-drug-discovery.html</guid>
		</item>	
				<item>
			<title>USFDA grants priority to XTANDI&#039;s sNDA</title>
			<atom:link href="https://biospectrumasia.com/news/50/10507/usfda-grants-priority-to-xtandis-snda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10507/usfda-grants-priority-to-xtandis-snda.html</link>
			<pubDate>Tue, 20 Mar 2018 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/court_hammer_648x430-10507.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10507/usfda-grants-priority-to-xtandis-snda.html</guid>
		</item>	
				<item>
			<title>Japan donates $1.5 M for healthcare services in Yemen</title>
			<atom:link href="https://biospectrumasia.com/news/50/10501/japan-donates-1-5-m-for-healthcare-services-in-yemen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10501/japan-donates-1-5-m-for-healthcare-services-in-yemen.html</link>
			<pubDate>Mon, 19 Mar 2018 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/car_2545442_960_720-10501.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10501/japan-donates-1-5-m-for-healthcare-services-in-yemen.html</guid>
		</item>	
				<item>
			<title>Japan provides aid to Sri Lankan health services</title>
			<atom:link href="https://biospectrumasia.com/news/50/10490/japan-provides-aid-to-sri-lankan-health-services.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10490/japan-provides-aid-to-sri-lankan-health-services.html</link>
			<pubDate>Fri, 16 Mar 2018 10:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10490.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10490/japan-provides-aid-to-sri-lankan-health-services.html</guid>
		</item>	
				<item>
			<title>PierianDx unites with Cancer Genetics to enrich patient&#039;s care</title>
			<atom:link href="https://biospectrumasia.com/news/50/10488/pieriandx-unites-with-cancer-genetics-to-enrich-patients-care.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10488/pieriandx-unites-with-cancer-genetics-to-enrich-patients-care.html</link>
			<pubDate>Thu, 15 Mar 2018 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-10488.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10488/pieriandx-unites-with-cancer-genetics-to-enrich-patients-care.html</guid>
		</item>	
				<item>
			<title>AGC Biologics sign up new Sr. Vice Presidents of BD</title>
			<atom:link href="https://biospectrumasia.com/news/50/10481/agc-biologics-sign-up-new-sr-vice-presidents-of-bd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10481/agc-biologics-sign-up-new-sr-vice-presidents-of-bd.html</link>
			<pubDate>Wed, 14 Mar 2018 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/recruit_jpg_2-10481.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10481/agc-biologics-sign-up-new-sr-vice-presidents-of-bd.html</guid>
		</item>	
				<item>
			<title>Eisai, Merck develop a strategic oncology collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/50/10465/eisai-merck-develop-a-strategic-oncology-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10465/eisai-merck-develop-a-strategic-oncology-collaboration.html</link>
			<pubDate>Fri, 09 Mar 2018 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10465.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10465/eisai-merck-develop-a-strategic-oncology-collaboration.html</guid>
		</item>	
				<item>
			<title>Japan to further reduce price of Opidivo by 23 percent</title>
			<atom:link href="https://biospectrumasia.com/news/50/10448/japan-to-further-reduce-price-of-opidivo-by-23-percent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10448/japan-to-further-reduce-price-of-opidivo-by-23-percent.html</link>
			<pubDate>Wed, 07 Mar 2018 14:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/court_hammer_648x430-10448.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10448/japan-to-further-reduce-price-of-opidivo-by-23-percent.html</guid>
		</item>	
				<item>
			<title>Constant Pharma announces Japanese patent issuance</title>
			<atom:link href="https://biospectrumasia.com/news/50/10440/constant-pharma-announces-japanese-patent-issuance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10440/constant-pharma-announces-japanese-patent-issuance.html</link>
			<pubDate>Wed, 07 Mar 2018 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10440.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10440/constant-pharma-announces-japanese-patent-issuance.html</guid>
		</item>	
				<item>
			<title>Takeda to build new facility in Dublin creating 70 new jobs</title>
			<atom:link href="https://biospectrumasia.com/news/50/10423/takeda-to-build-new-facility-in-dublin-creating-70-new-jobs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10423/takeda-to-build-new-facility-in-dublin-creating-70-new-jobs.html</link>
			<pubDate>Mon, 05 Mar 2018 14:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_163464__340-10423.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10423/takeda-to-build-new-facility-in-dublin-creating-70-new-jobs.html</guid>
		</item>	
				<item>
			<title>Takeda establishes centre of excellence for vaccine process optimisation</title>
			<atom:link href="https://biospectrumasia.com/news/50/10410/takeda-establishes-centre-of-excellence-for-vaccine-process-optimisation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10410/takeda-establishes-centre-of-excellence-for-vaccine-process-optimisation.html</link>
			<pubDate>Thu, 01 Mar 2018 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-10410.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10410/takeda-establishes-centre-of-excellence-for-vaccine-process-optimisation.html</guid>
		</item>	
				<item>
			<title>Roche and Takeda use Organs-On-Chip technology for R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/50/10406/roche-and-takeda-use-organs-on-chip-technology-for-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10406/roche-and-takeda-use-organs-on-chip-technology-for-rd.html</link>
			<pubDate>Thu, 01 Mar 2018 15:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/organ_on_chip-10406.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10406/roche-and-takeda-use-organs-on-chip-technology-for-rd.html</guid>
		</item>	
				<item>
			<title>Valeant teams up with Kaken for psoriasis treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/10403/valeant-teams-up-with-kaken-for-psoriasis-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10403/valeant-teams-up-with-kaken-for-psoriasis-treatment.html</link>
			<pubDate>Thu, 01 Mar 2018 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership1-10403.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10403/valeant-teams-up-with-kaken-for-psoriasis-treatment.html</guid>
		</item>	
				<item>
			<title>Genesis Healthcare raises 1.65 B Yen </title>
			<atom:link href="https://biospectrumasia.com/news/50/10395/genesis-healthcare-raises-1-65-b-yen-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10395/genesis-healthcare-raises-1-65-b-yen-.html</link>
			<pubDate>Tue, 27 Feb 2018 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10395.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10395/genesis-healthcare-raises-1-65-b-yen-.html</guid>
		</item>	
				<item>
			<title>Shionogi&#039;s thrombocytopenia drug receives &#039;priority review&#039; designation by the US FDA</title>
			<atom:link href="https://biospectrumasia.com/news/50/10392/shionogis-thrombocytopenia-drug-receives-priority-review-designation-by-the-us-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10392/shionogis-thrombocytopenia-drug-receives-priority-review-designation-by-the-us-fda.html</link>
			<pubDate>Tue, 27 Feb 2018 09:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fish_oil_1915423__340-10392.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10392/shionogis-thrombocytopenia-drug-receives-priority-review-designation-by-the-us-fda.html</guid>
		</item>	
				<item>
			<title>Sumitomo Dainippon appoints Nomura as President &amp; CEO</title>
			<atom:link href="https://biospectrumasia.com/news/50/10386/sumitomo-dainippon-appoints-nomura-as-president-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10386/sumitomo-dainippon-appoints-nomura-as-president-ceo.html</link>
			<pubDate>Mon, 26 Feb 2018 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10386.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10386/sumitomo-dainippon-appoints-nomura-as-president-ceo.html</guid>
		</item>	
				<item>
			<title>Medical Japan 2018: Japan&#039;s only comprehensive medical show concludes successfully</title>
			<atom:link href="https://biospectrumasia.com/news/50/10384/medical-japan-2018-japans-only-comprehensive-medical-show-concludes-successfully.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10384/medical-japan-2018-japans-only-comprehensive-medical-show-concludes-successfully.html</link>
			<pubDate>Fri, 23 Feb 2018 23:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/img_9366-10384.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10384/medical-japan-2018-japans-only-comprehensive-medical-show-concludes-successfully.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo seeks approval for Diagnogreen</title>
			<atom:link href="https://biospectrumasia.com/news/50/10378/daiichi-sankyo-seeks-approval-for-diagnogreen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10378/daiichi-sankyo-seeks-approval-for-diagnogreen.html</link>
			<pubDate>Fri, 23 Feb 2018 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-10378.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10378/daiichi-sankyo-seeks-approval-for-diagnogreen.html</guid>
		</item>	
				<item>
			<title>Takeda collaborates with Wave Life Sciences</title>
			<atom:link href="https://biospectrumasia.com/news/50/10374/takeda-collaborates-with-wave-life-sciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10374/takeda-collaborates-with-wave-life-sciences.html</link>
			<pubDate>Wed, 21 Feb 2018 17:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/icollaboration_274x186-10374.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10374/takeda-collaborates-with-wave-life-sciences.html</guid>
		</item>	
				<item>
			<title>Scientists in Tokyo design smart skin ECG device</title>
			<atom:link href="https://biospectrumasia.com/news/50/10370/scientists-in-tokyo-design-smart-skin-ecg-device.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10370/scientists-in-tokyo-design-smart-skin-ecg-device.html</link>
			<pubDate>Wed, 21 Feb 2018 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10370.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10370/scientists-in-tokyo-design-smart-skin-ecg-device.html</guid>
		</item>	
				<item>
			<title>Researchers in Japan develop a novel biosensing method</title>
			<atom:link href="https://biospectrumasia.com/news/50/10364/researchers-in-japan-develop-a-novel-biosensing-method.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10364/researchers-in-japan-develop-a-novel-biosensing-method.html</link>
			<pubDate>Tue, 20 Feb 2018 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10364.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10364/researchers-in-japan-develop-a-novel-biosensing-method.html</guid>
		</item>	
				<item>
			<title>Iran health sector receives $14M aid from Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/10362/iran-health-sector-receives-14m-aid-from-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10362/iran-health-sector-receives-14m-aid-from-japan.html</link>
			<pubDate>Tue, 20 Feb 2018 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10362.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10362/iran-health-sector-receives-14m-aid-from-japan.html</guid>
		</item>	
				<item>
			<title>Japanese researchers design water-soluble warped nanographene</title>
			<atom:link href="https://biospectrumasia.com/news/50/10327/japanese-researchers-design-water-soluble-warped-nanographene.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10327/japanese-researchers-design-water-soluble-warped-nanographene.html</link>
			<pubDate>Tue, 13 Feb 2018 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10327.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10327/japanese-researchers-design-water-soluble-warped-nanographene.html</guid>
		</item>	
				<item>
			<title>Japanese engineers test titanium fiber plates for fixing bone injuries</title>
			<atom:link href="https://biospectrumasia.com/news/50/10306/japanese-engineers-test-titanium-fiber-plates-for-fixing-bone-injuries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10306/japanese-engineers-test-titanium-fiber-plates-for-fixing-bone-injuries.html</link>
			<pubDate>Fri, 09 Feb 2018 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10306.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10306/japanese-engineers-test-titanium-fiber-plates-for-fixing-bone-injuries.html</guid>
		</item>	
				<item>
			<title>Takeda teams with Cedars Sinai on tech tool to personalize IBD treatment choices</title>
			<atom:link href="https://biospectrumasia.com/news/50/10301/takeda-teams-with-cedars-sinai-on-tech-tool-to-personalize-ibd-treatment-choices.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10301/takeda-teams-with-cedars-sinai-on-tech-tool-to-personalize-ibd-treatment-choices.html</link>
			<pubDate>Thu, 08 Feb 2018 23:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-10301.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10301/takeda-teams-with-cedars-sinai-on-tech-tool-to-personalize-ibd-treatment-choices.html</guid>
		</item>	
				<item>
			<title>Lupin&#039;s JV yields positive results for Etanercept clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/10287/lupins-jv-yields-positive-results-for-etanercept-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10287/lupins-jv-yields-positive-results-for-etanercept-clinical-trials.html</link>
			<pubDate>Thu, 08 Feb 2018 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10287.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10287/lupins-jv-yields-positive-results-for-etanercept-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Scottish biotech firm inks deal with Japan&#039;s NIPRO to co develop cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/10286/scottish-biotech-firm-inks-deal-with-japans-nipro-to-co-develop-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10286/scottish-biotech-firm-inks-deal-with-japans-nipro-to-co-develop-cancer-drug.html</link>
			<pubDate>Thu, 08 Feb 2018 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal_1457947__340-10286.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10286/scottish-biotech-firm-inks-deal-with-japans-nipro-to-co-develop-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Immunologist Max Cooper receives 2018 Japan Prize</title>
			<atom:link href="https://biospectrumasia.com/news/50/10266/immunologist-max-cooper-receives-2018-japan-prize.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10266/immunologist-max-cooper-receives-2018-japan-prize.html</link>
			<pubDate>Tue, 06 Feb 2018 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10266.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10266/immunologist-max-cooper-receives-2018-japan-prize.html</guid>
		</item>	
				<item>
			<title>Japan, Australia researchers work on early Alzheimer&#039;s detection</title>
			<atom:link href="https://biospectrumasia.com/news/50/10265/japan-australia-researchers-work-on-early-alzheimers-detection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10265/japan-australia-researchers-work-on-early-alzheimers-detection.html</link>
			<pubDate>Tue, 06 Feb 2018 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10265.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10265/japan-australia-researchers-work-on-early-alzheimers-detection.html</guid>
		</item>	
				<item>
			<title>Scientists develop technology for studying blood vessel formation</title>
			<atom:link href="https://biospectrumasia.com/news/50/10233/scientists-develop-technology-for-studying-blood-vessel-formation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10233/scientists-develop-technology-for-studying-blood-vessel-formation.html</link>
			<pubDate>Thu, 01 Feb 2018 10:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10233.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10233/scientists-develop-technology-for-studying-blood-vessel-formation.html</guid>
		</item>	
				<item>
			<title>BiomX in-licenses novel bacterial targets for IBD treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/10230/biomx-in-licenses-novel-bacterial-targets-for-ibd-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10230/biomx-in-licenses-novel-bacterial-targets-for-ibd-treatment.html</link>
			<pubDate>Wed, 31 Jan 2018 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ibd-10230.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10230/biomx-in-licenses-novel-bacterial-targets-for-ibd-treatment.html</guid>
		</item>	
				<item>
			<title>Experts in Tokyo design a novel flourescent probe</title>
			<atom:link href="https://biospectrumasia.com/news/50/10210/experts-in-tokyo-design-a-novel-flourescent-probe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10210/experts-in-tokyo-design-a-novel-flourescent-probe.html</link>
			<pubDate>Thu, 25 Jan 2018 16:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10210.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10210/experts-in-tokyo-design-a-novel-flourescent-probe.html</guid>
		</item>	
				<item>
			<title>HITACHI secures FDA 510(k) Clearance for its system</title>
			<atom:link href="https://biospectrumasia.com/news/50/10207/hitachi-secures-fda-510k-clearance-for-its-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10207/hitachi-secures-fda-510k-clearance-for-its-system.html</link>
			<pubDate>Thu, 25 Jan 2018 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_devices-10207.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10207/hitachi-secures-fda-510k-clearance-for-its-system.html</guid>
		</item>	
				<item>
			<title>Astellas completes acquisition of Mitobridge</title>
			<atom:link href="https://biospectrumasia.com/news/50/10199/astellas-completes-acquisition-of-mitobridge.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10199/astellas-completes-acquisition-of-mitobridge.html</link>
			<pubDate>Wed, 24 Jan 2018 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10199.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10199/astellas-completes-acquisition-of-mitobridge.html</guid>
		</item>	
				<item>
			<title>Japan approves use of Nailin capsules to treat onychomycosis</title>
			<atom:link href="https://biospectrumasia.com/news/50/10183/japan-approves-use-of-nailin-capsules-to-treat-onychomycosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10183/japan-approves-use-of-nailin-capsules-to-treat-onychomycosis.html</link>
			<pubDate>Mon, 22 Jan 2018 13:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10183.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10183/japan-approves-use-of-nailin-capsules-to-treat-onychomycosis.html</guid>
		</item>	
				<item>
			<title>Telix Pharmaceuticals establishes Japanese Subsidiary, Appoints Key Executives</title>
			<atom:link href="https://biospectrumasia.com/news/50/10143/telix-pharmaceuticals-establishes-japanese-subsidiary-appoints-key-executives.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10143/telix-pharmaceuticals-establishes-japanese-subsidiary-appoints-key-executives.html</link>
			<pubDate>Mon, 15 Jan 2018 09:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_1012459__340-10143.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10143/telix-pharmaceuticals-establishes-japanese-subsidiary-appoints-key-executives.html</guid>
		</item>	
				<item>
			<title>Japanese investors back a Cambridge Life Sciences firm, Storm Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/10141/japanese-investors-back-a-cambridge-life-sciences-firm-storm-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10141/japanese-investors-back-a-cambridge-life-sciences-firm-storm-therapeutics.html</link>
			<pubDate>Fri, 12 Jan 2018 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/financing-10141.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10141/japanese-investors-back-a-cambridge-life-sciences-firm-storm-therapeutics.html</guid>
		</item>	
				<item>
			<title>Takeda to buy TiGenix for $626 M</title>
			<atom:link href="https://biospectrumasia.com/news/50/10108/takeda-to-buy-tigenix-for-626-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10108/takeda-to-buy-tigenix-for-626-m.html</link>
			<pubDate>Sun, 07 Jan 2018 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10108.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10108/takeda-to-buy-tigenix-for-626-m.html</guid>
		</item>	
				<item>
			<title>Alexion bags Japanese approval for Soliris</title>
			<atom:link href="https://biospectrumasia.com/news/50/10092/alexion-bags-japanese-approval-for-soliris.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10092/alexion-bags-japanese-approval-for-soliris.html</link>
			<pubDate>Wed, 03 Jan 2018 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands_1903104__340-10092.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10092/alexion-bags-japanese-approval-for-soliris.html</guid>
		</item>	
				<item>
			<title>Researchers in Japan develop new strategy for 3D printing of tissues</title>
			<atom:link href="https://biospectrumasia.com/news/50/10069/researchers-in-japan-develop-new-strategy-for-3d-printing-of-tissues.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10069/researchers-in-japan-develop-new-strategy-for-3d-printing-of-tissues.html</link>
			<pubDate>Thu, 28 Dec 2017 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10069.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10069/researchers-in-japan-develop-new-strategy-for-3d-printing-of-tissues.html</guid>
		</item>	
				<item>
			<title>Otsuka collaborates with X-Chem for new drug compounds</title>
			<atom:link href="https://biospectrumasia.com/news/50/10054/otsuka-collaborates-with-x-chem-for-new-drug-compounds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10054/otsuka-collaborates-with-x-chem-for-new-drug-compounds.html</link>
			<pubDate>Tue, 26 Dec 2017 12:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10054.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10054/otsuka-collaborates-with-x-chem-for-new-drug-compounds.html</guid>
		</item>	
				<item>
			<title>Japanese scientists create a database of human plasma compounds</title>
			<atom:link href="https://biospectrumasia.com/news/50/10052/japanese-scientists-create-a-database-of-human-plasma-compounds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/10052/japanese-scientists-create-a-database-of-human-plasma-compounds.html</link>
			<pubDate>Tue, 26 Dec 2017 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10052.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/10052/japanese-scientists-create-a-database-of-human-plasma-compounds.html</guid>
		</item>	
				<item>
			<title>Israeli firm to invest in Japanese startups</title>
			<atom:link href="https://biospectrumasia.com/news/50/9979/israeli-firm-to-invest-in-japanese-startups.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9979/israeli-firm-to-invest-in-japanese-startups.html</link>
			<pubDate>Thu, 14 Dec 2017 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9979.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9979/israeli-firm-to-invest-in-japanese-startups.html</guid>
		</item>	
				<item>
			<title>Kenya partners with Japan to promote healthcare</title>
			<atom:link href="https://biospectrumasia.com/news/50/9914/kenya-partners-with-japan-to-promote-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9914/kenya-partners-with-japan-to-promote-healthcare.html</link>
			<pubDate>Mon, 04 Dec 2017 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9914.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9914/kenya-partners-with-japan-to-promote-healthcare.html</guid>
		</item>	
				<item>
			<title>Takeda appoints Fujimoto as Health Innovation Park GM</title>
			<atom:link href="https://biospectrumasia.com/news/50/9905/takeda-appoints-fujimoto-as-health-innovation-park-gm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9905/takeda-appoints-fujimoto-as-health-innovation-park-gm.html</link>
			<pubDate>Fri, 01 Dec 2017 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9905.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9905/takeda-appoints-fujimoto-as-health-innovation-park-gm.html</guid>
		</item>	
				<item>
			<title>Toshiba introduces advanced imaging technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/9888/toshiba-introduces-advanced-imaging-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9888/toshiba-introduces-advanced-imaging-technology.html</link>
			<pubDate>Wed, 29 Nov 2017 14:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9888.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9888/toshiba-introduces-advanced-imaging-technology.html</guid>
		</item>	
				<item>
			<title>Researchers in Japan develop a color device for the heart</title>
			<atom:link href="https://biospectrumasia.com/news/50/9816/researchers-in-japan-develop-a-color-device-for-the-heart.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9816/researchers-in-japan-develop-a-color-device-for-the-heart.html</link>
			<pubDate>Tue, 21 Nov 2017 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9816.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9816/researchers-in-japan-develop-a-color-device-for-the-heart.html</guid>
		</item>	
				<item>
			<title>Mitsubhishi Tanabe Pharma&#039;s ALS drug treats more than 1000 people in three months</title>
			<atom:link href="https://biospectrumasia.com/news/50/9812/mitsubhishi-tanabe-pharmas-als-drug-treats-more-than-1000-people-in-three-months.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9812/mitsubhishi-tanabe-pharmas-als-drug-treats-more-than-1000-people-in-three-months.html</link>
			<pubDate>Fri, 17 Nov 2017 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drugs_206150__340-9812.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9812/mitsubhishi-tanabe-pharmas-als-drug-treats-more-than-1000-people-in-three-months.html</guid>
		</item>	
				<item>
			<title>Health Ministry to increase hospitals in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/9810/health-ministry-to-increase-hospitals-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9810/health-ministry-to-increase-hospitals-in-japan.html</link>
			<pubDate>Fri, 17 Nov 2017 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/d-9810.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9810/health-ministry-to-increase-hospitals-in-japan.html</guid>
		</item>	
				<item>
			<title>World&#039;s first health management smart belt &quot;Welt&quot; arrives in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/9793/worlds-first-health-management-smart-belt-welt-arrives-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9793/worlds-first-health-management-smart-belt-welt-arrives-in-japan.html</link>
			<pubDate>Wed, 15 Nov 2017 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9793.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9793/worlds-first-health-management-smart-belt-welt-arrives-in-japan.html</guid>
		</item>	
				<item>
			<title>Shimadzu enters into partnership with Cure &amp; CK Sciences</title>
			<atom:link href="https://biospectrumasia.com/news/50/9712/shimadzu-enters-into-partnership-with-cure-ck-sciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9712/shimadzu-enters-into-partnership-with-cure-ck-sciences.html</link>
			<pubDate>Thu, 02 Nov 2017 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9712.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9712/shimadzu-enters-into-partnership-with-cure-ck-sciences.html</guid>
		</item>	
				<item>
			<title>Poxel, Sumitomo Dianippon Pharma ink $300 mn Asian deal for diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/9701/poxel-sumitomo-dianippon-pharma-ink-300-mn-asian-deal-for-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9701/poxel-sumitomo-dianippon-pharma-ink-300-mn-asian-deal-for-diabetes-drug.html</link>
			<pubDate>Wed, 01 Nov 2017 00:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands_1903104__340-9701.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9701/poxel-sumitomo-dianippon-pharma-ink-300-mn-asian-deal-for-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>Eisai, Biogen expand their agreement to codevelop and commercialize AD drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/9644/eisai-biogen-expand-their-agreement-to-codevelop-and-commercialize-ad-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9644/eisai-biogen-expand-their-agreement-to-codevelop-and-commercialize-ad-drug.html</link>
			<pubDate>Tue, 24 Oct 2017 20:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal_1457947__340-9644.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9644/eisai-biogen-expand-their-agreement-to-codevelop-and-commercialize-ad-drug.html</guid>
		</item>	
				<item>
			<title>Biogen extends collaboration with Eisai</title>
			<atom:link href="https://biospectrumasia.com/news/50/9639/biogen-extends-collaboration-with-eisai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9639/biogen-extends-collaboration-with-eisai.html</link>
			<pubDate>Tue, 24 Oct 2017 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9639.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9639/biogen-extends-collaboration-with-eisai.html</guid>
		</item>	
				<item>
			<title>Japanese scientists devise a method for developing living antibiotic</title>
			<atom:link href="https://biospectrumasia.com/news/50/9620/japanese-scientists-devise-a-method-for-developing-living-antibiotic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9620/japanese-scientists-devise-a-method-for-developing-living-antibiotic.html</link>
			<pubDate>Mon, 23 Oct 2017 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-9620.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9620/japanese-scientists-devise-a-method-for-developing-living-antibiotic.html</guid>
		</item>	
				<item>
			<title>Japan provides funds to Pakistan for eradicating polio</title>
			<atom:link href="https://biospectrumasia.com/news/50/9614/japan-provides-funds-to-pakistan-for-eradicating-polio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9614/japan-provides-funds-to-pakistan-for-eradicating-polio.html</link>
			<pubDate>Thu, 19 Oct 2017 20:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9614.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9614/japan-provides-funds-to-pakistan-for-eradicating-polio.html</guid>
		</item>	
				<item>
			<title>McGill teams up with Japan&#039;s NIPS for neuroscience research</title>
			<atom:link href="https://biospectrumasia.com/news/50/9610/mcgill-teams-up-with-japans-nips-for-neuroscience-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9610/mcgill-teams-up-with-japans-nips-for-neuroscience-research.html</link>
			<pubDate>Wed, 18 Oct 2017 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9610.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9610/mcgill-teams-up-with-japans-nips-for-neuroscience-research.html</guid>
		</item>	
				<item>
			<title>Japanese scientists grow drugs In chicken eggs</title>
			<atom:link href="https://biospectrumasia.com/news/50/9591/japanese-scientists-grow-drugs-in-chicken-eggs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9591/japanese-scientists-grow-drugs-in-chicken-eggs.html</link>
			<pubDate>Fri, 13 Oct 2017 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9591.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9591/japanese-scientists-grow-drugs-in-chicken-eggs.html</guid>
		</item>	
				<item>
			<title>Japan signs health agreement with Denmark</title>
			<atom:link href="https://biospectrumasia.com/news/50/9590/japan-signs-health-agreement-with-denmark.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9590/japan-signs-health-agreement-with-denmark.html</link>
			<pubDate>Fri, 13 Oct 2017 15:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration1-9590.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9590/japan-signs-health-agreement-with-denmark.html</guid>
		</item>	
				<item>
			<title>Indonesia to cooperate with Japan for healthcare</title>
			<atom:link href="https://biospectrumasia.com/news/50/9557/indonesia-to-cooperate-with-japan-for-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9557/indonesia-to-cooperate-with-japan-for-healthcare.html</link>
			<pubDate>Fri, 06 Oct 2017 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9557.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9557/indonesia-to-cooperate-with-japan-for-healthcare.html</guid>
		</item>	
				<item>
			<title>Sato And Eisai Pharma co-promote antifungal agent in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/9530/sato-and-eisai-pharma-co-promote-antifungal-agent-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9530/sato-and-eisai-pharma-co-promote-antifungal-agent-in-japan.html</link>
			<pubDate>Tue, 03 Oct 2017 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9530.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9530/sato-and-eisai-pharma-co-promote-antifungal-agent-in-japan.html</guid>
		</item>	
				<item>
			<title>GSK receives Japanese nod for Benylsta</title>
			<atom:link href="https://biospectrumasia.com/news/50/9518/gsk-receives-japanese-nod-for-benylsta.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9518/gsk-receives-japanese-nod-for-benylsta.html</link>
			<pubDate>Wed, 27 Sep 2017 16:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands_1903104__340-9518.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9518/gsk-receives-japanese-nod-for-benylsta.html</guid>
		</item>	
				<item>
			<title>Suven gets product patent from India and Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/9510/suven-gets-product-patent-from-india-and-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9510/suven-gets-product-patent-from-india-and-japan.html</link>
			<pubDate>Tue, 26 Sep 2017 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-9510.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9510/suven-gets-product-patent-from-india-and-japan.html</guid>
		</item>	
				<item>
			<title>SymBio receives licensing rights from Eagle Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/9491/symbio-receives-licensing-rights-from-eagle-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9491/symbio-receives-licensing-rights-from-eagle-pharma.html</link>
			<pubDate>Wed, 20 Sep 2017 16:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9491.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9491/symbio-receives-licensing-rights-from-eagle-pharma.html</guid>
		</item>	
				<item>
			<title>India and Japan join hands for stem cell research</title>
			<atom:link href="https://biospectrumasia.com/news/50/9464/india-and-japan-join-hands-for-stem-cell-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9464/india-and-japan-join-hands-for-stem-cell-research.html</link>
			<pubDate>Thu, 14 Sep 2017 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-9464.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9464/india-and-japan-join-hands-for-stem-cell-research.html</guid>
		</item>	
				<item>
			<title>Eisai announces combined clinical trial results on cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/9459/eisai-announces-combined-clinical-trial-results-on-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9459/eisai-announces-combined-clinical-trial-results-on-cancer.html</link>
			<pubDate>Wed, 13 Sep 2017 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/13-9459.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9459/eisai-announces-combined-clinical-trial-results-on-cancer.html</guid>
		</item>	
				<item>
			<title>Takeda collaborates with Noile-Immune Biotech </title>
			<atom:link href="https://biospectrumasia.com/news/50/9445/takeda-collaborates-with-noile-immune-biotech-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9445/takeda-collaborates-with-noile-immune-biotech-.html</link>
			<pubDate>Fri, 08 Sep 2017 16:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-9445.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9445/takeda-collaborates-with-noile-immune-biotech-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s iCure gets associated with Inter Milan</title>
			<atom:link href="https://biospectrumasia.com/news/50/9443/japans-icure-gets-associated-with-inter-milan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9443/japans-icure-gets-associated-with-inter-milan.html</link>
			<pubDate>Fri, 08 Sep 2017 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_1_-9443.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9443/japans-icure-gets-associated-with-inter-milan.html</guid>
		</item>	
				<item>
			<title>Scientists devise breakthrough therapy for Parkinson&#039;s </title>
			<atom:link href="https://biospectrumasia.com/news/50/9412/scientists-devise-breakthrough-therapy-for-parkinsons-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9412/scientists-devise-breakthrough-therapy-for-parkinsons-.html</link>
			<pubDate>Mon, 04 Sep 2017 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cultureware_hero-9412.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9412/scientists-devise-breakthrough-therapy-for-parkinsons-.html</guid>
		</item>	
				<item>
			<title>Nobel Laureate honoured by Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/9398/nobel-laureate-honoured-by-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9398/nobel-laureate-honoured-by-japan.html</link>
			<pubDate>Thu, 31 Aug 2017 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nobel-9398.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9398/nobel-laureate-honoured-by-japan.html</guid>
		</item>	
				<item>
			<title>Japanese researchers design device for drug toxicity</title>
			<atom:link href="https://biospectrumasia.com/news/50/9383/japanese-researchers-design-device-for-drug-toxicity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9383/japanese-researchers-design-device-for-drug-toxicity.html</link>
			<pubDate>Mon, 28 Aug 2017 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lab-9383.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9383/japanese-researchers-design-device-for-drug-toxicity.html</guid>
		</item>	
				<item>
			<title>MDR TB drug by Otsuka reaches India</title>
			<atom:link href="https://biospectrumasia.com/news/50/9373/mdr-tb-drug-by-otsuka-reaches-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9373/mdr-tb-drug-by-otsuka-reaches-india.html</link>
			<pubDate>Fri, 25 Aug 2017 08:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills-9373.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9373/mdr-tb-drug-by-otsuka-reaches-india.html</guid>
		</item>	
				<item>
			<title>Japanese researchers develop a long-lasting insulin analog </title>
			<atom:link href="https://biospectrumasia.com/news/50/9371/japanese-researchers-develop-a-long-lasting-insulin-analog-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9371/japanese-researchers-develop-a-long-lasting-insulin-analog-.html</link>
			<pubDate>Thu, 24 Aug 2017 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientist-9371.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9371/japanese-researchers-develop-a-long-lasting-insulin-analog-.html</guid>
		</item>	
				<item>
			<title>Japanese researchers use brain imaging to detect kidney disease </title>
			<atom:link href="https://biospectrumasia.com/news/50/9363/japanese-researchers-use-brain-imaging-to-detect-kidney-disease-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9363/japanese-researchers-use-brain-imaging-to-detect-kidney-disease-.html</link>
			<pubDate>Wed, 23 Aug 2017 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mri-9363.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9363/japanese-researchers-use-brain-imaging-to-detect-kidney-disease-.html</guid>
		</item>	
				<item>
			<title>Takeda partners with Cardurion Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/9293/takeda-partners-with-cardurion-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9293/takeda-partners-with-cardurion-pharma.html</link>
			<pubDate>Fri, 04 Aug 2017 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partner-9293.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9293/takeda-partners-with-cardurion-pharma.html</guid>
		</item>	
				<item>
			<title>Researchers create a unique system for drug delivery</title>
			<atom:link href="https://biospectrumasia.com/news/50/9256/researchers-create-a-unique-system-for-drug-delivery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9256/researchers-create-a-unique-system-for-drug-delivery.html</link>
			<pubDate>Fri, 28 Jul 2017 11:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lab-9256.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9256/researchers-create-a-unique-system-for-drug-delivery.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe Pharma to buy Neuroderm for $1.1 B </title>
			<atom:link href="https://biospectrumasia.com/news/50/9242/mitsubishi-tanabe-pharma-to-buy-neuroderm-for-1-1-b-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9242/mitsubishi-tanabe-pharma-to-buy-neuroderm-for-1-1-b-.html</link>
			<pubDate>Wed, 26 Jul 2017 14:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition-9242.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9242/mitsubishi-tanabe-pharma-to-buy-neuroderm-for-1-1-b-.html</guid>
		</item>	
				<item>
			<title>Japan MHLW grants marketing approval for RA treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/9207/japan-mhlw-grants-marketing-approval-for-ra-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9207/japan-mhlw-grants-marketing-approval-for-ra-treatment.html</link>
			<pubDate>Tue, 18 Jul 2017 16:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills1-9207.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9207/japan-mhlw-grants-marketing-approval-for-ra-treatment.html</guid>
		</item>	
				<item>
			<title>Malaysia, Japan ink deal to promote UHC</title>
			<atom:link href="https://biospectrumasia.com/news/50/9206/malaysia-japan-ink-deal-to-promote-uhc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9206/malaysia-japan-ink-deal-to-promote-uhc.html</link>
			<pubDate>Tue, 18 Jul 2017 16:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/malaysia_japan-9206.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9206/malaysia-japan-ink-deal-to-promote-uhc.html</guid>
		</item>	
				<item>
			<title>Scientists develop skin sensor to monitor health</title>
			<atom:link href="https://biospectrumasia.com/news/50/9205/scientists-develop-skin-sensor-to-monitor-health.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9205/scientists-develop-skin-sensor-to-monitor-health.html</link>
			<pubDate>Tue, 18 Jul 2017 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/device-9205.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9205/scientists-develop-skin-sensor-to-monitor-health.html</guid>
		</item>	
				<item>
			<title>Solasia announces Episil approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/9164/solasia-announces-episil-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9164/solasia-announces-episil-approval-in-japan.html</link>
			<pubDate>Mon, 10 Jul 2017 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicine-9164.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9164/solasia-announces-episil-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>European VC invests in Japan&#039;s Anaeropharma Science</title>
			<atom:link href="https://biospectrumasia.com/news/50/9145/european-vc-invests-in-japans-anaeropharma-science.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9145/european-vc-invests-in-japans-anaeropharma-science.html</link>
			<pubDate>Thu, 06 Jul 2017 13:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/currency_163476__340-9145.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9145/european-vc-invests-in-japans-anaeropharma-science.html</guid>
		</item>	
				<item>
			<title>Japanese regulators grant additional approval for the sale of Ipsen&#039;s rare cancer drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/9135/japanese-regulators-grant-additional-approval-for-the-sale-of-ipsens-rare-cancer-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9135/japanese-regulators-grant-additional-approval-for-the-sale-of-ipsens-rare-cancer-drug-in-japan.html</link>
			<pubDate>Tue, 04 Jul 2017 13:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fish_oil_1915423__340-9135.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9135/japanese-regulators-grant-additional-approval-for-the-sale-of-ipsens-rare-cancer-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Shimadzu expands joint research in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/9112/shimadzu-expands-joint-research-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9112/shimadzu-expands-joint-research-in-china.html</link>
			<pubDate>Wed, 28 Jun 2017 16:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shimadzu-9112.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9112/shimadzu-expands-joint-research-in-china.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Z- Works raises funding</title>
			<atom:link href="https://biospectrumasia.com/news/50/9110/japans-z-works-raises-funding.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9110/japans-z-works-raises-funding.html</link>
			<pubDate>Wed, 28 Jun 2017 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/funding-9110.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9110/japans-z-works-raises-funding.html</guid>
		</item>	
				<item>
			<title>Takeda, Biological E ink pact to develop and commercialize vaccines</title>
			<atom:link href="https://biospectrumasia.com/news/50/9108/takeda-biological-e-ink-pact-to-develop-and-commercialize-vaccines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9108/takeda-biological-e-ink-pact-to-develop-and-commercialize-vaccines.html</link>
			<pubDate>Tue, 27 Jun 2017 16:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/syringe_2091751_960_720-9108.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9108/takeda-biological-e-ink-pact-to-develop-and-commercialize-vaccines.html</guid>
		</item>	
				<item>
			<title>Canopy Biosciences Announces Distribution Agreement with Cosmo Bio</title>
			<atom:link href="https://biospectrumasia.com/news/50/9094/canopy-biosciences-announces-distribution-agreement-with-cosmo-bio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9094/canopy-biosciences-announces-distribution-agreement-with-cosmo-bio.html</link>
			<pubDate>Fri, 23 Jun 2017 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement_1-9094.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9094/canopy-biosciences-announces-distribution-agreement-with-cosmo-bio.html</guid>
		</item>	
				<item>
			<title>Plant based medicine to treat Alzheimer&#039;s </title>
			<atom:link href="https://biospectrumasia.com/news/50/9083/plant-based-medicine-to-treat-alzheimers-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9083/plant-based-medicine-to-treat-alzheimers-.html</link>
			<pubDate>Wed, 21 Jun 2017 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/plant-9083.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9083/plant-based-medicine-to-treat-alzheimers-.html</guid>
		</item>	
				<item>
			<title>Nanosonics expands into Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/9066/nanosonics-expands-into-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9066/nanosonics-expands-into-japan.html</link>
			<pubDate>Mon, 19 Jun 2017 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/expanding_plants-9066.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9066/nanosonics-expands-into-japan.html</guid>
		</item>	
				<item>
			<title>Nanosonics partners with Sakura Seiki</title>
			<atom:link href="https://biospectrumasia.com/news/50/9065/nanosonics-partners-with-sakura-seiki.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9065/nanosonics-partners-with-sakura-seiki.html</link>
			<pubDate>Mon, 19 Jun 2017 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership_small-9065.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9065/nanosonics-partners-with-sakura-seiki.html</guid>
		</item>	
				<item>
			<title>Shimadzu launches new analytical balances</title>
			<atom:link href="https://biospectrumasia.com/news/50/9006/shimadzu-launches-new-analytical-balances.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9006/shimadzu-launches-new-analytical-balances.html</link>
			<pubDate>Mon, 05 Jun 2017 15:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shimadzu-9006.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9006/shimadzu-launches-new-analytical-balances.html</guid>
		</item>	
				<item>
			<title>Shimadzu in agreement with Phytronix</title>
			<atom:link href="https://biospectrumasia.com/news/50/9005/shimadzu-in-agreement-with-phytronix.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/9005/shimadzu-in-agreement-with-phytronix.html</link>
			<pubDate>Mon, 05 Jun 2017 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaborate-9005.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/9005/shimadzu-in-agreement-with-phytronix.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Maz World opens lab in Hong Kong</title>
			<atom:link href="https://biospectrumasia.com/news/50/8973/japans-maz-world-opens-lab-in-hong-kong.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8973/japans-maz-world-opens-lab-in-hong-kong.html</link>
			<pubDate>Mon, 29 May 2017 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/engineering_new_bldg-8973.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8973/japans-maz-world-opens-lab-in-hong-kong.html</guid>
		</item>	
				<item>
			<title>Japan ratifies Nagoya Protocol on use of genetic resources</title>
			<atom:link href="https://biospectrumasia.com/news/50/8965/japan-ratifies-nagoya-protocol-on-use-of-genetic-resources.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8965/japan-ratifies-nagoya-protocol-on-use-of-genetic-resources.html</link>
			<pubDate>Wed, 24 May 2017 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership-8965.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8965/japan-ratifies-nagoya-protocol-on-use-of-genetic-resources.html</guid>
		</item>	
				<item>
			<title>A palm sized medical gamma-ray camera invented</title>
			<atom:link href="https://biospectrumasia.com/news/50/8956/a-palm-sized-medical-gamma-ray-camera-invented.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8956/a-palm-sized-medical-gamma-ray-camera-invented.html</link>
			<pubDate>Tue, 23 May 2017 17:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/polaroid_cube_1440p_mini_23022-8956.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8956/a-palm-sized-medical-gamma-ray-camera-invented.html</guid>
		</item>	
				<item>
			<title>India and Japan intensify cooperation in medical device regulations</title>
			<atom:link href="https://biospectrumasia.com/news/50/8870/india-and-japan-intensify-cooperation-in-medical-device-regulations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8870/india-and-japan-intensify-cooperation-in-medical-device-regulations.html</link>
			<pubDate>Fri, 05 May 2017 17:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration-8870.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8870/india-and-japan-intensify-cooperation-in-medical-device-regulations.html</guid>
		</item>	
				<item>
			<title>A $21 million Series A funding closed by LensGen </title>
			<atom:link href="https://biospectrumasia.com/news/50/8852/a-21-million-series-a-funding-closed-by-lensgen-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8852/a-21-million-series-a-funding-closed-by-lensgen-.html</link>
			<pubDate>Tue, 02 May 2017 16:03:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eye1-8852.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8852/a-21-million-series-a-funding-closed-by-lensgen-.html</guid>
		</item>	
				<item>
			<title>Takeda announces FDA Accelerated approval of ALUNBRIG (brigatin)</title>
			<atom:link href="https://biospectrumasia.com/news/50/8847/takeda-announces-fda-accelerated-approval-of-alunbrig-brigatin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8847/takeda-announces-fda-accelerated-approval-of-alunbrig-brigatin.html</link>
			<pubDate>Tue, 02 May 2017 12:49:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills_161087__340-8847.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8847/takeda-announces-fda-accelerated-approval-of-alunbrig-brigatin.html</guid>
		</item>	
				<item>
			<title>Janssen inks deal with Japan&#039;s PeptiDream</title>
			<atom:link href="https://biospectrumasia.com/news/50/8918/janssen-inks-deal-with-japans-peptidream.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8918/janssen-inks-deal-with-japans-peptidream.html</link>
			<pubDate>Tue, 18 Apr 2017 15:30:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/office-227746-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8918/janssen-inks-deal-with-japans-peptidream.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas pharma to acquire Belgium firm Ogeda</title>
			<atom:link href="https://biospectrumasia.com/news/50/8804/japans-astellas-pharma-to-acquire-belgium-firm-ogeda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8804/japans-astellas-pharma-to-acquire-belgium-firm-ogeda.html</link>
			<pubDate>Fri, 07 Apr 2017 15:50:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-chris-viehbacher-ceo-sanofi-makes-some-stark-revelations-about-the-firm-s-future-plans-regarding-buying-and-selling-of-its-stakes-in-l-oreal-and-regeneron.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8804/japans-astellas-pharma-to-acquire-belgium-firm-ogeda.html</guid>
		</item>	
				<item>
			<title>Takeda off-loads some drug development to JV</title>
			<atom:link href="https://biospectrumasia.com/news/50/8769/takeda-off-loads-some-drug-development-to-jv.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8769/takeda-off-loads-some-drug-development-to-jv.html</link>
			<pubDate>Wed, 15 Mar 2017 15:55:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gilead-s-hepatitis-c-drug-sovaldi-can-cure-the-disease-faster-and-more-reliably-than-previous-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8769/takeda-off-loads-some-drug-development-to-jv.html</guid>
		</item>	
				<item>
			<title>Lupin inks pact to distribute antidepressant drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/8735/lupin-inks-pact-to-distribute-antidepressant-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8735/lupin-inks-pact-to-distribute-antidepressant-drug-in-japan.html</link>
			<pubDate>Mon, 27 Feb 2017 14:16:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8735/lupin-inks-pact-to-distribute-antidepressant-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo closes its Japanese research subsidiary</title>
			<atom:link href="https://biospectrumasia.com/news/50/8719/daiichi-sankyo-closes-its-japanese-research-subsidiary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8719/daiichi-sankyo-closes-its-japanese-research-subsidiary.html</link>
			<pubDate>Mon, 13 Feb 2017 15:50:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/padlock-406986-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8719/daiichi-sankyo-closes-its-japanese-research-subsidiary.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Takeda to invest Ã¢â€šÂ¬40 million in Irish facility</title>
			<atom:link href="https://biospectrumasia.com/news/50/8663/japans-takeda-to-invest-40-million-in-irish-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8663/japans-takeda-to-invest-40-million-in-irish-facility.html</link>
			<pubDate>Tue, 06 Dec 2016 15:48:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money-invested-research-center.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8663/japans-takeda-to-invest-40-million-in-irish-facility.html</guid>
		</item>	
				<item>
			<title>Sanofi to launch 20 new drugs in Japan by 2020</title>
			<atom:link href="https://biospectrumasia.com/news/50/8649/sanofi-to-launch-20-new-drugs-in-japan-by-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8649/sanofi-to-launch-20-new-drugs-in-japan-by-2020.html</link>
			<pubDate>Tue, 29 Nov 2016 14:36:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10082836.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8649/sanofi-to-launch-20-new-drugs-in-japan-by-2020.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Towa Phamaceuticals to enter the US market</title>
			<atom:link href="https://biospectrumasia.com/news/50/8599/japans-towa-phamaceuticals-to-enter-the-us-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8599/japans-towa-phamaceuticals-to-enter-the-us-market.html</link>
			<pubDate>Tue, 15 Nov 2016 14:08:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gilead-s-hepatitis-c-drug-sovaldi-can-cure-the-disease-faster-and-more-reliably-than-previous-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8599/japans-towa-phamaceuticals-to-enter-the-us-market.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Fujifilm Holdings to acquire Takeda&#039;s arm?</title>
			<atom:link href="https://biospectrumasia.com/news/50/8627/japans-fujifilm-holdings-to-acquire-takedas-arm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8627/japans-fujifilm-holdings-to-acquire-takedas-arm.html</link>
			<pubDate>Mon, 07 Nov 2016 12:36:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100229135.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8627/japans-fujifilm-holdings-to-acquire-takedas-arm.html</guid>
		</item>	
				<item>
			<title>Japanese firm invests $11.4 mn in TB and malaria research</title>
			<atom:link href="https://biospectrumasia.com/news/50/8625/japanese-firm-invests-11-4-mn-in-tb-and-malaria-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8625/japanese-firm-invests-11-4-mn-in-tb-and-malaria-research.html</link>
			<pubDate>Thu, 03 Nov 2016 14:39:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tb-fight-needs-money.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8625/japanese-firm-invests-11-4-mn-in-tb-and-malaria-research.html</guid>
		</item>	
				<item>
			<title>Cardinal Health expands cardiovascular portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/50/8622/cardinal-health-expands-cardiovascular-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8622/cardinal-health-expands-cardiovascular-portfolio.html</link>
			<pubDate>Wed, 02 Nov 2016 13:42:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10046979.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8622/cardinal-health-expands-cardiovascular-portfolio.html</guid>
		</item>	
				<item>
			<title>Clinigen makes foray into Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/8606/clinigen-makes-foray-into-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8606/clinigen-makes-foray-into-japan.html</link>
			<pubDate>Wed, 19 Oct 2016 13:13:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100262389.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8606/clinigen-makes-foray-into-japan.html</guid>
		</item>	
				<item>
			<title>India urges Japan to provide wider pharma market access </title>
			<atom:link href="https://biospectrumasia.com/news/50/8596/india-urges-japan-to-provide-wider-pharma-market-access-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8596/india-urges-japan-to-provide-wider-pharma-market-access-.html</link>
			<pubDate>Fri, 14 Oct 2016 14:02:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bulgaria.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8596/india-urges-japan-to-provide-wider-pharma-market-access-.html</guid>
		</item>	
				<item>
			<title>Zydus Cadila, Takeda to co-develop vaccine for chikungunya</title>
			<atom:link href="https://biospectrumasia.com/news/50/8559/zydus-cadila-takeda-to-co-develop-vaccine-for-chikungunya.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8559/zydus-cadila-takeda-to-co-develop-vaccine-for-chikungunya.html</link>
			<pubDate>Fri, 23 Sep 2016 14:16:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100274805.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8559/zydus-cadila-takeda-to-co-develop-vaccine-for-chikungunya.html</guid>
		</item>	
				<item>
			<title>Teijin, Versartis partner for commercialization of Somavaratan in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/8478/teijin-versartis-partner-for-commercialization-of-somavaratan-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8478/teijin-versartis-partner-for-commercialization-of-somavaratan-in-japan-.html</link>
			<pubDate>Thu, 11 Aug 2016 16:36:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/13593-np0cnt.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8478/teijin-versartis-partner-for-commercialization-of-somavaratan-in-japan-.html</guid>
		</item>	
				<item>
			<title>Columbia Asia receives $101mn investment from Mitsui &amp; Co.</title>
			<atom:link href="https://biospectrumasia.com/news/50/8493/columbia-asia-receives-101mn-investment-from-mitsui-co-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8493/columbia-asia-receives-101mn-investment-from-mitsui-co-.html</link>
			<pubDate>Wed, 27 Jul 2016 11:32:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money-434709-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8493/columbia-asia-receives-101mn-investment-from-mitsui-co-.html</guid>
		</item>	
				<item>
			<title>Eisai receives positive CHMP opinion on new indication for anticancer agent </title>
			<atom:link href="https://biospectrumasia.com/news/50/8144/eisai-receives-positive-chmp-opinion-on-new-indication-for-anticancer-agent-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8144/eisai-receives-positive-chmp-opinion-on-new-indication-for-anticancer-agent-.html</link>
			<pubDate>Tue, 26 Jul 2016 11:28:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100294534.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8144/eisai-receives-positive-chmp-opinion-on-new-indication-for-anticancer-agent-.html</guid>
		</item>	
				<item>
			<title>Biocon, Fujifilm launch Insulin Glargine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7685/biocon-fujifilm-launch-insulin-glargine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7685/biocon-fujifilm-launch-insulin-glargine-in-japan.html</link>
			<pubDate>Tue, 19 Jul 2016 14:45:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100125026.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7685/biocon-fujifilm-launch-insulin-glargine-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Taisho forays into Vietnam market</title>
			<atom:link href="https://biospectrumasia.com/news/50/6334/japans-taisho-forays-into-vietnam-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6334/japans-taisho-forays-into-vietnam-market.html</link>
			<pubDate>Thu, 07 Jul 2016 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100180388.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6334/japans-taisho-forays-into-vietnam-market.html</guid>
		</item>	
				<item>
			<title>Japan approves Teijin Pharma&#039;s Feburic </title>
			<atom:link href="https://biospectrumasia.com/news/50/4672/japan-approves-teijin-pharmas-feburic-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4672/japan-approves-teijin-pharmas-feburic-.html</link>
			<pubDate>Wed, 25 May 2016 11:52:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10014542.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4672/japan-approves-teijin-pharmas-feburic-.html</guid>
		</item>	
				<item>
			<title>Ono, Bristol-Myers launch Orencia Auto-injector for treatment of Rheumatoid Arthritis </title>
			<atom:link href="https://biospectrumasia.com/news/50/7415/ono-bristol-myers-launch-orencia-auto-injector-for-treatment-of-rheumatoid-arthritis-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7415/ono-bristol-myers-launch-orencia-auto-injector-for-treatment-of-rheumatoid-arthritis-.html</link>
			<pubDate>Wed, 25 May 2016 11:49:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/regular-shots-of-influenza-injections-have-the-added-benefit-of-reducing-the-risk-of-heart-attacks-in-people-in-the-40-to-64-age-group-if-they-have-narrowed-arteries.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7415/ono-bristol-myers-launch-orencia-auto-injector-for-treatment-of-rheumatoid-arthritis-.html</guid>
		</item>	
				<item>
			<title>Allergan&#039;s Botox Vista receives marketing authorization in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/8348/allergans-botox-vista-receives-marketing-authorization-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8348/allergans-botox-vista-receives-marketing-authorization-in-japan-.html</link>
			<pubDate>Wed, 25 May 2016 11:44:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/c.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8348/allergans-botox-vista-receives-marketing-authorization-in-japan-.html</guid>
		</item>	
				<item>
			<title>Phosphagenics licenses TPM/Oxycodone Patch to an undisclosed Japanese company</title>
			<atom:link href="https://biospectrumasia.com/news/50/6790/phosphagenics-licenses-tpm-oxycodone-patch-to-an-undisclosed-japanese-company.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6790/phosphagenics-licenses-tpm-oxycodone-patch-to-an-undisclosed-japanese-company.html</link>
			<pubDate>Wed, 18 May 2016 11:46:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088852.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6790/phosphagenics-licenses-tpm-oxycodone-patch-to-an-undisclosed-japanese-company.html</guid>
		</item>	
				<item>
			<title>FDA approves additional indication of Eisai&#039;s anticancer agent Lenvima </title>
			<atom:link href="https://biospectrumasia.com/news/50/7092/fda-approves-additional-indication-of-eisais-anticancer-agent-lenvima-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7092/fda-approves-additional-indication-of-eisais-anticancer-agent-lenvima-.html</link>
			<pubDate>Tue, 17 May 2016 11:23:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yes-68480-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7092/fda-approves-additional-indication-of-eisais-anticancer-agent-lenvima-.html</guid>
		</item>	
				<item>
			<title>Chugai gets positive outcome from Actemra Subcutaneous Injection trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/8428/chugai-gets-positive-outcome-from-actemra-subcutaneous-injection-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8428/chugai-gets-positive-outcome-from-actemra-subcutaneous-injection-trials.html</link>
			<pubDate>Tue, 17 May 2016 11:20:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mark-43729-640.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8428/chugai-gets-positive-outcome-from-actemra-subcutaneous-injection-trials.html</guid>
		</item>	
				<item>
			<title>Takeda appoints James Kehoe as CFO</title>
			<atom:link href="https://biospectrumasia.com/news/50/6706/takeda-appoints-james-kehoe-as-cfo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6706/takeda-appoints-james-kehoe-as-cfo.html</link>
			<pubDate>Mon, 16 May 2016 11:11:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/st-jude-medical-reorg.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6706/takeda-appoints-james-kehoe-as-cfo.html</guid>
		</item>	
				<item>
			<title>Histogenics to develop Purpose&#039;s NeoCart for Japanese Market</title>
			<atom:link href="https://biospectrumasia.com/news/50/8402/histogenics-to-develop-purposes-neocart-for-japanese-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8402/histogenics-to-develop-purposes-neocart-for-japanese-market.html</link>
			<pubDate>Wed, 11 May 2016 11:11:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088852.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8402/histogenics-to-develop-purposes-neocart-for-japanese-market.html</guid>
		</item>	
				<item>
			<title>Taiho establishes Taiho Ventures to foster oncology biotech start-ups</title>
			<atom:link href="https://biospectrumasia.com/news/50/8033/taiho-establishes-taiho-ventures-to-foster-oncology-biotech-start-ups.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8033/taiho-establishes-taiho-ventures-to-foster-oncology-biotech-start-ups.html</link>
			<pubDate>Wed, 11 May 2016 11:09:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/connect-20333-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8033/taiho-establishes-taiho-ventures-to-foster-oncology-biotech-start-ups.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo to develop Cell Therapy&#039;s Heartcel for Japanese market </title>
			<atom:link href="https://biospectrumasia.com/news/50/7673/daiichi-sankyo-to-develop-cell-therapys-heartcel-for-japanese-market-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7673/daiichi-sankyo-to-develop-cell-therapys-heartcel-for-japanese-market-.html</link>
			<pubDate>Wed, 11 May 2016 11:06:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-cell-163711-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7673/daiichi-sankyo-to-develop-cell-therapys-heartcel-for-japanese-market-.html</guid>
		</item>	
				<item>
			<title>Prosetta Biosciences, Takeda to co-discover drugs for neurodegenerative diseases</title>
			<atom:link href="https://biospectrumasia.com/news/50/8421/prosetta-biosciences-takeda-to-co-discover-drugs-for-neurodegenerative-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8421/prosetta-biosciences-takeda-to-co-discover-drugs-for-neurodegenerative-diseases.html</link>
			<pubDate>Tue, 03 May 2016 10:01:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10014542.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8421/prosetta-biosciences-takeda-to-co-discover-drugs-for-neurodegenerative-diseases.html</guid>
		</item>	
				<item>
			<title>Prima BioMed&#039;s immunotherapeutic drug secures Japanese patent</title>
			<atom:link href="https://biospectrumasia.com/news/50/6514/prima-biomeds-immunotherapeutic-drug-secures-japanese-patent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6514/prima-biomeds-immunotherapeutic-drug-secures-japanese-patent.html</link>
			<pubDate>Tue, 03 May 2016 09:58:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/resmed-wins-patent-case-against-china-firm-in-germany.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6514/prima-biomeds-immunotherapeutic-drug-secures-japanese-patent.html</guid>
		</item>	
				<item>
			<title>Amgen,Astellas announce the launch of Repatha in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/8027/amgenastellas-announce-the-launch-of-repatha-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8027/amgenastellas-announce-the-launch-of-repatha-in-japan.html</link>
			<pubDate>Thu, 28 Apr 2016 14:57:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/apotex-recalls-15-lots-of-piperacillin-and-tazobactam-for-injection-on-behalf-of-hospira.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8027/amgenastellas-announce-the-launch-of-repatha-in-japan.html</guid>
		</item>	
				<item>
			<title>Taconic Biosciences expands its pact with Japan&#039;s Micell </title>
			<atom:link href="https://biospectrumasia.com/news/50/5730/taconic-biosciences-expands-its-pact-with-japans-micell-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5730/taconic-biosciences-expands-its-pact-with-japans-micell-.html</link>
			<pubDate>Sun, 24 Apr 2016 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100247127.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5730/taconic-biosciences-expands-its-pact-with-japans-micell-.html</guid>
		</item>	
				<item>
			<title>Japanese pharma market to be $80 bn by 2020: Analyst</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5857/japanese-pharma-market-to-be-80-bn-by-2020-analyst.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5857/japanese-pharma-market-to-be-80-bn-by-2020-analyst.html</link>
			<pubDate>Sun, 24 Apr 2016 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100220917.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5857/japanese-pharma-market-to-be-80-bn-by-2020-analyst.html</guid>
		</item>	
				<item>
			<title>Takeda partners with WIPO to accelerate R&amp;D </title>
			<atom:link href="https://biospectrumasia.com/news/50/7011/takeda-partners-with-wipo-to-accelerate-rd-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7011/takeda-partners-with-wipo-to-accelerate-rd-.html</link>
			<pubDate>Sun, 24 Apr 2016 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hg.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7011/takeda-partners-with-wipo-to-accelerate-rd-.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo announces closure of its Hiratsuka Plant</title>
			<atom:link href="https://biospectrumasia.com/news/50/8333/daiichi-sankyo-announces-closure-of-its-hiratsuka-plant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8333/daiichi-sankyo-announces-closure-of-its-hiratsuka-plant.html</link>
			<pubDate>Mon, 04 Apr 2016 10:45:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/closed.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8333/daiichi-sankyo-announces-closure-of-its-hiratsuka-plant.html</guid>
		</item>	
				<item>
			<title>GSK receives marketing authorization for Nucala in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/7476/gsk-receives-marketing-authorization-for-nucala-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7476/gsk-receives-marketing-authorization-for-nucala-in-japan-.html</link>
			<pubDate>Wed, 30 Mar 2016 14:54:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/waters.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7476/gsk-receives-marketing-authorization-for-nucala-in-japan-.html</guid>
		</item>	
				<item>
			<title>Sun Pharma enters Japanese prescription market</title>
			<atom:link href="https://biospectrumasia.com/news/50/7540/sun-pharma-enters-japanese-prescription-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7540/sun-pharma-enters-japanese-prescription-market.html</link>
			<pubDate>Wed, 30 Mar 2016 12:19:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/outline-38268-640.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7540/sun-pharma-enters-japanese-prescription-market.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo launches  LIXIANA sales alliance in Europe </title>
			<atom:link href="https://biospectrumasia.com/news/50/7879/daiichi-sankyo-launches-lixiana-sales-alliance-in-europe-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7879/daiichi-sankyo-launches-lixiana-sales-alliance-in-europe-.html</link>
			<pubDate>Thu, 18 Feb 2016 13:18:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100211120.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7879/daiichi-sankyo-launches-lixiana-sales-alliance-in-europe-.html</guid>
		</item>	
				<item>
			<title>Eisai, Sysmex partner to develop diagnostic for dementia</title>
			<atom:link href="https://biospectrumasia.com/news/50/8274/eisai-sysmex-partner-to-develop-diagnostic-for-dementia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8274/eisai-sysmex-partner-to-develop-diagnostic-for-dementia.html</link>
			<pubDate>Tue, 16 Feb 2016 11:30:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100234314.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8274/eisai-sysmex-partner-to-develop-diagnostic-for-dementia.html</guid>
		</item>	
				<item>
			<title>Breast cancer market will rise to $3.4 billion by 2021&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/50/8248/breast-cancer-market-will-rise-to-3-4-billion-by-2021.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8248/breast-cancer-market-will-rise-to-3-4-billion-by-2021.html</link>
			<pubDate>Tue, 16 Feb 2016 10:46:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10015674.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8248/breast-cancer-market-will-rise-to-3-4-billion-by-2021.html</guid>
		</item>	
				<item>
			<title>Eisai enters license agreement with HUYA Bioscience </title>
			<atom:link href="https://biospectrumasia.com/news/50/8151/eisai-enters-license-agreement-with-huya-bioscience-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8151/eisai-enters-license-agreement-with-huya-bioscience-.html</link>
			<pubDate>Tue, 02 Feb 2016 11:10:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088852.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8151/eisai-enters-license-agreement-with-huya-bioscience-.html</guid>
		</item>	
				<item>
			<title>NCRM gets Japanese patent for nanotechnology-based corneal stem cell transplant</title>
			<atom:link href="https://biospectrumasia.com/news/50/8353/ncrm-gets-japanese-patent-for-nanotechnology-based-corneal-stem-cell-transplant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8353/ncrm-gets-japanese-patent-for-nanotechnology-based-corneal-stem-cell-transplant.html</link>
			<pubDate>Mon, 01 Feb 2016 11:35:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eye.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8353/ncrm-gets-japanese-patent-for-nanotechnology-based-corneal-stem-cell-transplant.html</guid>
		</item>	
				<item>
			<title>Japan market forecast</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/8512/japan-market-forecast.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/8512/japan-market-forecast.html</link>
			<pubDate>Wed, 20 Jan 2016 11:03:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1280px-flag-of-japan-svg.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/8512/japan-market-forecast.html</guid>
		</item>	
				<item>
			<title>Challenges in mHealth integration&#039;</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/7948/challenges-in-mhealth-integration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/7948/challenges-in-mhealth-integration.html</link>
			<pubDate>Tue, 19 Jan 2016 14:33:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/motophide-nishi.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/7948/challenges-in-mhealth-integration.html</guid>
		</item>	
				<item>
			<title>Global respiratory syncytial virus treatment market to touch $2.3 bn by 2024</title>
			<atom:link href="https://biospectrumasia.com/news/50/8160/global-respiratory-syncytial-virus-treatment-market-to-touch-2-3-bn-by-2024.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8160/global-respiratory-syncytial-virus-treatment-market-to-touch-2-3-bn-by-2024.html</link>
			<pubDate>Thu, 14 Jan 2016 12:00:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191614-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8160/global-respiratory-syncytial-virus-treatment-market-to-touch-2-3-bn-by-2024.html</guid>
		</item>	
				<item>
			<title>Takeda acquires US biologics manufacturing facility </title>
			<atom:link href="https://biospectrumasia.com/news/50/7151/takeda-acquires-us-biologics-manufacturing-facility-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7151/takeda-acquires-us-biologics-manufacturing-facility-.html</link>
			<pubDate>Thu, 07 Jan 2016 10:58:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sugar-837719-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7151/takeda-acquires-us-biologics-manufacturing-facility-.html</guid>
		</item>	
				<item>
			<title>Shimadzu Global Pharma Summit gathers veterans to share regulatory challenges</title>
			<atom:link href="https://biospectrumasia.com/news/50/8096/shimadzu-global-pharma-summit-gathers-veterans-to-share-regulatory-challenges.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8096/shimadzu-global-pharma-summit-gathers-veterans-to-share-regulatory-challenges.html</link>
			<pubDate>Thu, 07 Jan 2016 10:20:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5th-shimadzu-global-pharma-summit-2015-group-photo-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8096/shimadzu-global-pharma-summit-gathers-veterans-to-share-regulatory-challenges.html</guid>
		</item>	
				<item>
			<title>Eisai buys Chinese Generics Company Liaoning TianYi</title>
			<atom:link href="https://biospectrumasia.com/news/50/8095/eisai-buys-chinese-generics-company-liaoning-tianyi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8095/eisai-buys-chinese-generics-company-liaoning-tianyi.html</link>
			<pubDate>Wed, 06 Jan 2016 11:27:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hhh.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8095/eisai-buys-chinese-generics-company-liaoning-tianyi.html</guid>
		</item>	
				<item>
			<title>Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection</title>
			<atom:link href="https://biospectrumasia.com/news/50/7808/teikoku-pharma-gets-usfda-nod-for-non-alcohol-docetaxel-injection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7808/teikoku-pharma-gets-usfda-nod-for-non-alcohol-docetaxel-injection.html</link>
			<pubDate>Mon, 04 Jan 2016 11:48:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088852.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7808/teikoku-pharma-gets-usfda-nod-for-non-alcohol-docetaxel-injection.html</guid>
		</item>	
				<item>
			<title>Investment arm of Dentsu invests in Cue&#039;s at-home health tracker </title>
			<atom:link href="https://biospectrumasia.com/news/50/7501/investment-arm-of-dentsu-invests-in-cues-at-home-health-tracker-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7501/investment-arm-of-dentsu-invests-in-cues-at-home-health-tracker-.html</link>
			<pubDate>Wed, 30 Dec 2015 11:47:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cue-1.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7501/investment-arm-of-dentsu-invests-in-cues-at-home-health-tracker-.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo Korea, Daewoong Pharma to co-promote oral anti-coagulant in Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/6979/daiichi-sankyo-korea-daewoong-pharma-to-co-promote-oral-anti-coagulant-in-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6979/daiichi-sankyo-korea-daewoong-pharma-to-co-promote-oral-anti-coagulant-in-korea.html</link>
			<pubDate>Mon, 28 Dec 2015 10:28:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-big-question-to-collaborate-or-not-to.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6979/daiichi-sankyo-korea-daewoong-pharma-to-co-promote-oral-anti-coagulant-in-korea.html</guid>
		</item>	
				<item>
			<title>CSL Behring seeks Japan PMDA approval for Hemophilia drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/7781/csl-behring-seeks-japan-pmda-approval-for-hemophilia-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7781/csl-behring-seeks-japan-pmda-approval-for-hemophilia-drug-.html</link>
			<pubDate>Tue, 22 Dec 2015 12:18:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7781/csl-behring-seeks-japan-pmda-approval-for-hemophilia-drug-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PeptiDream partners with Genentech</title>
			<atom:link href="https://biospectrumasia.com/news/50/8111/japans-peptidream-partners-with-genentech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8111/japans-peptidream-partners-with-genentech.html</link>
			<pubDate>Tue, 22 Dec 2015 10:33:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pact.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8111/japans-peptidream-partners-with-genentech.html</guid>
		</item>	
				<item>
			<title>Serendex signs $11.5 million-worth deal with an undisclosed Japanese company</title>
			<atom:link href="https://biospectrumasia.com/news/50/7559/serendex-signs-11-5-million-worth-deal-with-an-undisclosed-japanese-company.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7559/serendex-signs-11-5-million-worth-deal-with-an-undisclosed-japanese-company.html</link>
			<pubDate>Mon, 21 Dec 2015 10:47:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100234314.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7559/serendex-signs-11-5-million-worth-deal-with-an-undisclosed-japanese-company.html</guid>
		</item>	
				<item>
			<title>OphthaliX secures patent from Japan for intraocular pressure therapeutic</title>
			<atom:link href="https://biospectrumasia.com/news/50/7551/ophthalix-secures-patent-from-japan-for-intraocular-pressure-therapeutic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7551/ophthalix-secures-patent-from-japan-for-intraocular-pressure-therapeutic.html</link>
			<pubDate>Mon, 21 Dec 2015 10:41:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eye.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7551/ophthalix-secures-patent-from-japan-for-intraocular-pressure-therapeutic.html</guid>
		</item>	
				<item>
			<title>Asahi Kasei-SPI Pharma form alliance to market pharmaceutical additives </title>
			<atom:link href="https://biospectrumasia.com/news/50/5817/asahi-kasei-spi-pharma-form-alliance-to-market-pharmaceutical-additives-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5817/asahi-kasei-spi-pharma-form-alliance-to-market-pharmaceutical-additives-.html</link>
			<pubDate>Wed, 16 Dec 2015 10:36:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medtronic-lifetech.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5817/asahi-kasei-spi-pharma-form-alliance-to-market-pharmaceutical-additives-.html</guid>
		</item>	
				<item>
			<title>Akebia, Mitsubishi Tanabe Pharma partner for &#039;Vadadustat&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/50/5835/akebia-mitsubishi-tanabe-pharma-partner-for-vadadustat.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5835/akebia-mitsubishi-tanabe-pharma-partner-for-vadadustat.html</link>
			<pubDate>Tue, 15 Dec 2015 11:18:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100234314.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5835/akebia-mitsubishi-tanabe-pharma-partner-for-vadadustat.html</guid>
		</item>	
				<item>
			<title>Novartis&#039; Alcon recalling more intraocular lenses in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/8172/novartis-alcon-recalling-more-intraocular-lenses-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8172/novartis-alcon-recalling-more-intraocular-lenses-in-japan.html</link>
			<pubDate>Mon, 07 Dec 2015 11:51:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/recall1-1-jpg-475x310-q85.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8172/novartis-alcon-recalling-more-intraocular-lenses-in-japan.html</guid>
		</item>	
				<item>
			<title>Teva announces partnership with Takeda </title>
			<atom:link href="https://biospectrumasia.com/news/50/7578/teva-announces-partnership-with-takeda-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7578/teva-announces-partnership-with-takeda-.html</link>
			<pubDate>Tue, 01 Dec 2015 11:32:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pact.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7578/teva-announces-partnership-with-takeda-.html</guid>
		</item>	
				<item>
			<title>Mochida seeks Ulcerative Colitis drug approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5015/mochida-seeks-ulcerative-colitis-drug-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5015/mochida-seeks-ulcerative-colitis-drug-approval-in-japan.html</link>
			<pubDate>Fri, 06 Nov 2015 10:29:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5015/mochida-seeks-ulcerative-colitis-drug-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>ICON appoints APAC and Japan VPs</title>
			<atom:link href="https://biospectrumasia.com/news/50/7886/icon-appoints-apac-and-japan-vps.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7886/icon-appoints-apac-and-japan-vps.html</link>
			<pubDate>Tue, 03 Nov 2015 13:34:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bj.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7886/icon-appoints-apac-and-japan-vps.html</guid>
		</item>	
				<item>
			<title>Mallinckrodt&#039;s pharmaceutical gas approved in Australia and Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/8138/mallinckrodts-pharmaceutical-gas-approved-in-australia-and-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8138/mallinckrodts-pharmaceutical-gas-approved-in-australia-and-japan-.html</link>
			<pubDate>Mon, 02 Nov 2015 12:23:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100229135.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8138/mallinckrodts-pharmaceutical-gas-approved-in-australia-and-japan-.html</guid>
		</item>	
				<item>
			<title>Intercept-Sumitomo completes liver cirrhosis drug&#039;s phase II trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/7232/intercept-sumitomo-completes-liver-cirrhosis-drugs-phase-ii-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7232/intercept-sumitomo-completes-liver-cirrhosis-drugs-phase-ii-trials.html</link>
			<pubDate>Mon, 02 Nov 2015 12:13:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/almac-establishes-regional-hubs-in-singapore-and-japan-to-provide-clinical-trial-solutions.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7232/intercept-sumitomo-completes-liver-cirrhosis-drugs-phase-ii-trials.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo&#039;s tumor treatment gets Breakthrough Therapy Designation</title>
			<atom:link href="https://biospectrumasia.com/news/50/7990/daiichi-sankyos-tumor-treatment-gets-breakthrough-therapy-designation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7990/daiichi-sankyos-tumor-treatment-gets-breakthrough-therapy-designation.html</link>
			<pubDate>Mon, 02 Nov 2015 12:08:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yes-68480-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7990/daiichi-sankyos-tumor-treatment-gets-breakthrough-therapy-designation.html</guid>
		</item>	
				<item>
			<title>Astellas sells Kiyosu Plant business to MicroBiopharm Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/7049/astellas-sells-kiyosu-plant-business-to-microbiopharm-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7049/astellas-sells-kiyosu-plant-business-to-microbiopharm-japan-.html</link>
			<pubDate>Mon, 02 Nov 2015 12:03:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal-boehringer-to-transfer-xoma-s-technology-for-manufacturing-gevokizumab.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7049/astellas-sells-kiyosu-plant-business-to-microbiopharm-japan-.html</guid>
		</item>	
				<item>
			<title>More clinical trials are being conducted across Asia&#039;</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/4969/more-clinical-trials-are-being-conducted-across-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/4969/more-clinical-trials-are-being-conducted-across-asia.html</link>
			<pubDate>Mon, 12 Oct 2015 15:48:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/arthurdlittle-capturing-values-in-the-mhealth-oasis-540.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/4969/more-clinical-trials-are-being-conducted-across-asia.html</guid>
		</item>	
				<item>
			<title>Belgium&#039;s genae incorporates office in Tokyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/7224/belgiums-genae-incorporates-office-in-tokyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7224/belgiums-genae-incorporates-office-in-tokyo.html</link>
			<pubDate>Wed, 07 Oct 2015 11:54:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thailand-science-park-tsp-will-lend-its-laboratory-and-office-space-to-austrianova-s-wholly-owned-thai-subsidiary.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7224/belgiums-genae-incorporates-office-in-tokyo.html</guid>
		</item>	
				<item>
			<title>Mitsubhisi Tanabe gains commercial rights to Regeneron&#039;s antibody drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/7228/mitsubhisi-tanabe-gains-commercial-rights-to-regenerons-antibody-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7228/mitsubhisi-tanabe-gains-commercial-rights-to-regenerons-antibody-drug.html</link>
			<pubDate>Mon, 05 Oct 2015 11:29:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10016847.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7228/mitsubhisi-tanabe-gains-commercial-rights-to-regenerons-antibody-drug.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo initiates TaNeDS drug discovery program in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/50/4894/daiichi-sankyo-initiates-taneds-drug-discovery-program-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4894/daiichi-sankyo-initiates-taneds-drug-discovery-program-in-europe.html</link>
			<pubDate>Thu, 01 Oct 2015 12:54:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biorx-venture-advisors-biorx-bio-acceleration-program-will-be-held-from-september-21-23-2013-at-new-delhi-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4894/daiichi-sankyo-initiates-taneds-drug-discovery-program-in-europe.html</guid>
		</item>	
				<item>
			<title>PeptiDream, Teijin to co-discover peptide-based therapeutics </title>
			<atom:link href="https://biospectrumasia.com/news/50/7446/peptidream-teijin-to-co-discover-peptide-based-therapeutics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7446/peptidream-teijin-to-co-discover-peptide-based-therapeutics-.html</link>
			<pubDate>Wed, 30 Sep 2015 10:26:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/exchange-of-ideas-81822-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7446/peptidream-teijin-to-co-discover-peptide-based-therapeutics-.html</guid>
		</item>	
				<item>
			<title>Milestone drug approvals on a single day pave way for new therapies in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7195/milestone-drug-approvals-on-a-single-day-pave-way-for-new-therapies-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7195/milestone-drug-approvals-on-a-single-day-pave-way-for-new-therapies-in-japan.html</link>
			<pubDate>Wed, 30 Sep 2015 10:17:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100246947.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7195/milestone-drug-approvals-on-a-single-day-pave-way-for-new-therapies-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda gets Japan&#039;s nod for multiple sclerosis injection</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/4670/takeda-gets-japans-nod-for-multiple-sclerosis-injection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/4670/takeda-gets-japans-nod-for-multiple-sclerosis-injection.html</link>
			<pubDate>Tue, 29 Sep 2015 14:48:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/v.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/4670/takeda-gets-japans-nod-for-multiple-sclerosis-injection.html</guid>
		</item>	
				<item>
			<title>Syros to replicate Japanese clinical trials of cancer drug in US and Europe</title>
			<atom:link href="https://biospectrumasia.com/news/50/6918/syros-to-replicate-japanese-clinical-trials-of-cancer-drug-in-us-and-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6918/syros-to-replicate-japanese-clinical-trials-of-cancer-drug-in-us-and-europe.html</link>
			<pubDate>Mon, 28 Sep 2015 13:13:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10056679.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6918/syros-to-replicate-japanese-clinical-trials-of-cancer-drug-in-us-and-europe.html</guid>
		</item>	
				<item>
			<title>Japan approves Daiichi Sankyo&#039;s Cravit Injections</title>
			<atom:link href="https://biospectrumasia.com/news/50/7262/japan-approves-daiichi-sankyos-cravit-injections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7262/japan-approves-daiichi-sankyos-cravit-injections.html</link>
			<pubDate>Mon, 28 Sep 2015 13:10:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10041330.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7262/japan-approves-daiichi-sankyos-cravit-injections.html</guid>
		</item>	
				<item>
			<title>Bayer&#039;s thrombosis drug approved in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/7259/bayers-thrombosis-drug-approved-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7259/bayers-thrombosis-drug-approved-in-japan-.html</link>
			<pubDate>Mon, 28 Sep 2015 13:07:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neuron-signals.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7259/bayers-thrombosis-drug-approved-in-japan-.html</guid>
		</item>	
				<item>
			<title>Astellas EMEA appoints Eugene Van Rensburg as CFO </title>
			<atom:link href="https://biospectrumasia.com/news/50/8288/astellas-emea-appoints-eugene-van-rensburg-as-cfo-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8288/astellas-emea-appoints-eugene-van-rensburg-as-cfo-.html</link>
			<pubDate>Fri, 18 Sep 2015 11:55:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100193249-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8288/astellas-emea-appoints-eugene-van-rensburg-as-cfo-.html</guid>
		</item>	
				<item>
			<title>Nipro strengthens US business with Infraredx acquisition</title>
			<atom:link href="https://biospectrumasia.com/news/50/7520/nipro-strengthens-us-business-with-infraredx-acquisition.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7520/nipro-strengthens-us-business-with-infraredx-acquisition.html</link>
			<pubDate>Mon, 14 Sep 2015 11:43:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-chris-viehbacher-ceo-sanofi-makes-some-stark-revelations-about-the-firm-s-future-plans-regarding-buying-and-selling-of-its-stakes-in-l-oreal-and-regeneron.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7520/nipro-strengthens-us-business-with-infraredx-acquisition.html</guid>
		</item>	
				<item>
			<title>Biogen inks autoimmune deal with Mitsubhishi Tanabe pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/7264/biogen-inks-autoimmune-deal-with-mitsubhishi-tanabe-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7264/biogen-inks-autoimmune-deal-with-mitsubhishi-tanabe-pharma.html</link>
			<pubDate>Fri, 11 Sep 2015 12:13:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10041896.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7264/biogen-inks-autoimmune-deal-with-mitsubhishi-tanabe-pharma.html</guid>
		</item>	
				<item>
			<title>ILS strengthens Bachem&#039;s peptide business in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/7066/ils-strengthens-bachems-peptide-business-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7066/ils-strengthens-bachems-peptide-business-in-japan-.html</link>
			<pubDate>Wed, 09 Sep 2015 11:36:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/exchange-of-ideas-81822-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7066/ils-strengthens-bachems-peptide-business-in-japan-.html</guid>
		</item>	
				<item>
			<title>Ã¢â‚¬Å“We think India is a worthy country to expand our businessÃ¢â‚¬Â</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/7832/we-think-india-is-a-worthy-country-to-expand-our-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/7832/we-think-india-is-a-worthy-country-to-expand-our-business.html</link>
			<pubDate>Tue, 08 Sep 2015 11:15:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nakamura-2-cmic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/7832/we-think-india-is-a-worthy-country-to-expand-our-business.html</guid>
		</item>	
				<item>
			<title>Allergan Japan implements new software to meet regulatory requirements</title>
			<atom:link href="https://biospectrumasia.com/news/50/7583/allergan-japan-implements-new-software-to-meet-regulatory-requirements.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7583/allergan-japan-implements-new-software-to-meet-regulatory-requirements.html</link>
			<pubDate>Mon, 07 Sep 2015 12:04:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ubiquitous-access-of-smart-mobile-devices-has-enabled-diagnostic-and-monitoring-devices-to-render-seamless-healthcare-services.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7583/allergan-japan-implements-new-software-to-meet-regulatory-requirements.html</guid>
		</item>	
				<item>
			<title>Mesoblast files for approval of stem cell product in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6922/mesoblast-files-for-approval-of-stem-cell-product-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6922/mesoblast-files-for-approval-of-stem-cell-product-in-japan.html</link>
			<pubDate>Mon, 07 Sep 2015 11:56:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100241307.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6922/mesoblast-files-for-approval-of-stem-cell-product-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai, Purdue to co-develop insomnia drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/7510/eisai-purdue-to-co-develop-insomnia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7510/eisai-purdue-to-co-develop-insomnia-drug.html</link>
			<pubDate>Fri, 04 Sep 2015 14:07:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-individuals-who-snore-wearing-a-simple-chinstrap-while-you-sleep-can-be-an-effective-treatment-for-snoring.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7510/eisai-purdue-to-co-develop-insomnia-drug.html</guid>
		</item>	
				<item>
			<title>Abbott marks success with naturally dissolving stent in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/7909/abbott-marks-success-with-naturally-dissolving-stent-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7909/abbott-marks-success-with-naturally-dissolving-stent-in-japan-.html</link>
			<pubDate>Wed, 02 Sep 2015 12:10:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene-therapy-virus-encapsulated.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7909/abbott-marks-success-with-naturally-dissolving-stent-in-japan-.html</guid>
		</item>	
				<item>
			<title>PharmaMar seeks Japan PMDA approval for tissue sarcoma drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/7075/pharmamar-seeks-japan-pmda-approval-for-tissue-sarcoma-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7075/pharmamar-seeks-japan-pmda-approval-for-tissue-sarcoma-drug-.html</link>
			<pubDate>Wed, 02 Sep 2015 12:06:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-colorectal-cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7075/pharmamar-seeks-japan-pmda-approval-for-tissue-sarcoma-drug-.html</guid>
		</item>	
				<item>
			<title>Japan Pharma Manufacturers Association partners with Medidata  </title>
			<atom:link href="https://biospectrumasia.com/news/50/7020/japan-pharma-manufacturers-association-partners-with-medidata-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7020/japan-pharma-manufacturers-association-partners-with-medidata-.html</link>
			<pubDate>Tue, 01 Sep 2015 13:59:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/s.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7020/japan-pharma-manufacturers-association-partners-with-medidata-.html</guid>
		</item>	
				<item>
			<title>Academia, industry team up for Japan&#039;s genomic research project</title>
			<atom:link href="https://biospectrumasia.com/news/50/7824/academia-industry-team-up-for-japans-genomic-research-project.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7824/academia-industry-team-up-for-japans-genomic-research-project.html</link>
			<pubDate>Mon, 31 Aug 2015 15:02:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/case-study-research-design.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7824/academia-industry-team-up-for-japans-genomic-research-project.html</guid>
		</item>	
				<item>
			<title>Sucampo to acquire Japan&#039;s R-Tech Ueno for $278 mn</title>
			<atom:link href="https://biospectrumasia.com/news/50/3602/sucampo-to-acquire-japans-r-tech-ueno-for-278-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3602/sucampo-to-acquire-japans-r-tech-ueno-for-278-mn.html</link>
			<pubDate>Mon, 31 Aug 2015 12:19:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medi.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3602/sucampo-to-acquire-japans-r-tech-ueno-for-278-mn.html</guid>
		</item>	
				<item>
			<title>Yokohama sets platform for 700 bio-pharmas to convene at BioJapan 2015</title>
			<atom:link href="https://biospectrumasia.com/news/50/5003/yokohama-sets-platform-for-700-bio-pharmas-to-convene-at-biojapan-2015.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5003/yokohama-sets-platform-for-700-bio-pharmas-to-convene-at-biojapan-2015.html</link>
			<pubDate>Mon, 31 Aug 2015 12:13:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo4c-biojapan-2015.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5003/yokohama-sets-platform-for-700-bio-pharmas-to-convene-at-biojapan-2015.html</guid>
		</item>	
				<item>
			<title>Takeda partners with Nanotherapeutics to expand influenza vaccine program</title>
			<atom:link href="https://biospectrumasia.com/news/50/8012/takeda-partners-with-nanotherapeutics-to-expand-influenza-vaccine-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8012/takeda-partners-with-nanotherapeutics-to-expand-influenza-vaccine-program.html</link>
			<pubDate>Fri, 28 Aug 2015 12:24:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/v.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8012/takeda-partners-with-nanotherapeutics-to-expand-influenza-vaccine-program.html</guid>
		</item>	
				<item>
			<title>WuXi&#039;s subsidiary gets manufacturing nod in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7411/wuxis-subsidiary-gets-manufacturing-nod-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7411/wuxis-subsidiary-gets-manufacturing-nod-in-japan.html</link>
			<pubDate>Fri, 28 Aug 2015 12:23:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/meeting.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7411/wuxis-subsidiary-gets-manufacturing-nod-in-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo Espha&#039;s TB drugs approved in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6875/daiichi-sankyo-esphas-tb-drugs-approved-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6875/daiichi-sankyo-esphas-tb-drugs-approved-in-japan.html</link>
			<pubDate>Tue, 25 Aug 2015 14:37:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100179874.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6875/daiichi-sankyo-esphas-tb-drugs-approved-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese researchers discover potential drug target for muscle disease </title>
			<atom:link href="https://biospectrumasia.com/news/50/7692/japanese-researchers-discover-potential-drug-target-for-muscle-disease-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7692/japanese-researchers-discover-potential-drug-target-for-muscle-disease-.html</link>
			<pubDate>Mon, 24 Aug 2015 10:35:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-received-29-reports-of-problems-associated-with-use-of-the-product-including-fatigue-muscle-cramping-muscle-pain-abnormal-liver-and-thyroid-and-cholesterol-tests.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7692/japanese-researchers-discover-potential-drug-target-for-muscle-disease-.html</guid>
		</item>	
				<item>
			<title>Multiple myeloma treatment market to reach $8.9 bn by 2021, analyst</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/7757/multiple-myeloma-treatment-market-to-reach-8-9-bn-by-2021-analyst.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/7757/multiple-myeloma-treatment-market-to-reach-8-9-bn-by-2021-analyst.html</link>
			<pubDate>Fri, 21 Aug 2015 12:15:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10071146.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/7757/multiple-myeloma-treatment-market-to-reach-8-9-bn-by-2021-analyst.html</guid>
		</item>	
				<item>
			<title>Ã¢â‚¬Å“Many foreign CROs are often hesitant to make big investments in JapanÃ¢â‚¬Â</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/7125/many-foreign-cros-are-often-hesitant-to-make-big-investments-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/7125/many-foreign-cros-are-often-hesitant-to-make-big-investments-in-japan.html</link>
			<pubDate>Fri, 14 Aug 2015 10:57:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/toshio-mori-2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/7125/many-foreign-cros-are-often-hesitant-to-make-big-investments-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan accepts Pluristem&#039;s regenerative cells as safe</title>
			<atom:link href="https://biospectrumasia.com/news/50/7664/japan-accepts-pluristems-regenerative-cells-as-safe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7664/japan-accepts-pluristems-regenerative-cells-as-safe.html</link>
			<pubDate>Thu, 13 Aug 2015 13:07:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/korea-ministry-of-food-and-drug-safety-mfds-has-approved-transcranial-magnetic-stimulation-technology-tms.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7664/japan-accepts-pluristems-regenerative-cells-as-safe.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Denka group to acquire German biopharma business</title>
			<atom:link href="https://biospectrumasia.com/news/50/7445/japans-denka-group-to-acquire-german-biopharma-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7445/japans-denka-group-to-acquire-german-biopharma-business.html</link>
			<pubDate>Wed, 12 Aug 2015 13:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100137382.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7445/japans-denka-group-to-acquire-german-biopharma-business.html</guid>
		</item>	
				<item>
			<title>FDA to review Takeda&#039;s depression drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/6182/fda-to-review-takedas-depression-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6182/fda-to-review-takedas-depression-drug.html</link>
			<pubDate>Tue, 11 Aug 2015 13:16:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100186667.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6182/fda-to-review-takedas-depression-drug.html</guid>
		</item>	
				<item>
			<title>ALK&#039;s Japanese partner reports positive results for hay fever drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/8259/alks-japanese-partner-reports-positive-results-for-hay-fever-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8259/alks-japanese-partner-reports-positive-results-for-hay-fever-drug.html</link>
			<pubDate>Mon, 10 Aug 2015 12:51:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/china-surpasses-korea-in-scintific-technology-competitiveness.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8259/alks-japanese-partner-reports-positive-results-for-hay-fever-drug.html</guid>
		</item>	
				<item>
			<title>TNAU, Japanese professors unravel key genetic features of barley</title>
			<atom:link href="https://biospectrumasia.com/news/50/8280/tnau-japanese-professors-unravel-key-genetic-features-of-barley.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8280/tnau-japanese-professors-unravel-key-genetic-features-of-barley.html</link>
			<pubDate>Wed, 05 Aug 2015 14:49:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/barley-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8280/tnau-japanese-professors-unravel-key-genetic-features-of-barley.html</guid>
		</item>	
				<item>
			<title>Shionogi&#039;s constipation medicine proves effective in trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/5822/shionogis-constipation-medicine-proves-effective-in-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5822/shionogis-constipation-medicine-proves-effective-in-trials.html</link>
			<pubDate>Tue, 04 Aug 2015 11:56:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5822/shionogis-constipation-medicine-proves-effective-in-trials.html</guid>
		</item>	
				<item>
			<title>MIT, Kyoto researchers invent RNA-based gene circuits</title>
			<atom:link href="https://biospectrumasia.com/news/50/7966/mit-kyoto-researchers-invent-rna-based-gene-circuits.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7966/mit-kyoto-researchers-invent-rna-based-gene-circuits.html</link>
			<pubDate>Tue, 04 Aug 2015 11:47:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/me.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7966/mit-kyoto-researchers-invent-rna-based-gene-circuits.html</guid>
		</item>	
				<item>
			<title>Eisai seeks simultaneous approval for anticancer agent in Japan, US and Europe </title>
			<atom:link href="https://biospectrumasia.com/news/50/7499/eisai-seeks-simultaneous-approval-for-anticancer-agent-in-japan-us-and-europe-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7499/eisai-seeks-simultaneous-approval-for-anticancer-agent-in-japan-us-and-europe-.html</link>
			<pubDate>Fri, 31 Jul 2015 10:33:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/me.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7499/eisai-seeks-simultaneous-approval-for-anticancer-agent-in-japan-us-and-europe-.html</guid>
		</item>	
				<item>
			<title>BIO joins coalition to caution against further restructuring of Japan&#039;s Pharmaceutical Pricing</title>
			<atom:link href="https://biospectrumasia.com/news/50/7694/bio-joins-coalition-to-caution-against-further-restructuring-of-japans-pharmaceutical-pricing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7694/bio-joins-coalition-to-caution-against-further-restructuring-of-japans-pharmaceutical-pricing.html</link>
			<pubDate>Fri, 31 Jul 2015 10:27:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/med.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7694/bio-joins-coalition-to-caution-against-further-restructuring-of-japans-pharmaceutical-pricing.html</guid>
		</item>	
				<item>
			<title>BMS, Japan firm collaborate to develop new immunotherapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/6850/bms-japan-firm-collaborate-to-develop-new-immunotherapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6850/bms-japan-firm-collaborate-to-develop-new-immunotherapies.html</link>
			<pubDate>Thu, 30 Jul 2015 14:15:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/i.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6850/bms-japan-firm-collaborate-to-develop-new-immunotherapies.html</guid>
		</item>	
				<item>
			<title>Takeda, DND to accelerate drug discovery for parasite infection</title>
			<atom:link href="https://biospectrumasia.com/news/50/7918/takeda-dnd-to-accelerate-drug-discovery-for-parasite-infection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7918/takeda-dnd-to-accelerate-drug-discovery-for-parasite-infection.html</link>
			<pubDate>Wed, 29 Jul 2015 15:11:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/j.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7918/takeda-dnd-to-accelerate-drug-discovery-for-parasite-infection.html</guid>
		</item>	
				<item>
			<title>Belgium 3D printing firm forays into Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/7722/belgium-3d-printing-firm-forays-into-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7722/belgium-3d-printing-firm-forays-into-japan-.html</link>
			<pubDate>Tue, 28 Jul 2015 12:26:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7722/belgium-3d-printing-firm-forays-into-japan-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Mitsubishi Tanabe pharma to revamp operations</title>
			<atom:link href="https://biospectrumasia.com/news/50/7721/japans-mitsubishi-tanabe-pharma-to-revamp-operations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7721/japans-mitsubishi-tanabe-pharma-to-revamp-operations.html</link>
			<pubDate>Tue, 28 Jul 2015 11:38:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business-313592-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7721/japans-mitsubishi-tanabe-pharma-to-revamp-operations.html</guid>
		</item>	
				<item>
			<title>Three major Japanese labs collaborate on Parkinson&#039;s disease research</title>
			<atom:link href="https://biospectrumasia.com/news/50/7695/three-major-japanese-labs-collaborate-on-parkinsons-disease-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7695/three-major-japanese-labs-collaborate-on-parkinsons-disease-research.html</link>
			<pubDate>Mon, 27 Jul 2015 12:55:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/silhouettes.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7695/three-major-japanese-labs-collaborate-on-parkinsons-disease-research.html</guid>
		</item>	
				<item>
			<title>American Cryostem forays into Japanese biotechnology market </title>
			<atom:link href="https://biospectrumasia.com/news/50/6324/american-cryostem-forays-into-japanese-biotechnology-market-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6324/american-cryostem-forays-into-japanese-biotechnology-market-.html</link>
			<pubDate>Fri, 24 Jul 2015 11:25:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-james-thorburn-the-new-hong-kong-head-of-uk-based-specialist-contract-research-organization-cro-transcrip-partners.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6324/american-cryostem-forays-into-japanese-biotechnology-market-.html</guid>
		</item>	
				<item>
			<title>Kowa, Chugai to market liver cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/7675/kowa-chugai-to-market-liver-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7675/kowa-chugai-to-market-liver-cancer-drug.html</link>
			<pubDate>Tue, 21 Jul 2015 14:06:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/j.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7675/kowa-chugai-to-market-liver-cancer-drug.html</guid>
		</item>	
				<item>
			<title>No more needles, no more pain!</title>
			<atom:link href="https://biospectrumasia.com/news/50/7680/no-more-needles-no-more-pain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7680/no-more-needles-no-more-pain.html</link>
			<pubDate>Tue, 21 Jul 2015 13:03:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vaccines-4.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7680/no-more-needles-no-more-pain.html</guid>
		</item>	
				<item>
			<title>Japan approves BioSpecifics&#039; Dupuytren&#039;s Contracture treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/7164/japan-approves-biospecifics-dupuytrens-contracture-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7164/japan-approves-biospecifics-dupuytrens-contracture-treatment.html</link>
			<pubDate>Tue, 21 Jul 2015 12:11:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yes-68480-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7164/japan-approves-biospecifics-dupuytrens-contracture-treatment.html</guid>
		</item>	
				<item>
			<title>Takeda USA joins National Pharmaceutical Council</title>
			<atom:link href="https://biospectrumasia.com/news/50/7683/takeda-usa-joins-national-pharmaceutical-council.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7683/takeda-usa-joins-national-pharmaceutical-council.html</link>
			<pubDate>Wed, 15 Jul 2015 12:10:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/silhouettes.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7683/takeda-usa-joins-national-pharmaceutical-council.html</guid>
		</item>	
				<item>
			<title>Japan approves extended indication of CryoLife&#039;s BioGlue</title>
			<atom:link href="https://biospectrumasia.com/news/50/5669/japan-approves-extended-indication-of-cryolifes-bioglue.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5669/japan-approves-extended-indication-of-cryolifes-bioglue.html</link>
			<pubDate>Fri, 10 Jul 2015 10:50:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yes-68480-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5669/japan-approves-extended-indication-of-cryolifes-bioglue.html</guid>
		</item>	
				<item>
			<title>Treatment for rare metabolic disorder approved in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7070/treatment-for-rare-metabolic-disorder-approved-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7070/treatment-for-rare-metabolic-disorder-approved-in-japan.html</link>
			<pubDate>Tue, 07 Jul 2015 12:19:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100246947.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7070/treatment-for-rare-metabolic-disorder-approved-in-japan.html</guid>
		</item>	
				<item>
			<title>Nihon University to host 8K Imaging Technology Symposium </title>
			<atom:link href="https://biospectrumasia.com/news/50/7563/nihon-university-to-host-8k-imaging-technology-symposium-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7563/nihon-university-to-host-8k-imaging-technology-symposium-.html</link>
			<pubDate>Tue, 07 Jul 2015 12:14:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7563/nihon-university-to-host-8k-imaging-technology-symposium-.html</guid>
		</item>	
				<item>
			<title>Japan Okays Sanofi&#039;s Basal Insulin Drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/7530/japan-okays-sanofis-basal-insulin-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7530/japan-okays-sanofis-basal-insulin-drug.html</link>
			<pubDate>Mon, 06 Jul 2015 10:37:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100129427.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7530/japan-okays-sanofis-basal-insulin-drug.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s MHLW approves Gilead&#039;s Hep C drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/6325/japans-mhlw-approves-gileads-hep-c-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6325/japans-mhlw-approves-gileads-hep-c-drug.html</link>
			<pubDate>Mon, 06 Jul 2015 10:33:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yes-68480-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6325/japans-mhlw-approves-gileads-hep-c-drug.html</guid>
		</item>	
				<item>
			<title>HUYA appoints Yoshiki Shimamura as VP for Japan Operations</title>
			<atom:link href="https://biospectrumasia.com/news/50/7677/huya-appoints-yoshiki-shimamura-as-vp-for-japan-operations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7677/huya-appoints-yoshiki-shimamura-as-vp-for-japan-operations.html</link>
			<pubDate>Wed, 01 Jul 2015 12:14:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/person.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7677/huya-appoints-yoshiki-shimamura-as-vp-for-japan-operations.html</guid>
		</item>	
				<item>
			<title>Ã¢â‚¬Å“Engineered 3D human tissue will bring efficiencies in drug screening and drug safety testingÃ¢â‚¬Â</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/7040/engineered-3d-human-tissue-will-bring-efficiencies-in-drug-screening-and-drug-safety-testing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/7040/engineered-3d-human-tissue-will-bring-efficiencies-in-drug-screening-and-drug-safety-testing.html</link>
			<pubDate>Tue, 30 Jun 2015 10:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/discussion.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/7040/engineered-3d-human-tissue-will-bring-efficiencies-in-drug-screening-and-drug-safety-testing.html</guid>
		</item>	
				<item>
			<title>Japan approves Bayer&#039;s EYLEA Injection</title>
			<atom:link href="https://biospectrumasia.com/news/50/7823/japan-approves-bayers-eylea-injection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7823/japan-approves-bayers-eylea-injection.html</link>
			<pubDate>Mon, 29 Jun 2015 12:05:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vac.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7823/japan-approves-bayers-eylea-injection.html</guid>
		</item>	
				<item>
			<title>Daiichi, UCB seek marketing authorization for epilepsy drug in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/7448/daiichi-ucb-seek-marketing-authorization-for-epilepsy-drug-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7448/daiichi-ucb-seek-marketing-authorization-for-epilepsy-drug-in-japan-.html</link>
			<pubDate>Fri, 26 Jun 2015 11:48:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/h.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7448/daiichi-ucb-seek-marketing-authorization-for-epilepsy-drug-in-japan-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s JCR adopts Medidata&#039;s Clinical Cloud solution</title>
			<atom:link href="https://biospectrumasia.com/news/50/6783/japans-jcr-adopts-medidatas-clinical-cloud-solution.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6783/japans-jcr-adopts-medidatas-clinical-cloud-solution.html</link>
			<pubDate>Fri, 26 Jun 2015 11:36:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cloud.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6783/japans-jcr-adopts-medidatas-clinical-cloud-solution.html</guid>
		</item>	
				<item>
			<title>Accenture wins contract to handle IT maintenance and operations for Eisai </title>
			<atom:link href="https://biospectrumasia.com/news/50/6045/accenture-wins-contract-to-handle-it-maintenance-and-operations-for-eisai-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6045/accenture-wins-contract-to-handle-it-maintenance-and-operations-for-eisai-.html</link>
			<pubDate>Thu, 25 Jun 2015 11:47:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tech.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6045/accenture-wins-contract-to-handle-it-maintenance-and-operations-for-eisai-.html</guid>
		</item>	
				<item>
			<title>Novasep inks two deals with Japanese firms</title>
			<atom:link href="https://biospectrumasia.com/news/50/4540/novasep-inks-two-deals-with-japanese-firms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4540/novasep-inks-two-deals-with-japanese-firms.html</link>
			<pubDate>Mon, 22 Jun 2015 14:58:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/de.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4540/novasep-inks-two-deals-with-japanese-firms.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo initiates Hokusai-VTE cancer study </title>
			<atom:link href="https://biospectrumasia.com/news/50/6928/daiichi-sankyo-initiates-hokusai-vte-cancer-study-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6928/daiichi-sankyo-initiates-hokusai-vte-cancer-study-.html</link>
			<pubDate>Fri, 19 Jun 2015 11:52:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6928/daiichi-sankyo-initiates-hokusai-vte-cancer-study-.html</guid>
		</item>	
				<item>
			<title>New device promises to detect cancer in 3 min!</title>
			<atom:link href="https://biospectrumasia.com/news/50/5019/new-device-promises-to-detect-cancer-in-3-min.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5019/new-device-promises-to-detect-cancer-in-3-min.html</link>
			<pubDate>Fri, 19 Jun 2015 11:09:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100211998.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5019/new-device-promises-to-detect-cancer-in-3-min.html</guid>
		</item>	
				<item>
			<title>INTERPHEX JAPAN / in-PHARMA JAPAN 2015 to be held at Tokyo Big Sight, Japan  </title>
			<atom:link href="https://biospectrumasia.com/news/50/7145/interphex-japan-in-pharma-japan-2015-to-be-held-at-tokyo-big-sight-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7145/interphex-japan-in-pharma-japan-2015-to-be-held-at-tokyo-big-sight-japan-.html</link>
			<pubDate>Fri, 19 Jun 2015 11:09:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ipjpi.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7145/interphex-japan-in-pharma-japan-2015-to-be-held-at-tokyo-big-sight-japan-.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo&#039;s subsidiary launches four new generic drugs </title>
			<atom:link href="https://biospectrumasia.com/news/50/7812/daiichi-sankyos-subsidiary-launches-four-new-generic-drugs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7812/daiichi-sankyos-subsidiary-launches-four-new-generic-drugs-.html</link>
			<pubDate>Thu, 18 Jun 2015 12:48:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7812/daiichi-sankyos-subsidiary-launches-four-new-generic-drugs-.html</guid>
		</item>	
				<item>
			<title>BBK Worldwide opens Tokyo office; appoints new Managing Director</title>
			<atom:link href="https://biospectrumasia.com/news/50/7779/bbk-worldwide-opens-tokyo-office-appoints-new-managing-director.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7779/bbk-worldwide-opens-tokyo-office-appoints-new-managing-director.html</link>
			<pubDate>Thu, 18 Jun 2015 12:24:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/silhouettes.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7779/bbk-worldwide-opens-tokyo-office-appoints-new-managing-director.html</guid>
		</item>	
				<item>
			<title>Gore&#039;s new endovascular therapy set to go for trials in Japan and US</title>
			<atom:link href="https://biospectrumasia.com/news/50/7771/gores-new-endovascular-therapy-set-to-go-for-trials-in-japan-and-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7771/gores-new-endovascular-therapy-set-to-go-for-trials-in-japan-and-us.html</link>
			<pubDate>Thu, 18 Jun 2015 12:17:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7771/gores-new-endovascular-therapy-set-to-go-for-trials-in-japan-and-us.html</guid>
		</item>	
				<item>
			<title>Baylor Miraca Genetics appoints Gary Huff as President, CEO </title>
			<atom:link href="https://biospectrumasia.com/news/50/7764/baylor-miraca-genetics-appoints-gary-huff-as-president-ceo-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7764/baylor-miraca-genetics-appoints-gary-huff-as-president-ceo-.html</link>
			<pubDate>Thu, 18 Jun 2015 12:12:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tie.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7764/baylor-miraca-genetics-appoints-gary-huff-as-president-ceo-.html</guid>
		</item>	
				<item>
			<title>Taiho licenses oral anticancer drug to France&#039;s Servier</title>
			<atom:link href="https://biospectrumasia.com/news/50/7450/taiho-licenses-oral-anticancer-drug-to-frances-servier.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7450/taiho-licenses-oral-anticancer-drug-to-frances-servier.html</link>
			<pubDate>Tue, 16 Jun 2015 12:14:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vietnam-quintiles-enter-deal-to-advance-clinical-trials.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7450/taiho-licenses-oral-anticancer-drug-to-frances-servier.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Carna Biosciences collaborates with Johnson &amp; Johnson Innovation</title>
			<atom:link href="https://biospectrumasia.com/news/50/6941/japans-carna-biosciences-collaborates-with-johnson-johnson-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6941/japans-carna-biosciences-collaborates-with-johnson-johnson-innovation.html</link>
			<pubDate>Fri, 12 Jun 2015 12:25:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/personal-95715-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6941/japans-carna-biosciences-collaborates-with-johnson-johnson-innovation.html</guid>
		</item>	
				<item>
			<title>Eisai launches thyroid cancer therapy in UK</title>
			<atom:link href="https://biospectrumasia.com/news/50/6120/eisai-launches-thyroid-cancer-therapy-in-uk.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6120/eisai-launches-thyroid-cancer-therapy-in-uk.html</link>
			<pubDate>Thu, 11 Jun 2015 11:56:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6120/eisai-launches-thyroid-cancer-therapy-in-uk.html</guid>
		</item>	
				<item>
			<title>Zeria Group&#039;s Tillotts, Numab collaborate to co-develop Inflammatory Bowel Disease therapeutics </title>
			<atom:link href="https://biospectrumasia.com/news/50/5488/zeria-groups-tillotts-numab-collaborate-to-co-develop-inflammatory-bowel-disease-therapeutics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5488/zeria-groups-tillotts-numab-collaborate-to-co-develop-inflammatory-bowel-disease-therapeutics-.html</link>
			<pubDate>Wed, 10 Jun 2015 13:02:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10013140.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5488/zeria-groups-tillotts-numab-collaborate-to-co-develop-inflammatory-bowel-disease-therapeutics-.html</guid>
		</item>	
				<item>
			<title>Sanford Consortium, Takeda Pharmaceutical partner in $10-million innovation alliance</title>
			<atom:link href="https://biospectrumasia.com/news/50/6965/sanford-consortium-takeda-pharmaceutical-partner-in-10-million-innovation-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6965/sanford-consortium-takeda-pharmaceutical-partner-in-10-million-innovation-alliance.html</link>
			<pubDate>Wed, 10 Jun 2015 12:41:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/personal-95715-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6965/sanford-consortium-takeda-pharmaceutical-partner-in-10-million-innovation-alliance.html</guid>
		</item>	
				<item>
			<title>Nagoya scientists discover new molecules that change circadian rhythm </title>
			<atom:link href="https://biospectrumasia.com/news/50/7332/nagoya-scientists-discover-new-molecules-that-change-circadian-rhythm-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7332/nagoya-scientists-discover-new-molecules-that-change-circadian-rhythm-.html</link>
			<pubDate>Wed, 10 Jun 2015 12:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7332/nagoya-scientists-discover-new-molecules-that-change-circadian-rhythm-.html</guid>
		</item>	
				<item>
			<title>Roche to develop companion diagnostic test for Acute Coronary Syndrome</title>
			<atom:link href="https://biospectrumasia.com/news/50/6944/roche-to-develop-companion-diagnostic-test-for-acute-coronary-syndrome.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6944/roche-to-develop-companion-diagnostic-test-for-acute-coronary-syndrome.html</link>
			<pubDate>Wed, 10 Jun 2015 12:32:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/people-219985-640-2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6944/roche-to-develop-companion-diagnostic-test-for-acute-coronary-syndrome.html</guid>
		</item>	
				<item>
			<title>Synageva BioPharma seeks approval for Kanuma in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7261/synageva-biopharma-seeks-approval-for-kanuma-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7261/synageva-biopharma-seeks-approval-for-kanuma-in-japan.html</link>
			<pubDate>Mon, 01 Jun 2015 12:20:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7261/synageva-biopharma-seeks-approval-for-kanuma-in-japan.html</guid>
		</item>	
				<item>
			<title>Novocure launches Optune in 23 brain cancer centers in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7560/novocure-launches-optune-in-23-brain-cancer-centers-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7560/novocure-launches-optune-in-23-brain-cancer-centers-in-japan.html</link>
			<pubDate>Mon, 01 Jun 2015 12:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7560/novocure-launches-optune-in-23-brain-cancer-centers-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s MHLW lifts prescription period limitation for Daiichi Sankyo&#039;s antiplatelet agent</title>
			<atom:link href="https://biospectrumasia.com/news/50/7619/japans-mhlw-lifts-prescription-period-limitation-for-daiichi-sankyos-antiplatelet-agent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7619/japans-mhlw-lifts-prescription-period-limitation-for-daiichi-sankyos-antiplatelet-agent.html</link>
			<pubDate>Mon, 01 Jun 2015 12:12:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7619/japans-mhlw-lifts-prescription-period-limitation-for-daiichi-sankyos-antiplatelet-agent.html</guid>
		</item>	
				<item>
			<title>French firm successfully completes Ph I trial of diabetes drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7292/french-firm-successfully-completes-ph-i-trial-of-diabetes-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7292/french-firm-successfully-completes-ph-i-trial-of-diabetes-drug-in-japan.html</link>
			<pubDate>Thu, 28 May 2015 12:31:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7292/french-firm-successfully-completes-ph-i-trial-of-diabetes-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Abbott partners with Japan&#039;s Sekisui</title>
			<atom:link href="https://biospectrumasia.com/news/50/5953/abbott-partners-with-japans-sekisui.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5953/abbott-partners-with-japans-sekisui.html</link>
			<pubDate>Fri, 22 May 2015 12:46:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-james-thorburn-the-new-hong-kong-head-of-uk-based-specialist-contract-research-organization-cro-transcrip-partners.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5953/abbott-partners-with-japans-sekisui.html</guid>
		</item>	
				<item>
			<title>Takeda to distribute Kaketsuken&#039;s influenza vaccine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5064/takeda-to-distribute-kaketsukens-influenza-vaccine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5064/takeda-to-distribute-kaketsukens-influenza-vaccine-in-japan.html</link>
			<pubDate>Thu, 21 May 2015 12:13:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10075902.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5064/takeda-to-distribute-kaketsukens-influenza-vaccine-in-japan.html</guid>
		</item>	
				<item>
			<title>R-Tech Ueno, Hokkaido University to co-develop diabetic intervention </title>
			<atom:link href="https://biospectrumasia.com/news/50/8051/r-tech-ueno-hokkaido-university-to-co-develop-diabetic-intervention-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8051/r-tech-ueno-hokkaido-university-to-co-develop-diabetic-intervention-.html</link>
			<pubDate>Tue, 19 May 2015 11:23:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8051/r-tech-ueno-hokkaido-university-to-co-develop-diabetic-intervention-.html</guid>
		</item>	
				<item>
			<title>Takeda has innovative plan to invest in Israel through TVI</title>
			<atom:link href="https://biospectrumasia.com/news/50/6788/takeda-has-innovative-plan-to-invest-in-israel-through-tvi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6788/takeda-has-innovative-plan-to-invest-in-israel-through-tvi.html</link>
			<pubDate>Sun, 17 May 2015 07:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ppps-attract-investment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6788/takeda-has-innovative-plan-to-invest-in-israel-through-tvi.html</guid>
		</item>	
				<item>
			<title>Pluristem&#039;s regenerative medicine convinces Japan PMDA </title>
			<atom:link href="https://biospectrumasia.com/news/50/5736/pluristems-regenerative-medicine-convinces-japan-pmda-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5736/pluristems-regenerative-medicine-convinces-japan-pmda-.html</link>
			<pubDate>Thu, 14 May 2015 10:02:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100265496.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5736/pluristems-regenerative-medicine-convinces-japan-pmda-.html</guid>
		</item>	
				<item>
			<title>Hyperion to succeed Santen&#039;s anti-rheumatic business</title>
			<atom:link href="https://biospectrumasia.com/news/50/7235/hyperion-to-succeed-santens-anti-rheumatic-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7235/hyperion-to-succeed-santens-anti-rheumatic-business.html</link>
			<pubDate>Wed, 13 May 2015 15:10:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100309977.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7235/hyperion-to-succeed-santens-anti-rheumatic-business.html</guid>
		</item>	
				<item>
			<title>Astellas-Cyclenium ink drug discovery collaboration </title>
			<atom:link href="https://biospectrumasia.com/news/50/7158/astellas-cyclenium-ink-drug-discovery-collaboration-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7158/astellas-cyclenium-ink-drug-discovery-collaboration-.html</link>
			<pubDate>Wed, 13 May 2015 13:21:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/network-665237-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7158/astellas-cyclenium-ink-drug-discovery-collaboration-.html</guid>
		</item>	
				<item>
			<title>CHA Health Systems partners with Otsubo-Kai</title>
			<atom:link href="https://biospectrumasia.com/news/50/6855/cha-health-systems-partners-with-otsubo-kai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6855/cha-health-systems-partners-with-otsubo-kai.html</link>
			<pubDate>Tue, 12 May 2015 14:16:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100260363.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6855/cha-health-systems-partners-with-otsubo-kai.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s NEC to exploit Prima BioMed&#039;s cancer immunotherapeutic technology </title>
			<atom:link href="https://biospectrumasia.com/news/50/6680/japans-nec-to-exploit-prima-biomeds-cancer-immunotherapeutic-technology-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6680/japans-nec-to-exploit-prima-biomeds-cancer-immunotherapeutic-technology-.html</link>
			<pubDate>Tue, 12 May 2015 10:37:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100186558.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6680/japans-nec-to-exploit-prima-biomeds-cancer-immunotherapeutic-technology-.html</guid>
		</item>	
				<item>
			<title>Takeda partners with Japan&#039;s National Cancer Center </title>
			<atom:link href="https://biospectrumasia.com/news/50/6320/takeda-partners-with-japans-national-cancer-center-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6320/takeda-partners-with-japans-national-cancer-center-.html</link>
			<pubDate>Mon, 11 May 2015 12:17:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100293363.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6320/takeda-partners-with-japans-national-cancer-center-.html</guid>
		</item>	
				<item>
			<title>Nikon joins hands with Lonza group for cell and gene therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/6322/nikon-joins-hands-with-lonza-group-for-cell-and-gene-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6322/nikon-joins-hands-with-lonza-group-for-cell-and-gene-therapies.html</link>
			<pubDate>Fri, 08 May 2015 12:39:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-big-question-to-collaborate-or-not-to.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6322/nikon-joins-hands-with-lonza-group-for-cell-and-gene-therapies.html</guid>
		</item>	
				<item>
			<title>Toshiba adds new products to its portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/50/6122/toshiba-adds-new-products-to-its-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6122/toshiba-adds-new-products-to-its-portfolio.html</link>
			<pubDate>Sat, 02 May 2015 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/personal-95714-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6122/toshiba-adds-new-products-to-its-portfolio.html</guid>
		</item>	
				<item>
			<title>Dotmatics appoints Takashi Fukuyama to spearhead new Japanese business</title>
			<atom:link href="https://biospectrumasia.com/news/50/6803/dotmatics-appoints-takashi-fukuyama-to-spearhead-new-japanese-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6803/dotmatics-appoints-takashi-fukuyama-to-spearhead-new-japanese-business.html</link>
			<pubDate>Wed, 29 Apr 2015 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/personal-95715-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6803/dotmatics-appoints-takashi-fukuyama-to-spearhead-new-japanese-business.html</guid>
		</item>	
				<item>
			<title>Singulex&#039;s cardiovascular biomarker granted Japanese patent</title>
			<atom:link href="https://biospectrumasia.com/news/50/7382/singulexs-cardiovascular-biomarker-granted-japanese-patent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7382/singulexs-cardiovascular-biomarker-granted-japanese-patent.html</link>
			<pubDate>Wed, 29 Apr 2015 11:47:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-neurodegenerative-patients-suven-gets-patents-in-canada-china-and-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7382/singulexs-cardiovascular-biomarker-granted-japanese-patent.html</guid>
		</item>	
				<item>
			<title>Invivoscribe, Astellas sign agreement for companion diagnostics </title>
			<atom:link href="https://biospectrumasia.com/news/50/7034/invivoscribe-astellas-sign-agreement-for-companion-diagnostics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7034/invivoscribe-astellas-sign-agreement-for-companion-diagnostics-.html</link>
			<pubDate>Wed, 29 Apr 2015 11:39:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10057958.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7034/invivoscribe-astellas-sign-agreement-for-companion-diagnostics-.html</guid>
		</item>	
				<item>
			<title>R-Tech Ueno acquires right to develop Santen Pharma&#039;s ophthalmic solution </title>
			<atom:link href="https://biospectrumasia.com/news/50/7294/r-tech-ueno-acquires-right-to-develop-santen-pharmas-ophthalmic-solution-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7294/r-tech-ueno-acquires-right-to-develop-santen-pharmas-ophthalmic-solution-.html</link>
			<pubDate>Tue, 28 Apr 2015 10:05:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100259719.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7294/r-tech-ueno-acquires-right-to-develop-santen-pharmas-ophthalmic-solution-.html</guid>
		</item>	
				<item>
			<title>Eisai, Nihon Medi-Physics to work on dementia intervention </title>
			<atom:link href="https://biospectrumasia.com/news/50/7296/eisai-nihon-medi-physics-to-work-on-dementia-intervention-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7296/eisai-nihon-medi-physics-to-work-on-dementia-intervention-.html</link>
			<pubDate>Tue, 28 Apr 2015 09:57:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7296/eisai-nihon-medi-physics-to-work-on-dementia-intervention-.html</guid>
		</item>	
				<item>
			<title> Medtech Partnering Forum 2015 to be held in Tokyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/7239/-medtech-partnering-forum-2015-to-be-held-in-tokyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7239/-medtech-partnering-forum-2015-to-be-held-in-tokyo.html</link>
			<pubDate>Fri, 24 Apr 2015 08:24:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/untitled.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7239/-medtech-partnering-forum-2015-to-be-held-in-tokyo.html</guid>
		</item>	
				<item>
			<title>Aerocrine initiates pulmonary device sales in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5793/aerocrine-initiates-pulmonary-device-sales-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5793/aerocrine-initiates-pulmonary-device-sales-in-japan.html</link>
			<pubDate>Fri, 24 Apr 2015 08:23:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/annual-report-61851-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5793/aerocrine-initiates-pulmonary-device-sales-in-japan.html</guid>
		</item>	
				<item>
			<title>Astella, Potenza partner to enhance immune-oncology programs </title>
			<atom:link href="https://biospectrumasia.com/news/50/6999/astella-potenza-partner-to-enhance-immune-oncology-programs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6999/astella-potenza-partner-to-enhance-immune-oncology-programs-.html</link>
			<pubDate>Thu, 23 Apr 2015 12:22:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6999/astella-potenza-partner-to-enhance-immune-oncology-programs-.html</guid>
		</item>	
				<item>
			<title>Takeda collaborates with Keio University</title>
			<atom:link href="https://biospectrumasia.com/news/50/7098/takeda-collaborates-with-keio-university.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7098/takeda-collaborates-with-keio-university.html</link>
			<pubDate>Thu, 23 Apr 2015 11:23:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/join-forces-blackboard-means-work-together-and-partnership-100259726.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7098/takeda-collaborates-with-keio-university.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo exits Sun Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/5041/daiichi-sankyo-exits-sun-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5041/daiichi-sankyo-exits-sun-pharma.html</link>
			<pubDate>Tue, 21 Apr 2015 12:29:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10064822.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5041/daiichi-sankyo-exits-sun-pharma.html</guid>
		</item>	
				<item>
			<title>Tosoh buys an Indian invitro diagnostics company</title>
			<atom:link href="https://biospectrumasia.com/news/50/6998/tosoh-buys-an-indian-invitro-diagnostics-company.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6998/tosoh-buys-an-indian-invitro-diagnostics-company.html</link>
			<pubDate>Tue, 21 Apr 2015 12:26:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bridgepoint-to-acquire-quotient-clinical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6998/tosoh-buys-an-indian-invitro-diagnostics-company.html</guid>
		</item>	
				<item>
			<title>CPhI Japan set to begin tomorrow</title>
			<atom:link href="https://biospectrumasia.com/news/50/7005/cphi-japan-set-to-begin-tomorrow.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7005/cphi-japan-set-to-begin-tomorrow.html</link>
			<pubDate>Tue, 21 Apr 2015 12:24:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/abexome-biosciences-and-bioneeds-join-hands-to-provide-pre-clinical-and-core-biology-services.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7005/cphi-japan-set-to-begin-tomorrow.html</guid>
		</item>	
				<item>
			<title>Takeda, Kyoto University to co-develop stem cell therapies</title>
			<atom:link href="https://biospectrumasia.com/news/50/6841/takeda-kyoto-university-to-co-develop-stem-cell-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6841/takeda-kyoto-university-to-co-develop-stem-cell-therapies.html</link>
			<pubDate>Mon, 20 Apr 2015 13:07:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/orcell-can-heal-damaged-tissue-using-muscle-stem-cells.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6841/takeda-kyoto-university-to-co-develop-stem-cell-therapies.html</guid>
		</item>	
				<item>
			<title>Germany, Japan researchers reveal neuron behavior</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/6799/germany-japan-researchers-reveal-neuron-behavior.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/6799/germany-japan-researchers-reveal-neuron-behavior.html</link>
			<pubDate>Fri, 17 Apr 2015 11:58:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/complaint.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/6799/germany-japan-researchers-reveal-neuron-behavior.html</guid>
		</item>	
				<item>
			<title>Roche, Astellas pharma ink pact to develop tissue diagnostic solutions</title>
			<atom:link href="https://biospectrumasia.com/news/50/6197/roche-astellas-pharma-ink-pact-to-develop-tissue-diagnostic-solutions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6197/roche-astellas-pharma-ink-pact-to-develop-tissue-diagnostic-solutions.html</link>
			<pubDate>Thu, 16 Apr 2015 11:42:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100175951.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6197/roche-astellas-pharma-ink-pact-to-develop-tissue-diagnostic-solutions.html</guid>
		</item>	
				<item>
			<title>Eisai leverages genetic research with Genomics  </title>
			<atom:link href="https://biospectrumasia.com/news/50/5656/eisai-leverages-genetic-research-with-genomics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5656/eisai-leverages-genetic-research-with-genomics-.html</link>
			<pubDate>Mon, 13 Apr 2015 12:06:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/test-214186-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5656/eisai-leverages-genetic-research-with-genomics-.html</guid>
		</item>	
				<item>
			<title>IBA, Toshiba partner to advance particle therapy worldwide</title>
			<atom:link href="https://biospectrumasia.com/news/50/6719/iba-toshiba-partner-to-advance-particle-therapy-worldwide.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6719/iba-toshiba-partner-to-advance-particle-therapy-worldwide.html</link>
			<pubDate>Fri, 10 Apr 2015 10:45:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100259719.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6719/iba-toshiba-partner-to-advance-particle-therapy-worldwide.html</guid>
		</item>	
				<item>
			<title>PPD forms JV to tap Japan clinical trial market</title>
			<atom:link href="https://biospectrumasia.com/news/50/4871/ppd-forms-jv-to-tap-japan-clinical-trial-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4871/ppd-forms-jv-to-tap-japan-clinical-trial-market.html</link>
			<pubDate>Thu, 09 Apr 2015 10:53:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100259719.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4871/ppd-forms-jv-to-tap-japan-clinical-trial-market.html</guid>
		</item>	
				<item>
			<title>Progenics initiates Fuji&#039;s Phase 2 Trial for prostate cancer drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6887/progenics-initiates-fujis-phase-2-trial-for-prostate-cancer-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6887/progenics-initiates-fujis-phase-2-trial-for-prostate-cancer-drug-in-japan.html</link>
			<pubDate>Wed, 08 Apr 2015 15:03:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6887/progenics-initiates-fujis-phase-2-trial-for-prostate-cancer-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>MD Anderson, Astellas collaborate to develop new drug for Acute Myeloid Leukemia</title>
			<atom:link href="https://biospectrumasia.com/news/50/6502/md-anderson-astellas-collaborate-to-develop-new-drug-for-acute-myeloid-leukemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6502/md-anderson-astellas-collaborate-to-develop-new-drug-for-acute-myeloid-leukemia.html</link>
			<pubDate>Wed, 08 Apr 2015 14:57:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100260363.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6502/md-anderson-astellas-collaborate-to-develop-new-drug-for-acute-myeloid-leukemia.html</guid>
		</item>	
				<item>
			<title>Merck, Pfizer to co-market potential cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/6659/merck-pfizer-to-co-market-potential-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6659/merck-pfizer-to-co-market-potential-cancer-drug.html</link>
			<pubDate>Wed, 08 Apr 2015 14:02:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10058597.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6659/merck-pfizer-to-co-market-potential-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo and Asubio merge to streamline operations</title>
			<atom:link href="https://biospectrumasia.com/news/50/2223/daiichi-sankyo-and-asubio-merge-to-streamline-operations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2223/daiichi-sankyo-and-asubio-merge-to-streamline-operations.html</link>
			<pubDate>Sun, 05 Apr 2015 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/apac-witnesses-mergers-acquisitions-m-a-galore-during-q1-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2223/daiichi-sankyo-and-asubio-merge-to-streamline-operations.html</guid>
		</item>	
				<item>
			<title>Brickell Biotech-Kaken Pharma to co-develop dermatology drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/7219/brickell-biotech-kaken-pharma-to-co-develop-dermatology-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7219/brickell-biotech-kaken-pharma-to-co-develop-dermatology-drug-.html</link>
			<pubDate>Sun, 05 Apr 2015 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7219/brickell-biotech-kaken-pharma-to-co-develop-dermatology-drug-.html</guid>
		</item>	
				<item>
			<title>Neurocrine Biosciences collaborates with Mitsubishi Tanabe Pharma </title>
			<atom:link href="https://biospectrumasia.com/news/50/4899/neurocrine-biosciences-collaborates-with-mitsubishi-tanabe-pharma-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4899/neurocrine-biosciences-collaborates-with-mitsubishi-tanabe-pharma-.html</link>
			<pubDate>Sun, 05 Apr 2015 09:19:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100259719.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4899/neurocrine-biosciences-collaborates-with-mitsubishi-tanabe-pharma-.html</guid>
		</item>	
				<item>
			<title>Medtronic&#039;s CoreValve system approved in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7921/medtronics-corevalve-system-approved-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7921/medtronics-corevalve-system-approved-in-japan.html</link>
			<pubDate>Wed, 01 Apr 2015 12:09:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-160120-150.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7921/medtronics-corevalve-system-approved-in-japan.html</guid>
		</item>	
				<item>
			<title>Genzyme&#039;s Cerdelga capsules approved in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5429/genzymes-cerdelga-capsules-approved-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5429/genzymes-cerdelga-capsules-approved-in-japan.html</link>
			<pubDate>Wed, 01 Apr 2015 11:52:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yes-68480-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5429/genzymes-cerdelga-capsules-approved-in-japan.html</guid>
		</item>	
				<item>
			<title>Mesoblast&#039;s heart treatment MPCs patented in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/4673/mesoblasts-heart-treatment-mpcs-patented-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4673/mesoblasts-heart-treatment-mpcs-patented-in-japan.html</link>
			<pubDate>Mon, 30 Mar 2015 11:42:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100259735.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4673/mesoblasts-heart-treatment-mpcs-patented-in-japan.html</guid>
		</item>	
				<item>
			<title>Bayer receives approval for Gadovist injection in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/4210/bayer-receives-approval-for-gadovist-injection-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4210/bayer-receives-approval-for-gadovist-injection-in-japan.html</link>
			<pubDate>Mon, 30 Mar 2015 11:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100146305.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4210/bayer-receives-approval-for-gadovist-injection-in-japan.html</guid>
		</item>	
				<item>
			<title>Chugai, Gilead get Japanese approval for additional indication of antiviral drug Copegus</title>
			<atom:link href="https://biospectrumasia.com/news/50/7181/chugai-gilead-get-japanese-approval-for-additional-indication-of-antiviral-drug-copegus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7181/chugai-gilead-get-japanese-approval-for-additional-indication-of-antiviral-drug-copegus.html</link>
			<pubDate>Mon, 30 Mar 2015 11:33:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7181/chugai-gilead-get-japanese-approval-for-additional-indication-of-antiviral-drug-copegus.html</guid>
		</item>	
				<item>
			<title>Suven secures three product patents for their NCEs in Canada, Japan and Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/5902/suven-secures-three-product-patents-for-their-nces-in-canada-japan-and-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5902/suven-secures-three-product-patents-for-their-nces-in-canada-japan-and-korea.html</link>
			<pubDate>Thu, 26 Mar 2015 12:13:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/j.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5902/suven-secures-three-product-patents-for-their-nces-in-canada-japan-and-korea.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo&#039;s Subsidiary Ranbaxy merged with Sun Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/6897/daiichi-sankyos-subsidiary-ranbaxy-merged-with-sun-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6897/daiichi-sankyos-subsidiary-ranbaxy-merged-with-sun-pharma.html</link>
			<pubDate>Thu, 26 Mar 2015 11:59:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6897/daiichi-sankyos-subsidiary-ranbaxy-merged-with-sun-pharma.html</guid>
		</item>	
				<item>
			<title>Takeda, Immunogen in a cancer drug deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/6833/takeda-immunogen-in-a-cancer-drug-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6833/takeda-immunogen-in-a-cancer-drug-deal.html</link>
			<pubDate>Wed, 25 Mar 2015 15:04:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cellular-biomedicine-launches-a-stromal-adipose-stromal-cell-purification-kit-in-china-and-also-signs-deal-for-proceller-computer-controlled-processing-system-for-mainland-china-and-hong-kong.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6833/takeda-immunogen-in-a-cancer-drug-deal.html</guid>
		</item>	
				<item>
			<title>Japanese scientists discover anti-cancer property in diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/5615/japanese-scientists-discover-anti-cancer-property-in-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5615/japanese-scientists-discover-anti-cancer-property-in-diabetes-drug.html</link>
			<pubDate>Tue, 24 Mar 2015 13:27:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191233.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5615/japanese-scientists-discover-anti-cancer-property-in-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>Takeda, ImmunoGen, sign technology licensing agreement </title>
			<atom:link href="https://biospectrumasia.com/news/50/6635/takeda-immunogen-sign-technology-licensing-agreement-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6635/takeda-immunogen-sign-technology-licensing-agreement-.html</link>
			<pubDate>Tue, 24 Mar 2015 13:22:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100257378.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6635/takeda-immunogen-sign-technology-licensing-agreement-.html</guid>
		</item>	
				<item>
			<title>HUYA Bioscience completes cancer drug&#039;s first cohort study in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/6472/huya-bioscience-completes-cancer-drugs-first-cohort-study-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6472/huya-bioscience-completes-cancer-drugs-first-cohort-study-in-japan-.html</link>
			<pubDate>Mon, 23 Mar 2015 15:09:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10057958.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6472/huya-bioscience-completes-cancer-drugs-first-cohort-study-in-japan-.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo launches Methylene Blue Injection in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6482/daiichi-sankyo-launches-methylene-blue-injection-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6482/daiichi-sankyo-launches-methylene-blue-injection-in-japan.html</link>
			<pubDate>Mon, 23 Mar 2015 15:06:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6482/daiichi-sankyo-launches-methylene-blue-injection-in-japan.html</guid>
		</item>	
				<item>
			<title>Amgen seeks approval for anti-cholesterol drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6470/amgen-seeks-approval-for-anti-cholesterol-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6470/amgen-seeks-approval-for-anti-cholesterol-drug-in-japan.html</link>
			<pubDate>Mon, 23 Mar 2015 15:03:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6470/amgen-seeks-approval-for-anti-cholesterol-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>AstraZeneca to commercialize Daiichi Sankyo&#039;s OIC drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/5705/astrazeneca-to-commercialize-daiichi-sankyos-oic-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5705/astrazeneca-to-commercialize-daiichi-sankyos-oic-drug.html</link>
			<pubDate>Fri, 20 Mar 2015 11:16:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100144925.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5705/astrazeneca-to-commercialize-daiichi-sankyos-oic-drug.html</guid>
		</item>	
				<item>
			<title>IHH healthcare acquires 5 nursing homes in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5491/ihh-healthcare-acquires-5-nursing-homes-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5491/ihh-healthcare-acquires-5-nursing-homes-in-japan.html</link>
			<pubDate>Thu, 19 Mar 2015 14:31:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10064000.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5491/ihh-healthcare-acquires-5-nursing-homes-in-japan.html</guid>
		</item>	
				<item>
			<title>Boston Therapeutics, Advance Pharmaceutical to market diabetes drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5363/boston-therapeutics-advance-pharmaceutical-to-market-diabetes-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5363/boston-therapeutics-advance-pharmaceutical-to-market-diabetes-drug-in-japan.html</link>
			<pubDate>Thu, 19 Mar 2015 11:55:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10085394.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5363/boston-therapeutics-advance-pharmaceutical-to-market-diabetes-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>International Stem Cell Corporation receives Stem Cell Patent in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/5368/international-stem-cell-corporation-receives-stem-cell-patent-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5368/international-stem-cell-corporation-receives-stem-cell-patent-in-japan-.html</link>
			<pubDate>Thu, 19 Mar 2015 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100265496.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5368/international-stem-cell-corporation-receives-stem-cell-patent-in-japan-.html</guid>
		</item>	
				<item>
			<title>Taconic strengthens distribution and animal breeding partnerships in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5369/taconic-strengthens-distribution-and-animal-breeding-partnerships-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5369/taconic-strengthens-distribution-and-animal-breeding-partnerships-in-japan.html</link>
			<pubDate>Thu, 19 Mar 2015 11:47:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100146305.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5369/taconic-strengthens-distribution-and-animal-breeding-partnerships-in-japan.html</guid>
		</item>	
				<item>
			<title>Global Type1 diabetes market to touch $13.6 bn by 2023&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5356/global-type1-diabetes-market-to-touch-13-6-bn-by-2023.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5356/global-type1-diabetes-market-to-touch-13-6-bn-by-2023.html</link>
			<pubDate>Thu, 19 Mar 2015 11:43:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5356/global-type1-diabetes-market-to-touch-13-6-bn-by-2023.html</guid>
		</item>	
				<item>
			<title>Companion diagnostic drug for prostate cancer from Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/4835/companion-diagnostic-drug-for-prostate-cancer-from-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4835/companion-diagnostic-drug-for-prostate-cancer-from-japan.html</link>
			<pubDate>Tue, 17 Mar 2015 10:52:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/symbol-451848-640.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4835/companion-diagnostic-drug-for-prostate-cancer-from-japan.html</guid>
		</item>	
				<item>
			<title>Takeda transfers HPV vaccine license to Japanese firm</title>
			<atom:link href="https://biospectrumasia.com/news/50/7249/takeda-transfers-hpv-vaccine-license-to-japanese-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7249/takeda-transfers-hpv-vaccine-license-to-japanese-firm.html</link>
			<pubDate>Thu, 12 Mar 2015 12:45:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7249/takeda-transfers-hpv-vaccine-license-to-japanese-firm.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s new medical device receives FDA nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/5760/japans-new-medical-device-receives-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5760/japans-new-medical-device-receives-fda-nod.html</link>
			<pubDate>Mon, 09 Mar 2015 14:45:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100246947.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5760/japans-new-medical-device-receives-fda-nod.html</guid>
		</item>	
				<item>
			<title>Japan to provide medical assistance to Kyrgyzstan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7052/japan-to-provide-medical-assistance-to-kyrgyzstan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7052/japan-to-provide-medical-assistance-to-kyrgyzstan.html</link>
			<pubDate>Mon, 09 Mar 2015 14:44:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/help-button-66608-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7052/japan-to-provide-medical-assistance-to-kyrgyzstan.html</guid>
		</item>	
				<item>
			<title>Asia an emerging hotspot in medical tourism</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/7493/asia-an-emerging-hotspot-in-medical-tourism.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/7493/asia-an-emerging-hotspot-in-medical-tourism.html</link>
			<pubDate>Mon, 09 Mar 2015 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ship-docking-in-nassau-nassau-bahamas-1152-12829312102-tpfil02aw-26334.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/7493/asia-an-emerging-hotspot-in-medical-tourism.html</guid>
		</item>	
				<item>
			<title>Chugai-Athersys collaborate to develop MultiStem Cell Therapy </title>
			<atom:link href="https://biospectrumasia.com/news/50/6973/chugai-athersys-collaborate-to-develop-multistem-cell-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6973/chugai-athersys-collaborate-to-develop-multistem-cell-therapy-.html</link>
			<pubDate>Thu, 05 Mar 2015 08:44:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-cell-163711-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6973/chugai-athersys-collaborate-to-develop-multistem-cell-therapy-.html</guid>
		</item>	
				<item>
			<title>Japan pharma market worth $80 billion by 2020: Global Data</title>
			<atom:link href="https://biospectrumasia.com/news/50/7141/japan-pharma-market-worth-80-billion-by-2020-global-data.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7141/japan-pharma-market-worth-80-billion-by-2020-global-data.html</link>
			<pubDate>Sun, 01 Mar 2015 08:11:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7141/japan-pharma-market-worth-80-billion-by-2020-global-data.html</guid>
		</item>	
				<item>
			<title>Iran, Japan to collaborate on health projects</title>
			<atom:link href="https://biospectrumasia.com/news/50/6515/iran-japan-to-collaborate-on-health-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6515/iran-japan-to-collaborate-on-health-projects.html</link>
			<pubDate>Fri, 27 Feb 2015 12:43:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/81518081-6295635.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6515/iran-japan-to-collaborate-on-health-projects.html</guid>
		</item>	
				<item>
			<title>Takeda expands Singapore operation</title>
			<atom:link href="https://biospectrumasia.com/news/50/6764/takeda-expands-singapore-operation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6764/takeda-expands-singapore-operation.html</link>
			<pubDate>Thu, 26 Feb 2015 13:02:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biosimilar.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6764/takeda-expands-singapore-operation.html</guid>
		</item>	
				<item>
			<title>Takeda boosts business presence in Turkey</title>
			<atom:link href="https://biospectrumasia.com/news/50/6193/takeda-boosts-business-presence-in-turkey.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6193/takeda-boosts-business-presence-in-turkey.html</link>
			<pubDate>Wed, 25 Feb 2015 14:56:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100265025.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6193/takeda-boosts-business-presence-in-turkey.html</guid>
		</item>	
				<item>
			<title>Antiviral drug for Ebola shows signs of efficacy </title>
			<atom:link href="https://biospectrumasia.com/news/50/6030/antiviral-drug-for-ebola-shows-signs-of-efficacy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6030/antiviral-drug-for-ebola-shows-signs-of-efficacy-.html</link>
			<pubDate>Wed, 25 Feb 2015 14:49:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/virus-174051-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6030/antiviral-drug-for-ebola-shows-signs-of-efficacy-.html</guid>
		</item>	
				<item>
			<title>Sosei buys Heptares Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/5667/sosei-buys-heptares-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5667/sosei-buys-heptares-therapeutics.html</link>
			<pubDate>Tue, 24 Feb 2015 11:42:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10095171.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5667/sosei-buys-heptares-therapeutics.html</guid>
		</item>	
				<item>
			<title>Targeted Medical Pharma assigns J-Network as distributor</title>
			<atom:link href="https://biospectrumasia.com/news/50/5682/targeted-medical-pharma-assigns-j-network-as-distributor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5682/targeted-medical-pharma-assigns-j-network-as-distributor.html</link>
			<pubDate>Tue, 24 Feb 2015 11:33:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/human-112227-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5682/targeted-medical-pharma-assigns-j-network-as-distributor.html</guid>
		</item>	
				<item>
			<title>HealthPatch MD receives Japanese nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/261/healthpatch-md-receives-japanese-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/261/healthpatch-md-receives-japanese-nod.html</link>
			<pubDate>Thu, 19 Feb 2015 15:45:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10043669.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/261/healthpatch-md-receives-japanese-nod.html</guid>
		</item>	
				<item>
			<title>TAKE&#039;s attempt to bring talented workforce to the market </title>
			<atom:link href="https://biospectrumasia.com/news/50/6640/takes-attempt-to-bring-talented-workforce-to-the-market-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6640/takes-attempt-to-bring-talented-workforce-to-the-market-.html</link>
			<pubDate>Thu, 19 Feb 2015 11:39:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tall-1-2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6640/takes-attempt-to-bring-talented-workforce-to-the-market-.html</guid>
		</item>	
				<item>
			<title>Dako partners with Ono pharmaceuticals</title>
			<atom:link href="https://biospectrumasia.com/news/50/4613/dako-partners-with-ono-pharmaceuticals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4613/dako-partners-with-ono-pharmaceuticals.html</link>
			<pubDate>Tue, 17 Feb 2015 16:20:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/join-forces-blackboard-means-work-together-and-partnership-100259726.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4613/dako-partners-with-ono-pharmaceuticals.html</guid>
		</item>	
				<item>
			<title>Cancer detection in less than an hour?</title>
			<atom:link href="https://biospectrumasia.com/news/50/6209/cancer-detection-in-less-than-an-hour.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6209/cancer-detection-in-less-than-an-hour.html</link>
			<pubDate>Mon, 16 Feb 2015 12:22:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-biology.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6209/cancer-detection-in-less-than-an-hour.html</guid>
		</item>	
				<item>
			<title>Rosetta Genomics receives first patent allowance in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6225/rosetta-genomics-receives-first-patent-allowance-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6225/rosetta-genomics-receives-first-patent-allowance-in-japan.html</link>
			<pubDate>Mon, 16 Feb 2015 10:49:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100216170.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6225/rosetta-genomics-receives-first-patent-allowance-in-japan.html</guid>
		</item>	
				<item>
			<title>AbbVie Submits NDA for Hep C drug in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/6064/abbvie-submits-nda-for-hep-c-drug-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6064/abbvie-submits-nda-for-hep-c-drug-in-japan-.html</link>
			<pubDate>Mon, 16 Feb 2015 10:44:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets-193666-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6064/abbvie-submits-nda-for-hep-c-drug-in-japan-.html</guid>
		</item>	
				<item>
			<title>Thailand, Japan to develop medical robots</title>
			<atom:link href="https://biospectrumasia.com/news/50/8137/thailand-japan-to-develop-medical-robots.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8137/thailand-japan-to-develop-medical-robots.html</link>
			<pubDate>Fri, 13 Feb 2015 13:14:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8137/thailand-japan-to-develop-medical-robots.html</guid>
		</item>	
				<item>
			<title>Japan, Vietnam sign MoU to advance healthcare</title>
			<atom:link href="https://biospectrumasia.com/news/50/5375/japan-vietnam-sign-mou-to-advance-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5375/japan-vietnam-sign-mou-to-advance-healthcare.html</link>
			<pubDate>Fri, 13 Feb 2015 13:05:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5375/japan-vietnam-sign-mou-to-advance-healthcare.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s multiple myeloma drug meets primary endpoints </title>
			<atom:link href="https://biospectrumasia.com/news/50/5858/takedas-multiple-myeloma-drug-meets-primary-endpoints-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5858/takedas-multiple-myeloma-drug-meets-primary-endpoints-.html</link>
			<pubDate>Wed, 11 Feb 2015 11:32:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5858/takedas-multiple-myeloma-drug-meets-primary-endpoints-.html</guid>
		</item>	
				<item>
			<title>LEADERS Free Japan Trial Completes Enrollment</title>
			<atom:link href="https://biospectrumasia.com/news/50/4719/leaders-free-japan-trial-completes-enrollment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4719/leaders-free-japan-trial-completes-enrollment.html</link>
			<pubDate>Wed, 11 Feb 2015 10:32:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biofreedom-web-main.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4719/leaders-free-japan-trial-completes-enrollment.html</guid>
		</item>	
				<item>
			<title>Anti-ebola drug to be used widely</title>
			<atom:link href="https://biospectrumasia.com/news/50/4656/anti-ebola-drug-to-be-used-widely.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4656/anti-ebola-drug-to-be-used-widely.html</link>
			<pubDate>Mon, 09 Feb 2015 17:34:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10086971.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4656/anti-ebola-drug-to-be-used-widely.html</guid>
		</item>	
				<item>
			<title>Novartis&#039; Cosentyx receives Japanese nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/5093/novartis-cosentyx-receives-japanese-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5093/novartis-cosentyx-receives-japanese-nod.html</link>
			<pubDate>Fri, 06 Feb 2015 16:32:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bacteria-96601-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5093/novartis-cosentyx-receives-japanese-nod.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s GHIT fund pumps $637,000 to support antimalarial drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/6451/japans-ghit-fund-pumps-637000-to-support-antimalarial-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6451/japans-ghit-fund-pumps-637000-to-support-antimalarial-drug-discovery.html</link>
			<pubDate>Fri, 06 Feb 2015 10:04:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6451/japans-ghit-fund-pumps-637000-to-support-antimalarial-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Sun Pharma gets US FTC nod to buy Ranbaxy</title>
			<atom:link href="https://biospectrumasia.com/news/50/6067/sun-pharma-gets-us-ftc-nod-to-buy-ranbaxy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6067/sun-pharma-gets-us-ftc-nod-to-buy-ranbaxy.html</link>
			<pubDate>Thu, 05 Feb 2015 11:44:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6067/sun-pharma-gets-us-ftc-nod-to-buy-ranbaxy.html</guid>
		</item>	
				<item>
			<title>Japan to temporarily suspend Novartis business</title>
			<atom:link href="https://biospectrumasia.com/news/50/6607/japan-to-temporarily-suspend-novartis-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6607/japan-to-temporarily-suspend-novartis-business.html</link>
			<pubDate>Wed, 04 Feb 2015 15:51:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100246865.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6607/japan-to-temporarily-suspend-novartis-business.html</guid>
		</item>	
				<item>
			<title>WaVe Life Sciences raises $18 mn to develop nucleic acid therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/6834/wave-life-sciences-raises-18-mn-to-develop-nucleic-acid-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6834/wave-life-sciences-raises-18-mn-to-develop-nucleic-acid-therapeutics.html</link>
			<pubDate>Wed, 04 Feb 2015 10:28:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10052975.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6834/wave-life-sciences-raises-18-mn-to-develop-nucleic-acid-therapeutics.html</guid>
		</item>	
				<item>
			<title>Dr Freidman receives the Japanese award for gene therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/6684/dr-freidman-receives-the-japanese-award-for-gene-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6684/dr-freidman-receives-the-japanese-award-for-gene-therapy.html</link>
			<pubDate>Sat, 31 Jan 2015 09:34:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100249946.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6684/dr-freidman-receives-the-japanese-award-for-gene-therapy.html</guid>
		</item>	
				<item>
			<title>Astellas inks a pact with Immunomic therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/4991/astellas-inks-a-pact-with-immunomic-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4991/astellas-inks-a-pact-with-immunomic-therapeutics.html</link>
			<pubDate>Fri, 30 Jan 2015 13:05:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/join-forces-blackboard-means-work-together-and-partnership-100259726.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4991/astellas-inks-a-pact-with-immunomic-therapeutics.html</guid>
		</item>	
				<item>
			<title>APAC ovarian cancer drug market to grow modestly&#039; </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/150/apac-ovarian-cancer-drug-market-to-grow-modestly-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/150/apac-ovarian-cancer-drug-market-to-grow-modestly-.html</link>
			<pubDate>Fri, 30 Jan 2015 11:59:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/150/apac-ovarian-cancer-drug-market-to-grow-modestly-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka expands in Australia</title>
			<atom:link href="https://biospectrumasia.com/news/50/4611/japans-otsuka-expands-in-australia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4611/japans-otsuka-expands-in-australia.html</link>
			<pubDate>Thu, 29 Jan 2015 12:18:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/expand.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4611/japans-otsuka-expands-in-australia.html</guid>
		</item>	
				<item>
			<title>Japan, Qatar collaborate on personalized medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/5664/japan-qatar-collaborate-on-personalized-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5664/japan-qatar-collaborate-on-personalized-medicine.html</link>
			<pubDate>Thu, 29 Jan 2015 09:34:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-390297-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5664/japan-qatar-collaborate-on-personalized-medicine.html</guid>
		</item>	
				<item>
			<title>Roche, Meiji Seika Pharma, Fedora collaborate to develop bacterial resistance to antibiotics</title>
			<atom:link href="https://biospectrumasia.com/news/50/5560/roche-meiji-seika-pharma-fedora-collaborate-to-develop-bacterial-resistance-to-antibiotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5560/roche-meiji-seika-pharma-fedora-collaborate-to-develop-bacterial-resistance-to-antibiotics.html</link>
			<pubDate>Fri, 16 Jan 2015 12:36:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5560/roche-meiji-seika-pharma-fedora-collaborate-to-develop-bacterial-resistance-to-antibiotics.html</guid>
		</item>	
				<item>
			<title>Mersana Therapeutics inks a pact with Takeda</title>
			<atom:link href="https://biospectrumasia.com/news/50/4909/mersana-therapeutics-inks-a-pact-with-takeda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4909/mersana-therapeutics-inks-a-pact-with-takeda.html</link>
			<pubDate>Wed, 14 Jan 2015 15:06:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100175951.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4909/mersana-therapeutics-inks-a-pact-with-takeda.html</guid>
		</item>	
				<item>
			<title>Prasco Lab to market generics version of Colcrys in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/6043/prasco-lab-to-market-generics-version-of-colcrys-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6043/prasco-lab-to-market-generics-version-of-colcrys-in-us.html</link>
			<pubDate>Tue, 13 Jan 2015 13:06:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/regu4.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6043/prasco-lab-to-market-generics-version-of-colcrys-in-us.html</guid>
		</item>	
				<item>
			<title>Japanese, Korean firm to jointly develop breast cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/5128/japanese-korean-firm-to-jointly-develop-breast-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5128/japanese-korean-firm-to-jointly-develop-breast-cancer-drug.html</link>
			<pubDate>Thu, 08 Jan 2015 14:59:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100257378.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5128/japanese-korean-firm-to-jointly-develop-breast-cancer-drug.html</guid>
		</item>	
				<item>
			<title>UK delists breast cancer drug, eribulin, from Cancer Drug Fund</title>
			<atom:link href="https://biospectrumasia.com/news/50/5090/uk-delists-breast-cancer-drug-eribulin-from-cancer-drug-fund.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5090/uk-delists-breast-cancer-drug-eribulin-from-cancer-drug-fund.html</link>
			<pubDate>Thu, 08 Jan 2015 13:17:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5090/uk-delists-breast-cancer-drug-eribulin-from-cancer-drug-fund.html</guid>
		</item>	
				<item>
			<title>APAC type 2 diabetes market to touch $10.5 bn by 2020&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/4971/apac-type-2-diabetes-market-to-touch-10-5-bn-by-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/4971/apac-type-2-diabetes-market-to-touch-10-5-bn-by-2020.html</link>
			<pubDate>Wed, 07 Jan 2015 15:16:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/4971/apac-type-2-diabetes-market-to-touch-10-5-bn-by-2020.html</guid>
		</item>	
				<item>
			<title>Japanese medical firms enter into the Philippines</title>
			<atom:link href="https://biospectrumasia.com/news/50/7566/japanese-medical-firms-enter-into-the-philippines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7566/japanese-medical-firms-enter-into-the-philippines.html</link>
			<pubDate>Fri, 02 Jan 2015 13:07:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/investment4.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7566/japanese-medical-firms-enter-into-the-philippines.html</guid>
		</item>	
				<item>
			<title>Japan approves Novartis&#039; psoriasis drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/4981/japan-approves-novartis-psoriasis-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4981/japan-approves-novartis-psoriasis-drug.html</link>
			<pubDate>Fri, 26 Dec 2014 14:06:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100232367.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4981/japan-approves-novartis-psoriasis-drug.html</guid>
		</item>	
				<item>
			<title>Takeda files NDA for multiple sclerosis drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5851/takeda-files-nda-for-multiple-sclerosis-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5851/takeda-files-nda-for-multiple-sclerosis-drug-in-japan.html</link>
			<pubDate>Fri, 26 Dec 2014 12:09:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/termeric-pillsl.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5851/takeda-files-nda-for-multiple-sclerosis-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>PPD  forms joint venture in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6507/ppd-forms-joint-venture-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6507/ppd-forms-joint-venture-in-japan.html</link>
			<pubDate>Fri, 26 Dec 2014 11:10:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100257378.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6507/ppd-forms-joint-venture-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda appoints new chief medical and scientific officer</title>
			<atom:link href="https://biospectrumasia.com/news/50/6281/takeda-appoints-new-chief-medical-and-scientific-officer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6281/takeda-appoints-new-chief-medical-and-scientific-officer.html</link>
			<pubDate>Tue, 23 Dec 2014 14:57:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100266100.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6281/takeda-appoints-new-chief-medical-and-scientific-officer.html</guid>
		</item>	
				<item>
			<title>Ono pharma partners with Gilead lifesciences</title>
			<atom:link href="https://biospectrumasia.com/news/50/5845/ono-pharma-partners-with-gilead-lifesciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5845/ono-pharma-partners-with-gilead-lifesciences.html</link>
			<pubDate>Mon, 22 Dec 2014 14:36:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100261976.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5845/ono-pharma-partners-with-gilead-lifesciences.html</guid>
		</item>	
				<item>
			<title>Takeda taps Sanofi&#039;s top exec to lead global R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/50/5532/takeda-taps-sanofis-top-exec-to-lead-global-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5532/takeda-taps-sanofis-top-exec-to-lead-global-rd.html</link>
			<pubDate>Fri, 19 Dec 2014 13:06:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aplump.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5532/takeda-taps-sanofis-top-exec-to-lead-global-rd.html</guid>
		</item>	
				<item>
			<title>Toshiba inaugurates a new healthcare unit in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5387/toshiba-inaugurates-a-new-healthcare-unit-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5387/toshiba-inaugurates-a-new-healthcare-unit-in-japan.html</link>
			<pubDate>Thu, 18 Dec 2014 15:59:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/personal-95714-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5387/toshiba-inaugurates-a-new-healthcare-unit-in-japan.html</guid>
		</item>	
				<item>
			<title>APAC colorectal cancer market to touch $2.9 bn by 2020</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5364/apac-colorectal-cancer-market-to-touch-2-9-bn-by-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5364/apac-colorectal-cancer-market-to-touch-2-9-bn-by-2020.html</link>
			<pubDate>Thu, 18 Dec 2014 13:10:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100232464.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5364/apac-colorectal-cancer-market-to-touch-2-9-bn-by-2020.html</guid>
		</item>	
				<item>
			<title>Suven Lifesciences receives five patents from four countries</title>
			<atom:link href="https://biospectrumasia.com/news/50/5261/suven-lifesciences-receives-five-patents-from-four-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5261/suven-lifesciences-receives-five-patents-from-four-countries.html</link>
			<pubDate>Wed, 17 Dec 2014 13:21:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/j.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5261/suven-lifesciences-receives-five-patents-from-four-countries.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sosei group to buy Jitsubo</title>
			<atom:link href="https://biospectrumasia.com/news/50/5374/japans-sosei-group-to-buy-jitsubo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5374/japans-sosei-group-to-buy-jitsubo.html</link>
			<pubDate>Mon, 15 Dec 2014 17:40:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100229135.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5374/japans-sosei-group-to-buy-jitsubo.html</guid>
		</item>	
				<item>
			<title>BMS takes on combination drug for cancer therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/6135/bms-takes-on-combination-drug-for-cancer-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6135/bms-takes-on-combination-drug-for-cancer-therapy.html</link>
			<pubDate>Thu, 11 Dec 2014 14:20:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100232464.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6135/bms-takes-on-combination-drug-for-cancer-therapy.html</guid>
		</item>	
				<item>
			<title>Takeda partners with Monash University</title>
			<atom:link href="https://biospectrumasia.com/news/50/4583/takeda-partners-with-monash-university.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4583/takeda-partners-with-monash-university.html</link>
			<pubDate>Thu, 11 Dec 2014 14:19:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100266100.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4583/takeda-partners-with-monash-university.html</guid>
		</item>	
				<item>
			<title>Pharma sector may lose $65 bn by 2019: Analyst</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/4987/pharma-sector-may-lose-65-bn-by-2019-analyst.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/4987/pharma-sector-may-lose-65-bn-by-2019-analyst.html</link>
			<pubDate>Thu, 11 Dec 2014 14:16:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100225328.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/4987/pharma-sector-may-lose-65-bn-by-2019-analyst.html</guid>
		</item>	
				<item>
			<title>GVK BIO strengthens tie-up with CTC Life Science Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6138/gvk-bio-strengthens-tie-up-with-ctc-life-science-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6138/gvk-bio-strengthens-tie-up-with-ctc-life-science-japan.html</link>
			<pubDate>Tue, 09 Dec 2014 15:40:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10064822.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6138/gvk-bio-strengthens-tie-up-with-ctc-life-science-japan.html</guid>
		</item>	
				<item>
			<title>Astella&#039;s Xtandi variation receives EU nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/6707/astellas-xtandi-variation-receives-eu-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6707/astellas-xtandi-variation-receives-eu-nod.html</link>
			<pubDate>Thu, 04 Dec 2014 17:47:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ge-healthcare-2012-cell-imaging-competition-winners-ms-jane-stout-ms-anushree-balachandran-and-mr-markus-posch.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6707/astellas-xtandi-variation-receives-eu-nod.html</guid>
		</item>	
				<item>
			<title>Otsuka buys Avanir pharmaceuticals for $3.5bn</title>
			<atom:link href="https://biospectrumasia.com/news/50/5960/otsuka-buys-avanir-pharmaceuticals-for-3-5bn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5960/otsuka-buys-avanir-pharmaceuticals-for-3-5bn.html</link>
			<pubDate>Wed, 03 Dec 2014 14:57:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10095171.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5960/otsuka-buys-avanir-pharmaceuticals-for-3-5bn.html</guid>
		</item>	
				<item>
			<title>Eisai gets direct presence in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/6781/eisai-gets-direct-presence-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6781/eisai-gets-direct-presence-in-china.html</link>
			<pubDate>Wed, 03 Dec 2014 09:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/buildings-304004-640.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6781/eisai-gets-direct-presence-in-china.html</guid>
		</item>	
				<item>
			<title>Eisai submits marketing application for thyroid cancer drug </title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/4580/eisai-submits-marketing-application-for-thyroid-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/4580/eisai-submits-marketing-application-for-thyroid-cancer-drug-.html</link>
			<pubDate>Tue, 02 Dec 2014 11:03:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/termeric-pillsl.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/4580/eisai-submits-marketing-application-for-thyroid-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Baring to acquire Japan&#039;s Bushu pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/5426/baring-to-acquire-japans-bushu-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5426/baring-to-acquire-japans-bushu-pharma.html</link>
			<pubDate>Tue, 18 Nov 2014 14:40:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/quest-diagnostics-acquires-converge-diagnostic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5426/baring-to-acquire-japans-bushu-pharma.html</guid>
		</item>	
				<item>
			<title>Drug development challenges and opportunities in Asia</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/4582/drug-development-challenges-and-opportunities-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/4582/drug-development-challenges-and-opportunities-in-asia.html</link>
			<pubDate>Thu, 13 Nov 2014 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/albert-liou-parexel.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/4582/drug-development-challenges-and-opportunities-in-asia.html</guid>
		</item>	
				<item>
			<title>Fujifilm hopeful for anti-influenza drug as ebola treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/5153/fujifilm-hopeful-for-anti-influenza-drug-as-ebola-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5153/fujifilm-hopeful-for-anti-influenza-drug-as-ebola-treatment.html</link>
			<pubDate>Wed, 12 Nov 2014 12:01:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100291312.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5153/fujifilm-hopeful-for-anti-influenza-drug-as-ebola-treatment.html</guid>
		</item>	
				<item>
			<title>Eisai pharma opens its new Australia division</title>
			<atom:link href="https://biospectrumasia.com/news/50/2374/eisai-pharma-opens-its-new-australia-division.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2374/eisai-pharma-opens-its-new-australia-division.html</link>
			<pubDate>Tue, 11 Nov 2014 15:59:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100176552.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2374/eisai-pharma-opens-its-new-australia-division.html</guid>
		</item>	
				<item>
			<title>Bangkok to adopt Japanese technology to treat cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/546/bangkok-to-adopt-japanese-technology-to-treat-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/546/bangkok-to-adopt-japanese-technology-to-treat-cancer.html</link>
			<pubDate>Thu, 06 Nov 2014 15:07:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-institute-singapore.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/546/bangkok-to-adopt-japanese-technology-to-treat-cancer.html</guid>
		</item>	
				<item>
			<title>Fujifilm to acquire US-based vaccine maker</title>
			<atom:link href="https://biospectrumasia.com/news/50/6484/fujifilm-to-acquire-us-based-vaccine-maker.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6484/fujifilm-to-acquire-us-based-vaccine-maker.html</link>
			<pubDate>Fri, 31 Oct 2014 15:05:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bridgepoint-to-acquire-quotient-clinical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6484/fujifilm-to-acquire-us-based-vaccine-maker.html</guid>
		</item>	
				<item>
			<title>Alexion files NDA in Japan for Asfotase Alfa</title>
			<atom:link href="https://biospectrumasia.com/news/50/5863/alexion-files-nda-in-japan-for-asfotase-alfa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5863/alexion-files-nda-in-japan-for-asfotase-alfa.html</link>
			<pubDate>Tue, 28 Oct 2014 15:26:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ema-gives-patrys-cancer-drug-orphan-status.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5863/alexion-files-nda-in-japan-for-asfotase-alfa.html</guid>
		</item>	
				<item>
			<title>Aortic stent grafts market to grow at slow pace&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/7570/aortic-stent-grafts-market-to-grow-at-slow-pace.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/7570/aortic-stent-grafts-market-to-grow-at-slow-pace.html</link>
			<pubDate>Fri, 17 Oct 2014 12:43:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10057221-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/7570/aortic-stent-grafts-market-to-grow-at-slow-pace.html</guid>
		</item>	
				<item>
			<title>Aspen to market some of GSK&#039;s generic drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/6098/aspen-to-market-some-of-gsks-generic-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6098/aspen-to-market-some-of-gsks-generic-drugs.html</link>
			<pubDate>Fri, 10 Oct 2014 15:04:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amgen-and-shanghaitech-university-china-sign-mou-to-form-a-strategic-partnership-for-the-advancement-of-biopharmaceutical-discovery-and-translational-research-in-china.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6098/aspen-to-market-some-of-gsks-generic-drugs.html</guid>
		</item>	
				<item>
			<title>One Lambda partners with GenoDive</title>
			<atom:link href="https://biospectrumasia.com/news/50/5936/one-lambda-partners-with-genodive.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5936/one-lambda-partners-with-genodive.html</link>
			<pubDate>Fri, 10 Oct 2014 14:39:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/exchange-of-ideas-81822-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5936/one-lambda-partners-with-genodive.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo seeks approval for TB drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5888/daiichi-sankyo-seeks-approval-for-tb-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5888/daiichi-sankyo-seeks-approval-for-tb-drug-in-japan.html</link>
			<pubDate>Mon, 06 Oct 2014 17:38:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications-257344-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5888/daiichi-sankyo-seeks-approval-for-tb-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Pfizer, Japanese firm to jointly asses mAB for tumor</title>
			<atom:link href="https://biospectrumasia.com/news/50/6165/pfizer-japanese-firm-to-jointly-asses-mab-for-tumor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6165/pfizer-japanese-firm-to-jointly-asses-mab-for-tumor.html</link>
			<pubDate>Tue, 30 Sep 2014 10:01:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gear-403504-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6165/pfizer-japanese-firm-to-jointly-asses-mab-for-tumor.html</guid>
		</item>	
				<item>
			<title>Daiichi&#039;s Lixiana approved for ischemic stroke</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/5490/daiichis-lixiana-approved-for-ischemic-stroke.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/5490/daiichis-lixiana-approved-for-ischemic-stroke.html</link>
			<pubDate>Mon, 29 Sep 2014 11:21:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/doctor-237479-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/5490/daiichis-lixiana-approved-for-ischemic-stroke.html</guid>
		</item>	
				<item>
			<title>Takeda, US-based BioMotiv join hands</title>
			<atom:link href="https://biospectrumasia.com/news/50/5314/takeda-us-based-biomotiv-join-hands.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5314/takeda-us-based-biomotiv-join-hands.html</link>
			<pubDate>Fri, 26 Sep 2014 17:14:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/connect-316638-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5314/takeda-us-based-biomotiv-join-hands.html</guid>
		</item>	
				<item>
			<title>APAC Non-Hodgkin Lymphoma treatment market to touch $1.7 bn&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5292/apac-non-hodgkin-lymphoma-treatment-market-to-touch-1-7-bn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5292/apac-non-hodgkin-lymphoma-treatment-market-to-touch-1-7-bn.html</link>
			<pubDate>Fri, 26 Sep 2014 11:34:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/arrows-399970-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5292/apac-non-hodgkin-lymphoma-treatment-market-to-touch-1-7-bn.html</guid>
		</item>	
				<item>
			<title>Japan: 1 out of 27 babies born through IVF in 2013</title>
			<atom:link href="https://biospectrumasia.com/news/50/4997/japan-1-out-of-27-babies-born-through-ivf-in-2013.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4997/japan-1-out-of-27-babies-born-through-ivf-in-2013.html</link>
			<pubDate>Tue, 23 Sep 2014 11:33:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/baby-21098-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4997/japan-1-out-of-27-babies-born-through-ivf-in-2013.html</guid>
		</item>	
				<item>
			<title>Eylea by Bayer gets Japanese nod for myopic CNV</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/4998/eylea-by-bayer-gets-japanese-nod-for-myopic-cnv.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/4998/eylea-by-bayer-gets-japanese-nod-for-myopic-cnv.html</link>
			<pubDate>Tue, 23 Sep 2014 11:23:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/arrows-399970-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/4998/eylea-by-bayer-gets-japanese-nod-for-myopic-cnv.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher next gen sequencing system is for clinical use&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/50/5416/thermo-fisher-next-gen-sequencing-system-is-for-clinical-use.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5416/thermo-fisher-next-gen-sequencing-system-is-for-clinical-use.html</link>
			<pubDate>Fri, 19 Sep 2014 11:30:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dna-163710-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5416/thermo-fisher-next-gen-sequencing-system-is-for-clinical-use.html</guid>
		</item>	
				<item>
			<title>Aussie man contracts dengue in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6245/aussie-man-contracts-dengue-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6245/aussie-man-contracts-dengue-in-japan.html</link>
			<pubDate>Mon, 15 Sep 2014 12:23:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dengue-mosquito.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6245/aussie-man-contracts-dengue-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan worried as Dengue infections rise</title>
			<atom:link href="https://biospectrumasia.com/news/50/5880/japan-worried-as-dengue-infections-rise.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5880/japan-worried-as-dengue-infections-rise.html</link>
			<pubDate>Fri, 12 Sep 2014 12:56:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10065554.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5880/japan-worried-as-dengue-infections-rise.html</guid>
		</item>	
				<item>
			<title>Toshiba, Johns Hopkins collaborate on big-data research</title>
			<atom:link href="https://biospectrumasia.com/news/50/5479/toshiba-johns-hopkins-collaborate-on-big-data-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5479/toshiba-johns-hopkins-collaborate-on-big-data-research.html</link>
			<pubDate>Thu, 11 Sep 2014 12:45:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/head-70185-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5479/toshiba-johns-hopkins-collaborate-on-big-data-research.html</guid>
		</item>	
				<item>
			<title>NUS, Thermo Fisher Scientific strike alliance </title>
			<atom:link href="https://biospectrumasia.com/news/50/6668/nus-thermo-fisher-scientific-strike-alliance-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6668/nus-thermo-fisher-scientific-strike-alliance-.html</link>
			<pubDate>Tue, 09 Sep 2014 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nus-thermo-fisher-strategic-alliance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6668/nus-thermo-fisher-scientific-strike-alliance-.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s dengue vaccine trials to being in 2015</title>
			<atom:link href="https://biospectrumasia.com/news/50/6089/takedas-dengue-vaccine-trials-to-being-in-2015.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6089/takedas-dengue-vaccine-trials-to-being-in-2015.html</link>
			<pubDate>Mon, 08 Sep 2014 12:40:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100274805.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6089/takedas-dengue-vaccine-trials-to-being-in-2015.html</guid>
		</item>	
				<item>
			<title>Asthma therapy market to touch $23.1 bn by 2023</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5040/asthma-therapy-market-to-touch-23-1-bn-by-2023.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5040/asthma-therapy-market-to-touch-23-1-bn-by-2023.html</link>
			<pubDate>Mon, 08 Sep 2014 11:57:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10057221-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5040/asthma-therapy-market-to-touch-23-1-bn-by-2023.html</guid>
		</item>	
				<item>
			<title>New testing kit fast tracks Ebola diagnosis</title>
			<atom:link href="https://biospectrumasia.com/news/50/5652/new-testing-kit-fast-tracks-ebola-diagnosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5652/new-testing-kit-fast-tracks-ebola-diagnosis.html</link>
			<pubDate>Wed, 03 Sep 2014 15:35:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lupus-drug-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5652/new-testing-kit-fast-tracks-ebola-diagnosis.html</guid>
		</item>	
				<item>
			<title>India, Japan to find a remedy for sickle cell anemia</title>
			<atom:link href="https://biospectrumasia.com/news/50/4503/india-japan-to-find-a-remedy-for-sickle-cell-anemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4503/india-japan-to-find-a-remedy-for-sickle-cell-anemia.html</link>
			<pubDate>Tue, 02 Sep 2014 12:33:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/blood-75301-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4503/india-japan-to-find-a-remedy-for-sickle-cell-anemia.html</guid>
		</item>	
				<item>
			<title>Novartis Japan admits to concealing side effects</title>
			<atom:link href="https://biospectrumasia.com/news/50/5214/novartis-japan-admits-to-concealing-side-effects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5214/novartis-japan-admits-to-concealing-side-effects.html</link>
			<pubDate>Tue, 02 Sep 2014 11:55:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/truth-257160-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5214/novartis-japan-admits-to-concealing-side-effects.html</guid>
		</item>	
				<item>
			<title>Mundipharma appoints new president in Japan</title>
			<atom:link href="https://biospectrumasia.com/influencers/50/4676/mundipharma-appoints-new-president-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/50/4676/mundipharma-appoints-new-president-in-japan.html</link>
			<pubDate>Tue, 26 Aug 2014 13:13:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/monitor-376211-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/50/4676/mundipharma-appoints-new-president-in-japan.html</guid>
		</item>	
				<item>
			<title>Novel Solutions for Emerging Diseases: Molcure</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/6207/novel-solutions-for-emerging-diseases-molcure.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/6207/novel-solutions-for-emerging-diseases-molcure.html</link>
			<pubDate>Sun, 24 Aug 2014 09:08:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/6207/novel-solutions-for-emerging-diseases-molcure.html</guid>
		</item>	
				<item>
			<title>A*STAR, Japanese bank ink partnership </title>
			<atom:link href="https://biospectrumasia.com/news/50/6105/astar-japanese-bank-ink-partnership-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6105/astar-japanese-bank-ink-partnership-.html</link>
			<pubDate>Wed, 20 Aug 2014 16:14:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astar-smbcweb2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6105/astar-japanese-bank-ink-partnership-.html</guid>
		</item>	
				<item>
			<title>FUJIFILM expands cell manufacturing capacity</title>
			<atom:link href="https://biospectrumasia.com/news/50/6096/fujifilm-expands-cell-manufacturing-capacity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6096/fujifilm-expands-cell-manufacturing-capacity.html</link>
			<pubDate>Wed, 20 Aug 2014 13:14:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/merck-millipore-to-develop-new-ways-to-harvest-stem-cell-from-bioreactor-based-cultures.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6096/fujifilm-expands-cell-manufacturing-capacity.html</guid>
		</item>	
				<item>
			<title>Roche has no plans to acquire Chugai&#039; </title>
			<atom:link href="https://biospectrumasia.com/news/50/6092/roche-has-no-plans-to-acquire-chugai-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6092/roche-has-no-plans-to-acquire-chugai-.html</link>
			<pubDate>Wed, 20 Aug 2014 13:08:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/figures-96100-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6092/roche-has-no-plans-to-acquire-chugai-.html</guid>
		</item>	
				<item>
			<title>Ready, Fit, Build and Run: Solutions fast tracked</title>
			<atom:link href="https://biospectrumasia.com/news/50/6020/ready-fit-build-and-run-solutions-fast-tracked.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6020/ready-fit-build-and-run-solutions-fast-tracked.html</link>
			<pubDate>Tue, 19 Aug 2014 12:46:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unigen.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6020/ready-fit-build-and-run-solutions-fast-tracked.html</guid>
		</item>	
				<item>
			<title>NCKU Taiwan, Fujistu Taiwan ink a pact to establish cloud computing platform</title>
			<atom:link href="https://biospectrumasia.com/news/50/5660/ncku-taiwan-fujistu-taiwan-ink-a-pact-to-establish-cloud-computing-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5660/ncku-taiwan-fujistu-taiwan-ink-a-pact-to-establish-cloud-computing-platform.html</link>
			<pubDate>Thu, 14 Aug 2014 15:08:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100221503.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5660/ncku-taiwan-fujistu-taiwan-ink-a-pact-to-establish-cloud-computing-platform.html</guid>
		</item>	
				<item>
			<title>Bristol-Myers collaborates with Onopharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/5422/bristol-myers-collaborates-with-onopharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5422/bristol-myers-collaborates-with-onopharma.html</link>
			<pubDate>Wed, 06 Aug 2014 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10045469.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5422/bristol-myers-collaborates-with-onopharma.html</guid>
		</item>	
				<item>
			<title>Taiho terminates oranitib Ph III trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/5136/taiho-terminates-oranitib-ph-iii-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5136/taiho-terminates-oranitib-ph-iii-trial.html</link>
			<pubDate>Tue, 05 Aug 2014 13:33:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications-342480-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5136/taiho-terminates-oranitib-ph-iii-trial.html</guid>
		</item>	
				<item>
			<title>Stem cell scientist Dr Yoshiki Sasai is dead</title>
			<atom:link href="https://biospectrumasia.com/news/50/5146/stem-cell-scientist-dr-yoshiki-sasai-is-dead.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5146/stem-cell-scientist-dr-yoshiki-sasai-is-dead.html</link>
			<pubDate>Tue, 05 Aug 2014 12:42:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/speaker-img2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5146/stem-cell-scientist-dr-yoshiki-sasai-is-dead.html</guid>
		</item>	
				<item>
			<title>Japan gets Certara&#039;s D360 to boost drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/5232/japan-gets-certaras-d360-to-boost-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5232/japan-gets-certaras-d360-to-boost-drug-discovery.html</link>
			<pubDate>Mon, 04 Aug 2014 10:47:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100241307.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5232/japan-gets-certaras-d360-to-boost-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan says NO to smoking, first dip since 1965</title>
			<atom:link href="https://biospectrumasia.com/news/50/5528/japan-says-no-to-smoking-first-dip-since-1965.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5528/japan-says-no-to-smoking-first-dip-since-1965.html</link>
			<pubDate>Fri, 01 Aug 2014 16:16:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100173624.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5528/japan-says-no-to-smoking-first-dip-since-1965.html</guid>
		</item>	
				<item>
			<title>Breast cancer drug market to touch $13.1 bn by 2020&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/4662/breast-cancer-drug-market-to-touch-13-1-bn-by-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/4662/breast-cancer-drug-market-to-touch-13-1-bn-by-2020.html</link>
			<pubDate>Thu, 24 Jul 2014 10:48:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100190703.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/4662/breast-cancer-drug-market-to-touch-13-1-bn-by-2020.html</guid>
		</item>	
				<item>
			<title>Otsuka, Lundbeck files NDA for schizophrenia drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/262/otsuka-lundbeck-files-nda-for-schizophrenia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/262/otsuka-lundbeck-files-nda-for-schizophrenia-drug.html</link>
			<pubDate>Tue, 15 Jul 2014 15:00:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100110567.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/262/otsuka-lundbeck-files-nda-for-schizophrenia-drug.html</guid>
		</item>	
				<item>
			<title>Boston Strategics gets rights for Eisai&#039;s cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/4389/boston-strategics-gets-rights-for-eisais-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4389/boston-strategics-gets-rights-for-eisais-cancer-drug-.html</link>
			<pubDate>Thu, 10 Jul 2014 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100234673.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4389/boston-strategics-gets-rights-for-eisais-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Shimadzu launches smart device enabled HPLC system </title>
			<atom:link href="https://biospectrumasia.com/news/50/1589/shimadzu-launches-smart-device-enabled-hplc-system-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1589/shimadzu-launches-smart-device-enabled-hplc-system-.html</link>
			<pubDate>Wed, 09 Jul 2014 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shimadzu.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1589/shimadzu-launches-smart-device-enabled-hplc-system-.html</guid>
		</item>	
				<item>
			<title>Japanese MMA for Mitsubishi&#039;s diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3039/japanese-mma-for-mitsubishis-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3039/japanese-mma-for-mitsubishis-diabetes-drug.html</link>
			<pubDate>Wed, 09 Jul 2014 08:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100253650.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3039/japanese-mma-for-mitsubishis-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>Growth ahead for Japan&#039;s pharma, medtech </title>
			<atom:link href="https://biospectrumasia.com/news/50/1790/growth-ahead-for-japans-pharma-medtech-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1790/growth-ahead-for-japans-pharma-medtech-.html</link>
			<pubDate>Tue, 08 Jul 2014 02:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/annual-report-61851-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1790/growth-ahead-for-japans-pharma-medtech-.html</guid>
		</item>	
				<item>
			<title>Smartphones preferred channel for healthcare&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/4444/smartphones-preferred-channel-for-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/4444/smartphones-preferred-channel-for-healthcare.html</link>
			<pubDate>Sun, 06 Jul 2014 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/4444/smartphones-preferred-channel-for-healthcare.html</guid>
		</item>	
				<item>
			<title>Indian pharma to put up a grand show at Tokyo fair</title>
			<atom:link href="https://biospectrumasia.com/news/50/1214/indian-pharma-to-put-up-a-grand-show-at-tokyo-fair.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1214/indian-pharma-to-put-up-a-grand-show-at-tokyo-fair.html</link>
			<pubDate>Wed, 02 Jul 2014 13:59:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1214/indian-pharma-to-put-up-a-grand-show-at-tokyo-fair.html</guid>
		</item>	
				<item>
			<title>New VP for Government affairs at Astellas </title>
			<atom:link href="https://biospectrumasia.com/news/50/973/new-vp-for-government-affairs-at-astellas-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/973/new-vp-for-government-affairs-at-astellas-.html</link>
			<pubDate>Tue, 01 Jul 2014 10:16:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100270716.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/973/new-vp-for-government-affairs-at-astellas-.html</guid>
		</item>	
				<item>
			<title>Gilead files NDA for Hep C drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/424/gilead-files-nda-for-hep-c-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/424/gilead-files-nda-for-hep-c-drug-in-japan.html</link>
			<pubDate>Mon, 30 Jun 2014 11:00:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100108924.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/424/gilead-files-nda-for-hep-c-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Meiji Seika Pharma buys Medreich</title>
			<atom:link href="https://biospectrumasia.com/news/50/1666/japans-meiji-seika-pharma-buys-medreich.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1666/japans-meiji-seika-pharma-buys-medreich.html</link>
			<pubDate>Fri, 27 Jun 2014 13:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10064000.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1666/japans-meiji-seika-pharma-buys-medreich.html</guid>
		</item>	
				<item>
			<title>Takeda terminates prostrate cancer drug trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/5413/takeda-terminates-prostrate-cancer-drug-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5413/takeda-terminates-prostrate-cancer-drug-trial.html</link>
			<pubDate>Tue, 24 Jun 2014 09:27:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100180747.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5413/takeda-terminates-prostrate-cancer-drug-trial.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s foreign recruitments suffer hostility </title>
			<atom:link href="https://biospectrumasia.com/news/50/3111/takedas-foreign-recruitments-suffer-hostility-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3111/takedas-foreign-recruitments-suffer-hostility-.html</link>
			<pubDate>Tue, 24 Jun 2014 09:13:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10082836.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3111/takedas-foreign-recruitments-suffer-hostility-.html</guid>
		</item>	
				<item>
			<title>Japanese nod for Bayer&#039;s thyroid cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/5781/japanese-nod-for-bayers-thyroid-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5781/japanese-nod-for-bayers-thyroid-cancer-drug-.html</link>
			<pubDate>Mon, 23 Jun 2014 16:08:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100246947.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5781/japanese-nod-for-bayers-thyroid-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Tobacco prevalence in Asia raising death toll</title>
			<atom:link href="https://biospectrumasia.com/news/50/6250/tobacco-prevalence-in-asia-raising-death-toll.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6250/tobacco-prevalence-in-asia-raising-death-toll.html</link>
			<pubDate>Tue, 17 Jun 2014 11:10:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cig.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6250/tobacco-prevalence-in-asia-raising-death-toll.html</guid>
		</item>	
				<item>
			<title>Ex-Novartis employee arrested for fudging data </title>
			<atom:link href="https://biospectrumasia.com/news/50/4076/ex-novartis-employee-arrested-for-fudging-data-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4076/ex-novartis-employee-arrested-for-fudging-data-.html</link>
			<pubDate>Thu, 12 Jun 2014 16:50:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10032599.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4076/ex-novartis-employee-arrested-for-fudging-data-.html</guid>
		</item>	
				<item>
			<title>Mistubishi to elevate particle therapy portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/50/2602/mistubishi-to-elevate-particle-therapy-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2602/mistubishi-to-elevate-particle-therapy-portfolio.html</link>
			<pubDate>Wed, 11 Jun 2014 11:44:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100247424.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2602/mistubishi-to-elevate-particle-therapy-portfolio.html</guid>
		</item>	
				<item>
			<title>BIOtech Japan 2014 introduces new features</title>
			<atom:link href="https://biospectrumasia.com/news/50/4036/biotech-japan-2014-introduces-new-features.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4036/biotech-japan-2014-introduces-new-features.html</link>
			<pubDate>Thu, 05 Jun 2014 17:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/untitled.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4036/biotech-japan-2014-introduces-new-features.html</guid>
		</item>	
				<item>
			<title>Astellas, UMN pharma to curb influenza in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2251/astellas-umn-pharma-to-curb-influenza-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2251/astellas-umn-pharma-to-curb-influenza-in-japan.html</link>
			<pubDate>Tue, 03 Jun 2014 10:50:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10014143.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2251/astellas-umn-pharma-to-curb-influenza-in-japan.html</guid>
		</item>	
				<item>
			<title>GSK seeks Japanese approval for NDA</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/6760/gsk-seeks-japanese-approval-for-nda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/6760/gsk-seeks-japanese-approval-for-nda.html</link>
			<pubDate>Thu, 29 May 2014 13:32:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approvals-274x186.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/6760/gsk-seeks-japanese-approval-for-nda.html</guid>
		</item>	
				<item>
			<title>Hoya appoints new executive officer</title>
			<atom:link href="https://biospectrumasia.com/news/50/757/hoya-appoints-new-executive-officer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/757/hoya-appoints-new-executive-officer.html</link>
			<pubDate>Mon, 26 May 2014 09:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10033686.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/757/hoya-appoints-new-executive-officer.html</guid>
		</item>	
				<item>
			<title>Sanford-Burnham, Daiichi form new alliance</title>
			<atom:link href="https://biospectrumasia.com/news/50/581/sanford-burnham-daiichi-form-new-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/581/sanford-burnham-daiichi-form-new-alliance.html</link>
			<pubDate>Mon, 26 May 2014 09:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10048225.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/581/sanford-burnham-daiichi-form-new-alliance.html</guid>
		</item>	
				<item>
			<title>Takeda drug gets FDA nod for new biologic therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/1721/takeda-drug-gets-fda-nod-for-new-biologic-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1721/takeda-drug-gets-fda-nod-for-new-biologic-therapy.html</link>
			<pubDate>Thu, 22 May 2014 10:51:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1721/takeda-drug-gets-fda-nod-for-new-biologic-therapy.html</guid>
		</item>	
				<item>
			<title>Life expectancy gains worldwide: WHO</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/4694/life-expectancy-gains-worldwide-who.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/4694/life-expectancy-gains-worldwide-who.html</link>
			<pubDate>Wed, 21 May 2014 10:50:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/who-logo1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/4694/life-expectancy-gains-worldwide-who.html</guid>
		</item>	
				<item>
			<title>Takeda partners with Wipro for IT solutions</title>
			<atom:link href="https://biospectrumasia.com/news/50/1336/takeda-partners-with-wipro-for-it-solutions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1336/takeda-partners-with-wipro-for-it-solutions.html</link>
			<pubDate>Wed, 21 May 2014 09:04:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10074810.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1336/takeda-partners-with-wipro-for-it-solutions.html</guid>
		</item>	
				<item>
			<title>Novartis under fire from Tasigna allegations</title>
			<atom:link href="https://biospectrumasia.com/news/50/545/novartis-under-fire-from-tasigna-allegations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/545/novartis-under-fire-from-tasigna-allegations.html</link>
			<pubDate>Wed, 14 May 2014 10:24:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/545/novartis-under-fire-from-tasigna-allegations.html</guid>
		</item>	
				<item>
			<title>Future of Healthcare in Asia</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/7989/future-of-healthcare-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/7989/future-of-healthcare-in-asia.html</link>
			<pubDate>Mon, 05 May 2014 09:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/untitled.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/7989/future-of-healthcare-in-asia.html</guid>
		</item>	
				<item>
			<title>Chugai Pharma appoints new CMO</title>
			<atom:link href="https://biospectrumasia.com/news/50/2893/chugai-pharma-appoints-new-cmo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2893/chugai-pharma-appoints-new-cmo.html</link>
			<pubDate>Tue, 29 Apr 2014 10:32:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100232780.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2893/chugai-pharma-appoints-new-cmo.html</guid>
		</item>	
				<item>
			<title>Eisai signs agreement with Epizyme and Roche</title>
			<atom:link href="https://biospectrumasia.com/news/50/1063/eisai-signs-agreement-with-epizyme-and-roche.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1063/eisai-signs-agreement-with-epizyme-and-roche.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1063/eisai-signs-agreement-with-epizyme-and-roche.html</guid>
		</item>	
				<item>
			<title>FDA approves ABILIFY MAINTENA</title>
			<atom:link href="https://biospectrumasia.com/news/50/1507/fda-approves-abilify-maintena.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1507/fda-approves-abilify-maintena.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1507/fda-approves-abilify-maintena.html</guid>
		</item>	
				<item>
			<title>Takeda, UCL collaborate on brain diseases </title>
			<atom:link href="https://biospectrumasia.com/news/50/1540/takeda-ucl-collaborate-on-brain-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1540/takeda-ucl-collaborate-on-brain-diseases-.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hand-774847-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1540/takeda-ucl-collaborate-on-brain-diseases-.html</guid>
		</item>	
				<item>
			<title>FDA approves Eisai&#039;s ACIPHEX</title>
			<atom:link href="https://biospectrumasia.com/news/50/1655/fda-approves-eisais-aciphex.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1655/fda-approves-eisais-aciphex.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1655/fda-approves-eisais-aciphex.html</guid>
		</item>	
				<item>
			<title>Scientists in Japan make progress in vaccine against norovirus</title>
			<atom:link href="https://biospectrumasia.com/news/50/1665/scientists-in-japan-make-progress-in-vaccine-against-norovirus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1665/scientists-in-japan-make-progress-in-vaccine-against-norovirus.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ligocyte-vaccine-candidate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1665/scientists-in-japan-make-progress-in-vaccine-against-norovirus.html</guid>
		</item>	
				<item>
			<title>Ex-GSK boss promoted as Takeda&#039;s CEO</title>
			<atom:link href="https://biospectrumasia.com/influencers/50/2092/ex-gsk-boss-promoted-as-takedas-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/50/2092/ex-gsk-boss-promoted-as-takedas-ceo.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191233.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/50/2092/ex-gsk-boss-promoted-as-takedas-ceo.html</guid>
		</item>	
				<item>
			<title>Japan drug maker Novartis, in trouble again!</title>
			<atom:link href="https://biospectrumasia.com/news/50/2626/japan-drug-maker-novartis-in-trouble-again.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2626/japan-drug-maker-novartis-in-trouble-again.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10024080.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2626/japan-drug-maker-novartis-in-trouble-again.html</guid>
		</item>	
				<item>
			<title>FDA recommends Takeda&#039;s drug for Chrohn&#039;s disease</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2671/fda-recommends-takedas-drug-for-chrohns-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2671/fda-recommends-takedas-drug-for-chrohns-disease.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2671/fda-recommends-takedas-drug-for-chrohns-disease.html</guid>
		</item>	
				<item>
			<title>Aegerion begins phase III clinical trials in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3720/aegerion-begins-phase-iii-clinical-trials-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3720/aegerion-begins-phase-iii-clinical-trials-in-japan.html</link>
			<pubDate>Fri, 11 Apr 2014 13:13:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100202681.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3720/aegerion-begins-phase-iii-clinical-trials-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda fined $6 bn by US Federal jury</title>
			<atom:link href="https://biospectrumasia.com/news/50/3696/takeda-fined-6-bn-by-us-federal-jury.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3696/takeda-fined-6-bn-by-us-federal-jury.html</link>
			<pubDate>Fri, 11 Apr 2014 12:52:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10061387.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3696/takeda-fined-6-bn-by-us-federal-jury.html</guid>
		</item>	
				<item>
			<title>Dr Reddy&#039;s plans to enter into Japanese market</title>
			<atom:link href="https://biospectrumasia.com/news/50/4024/dr-reddys-plans-to-enter-into-japanese-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4024/dr-reddys-plans-to-enter-into-japanese-market.html</link>
			<pubDate>Wed, 02 Apr 2014 16:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100174164.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4024/dr-reddys-plans-to-enter-into-japanese-market.html</guid>
		</item>	
				<item>
			<title>Takeda gets Japan&#039;s approval for hypertension drug NDA</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3618/takeda-gets-japans-approval-for-hypertension-drug-nda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3618/takeda-gets-japans-approval-for-hypertension-drug-nda.html</link>
			<pubDate>Thu, 27 Mar 2014 10:46:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3618/takeda-gets-japans-approval-for-hypertension-drug-nda.html</guid>
		</item>	
				<item>
			<title>Asia gets $15 mn donation for better sanitation </title>
			<atom:link href="https://biospectrumasia.com/news/50/5543/asia-gets-15-mn-donation-for-better-sanitation-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5543/asia-gets-15-mn-donation-for-better-sanitation-.html</link>
			<pubDate>Fri, 21 Mar 2014 13:32:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bill-og-melinda-gates-2009-06-03-bilde-01.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5543/asia-gets-15-mn-donation-for-better-sanitation-.html</guid>
		</item>	
				<item>
			<title>APAC&#039;s NSCLC market to show robust growth by 2019</title>
			<atom:link href="https://biospectrumasia.com/news/50/3753/apacs-nsclc-market-to-show-robust-growth-by-2019.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3753/apacs-nsclc-market-to-show-robust-growth-by-2019.html</link>
			<pubDate>Fri, 21 Mar 2014 12:21:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nonsmallcell-274x186.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3753/apacs-nsclc-market-to-show-robust-growth-by-2019.html</guid>
		</item>	
				<item>
			<title>Non-small cell lung cancer therapeutics APAC market to touch $2.9 bn by 2019&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/4165/non-small-cell-lung-cancer-therapeutics-apac-market-to-touch-2-9-bn-by-2019.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/4165/non-small-cell-lung-cancer-therapeutics-apac-market-to-touch-2-9-bn-by-2019.html</link>
			<pubDate>Wed, 19 Mar 2014 09:04:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/4165/non-small-cell-lung-cancer-therapeutics-apac-market-to-touch-2-9-bn-by-2019.html</guid>
		</item>	
				<item>
			<title>Almac expands in Singapore, Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/4884/almac-expands-in-singapore-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4884/almac-expands-in-singapore-japan.html</link>
			<pubDate>Thu, 13 Mar 2014 11:31:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/almac-establishes-regional-hubs-in-singapore-and-japan-to-provide-clinical-trial-solutions.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4884/almac-expands-in-singapore-japan.html</guid>
		</item>	
				<item>
			<title>Eisai US to replace its president, CEO </title>
			<atom:link href="https://biospectrumasia.com/news/50/1435/eisai-us-to-replace-its-president-ceo-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1435/eisai-us-to-replace-its-president-ceo-.html</link>
			<pubDate>Wed, 12 Mar 2014 16:24:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-us-appoints-mr-yuji-matsue-as-chairman-and-ceo-and-mr-shaji-procida-as-president-and-coo.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1435/eisai-us-to-replace-its-president-ceo-.html</guid>
		</item>	
				<item>
			<title>Ranbaxy now recalls 64,000 bottles of generic heart drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/4801/ranbaxy-now-recalls-64000-bottles-of-generic-heart-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4801/ranbaxy-now-recalls-64000-bottles-of-generic-heart-drug-.html</link>
			<pubDate>Tue, 11 Mar 2014 17:31:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxy-recalls-more-than-64-000-bottles-containing-tablets-of-lipitor-generic-atorvastatin-calcium.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4801/ranbaxy-now-recalls-64000-bottles-of-generic-heart-drug-.html</guid>
		</item>	
				<item>
			<title>BioAsia 2014: Innovation, collaboration identified as success keys</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/6572/bioasia-2014-innovation-collaboration-identified-as-success-keys.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/6572/bioasia-2014-innovation-collaboration-identified-as-success-keys.html</link>
			<pubDate>Wed, 05 Mar 2014 00:14:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rsz-bio-asia-274x186.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/6572/bioasia-2014-innovation-collaboration-identified-as-success-keys.html</guid>
		</item>	
				<item>
			<title>Edison Pharma, DSP enter $4 bn metablosim drug deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/430/edison-pharma-dsp-enter-4-bn-metablosim-drug-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/430/edison-pharma-dsp-enter-4-bn-metablosim-drug-deal.html</link>
			<pubDate>Tue, 04 Feb 2014 14:52:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/edison-pharma-dsp-to-co-develop-cellular-metablosim-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/430/edison-pharma-dsp-enter-4-bn-metablosim-drug-deal.html</guid>
		</item>	
				<item>
			<title>Takeda receives Japanese nod for Adcetris</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/879/takeda-receives-japanese-nod-for-adcetris.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/879/takeda-receives-japanese-nod-for-adcetris.html</link>
			<pubDate>Tue, 21 Jan 2014 10:01:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10036210.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/879/takeda-receives-japanese-nod-for-adcetris.html</guid>
		</item>	
				<item>
			<title>Japan files criminal complaint against Novartis</title>
			<atom:link href="https://biospectrumasia.com/news/50/3902/japan-files-criminal-complaint-against-novartis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3902/japan-files-criminal-complaint-against-novartis.html</link>
			<pubDate>Fri, 10 Jan 2014 11:39:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10099027.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3902/japan-files-criminal-complaint-against-novartis.html</guid>
		</item>	
				<item>
			<title>Astellas, ClearPath to enter strategic partnership</title>
			<atom:link href="https://biospectrumasia.com/news/50/7497/astellas-clearpath-to-enter-strategic-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7497/astellas-clearpath-to-enter-strategic-partnership.html</link>
			<pubDate>Mon, 06 Jan 2014 14:56:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100136721.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7497/astellas-clearpath-to-enter-strategic-partnership.html</guid>
		</item>	
				<item>
			<title>BioSpectrum announces the hits and misses of 2013</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/7126/biospectrum-announces-the-hits-and-misses-of-2013.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/7126/biospectrum-announces-the-hits-and-misses-of-2013.html</link>
			<pubDate>Thu, 02 Jan 2014 17:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/what-were-the-biggest-hits-and-misses-of-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/7126/biospectrum-announces-the-hits-and-misses-of-2013.html</guid>
		</item>	
				<item>
			<title>Japan to launch emergency center in Cambodia</title>
			<atom:link href="https://biospectrumasia.com/news/50/2329/japan-to-launch-emergency-center-in-cambodia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2329/japan-to-launch-emergency-center-in-cambodia.html</link>
			<pubDate>Thu, 26 Dec 2013 11:26:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100151048.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2329/japan-to-launch-emergency-center-in-cambodia.html</guid>
		</item>	
				<item>
			<title>Chugai Pharma to set up sales unit in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/7376/chugai-pharma-to-set-up-sales-unit-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7376/chugai-pharma-to-set-up-sales-unit-in-china.html</link>
			<pubDate>Thu, 26 Dec 2013 11:16:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10025043.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7376/chugai-pharma-to-set-up-sales-unit-in-china.html</guid>
		</item>	
				<item>
			<title>Japan to gather nanotechnology experts in 2014 </title>
			<atom:link href="https://biospectrumasia.com/news/50/6560/japan-to-gather-nanotechnology-experts-in-2014-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6560/japan-to-gather-nanotechnology-experts-in-2014-.html</link>
			<pubDate>Wed, 18 Dec 2013 13:41:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nanotechnology-event.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6560/japan-to-gather-nanotechnology-experts-in-2014-.html</guid>
		</item>	
				<item>
			<title>Thomson Reuters to restore Tohoku to pre-earthquake state</title>
			<atom:link href="https://biospectrumasia.com/news/50/2685/thomson-reuters-to-restore-tohoku-to-pre-earthquake-state.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2685/thomson-reuters-to-restore-tohoku-to-pre-earthquake-state.html</link>
			<pubDate>Fri, 13 Dec 2013 17:45:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thomson-reuters-is-providing-its-cortellis-for-informatics-gene-variant-database-to-support-japan-s-tohoku-university-and-tohoku-medical-megabank-organization-tommo.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2685/thomson-reuters-to-restore-tohoku-to-pre-earthquake-state.html</guid>
		</item>	
				<item>
			<title>Astellas Pharma opens office in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/50/666/astellas-pharma-opens-office-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/666/astellas-pharma-opens-office-in-singapore.html</link>
			<pubDate>Thu, 12 Dec 2013 12:19:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-pharma-singapore.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/666/astellas-pharma-opens-office-in-singapore.html</guid>
		</item>	
				<item>
			<title>Harlan Japan appoints Hiroharu Okochi as president </title>
			<atom:link href="https://biospectrumasia.com/influencers/50/2670/harlan-japan-appoints-hiroharu-okochi-as-president-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/50/2670/harlan-japan-appoints-hiroharu-okochi-as-president-.html</link>
			<pubDate>Tue, 10 Dec 2013 10:41:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10015624.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/50/2670/harlan-japan-appoints-hiroharu-okochi-as-president-.html</guid>
		</item>	
				<item>
			<title>Takeda, Teva working on glatiramer deals in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/5310/takeda-teva-working-on-glatiramer-deals-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5310/takeda-teva-working-on-glatiramer-deals-in-japan-.html</link>
			<pubDate>Fri, 06 Dec 2013 11:58:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10046681.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5310/takeda-teva-working-on-glatiramer-deals-in-japan-.html</guid>
		</item>	
				<item>
			<title>Takeda appoints first-ever non-Japanese president</title>
			<atom:link href="https://biospectrumasia.com/news/50/1079/takeda-appoints-first-ever-non-japanese-president.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1079/takeda-appoints-first-ever-non-japanese-president.html</link>
			<pubDate>Mon, 02 Dec 2013 13:22:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-christophe-weber-the-new-president-of-takeda-pharmaceuticals.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1079/takeda-appoints-first-ever-non-japanese-president.html</guid>
		</item>	
				<item>
			<title>Shionogi, Egalet sign deal for opioid products </title>
			<atom:link href="https://biospectrumasia.com/news/50/6676/shionogi-egalet-sign-deal-for-opioid-products-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6676/shionogi-egalet-sign-deal-for-opioid-products-.html</link>
			<pubDate>Mon, 02 Dec 2013 09:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/china-firms-ge-setup-medical-imaging-center.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6676/shionogi-egalet-sign-deal-for-opioid-products-.html</guid>
		</item>	
				<item>
			<title>Japan, Singapore to bring innovation in drug, device, technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/907/japan-singapore-to-bring-innovation-in-drug-device-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/907/japan-singapore-to-bring-innovation-in-drug-device-technology.html</link>
			<pubDate>Fri, 29 Nov 2013 11:13:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/907/japan-singapore-to-bring-innovation-in-drug-device-technology.html</guid>
		</item>	
				<item>
			<title>Mundipharma, Shionogi tie up for pain treatment in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/617/mundipharma-shionogi-tie-up-for-pain-treatment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/617/mundipharma-shionogi-tie-up-for-pain-treatment-in-japan.html</link>
			<pubDate>Fri, 22 Nov 2013 14:19:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pain-no-more-mundipharma-and-shionogi-sign-deal-for-oxycodone-oxycontin-neo-tablets-and-targin-tablets-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/617/mundipharma-shionogi-tie-up-for-pain-treatment-in-japan.html</guid>
		</item>	
				<item>
			<title>TriReme catheter gets approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7936/trireme-catheter-gets-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7936/trireme-catheter-gets-approval-in-japan.html</link>
			<pubDate>Thu, 21 Nov 2013 12:27:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/trireme-catheter-gets-approval-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7936/trireme-catheter-gets-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>Ranbaxy aiming to sell its generics in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2238/ranbaxy-aiming-to-sell-its-generics-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2238/ranbaxy-aiming-to-sell-its-generics-in-japan.html</link>
			<pubDate>Mon, 18 Nov 2013 11:24:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10036213.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2238/ranbaxy-aiming-to-sell-its-generics-in-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi accuses Singh brothers of concealing facts</title>
			<atom:link href="https://biospectrumasia.com/news/50/5886/daiichi-accuses-singh-brothers-of-concealing-facts.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5886/daiichi-accuses-singh-brothers-of-concealing-facts.html</link>
			<pubDate>Tue, 12 Nov 2013 16:50:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10022494.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5886/daiichi-accuses-singh-brothers-of-concealing-facts.html</guid>
		</item>	
				<item>
			<title>BMS seeks Hep C therapy approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2532/bms-seeks-hep-c-therapy-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2532/bms-seeks-hep-c-therapy-approval-in-japan.html</link>
			<pubDate>Thu, 07 Nov 2013 10:50:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2532/bms-seeks-hep-c-therapy-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>APAC healthcare industry becomes cloud friendly</title>
			<atom:link href="https://biospectrumasia.com/news/50/1065/apac-healthcare-industry-becomes-cloud-friendly.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1065/apac-healthcare-industry-becomes-cloud-friendly.html</link>
			<pubDate>Thu, 07 Nov 2013 03:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100203632.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1065/apac-healthcare-industry-becomes-cloud-friendly.html</guid>
		</item>	
				<item>
			<title>Eisai to launch breast cancer drug in India</title>
			<atom:link href="https://biospectrumasia.com/news/50/1764/eisai-to-launch-breast-cancer-drug-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1764/eisai-to-launch-breast-cancer-drug-in-india.html</link>
			<pubDate>Wed, 06 Nov 2013 14:12:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10044795.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1764/eisai-to-launch-breast-cancer-drug-in-india.html</guid>
		</item>	
				<item>
			<title>MNCs on medtech growth trail </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/6469/mncs-on-medtech-growth-trail-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/6469/mncs-on-medtech-growth-trail-.html</link>
			<pubDate>Tue, 05 Nov 2013 09:34:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10069876.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/6469/mncs-on-medtech-growth-trail-.html</guid>
		</item>	
				<item>
			<title>Bristol seeks Japanese nod of all-oral hepatitis C treatment</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/5470/bristol-seeks-japanese-nod-of-all-oral-hepatitis-c-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/5470/bristol-seeks-japanese-nod-of-all-oral-hepatitis-c-treatment.html</link>
			<pubDate>Mon, 04 Nov 2013 16:32:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10014936.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/5470/bristol-seeks-japanese-nod-of-all-oral-hepatitis-c-treatment.html</guid>
		</item>	
				<item>
			<title>Astellas to axe 300 jobs in home country in FY14</title>
			<atom:link href="https://biospectrumasia.com/news/50/5698/astellas-to-axe-300-jobs-in-home-country-in-fy14.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5698/astellas-to-axe-300-jobs-in-home-country-in-fy14.html</link>
			<pubDate>Mon, 04 Nov 2013 15:45:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10099027.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5698/astellas-to-axe-300-jobs-in-home-country-in-fy14.html</guid>
		</item>	
				<item>
			<title>Life Tech, Japanese firm to launch stem cell kit</title>
			<atom:link href="https://biospectrumasia.com/news/50/1798/life-tech-japanese-firm-to-launch-stem-cell-kit.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1798/life-tech-japanese-firm-to-launch-stem-cell-kit.html</link>
			<pubDate>Thu, 24 Oct 2013 10:38:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/life-technologies-and-dnavec-to-jointly-launch-cytotune-ips-2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1798/life-tech-japanese-firm-to-launch-stem-cell-kit.html</guid>
		</item>	
				<item>
			<title>Astellas announces global team promotions</title>
			<atom:link href="https://biospectrumasia.com/news/50/5996/astellas-announces-global-team-promotions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5996/astellas-announces-global-team-promotions.html</link>
			<pubDate>Wed, 23 Oct 2013 12:29:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10070796.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5996/astellas-announces-global-team-promotions.html</guid>
		</item>	
				<item>
			<title>mHealth apps market to reach $20.7 bn by 2018: Report</title>
			<atom:link href="https://biospectrumasia.com/news/50/7786/mhealth-apps-market-to-reach-20-7-bn-by-2018-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7786/mhealth-apps-market-to-reach-20-7-bn-by-2018-report.html</link>
			<pubDate>Tue, 22 Oct 2013 14:01:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/increasing-awareness-of-chronic-diseases-growing-adoption-of-smartphones-high-penetration-of-3g-and-4g-network-and-advanced-mobile-connectivity-are-fuelling-growth-of-mobile-health.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7786/mhealth-apps-market-to-reach-20-7-bn-by-2018-report.html</guid>
		</item>	
				<item>
			<title>Neurons reveal brain, whiskers network link</title>
			<atom:link href="https://biospectrumasia.com/news/50/5187/neurons-reveal-brain-whiskers-network-link.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5187/neurons-reveal-brain-whiskers-network-link.html</link>
			<pubDate>Thu, 17 Oct 2013 11:49:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neurons.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5187/neurons-reveal-brain-whiskers-network-link.html</guid>
		</item>	
				<item>
			<title>CMI announces SNaP system sales in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/4035/cmi-announces-snap-system-sales-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4035/cmi-announces-snap-system-sales-in-japan-.html</link>
			<pubDate>Tue, 15 Oct 2013 10:34:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/following-its-mission-statement-science-for-a-better-life-bayer-will-further-five-drug-candidates-in-its-pipeline.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4035/cmi-announces-snap-system-sales-in-japan-.html</guid>
		</item>	
				<item>
			<title>Dainippon sets up cancer drug subsidiary in the US</title>
			<atom:link href="https://biospectrumasia.com/news/50/5130/dainippon-sets-up-cancer-drug-subsidiary-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5130/dainippon-sets-up-cancer-drug-subsidiary-in-the-us.html</link>
			<pubDate>Thu, 10 Oct 2013 11:51:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dainippon-sumitomo-pharma-dsp-owned-boston-biomedical-will-set-up-an-anti-cancer-drugs-sales-subsidiary-in-the-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5130/dainippon-sets-up-cancer-drug-subsidiary-in-the-us.html</guid>
		</item>	
				<item>
			<title>Japanese find body &#039;clock&#039; that controls jet-lag</title>
			<atom:link href="https://biospectrumasia.com/news/50/3683/japanese-find-body-clock-that-controls-jet-lag.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3683/japanese-find-body-clock-that-controls-jet-lag.html</link>
			<pubDate>Thu, 10 Oct 2013 08:56:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-chung-yi-wu-associate-research-fellow-genomics-research-center-taiwan-winner-of-the-2014-david-y-gin-new-investigator-award.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3683/japanese-find-body-clock-that-controls-jet-lag.html</guid>
		</item>	
				<item>
			<title>India invites Japanese firms to invest in healthcare</title>
			<atom:link href="https://biospectrumasia.com/news/50/2789/india-invites-japanese-firms-to-invest-in-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2789/india-invites-japanese-firms-to-invest-in-healthcare.html</link>
			<pubDate>Mon, 07 Oct 2013 12:49:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-manufacturing-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2789/india-invites-japanese-firms-to-invest-in-healthcare.html</guid>
		</item>	
				<item>
			<title>Takeda gastro norovirus vaccine shows +ve results</title>
			<atom:link href="https://biospectrumasia.com/news/50/5683/takeda-gastro-norovirus-vaccine-shows-ve-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5683/takeda-gastro-norovirus-vaccine-shows-ve-results.html</link>
			<pubDate>Mon, 07 Oct 2013 09:33:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/imaxio-s-begins-phase-i-human-trials-of-tuberculosis-tb-vaccine-candidate-mva85a-imx313-which-is-a-viral-vector-vaccine-encoding-the-tb-antigen-85a-fused-to-imaxio-s-imx313.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5683/takeda-gastro-norovirus-vaccine-shows-ve-results.html</guid>
		</item>	
				<item>
			<title>Daiichi US appoints Glenn Gormley as chairman</title>
			<atom:link href="https://biospectrumasia.com/influencers/50/2530/daiichi-us-appoints-glenn-gormley-as-chairman.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/50/2530/daiichi-us-appoints-glenn-gormley-as-chairman.html</link>
			<pubDate>Fri, 04 Oct 2013 12:57:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-glenn-gormley-the-new-president-and-chairman-of-daiichi-sankyo-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/50/2530/daiichi-us-appoints-glenn-gormley-as-chairman.html</guid>
		</item>	
				<item>
			<title>Ganesh Ramaswamy is Pentax&#039;s global president</title>
			<atom:link href="https://biospectrumasia.com/news/50/2475/ganesh-ramaswamy-is-pentaxs-global-president.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2475/ganesh-ramaswamy-is-pentaxs-global-president.html</link>
			<pubDate>Fri, 04 Oct 2013 12:36:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-ganesh-ramaswamy-the-new-global-president-of-pentax-medical.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2475/ganesh-ramaswamy-is-pentaxs-global-president.html</guid>
		</item>	
				<item>
			<title>Oramed granted patent in Japan for its POD Tech</title>
			<atom:link href="https://biospectrumasia.com/news/50/1282/oramed-granted-patent-in-japan-for-its-pod-tech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1282/oramed-granted-patent-in-japan-for-its-pod-tech.html</link>
			<pubDate>Fri, 04 Oct 2013 10:30:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approval-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1282/oramed-granted-patent-in-japan-for-its-pod-tech.html</guid>
		</item>	
				<item>
			<title>Ovaries of early menopausal women &#039;awakened&#039; to conceive baby </title>
			<atom:link href="https://biospectrumasia.com/news/50/2495/ovaries-of-early-menopausal-women-awakened-to-conceive-baby-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2495/ovaries-of-early-menopausal-women-awakened-to-conceive-baby-.html</link>
			<pubDate>Thu, 03 Oct 2013 17:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-team-of-doctors-removed-the-ovaries-activated-them-in-the-laboratory-and-re-implanted-fragments-of-ovarian-tissue-in-the-mother.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2495/ovaries-of-early-menopausal-women-awakened-to-conceive-baby-.html</guid>
		</item>	
				<item>
			<title>Mystic gets Japan, China patent nod for containers</title>
			<atom:link href="https://biospectrumasia.com/news/50/2948/mystic-gets-japan-china-patent-nod-for-containers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2948/mystic-gets-japan-china-patent-nod-for-containers.html</link>
			<pubDate>Thu, 03 Oct 2013 16:49:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mystic-pharma-gets-notices-of-allowance-from-china-for-its-deep-draw-container-forming-method-and-japan-for-its-combination-unit-dose-dispensing-container.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2948/mystic-gets-japan-china-patent-nod-for-containers.html</guid>
		</item>	
				<item>
			<title>Yaskawa Electric invests in ReWalk exoskeleton</title>
			<atom:link href="https://biospectrumasia.com/news/50/3327/yaskawa-electric-invests-in-rewalk-exoskeleton.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3327/yaskawa-electric-invests-in-rewalk-exoskeleton.html</link>
			<pubDate>Thu, 03 Oct 2013 14:59:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/03oct-rewalk.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3327/yaskawa-electric-invests-in-rewalk-exoskeleton.html</guid>
		</item>	
				<item>
			<title>Mitsubishi proton system aids cancer therapy in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1031/mitsubishi-proton-system-aids-cancer-therapy-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1031/mitsubishi-proton-system-aids-cancer-therapy-in-japan.html</link>
			<pubDate>Tue, 01 Oct 2013 13:11:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mitsubishi-electric-to-supply-proton-beam-therapy-system-to-tsuyama-chuo-hospital-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1031/mitsubishi-proton-system-aids-cancer-therapy-in-japan.html</guid>
		</item>	
				<item>
			<title>Nexavar seeks marketing authorization in Japan </title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/1135/nexavar-seeks-marketing-authorization-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/1135/nexavar-seeks-marketing-authorization-in-japan-.html</link>
			<pubDate>Tue, 01 Oct 2013 11:39:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drugs-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/1135/nexavar-seeks-marketing-authorization-in-japan-.html</guid>
		</item>	
				<item>
			<title>Japanese nod for Given Imaging&#039;s PillCam SB 3</title>
			<atom:link href="https://biospectrumasia.com/news/50/5191/japanese-nod-for-given-imagings-pillcam-sb-3.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5191/japanese-nod-for-given-imagings-pillcam-sb-3.html</link>
			<pubDate>Thu, 26 Sep 2013 12:47:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/25-pillcam-sb-3.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5191/japanese-nod-for-given-imagings-pillcam-sb-3.html</guid>
		</item>	
				<item>
			<title>Novartis&#039;s Ultibro Breezhaler receives EC, Japanese nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/2119/novartiss-ultibro-breezhaler-receives-ec-japanese-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2119/novartiss-ultibro-breezhaler-receives-ec-japanese-nod.html</link>
			<pubDate>Thu, 26 Sep 2013 12:22:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hard-breathing.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2119/novartiss-ultibro-breezhaler-receives-ec-japanese-nod.html</guid>
		</item>	
				<item>
			<title>Daiichi  to work with US FDA to solve Ranbaxy quality issue</title>
			<atom:link href="https://biospectrumasia.com/news/50/2256/daiichi-to-work-with-us-fda-to-solve-ranbaxy-quality-issue.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2256/daiichi-to-work-with-us-fda-to-solve-ranbaxy-quality-issue.html</link>
			<pubDate>Wed, 25 Sep 2013 14:33:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10095073.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2256/daiichi-to-work-with-us-fda-to-solve-ranbaxy-quality-issue.html</guid>
		</item>	
				<item>
			<title>Chugai gets Japanese nod cancer drug Kadcyla</title>
			<atom:link href="https://biospectrumasia.com/news/50/1148/chugai-gets-japanese-nod-cancer-drug-kadcyla.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1148/chugai-gets-japanese-nod-cancer-drug-kadcyla.html</link>
			<pubDate>Mon, 23 Sep 2013 13:32:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10060402.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1148/chugai-gets-japanese-nod-cancer-drug-kadcyla.html</guid>
		</item>	
				<item>
			<title>Takeda gets Japanese NDA approval for obesity drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/939/takeda-gets-japanese-nda-approval-for-obesity-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/939/takeda-gets-japanese-nda-approval-for-obesity-drug.html</link>
			<pubDate>Mon, 23 Sep 2013 10:55:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oblean-is-a-lipase-inhibitor-discovered-by-uk-based-alizyme-therapeutics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/939/takeda-gets-japanese-nda-approval-for-obesity-drug.html</guid>
		</item>	
				<item>
			<title>Japan to host its first-ever medicine expo in 2014</title>
			<atom:link href="https://biospectrumasia.com/news/50/2888/japan-to-host-its-first-ever-medicine-expo-in-2014.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2888/japan-to-host-its-first-ever-medicine-expo-in-2014.html</link>
			<pubDate>Fri, 20 Sep 2013 13:32:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-is-hosting-its-first-personalised-medicine-and-diagnostics-expo-in-may-14-16-2014.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2888/japan-to-host-its-first-ever-medicine-expo-in-2014.html</guid>
		</item>	
				<item>
			<title>NDA approval for obesity drug Oblean in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/8121/nda-approval-for-obesity-drug-oblean-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8121/nda-approval-for-obesity-drug-oblean-in-japan.html</link>
			<pubDate>Fri, 20 Sep 2013 12:32:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8121/nda-approval-for-obesity-drug-oblean-in-japan.html</guid>
		</item>	
				<item>
			<title>MTPC completes acquisition of Medicago</title>
			<atom:link href="https://biospectrumasia.com/news/50/1019/mtpc-completes-acquisition-of-medicago.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1019/mtpc-completes-acquisition-of-medicago.html</link>
			<pubDate>Thu, 19 Sep 2013 11:48:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/in-the-race-to-acquire-elder-pharma-sanofi-and-gsk-have-put-in-non-binding-bids-while-novartis-signed-a-non-disclosure-deal-with-elder.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1019/mtpc-completes-acquisition-of-medicago.html</guid>
		</item>	
				<item>
			<title>What the future holds for the APAC CRO market?</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/374/what-the-future-holds-for-the-apac-cro-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/374/what-the-future-holds-for-the-apac-cro-market.html</link>
			<pubDate>Wed, 18 Sep 2013 13:25:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/10.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/374/what-the-future-holds-for-the-apac-cro-market.html</guid>
		</item>	
				<item>
			<title>What functional roles do CROs play in APAC?</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2222/what-functional-roles-do-cros-play-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2222/what-functional-roles-do-cros-play-in-apac.html</link>
			<pubDate>Wed, 18 Sep 2013 13:16:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/9.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2222/what-functional-roles-do-cros-play-in-apac.html</guid>
		</item>	
				<item>
			<title>BSA-CMR Survey: Asian CROs optimistic in a gloomy pharma market</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/6819/bsa-cmr-survey-asian-cros-optimistic-in-a-gloomy-pharma-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/6819/bsa-cmr-survey-asian-cros-optimistic-in-a-gloomy-pharma-market.html</link>
			<pubDate>Wed, 18 Sep 2013 13:13:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10078509.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/6819/bsa-cmr-survey-asian-cros-optimistic-in-a-gloomy-pharma-market.html</guid>
		</item>	
				<item>
			<title>Which domain of clinical research do APAC CROs focus on?</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/3735/which-domain-of-clinical-research-do-apac-cros-focus-on.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/3735/which-domain-of-clinical-research-do-apac-cros-focus-on.html</link>
			<pubDate>Wed, 18 Sep 2013 13:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/8.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/3735/which-domain-of-clinical-research-do-apac-cros-focus-on.html</guid>
		</item>	
				<item>
			<title>Additional indication for Otsuka&#039;s Samsca in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6794/additional-indication-for-otsukas-samsca-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6794/additional-indication-for-otsukas-samsca-in-japan.html</link>
			<pubDate>Wed, 18 Sep 2013 11:38:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/australia-based-nanosonics-disinfection-technology-trophon-epr-gets-marketing-approval-from-korean-food-and-drug-administration-kfda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6794/additional-indication-for-otsukas-samsca-in-japan.html</guid>
		</item>	
				<item>
			<title>BSA-CMR Survey: APAC CROs stick to an average of 50 clients</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2738/bsa-cmr-survey-apac-cros-stick-to-an-average-of-50-clients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2738/bsa-cmr-survey-apac-cros-stick-to-an-average-of-50-clients.html</link>
			<pubDate>Wed, 18 Sep 2013 11:19:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/7.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2738/bsa-cmr-survey-apac-cros-stick-to-an-average-of-50-clients.html</guid>
		</item>	
				<item>
			<title>What is the revenue size, range of CROs in APAC?</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/3057/what-is-the-revenue-size-range-of-cros-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/3057/what-is-the-revenue-size-range-of-cros-in-apac.html</link>
			<pubDate>Wed, 18 Sep 2013 11:07:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/3057/what-is-the-revenue-size-range-of-cros-in-apac.html</guid>
		</item>	
				<item>
			<title>What services do APAC CROs offer to their clients?</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2654/what-services-do-apac-cros-offer-to-their-clients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2654/what-services-do-apac-cros-offer-to-their-clients.html</link>
			<pubDate>Wed, 18 Sep 2013 11:00:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patient-and-investigator-recruitment-clinical-trials-monitoring-project-management-bioanalytical-laboratories-data-intelligence-and-medical-writing-are-some-of-the-services-offered-by-cros-in-apac.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2654/what-services-do-apac-cros-offer-to-their-clients.html</guid>
		</item>	
				<item>
			<title>Japan creates sperm bank for endangered species </title>
			<atom:link href="https://biospectrumasia.com/news/50/7959/japan-creates-sperm-bank-for-endangered-species-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7959/japan-creates-sperm-bank-for-endangered-species-.html</link>
			<pubDate>Wed, 18 Sep 2013 04:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-temperature-used-by-the-scientists-is-much-higher-and-less-energy-intensive-as-compared-to-conventional-ways-of-storing-sperm.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7959/japan-creates-sperm-bank-for-endangered-species-.html</guid>
		</item>	
				<item>
			<title>BSA-CMR Survey: Oncology is the top therapeutic focus area for CROs in APAC</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/3423/bsa-cmr-survey-oncology-is-the-top-therapeutic-focus-area-for-cros-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/3423/bsa-cmr-survey-oncology-is-the-top-therapeutic-focus-area-for-cros-in-apac.html</link>
			<pubDate>Wed, 18 Sep 2013 02:34:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/3423/bsa-cmr-survey-oncology-is-the-top-therapeutic-focus-area-for-cros-in-apac.html</guid>
		</item>	
				<item>
			<title>BSA-CMR Survey: India, China lead in APAC CRO sector</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/3328/bsa-cmr-survey-india-china-lead-in-apac-cro-sector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/3328/bsa-cmr-survey-india-china-lead-in-apac-cro-sector.html</link>
			<pubDate>Wed, 18 Sep 2013 02:27:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/3328/bsa-cmr-survey-india-china-lead-in-apac-cro-sector.html</guid>
		</item>	
				<item>
			<title>BSA-CMR Survey: CROs hopeful despite stifled growth</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5566/bsa-cmr-survey-cros-hopeful-despite-stifled-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5566/bsa-cmr-survey-cros-hopeful-despite-stifled-growth.html</link>
			<pubDate>Wed, 18 Sep 2013 02:14:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5566/bsa-cmr-survey-cros-hopeful-despite-stifled-growth.html</guid>
		</item>	
				<item>
			<title>BSA-CMR Survey: New CRO players emerge in APAC</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2176/bsa-cmr-survey-new-cro-players-emerge-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2176/bsa-cmr-survey-new-cro-players-emerge-in-apac.html</link>
			<pubDate>Wed, 18 Sep 2013 01:59:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2176/bsa-cmr-survey-new-cro-players-emerge-in-apac.html</guid>
		</item>	
				<item>
			<title>Riken launches joint research centers in India</title>
			<atom:link href="https://biospectrumasia.com/news/50/2613/riken-launches-joint-research-centers-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2613/riken-launches-joint-research-centers-in-india.html</link>
			<pubDate>Tue, 17 Sep 2013 17:18:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2613/riken-launches-joint-research-centers-in-india.html</guid>
		</item>	
				<item>
			<title>Celltrion files for Remsima approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3705/celltrion-files-for-remsima-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3705/celltrion-files-for-remsima-approval-in-japan.html</link>
			<pubDate>Tue, 17 Sep 2013 10:27:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3705/celltrion-files-for-remsima-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai expands R&amp;D in Belgium with office in Brussels</title>
			<atom:link href="https://biospectrumasia.com/news/50/5447/eisai-expands-rd-in-belgium-with-office-in-brussels.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5447/eisai-expands-rd-in-belgium-with-office-in-brussels.html</link>
			<pubDate>Mon, 16 Sep 2013 14:35:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-emea-europe-middle-east-africa-russia-and-oceania-opens-office-in-brussels-belgium.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5447/eisai-expands-rd-in-belgium-with-office-in-brussels.html</guid>
		</item>	
				<item>
			<title>AB Sciex proteomics scientist wins prestigious award</title>
			<atom:link href="https://biospectrumasia.com/influencers/50/3421/ab-sciex-proteomics-scientist-wins-prestigious-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/50/3421/ab-sciex-proteomics-scientist-wins-prestigious-award.html</link>
			<pubDate>Tue, 10 Sep 2013 13:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-christie-hunter-director-of-proteomics-applications-of-ab-sciex-received-the-2013-science-and-technology-award-by-human-proteome-organization-hupo.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/50/3421/ab-sciex-proteomics-scientist-wins-prestigious-award.html</guid>
		</item>	
				<item>
			<title>Japanese food giant to buy GSK drinks for $2.35 bn </title>
			<atom:link href="https://biospectrumasia.com/news/50/4390/japanese-food-giant-to-buy-gsk-drinks-for-2-35-bn-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4390/japanese-food-giant-to-buy-gsk-drinks-for-2-35-bn-.html</link>
			<pubDate>Mon, 09 Sep 2013 17:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gsk-to-sell-its-lucozade-and-ribena-food-drinks-for-usd2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4390/japanese-food-giant-to-buy-gsk-drinks-for-2-35-bn-.html</guid>
		</item>	
				<item>
			<title>Japanese biomedical firm sets up lab in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/50/2311/japanese-biomedical-firm-sets-up-lab-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2311/japanese-biomedical-firm-sets-up-lab-in-singapore.html</link>
			<pubDate>Mon, 09 Sep 2013 11:14:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kyowa-hakko-kirin-khk-has-setup-singapore-translational-research-laboratory-strl-an-international-r-d-center-in-singapore-for-biomedical-sciences.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2311/japanese-biomedical-firm-sets-up-lab-in-singapore.html</guid>
		</item>	
				<item>
			<title>Otsuka to acquire Astex for $866 mn in cash</title>
			<atom:link href="https://biospectrumasia.com/news/50/3306/otsuka-to-acquire-astex-for-866-mn-in-cash.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3306/otsuka-to-acquire-astex-for-866-mn-in-cash.html</link>
			<pubDate>Fri, 06 Sep 2013 09:05:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-acquisition-of-astex-adds-to-otsuka-s-existing-discovery-capabilities-and-pipeline-of-therapeutic-products-for-neuroscience-cardiovascular-and-oncology-indications.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3306/otsuka-to-acquire-astex-for-866-mn-in-cash.html</guid>
		</item>	
				<item>
			<title>Eisai&#039;s Halaven now available in Spain </title>
			<atom:link href="https://biospectrumasia.com/news/50/2871/eisais-halaven-now-available-in-spain-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2871/eisais-halaven-now-available-in-spain-.html</link>
			<pubDate>Thu, 05 Sep 2013 12:15:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/breast-cancer-ribbon.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2871/eisais-halaven-now-available-in-spain-.html</guid>
		</item>	
				<item>
			<title>US FDA&#039;s Priority Review Status for Takeda&#039;s IND</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2823/us-fdas-priority-review-status-for-takedas-ind.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2823/us-fdas-priority-review-status-for-takedas-ind.html</link>
			<pubDate>Thu, 05 Sep 2013 11:09:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-us-fda-approved-glaxosmithkline-gsk-flulaval-quadrivalent-influenza-virus-vaccine-for-the-active-immunization-of-persons-three-years-of-age-and-older.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2823/us-fdas-priority-review-status-for-takedas-ind.html</guid>
		</item>	
				<item>
			<title>Sale of wound care devices spurs in Asia-Pacific: Frost &amp; Sullivan analysis report</title>
			<atom:link href="https://biospectrumasia.com/news/50/7270/sale-of-wound-care-devices-spurs-in-asia-pacific-frost-sullivan-analysis-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7270/sale-of-wound-care-devices-spurs-in-asia-pacific-frost-sullivan-analysis-report.html</link>
			<pubDate>Wed, 04 Sep 2013 10:50:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wound-care.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7270/sale-of-wound-care-devices-spurs-in-asia-pacific-frost-sullivan-analysis-report.html</guid>
		</item>	
				<item>
			<title>Japan to develop vaccine for H7N9 bird flu</title>
			<atom:link href="https://biospectrumasia.com/news/50/2149/japan-to-develop-vaccine-for-h7n9-bird-flu.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2149/japan-to-develop-vaccine-for-h7n9-bird-flu.html</link>
			<pubDate>Tue, 03 Sep 2013 12:12:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicago-reports-positive-interim-results-from-a-preclinical-trial-for-an-h7n9-avian-influenza-vlp-vaccine-candidate-h7-vaccine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2149/japan-to-develop-vaccine-for-h7n9-bird-flu.html</guid>
		</item>	
				<item>
			<title>Eisai gets WHO prequalification, will donate 2.2 bn doses</title>
			<atom:link href="https://biospectrumasia.com/news/50/2744/eisai-gets-who-prequalification-will-donate-2-2-bn-doses.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2744/eisai-gets-who-prequalification-will-donate-2-2-bn-doses.html</link>
			<pubDate>Tue, 03 Sep 2013 11:57:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-s-100-mg-tablet-of-diethylcarbamazine-dec-for-treatment-of-elephantiasis-gets-who-prequalification.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2744/eisai-gets-who-prequalification-will-donate-2-2-bn-doses.html</guid>
		</item>	
				<item>
			<title>Astellas, Merck enter co-promotion deal in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1001/astellas-merck-enter-co-promotion-deal-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1001/astellas-merck-enter-co-promotion-deal-in-japan.html</link>
			<pubDate>Tue, 03 Sep 2013 11:12:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-diabetes-patients-mitsubishi-tanabe-pharma-seeks-approval-of-ta-7284-canagliflozin-a-sodium-glucose-co-transporter-2-sglt2-inhibitor-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1001/astellas-merck-enter-co-promotion-deal-in-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi&#039;s thrombosis drug meets primary endpoint </title>
			<atom:link href="https://biospectrumasia.com/news/50/6558/daiichis-thrombosis-drug-meets-primary-endpoint-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6558/daiichis-thrombosis-drug-meets-primary-endpoint-.html</link>
			<pubDate>Mon, 02 Sep 2013 13:17:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-phase-iii-clinical-trial-of-once-daily-edoxaban-for-the-treatment-of-acute-symptomatic-deep-vein-thrombosis-dvt-and-pulmonary-embolism-pe-met-its-primary-efficacy-endpoint.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6558/daiichis-thrombosis-drug-meets-primary-endpoint-.html</guid>
		</item>	
				<item>
			<title>FranÃƒÂ§ois-Xavier Roge is Takeda&#039;s new CFO</title>
			<atom:link href="https://biospectrumasia.com/influencers/50/1416/franois-xavier-roge-is-takedas-new-cfo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/50/1416/franois-xavier-roge-is-takedas-new-cfo.html</link>
			<pubDate>Wed, 28 Aug 2013 12:32:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-fran-ois-xavier-roger-the-chief-financial-officer-cfo-of-takeda-pharmaceutical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/50/1416/franois-xavier-roge-is-takedas-new-cfo.html</guid>
		</item>	
				<item>
			<title>US firm files antibody patent in Japan, Korea </title>
			<atom:link href="https://biospectrumasia.com/news/50/5350/us-firm-files-antibody-patent-in-japan-korea-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5350/us-firm-files-antibody-patent-in-japan-korea-.html</link>
			<pubDate>Tue, 27 Aug 2013 10:43:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mmr-global-files-divisional-application-for-its-antibody-technology-in-japan-and-south-korea.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5350/us-firm-files-antibody-patent-in-japan-korea-.html</guid>
		</item>	
				<item>
			<title>Amgen to acquire Onyx for $10 bn cash </title>
			<atom:link href="https://biospectrumasia.com/news/50/699/amgen-to-acquire-onyx-for-10-bn-cash-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/699/amgen-to-acquire-onyx-for-10-bn-cash-.html</link>
			<pubDate>Mon, 26 Aug 2013 11:45:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amgen-plans-to-acquire-all-the-outstanding-shares-of-onyx-pharmaceuticals-for-usd125-per-share.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/699/amgen-to-acquire-onyx-for-10-bn-cash-.html</guid>
		</item>	
				<item>
			<title>BabyLance safety heelstick receives EU patent</title>
			<atom:link href="https://biospectrumasia.com/news/50/2556/babylance-safety-heelstick-receives-eu-patent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2556/babylance-safety-heelstick-receives-eu-patent.html</link>
			<pubDate>Mon, 26 Aug 2013 10:30:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/26aug-babylance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2556/babylance-safety-heelstick-receives-eu-patent.html</guid>
		</item>	
				<item>
			<title>Japan approves reimbursement for Edwards&#039; Sapien XT valve</title>
			<atom:link href="https://biospectrumasia.com/news/50/1027/japan-approves-reimbursement-for-edwards-sapien-xt-valve.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1027/japan-approves-reimbursement-for-edwards-sapien-xt-valve.html</link>
			<pubDate>Thu, 22 Aug 2013 09:45:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/22aug-edwards-japan.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1027/japan-approves-reimbursement-for-edwards-sapien-xt-valve.html</guid>
		</item>	
				<item>
			<title>Bayer gets Japan&#039;s nod for gastro tumor drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/1677/bayer-gets-japans-nod-for-gastro-tumor-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/1677/bayer-gets-japans-nod-for-gastro-tumor-drug.html</link>
			<pubDate>Thu, 22 Aug 2013 09:35:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bayer-gets-japan-s-nod-for-gastro-tumor-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/1677/bayer-gets-japans-nod-for-gastro-tumor-drug.html</guid>
		</item>	
				<item>
			<title>Boston Scientific completes enrollment in SuperNOVA trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/7787/boston-scientific-completes-enrollment-in-supernova-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7787/boston-scientific-completes-enrollment-in-supernova-trial.html</link>
			<pubDate>Wed, 21 Aug 2013 10:32:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21aug-supernova-stent.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7787/boston-scientific-completes-enrollment-in-supernova-trial.html</guid>
		</item>	
				<item>
			<title>Multiple sclerosis market to peak at $18.3 bn in 2018</title>
			<atom:link href="https://biospectrumasia.com/news/50/8303/multiple-sclerosis-market-to-peak-at-18-3-bn-in-2018.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8303/multiple-sclerosis-market-to-peak-at-18-3-bn-in-2018.html</link>
			<pubDate>Tue, 20 Aug 2013 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/heartbeat-recorded-substantial-growth-in-china-in-its-user-base-for-its-stakeholder-management-software-data-analytics-solutions-and-stakeholder-data-offering.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8303/multiple-sclerosis-market-to-peak-at-18-3-bn-in-2018.html</guid>
		</item>	
				<item>
			<title>GE Healthcare, Osaka University join hands</title>
			<atom:link href="https://biospectrumasia.com/news/50/2462/ge-healthcare-osaka-university-join-hands.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2462/ge-healthcare-osaka-university-join-hands.html</link>
			<pubDate>Tue, 20 Aug 2013 10:42:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/osaka-university-students-will-have-access-to-ge-healthcare-s-expertise-in-training-and-technologies-for-biopharmaceutical-research-and-manufacturing.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2462/ge-healthcare-osaka-university-join-hands.html</guid>
		</item>	
				<item>
			<title>Vifor and Zeria sign deal for Ferinject in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/932/vifor-and-zeria-sign-deal-for-ferinject-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/932/vifor-and-zeria-sign-deal-for-ferinject-in-japan.html</link>
			<pubDate>Mon, 19 Aug 2013 10:41:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/blood-disease.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/932/vifor-and-zeria-sign-deal-for-ferinject-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai website to help its staff manage obesity </title>
			<atom:link href="https://biospectrumasia.com/news/50/6355/eisai-website-to-help-its-staff-manage-obesity-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6355/eisai-website-to-help-its-staff-manage-obesity-.html</link>
			<pubDate>Fri, 16 Aug 2013 10:44:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/caring-for-its-staff-eisai-s-launches-new-website-to-provide-its-staff-with-educational-resources-for-obesity-management.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6355/eisai-website-to-help-its-staff-manage-obesity-.html</guid>
		</item>	
				<item>
			<title>Exlites launches e-commerce website with core products</title>
			<atom:link href="https://biospectrumasia.com/news/50/6299/exlites-launches-e-commerce-website-with-core-products.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6299/exlites-launches-e-commerce-website-with-core-products.html</link>
			<pubDate>Wed, 14 Aug 2013 13:05:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/australian-clinical-trials-website-launched-to-boost-patient-recruitment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6299/exlites-launches-e-commerce-website-with-core-products.html</guid>
		</item>	
				<item>
			<title>Mizuho to distribute Precision Spine products in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/4125/mizuho-to-distribute-precision-spine-products-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4125/mizuho-to-distribute-precision-spine-products-in-japan.html</link>
			<pubDate>Wed, 14 Aug 2013 12:42:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/many-patients-choose-conventional-minimally-invasive-spine-surgery-because-they-know-the-outcomes-are-predictable1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4125/mizuho-to-distribute-precision-spine-products-in-japan.html</guid>
		</item>	
				<item>
			<title>Exlites eyes more medtech deals from China, Taiwan, Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3221/exlites-eyes-more-medtech-deals-from-china-taiwan-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3221/exlites-eyes-more-medtech-deals-from-china-taiwan-japan.html</link>
			<pubDate>Tue, 13 Aug 2013 12:15:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/singapore-based-trireme-medical-expands-its-presence-in-china-with-the-help-of-distributor-weihai-weigao-medical-devices.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3221/exlites-eyes-more-medtech-deals-from-china-taiwan-japan.html</guid>
		</item>	
				<item>
			<title>Cook gives Zilver PTX to doctors in US, EU, Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5118/cook-gives-zilver-ptx-to-doctors-in-us-eu-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5118/cook-gives-zilver-ptx-to-doctors-in-us-eu-japan.html</link>
			<pubDate>Tue, 13 Aug 2013 11:30:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/13aug-zilver-ptx.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5118/cook-gives-zilver-ptx-to-doctors-in-us-eu-japan.html</guid>
		</item>	
				<item>
			<title>Takeda, Dainippon to market schizophrenia drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/3269/takeda-dainippon-to-market-schizophrenia-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3269/takeda-dainippon-to-market-schizophrenia-drug-.html</link>
			<pubDate>Tue, 13 Aug 2013 11:25:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-schizophrenia-patients-dainippon-sumitomo-pharma-and-takeda-pharmaceutical-get-approval-for-marketing-authorization-by-swissmedic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3269/takeda-dainippon-to-market-schizophrenia-drug-.html</guid>
		</item>	
				<item>
			<title>Cardica&#039;s stapling cartridge seeks Japanese nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/5521/cardicas-stapling-cartridge-seeks-japanese-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/5521/cardicas-stapling-cartridge-seeks-japanese-nod.html</link>
			<pubDate>Tue, 13 Aug 2013 09:01:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/a-live-and-archived-webcast-of-the-conference-call-will-be-available-through-the-company-s-investor-relations-website.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/5521/cardicas-stapling-cartridge-seeks-japanese-nod.html</guid>
		</item>	
				<item>
			<title>Medical device packaging demand to exceed $25.7 billion in 2017</title>
			<atom:link href="https://biospectrumasia.com/news/50/4159/medical-device-packaging-demand-to-exceed-25-7-billion-in-2017.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4159/medical-device-packaging-demand-to-exceed-25-7-billion-in-2017.html</link>
			<pubDate>Mon, 12 Aug 2013 14:20:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/heartbeat-recorded-substantial-growth-in-china-in-its-user-base-for-its-stakeholder-management-software-data-analytics-solutions-and-stakeholder-data-offering.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4159/medical-device-packaging-demand-to-exceed-25-7-billion-in-2017.html</guid>
		</item>	
				<item>
			<title>Hong Kong to host international TCM exhibition, conference</title>
			<atom:link href="https://biospectrumasia.com/news/50/6592/hong-kong-to-host-international-tcm-exhibition-conference.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6592/hong-kong-to-host-international-tcm-exhibition-conference.html</link>
			<pubDate>Mon, 12 Aug 2013 10:43:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biotec-nstda-took-part-in-an-exhibition-of-kelantan-international-bio-carnival-conference-and-exhibition-2013-bio-k-on-february-28-march-2-2013-in-kelantan-malaysia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6592/hong-kong-to-host-international-tcm-exhibition-conference.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Tanabe Pharma to build new plant in China</title>
			<atom:link href="https://biospectrumasia.com/news/50/3691/japans-tanabe-pharma-to-build-new-plant-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3691/japans-tanabe-pharma-to-build-new-plant-in-china.html</link>
			<pubDate>Thu, 08 Aug 2013 16:51:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-philanthropist-mr-ehsanollah-bayat-builds-h-bayat-has-inaugurated-a-new-pediatric-intensive-care-unit-for-kids-in-afghanistan.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3691/japans-tanabe-pharma-to-build-new-plant-in-china.html</guid>
		</item>	
				<item>
			<title>Japanese HAL robotic suit certified in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/50/6039/japanese-hal-robotic-suit-certified-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6039/japanese-hal-robotic-suit-certified-in-europe.html</link>
			<pubDate>Thu, 08 Aug 2013 14:43:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cyberdyne-hal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6039/japanese-hal-robotic-suit-certified-in-europe.html</guid>
		</item>	
				<item>
			<title>URMC launches new heart device trial in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/6547/urmc-launches-new-heart-device-trial-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6547/urmc-launches-new-heart-device-trial-in-asia.html</link>
			<pubDate>Wed, 07 Aug 2013 08:41:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/study-shows-that-non-steroidal-anti-inflammatory-drugs-nsaids-and-painkillers-like-ibuprofen-diclofenac-and-coxibs-may-cause-severe-heart-problems.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6547/urmc-launches-new-heart-device-trial-in-asia.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo extends Medidata Clinical Cloud use to China</title>
			<atom:link href="https://biospectrumasia.com/news/50/3886/daiichi-sankyo-extends-medidata-clinical-cloud-use-to-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3886/daiichi-sankyo-extends-medidata-clinical-cloud-use-to-china.html</link>
			<pubDate>Wed, 07 Aug 2013 08:18:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3886/daiichi-sankyo-extends-medidata-clinical-cloud-use-to-china.html</guid>
		</item>	
				<item>
			<title>Recent 6 &#039;Big Pharma&#039; frauds</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/6598/recent-6-big-pharma-frauds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/6598/recent-6-big-pharma-frauds.html</link>
			<pubDate>Tue, 06 Aug 2013 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/big-pharma-under-scanner.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/6598/recent-6-big-pharma-frauds.html</guid>
		</item>	
				<item>
			<title>Takeda diabetes drug gets China&#039;s import license</title>
			<atom:link href="https://biospectrumasia.com/news/50/1098/takeda-diabetes-drug-gets-chinas-import-license.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1098/takeda-diabetes-drug-gets-chinas-import-license.html</link>
			<pubDate>Tue, 06 Aug 2013 13:22:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lyxumia-gets-japanese-nod-for-diabetes-therapy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1098/takeda-diabetes-drug-gets-chinas-import-license.html</guid>
		</item>	
				<item>
			<title>Japan to consider new legislation to regulate clinical studies</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2390/japan-to-consider-new-legislation-to-regulate-clinical-studies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2390/japan-to-consider-new-legislation-to-regulate-clinical-studies.html</link>
			<pubDate>Tue, 06 Aug 2013 12:51:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/parties-agree-to-dismiss-all-claims-and-counterclaims-in-two-lawsuits-brought-by-illumina.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2390/japan-to-consider-new-legislation-to-regulate-clinical-studies.html</guid>
		</item>	
				<item>
			<title>Novel oral RA treatment Xeljanz launched in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3264/novel-oral-ra-treatment-xeljanz-launched-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3264/novel-oral-ra-treatment-xeljanz-launched-in-japan.html</link>
			<pubDate>Tue, 06 Aug 2013 11:58:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/06aug-novel-oral-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3264/novel-oral-ra-treatment-xeljanz-launched-in-japan.html</guid>
		</item>	
				<item>
			<title>FDA not in favour of Otsuka&#039;s kidney drug Tolvaptan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6168/fda-not-in-favour-of-otsukas-kidney-drug-tolvaptan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6168/fda-not-in-favour-of-otsukas-kidney-drug-tolvaptan.html</link>
			<pubDate>Tue, 06 Aug 2013 07:57:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-not-in-favour-of-otsuka-s-kidney-drug-tolvaptan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6168/fda-not-in-favour-of-otsukas-kidney-drug-tolvaptan.html</guid>
		</item>	
				<item>
			<title>Pic Gallery - 7th in-Pharma Japan and 26th Interphex Japan</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/481/pic-gallery-7th-in-pharma-japan-and-26th-interphex-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/481/pic-gallery-7th-in-pharma-japan-and-26th-interphex-japan.html</link>
			<pubDate>Mon, 05 Aug 2013 14:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/481/pic-gallery-7th-in-pharma-japan-and-26th-interphex-japan.html</guid>
		</item>	
				<item>
			<title>Free software creates largest neural simulation</title>
			<atom:link href="https://biospectrumasia.com/news/50/1881/free-software-creates-largest-neural-simulation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1881/free-software-creates-largest-neural-simulation.html</link>
			<pubDate>Mon, 05 Aug 2013 10:26:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/05aug-riken-computer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1881/free-software-creates-largest-neural-simulation.html</guid>
		</item>	
				<item>
			<title>NovoTTF Therapy treats first recurrent glioblastoma patient in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6385/novottf-therapy-treats-first-recurrent-glioblastoma-patient-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6385/novottf-therapy-treats-first-recurrent-glioblastoma-patient-in-japan.html</link>
			<pubDate>Fri, 02 Aug 2013 11:21:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/02aug-novocure.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6385/novottf-therapy-treats-first-recurrent-glioblastoma-patient-in-japan.html</guid>
		</item>	
				<item>
			<title>Otsuka launches English website for global viewers</title>
			<atom:link href="https://biospectrumasia.com/news/50/1101/otsuka-launches-english-website-for-global-viewers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1101/otsuka-launches-english-website-for-global-viewers.html</link>
			<pubDate>Fri, 02 Aug 2013 08:30:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/otsuka-launched-a-newly-designed-english-corporate-website.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1101/otsuka-launches-english-website-for-global-viewers.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s diabetes drug gets Chinese FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/931/takedas-diabetes-drug-gets-chinese-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/931/takedas-diabetes-drug-gets-chinese-fda-nod.html</link>
			<pubDate>Thu, 01 Aug 2013 11:45:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diabetes-innovators-can-win-usd75-000-at-boehringer-ingelheim-funded-healthcare-innovation-world-cup.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/931/takedas-diabetes-drug-gets-chinese-fda-nod.html</guid>
		</item>	
				<item>
			<title>Riken launches iPS cell therapy pilot study</title>
			<atom:link href="https://biospectrumasia.com/news/50/6579/riken-launches-ips-cell-therapy-pilot-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6579/riken-launches-ips-cell-therapy-pilot-study.html</link>
			<pubDate>Thu, 01 Aug 2013 10:06:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/01aug-riken.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6579/riken-launches-ips-cell-therapy-pilot-study.html</guid>
		</item>	
				<item>
			<title>Zecotek receives $500,000 order from Hamamatsu</title>
			<atom:link href="https://biospectrumasia.com/news/50/5715/zecotek-receives-500000-order-from-hamamatsu.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5715/zecotek-receives-500000-order-from-hamamatsu.html</link>
			<pubDate>Thu, 01 Aug 2013 09:51:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/01aug-zecotek-scintillation-crystals.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5715/zecotek-receives-500000-order-from-hamamatsu.html</guid>
		</item>	
				<item>
			<title>Astellas, FibroGen start CKD anemia trial in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/7359/astellas-fibrogen-start-ckd-anemia-trial-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7359/astellas-fibrogen-start-ckd-anemia-trial-in-japan-.html</link>
			<pubDate>Wed, 31 Jul 2013 13:28:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-anemic-patients-with-chronic-kidney-disease-ckd-astellas-pharma-and-fibrogen-initiate-phase-ii-clinical-study-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7359/astellas-fibrogen-start-ckd-anemia-trial-in-japan-.html</guid>
		</item>	
				<item>
			<title>Another Japanese university finds data manipulation for Novartis drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/1194/another-japanese-university-finds-data-manipulation-for-novartis-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1194/another-japanese-university-finds-data-manipulation-for-novartis-drug.html</link>
			<pubDate>Wed, 31 Jul 2013 11:48:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1194/another-japanese-university-finds-data-manipulation-for-novartis-drug.html</guid>
		</item>	
				<item>
			<title>Novartis finds no evidence of wrongdoing in clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/4442/novartis-finds-no-evidence-of-wrongdoing-in-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4442/novartis-finds-no-evidence-of-wrongdoing-in-clinical-trials.html</link>
			<pubDate>Wed, 31 Jul 2013 10:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-service.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4442/novartis-finds-no-evidence-of-wrongdoing-in-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Lonza, BioWa sign research agreements with Pfizer</title>
			<atom:link href="https://biospectrumasia.com/news/50/2673/lonza-biowa-sign-research-agreements-with-pfizer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2673/lonza-biowa-sign-research-agreements-with-pfizer.html</link>
			<pubDate>Wed, 31 Jul 2013 09:55:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cap-s-laboratory-accreditation-surveys-pt-programs-and-other-quality-management-resources-combined-with-bd-s-in-depth-clinical-knowledge-of-preanalytical-systems-will-provide-a-comprehensive-expert-base.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2673/lonza-biowa-sign-research-agreements-with-pfizer.html</guid>
		</item>	
				<item>
			<title>BioSpectrum Asia launches 5th CRO survey</title>
			<atom:link href="https://biospectrumasia.com/news/50/2342/biospectrum-asia-launches-5th-cro-survey.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2342/biospectrum-asia-launches-5th-cro-survey.html</link>
			<pubDate>Tue, 30 Jul 2013 19:02:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum-asia-bsa-5th-annual-cro-survey.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2342/biospectrum-asia-launches-5th-cro-survey.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo expands drug discovery program </title>
			<atom:link href="https://biospectrumasia.com/news/50/1312/daiichi-sankyo-expands-drug-discovery-program-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1312/daiichi-sankyo-expands-drug-discovery-program-.html</link>
			<pubDate>Tue, 30 Jul 2013 11:51:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-clinical-trials.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1312/daiichi-sankyo-expands-drug-discovery-program-.html</guid>
		</item>	
				<item>
			<title>INC Research opens two new offices in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1999/inc-research-opens-two-new-offices-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1999/inc-research-opens-two-new-offices-in-japan.html</link>
			<pubDate>Tue, 30 Jul 2013 10:30:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-research-diabetes.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1999/inc-research-opens-two-new-offices-in-japan.html</guid>
		</item>	
				<item>
			<title>Mylan signs a settlement agreement with OSI Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/7277/mylan-signs-a-settlement-agreement-with-osi-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7277/mylan-signs-a-settlement-agreement-with-osi-pharma.html</link>
			<pubDate>Thu, 25 Jul 2013 15:48:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dna-logix-and-co-diagnostics-form-joint-venture-named-co-diagnostics-hbdc-to-sell-testing-products-and-services-to-middle-and-low-income-countries.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7277/mylan-signs-a-settlement-agreement-with-osi-pharma.html</guid>
		</item>	
				<item>
			<title>Japan team develops feather-light sensors</title>
			<atom:link href="https://biospectrumasia.com/news/50/3405/japan-team-develops-feather-light-sensors.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3405/japan-team-develops-feather-light-sensors.html</link>
			<pubDate>Thu, 25 Jul 2013 10:22:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sensors-university-of-tokyo.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3405/japan-team-develops-feather-light-sensors.html</guid>
		</item>	
				<item>
			<title>Mantra of Interphex Japan &amp; in-Pharma Japan: Lets innovate and focus on emerging markets </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/8197/mantra-of-interphex-japan-in-pharma-japan-lets-innovate-and-focus-on-emerging-markets-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/8197/mantra-of-interphex-japan-in-pharma-japan-lets-innovate-and-focus-on-emerging-markets-.html</link>
			<pubDate>Wed, 24 Jul 2013 08:49:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/close-to-33-000-individuals-and-970-exhibitors-participated-in-the-7th-in-pharma-japan-and-26th-interphex-japan-which-were-concurrently-held-from-july-10-12-2013-at-tokyo-big-sight-japan.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/8197/mantra-of-interphex-japan-in-pharma-japan-lets-innovate-and-focus-on-emerging-markets-.html</guid>
		</item>	
				<item>
			<title>Fujikura to license Cellmid&#039;s cancer antibody</title>
			<atom:link href="https://biospectrumasia.com/news/50/2472/fujikura-to-license-cellmids-cancer-antibody.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2472/fujikura-to-license-cellmids-cancer-antibody.html</link>
			<pubDate>Tue, 23 Jul 2013 12:30:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fujikura-to-use-cellmid-s-proprietary-antibodies-for-latex-based-tests.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2472/fujikura-to-license-cellmids-cancer-antibody.html</guid>
		</item>	
				<item>
			<title>Response Genetics renews deal with Taiho Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/4257/response-genetics-renews-deal-with-taiho-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4257/response-genetics-renews-deal-with-taiho-pharma.html</link>
			<pubDate>Tue, 23 Jul 2013 10:21:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medigene-syncore-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4257/response-genetics-renews-deal-with-taiho-pharma.html</guid>
		</item>	
				<item>
			<title>Astellas gets FDA nod for kidney transplant drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/360/astellas-gets-fda-nod-for-kidney-transplant-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/360/astellas-gets-fda-nod-for-kidney-transplant-drug.html</link>
			<pubDate>Mon, 22 Jul 2013 10:28:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-gets-fda-nod-for-kidney-transplant-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/360/astellas-gets-fda-nod-for-kidney-transplant-drug.html</guid>
		</item>	
				<item>
			<title>Fujitsu brings medical data to smartphones, iPad</title>
			<atom:link href="https://biospectrumasia.com/news/50/1441/fujitsu-brings-medical-data-to-smartphones-ipad.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1441/fujitsu-brings-medical-data-to-smartphones-ipad.html</link>
			<pubDate>Mon, 22 Jul 2013 10:01:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/global-mobile-health-market-to-grow-at-a-cagr-of-40.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1441/fujitsu-brings-medical-data-to-smartphones-ipad.html</guid>
		</item>	
				<item>
			<title>Medical laser market to reach $8.8 bn by 2018: GIA</title>
			<atom:link href="https://biospectrumasia.com/news/50/2019/medical-laser-market-to-reach-8-8-bn-by-2018-gia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2019/medical-laser-market-to-reach-8-8-bn-by-2018-gia.html</link>
			<pubDate>Fri, 19 Jul 2013 10:05:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novozymes-reports-five-percent-sales-growth-in-q1-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2019/medical-laser-market-to-reach-8-8-bn-by-2018-gia.html</guid>
		</item>	
				<item>
			<title>Given Imaging&#039;s Colon PillCam cleared in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2413/given-imagings-colon-pillcam-cleared-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2413/given-imagings-colon-pillcam-cleared-in-japan.html</link>
			<pubDate>Thu, 18 Jul 2013 11:27:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pillcamcolonimage.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2413/given-imagings-colon-pillcam-cleared-in-japan.html</guid>
		</item>	
				<item>
			<title>Challenges that Japan pharma will face in 2014 </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/1450/challenges-that-japan-pharma-will-face-in-2014-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/1450/challenges-that-japan-pharma-will-face-in-2014-.html</link>
			<pubDate>Thu, 18 Jul 2013 07:09:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/is-the-japanese-pharma-sector-going-to-face-substantial-hurdles-in-2014.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/1450/challenges-that-japan-pharma-will-face-in-2014-.html</guid>
		</item>	
				<item>
			<title>Fuji subsidiary AstaReal to build $30 mn plant in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5473/fuji-subsidiary-astareal-to-build-30-mn-plant-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5473/fuji-subsidiary-astareal-to-build-30-mn-plant-in-japan.html</link>
			<pubDate>Wed, 17 Jul 2013 14:24:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-based-avantor-performance-materials-set-up-current-good-manufacturing-practices-cgmp-production-facility-in-panoli-gujarat-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5473/fuji-subsidiary-astareal-to-build-30-mn-plant-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan to help export regenerative medicine tech to Qatar, KSA</title>
			<atom:link href="https://biospectrumasia.com/news/50/4211/japan-to-help-export-regenerative-medicine-tech-to-qatar-ksa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4211/japan-to-help-export-regenerative-medicine-tech-to-qatar-ksa.html</link>
			<pubDate>Wed, 17 Jul 2013 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/are-regulatory-bodies-purposely-delaying-approvals-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4211/japan-to-help-export-regenerative-medicine-tech-to-qatar-ksa.html</guid>
		</item>	
				<item>
			<title>Fujifilm opens new lens factory in Philippines</title>
			<atom:link href="https://biospectrumasia.com/news/50/2968/fujifilm-opens-new-lens-factory-in-philippines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2968/fujifilm-opens-new-lens-factory-in-philippines.html</link>
			<pubDate>Wed, 17 Jul 2013 11:35:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fujifilm-lens-factory.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2968/fujifilm-opens-new-lens-factory-in-philippines.html</guid>
		</item>	
				<item>
			<title>Zecotek and Hamamatsu Photonics join hands</title>
			<atom:link href="https://biospectrumasia.com/news/50/1288/zecotek-and-hamamatsu-photonics-join-hands.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1288/zecotek-and-hamamatsu-photonics-join-hands.html</link>
			<pubDate>Wed, 17 Jul 2013 11:02:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1288/zecotek-and-hamamatsu-photonics-join-hands.html</guid>
		</item>	
				<item>
			<title>Mitsubishi to acquire Medicago at $1.16 per share</title>
			<atom:link href="https://biospectrumasia.com/news/50/297/mitsubishi-to-acquire-medicago-at-1-16-per-share.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/297/mitsubishi-to-acquire-medicago-at-1-16-per-share.html</link>
			<pubDate>Wed, 17 Jul 2013 10:34:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mitsubishi-tanabe-pharma-to-acquire-medicago.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/297/mitsubishi-to-acquire-medicago-at-1-16-per-share.html</guid>
		</item>	
				<item>
			<title>MSD Japan head: Regulatory bodies are purposely delaying approvals</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/6508/msd-japan-head-regulatory-bodies-are-purposely-delaying-approvals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/6508/msd-japan-head-regulatory-bodies-are-purposely-delaying-approvals.html</link>
			<pubDate>Wed, 17 Jul 2013 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/are-regulatory-bodies-purposely-delaying-approvals-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/6508/msd-japan-head-regulatory-bodies-are-purposely-delaying-approvals.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Eisai to start Down&#039;s syndrome therapy test</title>
			<atom:link href="https://biospectrumasia.com/news/50/3816/japans-eisai-to-start-downs-syndrome-therapy-test.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3816/japans-eisai-to-start-downs-syndrome-therapy-test.html</link>
			<pubDate>Tue, 16 Jul 2013 18:14:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aricept.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3816/japans-eisai-to-start-downs-syndrome-therapy-test.html</guid>
		</item>	
				<item>
			<title>GSK, Theravance withdraw COPD drug from Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5605/gsk-theravance-withdraw-copd-drug-from-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5605/gsk-theravance-withdraw-copd-drug-from-japan.html</link>
			<pubDate>Tue, 16 Jul 2013 18:09:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/copd.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5605/gsk-theravance-withdraw-copd-drug-from-japan.html</guid>
		</item>	
				<item>
			<title>Japan to take action on Novartis&#039; fabricated data</title>
			<atom:link href="https://biospectrumasia.com/news/50/4460/japan-to-take-action-on-novartis-fabricated-data.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4460/japan-to-take-action-on-novartis-fabricated-data.html</link>
			<pubDate>Mon, 15 Jul 2013 15:37:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kyoto-prefectural-university-of-medicine-in-japan-novartis-blood-pressure-drug-valsartan-is-not-effective-in-controlling-high-blood-pressure.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4460/japan-to-take-action-on-novartis-fabricated-data.html</guid>
		</item>	
				<item>
			<title>Tech drive demand for 3D medical imaging</title>
			<atom:link href="https://biospectrumasia.com/news/50/5582/tech-drive-demand-for-3d-medical-imaging.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5582/tech-drive-demand-for-3d-medical-imaging.html</link>
			<pubDate>Fri, 12 Jul 2013 11:47:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mri-machine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5582/tech-drive-demand-for-3d-medical-imaging.html</guid>
		</item>	
				<item>
			<title>Singapore, Japan to develop eye disease detection technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/1528/singapore-japan-to-develop-eye-disease-detection-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1528/singapore-japan-to-develop-eye-disease-detection-technology.html</link>
			<pubDate>Fri, 12 Jul 2013 10:41:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/singapore-eye-hospital-bayer-raise-amd-awareness.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1528/singapore-japan-to-develop-eye-disease-detection-technology.html</guid>
		</item>	
				<item>
			<title>Japan pharma to grow at 2% CAGR from 2013-20</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/1066/japan-pharma-to-grow-at-2-cagr-from-2013-20.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/1066/japan-pharma-to-grow-at-2-cagr-from-2013-20.html</link>
			<pubDate>Thu, 11 Jul 2013 13:59:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jordan-s-pharma-market-witnessed-a-20-percent-growth-in-2012.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/1066/japan-pharma-to-grow-at-2-cagr-from-2013-20.html</guid>
		</item>	
				<item>
			<title>US FDA issues API bulk &amp; tapped density guidance</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3139/us-fda-issues-api-bulk-tapped-density-guidance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3139/us-fda-issues-api-bulk-tapped-density-guidance.html</link>
			<pubDate>Thu, 11 Jul 2013 13:51:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/orexo-received-us-fda-approval-for-opoid-zubsolv-buprenorphinenaloxone-sublingual-tablet.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3139/us-fda-issues-api-bulk-tapped-density-guidance.html</guid>
		</item>	
				<item>
			<title>Interphex Japan: Japan pharma eyes China, India</title>
			<atom:link href="https://biospectrumasia.com/news/50/1943/interphex-japan-japan-pharma-eyes-china-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1943/interphex-japan-japan-pharma-eyes-china-india.html</link>
			<pubDate>Wed, 10 Jul 2013 13:19:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image-1.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1943/interphex-japan-japan-pharma-eyes-china-india.html</guid>
		</item>	
				<item>
			<title>Consumers are winners in the BRCA gene case</title>
			<atom:link href="https://biospectrumasia.com/news/50/1744/consumers-are-winners-in-the-brca-gene-case.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1744/consumers-are-winners-in-the-brca-gene-case.html</link>
			<pubDate>Tue, 09 Jul 2013 16:36:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/frost-and-sullivan-life-sciences-industry-analysts-left-mr-justin-collishaw-and-ms-christi-bird.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1744/consumers-are-winners-in-the-brca-gene-case.html</guid>
		</item>	
				<item>
			<title>Biochips market to be worth $11.4 bn by 2018</title>
			<atom:link href="https://biospectrumasia.com/news/50/6468/biochips-market-to-be-worth-11-4-bn-by-2018.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6468/biochips-market-to-be-worth-11-4-bn-by-2018.html</link>
			<pubDate>Tue, 09 Jul 2013 13:33:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/all-domains-of-agilent-s-business-witnesses-considerable-growth-during-q1-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6468/biochips-market-to-be-worth-11-4-bn-by-2018.html</guid>
		</item>	
				<item>
			<title>Takeda close to releasing Norovirus vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/7958/takeda-close-to-releasing-norovirus-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7958/takeda-close-to-releasing-norovirus-vaccine.html</link>
			<pubDate>Mon, 08 Jul 2013 16:10:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/if-approved-takeda-s-norovirus-vaccine-would-be-the-first-to-protect-people-against-the-vomiting-germ.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7958/takeda-close-to-releasing-norovirus-vaccine.html</guid>
		</item>	
				<item>
			<title>FIPB clears seven pharma proposals, defers three</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3053/fipb-clears-seven-pharma-proposals-defers-three.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3053/fipb-clears-seven-pharma-proposals-defers-three.html</link>
			<pubDate>Mon, 08 Jul 2013 15:59:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/moleac-s-neuroaid-develops-stroke-treatment-based-on-traditional-chinese-medicine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3053/fipb-clears-seven-pharma-proposals-defers-three.html</guid>
		</item>	
				<item>
			<title>Japan approves world&#039;s first transdermal ÃƒÅ¸1-blocker patch</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2048/japan-approves-worlds-first-transdermal-1-blocker-patch.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2048/japan-approves-worlds-first-transdermal-1-blocker-patch.html</link>
			<pubDate>Fri, 05 Jul 2013 11:13:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/azilva-hypertension-takeda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2048/japan-approves-worlds-first-transdermal-1-blocker-patch.html</guid>
		</item>	
				<item>
			<title>Human stem cells used to create tiny human livers</title>
			<atom:link href="https://biospectrumasia.com/news/50/256/human-stem-cells-used-to-create-tiny-human-livers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/256/human-stem-cells-used-to-create-tiny-human-livers.html</link>
			<pubDate>Fri, 05 Jul 2013 08:36:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/256/human-stem-cells-used-to-create-tiny-human-livers.html</guid>
		</item>	
				<item>
			<title>Japan approves Lyxumia for diabetes therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/3413/japan-approves-lyxumia-for-diabetes-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3413/japan-approves-lyxumia-for-diabetes-therapy.html</link>
			<pubDate>Wed, 03 Jul 2013 07:58:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lyxumia-gets-japanese-nod-for-diabetes-therapy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3413/japan-approves-lyxumia-for-diabetes-therapy.html</guid>
		</item>	
				<item>
			<title>Japan approves Accent MRI Pacemaker</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3225/japan-approves-accent-mri-pacemaker.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3225/japan-approves-accent-mri-pacemaker.html</link>
			<pubDate>Tue, 02 Jul 2013 11:27:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/study-shows-that-non-steroidal-anti-inflammatory-drugs-nsaids-and-painkillers-like-ibuprofen-diclofenac-and-coxibs-may-cause-severe-heart-problems.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3225/japan-approves-accent-mri-pacemaker.html</guid>
		</item>	
				<item>
			<title>Seegene and Eidia to bring MoDx tests to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1879/seegene-and-eidia-to-bring-modx-tests-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1879/seegene-and-eidia-to-bring-modx-tests-to-japan.html</link>
			<pubDate>Tue, 02 Jul 2013 09:55:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/apac-witnesses-mergers-acquisitions-m-a-galore-during-q1-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1879/seegene-and-eidia-to-bring-modx-tests-to-japan.html</guid>
		</item>	
				<item>
			<title>Genetic diagnostics companies speed ahead</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/126/genetic-diagnostics-companies-speed-ahead.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/126/genetic-diagnostics-companies-speed-ahead.html</link>
			<pubDate>Fri, 28 Jun 2013 18:16:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ms-nandita-singh-editor-biospectrum-asia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/126/genetic-diagnostics-companies-speed-ahead.html</guid>
		</item>	
				<item>
			<title>Japan Minister: Dont be afraid of new science strategy </title>
			<atom:link href="https://biospectrumasia.com/news/50/1083/japan-minister-dont-be-afraid-of-new-science-strategy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1083/japan-minister-dont-be-afraid-of-new-science-strategy-.html</link>
			<pubDate>Wed, 26 Jun 2013 15:07:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japanese-academic-societies-say-that-the-government-must-preserve-the-bottom-up-approach-of-promoting-basic-research-under-which-individual-researchers-pursue-their-interests.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1083/japan-minister-dont-be-afraid-of-new-science-strategy-.html</guid>
		</item>	
				<item>
			<title>Takeda develops first-ever vomiting bug vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/50/5455/takeda-develops-first-ever-vomiting-bug-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5455/takeda-develops-first-ever-vomiting-bug-vaccine.html</link>
			<pubDate>Wed, 26 Jun 2013 13:49:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/if-approved-takeda-s-norovirus-vaccine-would-be-the-first-to-protect-people-against-the-vomiting-germ.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5455/takeda-develops-first-ever-vomiting-bug-vaccine.html</guid>
		</item>	
				<item>
			<title>Astellas, Cytokinetics sign $490 mn muscle deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/821/astellas-cytokinetics-sign-490-mn-muscle-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/821/astellas-cytokinetics-sign-490-mn-muscle-deal.html</link>
			<pubDate>Wed, 26 Jun 2013 12:42:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cytokinetics-and-astellas-join-hands-for-skeletal-muscle-activators.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/821/astellas-cytokinetics-sign-490-mn-muscle-deal.html</guid>
		</item>	
				<item>
			<title>Eisai pulls drug from Germany due to unsuitable policies</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/4251/eisai-pulls-drug-from-germany-due-to-unsuitable-policies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/4251/eisai-pulls-drug-from-germany-due-to-unsuitable-policies.html</link>
			<pubDate>Wed, 26 Jun 2013 12:28:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unfavorable-conditions-created-by-health-regulator-german-federal-joint-committee-g-ba-leads-eisai-to-pull-drug-from-germany.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/4251/eisai-pulls-drug-from-germany-due-to-unsuitable-policies.html</guid>
		</item>	
				<item>
			<title>Takeda makes massive changes in its organization </title>
			<atom:link href="https://biospectrumasia.com/news/50/1501/takeda-makes-massive-changes-in-its-organization-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1501/takeda-makes-massive-changes-in-its-organization-.html</link>
			<pubDate>Wed, 26 Jun 2013 11:00:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-establishes-new-organization-named-it-planning-and-administration-office-and-hr-development-office.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1501/takeda-makes-massive-changes-in-its-organization-.html</guid>
		</item>	
				<item>
			<title>Japan study: Sugar solution makes tissue transparent</title>
			<atom:link href="https://biospectrumasia.com/news/50/845/japan-study-sugar-solution-makes-tissue-transparent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/845/japan-study-sugar-solution-makes-tissue-transparent.html</link>
			<pubDate>Wed, 26 Jun 2013 08:38:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/seedb-is-an-inexpensive-quick-easy-and-safe-way-to-make-tissues-transparent-image-source-riken.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/845/japan-study-sugar-solution-makes-tissue-transparent.html</guid>
		</item>	
				<item>
			<title>Astellas prostrate cancer drug gets EU nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/8499/astellas-prostrate-cancer-drug-gets-eu-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8499/astellas-prostrate-cancer-drug-gets-eu-nod.html</link>
			<pubDate>Tue, 25 Jun 2013 14:49:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prostrate-cancer-zytiga.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8499/astellas-prostrate-cancer-drug-gets-eu-nod.html</guid>
		</item>	
				<item>
			<title>New details of rice fungus may help control disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/2514/new-details-of-rice-fungus-may-help-control-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2514/new-details-of-rice-fungus-may-help-control-disease.html</link>
			<pubDate>Thu, 20 Jun 2013 12:02:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biotec-collaborates-with-other-thai-universities-to-develop-a-new-variety-of-glutinuous-rice-with-resistance-to-both-blast-and-blight.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2514/new-details-of-rice-fungus-may-help-control-disease.html</guid>
		</item>	
				<item>
			<title>Shionogi partners with six Irish universities</title>
			<atom:link href="https://biospectrumasia.com/news/50/2647/shionogi-partners-with-six-irish-universities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2647/shionogi-partners-with-six-irish-universities.html</link>
			<pubDate>Wed, 19 Jun 2013 11:42:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-alzheimer-s-and-parkinson-s-patients-university-college-london-ucl-and-eisai-form-research-alliance-therapeutic-innovation-group-tig.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2647/shionogi-partners-with-six-irish-universities.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo files NDA for Prasugrel in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/8101/daiichi-sankyo-files-nda-for-prasugrel-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8101/daiichi-sankyo-files-nda-for-prasugrel-in-japan.html</link>
			<pubDate>Wed, 19 Jun 2013 11:20:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sodium-tablets-generic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8101/daiichi-sankyo-files-nda-for-prasugrel-in-japan.html</guid>
		</item>	
				<item>
			<title>Astellas looks to sell dermatology assets: Sources</title>
			<atom:link href="https://biospectrumasia.com/news/50/2084/astellas-looks-to-sell-dermatology-assets-sources.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2084/astellas-looks-to-sell-dermatology-assets-sources.html</link>
			<pubDate>Wed, 19 Jun 2013 10:16:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-japanese-government-astellas-eisai-daiichi-sankyo-shionogi-takeda-and-bill-melinda-gates-foundation-will-initiate-an-effort-worth-usd100-million-to-tackle-hiv-malaria-tuberculosis-and-tropical-diseas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2084/astellas-looks-to-sell-dermatology-assets-sources.html</guid>
		</item>	
				<item>
			<title>Asia vaccine strategists call for collaboration </title>
			<atom:link href="https://biospectrumasia.com/news/50/766/asia-vaccine-strategists-call-for-collaboration-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/766/asia-vaccine-strategists-call-for-collaboration-.html</link>
			<pubDate>Tue, 18 Jun 2013 14:49:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dsc0336.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/766/asia-vaccine-strategists-call-for-collaboration-.html</guid>
		</item>	
				<item>
			<title>Molecular diagnostics is key to future</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2469/molecular-diagnostics-is-key-to-future.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2469/molecular-diagnostics-is-key-to-future.html</link>
			<pubDate>Tue, 18 Jun 2013 13:19:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vela-diagnostics-pcr-based-research-use-only-will-identify-new-strain-of-bird-flu-h7n9-and-coronavirus-hcov-emc.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2469/molecular-diagnostics-is-key-to-future.html</guid>
		</item>	
				<item>
			<title>Japan approves Avastin for brain cancer treatment</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/6291/japan-approves-avastin-for-brain-cancer-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/6291/japan-approves-avastin-for-brain-cancer-treatment.html</link>
			<pubDate>Tue, 18 Jun 2013 11:07:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-alzheimer-s-disease-patients-shasun-and-debiopharm-will-manufacture-brain-drug-huperzine-a.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/6291/japan-approves-avastin-for-brain-cancer-treatment.html</guid>
		</item>	
				<item>
			<title>World&#039;s most powerful microscope ready for use</title>
			<atom:link href="https://biospectrumasia.com/news/50/5668/worlds-most-powerful-microscope-ready-for-use.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5668/worlds-most-powerful-microscope-ready-for-use.html</link>
			<pubDate>Tue, 18 Jun 2013 10:46:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-rodney-herring-professor-of-mechanical-engineering-and-director-of-advanced-microscopy-facility-university-of-victoria-canada-standing-beside-the-stehm.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5668/worlds-most-powerful-microscope-ready-for-use.html</guid>
		</item>	
				<item>
			<title>RetroNectin now available for clinical research</title>
			<atom:link href="https://biospectrumasia.com/news/50/5894/retronectin-now-available-for-clinical-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5894/retronectin-now-available-for-clinical-research.html</link>
			<pubDate>Tue, 18 Jun 2013 10:13:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/orcell-can-heal-damaged-tissue-using-muscle-stem-cells.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5894/retronectin-now-available-for-clinical-research.html</guid>
		</item>	
				<item>
			<title>Amgen-Cytokinetics collaboration to include Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/259/amgen-cytokinetics-collaboration-to-include-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/259/amgen-cytokinetics-collaboration-to-include-japan.html</link>
			<pubDate>Mon, 17 Jun 2013 11:04:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-based-avantor-performance-materials-set-up-current-good-manufacturing-practices-cgmp-production-facility-in-panoli-gujarat-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/259/amgen-cytokinetics-collaboration-to-include-japan.html</guid>
		</item>	
				<item>
			<title>Mauna Kea &amp; Amco to distribute Cellvizio in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5527/mauna-kea-amco-to-distribute-cellvizio-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5527/mauna-kea-amco-to-distribute-cellvizio-in-japan.html</link>
			<pubDate>Fri, 14 Jun 2013 13:08:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sartorius-stedim-biotech-and-aber-instruments-joins-hands-for-sensor-technology-used-in-biomass-measurement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5527/mauna-kea-amco-to-distribute-cellvizio-in-japan.html</guid>
		</item>	
				<item>
			<title>OHK &amp; Mitsubishi to launch HemaClear in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/2459/ohk-mitsubishi-to-launch-hemaclear-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2459/ohk-mitsubishi-to-launch-hemaclear-in-japan-.html</link>
			<pubDate>Fri, 14 Jun 2013 12:52:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lbt-innovations-and-hettich-joint-veture-to-develop-and-commercialize-automated-plate-assessment-system-apas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2459/ohk-mitsubishi-to-launch-hemaclear-in-japan-.html</guid>
		</item>	
				<item>
			<title>Prism to start PRI-724 trials to treat fibrosis</title>
			<atom:link href="https://biospectrumasia.com/news/50/1179/prism-to-start-pri-724-trials-to-treat-fibrosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1179/prism-to-start-pri-724-trials-to-treat-fibrosis.html</link>
			<pubDate>Fri, 14 Jun 2013 12:28:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astars-genome-institute-of-singapore-gis-and-oxford-biodynamics-obd-will-use-episwitch-platform-to-differentiate-epigenetic-footprint-of-various-stem-cells-from-their-cell-lines.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1179/prism-to-start-pri-724-trials-to-treat-fibrosis.html</guid>
		</item>	
				<item>
			<title>Abbott starts Absorb Japan trial in CAD patients</title>
			<atom:link href="https://biospectrumasia.com/news/50/2904/abbott-starts-absorb-japan-trial-in-cad-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2904/abbott-starts-absorb-japan-trial-in-cad-patients.html</link>
			<pubDate>Thu, 13 Jun 2013 11:23:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-patients-who-are-seeking-to-repaire-their-leaky-heart-valves-without-open-heart-surgery-phoenix-cardiac-devices-initiates-clinical-trial-for-its-bace-device.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2904/abbott-starts-absorb-japan-trial-in-cad-patients.html</guid>
		</item>	
				<item>
			<title>NZ value-added dairy product launches in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3203/nz-value-added-dairy-product-launches-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3203/nz-value-added-dairy-product-launches-in-japan.html</link>
			<pubDate>Thu, 13 Jun 2013 11:05:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/milk-glass.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3203/nz-value-added-dairy-product-launches-in-japan.html</guid>
		</item>	
				<item>
			<title>Amgen CEO speaks of firm&#039;s grand entry into Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/98/amgen-ceo-speaks-of-firms-grand-entry-into-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/98/amgen-ceo-speaks-of-firms-grand-entry-into-japan.html</link>
			<pubDate>Thu, 13 Jun 2013 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/robert-a-bradway-ceo-amgen.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/98/amgen-ceo-speaks-of-firms-grand-entry-into-japan.html</guid>
		</item>	
				<item>
			<title>Asia&#039;s Fastest 50 bio-firms shine</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/4509/asias-fastest-50-bio-firms-shine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/4509/asias-fastest-50-bio-firms-shine.html</link>
			<pubDate>Wed, 12 Jun 2013 16:32:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fastest-50.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/4509/asias-fastest-50-bio-firms-shine.html</guid>
		</item>	
				<item>
			<title>AstraZeneca-Takeda to bid for Israeli incubator</title>
			<atom:link href="https://biospectrumasia.com/news/50/4558/astrazeneca-takeda-to-bid-for-israeli-incubator.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4558/astrazeneca-takeda-to-bid-for-israeli-incubator.html</link>
			<pubDate>Wed, 12 Jun 2013 13:03:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/female-employees-file-usd100-million-lawsuit-against-daiichi-sankyo-for-gender-discrimination.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4558/astrazeneca-takeda-to-bid-for-israeli-incubator.html</guid>
		</item>	
				<item>
			<title>Investors eye Japan&#039;s pharma law reformation</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/5006/investors-eye-japans-pharma-law-reformation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/5006/investors-eye-japans-pharma-law-reformation.html</link>
			<pubDate>Wed, 12 Jun 2013 12:23:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/law-firm-pomerantz-investigates-tibet-pharma-statements.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/5006/investors-eye-japans-pharma-law-reformation.html</guid>
		</item>	
				<item>
			<title>Asia faces an acute skills gap challenge</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5311/asia-faces-an-acute-skills-gap-challenge.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5311/asia-faces-an-acute-skills-gap-challenge.html</link>
			<pubDate>Wed, 12 Jun 2013 11:32:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hr-analysis-biospectrum-asia-top-20-survey.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5311/asia-faces-an-acute-skills-gap-challenge.html</guid>
		</item>	
				<item>
			<title>Reverse Medical announces alliance in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1853/reverse-medical-announces-alliance-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1853/reverse-medical-announces-alliance-in-japan.html</link>
			<pubDate>Wed, 12 Jun 2013 11:29:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ms-nan-wang-is-the-new-cfo-of-sinovac-biotech.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1853/reverse-medical-announces-alliance-in-japan.html</guid>
		</item>	
				<item>
			<title>Samantha Su, Simranjit Singh: Finding skilled professionals is a challenge in Singapore</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/7584/samantha-su-simranjit-singh-finding-skilled-professionals-is-a-challenge-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/7584/samantha-su-simranjit-singh-finding-skilled-professionals-is-a-challenge-in-singapore.html</link>
			<pubDate>Wed, 12 Jun 2013 11:21:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ms-samantha-su-director-services-and-biomedical-spring-singapore-and-mr-simranjit-singh-chairman-biosingapore.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/7584/samantha-su-simranjit-singh-finding-skilled-professionals-is-a-challenge-in-singapore.html</guid>
		</item>	
				<item>
			<title>Matt Kerr: Tough task ahead for APAC HR managers</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/7251/matt-kerr-tough-task-ahead-for-apac-hr-managers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/7251/matt-kerr-tough-task-ahead-for-apac-hr-managers.html</link>
			<pubDate>Wed, 12 Jun 2013 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-matt-kerr-senior-manager-hays-recruiting-worldwide.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/7251/matt-kerr-tough-task-ahead-for-apac-hr-managers.html</guid>
		</item>	
				<item>
			<title>Kotaro Yoshida: China, Japan are the new M&amp;A hot spots</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/6872/kotaro-yoshida-china-japan-are-the-new-ma-hot-spots.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/6872/kotaro-yoshida-china-japan-are-the-new-ma-hot-spots.html</link>
			<pubDate>Wed, 12 Jun 2013 09:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-kotaro-yoshida-senior-research-analyst-biopharm-insight-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/6872/kotaro-yoshida-china-japan-are-the-new-ma-hot-spots.html</guid>
		</item>	
				<item>
			<title>Deep in debt Elder Pharma decides to sell itself</title>
			<atom:link href="https://biospectrumasia.com/news/50/3440/deep-in-debt-elder-pharma-decides-to-sell-itself.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3440/deep-in-debt-elder-pharma-decides-to-sell-itself.html</link>
			<pubDate>Tue, 11 Jun 2013 12:48:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mounting-debts-and-fierce-competition-forces-elder-pharmaceuticals-to-start-looking-for-buyers.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3440/deep-in-debt-elder-pharma-decides-to-sell-itself.html</guid>
		</item>	
				<item>
			<title>Apollo Pharmacy cautions against Ranbaxy drugs&#039; use</title>
			<atom:link href="https://biospectrumasia.com/news/50/6333/apollo-pharmacy-cautions-against-ranbaxy-drugs-use.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6333/apollo-pharmacy-cautions-against-ranbaxy-drugs-use.html</link>
			<pubDate>Mon, 10 Jun 2013 14:37:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/apollo-pharmacy-india-s-biggest-branded-drug-retail-network-issues-a-cautionary-advisory-against-drugs-manufactured-by-ranbaxy.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6333/apollo-pharmacy-cautions-against-ranbaxy-drugs-use.html</guid>
		</item>	
				<item>
			<title>New R&amp;D center to advance rice research in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2988/new-rd-center-to-advance-rice-research-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2988/new-rd-center-to-advance-rice-research-in-japan.html</link>
			<pubDate>Mon, 10 Jun 2013 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rice-as-vehicle-for-molecular-pharming.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2988/new-rd-center-to-advance-rice-research-in-japan.html</guid>
		</item>	
				<item>
			<title>New medtech market infographic published</title>
			<atom:link href="https://biospectrumasia.com/news/50/2720/new-medtech-market-infographic-published.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2720/new-medtech-market-infographic-published.html</link>
			<pubDate>Mon, 10 Jun 2013 10:03:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ema-chmp-gives-thumbs-up-to-pomalidomide-celgene-pomalidomide-for-treatment-of-multiple-myeloma-in-combination-with-dexamethasone.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2720/new-medtech-market-infographic-published.html</guid>
		</item>	
				<item>
			<title>Lawyer files suit to shut Ranbaxy plants in India</title>
			<atom:link href="https://biospectrumasia.com/news/50/6430/lawyer-files-suit-to-shut-ranbaxy-plants-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6430/lawyer-files-suit-to-shut-ranbaxy-plants-in-india.html</link>
			<pubDate>Mon, 10 Jun 2013 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6430/lawyer-files-suit-to-shut-ranbaxy-plants-in-india.html</guid>
		</item>	
				<item>
			<title>Astellas joins hands with Tecnofarma International</title>
			<atom:link href="https://biospectrumasia.com/news/50/2197/astellas-joins-hands-with-tecnofarma-international.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2197/astellas-joins-hands-with-tecnofarma-international.html</link>
			<pubDate>Fri, 07 Jun 2013 10:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sodium-tablets-generic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2197/astellas-joins-hands-with-tecnofarma-international.html</guid>
		</item>	
				<item>
			<title>NextDocs expands customer list by more than 10%</title>
			<atom:link href="https://biospectrumasia.com/news/50/7528/nextdocs-expands-customer-list-by-more-than-10.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7528/nextdocs-expands-customer-list-by-more-than-10.html</link>
			<pubDate>Tue, 04 Jun 2013 11:42:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/all-domains-of-agilent-s-business-witnesses-considerable-growth-during-q1-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7528/nextdocs-expands-customer-list-by-more-than-10.html</guid>
		</item>	
				<item>
			<title>Deregulation will boost Japanese pharma sector</title>
			<atom:link href="https://biospectrumasia.com/news/50/1968/deregulation-will-boost-japanese-pharma-sector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1968/deregulation-will-boost-japanese-pharma-sector.html</link>
			<pubDate>Tue, 04 Jun 2013 11:23:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-japanese-government-astellas-eisai-daiichi-sankyo-shionogi-takeda-and-bill-melinda-gates-foundation-will-initiate-an-effort-worth-usd100-million-to-tackle-hiv-malaria-tuberculosis-and-tropical-diseas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1968/deregulation-will-boost-japanese-pharma-sector.html</guid>
		</item>	
				<item>
			<title>Fujifilm, Dr Reddy&#039;s terminate generics JV</title>
			<atom:link href="https://biospectrumasia.com/news/50/1504/fujifilm-dr-reddys-terminate-generics-jv.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1504/fujifilm-dr-reddys-terminate-generics-jv.html</link>
			<pubDate>Tue, 04 Jun 2013 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1504/fujifilm-dr-reddys-terminate-generics-jv.html</guid>
		</item>	
				<item>
			<title>Ranbaxy advisory: All our products are safe and efficacious</title>
			<atom:link href="https://biospectrumasia.com/news/50/701/ranbaxy-advisory-all-our-products-are-safe-and-efficacious.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/701/ranbaxy-advisory-all-our-products-are-safe-and-efficacious.html</link>
			<pubDate>Mon, 03 Jun 2013 15:14:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxylab.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/701/ranbaxy-advisory-all-our-products-are-safe-and-efficacious.html</guid>
		</item>	
				<item>
			<title>Japan, Korea suspend wheat import from the US</title>
			<atom:link href="https://biospectrumasia.com/news/50/4799/japan-korea-suspend-wheat-import-from-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4799/japan-korea-suspend-wheat-import-from-the-us.html</link>
			<pubDate>Mon, 03 Jun 2013 11:58:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-south-korea-thailand-and-the-eu-are-taking-action-to-prevent-import-of-the-gm-wheat-from-the-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4799/japan-korea-suspend-wheat-import-from-the-us.html</guid>
		</item>	
				<item>
			<title>Japan BIOtech 2013 concludes in huge success </title>
			<atom:link href="https://biospectrumasia.com/news/50/1249/japan-biotech-2013-concludes-in-huge-success-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1249/japan-biotech-2013-concludes-in-huge-success-.html</link>
			<pubDate>Mon, 03 Jun 2013 11:04:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biotech-2013-in-japan-was-held-from-may-8-10-2013-in-tokyo.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1249/japan-biotech-2013-concludes-in-huge-success-.html</guid>
		</item>	
				<item>
			<title>Transcatheter heart devices to see surge in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6935/transcatheter-heart-devices-to-see-surge-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6935/transcatheter-heart-devices-to-see-surge-in-japan.html</link>
			<pubDate>Fri, 31 May 2013 11:09:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-patients-who-are-seeking-to-repaire-their-leaky-heart-valves-without-open-heart-surgery-phoenix-cardiac-devices-initiates-clinical-trial-for-its-bace-device.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6935/transcatheter-heart-devices-to-see-surge-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese use charred resin to make nano 3D structures</title>
			<atom:link href="https://biospectrumasia.com/news/50/3272/japanese-use-charred-resin-to-make-nano-3d-structures.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3272/japanese-use-charred-resin-to-make-nano-3d-structures.html</link>
			<pubDate>Fri, 31 May 2013 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/micro-bunny.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3272/japanese-use-charred-resin-to-make-nano-3d-structures.html</guid>
		</item>	
				<item>
			<title>FDA slams Shionogi for eyeing profit over patient safety</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2025/fda-slams-shionogi-for-eyeing-profit-over-patient-safety.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2025/fda-slams-shionogi-for-eyeing-profit-over-patient-safety.html</link>
			<pubDate>Thu, 30 May 2013 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shionogi-faces-monetary-penalties-for-not-offering-good-cause-for-its-failure-to-pursue-clinical-studies-despite-fda-s-order-to-carry-our-additional-trials-to-ensure-the-safety-of-its-pain-killer-rybix.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2025/fda-slams-shionogi-for-eyeing-profit-over-patient-safety.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s top 5 bio firms fund $100 mn HIV, TB research</title>
			<atom:link href="https://biospectrumasia.com/news/50/2752/japans-top-5-bio-firms-fund-100-mn-hiv-tb-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2752/japans-top-5-bio-firms-fund-100-mn-hiv-tb-research.html</link>
			<pubDate>Thu, 30 May 2013 13:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-japanese-government-astellas-eisai-daiichi-sankyo-shionogi-takeda-and-bill-melinda-gates-foundation-will-initiate-an-effort-worth-usd100-million-to-tackle-hiv-malaria-tuberculosis-and-tropical-diseas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2752/japans-top-5-bio-firms-fund-100-mn-hiv-tb-research.html</guid>
		</item>	
				<item>
			<title>Amgen &amp; Astellas form JV, will co-develop biologics</title>
			<atom:link href="https://biospectrumasia.com/news/50/4714/amgen-astellas-form-jv-will-co-develop-biologics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4714/amgen-astellas-form-jv-will-co-develop-biologics.html</link>
			<pubDate>Thu, 30 May 2013 12:21:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amgen-and-astellas-pharma-enter-a-strategic-alliance-to-develop-and-commercialize-five-amgen-pipeline-medicines-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4714/amgen-astellas-form-jv-will-co-develop-biologics.html</guid>
		</item>	
				<item>
			<title>Shimadzu to adopt Agilent&#039;s RC.Net instrument drivers</title>
			<atom:link href="https://biospectrumasia.com/news/50/5405/shimadzu-to-adopt-agilents-rc-net-instrument-drivers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5405/shimadzu-to-adopt-agilents-rc-net-instrument-drivers.html</link>
			<pubDate>Thu, 30 May 2013 11:58:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/done-deal-shimadzu-to-adopt-agilent-s-rapidcontrol.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5405/shimadzu-to-adopt-agilents-rc-net-instrument-drivers.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe files NDA for Canagliflozin</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2487/mitsubishi-tanabe-files-nda-for-canagliflozin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2487/mitsubishi-tanabe-files-nda-for-canagliflozin.html</link>
			<pubDate>Thu, 30 May 2013 11:43:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-diabetes-patients-mitsubishi-tanabe-pharma-seeks-approval-of-ta-7284-canagliflozin-a-sodium-glucose-co-transporter-2-sglt2-inhibitor-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2487/mitsubishi-tanabe-files-nda-for-canagliflozin.html</guid>
		</item>	
				<item>
			<title>Will Ranbaxy, Wockhardt incidents affect brand India? </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/1270/will-ranbaxy-wockhardt-incidents-affect-brand-india-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/1270/will-ranbaxy-wockhardt-incidents-affect-brand-india-.html</link>
			<pubDate>Wed, 29 May 2013 13:17:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/will-the-recent-controversies-surrounding-ranbaxy-and-wockhardt-hamper-the-strong-foothold-that-indian-pharma-has-established-over-the-past-two-decades-in-western-markets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/1270/will-ranbaxy-wockhardt-incidents-affect-brand-india-.html</guid>
		</item>	
				<item>
			<title>Ranbaxy&#039;s fall from grace </title>
			<atom:link href="https://biospectrumasia.com/opinion/50/3716/ranbaxys-fall-from-grace-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/3716/ranbaxys-fall-from-grace-.html</link>
			<pubDate>Wed, 29 May 2013 09:28:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ms-nandita-singh-editor-biospectrum-asia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/3716/ranbaxys-fall-from-grace-.html</guid>
		</item>	
				<item>
			<title>Japan medtech firm signs $9 mn deal with A*Star</title>
			<atom:link href="https://biospectrumasia.com/news/50/2977/japan-medtech-firm-signs-9-mn-deal-with-astar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2977/japan-medtech-firm-signs-9-mn-deal-with-astar.html</link>
			<pubDate>Mon, 27 May 2013 13:18:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-medtech-firm-arkray-signs-usd9.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2977/japan-medtech-firm-signs-9-mn-deal-with-astar.html</guid>
		</item>	
				<item>
			<title>BioDiem protozoan drug to get Japanese patent </title>
			<atom:link href="https://biospectrumasia.com/news/50/7331/biodiem-protozoan-drug-to-get-japanese-patent-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7331/biodiem-protozoan-drug-to-get-japanese-patent-.html</link>
			<pubDate>Mon, 27 May 2013 12:23:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/australia-based-biodiem-s-anti-protozoan-compound-bdm-i-gets-allowance-of-japanese-patent.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7331/biodiem-protozoan-drug-to-get-japanese-patent-.html</guid>
		</item>	
				<item>
			<title>Ranbaxy controversy: What have been the highlights?</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/3310/ranbaxy-controversy-what-have-been-the-highlights.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/3310/ranbaxy-controversy-what-have-been-the-highlights.html</link>
			<pubDate>Mon, 27 May 2013 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/will-the-ranbaxy-controversy-hamper-the-growth-of-other-indian-firms-in-the-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/3310/ranbaxy-controversy-what-have-been-the-highlights.html</guid>
		</item>	
				<item>
			<title>Daiichi&#039;s comments upset former Ranbaxy owners</title>
			<atom:link href="https://biospectrumasia.com/news/50/1600/daiichis-comments-upset-former-ranbaxy-owners.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1600/daiichis-comments-upset-former-ranbaxy-owners.html</link>
			<pubDate>Fri, 24 May 2013 20:21:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-s-comments-enrages-the-singh-family-the-former-shareholder-and-owners-of-ranbaxy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1600/daiichis-comments-upset-former-ranbaxy-owners.html</guid>
		</item>	
				<item>
			<title>Daiichi may take legal action against ex-Ranbaxy promoters</title>
			<atom:link href="https://biospectrumasia.com/news/50/1923/daiichi-may-take-legal-action-against-ex-ranbaxy-promoters.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1923/daiichi-may-take-legal-action-against-ex-ranbaxy-promoters.html</link>
			<pubDate>Fri, 24 May 2013 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-may-take-legal-action-against-former-shareholders-of-ranbaxy-as-it-believes-that-they-concealed-and-misrepresented-critical-information-concerning-the-us-department-of-justice-doj-and-us-fda-inves.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1923/daiichi-may-take-legal-action-against-ex-ranbaxy-promoters.html</guid>
		</item>	
				<item>
			<title>Japan leukemia market to grow to $565mn in 2022</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5908/japan-leukemia-market-to-grow-to-565mn-in-2022.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5908/japan-leukemia-market-to-grow-to-565mn-in-2022.html</link>
			<pubDate>Wed, 22 May 2013 10:51:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/globaldata-report-japan-s-branded-hronic-myeloid-leukemia-cml-therapeutics-market-will-grow-to-usd565-million-in-2022-at-a-cagr-of-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5908/japan-leukemia-market-to-grow-to-565mn-in-2022.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s BIOtech 2013 witnesses 10,362 visitors</title>
			<atom:link href="https://biospectrumasia.com/news/50/2960/japans-biotech-2013-witnesses-10362-visitors.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2960/japans-biotech-2013-witnesses-10362-visitors.html</link>
			<pubDate>Tue, 21 May 2013 17:33:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biotech-2013-in-japan-was-held-from-may-8-10-2013-in-tokyo.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2960/japans-biotech-2013-witnesses-10362-visitors.html</guid>
		</item>	
				<item>
			<title>Will Japan be able to reduce its generic drug prices?</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/7356/will-japan-be-able-to-reduce-its-generic-drug-prices.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/7356/will-japan-be-able-to-reduce-its-generic-drug-prices.html</link>
			<pubDate>Tue, 21 May 2013 08:59:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/is-japan-changing-its-attitude-towards-generic-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/7356/will-japan-be-able-to-reduce-its-generic-drug-prices.html</guid>
		</item>	
				<item>
			<title>Takeda, Lundbeck to present depression study data </title>
			<atom:link href="https://biospectrumasia.com/news/50/1055/takeda-lundbeck-to-present-depression-study-data-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1055/takeda-lundbeck-to-present-depression-study-data-.html</link>
			<pubDate>Mon, 20 May 2013 13:04:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-and-lundbeck-to-present-results-from-pivotal-phase-iii-clinical-trials-with-vortioxetine-which-can-used-for-the-treatment-of-major-depressive-disorder-mdd.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1055/takeda-lundbeck-to-present-depression-study-data-.html</guid>
		</item>	
				<item>
			<title>Stem cell scientist sues Nobel laureate for deception</title>
			<atom:link href="https://biospectrumasia.com/news/50/8510/stem-cell-scientist-sues-nobel-laureate-for-deception.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8510/stem-cell-scientist-sues-nobel-laureate-for-deception.html</link>
			<pubDate>Fri, 17 May 2013 12:16:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/renouned-medical-scientist-dr-rongxiang-xu-sues-dr-shinya-yamanaka-one-of-the-winners-of-the-2012-nobel-prize-in-physiology-or-medicine-in-the-superior-court-of-california-county-of-san-francisco-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8510/stem-cell-scientist-sues-nobel-laureate-for-deception.html</guid>
		</item>	
				<item>
			<title>Mitsubishi system reduces radiotherapy time to 1/4</title>
			<atom:link href="https://biospectrumasia.com/news/50/6063/mitsubishi-system-reduces-radiotherapy-time-to-1-4.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6063/mitsubishi-system-reduces-radiotherapy-time-to-1-4.html</link>
			<pubDate>Wed, 15 May 2013 12:55:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mitsubishi-electric-s-proton-therapy-system-reduces-irradiation-time-during-cancer-radiotherapy-to-one-fourth-of-the-current-level.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6063/mitsubishi-system-reduces-radiotherapy-time-to-1-4.html</guid>
		</item>	
				<item>
			<title>Tatsuya Kimura: Japan is a steadily growing market </title>
			<atom:link href="https://biospectrumasia.com/opinion/50/4164/tatsuya-kimura-japan-is-a-steadily-growing-market-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/4164/tatsuya-kimura-japan-is-a-steadily-growing-market-.html</link>
			<pubDate>Wed, 15 May 2013 08:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-tatsuya-kimura-drug-information-association-japan.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/4164/tatsuya-kimura-japan-is-a-steadily-growing-market-.html</guid>
		</item>	
				<item>
			<title>F&amp;S: Personalization is the new mantra in healthcare</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/4329/fs-personalization-is-the-new-mantra-in-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/4329/fs-personalization-is-the-new-mantra-in-healthcare.html</link>
			<pubDate>Tue, 14 May 2013 12:18:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/frost-sullivan-partner-ms-reenita-das-says-that-personalization-communication-decentralization-and-collaboration-are-the-new-mantra-in-healthcare.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/4329/fs-personalization-is-the-new-mantra-in-healthcare.html</guid>
		</item>	
				<item>
			<title>CEO of Takeda&#039;s Millennium Pharma quits abruptly </title>
			<atom:link href="https://biospectrumasia.com/news/50/2278/ceo-of-takedas-millennium-pharma-quits-abruptly-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2278/ceo-of-takedas-millennium-pharma-quits-abruptly-.html</link>
			<pubDate>Mon, 13 May 2013 13:31:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/farewell-ms-anna-protopapas-executive-vp-of-bd-takeda-will-replace-millennium-pharma-s-outgoing-ceo-ms-deborah-dunsire.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2278/ceo-of-takedas-millennium-pharma-quits-abruptly-.html</guid>
		</item>	
				<item>
			<title>Australian Cellmid acquires Japanese Advangen</title>
			<atom:link href="https://biospectrumasia.com/news/50/7730/australian-cellmid-acquires-japanese-advangen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7730/australian-cellmid-acquires-japanese-advangen.html</link>
			<pubDate>Thu, 09 May 2013 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/australian-cellmid-acquires-japanese-advangen.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7730/australian-cellmid-acquires-japanese-advangen.html</guid>
		</item>	
				<item>
			<title>Takeda to acquire Inviragen for $250 mn</title>
			<atom:link href="https://biospectrumasia.com/news/50/3277/takeda-to-acquire-inviragen-for-250-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3277/takeda-to-acquire-inviragen-for-250-mn.html</link>
			<pubDate>Wed, 08 May 2013 10:59:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-acquisition-combines-inviragen-s-expertise-in-viral-vaccine-r-d-and-takeda-s-resources-product-development-expertise-and-global-reach.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3277/takeda-to-acquire-inviragen-for-250-mn.html</guid>
		</item>	
				<item>
			<title>Japanese I&#039;rom acquires 18% in Australian IDT </title>
			<atom:link href="https://biospectrumasia.com/news/50/794/japanese-irom-acquires-18-in-australian-idt-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/794/japanese-irom-acquires-18-in-australian-idt-.html</link>
			<pubDate>Tue, 07 May 2013 15:10:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-based-irom-holdings-will-acquire-18.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/794/japanese-irom-acquires-18-in-australian-idt-.html</guid>
		</item>	
				<item>
			<title>Takeda asks judge to rule in its favor</title>
			<atom:link href="https://biospectrumasia.com/news/50/1819/takeda-asks-judge-to-rule-in-its-favor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1819/takeda-asks-judge-to-rule-in-its-favor.html</link>
			<pubDate>Tue, 30 Apr 2013 08:58:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-disagrees-with-jury-s-decision-to-give-jack-cooper-and-other-plaintiffs-usd6.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1819/takeda-asks-judge-to-rule-in-its-favor.html</guid>
		</item>	
				<item>
			<title>Scotland approves Eisai&#039;s Fycompa</title>
			<atom:link href="https://biospectrumasia.com/news/50/640/scotland-approves-eisais-fycompa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/640/scotland-approves-eisais-fycompa.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/640/scotland-approves-eisais-fycompa.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand</title>
			<atom:link href="https://biospectrumasia.com/news/50/760/daiichi-sankyo-ranbaxy-to-leverage-synergies-in-thailand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/760/daiichi-sankyo-ranbaxy-to-leverage-synergies-in-thailand.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/760/daiichi-sankyo-ranbaxy-to-leverage-synergies-in-thailand.html</guid>
		</item>	
				<item>
			<title>CRO INC Research expands to Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/872/cro-inc-research-expands-to-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/872/cro-inc-research-expands-to-japan-.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/taiwan-expansion.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/872/cro-inc-research-expands-to-japan-.html</guid>
		</item>	
				<item>
			<title>Eisai to launch Bi Chocola Collagen and Bi Chocola Collagen GelÃƒÂ©e</title>
			<atom:link href="https://biospectrumasia.com/news/50/997/eisai-to-launch-bi-chocola-collagen-and-bi-chocola-collagen-gele.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/997/eisai-to-launch-bi-chocola-collagen-and-bi-chocola-collagen-gele.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/997/eisai-to-launch-bi-chocola-collagen-and-bi-chocola-collagen-gele.html</guid>
		</item>	
				<item>
			<title>Century Medical gets Japanese nod for Glider catheter</title>
			<atom:link href="https://biospectrumasia.com/news/50/2945/century-medical-gets-japanese-nod-for-glider-catheter.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2945/century-medical-gets-japanese-nod-for-glider-catheter.html</link>
			<pubDate>Mon, 22 Apr 2013 12:10:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/trireme-receives-approval-in-japan-to-market-glider-catheter.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2945/century-medical-gets-japanese-nod-for-glider-catheter.html</guid>
		</item>	
				<item>
			<title>Shimadzu wins F&amp;S South Africa &#039;leadership award&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/50/4504/shimadzu-wins-fs-south-africa-leadership-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4504/shimadzu-wins-fs-south-africa-leadership-award.html</link>
			<pubDate>Fri, 19 Apr 2013 11:14:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shimadzu-wins-frost-and-sullivan-2013-south-africa-market-share-leadership-award.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4504/shimadzu-wins-fs-south-africa-leadership-award.html</guid>
		</item>	
				<item>
			<title>DHL expands secure cold chain network</title>
			<atom:link href="https://biospectrumasia.com/news/50/2427/dhl-expands-secure-cold-chain-network.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2427/dhl-expands-secure-cold-chain-network.html</link>
			<pubDate>Thu, 18 Apr 2013 11:40:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/trouble-free-logistic-support-dhl-expands-its-qualified-envirotainer-provider-qep-accreditation-to-30-stations-worldwide.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2427/dhl-expands-secure-cold-chain-network.html</guid>
		</item>	
				<item>
			<title>Daiichi, Ranbaxy promote generics in Brazil</title>
			<atom:link href="https://biospectrumasia.com/news/50/2982/daiichi-ranbaxy-promote-generics-in-brazil.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2982/daiichi-ranbaxy-promote-generics-in-brazil.html</link>
			<pubDate>Thu, 18 Apr 2013 07:38:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-brasil-farmaceutica-and-ranbaxy-farmaceutica-use-hybrid-business-model-to-promote-generics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2982/daiichi-ranbaxy-promote-generics-in-brazil.html</guid>
		</item>	
				<item>
			<title>Kinetic launches portable negative pressure therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/285/kinetic-launches-portable-negative-pressure-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/285/kinetic-launches-portable-negative-pressure-therapy.html</link>
			<pubDate>Wed, 10 Apr 2013 15:56:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kinetic-concepts-launches-portable-negative-pressure-therapy-activac-therapy-system-in-japan.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/285/kinetic-launches-portable-negative-pressure-therapy.html</guid>
		</item>	
				<item>
			<title>Eisai establishes subsidiary in Russia</title>
			<atom:link href="https://biospectrumasia.com/news/50/4752/eisai-establishes-subsidiary-in-russia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4752/eisai-establishes-subsidiary-in-russia.html</link>
			<pubDate>Tue, 09 Apr 2013 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-establishes-sales-subsidiary-in-russia-the-11th-largest-pharma-market-in-the-world.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4752/eisai-establishes-subsidiary-in-russia.html</guid>
		</item>	
				<item>
			<title>Now Eisai joins global health fund</title>
			<atom:link href="https://biospectrumasia.com/news/50/2442/now-eisai-joins-global-health-fund.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2442/now-eisai-joins-global-health-fund.html</link>
			<pubDate>Mon, 08 Apr 2013 13:29:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-shionogi-merck-astellas-takeda-the-government-of-japan-and-the-bill-melinda-gates-foundation-established-the-global-health-innovative-technology-fund-ghit-fund-to-help-patients-in-developing-nat.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2442/now-eisai-joins-global-health-fund.html</guid>
		</item>	
				<item>
			<title>Astellas to pay $300 mn for cancer drug conjugates</title>
			<atom:link href="https://biospectrumasia.com/news/50/3259/astellas-to-pay-300-mn-for-cancer-drug-conjugates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3259/astellas-to-pay-300-mn-for-cancer-drug-conjugates.html</link>
			<pubDate>Fri, 05 Apr 2013 11:58:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-to-pay-ambrx-close-to-usd300-million-for-its-antibody-drug-conjugates-adcs-in-oncology.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3259/astellas-to-pay-300-mn-for-cancer-drug-conjugates.html</guid>
		</item>	
				<item>
			<title>Oramed gets Japanese patent for protein delivery</title>
			<atom:link href="https://biospectrumasia.com/news/50/1456/oramed-gets-japanese-patent-for-protein-delivery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1456/oramed-gets-japanese-patent-for-protein-delivery.html</link>
			<pubDate>Thu, 04 Apr 2013 13:42:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oramed-gets-japanese-patent-for-protein-delivery.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1456/oramed-gets-japanese-patent-for-protein-delivery.html</guid>
		</item>	
				<item>
			<title>Astellas to do interim analysis of cancer trial </title>
			<atom:link href="https://biospectrumasia.com/news/50/1231/astellas-to-do-interim-analysis-of-cancer-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1231/astellas-to-do-interim-analysis-of-cancer-trial-.html</link>
			<pubDate>Wed, 03 Apr 2013 13:42:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medivation-and-astellas-pharma-to-conduct-an-interim-analysis-for-the-prevail-clinical-trial-in-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1231/astellas-to-do-interim-analysis-of-cancer-trial-.html</guid>
		</item>	
				<item>
			<title>Mednet, Biovisiq deal helps in zero-delay of trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/7393/mednet-biovisiq-deal-helps-in-zero-delay-of-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7393/mednet-biovisiq-deal-helps-in-zero-delay-of-trials.html</link>
			<pubDate>Wed, 03 Apr 2013 12:16:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ag-mednet-biovisiq-deal-to-reduce-image-related-query-stoppages-in-trials.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7393/mednet-biovisiq-deal-helps-in-zero-delay-of-trials.html</guid>
		</item>	
				<item>
			<title>Phospagenics, Nippon Zoki to develop pain drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/2963/phospagenics-nippon-zoki-to-develop-pain-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2963/phospagenics-nippon-zoki-to-develop-pain-drug.html</link>
			<pubDate>Tue, 02 Apr 2013 14:34:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/phospagenics-nippon-zoki-to-develop-pain-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2963/phospagenics-nippon-zoki-to-develop-pain-drug.html</guid>
		</item>	
				<item>
			<title>World&#039;s largest PK/PD group launches service in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/1700/worlds-largest-pk-pd-group-launches-service-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1700/worlds-largest-pk-pd-group-launches-service-in-asia.html</link>
			<pubDate>Tue, 02 Apr 2013 14:01:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/certara-welcomes-mr-hidefumi-kasai-to-lead-the-pacific-rim-division-of-pharsight-consulting-services.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1700/worlds-largest-pk-pd-group-launches-service-in-asia.html</guid>
		</item>	
				<item>
			<title>Dainippon invests in Retina Institute, gets stem cell technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/4097/dainippon-invests-in-retina-institute-gets-stem-cell-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4097/dainippon-invests-in-retina-institute-gets-stem-cell-technology.html</link>
			<pubDate>Mon, 01 Apr 2013 16:37:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/riken-s-retina-institute-japan-rij-will-provide-dainippon-sumitomo-pharma-dsp-with-its-induced-pluripotent-stem-cells-ips-technology.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4097/dainippon-invests-in-retina-institute-gets-stem-cell-technology.html</guid>
		</item>	
				<item>
			<title>Eisai botulinum toxin injection to help relax muscles</title>
			<atom:link href="https://biospectrumasia.com/news/50/5853/eisai-botulinum-toxin-injection-to-help-relax-muscles.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5853/eisai-botulinum-toxin-injection-to-help-relax-muscles.html</link>
			<pubDate>Mon, 01 Apr 2013 16:17:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-cervical-dystonia-patients-eisai-clostridium-botulinum-toxin-type-b-intramuscular-injection-nerbloc-has-been-launched-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5853/eisai-botulinum-toxin-injection-to-help-relax-muscles.html</guid>
		</item>	
				<item>
			<title>DSP, Edison sign deal for mitochondria disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/5674/dsp-edison-sign-deal-for-mitochondria-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5674/dsp-edison-sign-deal-for-mitochondria-disease.html</link>
			<pubDate>Mon, 01 Apr 2013 14:28:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dsp-edison-sign-deal-for-mitochondria-disease.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5674/dsp-edison-sign-deal-for-mitochondria-disease.html</guid>
		</item>	
				<item>
			<title>Zeria  gets nod for Acofide Tablets in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1644/zeria-gets-nod-for-acofide-tablets-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1644/zeria-gets-nod-for-acofide-tablets-in-japan.html</link>
			<pubDate>Mon, 01 Apr 2013 14:26:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/zeria-gets-nod-for-acofide-tablets-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1644/zeria-gets-nod-for-acofide-tablets-in-japan.html</guid>
		</item>	
				<item>
			<title>Teva pregnancy &#039;preventor&#039; gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/1795/teva-pregnancy-preventor-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1795/teva-pregnancy-preventor-gets-fda-nod.html</link>
			<pubDate>Mon, 01 Apr 2013 14:03:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pregnant-no-more-teva-extended-oral-contraceptive-quartette-gets-fda-nod.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1795/teva-pregnancy-preventor-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>Takeda cancer unit is in a WIN-win situation</title>
			<atom:link href="https://biospectrumasia.com/news/50/3479/takeda-cancer-unit-is-in-a-win-win-situation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3479/takeda-cancer-unit-is-in-a-win-win-situation.html</link>
			<pubDate>Mon, 01 Apr 2013 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-oncology-and-the-worldwide-innovative-network-win-consortium-form-partnership-to-advance-personalized-cancer-treatments.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3479/takeda-cancer-unit-is-in-a-win-win-situation.html</guid>
		</item>	
				<item>
			<title>Japanese develops eye-based autism detector</title>
			<atom:link href="https://biospectrumasia.com/news/50/5501/japanese-develops-eye-based-autism-detector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5501/japanese-develops-eye-based-autism-detector.html</link>
			<pubDate>Fri, 29 Mar 2013 11:29:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-autism-patients-professor-yoshinobu-ebisawa-at-japan-s-shizuoka-university-developed-a-autism-eye-gaze-detection-system-to-predict-likelihood-of-autism.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5501/japanese-develops-eye-based-autism-detector.html</guid>
		</item>	
				<item>
			<title>Japan nods Pfizer arthritis drug Xeljanz </title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/8058/japan-nods-pfizer-arthritis-drug-xeljanz-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/8058/japan-nods-pfizer-arthritis-drug-xeljanz-.html</link>
			<pubDate>Thu, 28 Mar 2013 16:24:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pfizer-s-xeljanz-tofacitinib-citrate-has-received-approval-for-the-treatment-of-adults-with-rheumatoid-arthritis-ra.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/8058/japan-nods-pfizer-arthritis-drug-xeljanz-.html</guid>
		</item>	
				<item>
			<title>ReSearch, Asklep JV to offer CRO services in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7524/research-asklep-jv-to-offer-cro-services-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7524/research-asklep-jv-to-offer-cro-services-in-japan.html</link>
			<pubDate>Thu, 28 Mar 2013 13:54:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-asklep-jv-to-offer-cro-services-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7524/research-asklep-jv-to-offer-cro-services-in-japan.html</guid>
		</item>	
				<item>
			<title>FDA approves Eisai&#039;s gastro reflux drug </title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/7494/fda-approves-eisais-gastro-reflux-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/7494/fda-approves-eisais-gastro-reflux-drug-.html</link>
			<pubDate>Wed, 27 Mar 2013 14:11:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-gastroesophageal-reflux-disease-gerd-patients-eisai-aciphex-sprinkle-gets-fda-nod.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/7494/fda-approves-eisais-gastro-reflux-drug-.html</guid>
		</item>	
				<item>
			<title>Otsuka, Lundbeck sign $825 mn Alzheimer&#039;s deal </title>
			<atom:link href="https://biospectrumasia.com/news/50/1726/otsuka-lundbeck-sign-825-mn-alzheimers-deal-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1726/otsuka-lundbeck-sign-825-mn-alzheimers-deal-.html</link>
			<pubDate>Wed, 27 Mar 2013 14:00:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/otsuka-lundbeck-sign-usd825-mn-alzheimer-s-deal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1726/otsuka-lundbeck-sign-825-mn-alzheimers-deal-.html</guid>
		</item>	
				<item>
			<title>Bayer colorectal cancer drug gets Japanese nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/457/bayer-colorectal-cancer-drug-gets-japanese-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/457/bayer-colorectal-cancer-drug-gets-japanese-nod.html</link>
			<pubDate>Tue, 26 Mar 2013 10:42:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-approves-bayer-healthcare-and-onyx-pharmaceuticals-s-stivarga-regorafenib-for-treatment-of-metastatic-colorectal-cancer-mcrc.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/457/bayer-colorectal-cancer-drug-gets-japanese-nod.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo kids tumor drug gets Japanese nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2580/daiichi-sankyo-kids-tumor-drug-gets-japanese-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2580/daiichi-sankyo-kids-tumor-drug-gets-japanese-nod.html</link>
			<pubDate>Tue, 26 Mar 2013 10:33:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-s-topotecin-intravenous-drip-infusion-gets-japanese-nod-as-an-indication-for-pediatric-malignant-solid-tumor.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2580/daiichi-sankyo-kids-tumor-drug-gets-japanese-nod.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo reveals its five-year business plan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2259/daiichi-sankyo-reveals-its-five-year-business-plan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2259/daiichi-sankyo-reveals-its-five-year-business-plan.html</link>
			<pubDate>Fri, 22 Mar 2013 11:02:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business-plan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2259/daiichi-sankyo-reveals-its-five-year-business-plan.html</guid>
		</item>	
				<item>
			<title>NTT&#039;s conductive fiber to help in biomedical recordings</title>
			<atom:link href="https://biospectrumasia.com/news/50/7705/ntts-conductive-fiber-to-help-in-biomedical-recordings.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7705/ntts-conductive-fiber-to-help-in-biomedical-recordings.html</link>
			<pubDate>Thu, 21 Mar 2013 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7705/ntts-conductive-fiber-to-help-in-biomedical-recordings.html</guid>
		</item>	
				<item>
			<title>NPS gets orphan drugs&#039; rights from Takeda</title>
			<atom:link href="https://biospectrumasia.com/news/50/5449/nps-gets-orphan-drugs-rights-from-takeda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5449/nps-gets-orphan-drugs-rights-from-takeda.html</link>
			<pubDate>Wed, 20 Mar 2013 10:01:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nps-gets-rights-to-develop-and-commercialize-teduglutide-and-pth-1-84.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5449/nps-gets-orphan-drugs-rights-from-takeda.html</guid>
		</item>	
				<item>
			<title>Why big pharma is busy acquiring injectables firms?</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2628/why-big-pharma-is-busy-acquiring-injectables-firms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2628/why-big-pharma-is-busy-acquiring-injectables-firms.html</link>
			<pubDate>Wed, 20 Mar 2013 09:53:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/big-pharma-on-a-shopping-spree-to-buy-injectables-firms-especially-in-apac.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2628/why-big-pharma-is-busy-acquiring-injectables-firms.html</guid>
		</item>	
				<item>
			<title>Harvard, Sony collaborate for Organs-on-Chips</title>
			<atom:link href="https://biospectrumasia.com/news/50/5852/harvard-sony-collaborate-for-organs-on-chips.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5852/harvard-sony-collaborate-for-organs-on-chips.html</link>
			<pubDate>Mon, 18 Mar 2013 13:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wyss-institute-founding-director-dr-don-ingber-displays-organs-on-chips.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5852/harvard-sony-collaborate-for-organs-on-chips.html</guid>
		</item>	
				<item>
			<title>Dainippon, Nippon Shinyaku sign deal for new drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/1831/dainippon-nippon-shinyaku-sign-deal-for-new-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1831/dainippon-nippon-shinyaku-sign-deal-for-new-drug.html</link>
			<pubDate>Mon, 18 Mar 2013 11:09:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dsp-nippon-partnership.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1831/dainippon-nippon-shinyaku-sign-deal-for-new-drug.html</guid>
		</item>	
				<item>
			<title>Daiichi gets positive results in prasugrel trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/1552/daiichi-gets-positive-results-in-prasugrel-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1552/daiichi-gets-positive-results-in-prasugrel-trial.html</link>
			<pubDate>Mon, 18 Mar 2013 10:54:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1552/daiichi-gets-positive-results-in-prasugrel-trial.html</guid>
		</item>	
				<item>
			<title>TSRI, Takeda expand research collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/50/797/tsri-takeda-expand-research-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/797/tsri-takeda-expand-research-collaboration.html</link>
			<pubDate>Thu, 14 Mar 2013 10:13:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/797/tsri-takeda-expand-research-collaboration.html</guid>
		</item>	
				<item>
			<title>Sosei initiates oropharyngeal candidiasis trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/855/sosei-initiates-oropharyngeal-candidiasis-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/855/sosei-initiates-oropharyngeal-candidiasis-trial.html</link>
			<pubDate>Wed, 13 Mar 2013 14:35:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sosei-initiates-oropharyngeal-candidiasis-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/855/sosei-initiates-oropharyngeal-candidiasis-trial.html</guid>
		</item>	
				<item>
			<title>Naveed Shams is CEO of Santen US subsidiary</title>
			<atom:link href="https://biospectrumasia.com/news/50/7834/naveed-shams-is-ceo-of-santen-us-subsidiary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7834/naveed-shams-is-ceo-of-santen-us-subsidiary.html</link>
			<pubDate>Wed, 13 Mar 2013 10:51:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-naveed-shams-the-new-president-ceo-and-chief-scientific-officer-of-santen-pharma-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7834/naveed-shams-is-ceo-of-santen-us-subsidiary.html</guid>
		</item>	
				<item>
			<title>Neuland Labs strengthens commitment to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2453/neuland-labs-strengthens-commitment-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2453/neuland-labs-strengthens-commitment-to-japan.html</link>
			<pubDate>Wed, 13 Mar 2013 09:40:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mitsubishi-chemical-healthcare-unit-apic-to-investment-in-neuland-laboratories-facilities.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2453/neuland-labs-strengthens-commitment-to-japan.html</guid>
		</item>	
				<item>
			<title>St Jude launches 3-D heart vessel imager </title>
			<atom:link href="https://biospectrumasia.com/news/50/3644/st-jude-launches-3-d-heart-vessel-imager-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3644/st-jude-launches-3-d-heart-vessel-imager-.html</link>
			<pubDate>Tue, 12 Mar 2013 18:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/st-jude-medical-launched-3d-heart-imager-ilumien-optis-system.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3644/st-jude-launches-3-d-heart-vessel-imager-.html</guid>
		</item>	
				<item>
			<title>Cubist gets right to Astellas&#039; ceftolozane</title>
			<atom:link href="https://biospectrumasia.com/news/50/8013/cubist-gets-right-to-astellas-ceftolozane.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8013/cubist-gets-right-to-astellas-ceftolozane.html</link>
			<pubDate>Tue, 12 Mar 2013 17:21:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-pharma-gives-cubist-pharmaceuticals-rights-to-ceftolozane.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8013/cubist-gets-right-to-astellas-ceftolozane.html</guid>
		</item>	
				<item>
			<title>Astellas, UMN: Recombinant flu vaccine is better </title>
			<atom:link href="https://biospectrumasia.com/news/50/4982/astellas-umn-recombinant-flu-vaccine-is-better-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4982/astellas-umn-recombinant-flu-vaccine-is-better-.html</link>
			<pubDate>Tue, 12 Mar 2013 15:03:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-pharma-and-umn-pharma-reveal-that-recombinant-seasonal-influenza-ha-vaccine-is-non-inferior-to-egg-derived-vaccine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4982/astellas-umn-recombinant-flu-vaccine-is-better-.html</guid>
		</item>	
				<item>
			<title>Astellas, Ambit terminate cancer drug deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/452/astellas-ambit-terminate-cancer-drug-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/452/astellas-ambit-terminate-cancer-drug-deal.html</link>
			<pubDate>Tue, 12 Mar 2013 13:03:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-pharma-and-ambit-biosciences-end-collaboration-and-development-deal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/452/astellas-ambit-terminate-cancer-drug-deal.html</guid>
		</item>	
				<item>
			<title>Otsuka expands collaboration with Lundbeck</title>
			<atom:link href="https://biospectrumasia.com/news/50/8175/otsuka-expands-collaboration-with-lundbeck.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8175/otsuka-expands-collaboration-with-lundbeck.html</link>
			<pubDate>Tue, 12 Mar 2013 11:21:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8175/otsuka-expands-collaboration-with-lundbeck.html</guid>
		</item>	
				<item>
			<title>Daiichi to aid drug discovery projects</title>
			<atom:link href="https://biospectrumasia.com/news/50/1634/daiichi-to-aid-drug-discovery-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1634/daiichi-to-aid-drug-discovery-projects.html</link>
			<pubDate>Tue, 12 Mar 2013 10:53:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-discovery.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1634/daiichi-to-aid-drug-discovery-projects.html</guid>
		</item>	
				<item>
			<title>Japan uses Dolly sheep&#039;s method to clone mouse</title>
			<atom:link href="https://biospectrumasia.com/news/50/6217/japan-uses-dolly-sheeps-method-to-clone-mouse.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6217/japan-uses-dolly-sheeps-method-to-clone-mouse.html</link>
			<pubDate>Mon, 11 Mar 2013 17:08:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/riken-has-used-the-technique-of-somatic-cell-nuclear-transfer-which-has-been-used-to-create-dolly-the-sheep-to-produce-mouse-clones.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6217/japan-uses-dolly-sheeps-method-to-clone-mouse.html</guid>
		</item>	
				<item>
			<title>Astellas, UCB launch Cimzia in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2558/astellas-ucb-launch-cimzia-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2558/astellas-ucb-launch-cimzia-in-japan.html</link>
			<pubDate>Mon, 11 Mar 2013 11:34:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/new-product-astellas-ucb.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2558/astellas-ucb-launch-cimzia-in-japan.html</guid>
		</item>	
				<item>
			<title>GlobalData: Osteoporosis market to be $8 bn </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/162/globaldata-osteoporosis-market-to-be-8-bn-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/162/globaldata-osteoporosis-market-to-be-8-bn-.html</link>
			<pubDate>Fri, 08 Mar 2013 13:09:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/globaldata-estimates-the-osteoporosis-therapeutics-market-to-reach-usd8-billion-in-2022-from-usd6-billion-in-2012.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/162/globaldata-osteoporosis-market-to-be-8-bn-.html</guid>
		</item>	
				<item>
			<title>Takeda seeks bowel drug marketing nod from EU</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3243/takeda-seeks-bowel-drug-marketing-nod-from-eu.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3243/takeda-seeks-bowel-drug-marketing-nod-from-eu.html</link>
			<pubDate>Fri, 08 Mar 2013 11:29:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-seeks-eu-marketing-authorization-for-vedolizumab.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3243/takeda-seeks-bowel-drug-marketing-nod-from-eu.html</guid>
		</item>	
				<item>
			<title>SymBio Pharma completes patient enrollment</title>
			<atom:link href="https://biospectrumasia.com/news/50/2082/symbio-pharma-completes-patient-enrollment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2082/symbio-pharma-completes-patient-enrollment.html</link>
			<pubDate>Fri, 08 Mar 2013 11:13:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2082/symbio-pharma-completes-patient-enrollment.html</guid>
		</item>	
				<item>
			<title>Ajinomoto acquires US firm Althea</title>
			<atom:link href="https://biospectrumasia.com/news/50/8323/ajinomoto-acquires-us-firm-althea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8323/ajinomoto-acquires-us-firm-althea.html</link>
			<pubDate>Thu, 07 Mar 2013 10:39:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ajinomoto-acquires-althea.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8323/ajinomoto-acquires-us-firm-althea.html</guid>
		</item>	
				<item>
			<title>Cellectricon expands to Asia with distributors in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3695/cellectricon-expands-to-asia-with-distributors-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3695/cellectricon-expands-to-asia-with-distributors-in-japan.html</link>
			<pubDate>Wed, 06 Mar 2013 14:04:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/asia-expansion.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3695/cellectricon-expands-to-asia-with-distributors-in-japan.html</guid>
		</item>	
				<item>
			<title>Alchemia gets US patent for oncology platform technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/2159/alchemia-gets-us-patent-for-oncology-platform-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2159/alchemia-gets-us-patent-for-oncology-platform-technology.html</link>
			<pubDate>Wed, 06 Mar 2013 11:25:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-patent-for-alchemia.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2159/alchemia-gets-us-patent-for-oncology-platform-technology.html</guid>
		</item>	
				<item>
			<title>Toshiba Medical to set up Korean subsidiary</title>
			<atom:link href="https://biospectrumasia.com/news/50/4750/toshiba-medical-to-set-up-korean-subsidiary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4750/toshiba-medical-to-set-up-korean-subsidiary.html</link>
			<pubDate>Tue, 05 Mar 2013 14:12:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/toshiba-medical-acquires-70-percent-stocks-in-ti-medical-systems-to-develop-it-into-its-korean-subsidiary.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4750/toshiba-medical-to-set-up-korean-subsidiary.html</guid>
		</item>	
				<item>
			<title>Japanese patent for Imugene drug delivery tech</title>
			<atom:link href="https://biospectrumasia.com/news/50/7817/japanese-patent-for-imugene-drug-delivery-tech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7817/japanese-patent-for-imugene-drug-delivery-tech.html</link>
			<pubDate>Tue, 05 Mar 2013 10:53:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/imugene-novel-linguet-drug-deluivery-technology-gets-japanese-patent.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7817/japanese-patent-for-imugene-drug-delivery-tech.html</guid>
		</item>	
				<item>
			<title>Japan approves broader indication for Lyrica</title>
			<atom:link href="https://biospectrumasia.com/news/50/1762/japan-approves-broader-indication-for-lyrica.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1762/japan-approves-broader-indication-for-lyrica.html</link>
			<pubDate>Fri, 01 Mar 2013 11:30:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pfizer-eisai-approval-lyrica.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1762/japan-approves-broader-indication-for-lyrica.html</guid>
		</item>	
				<item>
			<title>Otsuka schizophrenia relapse gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3191/otsuka-schizophrenia-relapse-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3191/otsuka-schizophrenia-relapse-gets-fda-nod.html</link>
			<pubDate>Fri, 01 Mar 2013 10:46:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-nod-for-the-first-drug-abilify-maintena-to-be-commercialized-by-the-otsuka-and-lundbeck-alliance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3191/otsuka-schizophrenia-relapse-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>PGA, Astellas conduct women&#039;s day at golf tour </title>
			<atom:link href="https://biospectrumasia.com/news/50/1715/pga-astellas-conduct-womens-day-at-golf-tour-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1715/pga-astellas-conduct-womens-day-at-golf-tour-.html</link>
			<pubDate>Thu, 28 Feb 2013 15:20:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pga-tour-and-astellas-pharma-us-introduces-astellas-presents-executive-women-s-day.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1715/pga-astellas-conduct-womens-day-at-golf-tour-.html</guid>
		</item>	
				<item>
			<title>Taiho seeks Japanese nod for oral cancer agent </title>
			<atom:link href="https://biospectrumasia.com/news/50/257/taiho-seeks-japanese-nod-for-oral-cancer-agent-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/257/taiho-seeks-japanese-nod-for-oral-cancer-agent-.html</link>
			<pubDate>Thu, 28 Feb 2013 13:44:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/taiho-pjarma-seeks-japanese-ministry-of-health-labor-and-welfare-nod-to-manufacture-oral-cancer-agent-tas-102.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/257/taiho-seeks-japanese-nod-for-oral-cancer-agent-.html</guid>
		</item>	
				<item>
			<title>Takeda, Resolve to develop, sell autoimmune drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/178/takeda-resolve-to-develop-sell-autoimmune-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/178/takeda-resolve-to-develop-sell-autoimmune-drugs.html</link>
			<pubDate>Thu, 28 Feb 2013 12:12:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-pharma-and-resolve-therapeutics-to-develop-and-commercialize-drugs-for-the-treatment-of-lupus-and-other-autoimmune-diseases.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/178/takeda-resolve-to-develop-sell-autoimmune-drugs.html</guid>
		</item>	
				<item>
			<title>Shionogi &#039;painful intercourse&#039; drug gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/4192/shionogi-painful-intercourse-drug-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/4192/shionogi-painful-intercourse-drug-gets-fda-nod.html</link>
			<pubDate>Wed, 27 Feb 2013 10:54:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-vaginal-atrophy-patients-shionogi-gets-us-fda-approval-for-osphena-ospemifene-tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/4192/shionogi-painful-intercourse-drug-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>Eisai launches beauty drink in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/742/eisai-launches-beauty-drink-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/742/eisai-launches-beauty-drink-in-japan.html</link>
			<pubDate>Tue, 26 Feb 2013 13:08:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-women-eisai-to-launch-chocola-bb-sparkling-fiber-drink-containing-niacin-dietary-fiber-collagen-vitamin-b6-and-vitamin-c-image-source-mediaren.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/742/eisai-launches-beauty-drink-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeshi Yura is AMRI Asia discovery VP</title>
			<atom:link href="https://biospectrumasia.com/news/50/1169/takeshi-yura-is-amri-asia-discovery-vp.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1169/takeshi-yura-is-amri-asia-discovery-vp.html</link>
			<pubDate>Tue, 26 Feb 2013 10:39:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-takeshi-yura-promoted-to-the-position-of-vp-discovery-and-development-services-asia-amri.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1169/takeshi-yura-is-amri-asia-discovery-vp.html</guid>
		</item>	
				<item>
			<title>Niigata Univ stroke therapy license for Shimojani</title>
			<atom:link href="https://biospectrumasia.com/news/50/8506/niigata-univ-stroke-therapy-license-for-shimojani.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8506/niigata-univ-stroke-therapy-license-for-shimojani.html</link>
			<pubDate>Mon, 25 Feb 2013 12:28:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shimojani-gets-exclusive-commercialization-license-from-japan-s-niigata-university.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8506/niigata-univ-stroke-therapy-license-for-shimojani.html</guid>
		</item>	
				<item>
			<title>Affymax, Takeda recall anemia drug Omontys</title>
			<atom:link href="https://biospectrumasia.com/news/50/1322/affymax-takeda-recall-anemia-drug-omontys.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1322/affymax-takeda-recall-anemia-drug-omontys.html</link>
			<pubDate>Mon, 25 Feb 2013 12:14:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/affymax-and-takeda-recall-anemia-injection-omontys-peginesatide-after-reports-of-hypersensitivity-reactions.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1322/affymax-takeda-recall-anemia-drug-omontys.html</guid>
		</item>	
				<item>
			<title>Google, Facebook, Apple launch &#039;Breakthrough Prize in Life Sciences&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/50/2991/google-facebook-apple-launch-breakthrough-prize-in-life-sciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2991/google-facebook-apple-launch-breakthrough-prize-in-life-sciences.html</link>
			<pubDate>Thu, 21 Feb 2013 12:13:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/google-co-founder-sergey-brin-l-and-facebook-co-founder-mark-zuckerberg-r-launch-the-breakthrough-prize-in-life-sciences-prize-along-with-their-spouses-and-chairman-of-apple-arthur-levinson-and-russian-entr.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2991/google-facebook-apple-launch-breakthrough-prize-in-life-sciences.html</guid>
		</item>	
				<item>
			<title>Daiichi, Sanofi seeks nod for baby vaccine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2489/daiichi-sanofi-seeks-nod-for-baby-vaccine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2489/daiichi-sanofi-seeks-nod-for-baby-vaccine-in-japan.html</link>
			<pubDate>Thu, 21 Feb 2013 10:46:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tetravalent-dpt-ipv-vaccine-combines-kitasato-daiichi-sankyo-dpt-vaccine-and-sanofi-pasteur-enhanced-inactivated-salk-poliomyelitis-vaccine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2489/daiichi-sanofi-seeks-nod-for-baby-vaccine-in-japan.html</guid>
		</item>	
				<item>
			<title>Boston Scientific launches neuro product in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/4055/boston-scientific-launches-neuro-product-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4055/boston-scientific-launches-neuro-product-in-japan.html</link>
			<pubDate>Thu, 21 Feb 2013 10:33:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fukuda-denshi-to-market-boston-scientific-neuromodulation-product-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4055/boston-scientific-launches-neuro-product-in-japan.html</guid>
		</item>	
				<item>
			<title>WaferGen, Qiagen sign Next-Gen sequencing deal </title>
			<atom:link href="https://biospectrumasia.com/news/50/2124/wafergen-qiagen-sign-next-gen-sequencing-deal-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2124/wafergen-qiagen-sign-next-gen-sequencing-deal-.html</link>
			<pubDate>Wed, 20 Feb 2013 12:57:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wafergen-bio-systems-and-qiagen-to-co-promote-ngs-products-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2124/wafergen-qiagen-sign-next-gen-sequencing-deal-.html</guid>
		</item>	
				<item>
			<title>Takeda subsidiary suspended for &#039;no drug label&#039; </title>
			<atom:link href="https://biospectrumasia.com/news/50/464/takeda-subsidiary-suspended-for-no-drug-label-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/464/takeda-subsidiary-suspended-for-no-drug-label-.html</link>
			<pubDate>Wed, 20 Feb 2013 12:42:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-subsidiary-nihon-pharma-is-suspended-for-missing-drug-label-on-alinamin-f5-injections.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/464/takeda-subsidiary-suspended-for-no-drug-label-.html</guid>
		</item>	
				<item>
			<title>Aveo, Astellas report cancer trial results</title>
			<atom:link href="https://biospectrumasia.com/news/50/919/aveo-astellas-report-cancer-trial-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/919/aveo-astellas-report-cancer-trial-results.html</link>
			<pubDate>Tue, 19 Feb 2013 12:32:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aveo-oncology-and-astellas-pharma-announce-overall-survival-os-for-phase-iii-tivozanib-versus-sorafenib-study-in-advanced-renal-cell-carcinoma-rcc.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/919/aveo-astellas-report-cancer-trial-results.html</guid>
		</item>	
				<item>
			<title>Shimadzu to launch gas chromatograph Tracera</title>
			<atom:link href="https://biospectrumasia.com/news/50/2497/shimadzu-to-launch-gas-chromatograph-tracera.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2497/shimadzu-to-launch-gas-chromatograph-tracera.html</link>
			<pubDate>Tue, 19 Feb 2013 12:12:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shimadzu-gas-chromatograph-tracera-features-a-barrier-discharge-ionization-detector-bid-capable-of-detecting-all-types-of-trace-0.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2497/shimadzu-to-launch-gas-chromatograph-tracera.html</guid>
		</item>	
				<item>
			<title>Daiichi forms new firm to treat muscular dystrophy</title>
			<atom:link href="https://biospectrumasia.com/news/50/6248/daiichi-forms-new-firm-to-treat-muscular-dystrophy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6248/daiichi-forms-new-firm-to-treat-muscular-dystrophy.html</link>
			<pubDate>Mon, 18 Feb 2013 10:25:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-duchenne-muscular-dystrophy-dmd-patients-daiichi-sankyo-innovation-network-corporation-of-japan-incj-and-mitsubishi-ufj-capital-to-develop-new-treatment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6248/daiichi-forms-new-firm-to-treat-muscular-dystrophy.html</guid>
		</item>	
				<item>
			<title>Indo-Japan ties on the rise</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/6192/indo-japan-ties-on-the-rise.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/6192/indo-japan-ties-on-the-rise.html</link>
			<pubDate>Mon, 18 Feb 2013 07:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-sun-is-shining-as-bright-as-ever-for-indo-japanese-life-science-relation.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/6192/indo-japan-ties-on-the-rise.html</guid>
		</item>	
				<item>
			<title>FDA grants orphan status to Eisai cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/5758/fda-grants-orphan-status-to-eisai-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5758/fda-grants-orphan-status-to-eisai-cancer-drug.html</link>
			<pubDate>Fri, 15 Feb 2013 13:17:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-grants-orphan-drug-status-to-eisai-cancer-drug-lenvatinib.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5758/fda-grants-orphan-status-to-eisai-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Rheumatoid arthritis mAb market to reach $15.7 bn </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/4722/rheumatoid-arthritis-mab-market-to-reach-15-7-bn-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/4722/rheumatoid-arthritis-mab-market-to-reach-15-7-bn-.html</link>
			<pubDate>Fri, 15 Feb 2013 12:46:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rheumatoid-arthritis-mab-market-to-touch-usd-15.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/4722/rheumatoid-arthritis-mab-market-to-reach-15-7-bn-.html</guid>
		</item>	
				<item>
			<title>Sigma-Aldrich, Tokyo university develop microRNA </title>
			<atom:link href="https://biospectrumasia.com/news/50/7547/sigma-aldrich-tokyo-university-develop-microrna-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7547/sigma-aldrich-tokyo-university-develop-microrna-.html</link>
			<pubDate>Thu, 14 Feb 2013 13:48:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sigma-aldrich-s-innovative-biological-products-business-sigma-life-science-collaborates-with-university-of-tokyo-researchers-to-develop-lentiviral-microrna-inhibitors.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7547/sigma-aldrich-tokyo-university-develop-microrna-.html</guid>
		</item>	
				<item>
			<title>Japan firms keen to collaborate with Indian pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/3260/japan-firms-keen-to-collaborate-with-indian-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3260/japan-firms-keen-to-collaborate-with-indian-pharma.html</link>
			<pubDate>Thu, 14 Feb 2013 11:50:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-india-collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3260/japan-firms-keen-to-collaborate-with-indian-pharma.html</guid>
		</item>	
				<item>
			<title>Photonics commercializes tissue surgery laser </title>
			<atom:link href="https://biospectrumasia.com/news/50/7189/photonics-commercializes-tissue-surgery-laser-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7189/photonics-commercializes-tissue-surgery-laser-.html</link>
			<pubDate>Wed, 13 Feb 2013 15:04:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/photonics-commercializes-stlase-laser-system-in-the-global-market-under-the-brand-name-alta.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7189/photonics-commercializes-tissue-surgery-laser-.html</guid>
		</item>	
				<item>
			<title>Italian, Japanese robot firms sign healthcare deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/5332/italian-japanese-robot-firms-sign-healthcare-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5332/italian-japanese-robot-firms-sign-healthcare-deal.html</link>
			<pubDate>Wed, 13 Feb 2013 12:19:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/italian-health-robotics-and-japanese-robotics-firm-tosho-join-hands-for-healthcare-sector-deal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5332/italian-japanese-robot-firms-sign-healthcare-deal.html</guid>
		</item>	
				<item>
			<title>Japan to revise medical device approval procedures</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/1211/japan-to-revise-medical-device-approval-procedures.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/1211/japan-to-revise-medical-device-approval-procedures.html</link>
			<pubDate>Wed, 13 Feb 2013 11:19:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/time-medical-device-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/1211/japan-to-revise-medical-device-approval-procedures.html</guid>
		</item>	
				<item>
			<title>Daiichi faces $100 mn law suit for gender discrimination</title>
			<atom:link href="https://biospectrumasia.com/news/50/3100/daiichi-faces-100-mn-law-suit-for-gender-discrimination.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3100/daiichi-faces-100-mn-law-suit-for-gender-discrimination.html</link>
			<pubDate>Wed, 13 Feb 2013 11:05:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/female-employees-file-usd100-million-lawsuit-against-daiichi-sankyo-for-gender-discrimination.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3100/daiichi-faces-100-mn-law-suit-for-gender-discrimination.html</guid>
		</item>	
				<item>
			<title>Nanotec Thailand, AIST Japan join hands for R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/50/3480/nanotec-thailand-aist-japan-join-hands-for-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3480/nanotec-thailand-aist-japan-join-hands-for-rd.html</link>
			<pubDate>Tue, 12 Feb 2013 17:19:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nanotec-thailand-and-nanosystem-research-institute-nri-of-the-national-institute-of-advanced-industrial-science-and-technology-aist-japan-sign-letter-of-intent-loi.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3480/nanotec-thailand-aist-japan-join-hands-for-rd.html</guid>
		</item>	
				<item>
			<title>Japan approves Zoll&#039;s temp management system</title>
			<atom:link href="https://biospectrumasia.com/news/50/3495/japan-approves-zolls-temp-management-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3495/japan-approves-zolls-temp-management-system.html</link>
			<pubDate>Tue, 12 Feb 2013 11:30:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-zoll-product-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3495/japan-approves-zolls-temp-management-system.html</guid>
		</item>	
				<item>
			<title>Sucampo, Takeda file patent suit against Aunchen</title>
			<atom:link href="https://biospectrumasia.com/news/50/3960/sucampo-takeda-file-patent-suit-against-aunchen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3960/sucampo-takeda-file-patent-suit-against-aunchen.html</link>
			<pubDate>Mon, 11 Feb 2013 12:46:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sucampo-takeda-files-patent-infringement-lawsuit-against-anchen-and-par.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3960/sucampo-takeda-file-patent-suit-against-aunchen.html</guid>
		</item>	
				<item>
			<title>OxOnc, Pfizer drug trial to be held in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/50/7037/oxonc-pfizer-drug-trial-to-be-held-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7037/oxonc-pfizer-drug-trial-to-be-held-in-asia.html</link>
			<pubDate>Mon, 11 Feb 2013 11:31:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7037/oxonc-pfizer-drug-trial-to-be-held-in-asia.html</guid>
		</item>	
				<item>
			<title>Cellmid to supply diagnostic antibodies to Fujikura</title>
			<atom:link href="https://biospectrumasia.com/news/50/6900/cellmid-to-supply-diagnostic-antibodies-to-fujikura.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6900/cellmid-to-supply-diagnostic-antibodies-to-fujikura.html</link>
			<pubDate>Mon, 11 Feb 2013 11:29:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cellmid-to-supply-anti-midkine-diagnostic-antibodies-to-fujikura-kasei.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6900/cellmid-to-supply-diagnostic-antibodies-to-fujikura.html</guid>
		</item>	
				<item>
			<title>Biosensors to collaborate with Terumo in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1142/biosensors-to-collaborate-with-terumo-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1142/biosensors-to-collaborate-with-terumo-in-japan.html</link>
			<pubDate>Fri, 08 Feb 2013 13:28:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-replicon-pfizer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1142/biosensors-to-collaborate-with-terumo-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese firm establishes Singapore subsidiary</title>
			<atom:link href="https://biospectrumasia.com/news/50/6608/japanese-firm-establishes-singapore-subsidiary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6608/japanese-firm-establishes-singapore-subsidiary.html</link>
			<pubDate>Fri, 08 Feb 2013 13:09:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/singapore-office.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6608/japanese-firm-establishes-singapore-subsidiary.html</guid>
		</item>	
				<item>
			<title>Solasia appoints Yoshihiro Arai as president</title>
			<atom:link href="https://biospectrumasia.com/news/50/2733/solasia-appoints-yoshihiro-arai-as-president.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2733/solasia-appoints-yoshihiro-arai-as-president.html</link>
			<pubDate>Thu, 07 Feb 2013 12:02:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/china-market-solasia-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2733/solasia-appoints-yoshihiro-arai-as-president.html</guid>
		</item>	
				<item>
			<title>Orphan blood disease drugs to gain market</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5462/orphan-blood-disease-drugs-to-gain-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5462/orphan-blood-disease-drugs-to-gain-market.html</link>
			<pubDate>Thu, 07 Feb 2013 10:32:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rare-blood-disorder-treatments.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5462/orphan-blood-disease-drugs-to-gain-market.html</guid>
		</item>	
				<item>
			<title>Astellas appoints Sef Kurstjens as CMO</title>
			<atom:link href="https://biospectrumasia.com/news/50/3331/astellas-appoints-sef-kurstjens-as-cmo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3331/astellas-appoints-sef-kurstjens-as-cmo.html</link>
			<pubDate>Wed, 06 Feb 2013 10:46:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-management-reorganization.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3331/astellas-appoints-sef-kurstjens-as-cmo.html</guid>
		</item>	
				<item>
			<title>RaQualia, Interprotein to research on pain drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/7669/raqualia-interprotein-to-research-on-pain-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7669/raqualia-interprotein-to-research-on-pain-drug-.html</link>
			<pubDate>Mon, 04 Feb 2013 12:39:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-patients-suffering-from-pain-raqualia-pharma-and-interprotein-enter-into-collaborative-research-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7669/raqualia-interprotein-to-research-on-pain-drug-.html</guid>
		</item>	
				<item>
			<title>Takeda gets FDA nod for three diabetes drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/1957/takeda-gets-fda-nod-for-three-diabetes-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1957/takeda-gets-fda-nod-for-three-diabetes-drugs.html</link>
			<pubDate>Mon, 04 Feb 2013 11:23:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-fda-aaproval.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1957/takeda-gets-fda-nod-for-three-diabetes-drugs.html</guid>
		</item>	
				<item>
			<title>Santen to give $7.9 mn fund to Clearside</title>
			<atom:link href="https://biospectrumasia.com/news/50/1342/santen-to-give-7-9-mn-fund-to-clearside.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1342/santen-to-give-7-9-mn-fund-to-clearside.html</link>
			<pubDate>Fri, 01 Feb 2013 17:42:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/santen-to-give-usd7.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1342/santen-to-give-7-9-mn-fund-to-clearside.html</guid>
		</item>	
				<item>
			<title>Daiichi, ArQule enroll patient for cancer trial </title>
			<atom:link href="https://biospectrumasia.com/news/50/7702/daiichi-arqule-enroll-patient-for-cancer-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7702/daiichi-arqule-enroll-patient-for-cancer-trial-.html</link>
			<pubDate>Fri, 01 Feb 2013 17:30:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-arqule-enroll-patient-for-hepatocellular-carcinoma-cancer-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7702/daiichi-arqule-enroll-patient-for-cancer-trial-.html</guid>
		</item>	
				<item>
			<title>Elsevier collaborates with Kanazawa Univ, Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6500/elsevier-collaborates-with-kanazawa-univ-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6500/elsevier-collaborates-with-kanazawa-univ-japan.html</link>
			<pubDate>Fri, 01 Feb 2013 15:03:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/elsevier-has-provided-japan-s-kanazawa-university-access-to-scival-consultative-support.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6500/elsevier-collaborates-with-kanazawa-univ-japan.html</guid>
		</item>	
				<item>
			<title>Japanese firm to begin clinical research in Bahrain</title>
			<atom:link href="https://biospectrumasia.com/news/50/3492/japanese-firm-to-begin-clinical-research-in-bahrain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3492/japanese-firm-to-begin-clinical-research-in-bahrain.html</link>
			<pubDate>Fri, 01 Feb 2013 11:42:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-research-diabetes.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3492/japanese-firm-to-begin-clinical-research-in-bahrain.html</guid>
		</item>	
				<item>
			<title>Chugai seeks nod for breast cancer drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2899/chugai-seeks-nod-for-breast-cancer-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2899/chugai-seeks-nod-for-breast-cancer-drug-in-japan.html</link>
			<pubDate>Fri, 01 Feb 2013 11:16:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chugai-application-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2899/chugai-seeks-nod-for-breast-cancer-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Medicago, Mitsubishi to co-cultivate plants</title>
			<atom:link href="https://biospectrumasia.com/news/50/6639/medicago-mitsubishi-to-co-cultivate-plants.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6639/medicago-mitsubishi-to-co-cultivate-plants.html</link>
			<pubDate>Thu, 31 Jan 2013 14:37:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicago-mitsubishi-to-develop-next-gen-technology-for-plant-production.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6639/medicago-mitsubishi-to-co-cultivate-plants.html</guid>
		</item>	
				<item>
			<title>What are the hurdles before stem cell research? </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2846/what-are-the-hurdles-before-stem-cell-research-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2846/what-are-the-hurdles-before-stem-cell-research-.html</link>
			<pubDate>Thu, 31 Jan 2013 08:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-stem-cell-industry-is-boldly-jumping-over-all-hurdles.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2846/what-are-the-hurdles-before-stem-cell-research-.html</guid>
		</item>	
				<item>
			<title>What&#039;s the stem cell regulatory scenario like in APAC? </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5632/whats-the-stem-cell-regulatory-scenario-like-in-apac-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5632/whats-the-stem-cell-regulatory-scenario-like-in-apac-.html</link>
			<pubDate>Thu, 31 Jan 2013 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/apac-stem-cell-industry-faces-a-severe-regulatory-bind.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5632/whats-the-stem-cell-regulatory-scenario-like-in-apac-.html</guid>
		</item>	
				<item>
			<title>Embryonic stem cells remain a sticky wicket</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/6077/embryonic-stem-cells-remain-a-sticky-wicket.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/6077/embryonic-stem-cells-remain-a-sticky-wicket.html</link>
			<pubDate>Thu, 31 Jan 2013 19:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientists-still-need-to-measure-ips-cells-against-the-gold-standard-of-human-embryonic-stem-cells.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/6077/embryonic-stem-cells-remain-a-sticky-wicket.html</guid>
		</item>	
				<item>
			<title>Stem cell industry has substantial growth potential </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2942/stem-cell-industry-has-substantial-growth-potential-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2942/stem-cell-industry-has-substantial-growth-potential-.html</link>
			<pubDate>Thu, 31 Jan 2013 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-cells-the-high-potential-growth-engine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2942/stem-cell-industry-has-substantial-growth-potential-.html</guid>
		</item>	
				<item>
			<title>Eisai seeks nod for cancer, epilepsy drug in S Africa</title>
			<atom:link href="https://biospectrumasia.com/news/50/1410/eisai-seeks-nod-for-cancer-epilepsy-drug-in-s-africa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1410/eisai-seeks-nod-for-cancer-epilepsy-drug-in-s-africa.html</link>
			<pubDate>Wed, 30 Jan 2013 14:17:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-cancer-nad-epilepsy-patients-eisai-seeks-nod-for-halaven-eribulin-and-fycompa-perampanel-from-medicines-control-council-mcc-south-africa.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1410/eisai-seeks-nod-for-cancer-epilepsy-drug-in-s-africa.html</guid>
		</item>	
				<item>
			<title>Dezima in-licenses CETP inhibitor from Mitsubishi</title>
			<atom:link href="https://biospectrumasia.com/news/50/3137/dezima-in-licenses-cetp-inhibitor-from-mitsubishi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3137/dezima-in-licenses-cetp-inhibitor-from-mitsubishi.html</link>
			<pubDate>Tue, 29 Jan 2013 11:20:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dezima-mitsubishi-license.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3137/dezima-in-licenses-cetp-inhibitor-from-mitsubishi.html</guid>
		</item>	
				<item>
			<title>Singapore, Japan immunology school concludes</title>
			<atom:link href="https://biospectrumasia.com/news/50/4213/singapore-japan-immunology-school-concludes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4213/singapore-japan-immunology-school-concludes.html</link>
			<pubDate>Fri, 25 Jan 2013 12:57:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/singapore-japan-join-hands-to-nurture-immunologists-in-asia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4213/singapore-japan-immunology-school-concludes.html</guid>
		</item>	
				<item>
			<title>Evolva, Ajinomoto enter development deal </title>
			<atom:link href="https://biospectrumasia.com/news/50/1784/evolva-ajinomoto-enter-development-deal-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1784/evolva-ajinomoto-enter-development-deal-.html</link>
			<pubDate>Thu, 24 Jan 2013 13:38:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/evolva-holding-and-ajinomoto-to-jointly-develop-novel-fermentation-production-routes.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1784/evolva-ajinomoto-enter-development-deal-.html</guid>
		</item>	
				<item>
			<title>Thailand, Japan collaborate on bioremediation</title>
			<atom:link href="https://biospectrumasia.com/news/50/908/thailand-japan-collaborate-on-bioremediation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/908/thailand-japan-collaborate-on-bioremediation.html</link>
			<pubDate>Tue, 22 Jan 2013 14:30:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thailand-japan-collaborate-on-bioremediation.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/908/thailand-japan-collaborate-on-bioremediation.html</guid>
		</item>	
				<item>
			<title>BIOTEC launches microbe management course</title>
			<atom:link href="https://biospectrumasia.com/news/50/8326/biotec-launches-microbe-management-course.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8326/biotec-launches-microbe-management-course.html</link>
			<pubDate>Tue, 22 Jan 2013 14:02:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/training-course-on-curation-and-management-of-microbial-resources-was-held-on-january-14-17-2013-at-biotec-thailand-science-park.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8326/biotec-launches-microbe-management-course.html</guid>
		</item>	
				<item>
			<title>Qualyst to supply B-Clear hepatocytes kits in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3516/qualyst-to-supply-b-clear-hepatocytes-kits-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3516/qualyst-to-supply-b-clear-hepatocytes-kits-in-japan.html</link>
			<pubDate>Tue, 22 Jan 2013 11:09:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/qualyst-to-supply-b-clear-hepatocytes-kits-in-japan-via-genomembrane.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3516/qualyst-to-supply-b-clear-hepatocytes-kits-in-japan.html</guid>
		</item>	
				<item>
			<title>Teijin, Ipsen launch gigantism drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/5171/teijin-ipsen-launch-gigantism-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5171/teijin-ipsen-launch-gigantism-drug-.html</link>
			<pubDate>Fri, 18 Jan 2013 13:25:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-acromegaly-and-pituitary-gigantism-patients-teijin-pharma-and-ipsen-launched-somatuline-injection.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5171/teijin-ipsen-launch-gigantism-drug-.html</guid>
		</item>	
				<item>
			<title>FDA accepts sNDA for Astellas cancer drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/732/fda-accepts-snda-for-astellas-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/732/fda-accepts-snda-for-astellas-cancer-drug.html</link>
			<pubDate>Thu, 17 Jan 2013 11:02:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-lung-cancer-patients-fda-accepts-astellas-supplemental-new-drug-application-for-tarceva-erlotinib-tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/732/fda-accepts-snda-for-astellas-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Daiichi, Ranbaxy integrate Thailand business</title>
			<atom:link href="https://biospectrumasia.com/news/50/2579/daiichi-ranbaxy-integrate-thailand-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2579/daiichi-ranbaxy-integrate-thailand-business.html</link>
			<pubDate>Wed, 16 Jan 2013 16:56:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-thailand-and-ranbaxy-unichem-will-integrate-their-business-operations-in-thailand.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2579/daiichi-ranbaxy-integrate-thailand-business.html</guid>
		</item>	
				<item>
			<title>US-based ERT expands in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/7640/us-based-ert-expands-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7640/us-based-ert-expands-in-japan-.html</link>
			<pubDate>Wed, 16 Jan 2013 08:42:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-based-ert-sets-up-shop-in-japan-under-the-name-of-ert-asia-group.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7640/us-based-ert-expands-in-japan-.html</guid>
		</item>	
				<item>
			<title>NovAliX, Kyowa Hakko Kirin sign deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/4105/novalix-kyowa-hakko-kirin-sign-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4105/novalix-kyowa-hakko-kirin-sign-deal.html</link>
			<pubDate>Tue, 15 Jan 2013 14:17:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novalix-and-kyowa-hakko-kirin-to-co-develop-novel-drug-candidates-against-protein-protein-interaction-targets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4105/novalix-kyowa-hakko-kirin-sign-deal.html</guid>
		</item>	
				<item>
			<title>Eisai subsidiary announces cancer trial results </title>
			<atom:link href="https://biospectrumasia.com/news/50/7841/eisai-subsidiary-announces-cancer-trial-results-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7841/eisai-subsidiary-announces-cancer-trial-results-.html</link>
			<pubDate>Tue, 15 Jan 2013 12:57:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-platinum-sensitive-epithelial-ovarian-cancer-patients-eisai-announced-preliminary-results-of-its-global-phase-iii-study-of-farletuzumab-morab-003.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7841/eisai-subsidiary-announces-cancer-trial-results-.html</guid>
		</item>	
				<item>
			<title>Astellas, Sanwa launch hyperkalemia treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/1778/astellas-sanwa-launch-hyperkalemia-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1778/astellas-sanwa-launch-hyperkalemia-treatment.html</link>
			<pubDate>Tue, 15 Jan 2013 10:44:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-sanwa-launch-hyperkalemia-treatment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1778/astellas-sanwa-launch-hyperkalemia-treatment.html</guid>
		</item>	
				<item>
			<title>Daiichi, ArQule cancer trial fails to meet endpoint </title>
			<atom:link href="https://biospectrumasia.com/news/50/4234/daiichi-arqule-cancer-trial-fails-to-meet-endpoint-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4234/daiichi-arqule-cancer-trial-fails-to-meet-endpoint-.html</link>
			<pubDate>Mon, 14 Jan 2013 14:17:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-arqule-s-relapsed-colorectal-cancer-crc-trial-did-not-meet-its-primary-endpoint-of-progression-free-survival-pfs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4234/daiichi-arqule-cancer-trial-fails-to-meet-endpoint-.html</guid>
		</item>	
				<item>
			<title>Eisai, Epizyme, Roche develop lymphoma tool </title>
			<atom:link href="https://biospectrumasia.com/news/50/4033/eisai-epizyme-roche-develop-lymphoma-tool-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4033/eisai-epizyme-roche-develop-lymphoma-tool-.html</link>
			<pubDate>Mon, 14 Jan 2013 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-epizyme-roche-collaborate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4033/eisai-epizyme-roche-develop-lymphoma-tool-.html</guid>
		</item>	
				<item>
			<title>Pronova, Takeda launch Lotriga in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5071/pronova-takeda-launch-lotriga-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5071/pronova-takeda-launch-lotriga-in-japan.html</link>
			<pubDate>Fri, 11 Jan 2013 11:32:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-hyperlipidemia-patients-pronova-biopharma-and-takeda-launch-lotriga-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5071/pronova-takeda-launch-lotriga-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai, Novartis terminate COPD deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/3344/eisai-novartis-terminate-copd-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3344/eisai-novartis-terminate-copd-deal.html</link>
			<pubDate>Fri, 11 Jan 2013 11:22:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-eisai-terminate-deal-for-three-copd-therapies-including-onbrez-and-seebri-inhalation-capsules-and-investigational-drug-qva149.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3344/eisai-novartis-terminate-copd-deal.html</guid>
		</item>	
				<item>
			<title>Eisai launches implantable anti-tumor agent </title>
			<atom:link href="https://biospectrumasia.com/news/50/4016/eisai-launches-implantable-anti-tumor-agent-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4016/eisai-launches-implantable-anti-tumor-agent-.html</link>
			<pubDate>Fri, 11 Jan 2013 11:13:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-neoplastic-patients-eisai-and-nobelpharma-launch-gliadel-7.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4016/eisai-launches-implantable-anti-tumor-agent-.html</guid>
		</item>	
				<item>
			<title>Chugai gives cancer drug license to Debiopharm</title>
			<atom:link href="https://biospectrumasia.com/news/50/1683/chugai-gives-cancer-drug-license-to-debiopharm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1683/chugai-gives-cancer-drug-license-to-debiopharm.html</link>
			<pubDate>Wed, 09 Jan 2013 11:21:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chugai-debiopharm-shake-hands-on-cancer-drug-candidate-deal-for-ff284-debio-1347.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1683/chugai-gives-cancer-drug-license-to-debiopharm.html</guid>
		</item>	
				<item>
			<title>Japanese stem cell firm ReproCell expands to US</title>
			<atom:link href="https://biospectrumasia.com/news/50/1261/japanese-stem-cell-firm-reprocell-expands-to-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1261/japanese-stem-cell-firm-reprocell-expands-to-us.html</link>
			<pubDate>Wed, 09 Jan 2013 10:39:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/reprocell-office-boston.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1261/japanese-stem-cell-firm-reprocell-expands-to-us.html</guid>
		</item>	
				<item>
			<title>Takeda enters into supply agreement for Omontys</title>
			<atom:link href="https://biospectrumasia.com/news/50/904/takeda-enters-into-supply-agreement-for-omontys.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/904/takeda-enters-into-supply-agreement-for-omontys.html</link>
			<pubDate>Tue, 08 Jan 2013 13:08:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-and-affymax-enter-deal-for-supply-of-omontys-peginesatide-injection-with-dsi-renal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/904/takeda-enters-into-supply-agreement-for-omontys.html</guid>
		</item>	
				<item>
			<title>Will Keryx&#039;s ferric citrate NDA get nod in Japan?</title>
			<atom:link href="https://biospectrumasia.com/news/50/736/will-keryxs-ferric-citrate-nda-get-nod-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/736/will-keryxs-ferric-citrate-nda-get-nod-in-japan.html</link>
			<pubDate>Tue, 08 Jan 2013 12:36:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/will-keryx-biopharma-s-new-drug-application-nda-for-marketing-approval-of-ferric-citrate-be-approved-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/736/will-keryxs-ferric-citrate-nda-get-nod-in-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi, Amplimmune join hands for protein R&amp;D </title>
			<atom:link href="https://biospectrumasia.com/news/50/3885/daiichi-amplimmune-join-hands-for-protein-rd-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3885/daiichi-amplimmune-join-hands-for-protein-rd-.html</link>
			<pubDate>Tue, 08 Jan 2013 12:02:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-patients-suffering-from-autoimmune-diseases-daiichi-sankyo-amplimmune-to-collaborate-on-fusion-protein-r-d.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3885/daiichi-amplimmune-join-hands-for-protein-rd-.html</guid>
		</item>	
				<item>
			<title>Cancer-specific killer T cells created from iPS cells</title>
			<atom:link href="https://biospectrumasia.com/news/50/7358/cancer-specific-killer-t-cells-created-from-ips-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7358/cancer-specific-killer-t-cells-created-from-ips-cells.html</link>
			<pubDate>Mon, 07 Jan 2013 10:08:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-ips-cell-riken.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7358/cancer-specific-killer-t-cells-created-from-ips-cells.html</guid>
		</item>	
				<item>
			<title>KHK advances DsiRNA cancer target, pays $5 mn</title>
			<atom:link href="https://biospectrumasia.com/news/50/2541/khk-advances-dsirna-cancer-target-pays-5-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2541/khk-advances-dsirna-cancer-target-pays-5-mn.html</link>
			<pubDate>Fri, 04 Jan 2013 12:05:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kyowa-hakko-kirin-khk-will-pay-dicerna-pharma-usd5-million-milestone-payment-for-advancing-second-therapeutic-oncology-candidate-dicer-substrate-sirna-from-the-r-d-stage.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2541/khk-advances-dsirna-cancer-target-pays-5-mn.html</guid>
		</item>	
				<item>
			<title>Affymax, Takeda announce J-code for Omontys</title>
			<atom:link href="https://biospectrumasia.com/news/50/2452/affymax-takeda-announce-j-code-for-omontys.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2452/affymax-takeda-announce-j-code-for-omontys.html</link>
			<pubDate>Fri, 04 Jan 2013 11:35:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/centers-for-medicare-and-medicaid-services-cms-assings-j-code-for-affymax-and-takeda-pharmaceuticals-omontys-peginesatide-injection-to-provide-for-streamlined-reimbursement-for-dialysis-organizations-presc.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2452/affymax-takeda-announce-j-code-for-omontys.html</guid>
		</item>	
				<item>
			<title>Fujifilm, Lantheus enter 10-year deal in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/4094/fujifilm-lantheus-enter-10-year-deal-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4094/fujifilm-lantheus-enter-10-year-deal-in-japan.html</link>
			<pubDate>Fri, 04 Jan 2013 11:06:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lantheus-medical-imaging-and-fujifilm-ri-pharma-fri-eneter-10-year-deal-to-license-and-distribute-cardiolite-and-neurolite-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4094/fujifilm-lantheus-enter-10-year-deal-in-japan.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk insulin analogue gets Japanese nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/1277/novo-nordisk-insulin-analogue-gets-japanese-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1277/novo-nordisk-insulin-analogue-gets-japanese-nod.html</link>
			<pubDate>Wed, 02 Jan 2013 11:06:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novo-nordisk-insulin-analogue-ryzodeg-approved-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1277/novo-nordisk-insulin-analogue-gets-japanese-nod.html</guid>
		</item>	
				<item>
			<title>Astellas, UCB announce approval of Cimzia in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/987/astellas-ucb-announce-approval-of-cimzia-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/987/astellas-ucb-announce-approval-of-cimzia-in-japan.html</link>
			<pubDate>Tue, 01 Jan 2013 23:16:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/987/astellas-ucb-announce-approval-of-cimzia-in-japan.html</guid>
		</item>	
				<item>
			<title>APAC stem cell therapy market to reach $972mn in 2018</title>
			<atom:link href="https://biospectrumasia.com/news/50/1164/apac-stem-cell-therapy-market-to-reach-972mn-in-2018.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1164/apac-stem-cell-therapy-market-to-reach-972mn-in-2018.html</link>
			<pubDate>Tue, 01 Jan 2013 13:31:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-cell-therapy-market-in-apac-to-be-worth-usd972-million-in-2018.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1164/apac-stem-cell-therapy-market-to-reach-972mn-in-2018.html</guid>
		</item>	
				<item>
			<title>Bionest and Scisive merge together </title>
			<atom:link href="https://biospectrumasia.com/news/50/1012/bionest-and-scisive-merge-together-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1012/bionest-and-scisive-merge-together-.html</link>
			<pubDate>Mon, 31 Dec 2012 13:51:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-life-science-firms-bionest-partners-and-scisive-consulting-merge-to-create-best-in-class-global-consulting-firm.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1012/bionest-and-scisive-merge-together-.html</guid>
		</item>	
				<item>
			<title>Japan approves Crimzia for arthritis patients</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/6551/japan-approves-crimzia-for-arthritis-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/6551/japan-approves-crimzia-for-arthritis-patients.html</link>
			<pubDate>Fri, 28 Dec 2012 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-approves-crimzia-certolizumab-pegol-for-rheumatoid-arthritis-patients.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/6551/japan-approves-crimzia-for-arthritis-patients.html</guid>
		</item>	
				<item>
			<title>RLS, Parkinson&#039;s drug Neupro gets Japanese nod </title>
			<atom:link href="https://biospectrumasia.com/news/50/632/rls-parkinsons-drug-neupro-gets-japanese-nod-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/632/rls-parkinsons-drug-neupro-gets-japanese-nod-.html</link>
			<pubDate>Fri, 28 Dec 2012 12:51:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neupro-rotigotine-transdermal-patch.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/632/rls-parkinsons-drug-neupro-gets-japanese-nod-.html</guid>
		</item>	
				<item>
			<title>Japan approves generic drug for osteoporosis</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/1047/japan-approves-generic-drug-for-osteoporosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/1047/japan-approves-generic-drug-for-osteoporosis.html</link>
			<pubDate>Fri, 28 Dec 2012 12:03:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-osteoporosis-patients-generics-of-risedronate-sodium-hydrate-by-ajinomoto-and-takeda-get-japanese-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/1047/japan-approves-generic-drug-for-osteoporosis.html</guid>
		</item>	
				<item>
			<title>BMS-Pfizer stroke drug gets Japanese nod</title>
			<atom:link href="https://biospectrumasia.com/news/50/1155/bms-pfizer-stroke-drug-gets-japanese-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1155/bms-pfizer-stroke-drug-gets-japanese-nod.html</link>
			<pubDate>Thu, 27 Dec 2012 12:04:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-ischemic-stroke-and-systemic-embolism-patients-japanese-health-ministry-approves-bristol-myers-squibb-and-pfizer-s-eliquis-apixaban.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1155/bms-pfizer-stroke-drug-gets-japanese-nod.html</guid>
		</item>	
				<item>
			<title>Takeda ends 3-year-old-deal with Amylin</title>
			<atom:link href="https://biospectrumasia.com/news/50/680/takeda-ends-3-year-old-deal-with-amylin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/680/takeda-ends-3-year-old-deal-with-amylin.html</link>
			<pubDate>Wed, 26 Dec 2012 15:04:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-amylin-terminate-anti-obesity-compound-deal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/680/takeda-ends-3-year-old-deal-with-amylin.html</guid>
		</item>	
				<item>
			<title>Eisai divests rights for Glidael Wafer to Arbor</title>
			<atom:link href="https://biospectrumasia.com/news/50/6005/eisai-divests-rights-for-glidael-wafer-to-arbor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6005/eisai-divests-rights-for-glidael-wafer-to-arbor.html</link>
			<pubDate>Tue, 25 Dec 2012 14:41:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-divests-rights-for-glidael-wafer-to-arbor.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6005/eisai-divests-rights-for-glidael-wafer-to-arbor.html</guid>
		</item>	
				<item>
			<title>Otsuka schizophrenia drug seeks EMA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/1387/otsuka-schizophrenia-drug-seeks-ema-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/1387/otsuka-schizophrenia-drug-seeks-ema-nod.html</link>
			<pubDate>Mon, 24 Dec 2012 12:23:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ema-to-decide-on-whether-to-give-positive-nod-to-otsuka-and-lundbeck-following-their-submission-of-marketing-authorization-application-maa-for-schizophrenia-drug-aripiprazole.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/1387/otsuka-schizophrenia-drug-seeks-ema-nod.html</guid>
		</item>	
				<item>
			<title>ASKLEP joins Medidata partner program </title>
			<atom:link href="https://biospectrumasia.com/news/50/1679/asklep-joins-medidata-partner-program-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1679/asklep-joins-medidata-partner-program-.html</link>
			<pubDate>Thu, 20 Dec 2012 13:28:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1679/asklep-joins-medidata-partner-program-.html</guid>
		</item>	
				<item>
			<title>Astellas completes patient recruitment in drug trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/1318/astellas-completes-patient-recruitment-in-drug-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1318/astellas-completes-patient-recruitment-in-drug-trial.html</link>
			<pubDate>Wed, 19 Dec 2012 11:36:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-patient-recruitment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1318/astellas-completes-patient-recruitment-in-drug-trial.html</guid>
		</item>	
				<item>
			<title>NuVasive spine surgery implant approved in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/312/nuvasive-spine-surgery-implant-approved-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/312/nuvasive-spine-surgery-implant-approved-in-japan.html</link>
			<pubDate>Wed, 19 Dec 2012 10:07:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/312/nuvasive-spine-surgery-implant-approved-in-japan.html</guid>
		</item>	
				<item>
			<title>Global collaborations is the way forward for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/346/global-collaborations-is-the-way-forward-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/346/global-collaborations-is-the-way-forward-for-drug-discovery.html</link>
			<pubDate>Wed, 19 Dec 2012 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/can-india-become-a-global-drug-discovery-collboration-hot-spot.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/346/global-collaborations-is-the-way-forward-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Sun Pharma buys Takeda subsidiary</title>
			<atom:link href="https://biospectrumasia.com/news/50/4763/sun-pharma-buys-takeda-subsidiary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4763/sun-pharma-buys-takeda-subsidiary.html</link>
			<pubDate>Tue, 18 Dec 2012 13:26:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sun-pharma-buys-takeda-subsidiary.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4763/sun-pharma-buys-takeda-subsidiary.html</guid>
		</item>	
				<item>
			<title>Eisai disagrees with IQWiG on epileptic drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/3782/eisai-disagrees-with-iqwig-on-epileptic-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3782/eisai-disagrees-with-iqwig-on-epileptic-drug-.html</link>
			<pubDate>Tue, 18 Dec 2012 13:13:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3782/eisai-disagrees-with-iqwig-on-epileptic-drug-.html</guid>
		</item>	
				<item>
			<title>Teva enters Korean pharmaceutical market</title>
			<atom:link href="https://biospectrumasia.com/news/50/2436/teva-enters-korean-pharmaceutical-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2436/teva-enters-korean-pharmaceutical-market.html</link>
			<pubDate>Mon, 17 Dec 2012 14:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/profit-from-the-jv-will-be-split-51-percent-and-49-percent-between-teva-and-handok-respectively.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2436/teva-enters-korean-pharmaceutical-market.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo generics&#039; unit to launch 5 drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/2524/daiichi-sankyo-generics-unit-to-launch-5-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2524/daiichi-sankyo-generics-unit-to-launch-5-drugs.html</link>
			<pubDate>Mon, 17 Dec 2012 13:36:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-espha-to-launch-five-generic-products-including-quetiapine-and-mosapride-citrate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2524/daiichi-sankyo-generics-unit-to-launch-5-drugs.html</guid>
		</item>	
				<item>
			<title>LCT, Otsuka to co-develop NTCELL for Parkinson&#039;s</title>
			<atom:link href="https://biospectrumasia.com/news/50/2326/lct-otsuka-to-co-develop-ntcell-for-parkinsons.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2326/lct-otsuka-to-co-develop-ntcell-for-parkinsons.html</link>
			<pubDate>Mon, 17 Dec 2012 13:09:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lct-otsuka-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2326/lct-otsuka-to-co-develop-ntcell-for-parkinsons.html</guid>
		</item>	
				<item>
			<title>Point-of-care diagnostics is revolutionary</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/6203/point-of-care-diagnostics-is-revolutionary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/6203/point-of-care-diagnostics-is-revolutionary.html</link>
			<pubDate>Mon, 17 Dec 2012 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/point-of-care-diagnostics-ushering-in-a-paradigm-shift-in-healthcare.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/6203/point-of-care-diagnostics-is-revolutionary.html</guid>
		</item>	
				<item>
			<title>Catalent, UMN collaborate for biosimilars</title>
			<atom:link href="https://biospectrumasia.com/news/50/2525/catalent-umn-collaborate-for-biosimilars.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2525/catalent-umn-collaborate-for-biosimilars.html</link>
			<pubDate>Fri, 14 Dec 2012 15:33:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/catalent-umn-collaborate-for-biosimilars.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2525/catalent-umn-collaborate-for-biosimilars.html</guid>
		</item>	
				<item>
			<title>Dehaier signs deal with Beijing Kanglian Medicine </title>
			<atom:link href="https://biospectrumasia.com/news/50/4369/dehaier-signs-deal-with-beijing-kanglian-medicine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4369/dehaier-signs-deal-with-beijing-kanglian-medicine-.html</link>
			<pubDate>Fri, 14 Dec 2012 12:41:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dehaier-medical-beijing-kanglian-sign-medical-equipment-procurement-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4369/dehaier-signs-deal-with-beijing-kanglian-medicine-.html</guid>
		</item>	
				<item>
			<title>Eisai, UCL form neuro R&amp;D alliance</title>
			<atom:link href="https://biospectrumasia.com/news/50/3826/eisai-ucl-form-neuro-rd-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3826/eisai-ucl-form-neuro-rd-alliance.html</link>
			<pubDate>Fri, 14 Dec 2012 12:26:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-alzheimer-s-and-parkinson-s-patients-university-college-london-ucl-and-eisai-form-research-alliance-therapeutic-innovation-group-tig.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3826/eisai-ucl-form-neuro-rd-alliance.html</guid>
		</item>	
				<item>
			<title>Eisai, Biogen boost manufacturing in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/2553/eisai-biogen-boost-manufacturing-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2553/eisai-biogen-boost-manufacturing-in-us.html</link>
			<pubDate>Thu, 13 Dec 2012 12:05:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-us-and-biogen-idec-will-jointly-use-the-former-s-facility-in-north-carolina-to-boost-manufacturing.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2553/eisai-biogen-boost-manufacturing-in-us.html</guid>
		</item>	
				<item>
			<title>Australia to grow Chinese anti-cancer fruit </title>
			<atom:link href="https://biospectrumasia.com/news/50/3976/australia-to-grow-chinese-anti-cancer-fruit-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3976/australia-to-grow-chinese-anti-cancer-fruit-.html</link>
			<pubDate>Thu, 13 Dec 2012 09:18:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/uq-in-talks-to-commercialise-chinese-red-bayberry-fruit.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3976/australia-to-grow-chinese-anti-cancer-fruit-.html</guid>
		</item>	
				<item>
			<title>Sucampo gets $15 mn payment from Abbott </title>
			<atom:link href="https://biospectrumasia.com/news/50/663/sucampo-gets-15-mn-payment-from-abbott-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/663/sucampo-gets-15-mn-payment-from-abbott-.html</link>
			<pubDate>Wed, 12 Dec 2012 12:11:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sucampo-pharma-gets-usd15-million-milestone-payment-from-abbott.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/663/sucampo-gets-15-mn-payment-from-abbott-.html</guid>
		</item>	
				<item>
			<title>FibroGen, Astellas start trial of anemia therapeutic agent</title>
			<atom:link href="https://biospectrumasia.com/news/50/4039/fibrogen-astellas-start-trial-of-anemia-therapeutic-agent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4039/fibrogen-astellas-start-trial-of-anemia-therapeutic-agent.html</link>
			<pubDate>Wed, 12 Dec 2012 11:47:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-fibrogen-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4039/fibrogen-astellas-start-trial-of-anemia-therapeutic-agent.html</guid>
		</item>	
				<item>
			<title>Eisai gets 6 months US exclusivity for Aciphex</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2928/eisai-gets-6-months-us-exclusivity-for-aciphex.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2928/eisai-gets-6-months-us-exclusivity-for-aciphex.html</link>
			<pubDate>Wed, 12 Dec 2012 10:41:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-gets-pediatric-exclusivity-for-aciphex-rabreprazole-sodium-after-meeting-all-written-request-requirements-of-the-fda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2928/eisai-gets-6-months-us-exclusivity-for-aciphex.html</guid>
		</item>	
				<item>
			<title>Scottish body approves Fycompa by Eisai</title>
			<atom:link href="https://biospectrumasia.com/news/50/1619/scottish-body-approves-fycompa-by-eisai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1619/scottish-body-approves-fycompa-by-eisai.html</link>
			<pubDate>Tue, 11 Dec 2012 11:36:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scottish-medicines-consortium-eisai.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1619/scottish-body-approves-fycompa-by-eisai.html</guid>
		</item>	
				<item>
			<title>Japan gives patent for Medgenics IFNa pump</title>
			<atom:link href="https://biospectrumasia.com/news/50/3267/japan-gives-patent-for-medgenics-ifna-pump.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3267/japan-gives-patent-for-medgenics-ifna-pump.html</link>
			<pubDate>Fri, 07 Dec 2012 13:33:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medgenics-gets-key-claim-protecting-the-use-of-infradure-from-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3267/japan-gives-patent-for-medgenics-ifna-pump.html</guid>
		</item>	
				<item>
			<title>Genmab in research deal with Kyowa Hakko Kirin</title>
			<atom:link href="https://biospectrumasia.com/news/50/526/genmab-in-research-deal-with-kyowa-hakko-kirin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/526/genmab-in-research-deal-with-kyowa-hakko-kirin.html</link>
			<pubDate>Fri, 07 Dec 2012 11:06:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-collaboration-genmab.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/526/genmab-in-research-deal-with-kyowa-hakko-kirin.html</guid>
		</item>	
				<item>
			<title>DIA executive director calls it quits</title>
			<atom:link href="https://biospectrumasia.com/news/50/6809/dia-executive-director-calls-it-quits.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6809/dia-executive-director-calls-it-quits.html</link>
			<pubDate>Thu, 06 Dec 2012 13:00:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-paul-pomerantz-to-quit-as-executive-director-of-dia-on-march-3-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6809/dia-executive-director-calls-it-quits.html</guid>
		</item>	
				<item>
			<title>Takara Bio enters deal with Invivoscribe</title>
			<atom:link href="https://biospectrumasia.com/news/50/318/takara-bio-enters-deal-with-invivoscribe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/318/takara-bio-enters-deal-with-invivoscribe.html</link>
			<pubDate>Thu, 06 Dec 2012 12:00:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene-mutation-test-takara-bio-invivoscribe-technologies.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/318/takara-bio-enters-deal-with-invivoscribe.html</guid>
		</item>	
				<item>
			<title>Chugai, Nippon Shinyaku tie up for drug development</title>
			<atom:link href="https://biospectrumasia.com/news/50/2018/chugai-nippon-shinyaku-tie-up-for-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2018/chugai-nippon-shinyaku-tie-up-for-drug-development.html</link>
			<pubDate>Thu, 06 Dec 2012 11:12:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-development-chugai-nippon-shinyaku.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2018/chugai-nippon-shinyaku-tie-up-for-drug-development.html</guid>
		</item>	
				<item>
			<title>FDA accepts Astellas&#039; NDA for organ rejection drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/1844/fda-accepts-astellas-nda-for-organ-rejection-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1844/fda-accepts-astellas-nda-for-organ-rejection-drug.html</link>
			<pubDate>Wed, 05 Dec 2012 12:55:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-accepts-nda-for-tacrolimus-extended-release-capsules.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1844/fda-accepts-astellas-nda-for-organ-rejection-drug.html</guid>
		</item>	
				<item>
			<title>US FDA to grant priority review to Eisai&#039;s AcipHex</title>
			<atom:link href="https://biospectrumasia.com/news/50/2421/us-fda-to-grant-priority-review-to-eisais-aciphex.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2421/us-fda-to-grant-priority-review-to-eisais-aciphex.html</link>
			<pubDate>Mon, 03 Dec 2012 10:19:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-review-eisai-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2421/us-fda-to-grant-priority-review-to-eisais-aciphex.html</guid>
		</item>	
				<item>
			<title>Telemedicine is revolutionizing healthcare access </title>
			<atom:link href="https://biospectrumasia.com/analysis/50/1797/telemedicine-is-revolutionizing-healthcare-access-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/1797/telemedicine-is-revolutionizing-healthcare-access-.html</link>
			<pubDate>Fri, 30 Nov 2012 15:01:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wireless-technologies-and-cloud-based-solutions-are-fueling-telemedicine-in-asia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/1797/telemedicine-is-revolutionizing-healthcare-access-.html</guid>
		</item>	
				<item>
			<title>BS Survey: Healthcare is getting smarter in Asia</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2787/bs-survey-healthcare-is-getting-smarter-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2787/bs-survey-healthcare-is-getting-smarter-in-asia.html</link>
			<pubDate>Fri, 30 Nov 2012 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum-smart-healthcare-2012.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2787/bs-survey-healthcare-is-getting-smarter-in-asia.html</guid>
		</item>	
				<item>
			<title>AVEO, Astellas cancer drug gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/626/aveo-astellas-cancer-drug-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/626/aveo-astellas-cancer-drug-gets-fda-nod.html</link>
			<pubDate>Thu, 29 Nov 2012 16:58:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-nod-for-aveo-and-astellas-renal-carcinoma-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/626/aveo-astellas-cancer-drug-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>Orient, NanoCarrier sign deal for Nanoplatin trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/8272/orient-nanocarrier-sign-deal-for-nanoplatin-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8272/orient-nanocarrier-sign-deal-for-nanoplatin-trial.html</link>
			<pubDate>Thu, 29 Nov 2012 13:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-nanocarrier-orient.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8272/orient-nanocarrier-sign-deal-for-nanoplatin-trial.html</guid>
		</item>	
				<item>
			<title>Sanofi gets 3rd rank on Access to Medicine Index</title>
			<atom:link href="https://biospectrumasia.com/news/50/5836/sanofi-gets-3rd-rank-on-access-to-medicine-index.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5836/sanofi-gets-3rd-rank-on-access-to-medicine-index.html</link>
			<pubDate>Thu, 29 Nov 2012 11:00:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gsk-j-j-sanofi-secure-the-top-3-ranks-in-2012-access-to-medicine-index.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5836/sanofi-gets-3rd-rank-on-access-to-medicine-index.html</guid>
		</item>	
				<item>
			<title>Sucampo, Abbott launch Amitiza in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/961/sucampo-abbott-launch-amitiza-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/961/sucampo-abbott-launch-amitiza-in-japan.html</link>
			<pubDate>Wed, 28 Nov 2012 10:23:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amitiza-sucampo-abbott-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/961/sucampo-abbott-launch-amitiza-in-japan.html</guid>
		</item>	
				<item>
			<title>Astellas boosts neglected diseases research</title>
			<atom:link href="https://biospectrumasia.com/news/50/6597/astellas-boosts-neglected-diseases-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6597/astellas-boosts-neglected-diseases-research.html</link>
			<pubDate>Tue, 27 Nov 2012 12:11:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-collaboration-astellas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6597/astellas-boosts-neglected-diseases-research.html</guid>
		</item>	
				<item>
			<title>Ospens enters distribution deal with Japanese firm</title>
			<atom:link href="https://biospectrumasia.com/news/50/1533/ospens-enters-distribution-deal-with-japanese-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1533/ospens-enters-distribution-deal-with-japanese-firm.html</link>
			<pubDate>Mon, 26 Nov 2012 14:22:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ospens-distribution-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1533/ospens-enters-distribution-deal-with-japanese-firm.html</guid>
		</item>	
				<item>
			<title>Takeda establishes global medical affairs dept in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1652/takeda-establishes-global-medical-affairs-dept-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1652/takeda-establishes-global-medical-affairs-dept-in-japan.html</link>
			<pubDate>Mon, 26 Nov 2012 11:11:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1652/takeda-establishes-global-medical-affairs-dept-in-japan.html</guid>
		</item>	
				<item>
			<title>CRO survey: India, China dominate market</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/4686/cro-survey-india-china-dominate-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/4686/cro-survey-india-china-dominate-market.html</link>
			<pubDate>Sat, 24 Nov 2012 20:14:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4th-annual-biospectrum-cmr-survey-of-contract-and-clinical-research-organizations-cro-2012.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/4686/cro-survey-india-china-dominate-market.html</guid>
		</item>	
				<item>
			<title>BioDiem granted Japanese patent for BDM-1</title>
			<atom:link href="https://biospectrumasia.com/news/50/1296/biodiem-granted-japanese-patent-for-bdm-1.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1296/biodiem-granted-japanese-patent-for-bdm-1.html</link>
			<pubDate>Fri, 23 Nov 2012 13:30:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biodiem-gets-japanese-patent-for-vulvovaginitis-drug-molecule-bdm-i.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1296/biodiem-granted-japanese-patent-for-bdm-1.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher enters into agreement Fujirebio</title>
			<atom:link href="https://biospectrumasia.com/news/50/458/thermo-fisher-enters-into-agreement-fujirebio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/458/thermo-fisher-enters-into-agreement-fujirebio.html</link>
			<pubDate>Wed, 21 Nov 2012 18:07:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thermo-fisher-enters-into-agreement-fujirebio.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/458/thermo-fisher-enters-into-agreement-fujirebio.html</guid>
		</item>	
				<item>
			<title>Hitachi Aloka launches advanced versatile ultrasound</title>
			<atom:link href="https://biospectrumasia.com/news/50/4812/hitachi-aloka-launches-advanced-versatile-ultrasound.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4812/hitachi-aloka-launches-advanced-versatile-ultrasound.html</link>
			<pubDate>Wed, 21 Nov 2012 17:25:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hitachi-aloka-medical-launches-noblus-ultrasound.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4812/hitachi-aloka-launches-advanced-versatile-ultrasound.html</guid>
		</item>	
				<item>
			<title>Orexo re-submits NDA for cancer pain killer in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3109/orexo-re-submits-nda-for-cancer-pain-killer-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3109/orexo-re-submits-nda-for-cancer-pain-killer-in-japan.html</link>
			<pubDate>Mon, 19 Nov 2012 14:43:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-patients-suffering-from-cancer-pain-orexo-s-partner-kyowa-hakko-kirin-re-submitts-nda-for-abstral-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3109/orexo-re-submits-nda-for-cancer-pain-killer-in-japan.html</guid>
		</item>	
				<item>
			<title>Oxford Immunotec TB test gets nod in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3477/oxford-immunotec-tb-test-gets-nod-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3477/oxford-immunotec-tb-test-gets-nod-in-japan.html</link>
			<pubDate>Mon, 19 Nov 2012 14:11:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oxford-immunotec-t-spot.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3477/oxford-immunotec-tb-test-gets-nod-in-japan.html</guid>
		</item>	
				<item>
			<title>Hitachi mRNA assay to target personalized medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/1771/hitachi-mrna-assay-to-target-personalized-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1771/hitachi-mrna-assay-to-target-personalized-medicine.html</link>
			<pubDate>Mon, 19 Nov 2012 13:33:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hitachi-develops-mrna-quantitative-assay-hem-a-system.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1771/hitachi-mrna-assay-to-target-personalized-medicine.html</guid>
		</item>	
				<item>
			<title>Daiichi seeks approval for influenza antiviral in Japan</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/507/daiichi-seeks-approval-for-influenza-antiviral-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/507/daiichi-seeks-approval-for-influenza-antiviral-in-japan.html</link>
			<pubDate>Mon, 19 Nov 2012 10:12:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-seeks-inavir-approval.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/507/daiichi-seeks-approval-for-influenza-antiviral-in-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi  to launch Inavir anti-influenza product in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2029/daiichi-to-launch-inavir-anti-influenza-product-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2029/daiichi-to-launch-inavir-anti-influenza-product-in-japan.html</link>
			<pubDate>Fri, 16 Nov 2012 14:24:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-new-for-influenza-patients-daiichi-sankyo-to-launch-inavir-dry-powder-inhaler-in-japan.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2029/daiichi-to-launch-inavir-anti-influenza-product-in-japan.html</guid>
		</item>	
				<item>
			<title>Otsuka, Abdi Ã„Â°brahim start joint venture in Turkey</title>
			<atom:link href="https://biospectrumasia.com/news/50/4366/otsuka-abdi-brahim-start-joint-venture-in-turkey.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4366/otsuka-abdi-brahim-start-joint-venture-in-turkey.html</link>
			<pubDate>Fri, 16 Nov 2012 12:29:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/otsuka-abdi-ibrahim-joint-venture.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4366/otsuka-abdi-brahim-start-joint-venture-in-turkey.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s center among Chicago&#039;s top 100 workplaces </title>
			<atom:link href="https://biospectrumasia.com/news/50/746/takedas-center-among-chicagos-top-100-workplaces-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/746/takedas-center-among-chicagos-top-100-workplaces-.html</link>
			<pubDate>Wed, 14 Nov 2012 11:45:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/746/takedas-center-among-chicagos-top-100-workplaces-.html</guid>
		</item>	
				<item>
			<title>HMT opens office in US</title>
			<atom:link href="https://biospectrumasia.com/news/50/8076/hmt-opens-office-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8076/hmt-opens-office-in-us.html</link>
			<pubDate>Tue, 13 Nov 2012 07:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hmt-opens-office-in-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8076/hmt-opens-office-in-us.html</guid>
		</item>	
				<item>
			<title>Japan, Korea lead in stem cell race</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/3223/japan-korea-lead-in-stem-cell-race.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/3223/japan-korea-lead-in-stem-cell-race.html</link>
			<pubDate>Mon, 12 Nov 2012 00:32:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/3223/japan-korea-lead-in-stem-cell-race.html</guid>
		</item>	
				<item>
			<title>RIKEN&#039;s new chip detects traces of miRNA in only 20 mins</title>
			<atom:link href="https://biospectrumasia.com/news/50/759/rikens-new-chip-detects-traces-of-mirna-in-only-20-mins.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/759/rikens-new-chip-detects-traces-of-mirna-in-only-20-mins.html</link>
			<pubDate>Fri, 09 Nov 2012 12:28:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/759/rikens-new-chip-detects-traces-of-mirna-in-only-20-mins.html</guid>
		</item>	
				<item>
			<title>Human Metabolome Technologies opens US office</title>
			<atom:link href="https://biospectrumasia.com/news/50/4279/human-metabolome-technologies-opens-us-office.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4279/human-metabolome-technologies-opens-us-office.html</link>
			<pubDate>Fri, 09 Nov 2012 10:42:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/human-metabolome-technologies-us-office.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4279/human-metabolome-technologies-opens-us-office.html</guid>
		</item>	
				<item>
			<title>Daiichi seeks approval of Topotecin use in children</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2999/daiichi-seeks-approval-of-topotecin-use-in-children.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2999/daiichi-seeks-approval-of-topotecin-use-in-children.html</link>
			<pubDate>Fri, 09 Nov 2012 10:26:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-approval-daiichi-sankyo.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2999/daiichi-seeks-approval-of-topotecin-use-in-children.html</guid>
		</item>	
				<item>
			<title>LG  to co-develop biosimilars with Mochida </title>
			<atom:link href="https://biospectrumasia.com/news/50/1453/lg-to-co-develop-biosimilars-with-mochida-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1453/lg-to-co-develop-biosimilars-with-mochida-.html</link>
			<pubDate>Wed, 07 Nov 2012 14:38:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lg-life-sciences-and-mochida-pharma-join-hands-for-biosimilar-development-in-s-korea-and-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1453/lg-to-co-develop-biosimilars-with-mochida-.html</guid>
		</item>	
				<item>
			<title>Covagen to collaborate with Mitsubishi for research</title>
			<atom:link href="https://biospectrumasia.com/news/50/4140/covagen-to-collaborate-with-mitsubishi-for-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4140/covagen-to-collaborate-with-mitsubishi-for-research.html</link>
			<pubDate>Wed, 07 Nov 2012 11:49:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-collaboration-mitsubishi-tanabe-covagen.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4140/covagen-to-collaborate-with-mitsubishi-for-research.html</guid>
		</item>	
				<item>
			<title>Otsuka, Pioneer form alliance to develop endoscope</title>
			<atom:link href="https://biospectrumasia.com/news/50/6208/otsuka-pioneer-form-alliance-to-develop-endoscope.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6208/otsuka-pioneer-form-alliance-to-develop-endoscope.html</link>
			<pubDate>Wed, 07 Nov 2012 11:10:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alliance-otsuka-pioneer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6208/otsuka-pioneer-form-alliance-to-develop-endoscope.html</guid>
		</item>	
				<item>
			<title>Study shows Lipitor well-tolerated among Asians</title>
			<atom:link href="https://biospectrumasia.com/news/50/1232/study-shows-lipitor-well-tolerated-among-asians.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1232/study-shows-lipitor-well-tolerated-among-asians.html</link>
			<pubDate>Wed, 07 Nov 2012 10:33:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chinese-sfda-approves-activiews-product.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1232/study-shows-lipitor-well-tolerated-among-asians.html</guid>
		</item>	
				<item>
			<title>Takeda to acquire Envoy Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/3091/takeda-to-acquire-envoy-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3091/takeda-to-acquire-envoy-therapeutics.html</link>
			<pubDate>Wed, 07 Nov 2012 10:16:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-acquire-envoy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3091/takeda-to-acquire-envoy-therapeutics.html</guid>
		</item>	
				<item>
			<title>Astellas Pharma launches new vaccine in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/2383/astellas-pharma-launches-new-vaccine-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2383/astellas-pharma-launches-new-vaccine-in-japan-.html</link>
			<pubDate>Tue, 06 Nov 2012 12:15:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vaccine-launch-japan-astellas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2383/astellas-pharma-launches-new-vaccine-in-japan-.html</guid>
		</item>	
				<item>
			<title>Shimadzu pharma summit concurs that innovation is the key</title>
			<atom:link href="https://biospectrumasia.com/news/50/1621/shimadzu-pharma-summit-concurs-that-innovation-is-the-key.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1621/shimadzu-pharma-summit-concurs-that-innovation-is-the-key.html</link>
			<pubDate>Fri, 02 Nov 2012 13:04:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shimadzu.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1621/shimadzu-pharma-summit-concurs-that-innovation-is-the-key.html</guid>
		</item>	
				<item>
			<title>Millennium and Takeda get EU approval for cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/6392/millennium-and-takeda-get-eu-approval-for-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6392/millennium-and-takeda-get-eu-approval-for-cancer-drug-.html</link>
			<pubDate>Thu, 01 Nov 2012 14:35:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/millennium-and-takeda-get-eu-approval-for-cancer-drug-adcetris-brentuximab-vedotin.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6392/millennium-and-takeda-get-eu-approval-for-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Takeda submits plea for cetilistat approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/4013/takeda-submits-plea-for-cetilistat-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/4013/takeda-submits-plea-for-cetilistat-approval-in-japan.html</link>
			<pubDate>Wed, 31 Oct 2012 11:18:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/obesity-treatment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/4013/takeda-submits-plea-for-cetilistat-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai collaborates with Brazilian agency for vaccines</title>
			<atom:link href="https://biospectrumasia.com/news/50/3523/eisai-collaborates-with-brazilian-agency-for-vaccines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3523/eisai-collaborates-with-brazilian-agency-for-vaccines.html</link>
			<pubDate>Wed, 31 Oct 2012 10:37:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-vaccine-research-collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3523/eisai-collaborates-with-brazilian-agency-for-vaccines.html</guid>
		</item>	
				<item>
			<title>Japanese, Thai institutes sign bio-conservation MoU</title>
			<atom:link href="https://biospectrumasia.com/news/50/888/japanese-thai-institutes-sign-bio-conservation-mou.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/888/japanese-thai-institutes-sign-bio-conservation-mou.html</link>
			<pubDate>Tue, 30 Oct 2012 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-kanyawim-kirtikara-executive-director-biotec-l-and-professor-itaru-yasui-president-nite-r-during-the-signing-of-the-mou.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/888/japanese-thai-institutes-sign-bio-conservation-mou.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo enrolls patients for edoxaban trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/3890/daiichi-sankyo-enrolls-patients-for-edoxaban-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3890/daiichi-sankyo-enrolls-patients-for-edoxaban-trial.html</link>
			<pubDate>Tue, 30 Oct 2012 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/edoxaban-clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3890/daiichi-sankyo-enrolls-patients-for-edoxaban-trial.html</guid>
		</item>	
				<item>
			<title>Japan approves Humira for Crohn&#039;s disease patients</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/1820/japan-approves-humira-for-crohns-disease-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/1820/japan-approves-humira-for-crohns-disease-patients.html</link>
			<pubDate>Tue, 30 Oct 2012 10:24:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-approves-humira.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/1820/japan-approves-humira-for-crohns-disease-patients.html</guid>
		</item>	
				<item>
			<title>AnGes, Mitsubishi Tanabe sign MoU  to market Collategene</title>
			<atom:link href="https://biospectrumasia.com/news/50/407/anges-mitsubishi-tanabe-sign-mou-to-market-collategene.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/407/anges-mitsubishi-tanabe-sign-mou-to-market-collategene.html</link>
			<pubDate>Mon, 29 Oct 2012 17:17:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/anges-mitsubishi-tanabe-join-hands-for-the-marketing-rights-of-collategene-in-the-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/407/anges-mitsubishi-tanabe-sign-mou-to-market-collategene.html</guid>
		</item>	
				<item>
			<title>EMA to review marketing plea for antipsychotic medication</title>
			<atom:link href="https://biospectrumasia.com/news/50/726/ema-to-review-marketing-plea-for-antipsychotic-medication.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/726/ema-to-review-marketing-plea-for-antipsychotic-medication.html</link>
			<pubDate>Mon, 29 Oct 2012 17:15:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ema-marketing-authorization-application.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/726/ema-to-review-marketing-plea-for-antipsychotic-medication.html</guid>
		</item>	
				<item>
			<title>Zoll establishes Japanese subsidiary</title>
			<atom:link href="https://biospectrumasia.com/news/50/635/zoll-establishes-japanese-subsidiary.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/635/zoll-establishes-japanese-subsidiary.html</link>
			<pubDate>Mon, 29 Oct 2012 13:32:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/635/zoll-establishes-japanese-subsidiary.html</guid>
		</item>	
				<item>
			<title>Shimadzu India aims at 15-20% growth </title>
			<atom:link href="https://biospectrumasia.com/influencers/50/2104/shimadzu-india-aims-at-15-20-growth-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/50/2104/shimadzu-india-aims-at-15-20-growth-.html</link>
			<pubDate>Mon, 29 Oct 2012 07:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-senya-imamichi-md-shimadzu-analytical-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/50/2104/shimadzu-india-aims-at-15-20-growth-.html</guid>
		</item>	
				<item>
			<title>There must be another way&#039;- thought  iPS cell guru Shinya Yamanaka</title>
			<atom:link href="https://biospectrumasia.com/influencers/50/2347/there-must-be-another-way-thought-ips-cell-guru-shinya-yamanaka.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/50/2347/there-must-be-another-way-thought-ips-cell-guru-shinya-yamanaka.html</link>
			<pubDate>Thu, 25 Oct 2012 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-shinya-yamanaka-creator-of-ips-cell-and-co-winner-of-the-the-2012-nobel-prize-in-physiology-or-medicine.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/50/2347/there-must-be-another-way-thought-ips-cell-guru-shinya-yamanaka.html</guid>
		</item>	
				<item>
			<title>Sysmex gets FDA nod for XN hematology analyzers</title>
			<atom:link href="https://biospectrumasia.com/news/50/7798/sysmex-gets-fda-nod-for-xn-hematology-analyzers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7798/sysmex-gets-fda-nod-for-xn-hematology-analyzers.html</link>
			<pubDate>Wed, 24 Oct 2012 12:43:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sysmex-gets-fda-nod-for-xn-hematology-analyzers.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7798/sysmex-gets-fda-nod-for-xn-hematology-analyzers.html</guid>
		</item>	
				<item>
			<title>Alnylam, Genzyme enter gene silencing deal</title>
			<atom:link href="https://biospectrumasia.com/news/50/3329/alnylam-genzyme-enter-gene-silencing-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3329/alnylam-genzyme-enter-gene-silencing-deal.html</link>
			<pubDate>Tue, 23 Oct 2012 09:03:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alnylam-genzyme-enter-rnai-alliance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3329/alnylam-genzyme-enter-gene-silencing-deal.html</guid>
		</item>	
				<item>
			<title>Influenza can get worse with every season</title>
			<atom:link href="https://biospectrumasia.com/news/50/5892/influenza-can-get-worse-with-every-season.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5892/influenza-can-get-worse-with-every-season.html</link>
			<pubDate>Tue, 23 Oct 2012 08:35:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/seasonal-influenza-boosts-vaccines-market.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5892/influenza-can-get-worse-with-every-season.html</guid>
		</item>	
				<item>
			<title>Museum gets $250,000 from Takeda to train teachers</title>
			<atom:link href="https://biospectrumasia.com/news/50/2555/museum-gets-250000-from-takeda-to-train-teachers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2555/museum-gets-250000-from-takeda-to-train-teachers.html</link>
			<pubDate>Tue, 23 Oct 2012 08:25:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/museum-gets-usd250-000-from-takeda-to-train-teachers.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2555/museum-gets-250000-from-takeda-to-train-teachers.html</guid>
		</item>	
				<item>
			<title>Pfizer trial of cancer drug INLYTA is a failure</title>
			<atom:link href="https://biospectrumasia.com/news/50/3633/pfizer-trial-of-cancer-drug-inlyta-is-a-failure.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3633/pfizer-trial-of-cancer-drug-inlyta-is-a-failure.html</link>
			<pubDate>Mon, 22 Oct 2012 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bad-news-for-cancer-patients-pfizer-inlyta-axitinib-fails-to-meet-primary-endpoint-in-advanced-renal-cell-carcinoma-phase-iii-trials.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3633/pfizer-trial-of-cancer-drug-inlyta-is-a-failure.html</guid>
		</item>	
				<item>
			<title>10 pharma giants join hands to speed up drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/50/2315/10-pharma-giants-join-hands-to-speed-up-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2315/10-pharma-giants-join-hands-to-speed-up-drug-discovery.html</link>
			<pubDate>Thu, 18 Oct 2012 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/abbott-astrazeneca-boehringer-bms-eli-lilly-gsk-j-j-pfizer-roche-and-sanofi-join-hands-to-form-transcelerate-biopharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2315/10-pharma-giants-join-hands-to-speed-up-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Daiichi develops antibody to prevent fracture </title>
			<atom:link href="https://biospectrumasia.com/news/50/3066/daiichi-develops-antibody-to-prevent-fracture-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3066/daiichi-develops-antibody-to-prevent-fracture-.html</link>
			<pubDate>Tue, 16 Oct 2012 11:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/new-human-monoclonal-antibody-by-daiichi-sankyo-denosumab-reduces-or-prevents-vertebral-fractures.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3066/daiichi-develops-antibody-to-prevent-fracture-.html</guid>
		</item>	
				<item>
			<title>Shinogi starts supply of Pirespa to Ildong</title>
			<atom:link href="https://biospectrumasia.com/news/50/1126/shinogi-starts-supply-of-pirespa-to-ildong.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1126/shinogi-starts-supply-of-pirespa-to-ildong.html</link>
			<pubDate>Tue, 16 Oct 2012 10:34:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shinogi-supply-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1126/shinogi-starts-supply-of-pirespa-to-ildong.html</guid>
		</item>	
				<item>
			<title>Kyoto University gets patents for iPS cell technology</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3050/kyoto-university-gets-patents-for-ips-cell-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3050/kyoto-university-gets-patents-for-ips-cell-technology.html</link>
			<pubDate>Thu, 11 Oct 2012 12:22:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patent-ips-cell-technology.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3050/kyoto-university-gets-patents-for-ips-cell-technology.html</guid>
		</item>	
				<item>
			<title>Eisai dissolves Palma Bee&#039;Z Research Institute</title>
			<atom:link href="https://biospectrumasia.com/news/50/3254/eisai-dissolves-palma-beez-research-institute.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3254/eisai-dissolves-palma-beez-research-institute.html</link>
			<pubDate>Thu, 11 Oct 2012 10:20:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3254/eisai-dissolves-palma-beez-research-institute.html</guid>
		</item>	
				<item>
			<title>Chugai to invest $160 mn in Singapore</title>
			<atom:link href="https://biospectrumasia.com/influencers/50/3925/chugai-to-invest-160-mn-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/50/3925/chugai-to-invest-160-mn-in-singapore.html</link>
			<pubDate>Thu, 11 Oct 2012 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-osamu-nagayama-chairman-president-and-ceo-chugai.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/50/3925/chugai-to-invest-160-mn-in-singapore.html</guid>
		</item>	
				<item>
			<title>Kane Biotech issued new patent in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6360/kane-biotech-issued-new-patent-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6360/kane-biotech-issued-new-patent-in-japan.html</link>
			<pubDate>Wed, 10 Oct 2012 16:05:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kane-biotech-japan-patent.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6360/kane-biotech-issued-new-patent-in-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi pays Pieris for developing Anticalin</title>
			<atom:link href="https://biospectrumasia.com/news/50/3506/daiichi-pays-pieris-for-developing-anticalin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3506/daiichi-pays-pieris-for-developing-anticalin.html</link>
			<pubDate>Wed, 10 Oct 2012 12:08:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-makes-first-milestone-payment-to-pieris-for-anticalin-discovery-and-development-collaboration.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3506/daiichi-pays-pieris-for-developing-anticalin.html</guid>
		</item>	
				<item>
			<title>Japan patent office upheld claims in gene silencing trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/6014/japan-patent-office-upheld-claims-in-gene-silencing-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6014/japan-patent-office-upheld-claims-in-gene-silencing-trial.html</link>
			<pubDate>Wed, 10 Oct 2012 11:41:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bad-news-for-bio-think-tank-alnylam-s-claims-are-upheld-by-japanese-patent-office-in-tuschl-ii-patent-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6014/japan-patent-office-upheld-claims-in-gene-silencing-trial.html</guid>
		</item>	
				<item>
			<title>Protein A chromatography resin for purification of antibody drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/4421/protein-a-chromatography-resin-for-purification-of-antibody-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4421/protein-a-chromatography-resin-for-purification-of-antibody-drugs.html</link>
			<pubDate>Tue, 09 Oct 2012 18:17:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4421/protein-a-chromatography-resin-for-purification-of-antibody-drugs.html</guid>
		</item>	
				<item>
			<title>Germany seeks closer partnership with Japan in biopharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/1949/germany-seeks-closer-partnership-with-japan-in-biopharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1949/germany-seeks-closer-partnership-with-japan-in-biopharma.html</link>
			<pubDate>Tue, 09 Oct 2012 11:37:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/german-representatives-will-outline-business-opportunities-for-japanese-executives-in-the-pharmaceutical-and-diagnostic-fields-in-biojapan-2012.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1949/germany-seeks-closer-partnership-with-japan-in-biopharma.html</guid>
		</item>	
				<item>
			<title>Japanese stem cell researcher wins 2012 Nobel in medicine</title>
			<atom:link href="https://biospectrumasia.com/news/50/2898/japanese-stem-cell-researcher-wins-2012-nobel-in-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2898/japanese-stem-cell-researcher-wins-2012-nobel-in-medicine.html</link>
			<pubDate>Mon, 08 Oct 2012 18:09:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-shinya-yamanaka-is-the-co-winner-of-the-2012-nobel-prize-in-physiology-or-medicine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2898/japanese-stem-cell-researcher-wins-2012-nobel-in-medicine.html</guid>
		</item>	
				<item>
			<title>Transcu appoints banking veteran as group CEO</title>
			<atom:link href="https://biospectrumasia.com/news/50/6776/transcu-appoints-banking-veteran-as-group-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6776/transcu-appoints-banking-veteran-as-group-ceo.html</link>
			<pubDate>Mon, 08 Oct 2012 14:38:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ceo-transcu.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6776/transcu-appoints-banking-veteran-as-group-ceo.html</guid>
		</item>	
				<item>
			<title>Takeda R&amp;D filed 7 NDAs in the last 8 months</title>
			<atom:link href="https://biospectrumasia.com/news/50/2842/takeda-rd-filed-7-ndas-in-the-last-8-months.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2842/takeda-rd-filed-7-ndas-in-the-last-8-months.html</link>
			<pubDate>Fri, 05 Oct 2012 12:01:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-r-d-filed-7-ndas-for-blood-pressure-and-diabetes-in-the-last-8-months-in-asia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2842/takeda-rd-filed-7-ndas-in-the-last-8-months.html</guid>
		</item>	
				<item>
			<title>Takeda to acquire LigoCyte Pharmaceuticals</title>
			<atom:link href="https://biospectrumasia.com/news/50/2577/takeda-to-acquire-ligocyte-pharmaceuticals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2577/takeda-to-acquire-ligocyte-pharmaceuticals.html</link>
			<pubDate>Fri, 05 Oct 2012 10:18:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ligocyte-vaccine-candidate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2577/takeda-to-acquire-ligocyte-pharmaceuticals.html</guid>
		</item>	
				<item>
			<title>Theravance, Alfa Wassermann collaborate</title>
			<atom:link href="https://biospectrumasia.com/news/50/1669/theravance-alfa-wassermann-collaborate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1669/theravance-alfa-wassermann-collaborate.html</link>
			<pubDate>Thu, 04 Oct 2012 13:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/theravance-and-alfa-wassermann-sign-agreement-for-velusetrag-theravance-s-investigational-5-ht4-agonist-in-development-for-gastrointestinal-motility-disorders.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1669/theravance-alfa-wassermann-collaborate.html</guid>
		</item>	
				<item>
			<title>Sankyo halts phase III trial of cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/3884/sankyo-halts-phase-iii-trial-of-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3884/sankyo-halts-phase-iii-trial-of-cancer-drug.html</link>
			<pubDate>Thu, 04 Oct 2012 11:34:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sankyo-s-phase-iii-marquee-cancer-trial-is-stopped.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3884/sankyo-halts-phase-iii-trial-of-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Advinus gets $36 mn research funding from Takeda</title>
			<atom:link href="https://biospectrumasia.com/news/50/1505/advinus-gets-36-mn-research-funding-from-takeda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1505/advinus-gets-36-mn-research-funding-from-takeda.html</link>
			<pubDate>Wed, 03 Oct 2012 16:46:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/done-deal-takeda-will-receive-commercial-rights-to-drug-candidates-and-advinus-will-receive-research-funding-of-usd36-million.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1505/advinus-gets-36-mn-research-funding-from-takeda.html</guid>
		</item>	
				<item>
			<title>NDA for Lundbeck&#039;s vortioxetine with US FDA</title>
			<atom:link href="https://biospectrumasia.com/news/50/4062/nda-for-lundbecks-vortioxetine-with-us-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4062/nda-for-lundbecks-vortioxetine-with-us-fda.html</link>
			<pubDate>Wed, 03 Oct 2012 10:21:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antidepressant.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4062/nda-for-lundbecks-vortioxetine-with-us-fda.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo to reorganize supply chain business </title>
			<atom:link href="https://biospectrumasia.com/news/50/8335/daiichi-sankyo-to-reorganize-supply-chain-business-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8335/daiichi-sankyo-to-reorganize-supply-chain-business-.html</link>
			<pubDate>Tue, 02 Oct 2012 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-to-reorganize-daiichi-sankyo-propharma-daiichi-sankyo-chemical-pharma-and-daiichi-sankyo-logistics-into-two-companies-by-2015.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8335/daiichi-sankyo-to-reorganize-supply-chain-business-.html</guid>
		</item>	
				<item>
			<title>Deal with Janssen gets Astellas $65 million up-front</title>
			<atom:link href="https://biospectrumasia.com/news/50/143/deal-with-janssen-gets-astellas-65-million-up-front.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/143/deal-with-janssen-gets-astellas-65-million-up-front.html</link>
			<pubDate>Tue, 02 Oct 2012 09:18:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-payment-from-janssen.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/143/deal-with-janssen-gets-astellas-65-million-up-front.html</guid>
		</item>	
				<item>
			<title>Medtronic starts trial of renal denervation system in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1157/medtronic-starts-trial-of-renal-denervation-system-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1157/medtronic-starts-trial-of-renal-denervation-system-in-japan.html</link>
			<pubDate>Tue, 02 Oct 2012 06:34:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/files-drug-development.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1157/medtronic-starts-trial-of-renal-denervation-system-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai overhauls production management structure </title>
			<atom:link href="https://biospectrumasia.com/news/50/4518/eisai-overhauls-production-management-structure-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4518/eisai-overhauls-production-management-structure-.html</link>
			<pubDate>Mon, 01 Oct 2012 12:07:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-introduces-demand-chain-units-and-core-function-units.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4518/eisai-overhauls-production-management-structure-.html</guid>
		</item>	
				<item>
			<title>Japan approves NDA for hyperlipidemia drug </title>
			<atom:link href="https://biospectrumasia.com/news/50/3060/japan-approves-nda-for-hyperlipidemia-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3060/japan-approves-nda-for-hyperlipidemia-drug-.html</link>
			<pubDate>Mon, 01 Oct 2012 10:39:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nda-lotriga-approved-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3060/japan-approves-nda-for-hyperlipidemia-drug-.html</guid>
		</item>	
				<item>
			<title>Teijin, Pulmagen enter agreement for asthma drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/7743/teijin-pulmagen-enter-agreement-for-asthma-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7743/teijin-pulmagen-enter-agreement-for-asthma-drug.html</link>
			<pubDate>Fri, 28 Sep 2012 10:37:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/teijin-pulmagen-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7743/teijin-pulmagen-enter-agreement-for-asthma-drug.html</guid>
		</item>	
				<item>
			<title>Takeda selected for Dow Jones social responsibility index</title>
			<atom:link href="https://biospectrumasia.com/news/50/7902/takeda-selected-for-dow-jones-social-responsibility-index.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7902/takeda-selected-for-dow-jones-social-responsibility-index.html</link>
			<pubDate>Thu, 27 Sep 2012 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-is-selected-for-dow-jones-sustainability-asia-pacific-index-for-its-social-responsibility-initiatives.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7902/takeda-selected-for-dow-jones-social-responsibility-index.html</guid>
		</item>	
				<item>
			<title>Eisai&#039;s UK manufacturing plant gets EU license</title>
			<atom:link href="https://biospectrumasia.com/news/50/4316/eisais-uk-manufacturing-plant-gets-eu-license.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4316/eisais-uk-manufacturing-plant-gets-eu-license.html</link>
			<pubDate>Thu, 27 Sep 2012 09:38:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eu-license-eisai-manufacturing-plant.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4316/eisais-uk-manufacturing-plant-gets-eu-license.html</guid>
		</item>	
				<item>
			<title>Eisai, Santen enter agreement for new ophthalmic drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/6037/eisai-santen-enter-agreement-for-new-ophthalmic-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6037/eisai-santen-enter-agreement-for-new-ophthalmic-drugs.html</link>
			<pubDate>Wed, 26 Sep 2012 15:10:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ophthalmology-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6037/eisai-santen-enter-agreement-for-new-ophthalmic-drugs.html</guid>
		</item>	
				<item>
			<title>Daiichi announces trial results for Prasugrel</title>
			<atom:link href="https://biospectrumasia.com/news/50/4133/daiichi-announces-trial-results-for-prasugrel.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4133/daiichi-announces-trial-results-for-prasugrel.html</link>
			<pubDate>Wed, 26 Sep 2012 13:27:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-daiichi.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4133/daiichi-announces-trial-results-for-prasugrel.html</guid>
		</item>	
				<item>
			<title>Astellas, KEK sign deal for neglected diseases research</title>
			<atom:link href="https://biospectrumasia.com/news/50/6780/astellas-kek-sign-deal-for-neglected-diseases-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6780/astellas-kek-sign-deal-for-neglected-diseases-research.html</link>
			<pubDate>Wed, 26 Sep 2012 10:46:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drugs-infectious-diseases.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6780/astellas-kek-sign-deal-for-neglected-diseases-research.html</guid>
		</item>	
				<item>
			<title>Tablet coating inspection technology developed in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2507/tablet-coating-inspection-technology-developed-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2507/tablet-coating-inspection-technology-developed-in-japan.html</link>
			<pubDate>Tue, 25 Sep 2012 13:51:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sumitomo-electric-industries-and-kwansei-gakuin-university-have-jointly-developed-a-tablet-coating-inspection-technology.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2507/tablet-coating-inspection-technology-developed-in-japan.html</guid>
		</item>	
				<item>
			<title>Chugai seeks approval for anti-cancer agent Avastin in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/6111/chugai-seeks-approval-for-anti-cancer-agent-avastin-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6111/chugai-seeks-approval-for-anti-cancer-agent-avastin-in-japan.html</link>
			<pubDate>Tue, 25 Sep 2012 12:09:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/what-will-japan-do-chugai-seeks-approval-for-anti-cancer-agent-avastin.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6111/chugai-seeks-approval-for-anti-cancer-agent-avastin-in-japan.html</guid>
		</item>	
				<item>
			<title>Debiopharm awards Japanese cancer scientists</title>
			<atom:link href="https://biospectrumasia.com/news/50/4407/debiopharm-awards-japanese-cancer-scientists.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4407/debiopharm-awards-japanese-cancer-scientists.html</link>
			<pubDate>Mon, 24 Sep 2012 14:05:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japanese-scientists-dr-masanobu-oshima-and-dr-shinji-tanaka-get-jca-mauvernay-award-from-the-debiopharm-group.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4407/debiopharm-awards-japanese-cancer-scientists.html</guid>
		</item>	
				<item>
			<title>Handheld hemoglobin testing device wins coveted Stevie award </title>
			<atom:link href="https://biospectrumasia.com/news/50/5977/handheld-hemoglobin-testing-device-wins-coveted-stevie-award-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5977/handheld-hemoglobin-testing-device-wins-coveted-stevie-award-.html</link>
			<pubDate>Mon, 24 Sep 2012 12:55:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/masimo-s-pronto-7-handheld-device-gets-a-2012-gold-stevie-american-business-award-for-the-best-new-product.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5977/handheld-hemoglobin-testing-device-wins-coveted-stevie-award-.html</guid>
		</item>	
				<item>
			<title>Kitasato Daiichi Sankyo to shut animal vaccine unit</title>
			<atom:link href="https://biospectrumasia.com/news/50/2137/kitasato-daiichi-sankyo-to-shut-animal-vaccine-unit.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2137/kitasato-daiichi-sankyo-to-shut-animal-vaccine-unit.html</link>
			<pubDate>Fri, 21 Sep 2012 12:42:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/beginning-of-the-end-daiichi-sankyo-to-close-down-its-animal-vaccine-unit-by-end-of-fy-2013.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2137/kitasato-daiichi-sankyo-to-shut-animal-vaccine-unit.html</guid>
		</item>	
				<item>
			<title>Spectrometry leader BiologicsFocus starts biologics initiative</title>
			<atom:link href="https://biospectrumasia.com/news/50/2625/spectrometry-leader-biologicsfocus-starts-biologics-initiative.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2625/spectrometry-leader-biologicsfocus-starts-biologics-initiative.html</link>
			<pubDate>Thu, 20 Sep 2012 09:10:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2625/spectrometry-leader-biologicsfocus-starts-biologics-initiative.html</guid>
		</item>	
				<item>
			<title>Eisai signs deal with Sabin Vaccine Institute</title>
			<atom:link href="https://biospectrumasia.com/news/50/5286/eisai-signs-deal-with-sabin-vaccine-institute.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5286/eisai-signs-deal-with-sabin-vaccine-institute.html</link>
			<pubDate>Wed, 19 Sep 2012 08:29:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-sabin-institute-agreement-vaccine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5286/eisai-signs-deal-with-sabin-vaccine-institute.html</guid>
		</item>	
				<item>
			<title>Kyowa Hakko Kirin to return rights of Busulfex</title>
			<atom:link href="https://biospectrumasia.com/news/50/3745/kyowa-hakko-kirin-to-return-rights-of-busulfex.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3745/kyowa-hakko-kirin-to-return-rights-of-busulfex.html</link>
			<pubDate>Mon, 17 Sep 2012 17:08:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-return-rights.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3745/kyowa-hakko-kirin-to-return-rights-of-busulfex.html</guid>
		</item>	
				<item>
			<title>Japan approves pioneering stem cell study for heart disease</title>
			<atom:link href="https://biospectrumasia.com/news/50/606/japan-approves-pioneering-stem-cell-study-for-heart-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/606/japan-approves-pioneering-stem-cell-study-for-heart-disease.html</link>
			<pubDate>Mon, 17 Sep 2012 10:41:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cytori-therapeutics-gets-nod-from-japan-for-stem-cell-treatment-study.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/606/japan-approves-pioneering-stem-cell-study-for-heart-disease.html</guid>
		</item>	
				<item>
			<title>First-of-its-kind stroke symposium concludes in Tokyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/3818/first-of-its-kind-stroke-symposium-concludes-in-tokyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3818/first-of-its-kind-stroke-symposium-concludes-in-tokyo.html</link>
			<pubDate>Fri, 14 Sep 2012 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/first-asia-pacific-symposium-on-stroke-held-in-tokyo-japan-on-september-13-2012.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3818/first-of-its-kind-stroke-symposium-concludes-in-tokyo.html</guid>
		</item>	
				<item>
			<title>Teva appoints new chairman for Japan, South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/1956/teva-appoints-new-chairman-for-japan-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1956/teva-appoints-new-chairman-for-japan-south-korea.html</link>
			<pubDate>Thu, 13 Sep 2012 17:34:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/teva-new-appointment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1956/teva-appoints-new-chairman-for-japan-south-korea.html</guid>
		</item>	
				<item>
			<title>Europe to get new epilepsy drug from Eisai</title>
			<atom:link href="https://biospectrumasia.com/news/50/2865/europe-to-get-new-epilepsy-drug-from-eisai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2865/europe-to-get-new-epilepsy-drug-from-eisai.html</link>
			<pubDate>Thu, 13 Sep 2012 10:27:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-anti-epileptic-pill1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2865/europe-to-get-new-epilepsy-drug-from-eisai.html</guid>
		</item>	
				<item>
			<title>Leading CMO to increase customer base in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/999/leading-cmo-to-increase-customer-base-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/999/leading-cmo-to-increase-customer-base-in-japan.html</link>
			<pubDate>Thu, 13 Sep 2012 10:25:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/999/leading-cmo-to-increase-customer-base-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda builds $96 mn production plant in Russia </title>
			<atom:link href="https://biospectrumasia.com/news/50/4221/takeda-builds-96-mn-production-plant-in-russia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4221/takeda-builds-96-mn-production-plant-in-russia-.html</link>
			<pubDate>Tue, 11 Sep 2012 15:31:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-spends-close-to-a-billion-dollars-to-construct-24-000-m2-production-plant-at-yaroslavl-russia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4221/takeda-builds-96-mn-production-plant-in-russia-.html</guid>
		</item>	
				<item>
			<title>Manchester United signs Toshiba for club&#039;s medical equipment</title>
			<atom:link href="https://biospectrumasia.com/news/50/4178/manchester-united-signs-toshiba-for-clubs-medical-equipment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4178/manchester-united-signs-toshiba-for-clubs-medical-equipment.html</link>
			<pubDate>Thu, 06 Sep 2012 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/toshiba-deal-manchester-united.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4178/manchester-united-signs-toshiba-for-clubs-medical-equipment.html</guid>
		</item>	
				<item>
			<title>Pharmacovigilance: A strategic opportunity</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/2310/pharmacovigilance-a-strategic-opportunity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/2310/pharmacovigilance-a-strategic-opportunity.html</link>
			<pubDate>Thu, 06 Sep 2012 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/several-conflicting-trends-have-emerged-in-pharmacovigilance-in-asia-photo-www.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/2310/pharmacovigilance-a-strategic-opportunity.html</guid>
		</item>	
				<item>
			<title>Netzsch acquires Bruker&#039;s thermal analyzer business in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7797/netzsch-acquires-brukers-thermal-analyzer-business-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7797/netzsch-acquires-brukers-thermal-analyzer-business-in-japan.html</link>
			<pubDate>Wed, 05 Sep 2012 14:51:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/netzsch-acquires-bruker-s-thermal-analysis-instruments-business-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7797/netzsch-acquires-brukers-thermal-analyzer-business-in-japan.html</guid>
		</item>	
				<item>
			<title>Otsuka brings best-selling psychotic drug to Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3609/otsuka-brings-best-selling-psychotic-drug-to-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3609/otsuka-brings-best-selling-psychotic-drug-to-japan.html</link>
			<pubDate>Wed, 05 Sep 2012 12:01:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antipsychotic-drug-abilify-launched-as-adjunctive-therapy-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3609/otsuka-brings-best-selling-psychotic-drug-to-japan.html</guid>
		</item>	
				<item>
			<title>South Korea approves Halaven for breast cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/3136/south-korea-approves-halaven-for-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3136/south-korea-approves-halaven-for-breast-cancer.html</link>
			<pubDate>Wed, 05 Sep 2012 11:12:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-halaven-south-korea.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3136/south-korea-approves-halaven-for-breast-cancer.html</guid>
		</item>	
				<item>
			<title>Takeda gets go ahead for teduglutide in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/50/2254/takeda-gets-go-ahead-for-teduglutide-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2254/takeda-gets-go-ahead-for-teduglutide-in-europe.html</link>
			<pubDate>Wed, 05 Sep 2012 10:29:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/teduglutide-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2254/takeda-gets-go-ahead-for-teduglutide-in-europe.html</guid>
		</item>	
				<item>
			<title>Ono ties up with BioFocus for drug research</title>
			<atom:link href="https://biospectrumasia.com/news/50/3778/ono-ties-up-with-biofocus-for-drug-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3778/ono-ties-up-with-biofocus-for-drug-research.html</link>
			<pubDate>Tue, 04 Sep 2012 10:28:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ono-biofocus-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3778/ono-ties-up-with-biofocus-for-drug-research.html</guid>
		</item>	
				<item>
			<title>Novartis announces positive results in COPD portfolio trials</title>
			<atom:link href="https://biospectrumasia.com/news/50/4177/novartis-announces-positive-results-in-copd-portfolio-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4177/novartis-announces-positive-results-in-copd-portfolio-trials.html</link>
			<pubDate>Tue, 04 Sep 2012 10:14:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/copd-portfolio-clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4177/novartis-announces-positive-results-in-copd-portfolio-trials.html</guid>
		</item>	
				<item>
			<title>Takeda to collaborate with BC Cancer Agency for new drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/4219/takeda-to-collaborate-with-bc-cancer-agency-for-new-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4219/takeda-to-collaborate-with-bc-cancer-agency-for-new-drugs.html</link>
			<pubDate>Mon, 03 Sep 2012 16:45:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientist-takeda-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4219/takeda-to-collaborate-with-bc-cancer-agency-for-new-drugs.html</guid>
		</item>	
				<item>
			<title>AZ, Takeda, Mitsubishi, Eisai to jointly wipe out H. pylori in Japan</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3303/az-takeda-mitsubishi-eisai-to-jointly-wipe-out-h-pylori-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3303/az-takeda-mitsubishi-eisai-to-jointly-wipe-out-h-pylori-in-japan.html</link>
			<pubDate>Mon, 03 Sep 2012 13:21:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-astrazeneca-mitsubishi-tanabe-and-eisai-join-hands-to-fight-h.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3303/az-takeda-mitsubishi-eisai-to-jointly-wipe-out-h-pylori-in-japan.html</guid>
		</item>	
				<item>
			<title>Plea seeks approval to treat H. pylori gastritis with triple therapy</title>
			<atom:link href="https://biospectrumasia.com/news/50/6216/plea-seeks-approval-to-treat-h-pylori-gastritis-with-triple-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6216/plea-seeks-approval-to-treat-h-pylori-gastritis-with-triple-therapy.html</link>
			<pubDate>Mon, 03 Sep 2012 11:07:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-approval-h-pylori.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6216/plea-seeks-approval-to-treat-h-pylori-gastritis-with-triple-therapy.html</guid>
		</item>	
				<item>
			<title>US FDA approves Xtandi for prostate cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/2486/us-fda-approves-xtandi-for-prostate-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2486/us-fda-approves-xtandi-for-prostate-cancer.html</link>
			<pubDate>Mon, 03 Sep 2012 10:31:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approval-xtandi.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2486/us-fda-approves-xtandi-for-prostate-cancer.html</guid>
		</item>	
				<item>
			<title>How to manage chronic obstructive pulmonary disease (COPD)? </title>
			<atom:link href="https://biospectrumasia.com/news/50/4167/how-to-manage-chronic-obstructive-pulmonary-disease-copd-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4167/how-to-manage-chronic-obstructive-pulmonary-disease-copd-.html</link>
			<pubDate>Mon, 03 Sep 2012 10:06:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/report-on-importance-of-risk-reduction-in-management-of-copd-is-out.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4167/how-to-manage-chronic-obstructive-pulmonary-disease-copd-.html</guid>
		</item>	
				<item>
			<title>Eisai seeks approval for antiepileptic agent in Japan</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/4412/eisai-seeks-approval-for-antiepileptic-agent-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/4412/eisai-seeks-approval-for-antiepileptic-agent-in-japan.html</link>
			<pubDate>Fri, 31 Aug 2012 10:30:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-anti-epileptic-pill.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/4412/eisai-seeks-approval-for-antiepileptic-agent-in-japan.html</guid>
		</item>	
				<item>
			<title>Novartis COPD trial meets primary endpoint</title>
			<atom:link href="https://biospectrumasia.com/news/50/3557/novartis-copd-trial-meets-primary-endpoint.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3557/novartis-copd-trial-meets-primary-endpoint.html</link>
			<pubDate>Thu, 30 Aug 2012 13:24:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-spark-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3557/novartis-copd-trial-meets-primary-endpoint.html</guid>
		</item>	
				<item>
			<title>Noven Pharma files NDA with US FDA</title>
			<atom:link href="https://biospectrumasia.com/news/50/1671/noven-pharma-files-nda-with-us-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1671/noven-pharma-files-nda-with-us-fda.html</link>
			<pubDate>Thu, 30 Aug 2012 13:03:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/noven-files-nda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1671/noven-pharma-files-nda-with-us-fda.html</guid>
		</item>	
				<item>
			<title>Medtronic launches stent system in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3463/medtronic-launches-stent-system-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3463/medtronic-launches-stent-system-in-japan.html</link>
			<pubDate>Thu, 30 Aug 2012 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medtronic-launches-resolute-integritycoronary-stent-system-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3463/medtronic-launches-stent-system-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese firm suspends trial of ArQule candidate</title>
			<atom:link href="https://biospectrumasia.com/news/50/1257/japanese-firm-suspends-trial-of-arqule-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1257/japanese-firm-suspends-trial-of-arqule-candidate.html</link>
			<pubDate>Thu, 30 Aug 2012 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-suspended.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1257/japanese-firm-suspends-trial-of-arqule-candidate.html</guid>
		</item>	
				<item>
			<title>Astellas to have new facility at Takahagi Technology Center</title>
			<atom:link href="https://biospectrumasia.com/news/50/3438/astellas-to-have-new-facility-at-takahagi-technology-center.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3438/astellas-to-have-new-facility-at-takahagi-technology-center.html</link>
			<pubDate>Tue, 28 Aug 2012 15:47:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/facility-astellas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3438/astellas-to-have-new-facility-at-takahagi-technology-center.html</guid>
		</item>	
				<item>
			<title>Mitsubishi and Daiichi Sankyo to launch diabetes drug in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/496/mitsubishi-and-daiichi-sankyo-to-launch-diabetes-drug-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/496/mitsubishi-and-daiichi-sankyo-to-launch-diabetes-drug-in-japan-.html</link>
			<pubDate>Tue, 28 Aug 2012 12:41:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-japanese-diabetics-tenelia-will-be-launched-on-september-10.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/496/mitsubishi-and-daiichi-sankyo-to-launch-diabetes-drug-in-japan-.html</guid>
		</item>	
				<item>
			<title>Eisai cancer drug gets orphan drug designation from Japan </title>
			<atom:link href="https://biospectrumasia.com/news/50/3916/eisai-cancer-drug-gets-orphan-drug-designation-from-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3916/eisai-cancer-drug-gets-orphan-drug-designation-from-japan-.html</link>
			<pubDate>Mon, 27 Aug 2012 12:01:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-s-health-ministry-gives-orphan-drug-designation-to-eisai-s-lenvatinib.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3916/eisai-cancer-drug-gets-orphan-drug-designation-from-japan-.html</guid>
		</item>	
				<item>
			<title>Microfluidics expert becomes Japan S&amp;T agency licensee</title>
			<atom:link href="https://biospectrumasia.com/news/50/8342/microfluidics-expert-becomes-japan-st-agency-licensee.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8342/microfluidics-expert-becomes-japan-st-agency-licensee.html</link>
			<pubDate>Mon, 27 Aug 2012 11:41:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dolomite-granted-license-by-japan-science-and-technology-agency.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8342/microfluidics-expert-becomes-japan-st-agency-licensee.html</guid>
		</item>	
				<item>
			<title>Effient trial by Daiichi, Lilly fails to meet primary endpoint</title>
			<atom:link href="https://biospectrumasia.com/news/50/690/effient-trial-by-daiichi-lilly-fails-to-meet-primary-endpoint.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/690/effient-trial-by-daiichi-lilly-fails-to-meet-primary-endpoint.html</link>
			<pubDate>Mon, 27 Aug 2012 10:53:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bigstock-clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/690/effient-trial-by-daiichi-lilly-fails-to-meet-primary-endpoint.html</guid>
		</item>	
				<item>
			<title>Pfizer, Mylan enter generics deal in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/325/pfizer-mylan-enter-generics-deal-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/325/pfizer-mylan-enter-generics-deal-in-japan.html</link>
			<pubDate>Thu, 23 Aug 2012 12:57:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pfizer-and-mylan-establish-long-term-strategic-collaboration-in-japan.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/325/pfizer-mylan-enter-generics-deal-in-japan.html</guid>
		</item>	
				<item>
			<title>Ariad begins phase I/II trial of ponatinib in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2938/ariad-begins-phase-i-ii-trial-of-ponatinib-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2938/ariad-begins-phase-i-ii-trial-of-ponatinib-in-japan.html</link>
			<pubDate>Thu, 23 Aug 2012 10:43:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-japan-ponatinib.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2938/ariad-begins-phase-i-ii-trial-of-ponatinib-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai subsidiary opens antibody facility in the US</title>
			<atom:link href="https://biospectrumasia.com/news/50/2619/eisai-subsidiary-opens-antibody-facility-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2619/eisai-subsidiary-opens-antibody-facility-in-the-us.html</link>
			<pubDate>Thu, 16 Aug 2012 12:48:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-morphotek-facility.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2619/eisai-subsidiary-opens-antibody-facility-in-the-us.html</guid>
		</item>	
				<item>
			<title>Honeycomb lung treatment Pirespa in South Korea</title>
			<atom:link href="https://biospectrumasia.com/news/50/6527/honeycomb-lung-treatment-pirespa-in-south-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6527/honeycomb-lung-treatment-pirespa-in-south-korea.html</link>
			<pubDate>Wed, 15 Aug 2012 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bigstock-female-doctor-xray-1749974.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6527/honeycomb-lung-treatment-pirespa-in-south-korea.html</guid>
		</item>	
				<item>
			<title>OptiMedica expands footprint in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2126/optimedica-expands-footprint-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2126/optimedica-expands-footprint-in-japan.html</link>
			<pubDate>Wed, 15 Aug 2012 11:09:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/expansion-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2126/optimedica-expands-footprint-in-japan.html</guid>
		</item>	
				<item>
			<title>Cytori system to be used for fistula repair study in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3478/cytori-system-to-be-used-for-fistula-repair-study-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3478/cytori-system-to-be-used-for-fistula-repair-study-in-japan.html</link>
			<pubDate>Mon, 13 Aug 2012 12:39:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-celution.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3478/cytori-system-to-be-used-for-fistula-repair-study-in-japan.html</guid>
		</item>	
				<item>
			<title>Abbott, Eisai receive approval to market Humira</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3070/abbott-eisai-receive-approval-to-market-humira.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3070/abbott-eisai-receive-approval-to-market-humira.html</link>
			<pubDate>Fri, 10 Aug 2012 14:36:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approval-humira-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3070/abbott-eisai-receive-approval-to-market-humira.html</guid>
		</item>	
				<item>
			<title>Fuji Pharma acquires Thai contract manufacturer Olic</title>
			<atom:link href="https://biospectrumasia.com/news/50/5571/fuji-pharma-acquires-thai-contract-manufacturer-olic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5571/fuji-pharma-acquires-thai-contract-manufacturer-olic.html</link>
			<pubDate>Fri, 10 Aug 2012 10:48:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fuji-pharma-olic-acquisition.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5571/fuji-pharma-acquires-thai-contract-manufacturer-olic.html</guid>
		</item>	
				<item>
			<title>Mylan and Pfizer enter deal for EpiPen in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3850/mylan-and-pfizer-enter-deal-for-epipen-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3850/mylan-and-pfizer-enter-deal-for-epipen-in-japan.html</link>
			<pubDate>Wed, 08 Aug 2012 11:22:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pfizer-gets-rights-to-market-mylan-s-epipen.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3850/mylan-and-pfizer-enter-deal-for-epipen-in-japan.html</guid>
		</item>	
				<item>
			<title>Shimadzu extends ultra fast mass spectrometry range</title>
			<atom:link href="https://biospectrumasia.com/news/50/3252/shimadzu-extends-ultra-fast-mass-spectrometry-range.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3252/shimadzu-extends-ultra-fast-mass-spectrometry-range.html</link>
			<pubDate>Wed, 08 Aug 2012 10:18:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3252/shimadzu-extends-ultra-fast-mass-spectrometry-range.html</guid>
		</item>	
				<item>
			<title>Naviscan gets Japan approval for PET</title>
			<atom:link href="https://biospectrumasia.com/news/50/6997/naviscan-gets-japan-approval-for-pet.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6997/naviscan-gets-japan-approval-for-pet.html</link>
			<pubDate>Wed, 01 Aug 2012 13:35:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/naviscan-s-pet-gets-shonin-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6997/naviscan-gets-japan-approval-for-pet.html</guid>
		</item>	
				<item>
			<title>OMRON reports performance for Q1 2012</title>
			<atom:link href="https://biospectrumasia.com/company-results/50/2075/omron-reports-performance-for-q1-2012.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/50/2075/omron-reports-performance-for-q1-2012.html</link>
			<pubDate>Wed, 01 Aug 2012 12:19:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cause-of-concern-omron-s-consolidated-q1-performance-shows-dip.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/50/2075/omron-reports-performance-for-q1-2012.html</guid>
		</item>	
				<item>
			<title>Otsuka launches joint venture in Vietnam</title>
			<atom:link href="https://biospectrumasia.com/news/50/7589/otsuka-launches-joint-venture-in-vietnam.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7589/otsuka-launches-joint-venture-in-vietnam.html</link>
			<pubDate>Wed, 01 Aug 2012 11:59:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/otsuka-joint-venture-to-launch-pocari-sweat-replenishment-drink-in-vietnam.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7589/otsuka-launches-joint-venture-in-vietnam.html</guid>
		</item>	
				<item>
			<title>Takeda resubmits NDA to the US FDA for alogliptin</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3677/takeda-resubmits-nda-to-the-us-fda-for-alogliptin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3677/takeda-resubmits-nda-to-the-us-fda-for-alogliptin.html</link>
			<pubDate>Mon, 30 Jul 2012 11:30:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-receives-resubmissions-of-alogliptin-ndas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3677/takeda-resubmits-nda-to-the-us-fda-for-alogliptin.html</guid>
		</item>	
				<item>
			<title>Snoasis initiates distribution in Japan through Hausten Healthcare</title>
			<atom:link href="https://biospectrumasia.com/news/50/4314/snoasis-initiates-distribution-in-japan-through-hausten-healthcare.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4314/snoasis-initiates-distribution-in-japan-through-hausten-healthcare.html</link>
			<pubDate>Mon, 30 Jul 2012 11:05:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4314/snoasis-initiates-distribution-in-japan-through-hausten-healthcare.html</guid>
		</item>	
				<item>
			<title>Japanese-Thai program to fund three projects</title>
			<atom:link href="https://biospectrumasia.com/news/50/519/japanese-thai-program-to-fund-three-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/519/japanese-thai-program-to-fund-three-projects.html</link>
			<pubDate>Fri, 27 Jul 2012 16:24:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japanese-thai-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/519/japanese-thai-program-to-fund-three-projects.html</guid>
		</item>	
				<item>
			<title>R&amp;D Antibodies gets nod from Japan Patent Office </title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/5688/rd-antibodies-gets-nod-from-japan-patent-office-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/5688/rd-antibodies-gets-nod-from-japan-patent-office-.html</link>
			<pubDate>Fri, 27 Jul 2012 12:51:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-patent-office-gives-notice-of-allowance-for-sepsis-detection-products.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/5688/rd-antibodies-gets-nod-from-japan-patent-office-.html</guid>
		</item>	
				<item>
			<title>Eisai publishes phase III results of anti-seizure drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/7495/eisai-publishes-phase-iii-results-of-anti-seizure-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7495/eisai-publishes-phase-iii-results-of-anti-seizure-drug.html</link>
			<pubDate>Thu, 26 Jul 2012 14:43:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-seizure-patients-eisai-reports-phase-iii-results-of-perampanel.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7495/eisai-publishes-phase-iii-results-of-anti-seizure-drug.html</guid>
		</item>	
				<item>
			<title>Astellas, FHU study finds neurogenesis deficits in schizophrenics</title>
			<atom:link href="https://biospectrumasia.com/news/50/7829/astellas-fhu-study-finds-neurogenesis-deficits-in-schizophrenics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7829/astellas-fhu-study-finds-neurogenesis-deficits-in-schizophrenics.html</link>
			<pubDate>Thu, 26 Jul 2012 12:27:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/study-finds-deficits-in-maturation-steps-of-hippocampus-neurogenesis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7829/astellas-fhu-study-finds-neurogenesis-deficits-in-schizophrenics.html</guid>
		</item>	
				<item>
			<title>Japan scientists pioneer new stem cell technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/370/japan-scientists-pioneer-new-stem-cell-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/370/japan-scientists-pioneer-new-stem-cell-technology.html</link>
			<pubDate>Tue, 24 Jul 2012 15:46:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nims-develop-new-extracellular-matrix-material.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/370/japan-scientists-pioneer-new-stem-cell-technology.html</guid>
		</item>	
				<item>
			<title>Tarceva tablets with Nexavar show no improvement</title>
			<atom:link href="https://biospectrumasia.com/news/50/7287/tarceva-tablets-with-nexavar-show-no-improvement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7287/tarceva-tablets-with-nexavar-show-no-improvement.html</link>
			<pubDate>Tue, 24 Jul 2012 11:02:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7287/tarceva-tablets-with-nexavar-show-no-improvement.html</guid>
		</item>	
				<item>
			<title>Takeda drug gets positive CHMP opinion</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3089/takeda-drug-gets-positive-chmp-opinion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3089/takeda-drug-gets-positive-chmp-opinion.html</link>
			<pubDate>Mon, 23 Jul 2012 13:19:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3089/takeda-drug-gets-positive-chmp-opinion.html</guid>
		</item>	
				<item>
			<title>Siemens renews partnership with Japanese lab solutions firm </title>
			<atom:link href="https://biospectrumasia.com/news/50/3968/siemens-renews-partnership-with-japanese-lab-solutions-firm-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3968/siemens-renews-partnership-with-japanese-lab-solutions-firm-.html</link>
			<pubDate>Fri, 20 Jul 2012 11:30:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sysmex-and-siemens-renew-partnership.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3968/siemens-renews-partnership-with-japanese-lab-solutions-firm-.html</guid>
		</item>	
				<item>
			<title>Pharma companies focus on supply chain in Japan</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/478/pharma-companies-focus-on-supply-chain-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/478/pharma-companies-focus-on-supply-chain-in-japan.html</link>
			<pubDate>Thu, 19 Jul 2012 10:19:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/478/pharma-companies-focus-on-supply-chain-in-japan.html</guid>
		</item>	
				<item>
			<title>St. Jude launches cardiac resynchronization therapy defibrillator</title>
			<atom:link href="https://biospectrumasia.com/news/50/8139/st-jude-launches-cardiac-resynchronization-therapy-defibrillator.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8139/st-jude-launches-cardiac-resynchronization-therapy-defibrillator.html</link>
			<pubDate>Wed, 18 Jul 2012 11:07:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cardiac-defibrillator.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8139/st-jude-launches-cardiac-resynchronization-therapy-defibrillator.html</guid>
		</item>	
				<item>
			<title>Intra-nasal vaccine: Answer to avian influenza threat</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/5829/intra-nasal-vaccine-answer-to-avian-influenza-threat.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/5829/intra-nasal-vaccine-answer-to-avian-influenza-threat.html</link>
			<pubDate>Wed, 18 Jul 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nasal-vaccine-drug-delivery.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/5829/intra-nasal-vaccine-answer-to-avian-influenza-threat.html</guid>
		</item>	
				<item>
			<title>CPhI Japan wins prestigious AEO Excellence Award</title>
			<atom:link href="https://biospectrumasia.com/news/50/2402/cphi-japan-wins-prestigious-aeo-excellence-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2402/cphi-japan-wins-prestigious-aeo-excellence-award.html</link>
			<pubDate>Tue, 17 Jul 2012 10:39:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cphi-japan-wins-aeo-award.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2402/cphi-japan-wins-prestigious-aeo-excellence-award.html</guid>
		</item>	
				<item>
			<title>Chugai expands in Singapore with research institute</title>
			<atom:link href="https://biospectrumasia.com/news/50/1438/chugai-expands-in-singapore-with-research-institute.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1438/chugai-expands-in-singapore-with-research-institute.html</link>
			<pubDate>Mon, 16 Jul 2012 10:05:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chugai-research-institute.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1438/chugai-expands-in-singapore-with-research-institute.html</guid>
		</item>	
				<item>
			<title>Takeda, Affymax announce supply agreement</title>
			<atom:link href="https://biospectrumasia.com/news/50/5268/takeda-affymax-announce-supply-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5268/takeda-affymax-announce-supply-agreement.html</link>
			<pubDate>Fri, 13 Jul 2012 11:23:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/supply-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5268/takeda-affymax-announce-supply-agreement.html</guid>
		</item>	
				<item>
			<title>Verastem enters research collaboration with Eisai</title>
			<atom:link href="https://biospectrumasia.com/news/50/876/verastem-enters-research-collaboration-with-eisai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/876/verastem-enters-research-collaboration-with-eisai.html</link>
			<pubDate>Fri, 13 Jul 2012 11:05:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/876/verastem-enters-research-collaboration-with-eisai.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo to build biopharmaceuticals facility for govt</title>
			<atom:link href="https://biospectrumasia.com/news/50/3752/daiichi-sankyo-to-build-biopharmaceuticals-facility-for-govt.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3752/daiichi-sankyo-to-build-biopharmaceuticals-facility-for-govt.html</link>
			<pubDate>Fri, 13 Jul 2012 10:14:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/investment-daiichi-sankyo.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3752/daiichi-sankyo-to-build-biopharmaceuticals-facility-for-govt.html</guid>
		</item>	
				<item>
			<title>Terumo completes patient enrollment in the US for trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/4300/terumo-completes-patient-enrollment-in-the-us-for-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4300/terumo-completes-patient-enrollment-in-the-us-for-trial.html</link>
			<pubDate>Thu, 12 Jul 2012 11:26:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-temura.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4300/terumo-completes-patient-enrollment-in-the-us-for-trial.html</guid>
		</item>	
				<item>
			<title>Shionogi-ViiV Healthcare announces trial results of dolutegravir</title>
			<atom:link href="https://biospectrumasia.com/news/50/3058/shionogi-viiv-healthcare-announces-trial-results-of-dolutegravir.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3058/shionogi-viiv-healthcare-announces-trial-results-of-dolutegravir.html</link>
			<pubDate>Wed, 11 Jul 2012 12:16:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shionogi-viiv-healthcare-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3058/shionogi-viiv-healthcare-announces-trial-results-of-dolutegravir.html</guid>
		</item>	
				<item>
			<title>Astellas, XenoPort launch Regnite in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/818/astellas-xenoport-launch-regnite-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/818/astellas-xenoport-launch-regnite-in-japan.html</link>
			<pubDate>Tue, 10 Jul 2012 11:14:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/818/astellas-xenoport-launch-regnite-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai reveals phase III results of breast cancer drug Halaven </title>
			<atom:link href="https://biospectrumasia.com/news/50/3106/eisai-reveals-phase-iii-results-of-breast-cancer-drug-halaven-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3106/eisai-reveals-phase-iii-results-of-breast-cancer-drug-halaven-.html</link>
			<pubDate>Tue, 10 Jul 2012 07:07:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/new-hope-for-breast-cancer-phase-iii-results-of-halaven-revealed.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3106/eisai-reveals-phase-iii-results-of-breast-cancer-drug-halaven-.html</guid>
		</item>	
				<item>
			<title>Shimadzu Asia Pacific appoints new MD</title>
			<atom:link href="https://biospectrumasia.com/news/50/3361/shimadzu-asia-pacific-appoints-new-md.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3361/shimadzu-asia-pacific-appoints-new-md.html</link>
			<pubDate>Mon, 09 Jul 2012 12:08:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kiminobu-imura-shimadzu.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3361/shimadzu-asia-pacific-appoints-new-md.html</guid>
		</item>	
				<item>
			<title>R-Tech Ueno loses case against Takeda</title>
			<atom:link href="https://biospectrumasia.com/news/50/152/r-tech-ueno-loses-case-against-takeda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/152/r-tech-ueno-loses-case-against-takeda.html</link>
			<pubDate>Mon, 09 Jul 2012 11:39:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/152/r-tech-ueno-loses-case-against-takeda.html</guid>
		</item>	
				<item>
			<title>Abbott and Sucampo get nod for AMITIZA in Japan </title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/1105/abbott-and-sucampo-get-nod-for-amitiza-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/1105/abbott-and-sucampo-get-nod-for-amitiza-in-japan-.html</link>
			<pubDate>Mon, 09 Jul 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sucampo-abbott-get-approval-for-amitiza-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/1105/abbott-and-sucampo-get-nod-for-amitiza-in-japan-.html</guid>
		</item>	
				<item>
			<title>Proteus, Otsuka to collaborate on new medicines</title>
			<atom:link href="https://biospectrumasia.com/news/50/2676/proteus-otsuka-to-collaborate-on-new-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2676/proteus-otsuka-to-collaborate-on-new-medicines.html</link>
			<pubDate>Fri, 06 Jul 2012 11:23:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/proteus-otsuka-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2676/proteus-otsuka-to-collaborate-on-new-medicines.html</guid>
		</item>	
				<item>
			<title>Shionogi launches London headquarter</title>
			<atom:link href="https://biospectrumasia.com/news/50/1011/shionogi-launches-london-headquarter.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1011/shionogi-launches-london-headquarter.html</link>
			<pubDate>Fri, 06 Jul 2012 10:03:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shionogi.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1011/shionogi-launches-london-headquarter.html</guid>
		</item>	
				<item>
			<title>Interphex Japan concludes in Tokyo</title>
			<atom:link href="https://biospectrumasia.com/news/50/1635/interphex-japan-concludes-in-tokyo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1635/interphex-japan-concludes-in-tokyo.html</link>
			<pubDate>Thu, 05 Jul 2012 10:43:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/interphex-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1635/interphex-japan-concludes-in-tokyo.html</guid>
		</item>	
				<item>
			<title>ThermoGenesis sells product line to Asahi</title>
			<atom:link href="https://biospectrumasia.com/news/50/583/thermogenesis-sells-product-line-to-asahi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/583/thermogenesis-sells-product-line-to-asahi.html</link>
			<pubDate>Tue, 03 Jul 2012 11:35:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sale-wound-care-line.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/583/thermogenesis-sells-product-line-to-asahi.html</guid>
		</item>	
				<item>
			<title>Sosei completes phase I trial for SO-1105 in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3774/sosei-completes-phase-i-trial-for-so-1105-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3774/sosei-completes-phase-i-trial-for-so-1105-in-japan.html</link>
			<pubDate>Tue, 03 Jul 2012 11:23:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3774/sosei-completes-phase-i-trial-for-so-1105-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan Vaccine begins operation</title>
			<atom:link href="https://biospectrumasia.com/news/50/1048/japan-vaccine-begins-operation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1048/japan-vaccine-begins-operation.html</link>
			<pubDate>Tue, 03 Jul 2012 10:01:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-vaccine-operation.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1048/japan-vaccine-begins-operation.html</guid>
		</item>	
				<item>
			<title>Millennium starts ph III trial for multiple myeloma drug</title>
			<atom:link href="https://biospectrumasia.com/news/50/2087/millennium-starts-ph-iii-trial-for-multiple-myeloma-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2087/millennium-starts-ph-iii-trial-for-multiple-myeloma-drug.html</link>
			<pubDate>Mon, 02 Jul 2012 13:16:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-millennium.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2087/millennium-starts-ph-iii-trial-for-multiple-myeloma-drug.html</guid>
		</item>	
				<item>
			<title>Japan driving innovation in drug delivery devices</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/8018/japan-driving-innovation-in-drug-delivery-devices.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/8018/japan-driving-innovation-in-drug-delivery-devices.html</link>
			<pubDate>Mon, 02 Jul 2012 12:31:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-delivery-device.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/8018/japan-driving-innovation-in-drug-delivery-devices.html</guid>
		</item>	
				<item>
			<title>Eisai, Toyama get marketing approval for iguratimod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2036/eisai-toyama-get-marketing-approval-for-iguratimod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2036/eisai-toyama-get-marketing-approval-for-iguratimod.html</link>
			<pubDate>Mon, 02 Jul 2012 10:36:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rheumatoid-arthritis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2036/eisai-toyama-get-marketing-approval-for-iguratimod.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe to manufacture diabetes drug Tenelia</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/8186/mitsubishi-tanabe-to-manufacture-diabetes-drug-tenelia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/8186/mitsubishi-tanabe-to-manufacture-diabetes-drug-tenelia.html</link>
			<pubDate>Mon, 02 Jul 2012 10:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mitusubishi-tanabe-approval-diabetes-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/8186/mitsubishi-tanabe-to-manufacture-diabetes-drug-tenelia.html</guid>
		</item>	
				<item>
			<title>Japan research foundation names awardees</title>
			<atom:link href="https://biospectrumasia.com/news/50/4041/japan-research-foundation-names-awardees.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4041/japan-research-foundation-names-awardees.html</link>
			<pubDate>Fri, 29 Jun 2012 10:49:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-award.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4041/japan-research-foundation-names-awardees.html</guid>
		</item>	
				<item>
			<title>Infraredx to launch TVC Imaging System in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/8211/infraredx-to-launch-tvc-imaging-system-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8211/infraredx-to-launch-tvc-imaging-system-in-japan.html</link>
			<pubDate>Thu, 28 Jun 2012 12:01:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/infraredx-apponts-nipron-as-distributor-of-tvc-imaging-system-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8211/infraredx-to-launch-tvc-imaging-system-in-japan.html</guid>
		</item>	
				<item>
			<title>Astellas seeks to market enzalutamide in Europe</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/3024/astellas-seeks-to-market-enzalutamide-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/3024/astellas-seeks-to-market-enzalutamide-in-europe.html</link>
			<pubDate>Wed, 27 Jun 2012 10:25:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/3024/astellas-seeks-to-market-enzalutamide-in-europe.html</guid>
		</item>	
				<item>
			<title>Rienso gets marketing authorization in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/50/1746/rienso-gets-marketing-authorization-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1746/rienso-gets-marketing-authorization-in-europe.html</link>
			<pubDate>Tue, 26 Jun 2012 10:58:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approval-marketing-takeda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1746/rienso-gets-marketing-authorization-in-europe.html</guid>
		</item>	
				<item>
			<title>FDA approval for Daiichi Sankyo packaging facility</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/2400/fda-approval-for-daiichi-sankyo-packaging-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/2400/fda-approval-for-daiichi-sankyo-packaging-facility.html</link>
			<pubDate>Tue, 26 Jun 2012 10:35:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approval-daiichi-sankyo-facility.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/2400/fda-approval-for-daiichi-sankyo-packaging-facility.html</guid>
		</item>	
				<item>
			<title>Nexium gets nod in Japan for gastric ulcer</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/4325/nexium-gets-nod-in-japan-for-gastric-ulcer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/4325/nexium-gets-nod-in-japan-for-gastric-ulcer.html</link>
			<pubDate>Mon, 25 Jun 2012 09:55:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nexium-approval-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/4325/nexium-gets-nod-in-japan-for-gastric-ulcer.html</guid>
		</item>	
				<item>
			<title>EMA committee positive on Teduglutide</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/676/ema-committee-positive-on-teduglutide.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/676/ema-committee-positive-on-teduglutide.html</link>
			<pubDate>Mon, 25 Jun 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/676/ema-committee-positive-on-teduglutide.html</guid>
		</item>	
				<item>
			<title>Accuray to expand services in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2658/accuray-to-expand-services-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2658/accuray-to-expand-services-in-japan.html</link>
			<pubDate>Thu, 21 Jun 2012 14:36:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/accuray-tomotherapy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2658/accuray-to-expand-services-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda to stop selling 13 Pfizer products in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3756/takeda-to-stop-selling-13-pfizer-products-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3756/takeda-to-stop-selling-13-pfizer-products-in-japan.html</link>
			<pubDate>Thu, 21 Jun 2012 10:17:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pfizer-takeda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3756/takeda-to-stop-selling-13-pfizer-products-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda strives to enter Europe&#039;s type 2 diabetes market</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/567/takeda-strives-to-enter-europes-type-2-diabetes-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/567/takeda-strives-to-enter-europes-type-2-diabetes-market.html</link>
			<pubDate>Thu, 21 Jun 2012 10:10:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/567/takeda-strives-to-enter-europes-type-2-diabetes-market.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo subsidiary to market products in Venezuela</title>
			<atom:link href="https://biospectrumasia.com/news/50/3340/daiichi-sankyo-subsidiary-to-market-products-in-venezuela.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3340/daiichi-sankyo-subsidiary-to-market-products-in-venezuela.html</link>
			<pubDate>Wed, 20 Jun 2012 10:28:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3340/daiichi-sankyo-subsidiary-to-market-products-in-venezuela.html</guid>
		</item>	
				<item>
			<title>Takeda to stop selling 13 of Pfizer&#039;s drugs</title>
			<atom:link href="https://biospectrumasia.com/news/50/4600/takeda-to-stop-selling-13-of-pfizers-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4600/takeda-to-stop-selling-13-of-pfizers-drugs.html</link>
			<pubDate>Tue, 19 Jun 2012 10:35:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pfizer-to-stop-selling-13-of-pfizer-s-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4600/takeda-to-stop-selling-13-of-pfizers-drugs.html</guid>
		</item>	
				<item>
			<title>Top pharma deals in the last 5 years in APAC</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/909/top-pharma-deals-in-the-last-5-years-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/909/top-pharma-deals-in-the-last-5-years-in-apac.html</link>
			<pubDate>Tue, 19 Jun 2012 07:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deals-top-10.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/909/top-pharma-deals-in-the-last-5-years-in-apac.html</guid>
		</item>	
				<item>
			<title>Big Pharma continues acquisitions</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2244/big-pharma-continues-acquisitions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2244/big-pharma-continues-acquisitions.html</link>
			<pubDate>Tue, 19 Jun 2012 07:32:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/world-pharma-market.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2244/big-pharma-continues-acquisitions.html</guid>
		</item>	
				<item>
			<title>Plasticell appoints Veritas as the exclusive distributor </title>
			<atom:link href="https://biospectrumasia.com/news/50/7553/plasticell-appoints-veritas-as-the-exclusive-distributor-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7553/plasticell-appoints-veritas-as-the-exclusive-distributor-.html</link>
			<pubDate>Mon, 18 Jun 2012 12:43:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/plasticell-appoints-veritas-as-exclusive-distibutor.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7553/plasticell-appoints-veritas-as-the-exclusive-distributor-.html</guid>
		</item>	
				<item>
			<title>Life Tech signs agreement with iPS Academia Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/7344/life-tech-signs-agreement-with-ips-academia-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7344/life-tech-signs-agreement-with-ips-academia-japan.html</link>
			<pubDate>Mon, 18 Jun 2012 09:58:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fat-stem-cell.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7344/life-tech-signs-agreement-with-ips-academia-japan.html</guid>
		</item>	
				<item>
			<title>Sysmex wins performance award in the US</title>
			<atom:link href="https://biospectrumasia.com/news/50/2734/sysmex-wins-performance-award-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2734/sysmex-wins-performance-award-in-the-us.html</link>
			<pubDate>Wed, 13 Jun 2012 11:06:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2734/sysmex-wins-performance-award-in-the-us.html</guid>
		</item>	
				<item>
			<title>Dr Takeshi Iwatsubo gets Takamine Memorial prize</title>
			<atom:link href="https://biospectrumasia.com/news/50/4150/dr-takeshi-iwatsubo-gets-takamine-memorial-prize.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4150/dr-takeshi-iwatsubo-gets-takamine-memorial-prize.html</link>
			<pubDate>Wed, 13 Jun 2012 10:22:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-award.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4150/dr-takeshi-iwatsubo-gets-takamine-memorial-prize.html</guid>
		</item>	
				<item>
			<title>Aricept leads Japan pharma market with $1.81 bn</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/8075/aricept-leads-japan-pharma-market-with-1-81-bn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/8075/aricept-leads-japan-pharma-market-with-1-81-bn.html</link>
			<pubDate>Tue, 12 Jun 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-aricept-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/8075/aricept-leads-japan-pharma-market-with-1-81-bn.html</guid>
		</item>	
				<item>
			<title>Biobanking has attractive prospects in Asia</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/8310/biobanking-has-attractive-prospects-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/8310/biobanking-has-attractive-prospects-in-asia.html</link>
			<pubDate>Tue, 12 Jun 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biobanks-growth-asia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/8310/biobanking-has-attractive-prospects-in-asia.html</guid>
		</item>	
				<item>
			<title>Japan team creates liver from stem cells</title>
			<atom:link href="https://biospectrumasia.com/news/50/4021/japan-team-creates-liver-from-stem-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4021/japan-team-creates-liver-from-stem-cells.html</link>
			<pubDate>Mon, 11 Jun 2012 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/artifcial-human-liver-created-from-induced-pluripotent-stem-cells.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4021/japan-team-creates-liver-from-stem-cells.html</guid>
		</item>	
				<item>
			<title>Sanofi seeks approval for Lyxumia in Japan</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/1777/sanofi-seeks-approval-for-lyxumia-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/1777/sanofi-seeks-approval-for-lyxumia-in-japan.html</link>
			<pubDate>Mon, 11 Jun 2012 13:14:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/1777/sanofi-seeks-approval-for-lyxumia-in-japan.html</guid>
		</item>	
				<item>
			<title>Openvas by Daiichi Sankyo launched in Mexico</title>
			<atom:link href="https://biospectrumasia.com/news/50/3330/openvas-by-daiichi-sankyo-launched-in-mexico.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3330/openvas-by-daiichi-sankyo-launched-in-mexico.html</link>
			<pubDate>Mon, 11 Jun 2012 09:55:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3330/openvas-by-daiichi-sankyo-launched-in-mexico.html</guid>
		</item>	
				<item>
			<title>ReproCELL to launch human iPS-derived neurons</title>
			<atom:link href="https://biospectrumasia.com/news/50/7914/reprocell-to-launch-human-ips-derived-neurons.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7914/reprocell-to-launch-human-ips-derived-neurons.html</link>
			<pubDate>Fri, 08 Jun 2012 15:54:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ips-derived-neurons.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7914/reprocell-to-launch-human-ips-derived-neurons.html</guid>
		</item>	
				<item>
			<title>Takeda acquires URL Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/138/takeda-acquires-url-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/138/takeda-acquires-url-pharma.html</link>
			<pubDate>Fri, 08 Jun 2012 10:18:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-acquires-url-pharma-for-usd800m.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/138/takeda-acquires-url-pharma.html</guid>
		</item>	
				<item>
			<title>Positive results for Otsuka&#039;s MDR-TB treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/7836/positive-results-for-otsukas-mdr-tb-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7836/positive-results-for-otsukas-mdr-tb-treatment.html</link>
			<pubDate>Thu, 07 Jun 2012 13:09:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-otsuka.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7836/positive-results-for-otsukas-mdr-tb-treatment.html</guid>
		</item>	
				<item>
			<title>Astellas invests $140 mn on expansion in the US</title>
			<atom:link href="https://biospectrumasia.com/news/50/2995/astellas-invests-140-mn-on-expansion-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2995/astellas-invests-140-mn-on-expansion-in-the-us.html</link>
			<pubDate>Thu, 07 Jun 2012 11:51:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-invests.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2995/astellas-invests-140-mn-on-expansion-in-the-us.html</guid>
		</item>	
				<item>
			<title>Astellas, Ambit Biosciences begin quizartinib trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/2438/astellas-ambit-biosciences-begin-quizartinib-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2438/astellas-ambit-biosciences-begin-quizartinib-trial.html</link>
			<pubDate>Wed, 06 Jun 2012 11:45:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/blood-cells1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2438/astellas-ambit-biosciences-begin-quizartinib-trial.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe, Cytochroma end agreement</title>
			<atom:link href="https://biospectrumasia.com/news/50/1274/mitsubishi-tanabe-cytochroma-end-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1274/mitsubishi-tanabe-cytochroma-end-agreement.html</link>
			<pubDate>Wed, 06 Jun 2012 11:41:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal-break.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1274/mitsubishi-tanabe-cytochroma-end-agreement.html</guid>
		</item>	
				<item>
			<title>Millennium announces positive results of orteronel study</title>
			<atom:link href="https://biospectrumasia.com/news/50/3773/millennium-announces-positive-results-of-orteronel-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3773/millennium-announces-positive-results-of-orteronel-study.html</link>
			<pubDate>Wed, 06 Jun 2012 09:55:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3773/millennium-announces-positive-results-of-orteronel-study.html</guid>
		</item>	
				<item>
			<title>Innovative dual chamber syringe for pharma market</title>
			<atom:link href="https://biospectrumasia.com/news/50/215/innovative-dual-chamber-syringe-for-pharma-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/215/innovative-dual-chamber-syringe-for-pharma-market.html</link>
			<pubDate>Tue, 05 Jun 2012 14:51:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lyophilized-dual-chamber-prefillable-syringe.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/215/innovative-dual-chamber-syringe-for-pharma-market.html</guid>
		</item>	
				<item>
			<title>Takeda acquires URL Pharma, adds to gout portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/50/4200/takeda-acquires-url-pharma-adds-to-gout-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4200/takeda-acquires-url-pharma-adds-to-gout-portfolio.html</link>
			<pubDate>Tue, 05 Jun 2012 14:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/increase-revenue-takeda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4200/takeda-acquires-url-pharma-adds-to-gout-portfolio.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo reports positive results for tivantinib</title>
			<atom:link href="https://biospectrumasia.com/news/50/3534/daiichi-sankyo-reports-positive-results-for-tivantinib.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3534/daiichi-sankyo-reports-positive-results-for-tivantinib.html</link>
			<pubDate>Mon, 04 Jun 2012 11:27:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-tivantinib1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3534/daiichi-sankyo-reports-positive-results-for-tivantinib.html</guid>
		</item>	
				<item>
			<title>International consortium sequences tomato genome </title>
			<atom:link href="https://biospectrumasia.com/news/50/2049/international-consortium-sequences-tomato-genome-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2049/international-consortium-sequences-tomato-genome-.html</link>
			<pubDate>Fri, 01 Jun 2012 18:22:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tgc-sequences-tomato-genome.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2049/international-consortium-sequences-tomato-genome-.html</guid>
		</item>	
				<item>
			<title>NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/983/novabay-gets-patents-in-australia-nz-japan-for-aganocide-compounds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/983/novabay-gets-patents-in-australia-nz-japan-for-aganocide-compounds.html</link>
			<pubDate>Fri, 01 Jun 2012 17:31:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/granted-novabay-gets-patents-in-australia-nz-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/983/novabay-gets-patents-in-australia-nz-japan-for-aganocide-compounds.html</guid>
		</item>	
				<item>
			<title>Medical devices: A hot segment in Japan</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/2882/medical-devices-a-hot-segment-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/2882/medical-devices-a-hot-segment-in-japan.html</link>
			<pubDate>Fri, 01 Jun 2012 11:32:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-medical-devices.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/2882/medical-devices-a-hot-segment-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai seeks nod for Helicobacter Pylori treatment</title>
			<atom:link href="https://biospectrumasia.com/news/50/738/eisai-seeks-nod-for-helicobacter-pylori-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/738/eisai-seeks-nod-for-helicobacter-pylori-treatment.html</link>
			<pubDate>Fri, 01 Jun 2012 10:52:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-combination-packs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/738/eisai-seeks-nod-for-helicobacter-pylori-treatment.html</guid>
		</item>	
				<item>
			<title>Aged society fuels growth of generics</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/3450/aged-society-fuels-growth-of-generics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/3450/aged-society-fuels-growth-of-generics.html</link>
			<pubDate>Fri, 01 Jun 2012 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/old-age.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/3450/aged-society-fuels-growth-of-generics.html</guid>
		</item>	
				<item>
			<title>Bioscience firms queue up for Japan market</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/3855/bioscience-firms-queue-up-for-japan-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/3855/bioscience-firms-queue-up-for-japan-market.html</link>
			<pubDate>Fri, 01 Jun 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/3855/bioscience-firms-queue-up-for-japan-market.html</guid>
		</item>	
				<item>
			<title>Taiho to start ph III trial in colorectal cancer</title>
			<atom:link href="https://biospectrumasia.com/news/50/1475/taiho-to-start-ph-iii-trial-in-colorectal-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1475/taiho-to-start-ph-iii-trial-in-colorectal-cancer.html</link>
			<pubDate>Thu, 31 May 2012 12:17:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-cell-taiho.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1475/taiho-to-start-ph-iii-trial-in-colorectal-cancer.html</guid>
		</item>	
				<item>
			<title>US-based TriReme looks for big growth in Asia</title>
			<atom:link href="https://biospectrumasia.com/influencers/50/1110/us-based-trireme-looks-for-big-growth-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/50/1110/us-based-trireme-looks-for-big-growth-in-asia.html</link>
			<pubDate>Thu, 31 May 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eitan-konstantino-ceo-trireme-medical1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/50/1110/us-based-trireme-looks-for-big-growth-in-asia.html</guid>
		</item>	
				<item>
			<title>OMRON develops hand gesture recognition technology</title>
			<atom:link href="https://biospectrumasia.com/news/50/4720/omron-develops-hand-gesture-recognition-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4720/omron-develops-hand-gesture-recognition-technology.html</link>
			<pubDate>Wed, 30 May 2012 12:21:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/quite-a-combo-omron-combines-hand-gesture-recognition-technology-with-facial-image-sensing.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4720/omron-develops-hand-gesture-recognition-technology.html</guid>
		</item>	
				<item>
			<title>Takeda drug Azilva launched in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1825/takeda-drug-azilva-launched-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1825/takeda-drug-azilva-launched-in-japan.html</link>
			<pubDate>Tue, 29 May 2012 16:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/azilva-hypertension-takeda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1825/takeda-drug-azilva-launched-in-japan.html</guid>
		</item>	
				<item>
			<title>A time to rethink talent management</title>
			<atom:link href="https://biospectrumasia.com/opinion/50/1009/a-time-to-rethink-talent-management.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/50/1009/a-time-to-rethink-talent-management.html</link>
			<pubDate>Tue, 29 May 2012 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/talent-life-sciences.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/50/1009/a-time-to-rethink-talent-management.html</guid>
		</item>	
				<item>
			<title>Iressa deaths: Japanese High Court rules in favor of AZ </title>
			<atom:link href="https://biospectrumasia.com/news/50/789/iressa-deaths-japanese-high-court-rules-in-favor-of-az-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/789/iressa-deaths-japanese-high-court-rules-in-favor-of-az-.html</link>
			<pubDate>Mon, 28 May 2012 17:07:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/not-guilty-osaka-high-court-rules-in-favor-of-az.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/789/iressa-deaths-japanese-high-court-rules-in-favor-of-az-.html</guid>
		</item>	
				<item>
			<title>Eisai receives positive opinion on epilepsy treatments in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/50/4067/eisai-receives-positive-opinion-on-epilepsy-treatments-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4067/eisai-receives-positive-opinion-on-epilepsy-treatments-in-europe.html</link>
			<pubDate>Mon, 28 May 2012 10:25:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chmp-opinion.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4067/eisai-receives-positive-opinion-on-epilepsy-treatments-in-europe.html</guid>
		</item>	
				<item>
			<title>Takeda to acquire Multilab in Brazil</title>
			<atom:link href="https://biospectrumasia.com/analysis/50/4849/takeda-to-acquire-multilab-in-brazil.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/50/4849/takeda-to-acquire-multilab-in-brazil.html</link>
			<pubDate>Mon, 28 May 2012 07:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/takeda-acquire-multilab-brazil.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/50/4849/takeda-to-acquire-multilab-in-brazil.html</guid>
		</item>	
				<item>
			<title>Sannova gets approval for vitamin K2 syrup</title>
			<atom:link href="https://biospectrumasia.com/news/50/6657/sannova-gets-approval-for-vitamin-k2-syrup.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/6657/sannova-gets-approval-for-vitamin-k2-syrup.html</link>
			<pubDate>Fri, 25 May 2012 14:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-approval-vitamin-k2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/6657/sannova-gets-approval-for-vitamin-k2-syrup.html</guid>
		</item>	
				<item>
			<title>EMA accepts market authorization plea for alogliptin</title>
			<atom:link href="https://biospectrumasia.com/news/50/1316/ema-accepts-market-authorization-plea-for-alogliptin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1316/ema-accepts-market-authorization-plea-for-alogliptin.html</link>
			<pubDate>Fri, 25 May 2012 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1316/ema-accepts-market-authorization-plea-for-alogliptin.html</guid>
		</item>	
				<item>
			<title>Omron launches wireless sleep monitor in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/1527/omron-launches-wireless-sleep-monitor-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1527/omron-launches-wireless-sleep-monitor-in-japan.html</link>
			<pubDate>Thu, 24 May 2012 11:38:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/omron-sleep-monitor.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1527/omron-launches-wireless-sleep-monitor-in-japan.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo, National Cancer Center enter research alliance</title>
			<atom:link href="https://biospectrumasia.com/news/50/2964/daiichi-sankyo-national-cancer-center-enter-research-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2964/daiichi-sankyo-national-cancer-center-enter-research-alliance.html</link>
			<pubDate>Wed, 23 May 2012 09:45:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2964/daiichi-sankyo-national-cancer-center-enter-research-alliance.html</guid>
		</item>	
				<item>
			<title>Isogenica appoints CTC Lab Systems to tap Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/591/isogenica-appoints-ctc-lab-systems-to-tap-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/591/isogenica-appoints-ctc-lab-systems-to-tap-japan.html</link>
			<pubDate>Tue, 22 May 2012 16:04:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/appointment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/591/isogenica-appoints-ctc-lab-systems-to-tap-japan.html</guid>
		</item>	
				<item>
			<title>Shimadzu launches gas chromatograph mass spectrometer</title>
			<atom:link href="https://biospectrumasia.com/news/50/2378/shimadzu-launches-gas-chromatograph-mass-spectrometer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2378/shimadzu-launches-gas-chromatograph-mass-spectrometer.html</link>
			<pubDate>Mon, 21 May 2012 13:17:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/liquid-chromatograph-mass-spectrometer-lcms-8080-photo-business-wire.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2378/shimadzu-launches-gas-chromatograph-mass-spectrometer.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo recruits patients for cancer trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/1703/daiichi-sankyo-recruits-patients-for-cancer-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1703/daiichi-sankyo-recruits-patients-for-cancer-trial.html</link>
			<pubDate>Mon, 21 May 2012 12:49:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patients-recruited-for-phase-iii-cancer-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1703/daiichi-sankyo-recruits-patients-for-cancer-trial.html</guid>
		</item>	
				<item>
			<title>Agenix gets patent protection in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3597/agenix-gets-patent-protection-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3597/agenix-gets-patent-protection-in-japan.html</link>
			<pubDate>Fri, 18 May 2012 12:34:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aginex-patent-protected.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3597/agenix-gets-patent-protection-in-japan.html</guid>
		</item>	
				<item>
			<title>Tivozanib shows superiority over sorafenib in trial</title>
			<atom:link href="https://biospectrumasia.com/news/50/8465/tivozanib-shows-superiority-over-sorafenib-in-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/8465/tivozanib-shows-superiority-over-sorafenib-in-trial.html</link>
			<pubDate>Fri, 18 May 2012 12:20:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kidney-cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/8465/tivozanib-shows-superiority-over-sorafenib-in-trial.html</guid>
		</item>	
				<item>
			<title>Medtronic to help rebuild hospital in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/2519/medtronic-to-help-rebuild-hospital-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/2519/medtronic-to-help-rebuild-hospital-in-japan.html</link>
			<pubDate>Thu, 17 May 2012 15:52:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/grant-tsunami-rebuilding.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/2519/medtronic-to-help-rebuild-hospital-in-japan.html</guid>
		</item>	
				<item>
			<title>First semi-rigid heart ring implanted in man</title>
			<atom:link href="https://biospectrumasia.com/news/50/5204/first-semi-rigid-heart-ring-implanted-in-man.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5204/first-semi-rigid-heart-ring-implanted-in-man.html</link>
			<pubDate>Thu, 17 May 2012 10:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-pmda-approves-sorin-heart-ring.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5204/first-semi-rigid-heart-ring-implanted-in-man.html</guid>
		</item>	
				<item>
			<title>Clearbridge wins Â¥3 mn award in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/3447/clearbridge-wins-3-mn-award-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/3447/clearbridge-wins-3-mn-award-in-japan.html</link>
			<pubDate>Wed, 16 May 2012 17:30:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clearbridge-biomedics-wins-2012-asian-entrepreneurhsip-award.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/3447/clearbridge-wins-3-mn-award-in-japan.html</guid>
		</item>	
				<item>
			<title>Furiex, Menarini sign agreement for Priligy</title>
			<atom:link href="https://biospectrumasia.com/news/50/4280/furiex-menarini-sign-agreement-for-priligy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4280/furiex-menarini-sign-agreement-for-priligy.html</link>
			<pubDate>Tue, 15 May 2012 13:17:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tie-up.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4280/furiex-menarini-sign-agreement-for-priligy.html</guid>
		</item>	
				<item>
			<title>FDA panel approves new obesity drug, Eisai to market it</title>
			<atom:link href="https://biospectrumasia.com/news/50/1073/fda-panel-approves-new-obesity-drug-eisai-to-market-it.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1073/fda-panel-approves-new-obesity-drug-eisai-to-market-it.html</link>
			<pubDate>Mon, 14 May 2012 18:22:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/arena-pharmaceuticals-obesity-drug-gets-fda-technical-clearance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1073/fda-panel-approves-new-obesity-drug-eisai-to-market-it.html</guid>
		</item>	
				<item>
			<title>BIOTEC to collaborate with Japanese research body on microbial community</title>
			<atom:link href="https://biospectrumasia.com/news/50/4463/biotec-to-collaborate-with-japanese-research-body-on-microbial-community.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/4463/biotec-to-collaborate-with-japanese-research-body-on-microbial-community.html</link>
			<pubDate>Mon, 14 May 2012 15:51:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/micro-organism.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/4463/biotec-to-collaborate-with-japanese-research-body-on-microbial-community.html</guid>
		</item>	
				<item>
			<title>McCann Healthcare forms new group in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/50/5542/mccann-healthcare-forms-new-group-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/5542/mccann-healthcare-forms-new-group-in-japan.html</link>
			<pubDate>Mon, 14 May 2012 11:57:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/5542/mccann-healthcare-forms-new-group-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda Gemini II trial shows positive results</title>
			<atom:link href="https://biospectrumasia.com/news/50/1266/takeda-gemini-ii-trial-shows-positive-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/1266/takeda-gemini-ii-trial-shows-positive-results.html</link>
			<pubDate>Mon, 14 May 2012 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/1266/takeda-gemini-ii-trial-shows-positive-results.html</guid>
		</item>	
				<item>
			<title>Lorcaserin receives positive vote from FDA advisory committee</title>
			<atom:link href="https://biospectrumasia.com/news/50/132/lorcaserin-receives-positive-vote-from-fda-advisory-committee.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/132/lorcaserin-receives-positive-vote-from-fda-advisory-committee.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/132/lorcaserin-receives-positive-vote-from-fda-advisory-committee.html</guid>
		</item>	
				<item>
			<title>Scil Proteins, Ono collaborate to develop Affilin therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/50/139/scil-proteins-ono-collaborate-to-develop-affilin-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/139/scil-proteins-ono-collaborate-to-develop-affilin-therapeutics.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock-41802454.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/139/scil-proteins-ono-collaborate-to-develop-affilin-therapeutics.html</guid>
		</item>	
				<item>
			<title>Agenix gets patent for ThromboView in Japan</title>
			<atom:link href="https://biospectrumasia.com/regulatory/50/145/agenix-gets-patent-for-thromboview-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/50/145/agenix-gets-patent-for-thromboview-in-japan.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/50/145/agenix-gets-patent-for-thromboview-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda acquires LigoCyte Pharmaceuticals at $60 mn</title>
			<atom:link href="https://biospectrumasia.com/news/50/166/takeda-acquires-ligocyte-pharmaceuticals-at-60-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/166/takeda-acquires-ligocyte-pharmaceuticals-at-60-mn.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/166/takeda-acquires-ligocyte-pharmaceuticals-at-60-mn.html</guid>
		</item>	
				<item>
			<title>BioJapan to kick off in October</title>
			<atom:link href="https://biospectrumasia.com/news/50/192/biojapan-to-kick-off-in-october.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/192/biojapan-to-kick-off-in-october.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bj.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/192/biojapan-to-kick-off-in-october.html</guid>
		</item>	
				<item>
			<title>Takeda to acquire LigoCyte Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/50/200/takeda-to-acquire-ligocyte-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/200/takeda-to-acquire-ligocyte-pharma.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/200/takeda-to-acquire-ligocyte-pharma.html</guid>
		</item>	
				<item>
			<title>FDA approves Eisai&#039;s Fycompa</title>
			<atom:link href="https://biospectrumasia.com/news/50/232/fda-approves-eisais-fycompa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/232/fda-approves-eisais-fycompa.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/232/fda-approves-eisais-fycompa.html</guid>
		</item>	
				<item>
			<title>Terumo and Biosensors to sell Nabori DES system</title>
			<atom:link href="https://biospectrumasia.com/news/50/278/terumo-and-biosensors-to-sell-nabori-des-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/278/terumo-and-biosensors-to-sell-nabori-des-system.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/278/terumo-and-biosensors-to-sell-nabori-des-system.html</guid>
		</item>	
				<item>
			<title>How will Asia tackle total drug resistant TB?</title>
			<atom:link href="https://biospectrumasia.com/news/50/7129/how-will-asia-tackle-total-drug-resistant-tb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/50/7129/how-will-asia-tackle-total-drug-resistant-tb.html</link>
			<pubDate>Fri, 23 Mar 2012 01:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tb-cases-reported-by-the-11-member-states-of-the-who-sea-region-by-type-2005-09.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/50/7129/how-will-asia-tackle-total-drug-resistant-tb.html</guid>
		</item>	
				</channel>
</rss>
